data_2n27_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n27 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.544 0.212 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -54.65 -48.32 72.45 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.528 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -65.62 -40.85 93.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.865 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -62.01 -44.05 97.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.659 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -66.98 -37.57 84.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.988 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.482 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.03 -27.9 65.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.806 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -57.81 -46.9 84.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.525 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 m -77.98 -21.41 50.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.691 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.0 tp -62.41 -42.83 99.73 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.419 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.482 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.3 m-85 -60.15 -51.02 71.4 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.439 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.2 t0 -76.9 -14.32 59.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.872 0.368 . . . . 0.0 111.366 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -45.59 -32.68 2.43 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.805 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 8.8 p-10 -53.72 -46.1 70.71 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.53 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.434 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -144.36 -151.6 5.47 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 30.8 p-10 -72.93 -47.28 47.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.733 0.301 . . . . 0.0 111.106 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.71 107.35 0.28 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 178.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 4.6 m -166.61 139.3 3.74 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.151 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 mp -115.13 109.23 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.6 p -128.72 170.24 13.53 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.882 0.373 . . . . 0.0 110.372 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.603 ' CB ' HE22 ' A' ' 49' ' ' GLN . 67.2 p -64.68 -33.05 75.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.789 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -61.69 -41.45 97.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.395 . . . . 0.0 109.983 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 26' ' ' THR . 90.0 mt-10 -63.4 -45.73 89.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.897 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.9 tp -64.16 -43.3 95.6 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.106 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.81 -26.07 53.5 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.1 m -63.9 -41.45 97.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.885 0.374 . . . . 0.0 110.098 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.1 t -56.23 -23.61 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.365 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.478 ' O ' ' N ' ' A' ' 40' ' ' GLY . 62.3 mmm -48.06 -30.27 4.29 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.667 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -64.36 -45.68 86.71 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 118.077 -1.449 . . . . 0.0 110.999 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -63.95 -21.96 66.71 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.837 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 41' ' ' GLN . 16.8 mt -107.73 3.7 24.87 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.097 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.2 -71.29 0.02 OUTLIER Glycine 0 N--CA 1.465 0.602 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 39' ' ' LEU . 87.8 mt-30 -145.44 109.45 4.83 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 44' ' ' THR . 41.4 t30 -125.56 70.88 65.21 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.091 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.551 ' O ' ' N ' ' A' ' 46' ' ' ALA . 84.7 Cg_exo -33.02 -30.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 122.63 2.22 . . . . 0.0 112.715 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 42' ' ' ASN . 26.3 m -39.27 -30.19 0.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.503 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.419 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.9 mt-10 -86.61 -34.96 19.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.291 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -59.07 -50.04 75.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.834 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.15 -46.07 71.78 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.176 0.512 . . . . 0.0 109.671 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 51' ' ' MET . 84.7 mt -64.87 -31.14 72.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.338 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.603 HE22 ' CB ' ' A' ' 29' ' ' THR . 61.1 tp60 -37.42 -51.29 1.11 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.879 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.31 -40.32 89.89 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.228 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 48' ' ' LEU . 33.1 ttp -62.44 -41.02 98.44 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.934 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.413 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 83.4 mt -61.98 -49.85 82.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.182 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.536 ' O ' ' N ' ' A' ' 57' ' ' ALA . 89.8 m-20 -62.95 -40.46 97.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.56 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -55.18 -61.5 2.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.238 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.92 -30.12 43.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.261 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 62' ' ' THR . 50.6 t0 -84.66 -13.2 52.19 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.568 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -72.02 13.06 0.33 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.859 0.362 . . . . 0.0 110.254 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.8 p30 -65.54 -28.9 69.5 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -150.53 -22.37 0.06 OUTLIER Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.578 ' C ' ' H ' ' A' ' 62' ' ' THR . 3.3 p30 173.17 151.84 0.08 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.93 34.64 0.14 Allowed Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.578 ' H ' ' C ' ' A' ' 60' ' ' ASN . 81.9 p -134.34 149.46 50.86 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.4 mt -120.98 134.48 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.14 162.36 28.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.461 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.473 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -64.61 -48.16 74.56 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.432 -179.045 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 50.2 Cg_exo -51.17 -37.44 58.72 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.195 1.93 . . . . 0.0 111.719 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -87.48 -22.33 24.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.31 -47.25 86.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.014 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.44 -42.94 98.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.543 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.1 m -63.97 -46.08 86.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.672 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.6 ttp -61.66 -47.57 84.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.062 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 82.0 mmm -65.75 -37.82 87.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.275 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.62 -49.97 75.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.01 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -71.46 -43.83 65.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.18 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.69 -43.64 88.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.681 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.434 ' O ' ' O ' ' A' ' 73' ' ' ALA . 22.4 mmm -104.3 127.47 51.94 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.08 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.7 tptt -84.99 141.18 30.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.893 0.378 . . . . 0.0 110.706 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.422 ' O ' ' O ' ' A' ' 77' ' ' LYS . 95.1 m-20 -48.93 179.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.239 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.6 p -75.5 -6.74 51.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.444 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.52 -15.43 62.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.567 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.1 m -61.94 -19.94 63.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.539 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -48.15 -44.71 32.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.374 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.97 -39.51 79.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.913 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.86 -45.15 83.22 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.023 0.439 . . . . 0.0 110.187 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.2 mt -66.1 -19.05 25.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.514 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -58.43 -45.41 88.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.205 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.63 -31.83 73.07 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.916 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -72.04 -14.62 61.92 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.212 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -58.04 -48.96 78.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.292 0.567 . . . . 0.0 111.046 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -64.1 -45.6 87.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.328 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.14 -51.59 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.897 0.379 . . . . 0.0 110.896 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.417 ' CE2' ' CD1' ' A' ' 100' ' ' ILE . 26.3 t80 -61.95 -47.2 85.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.628 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.422 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 18.1 t70 -108.97 94.21 4.93 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.24 -41.03 74.08 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.001 0.429 . . . . 0.0 110.536 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 20.1 p-10 -62.49 -39.75 94.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.021 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.51 -67.34 0.99 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.59 -16.53 63.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.93 0.395 . . . . 0.0 110.25 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.71 162.03 12.57 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.29 155.38 24.17 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.786 0.327 . . . . 0.0 110.247 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.417 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 94.2 mt -79.73 125.99 39.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.978 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.4 p -82.39 169.01 16.94 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.141 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.56 -37.98 89.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.499 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.72 -47.36 83.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.847 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.66 -32.83 72.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.955 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.5 tp -61.59 -41.7 97.81 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.405 0.622 . . . . 0.0 110.68 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -56.42 -43.3 79.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.816 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -58.48 -41.96 86.45 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.62 -43.39 90.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.692 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.1 mmm -62.02 -35.58 79.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.685 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.9 m -61.13 -44.37 97.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.014 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -59.8 -34.96 73.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.382 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.1 tp -61.18 -46.7 89.42 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.121 0.486 . . . . 0.0 110.384 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.47 -160.71 33.43 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -140.55 23.33 2.31 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.634 0.254 . . . . 0.0 110.78 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -63.57 -42.86 98.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.97 0.414 . . . . 0.0 110.24 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.6 mt -92.8 175.85 6.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.996 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.469 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -72.93 161.32 30.84 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.679 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -91.66 -22.5 20.23 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.928 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -87.92 -25.26 23.31 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.152 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.642 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.4 -61.28 0.45 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.141 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.642 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 20.3 m -67.39 -40.18 84.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -56.86 -47.0 81.43 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.521 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -86.02 -40.33 15.9 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.6 tmm? -59.57 -46.52 88.67 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.015 0.436 . . . . 0.0 109.896 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 91.9 mt -69.09 -16.58 20.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.475 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 -78.64 -50.53 11.31 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.085 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 129' ' ' ASP . 42.3 tp10 -87.65 -67.54 0.82 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.071 -0.651 . . . . 0.0 110.861 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.34 -26.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.745 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 127' ' ' GLU . 25.4 t0 -87.98 128.27 35.38 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.061 0.457 . . . . 0.0 111.091 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.536 ' H ' ' CD1' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.47 -43.36 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.442 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -65.4 -40.31 93.25 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.132 0.491 . . . . 0.0 110.15 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.37 -2.0 58.92 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' GLY . 55.2 p-10 -89.47 -8.97 51.78 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 57.44 115.47 0.01 OUTLIER Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.24 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.434 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 20.3 pt20 -160.65 133.6 6.47 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.0 t -123.46 136.96 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.04 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -151.41 172.42 15.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.252 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -54.77 -46.75 74.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.161 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 55.4 mp0 -58.73 -44.37 90.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.639 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 93.3 mt-10 -72.09 -29.33 64.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.753 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.86 -44.02 77.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.631 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 94.3 t -59.1 -46.34 91.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.289 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -69.37 -29.03 66.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.132 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.8 ttp -59.74 -42.82 94.03 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.832 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.49 138.87 50.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.912 0.387 . . . . 0.0 110.745 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 81.4 m -163.29 77.69 0.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.658 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.13 -27.75 68.95 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.451 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.695 -179.882 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.067 0 CA-C-O 120.433 0.159 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -54.78 -50.55 68.21 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.0 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -63.77 -44.08 94.47 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.715 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -62.57 -45.92 90.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.484 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -69.82 -35.72 75.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.923 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.506 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -63.13 -37.78 88.58 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.511 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -58.43 -46.29 86.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.535 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.4 m -80.87 -18.87 45.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.746 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.51 -43.08 98.26 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.792 0.329 . . . . 0.0 111.291 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.9 m-85 -58.06 -49.22 77.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.541 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 6.3 t0 -73.17 -13.43 61.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.693 0.282 . . . . 0.0 111.229 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -44.49 -33.48 1.74 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.965 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.413 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 7.2 p-10 -53.97 -45.67 71.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.858 0.361 . . . . 0.0 110.96 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -149.07 -150.89 5.34 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 24.9 p-10 -70.16 -47.4 61.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.901 0.382 . . . . 0.0 110.983 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.53 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.79 107.84 0.3 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.445 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 6.3 m -166.21 139.5 4.11 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.112 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.2 mp -120.66 110.6 28.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.8 p -130.99 169.33 15.98 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.978 0.418 . . . . 0.0 110.554 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.2 p -63.09 -31.45 72.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.304 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -62.14 -42.37 99.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.978 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.445 ' OE1' ' O ' ' A' ' 26' ' ' THR . 81.4 mt-10 -66.66 -45.9 77.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.004 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.92 -42.9 97.25 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.38 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.81 -25.04 28.52 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.9 m -63.96 -44.15 93.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.865 0.365 . . . . 0.0 110.743 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.2 t -55.54 -20.43 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.521 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.513 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 87.5 mmm -48.97 -34.86 13.85 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.613 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -63.12 -46.39 87.53 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 118.056 -1.458 . . . . 0.0 111.83 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.502 ' HG ' ' N ' ' A' ' 39' ' ' LEU . 39.5 p -60.85 -30.85 70.36 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 41' ' ' GLN . 24.8 mt -96.7 2.04 51.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.046 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.94 -67.91 0.02 OUTLIER Glycine 0 N--CA 1.467 0.743 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 39' ' ' LEU . 86.0 mt-30 -143.6 110.09 5.48 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -123.73 75.05 55.65 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.469 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 46' ' ' ALA . 99.3 Cg_exo -36.4 -35.74 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.743 1.629 . . . . 0.0 112.139 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.8 m -37.84 -31.51 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.734 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.513 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.2 mt-10 -87.34 -35.97 18.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.336 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.52 -51.96 67.68 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -68.4 -47.17 68.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.25 0.548 . . . . 0.0 109.969 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 49' ' ' GLN . 85.0 mt -64.08 -26.8 68.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.967 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 45' ' ' GLU . 58.7 tp60 -38.77 -46.42 1.26 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.72 0.295 . . . . 0.0 110.543 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.13 -41.72 66.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.536 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 40.1 ttp -62.17 -41.73 98.59 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.086 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.94 -51.97 67.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.354 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 57' ' ' ALA . 17.3 m120 -64.35 -40.08 95.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.668 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -55.53 -59.6 4.6 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.266 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.79 -34.42 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.012 0.434 . . . . 0.0 110.756 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 62' ' ' THR . 55.3 t0 -80.76 -13.56 58.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.53 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -72.2 16.12 0.14 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.294 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' A' ' 56' ' ' ASP . 21.5 p-10 -66.04 -24.61 66.77 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -154.58 -25.57 0.04 OUTLIER Glycine 0 C--N 1.337 0.637 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.627 ' C ' ' H ' ' A' ' 62' ' ' THR . 10.9 p30 -179.99 150.84 0.39 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.405 ' C ' ' OD2' ' A' ' 56' ' ' ASP . . . -65.55 32.5 0.13 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.627 ' H ' ' C ' ' A' ' 60' ' ' ASN . 65.7 p -130.46 148.86 52.32 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.1 mt -118.47 133.9 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.069 0.461 . . . . 0.0 110.45 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.34 169.09 18.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.48 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.435 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -67.3 -49.47 43.37 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.212 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.8 Cg_exo -52.08 -45.29 39.91 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.927 1.751 . . . . 0.0 111.925 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.03 -37.01 72.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.661 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -60.58 -46.46 90.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.007 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.8 mt -62.27 -44.29 96.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.861 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.0 m -65.22 -44.61 87.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.916 0.389 . . . . 0.0 110.287 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 44.8 ttp -62.05 -41.91 98.63 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.812 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 76' ' ' MET . 60.2 mmm -63.29 -40.9 98.66 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.598 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.97 -35.81 77.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.778 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -87.76 -56.24 3.43 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.752 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -63.15 -43.27 98.77 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.138 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 72' ' ' MET . 50.8 mmm -108.9 131.56 54.91 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.943 0.401 . . . . 0.0 110.162 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 78' ' ' ASP . 29.0 tptt -83.12 150.07 26.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.792 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 77' ' ' LYS . 5.7 m-20 -55.45 -159.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.481 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.8 p -96.16 -0.3 50.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.479 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -82.87 2.48 34.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.128 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 83' ' ' GLU . 1.6 m -62.07 -35.63 79.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.971 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -37.92 -29.69 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.839 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 81' ' ' SER . 71.5 mm-40 -74.15 -56.85 4.42 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.065 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -64.71 -38.76 92.08 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 85' ' ' ILE . 96.7 mt -58.67 -19.29 14.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.462 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.1 ttt-85 -57.65 -44.04 85.37 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 118.79 -1.164 . . . . 0.0 110.201 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -65.96 -32.99 74.79 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.745 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -63.02 -27.96 69.77 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -55.61 -46.0 77.39 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.358 0.599 . . . . 0.0 110.432 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -74.44 -51.12 15.82 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.779 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.0 t -64.06 -47.92 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.082 0.468 . . . . 0.0 110.57 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.445 ' CB ' ' O ' ' A' ' 88' ' ' ALA . 39.3 t80 -63.41 -45.9 88.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.246 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.487 ' OD2' ' N ' ' A' ' 96' ' ' GLY . 36.0 t70 -127.06 105.06 8.33 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.602 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -68.56 -42.09 78.85 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.935 0.398 . . . . 0.0 111.079 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 97' ' ' ASN . 1.5 p-10 -60.04 -46.59 89.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.801 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.487 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 73.78 -41.81 1.05 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.467 ' H ' ' C ' ' A' ' 95' ' ' ASP . 77.1 m-20 -80.25 -13.56 59.12 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.957 0.408 . . . . 0.0 110.002 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.96 161.22 12.81 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -113.25 149.9 33.17 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.694 0.283 . . . . 0.0 110.475 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.7 mt -96.87 116.55 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.954 0.407 . . . . 0.0 111.177 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.2 p -84.35 170.72 13.34 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.309 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.59 86.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.136 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.17 -47.21 84.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.917 0.389 . . . . 0.0 110.548 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.55 -36.04 75.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.487 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.35 -40.08 95.22 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.619 0.723 . . . . 0.0 110.68 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -52.44 -45.12 65.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.625 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -61.51 -45.13 95.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.057 0.456 . . . . 0.0 110.437 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.85 -44.94 98.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.321 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 48.3 mmm -64.41 -37.07 86.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.457 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 82.6 m -61.08 -46.18 91.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.846 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -67.08 -24.56 65.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.19 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.0 tp -61.47 -44.87 96.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.923 0.392 . . . . 0.0 110.846 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.52 -148.81 15.57 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -140.39 25.92 2.2 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.498 0.19 . . . . 0.0 111.048 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -64.79 -45.35 86.66 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.954 0.407 . . . . 0.0 110.926 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.8 mt -113.55 170.64 8.09 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.991 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.482 ' H ' ' HG1' ' A' ' 117' ' ' THR . 0.8 OUTLIER -69.43 161.54 29.23 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.934 0.397 . . . . 0.0 110.981 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -92.1 -24.0 19.27 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.806 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -88.06 -20.37 25.84 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.67 -67.42 0.16 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.576 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.9 m -64.48 -35.15 73.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -57.69 -66.52 0.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -64.37 -43.71 93.66 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.459 ' C ' ' SD ' ' A' ' 124' ' ' MET . 16.1 tmm? -57.32 -48.69 78.32 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.85 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.24 -23.79 30.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.209 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -77.17 -46.81 22.13 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 119.0 -1.08 . . . . 0.0 111.439 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -85.39 -68.22 0.74 Allowed 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.066 -0.653 . . . . 0.0 111.503 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.0 -33.37 0.08 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.45 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -94.66 146.73 23.94 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.826 0.346 . . . . 0.0 110.722 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.431 ' H ' ' CD1' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -89.36 -17.35 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 179.461 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 133' ' ' ASP . 95.1 m-20 -65.48 -44.47 87.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.051 0.453 . . . . 0.0 110.552 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.44 -11.11 5.64 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 41.1 p-10 -89.08 -19.36 25.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.923 0.392 . . . . 0.0 110.501 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.546 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 55.38 106.12 0.01 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.476 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 11.1 pt20 -140.12 134.75 31.71 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 92.3 t -116.97 132.06 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.96 0.41 . . . . 0.0 110.201 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -142.75 175.41 9.83 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.566 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -58.16 -45.87 86.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.162 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 54.2 mp0 -63.63 -36.87 85.24 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.442 -178.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.476 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 78.3 mt-10 -67.14 -33.92 76.46 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.073 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -61.98 -40.6 96.19 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.45 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.7 t -57.22 -45.74 84.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.513 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -82.84 -15.84 50.02 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.836 0.35 . . . . 0.0 111.217 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 43.8 ttp -60.97 -41.03 95.59 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.906 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 78.2 mtm -118.54 141.69 48.33 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.815 0.341 . . . . 0.0 110.694 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.6 m -159.55 84.51 0.77 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.809 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.7 -40.47 72.85 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.124 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.501 -179.548 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.085 0 CA-C-O 120.766 0.317 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -57.89 -44.61 86.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.483 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -62.66 -45.8 91.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.841 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -63.86 -46.75 83.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.736 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.52 -34.52 77.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.444 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.51 -13.83 61.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.762 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -55.95 -48.96 74.81 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.642 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -71.78 -30.01 65.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.934 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.6 tp -61.31 -42.41 98.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.38 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -60.11 -49.86 75.97 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.032 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 3.5 t70 -76.58 -14.39 60.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.245 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -43.67 -32.79 1.06 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.985 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 24.2 p-10 -53.8 -43.1 69.04 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.196 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -143.81 -155.89 6.6 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 29.1 p-10 -75.29 -47.26 28.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.846 0.355 . . . . 0.0 111.066 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.92 107.36 0.28 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 23.6 m -166.63 155.72 10.88 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.164 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.79 91.1 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.069 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.3 p -98.09 173.02 7.24 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.414 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.4 p -63.55 -32.6 74.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.998 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -62.7 -41.48 99.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.912 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 26' ' ' THR . 83.9 mt-10 -66.73 -44.48 81.43 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.336 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.0 tp -63.19 -45.75 90.28 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.938 0.399 . . . . 0.0 110.66 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -45.96 -25.21 1.6 Allowed Glycine 0 C--O 1.226 -0.377 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.401 ' C ' ' N ' ' A' ' 36' ' ' MET . 14.7 m -63.23 -42.35 99.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.867 0.365 . . . . 0.0 110.026 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 82.6 t -49.46 -18.76 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.285 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.401 ' N ' ' C ' ' A' ' 34' ' ' THR . 89.2 mmm -59.62 -41.01 89.46 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.097 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.5 ttt85 -65.43 -43.87 89.13 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 118.185 -1.406 . . . . 0.0 111.133 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.3 p -58.14 -33.1 68.8 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.852 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 40' ' ' GLY . 91.2 mt -97.33 7.05 47.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.611 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 42.96 97.21 0.01 OUTLIER Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 40' ' ' GLY . 87.0 mt-30 41.12 94.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.687 0.28 . . . . 0.0 110.485 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 44' ' ' THR . 48.8 t30 -130.35 75.68 78.8 Favored Pre-proline 0 N--CA 1.464 0.275 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 46' ' ' ALA . 95.0 Cg_exo -33.93 -26.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.367 2.044 . . . . 0.0 112.668 178.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.58 ' N ' ' O ' ' A' ' 42' ' ' ASN . 80.4 m -38.65 -25.97 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.564 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' PRO . 84.4 mt-10 -89.44 -33.38 16.84 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.499 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -56.58 -53.41 57.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.212 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.414 ' OE1' ' O ' ' A' ' 115' ' ' LYS . 1.5 tm-20 -67.96 -41.39 82.52 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.2 mt -73.02 -14.09 61.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.741 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' A' ' 45' ' ' GLU . 73.4 tp60 -53.08 -47.3 68.64 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -67.05 -37.13 83.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.97 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.0 ttp -60.32 -40.79 91.84 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.27 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.402 HD11 HG23 ' A' ' 52' ' ' ILE . 96.6 mt -62.23 -48.15 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.653 0.263 . . . . 0.0 111.378 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 57' ' ' ALA . 93.6 m-20 -62.03 -39.58 92.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.301 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -55.8 -57.51 11.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.068 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 p -74.92 -29.35 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.274 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 62' ' ' THR . 42.8 t0 -85.15 -12.99 51.52 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.584 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -71.8 2.63 5.12 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.181 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.5 p-10 -52.51 -26.79 14.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -155.64 -27.69 0.03 OUTLIER Glycine 0 C--N 1.339 0.704 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.591 ' C ' ' H ' ' A' ' 62' ' ' THR . 17.7 p30 -177.51 145.71 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.18 36.02 0.09 OUTLIER Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.591 ' H ' ' C ' ' A' ' 60' ' ' ASN . 72.5 p -133.45 152.59 51.93 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.405 HG22 HD12 ' A' ' 63' ' ' ILE . 91.7 mt -122.39 136.39 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.99 0.424 . . . . 0.0 110.253 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.6 OUTLIER -72.64 172.47 10.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.189 -179.464 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.445 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -72.88 -48.73 8.07 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.28 -178.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.9 Cg_exo -53.89 -39.79 83.15 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.279 1.986 . . . . 0.0 111.849 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -76.4 -35.25 58.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.876 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -59.75 -50.29 74.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.066 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -66.27 -42.17 88.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.618 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.9 m -63.43 -48.34 78.2 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.996 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 45.6 ttp -62.82 -44.84 95.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.585 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 42.9 mmm -64.47 -39.54 94.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.703 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.16 -46.26 90.28 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.97 0.414 . . . . 0.0 110.255 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -72.33 -44.64 62.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.335 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -69.6 -46.39 66.41 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.869 0.366 . . . . 0.0 111.644 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 16.3 mmm -101.59 131.06 47.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.671 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 78' ' ' ASP . 48.2 tptt -84.68 148.2 26.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.885 0.374 . . . . 0.0 110.311 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 77' ' ' LYS . 85.7 m-20 -48.85 -179.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.289 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.6 p -80.93 -8.86 59.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.422 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.02 -8.95 49.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.415 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 82' ' ' GLU . 9.4 m -61.01 -25.42 66.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.419 ' O ' ' OH ' ' A' ' 138' ' ' TYR . 82.2 tt0 -37.2 -48.05 0.83 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.759 0.314 . . . . 0.0 110.833 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -71.14 -44.14 66.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.253 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -63.95 -39.01 93.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.019 0.438 . . . . 0.0 110.104 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.3 -23.33 33.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 56.1 ttt-85 -56.89 -43.17 81.03 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 118.698 -1.201 . . . . 0.0 109.848 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -63.11 -34.76 78.3 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.64 -22.28 64.42 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -56.91 -49.81 74.46 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.317 0.579 . . . . 0.0 110.971 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -63.69 -45.99 87.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.992 -1.003 . . . . 0.0 111.309 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.5 t -66.22 -48.39 81.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.975 0.417 . . . . 0.0 110.183 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -64.45 -48.33 75.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.615 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -102.19 102.3 12.71 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.892 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.57 -41.52 88.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.106 0.479 . . . . 0.0 109.893 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -73.25 -42.67 62.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.261 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.75 -51.29 3.06 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -76.39 -14.53 60.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.067 0.46 . . . . 0.0 110.114 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.16 162.42 12.42 Favored Glycine 0 N--CA 1.465 0.592 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -112.13 150.44 30.77 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 95.6 mt -88.42 122.52 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.065 0.46 . . . . 0.0 111.114 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.6 p -88.78 176.39 7.09 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.205 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.5 -36.44 82.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.808 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.71 -52.61 64.96 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.476 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -67.95 -37.44 81.59 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.198 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.8 tp -62.59 -41.29 98.86 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.57 0.7 . . . . 0.0 110.298 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -55.7 -43.5 76.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.711 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -55.84 -41.72 74.71 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.4 t -66.35 -42.55 90.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.651 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 63.7 mmm -60.97 -38.03 84.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.617 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.3 m -61.17 -39.84 91.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.654 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -57.55 -40.21 78.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.558 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.4 tp -62.14 -43.68 98.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 0.0 110.138 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 146.31 -144.77 13.21 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -137.32 28.81 2.76 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.647 0.26 . . . . 0.0 110.403 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.414 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 48.7 mtmt -62.39 -42.06 99.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.218 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.2 mt -95.83 168.26 10.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.154 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.535 ' H ' ' HG1' ' A' ' 117' ' ' THR . 0.2 OUTLIER -63.76 161.7 14.72 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.819 0.342 . . . . 0.0 110.326 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -91.72 -22.42 20.22 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.539 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 120' ' ' GLU . 78.0 tt0 -86.17 -23.95 26.33 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.418 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.606 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -35.78 -64.38 0.31 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.566 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 14.4 m -63.93 -36.74 77.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.544 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -55.88 -66.67 0.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.596 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -69.69 -37.88 76.79 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.434 ' C ' ' SD ' ' A' ' 124' ' ' MET . 16.1 tmm? -59.07 -47.34 85.6 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.598 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.411 HD12 HG21 ' A' ' 125' ' ' ILE . 94.4 mt -70.18 -20.42 22.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.896 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -89.66 -60.24 1.99 Allowed 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.592 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -63.68 -68.34 0.35 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 119.519 -0.873 . . . . 0.0 111.405 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.13 -26.98 0.53 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.42 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -87.76 126.12 34.82 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.028 0.442 . . . . 0.0 111.15 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.413 ' H ' HD11 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -77.31 -23.45 14.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.422 179.255 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -74.95 -41.8 58.89 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.153 0.502 . . . . 0.0 110.004 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.79 2.24 56.44 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 41.7 p-10 -88.13 -18.54 28.57 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.36 111.15 0.04 OUTLIER Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -162.81 139.46 7.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.756 0.312 . . . . 0.0 110.26 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.9 t -126.22 132.98 69.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.182 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -146.73 166.76 25.65 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.187 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.419 ' OH ' ' O ' ' A' ' 82' ' ' GLU . 60.1 t80 -49.35 -37.42 24.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.649 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -59.77 -33.94 72.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.015 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -75.5 -37.06 60.41 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -61.29 -49.77 75.71 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.8 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.5 t -49.39 -48.24 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.42 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -68.91 -39.43 79.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.9 ttp -60.61 -44.73 95.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.768 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.412 ' O ' ' OG1' ' A' ' 146' ' ' THR . 67.1 mtt -89.18 121.18 31.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.898 0.38 . . . . 0.0 110.43 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 145' ' ' MET . 12.1 m -167.36 82.81 0.21 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.47 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.43 -46.2 89.65 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.815 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.456 -179.851 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.592 0.234 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.41 -45.14 55.41 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.488 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -63.05 -44.01 97.07 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.907 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -63.84 -46.52 84.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.293 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -67.38 -43.58 81.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.904 0.383 . . . . 0.0 111.174 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.34 -36.48 80.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.409 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -55.72 -51.07 68.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.975 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -72.77 -23.45 60.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.735 0.302 . . . . 0.0 110.763 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.08 -42.24 99.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.705 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.406 ' O ' ' CD ' ' A' ' 31' ' ' GLU . 79.4 m-85 -59.55 -49.0 79.47 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.169 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.7 t0 -74.81 -13.67 60.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.528 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -43.09 -32.64 0.72 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.998 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 10.9 p-10 -53.3 -45.6 69.04 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.65 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -148.79 -149.18 4.91 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 32.2 p-10 -72.09 -46.89 55.03 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.698 0.285 . . . . 0.0 111.208 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.99 107.57 0.29 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 m -166.0 142.61 5.18 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.099 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.61 108.05 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.4 p -128.39 169.82 13.82 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.965 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.606 ' CG2' HE22 ' A' ' 49' ' ' GLN . 75.7 p -64.77 -32.38 74.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.985 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -62.35 -41.42 98.58 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.579 -0.449 . . . . 0.0 109.901 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.406 ' CD ' ' O ' ' A' ' 19' ' ' PHE . 89.2 mt-10 -63.49 -45.82 88.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.808 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.8 tp -63.87 -45.0 91.39 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.122 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.87 -24.24 7.98 Favored Glycine 0 C--O 1.224 -0.493 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.5 m -64.98 -42.95 94.08 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.256 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.8 t -53.86 -18.23 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.291 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.43 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 91.3 mmm -57.36 -35.35 69.84 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.389 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -63.62 -43.94 95.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 118.004 -1.478 . . . . 0.0 110.148 -178.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.8 p -61.06 -35.76 77.8 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.844 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 41' ' ' GLN . 25.7 mt -96.36 3.61 52.8 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.944 0.402 . . . . 0.0 110.314 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.51 -66.9 0.02 OUTLIER Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 39' ' ' LEU . 80.8 mt-30 -145.05 104.8 4.01 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' A' ' 44' ' ' THR . 50.2 t30 -123.61 73.75 52.87 Favored Pre-proline 0 N--CA 1.466 0.371 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.159 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' A' ' 46' ' ' ALA . 80.4 Cg_exo -35.05 -32.61 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.58 2.186 . . . . 0.0 112.504 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 42' ' ' ASN . 29.1 m -38.25 -31.04 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.593 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 92.5 mt-10 -86.8 -35.89 18.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.327 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -57.44 -49.98 74.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.694 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -70.47 -45.72 65.18 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.141 0.496 . . . . 0.0 109.666 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.62 -31.43 72.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.948 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.606 HE22 ' CG2' ' A' ' 29' ' ' THR . 67.3 tp60 -40.17 -54.79 2.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.681 0.276 . . . . 0.0 110.997 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -63.6 -41.52 98.32 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.722 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.6 ttp -61.26 -38.95 88.55 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.201 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.5 mt -62.94 -46.61 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.329 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 57' ' ' ALA . 92.3 m-20 -62.81 -41.28 99.24 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.838 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -57.88 -57.16 14.01 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.644 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 p -70.45 -29.31 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.156 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 62' ' ' THR . 38.7 t0 -89.13 -12.48 40.93 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.849 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -71.62 13.46 0.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.484 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' A' ' 56' ' ' ASP . 38.9 p-10 -66.81 -28.79 68.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -149.62 -32.12 0.05 OUTLIER Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.643 ' C ' ' H ' ' A' ' 62' ' ' THR . 11.3 p30 -177.11 153.04 0.94 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.551 -0.324 . . . . 0.0 110.202 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.39 30.93 0.1 OUTLIER Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.643 ' H ' ' C ' ' A' ' 60' ' ' ASN . 57.9 p -127.56 146.07 50.64 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.4 mt -116.66 139.74 42.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.652 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.35 176.08 2.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.604 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.516 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -85.67 -46.68 0.6 Allowed Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.667 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 32.4 Cg_exo -55.89 -45.02 41.85 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.272 1.981 . . . . 0.0 111.756 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -70.05 -36.98 75.41 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -57.45 -41.77 81.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.458 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.17 -43.87 98.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.59 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.8 m -64.14 -43.19 96.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.875 0.369 . . . . 0.0 110.365 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 62.1 ttp -59.13 -43.62 92.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.527 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 88.5 mmm -64.83 -38.13 89.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.78 -46.3 84.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -72.88 -45.67 56.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.841 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -64.72 -45.06 88.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.056 0.455 . . . . 0.0 110.537 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 28.6 mmt -93.91 128.07 40.01 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.79 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -85.18 148.26 26.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.307 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -52.96 164.77 0.36 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.357 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 75.4 p -67.19 -21.5 65.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.634 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.13 -7.23 8.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.038 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.6 m -53.47 -34.73 59.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.447 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -38.17 -45.13 0.91 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -69.28 -44.87 70.97 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.008 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.56 -36.48 81.03 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.0 0.428 . . . . 0.0 110.296 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.47 -20.98 24.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -55.58 -45.19 77.43 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 118.758 -1.177 . . . . 0.0 109.539 -177.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -68.07 -33.09 73.89 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.195 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.96 -27.71 69.59 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -57.31 -51.39 69.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.294 0.568 . . . . 0.0 110.94 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -69.36 -45.22 69.9 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.699 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.6 t -68.13 -50.58 57.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.918 0.389 . . . . 0.0 110.769 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -63.39 -47.43 82.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.223 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.408 ' OD2' ' N ' ' A' ' 96' ' ' GLY . 22.5 t0 -110.07 107.63 17.55 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.801 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -68.91 -41.24 78.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.173 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 97' ' ' ASN . 1.1 p-10 -68.63 -37.39 79.68 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.257 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.408 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 67.69 -64.88 0.3 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 95' ' ' ASP . 56.0 m-80 -63.1 -14.38 47.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.958 0.409 . . . . 0.0 110.41 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.57 162.01 12.59 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -112.16 145.64 39.48 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 75.7 mt -83.72 125.08 40.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.038 0.447 . . . . 0.0 111.087 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.7 p -83.68 172.15 12.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.043 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.14 -39.07 92.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.012 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.62 76.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.869 0.366 . . . . 0.0 111.108 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.3 -33.18 74.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.652 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.6 tp -61.91 -43.11 99.52 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.408 0.623 . . . . 0.0 111.257 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -55.52 -43.22 75.54 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.883 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -60.35 -43.96 96.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.102 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 84.2 t -63.2 -45.22 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.695 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 86.7 mmm -63.61 -37.46 87.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.337 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 m -60.75 -41.02 94.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.603 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -55.5 -28.38 54.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.011 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.8 tp -60.88 -43.39 98.5 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.035 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 152.8 -141.76 8.71 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -137.58 27.23 2.78 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.7 0.286 . . . . 0.0 110.522 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -62.69 -43.43 98.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.013 0.435 . . . . 0.0 110.356 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 56.3 mt -108.9 -178.67 3.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.689 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.483 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -76.85 161.76 28.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.66 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -92.15 -22.12 20.03 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.099 0.476 . . . . 0.0 110.526 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -86.99 -24.17 24.78 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.14 -67.57 0.14 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.309 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.581 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 19.3 m -64.46 -34.24 68.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -57.08 -67.43 0.32 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.589 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -68.88 -38.01 79.41 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.418 ' C ' ' SD ' ' A' ' 124' ' ' MET . 15.2 tmm? -59.88 -47.09 87.18 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.035 0.445 . . . . 0.0 110.103 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 97.6 mt -68.84 -16.86 21.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.144 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -80.18 -51.61 8.76 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.08 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 129' ' ' ASP . 44.1 tp10 -86.2 -68.2 0.76 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 118.978 -1.089 . . . . 0.0 111.362 -177.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 127' ' ' GLU . . . -37.44 -25.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.635 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 127' ' ' GLU . 40.0 t0 -88.57 126.71 35.4 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.165 0.507 . . . . 0.0 110.849 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.529 ' H ' ' CD1' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -65.46 -41.19 90.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.95 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.97 -42.87 99.61 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.755 0.312 . . . . 0.0 110.501 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.45 -0.92 62.83 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 50.2 p-10 -94.26 -18.57 21.53 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.894 0.378 . . . . 0.0 110.097 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.513 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 64.84 121.22 0.01 OUTLIER Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -164.45 144.5 7.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.57 -0.315 . . . . 0.0 110.272 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 72.7 t -128.62 134.36 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.39 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -150.98 176.3 11.25 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.105 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -56.15 -46.75 79.14 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.338 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -55.53 -37.92 68.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.579 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -69.16 -39.68 78.62 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.446 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -61.92 -43.12 99.5 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.0 t -58.03 -45.93 88.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.769 0.319 . . . . 0.0 110.657 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -77.07 -24.32 51.92 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.684 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 44.5 ttp -63.88 -41.14 97.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.727 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.438 ' O ' ' OG1' ' A' ' 146' ' ' THR . 64.6 mtt -91.36 130.38 37.22 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.929 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 145' ' ' MET . 36.0 m -167.44 67.8 0.09 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.583 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.42 87.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.32 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 66.4 mttm . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.913 179.606 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.057 0 CA-C-O 120.626 0.251 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -43.95 -48.24 8.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.653 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -65.97 -39.8 90.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.67 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -65.36 -48.14 73.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.237 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -64.14 -33.96 76.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.512 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.64 -19.88 12.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.543 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -57.45 -49.25 76.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.823 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.4 m -60.93 -40.84 94.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.552 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.55 -42.85 99.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.982 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -59.31 -49.84 76.27 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.849 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.466 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.5 t0 -75.97 -15.62 60.13 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.644 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -43.58 -33.25 1.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.787 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.433 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 14.5 p-10 -53.43 -43.45 68.02 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.466 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -145.57 -153.69 5.95 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 26.7 p-10 -74.79 -47.26 31.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 110.59 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.71 107.22 0.28 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 178.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 8.4 m -166.65 149.91 6.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.143 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.8 mp -119.52 109.49 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.1 p -130.98 169.68 15.5 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.908 0.385 . . . . 0.0 110.473 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.465 ' CB ' HE22 ' A' ' 49' ' ' GLN . 82.4 p -63.43 -29.57 70.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.182 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -62.16 -41.25 98.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.252 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.448 ' OE2' ' O ' ' A' ' 26' ' ' THR . 89.6 mt-10 -67.0 -45.72 76.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.98 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.3 tp -65.96 -44.43 85.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.409 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.93 -22.5 4.57 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.5 m -67.06 -30.2 70.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.78 0.324 . . . . 0.0 110.446 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.4 t -62.24 -22.99 30.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.809 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.0 mmm -56.0 -37.14 68.74 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.702 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -63.19 -44.2 96.05 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 116.771 -1.971 . . . . 0.0 110.06 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 91.6 p -60.45 -37.9 82.44 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.166 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.1 mt -94.71 5.05 53.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.28 0.562 . . . . 0.0 110.505 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.46 -67.62 0.26 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -147.87 104.98 3.63 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 44' ' ' THR . 58.7 t30 -123.24 76.8 52.48 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.06 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' A' ' 46' ' ' ALA . 72.0 Cg_exo -36.63 -29.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.582 2.188 . . . . 0.0 112.653 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 42' ' ' ASN . 11.4 m -38.46 -31.98 0.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.358 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 49' ' ' GLN . 96.8 mt-10 -88.77 -36.19 16.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.195 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -55.01 -49.8 70.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.558 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -69.85 -49.14 55.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.26 0.552 . . . . 0.0 110.258 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.91 -21.36 65.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.683 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.465 HE22 ' CB ' ' A' ' 29' ' ' THR . 71.2 tp60 -45.55 -47.44 14.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.209 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 68.1 t0 -70.89 -38.6 73.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.492 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.465 ' CE ' ' HZ2' ' A' ' 75' ' ' LYS . 39.1 ttp -62.38 -42.83 99.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.922 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 87.1 mt -63.53 -46.28 95.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.541 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 57' ' ' ALA . 87.3 m-20 -64.02 -41.79 97.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.62 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -59.27 -59.15 5.92 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.491 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.8 p -66.07 -31.82 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.0 110.847 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.546 ' OD2' ' N ' ' A' ' 62' ' ' THR . 45.5 t0 -87.28 -12.6 46.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.737 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -72.24 13.01 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.048 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 56' ' ' ASP . 16.7 p-10 -63.98 -33.84 76.65 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.47 -26.41 0.08 OUTLIER Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.622 ' C ' ' H ' ' A' ' 62' ' ' THR . 16.5 p30 -178.25 148.21 0.47 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.513 -0.343 . . . . 0.0 110.262 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.92 34.23 0.1 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.622 ' H ' ' C ' ' A' ' 60' ' ' ASN . 70.7 p -129.68 151.49 50.21 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.0 mt -119.62 134.12 64.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.821 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -77.09 -155.43 0.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.042 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.49 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -96.52 -47.86 0.24 Allowed Pre-proline 0 N--CA 1.469 0.485 0 CA-C-O 120.501 0.191 . . . . 0.0 110.845 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 42.6 Cg_exo -54.93 -36.06 91.07 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.115 1.877 . . . . 0.0 111.606 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -83.61 -28.69 28.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.794 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -59.38 -46.42 88.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.7 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.0 -43.48 95.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.822 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.7 m -63.6 -45.29 91.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.113 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 46.8 ttp -62.18 -44.44 96.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.782 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 47.8 mmm -63.39 -42.2 98.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.718 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.77 -48.65 80.82 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.686 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -71.03 -50.13 37.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.565 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.465 ' HZ2' ' CE ' ' A' ' 51' ' ' MET . 69.3 mmtt -64.67 -41.8 95.82 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.371 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 32.1 mmm -121.17 127.02 51.13 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.219 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -82.77 153.14 25.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.675 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -52.54 -179.96 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.282 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.0 p -80.97 -9.74 59.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.651 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -65.95 -21.65 66.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.419 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.7 m -50.58 -32.25 18.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.407 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -38.19 -45.71 0.98 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.716 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -69.12 -46.6 67.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.145 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -65.02 -49.52 69.89 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.9 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.5 mt -56.37 -21.14 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -57.94 -44.94 87.24 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 118.466 -1.294 . . . . 0.0 109.649 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -66.16 -25.95 67.19 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.6 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.81 -14.14 58.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.071 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -56.56 -50.68 71.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.298 0.57 . . . . 0.0 111.121 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -63.37 -44.49 94.64 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.203 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.6 t -66.64 -45.63 87.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.807 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.429 ' CE2' ' CD1' ' A' ' 100' ' ' ILE . 19.3 t80 -62.55 -47.23 84.79 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.643 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.431 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 37.3 t0 -119.94 106.56 12.16 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.242 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -68.14 -44.29 76.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.011 0.434 . . . . 0.0 110.58 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.431 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 0.9 OUTLIER -62.36 -44.47 96.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.779 -179.312 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.1 -47.41 1.05 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 95' ' ' ASP . 62.6 m-20 -74.6 -14.44 60.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.017 0.437 . . . . 0.0 110.541 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.79 161.79 12.64 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -112.19 144.38 41.68 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.429 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 64.7 mt -74.95 129.49 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.902 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.5 p -83.05 168.79 16.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.284 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.86 97.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.85 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.14 -41.7 94.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.701 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -67.32 -37.36 83.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.086 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.2 tp -60.21 -43.19 96.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.2 0.524 . . . . 0.0 110.682 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -54.07 -40.68 67.39 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.846 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -59.09 -42.2 89.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.893 0.377 . . . . 0.0 110.002 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.11 -44.92 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.745 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 80.9 mmm -63.51 -35.48 80.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.568 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.4 m -61.23 -41.71 97.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.251 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -59.8 -39.16 84.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.634 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.39 -44.29 97.4 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.582 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.69 -143.95 10.03 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -144.33 30.49 1.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.817 0.342 . . . . 0.0 110.766 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -62.87 -40.8 98.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.414 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.5 mt -105.25 165.94 10.76 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.485 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -65.15 161.52 18.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 0.0 110.51 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.445 ' C ' ' OE1' ' A' ' 120' ' ' GLU . 83.8 m-20 -91.28 -20.37 21.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 178.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -89.3 -26.11 21.31 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.674 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -34.91 -65.18 0.23 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.559 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.674 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 31.0 m -68.6 -27.46 36.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -178.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -63.25 -43.78 97.03 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.614 -0.435 . . . . 0.0 112.002 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -88.46 -41.07 13.0 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.467 ' C ' ' SD ' ' A' ' 124' ' ' MET . 15.0 tmm? -60.57 -42.67 97.11 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.898 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.98 -15.88 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -87.2 -66.69 0.88 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 118.971 -1.092 . . . . 0.0 112.003 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 128' ' ' ALA . 50.9 tp10 -70.97 -68.5 0.43 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.304 -0.959 . . . . 0.0 111.939 -176.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 127' ' ' GLU . . . -37.31 -40.01 0.32 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.699 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -88.42 124.64 34.15 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.066 0.46 . . . . 0.0 110.436 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.484 ' H ' HD12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -72.24 -16.03 18.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.281 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 133' ' ' ASP . 51.0 m-20 -65.36 -45.65 83.28 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.623 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.07 -11.48 2.67 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 42.0 p30 -88.51 -17.41 30.35 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.097 0.475 . . . . 0.0 110.15 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 58.35 120.73 0.01 OUTLIER Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.443 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 10.4 pt20 -161.02 137.88 8.77 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.4 t -125.59 134.17 67.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.874 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.468 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.4 t30 -148.98 159.56 44.1 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.232 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -40.04 -35.36 0.37 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.334 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.468 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 53.1 mp0 -65.8 -42.32 90.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.17 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 80.3 mt-10 -71.83 -30.18 65.2 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.538 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -58.5 -45.57 88.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.248 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 58.9 t -60.19 -48.2 89.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.914 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -70.05 -32.13 70.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.833 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 37.6 ttp -56.62 -47.69 79.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.696 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 69.7 mtm -106.1 134.1 49.76 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.844 0.354 . . . . 0.0 110.613 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 88.7 m -160.14 81.69 0.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.325 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.95 -40.52 91.41 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.885 0.374 . . . . 0.0 110.571 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.627 179.997 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.035 0 CA-C-O 120.571 0.224 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -54.7 -48.23 72.72 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.537 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -65.67 -40.84 92.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.824 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -62.04 -44.03 97.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.631 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -66.96 -37.58 84.54 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.998 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.482 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.0 -27.99 65.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.779 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -57.77 -46.95 83.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.526 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 m -77.9 -21.51 51.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.693 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.37 -42.81 99.7 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.431 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.482 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.2 m-85 -60.17 -51.01 71.43 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.462 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.1 t0 -76.89 -14.35 59.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.893 0.377 . . . . 0.0 111.358 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -45.56 -32.67 2.39 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.893 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 8.8 p-10 -53.73 -46.11 70.73 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.542 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -144.37 -151.62 5.48 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 30.7 p-10 -72.97 -47.19 47.54 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.074 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.7 107.37 0.28 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 178.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 4.5 m -166.62 139.28 3.72 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.38 -0.482 . . . . 0.0 111.179 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 mp -115.13 109.23 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.6 p -128.66 170.31 13.42 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.817 0.342 . . . . 0.0 110.442 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.602 ' CB ' HE22 ' A' ' 49' ' ' GLN . 67.3 p -64.66 -33.11 75.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.788 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -61.71 -41.32 97.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.011 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 26' ' ' THR . 90.1 mt-10 -63.49 -45.71 89.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.863 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.2 tp -64.1 -43.35 95.61 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.149 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.78 -26.1 53.29 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.2 m -63.93 -41.41 97.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.843 0.354 . . . . 0.0 110.084 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.7 t -56.24 -23.56 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.363 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.483 ' O ' ' N ' ' A' ' 40' ' ' GLY . 62.1 mmm -48.14 -30.27 4.41 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.671 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -64.38 -45.64 86.81 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 118.042 -1.463 . . . . 0.0 110.975 -178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -63.94 -21.98 66.72 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.852 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 41' ' ' GLN . 16.8 mt -107.75 3.7 24.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.086 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.19 -71.2 0.02 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.512 ' N ' ' O ' ' A' ' 39' ' ' LEU . 87.8 mt-30 -145.43 109.47 4.84 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 44' ' ' THR . 41.3 t30 -125.61 70.87 65.55 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.552 ' O ' ' N ' ' A' ' 46' ' ' ALA . 84.8 Cg_exo -32.94 -30.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.65 2.233 . . . . 0.0 112.792 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.542 ' N ' ' O ' ' A' ' 42' ' ' ASN . 26.1 m -39.29 -30.15 0.06 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.545 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 49' ' ' GLN . 93.9 mt-10 -86.67 -34.85 19.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.332 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -59.04 -50.14 75.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.799 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.15 -46.13 71.63 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 51' ' ' MET . 84.5 mt -64.81 -31.07 72.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.382 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.602 HE22 ' CB ' ' A' ' 29' ' ' THR . 61.1 tp60 -37.5 -51.36 1.14 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.74 0.305 . . . . 0.0 110.761 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.22 -40.33 90.22 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.259 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 48' ' ' LEU . 33.1 ttp -62.45 -40.98 98.37 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.948 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.415 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 83.5 mt -61.99 -49.9 82.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.142 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.536 ' O ' ' N ' ' A' ' 57' ' ' ALA . 89.9 m-20 -62.99 -40.36 97.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.597 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -55.19 -61.52 2.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.213 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.87 -30.21 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.341 . . . . 0.0 111.28 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 62' ' ' THR . 50.6 t0 -84.63 -13.24 52.15 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.574 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -71.99 13.07 0.33 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.871 0.367 . . . . 0.0 110.284 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.5 p30 -65.58 -28.92 69.49 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.535 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -150.48 -22.34 0.06 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.581 ' C ' ' H ' ' A' ' 62' ' ' THR . 3.3 p30 173.14 151.87 0.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.99 34.71 0.15 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.581 ' H ' ' C ' ' A' ' 60' ' ' ASN . 81.7 p -134.33 149.49 50.87 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.6 mt -120.98 134.57 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.26 162.4 28.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.41 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.471 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -64.56 -48.12 74.99 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.513 -179.076 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 50.5 Cg_exo -51.3 -37.29 59.76 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.195 1.93 . . . . 0.0 111.71 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -87.59 -22.3 24.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.836 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.42 -47.14 87.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.048 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.54 -42.89 98.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.549 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.8 m -63.95 -46.08 86.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.647 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.6 ttp -61.69 -47.56 84.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.077 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.9 mmm -65.76 -37.85 87.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.282 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.53 -50.01 75.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.031 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -71.51 -43.75 65.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.203 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.73 -43.56 88.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.733 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.431 ' O ' ' O ' ' A' ' 73' ' ' ALA . 22.4 mmm -104.35 127.44 52.01 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.094 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.7 tptt -84.96 141.17 30.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.38 . . . . 0.0 110.712 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' LYS . 95.0 m-20 -48.92 179.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.226 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.8 p -75.53 -6.76 51.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.418 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.44 -15.54 62.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.509 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.0 m -61.92 -19.87 63.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.548 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -48.19 -44.76 33.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.342 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.95 -39.52 79.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.905 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.82 -45.22 83.11 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.006 0.431 . . . . 0.0 110.152 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.2 mt -66.04 -19.04 25.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.525 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -58.47 -45.38 88.73 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.218 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.64 -31.81 73.04 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.928 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.406 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -72.03 -14.69 61.94 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.138 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -57.94 -48.99 78.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.297 0.57 . . . . 0.0 111.116 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -64.09 -45.58 88.07 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.36 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.7 t -76.17 -51.54 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.381 . . . . 0.0 110.894 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.416 ' CE2' ' CD1' ' A' ' 100' ' ' ILE . 26.3 t80 -61.98 -47.22 85.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.598 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.43 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 18.2 t70 -108.95 94.15 4.89 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.21 -41.04 74.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.02 0.438 . . . . 0.0 110.578 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 19.9 p-10 -62.48 -39.74 94.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.969 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.44 -67.33 0.97 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.56 -16.52 63.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.917 0.389 . . . . 0.0 110.228 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.78 162.0 12.57 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.2 155.4 24.04 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.811 0.338 . . . . 0.0 110.237 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.416 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 94.0 mt -79.76 126.04 39.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.965 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.3 p -82.45 168.94 16.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.181 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.07 89.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.557 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.59 -47.4 83.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.65 -32.8 72.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.5 tp -61.57 -41.69 97.77 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.423 0.63 . . . . 0.0 110.691 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -56.51 -43.23 79.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.845 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -58.47 -41.96 86.42 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.7 t -66.64 -43.35 90.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.656 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.0 mmm -62.01 -35.65 79.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.634 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.4 m -61.04 -44.39 97.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.071 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -59.8 -34.99 73.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.348 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.0 tp -61.12 -46.75 89.29 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.068 0.461 . . . . 0.0 110.375 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.46 -160.71 33.42 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -140.53 23.38 2.31 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.654 0.264 . . . . 0.0 110.835 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -63.66 -42.82 98.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.983 0.42 . . . . 0.0 110.237 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.7 mt -92.8 175.8 6.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.965 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.468 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -72.87 161.33 30.84 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.672 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -91.69 -22.5 20.2 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.945 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -87.88 -25.35 23.31 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.167 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.641 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.44 -61.19 0.46 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.114 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.641 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 20.4 m -67.4 -40.21 84.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -56.76 -47.1 80.86 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.51 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -86.0 -40.3 15.95 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.6 tmm? -59.52 -46.49 88.69 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.061 0.458 . . . . 0.0 109.954 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 91.3 mt -69.2 -16.49 20.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.409 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -78.62 -50.61 11.19 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 119.397 -0.921 . . . . 0.0 112.09 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' ASP . 42.4 tp10 -87.64 -67.47 0.82 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.897 -178.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.37 -26.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.784 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' GLU . 25.4 t0 -88.02 128.32 35.4 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.092 0.472 . . . . 0.0 111.073 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.538 ' H ' ' CD1' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.51 -43.42 90.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.404 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -65.35 -40.28 93.41 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.122 0.487 . . . . 0.0 110.164 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.3 -1.98 58.67 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.334 -1.107 . . . . 0.0 110.334 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 134' ' ' GLY . 55.3 p-10 -89.53 -8.96 51.66 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 57.44 115.43 0.01 OUTLIER Glycine 0 CA--C 1.522 0.525 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.229 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 20.3 pt20 -160.62 133.59 6.5 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.4 t -123.45 136.92 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.066 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -151.36 172.5 15.82 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.221 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -54.8 -46.82 74.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.152 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -58.65 -44.32 90.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.71 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 93.3 mt-10 -72.09 -29.34 64.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.763 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.9 -43.99 77.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.587 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 94.7 t -59.1 -46.32 91.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.301 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.33 -29.13 66.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.136 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.7 ttp -59.69 -42.87 93.91 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.841 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.48 138.81 50.64 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.913 0.387 . . . . 0.0 110.754 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 80.8 m -163.19 77.73 0.43 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.664 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.19 -27.74 68.9 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.414 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.86 -1.067 . . . . 0.0 110.625 -179.853 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.163 0 CA-C-O 120.81 0.338 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -54.33 -42.25 69.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.044 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -67.78 -41.79 82.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.381 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -62.57 -43.76 98.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.956 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -67.2 -35.77 80.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.398 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.51 -24.17 66.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.768 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -55.4 -46.5 76.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.777 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.4 m -80.68 -19.41 45.26 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.808 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.18 -41.95 96.89 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.019 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.421 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.2 m-85 -58.84 -46.13 88.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.852 0.358 . . . . 0.0 111.107 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.3 t0 -79.58 -13.47 59.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.461 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -43.02 -32.77 0.71 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.867 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' CG ' ' OE2' ' A' ' 31' ' ' GLU . 10.9 p-10 -52.91 -45.13 67.44 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.49 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.433 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . -149.66 -151.26 5.46 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 21.3 p-10 -71.2 -46.86 60.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.712 0.292 . . . . 0.0 111.005 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.03 107.39 0.28 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.457 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 5.8 m -166.59 136.22 3.09 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.191 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.419 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.9 mp -110.58 118.27 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.0 p -134.73 167.08 21.5 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.881 0.372 . . . . 0.0 110.285 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.497 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.3 p -64.13 -33.65 76.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.283 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -62.56 -40.16 95.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.707 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.457 ' OE2' ' O ' ' A' ' 26' ' ' THR . 88.9 mt-10 -64.68 -48.51 74.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.366 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.8 tp -64.42 -43.75 93.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.252 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.31 -24.69 17.01 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -64.08 -41.04 97.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.851 0.358 . . . . 0.0 110.151 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.04 -22.47 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.207 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.6 mmm -48.78 -33.56 10.6 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.969 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -64.3 -45.5 87.69 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 118.163 -1.415 . . . . 0.0 110.272 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.3 p -59.0 -30.65 68.14 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.356 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 41' ' ' GLN . 9.3 mt -102.33 5.47 39.89 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.966 0.412 . . . . 0.0 110.443 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.27 -69.79 0.03 OUTLIER Glycine 0 N--CA 1.465 0.588 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 39' ' ' LEU . 85.7 mt-30 -143.25 116.29 8.88 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.1 t30 -132.66 69.75 79.45 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.906 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 46' ' ' ALA . 92.0 Cg_exo -33.1 -33.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 122.527 2.151 . . . . 0.0 112.49 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 42' ' ' ASN . 12.4 m -38.99 -29.35 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.476 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 43' ' ' PRO . 90.6 mt-10 -87.65 -35.22 18.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.463 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -61.26 -49.17 78.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.027 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -68.03 -48.61 65.18 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.403 0.621 . . . . 0.0 109.889 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.62 -22.75 66.64 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.018 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.497 HE22 ' CB ' ' A' ' 29' ' ' THR . 47.9 tp60 -40.21 -49.58 2.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 110.532 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.69 -39.8 73.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.472 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.1 ttp -61.54 -40.59 95.23 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.765 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.78 -46.93 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.658 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 57' ' ' ALA . 28.3 m120 -65.17 -39.84 93.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.333 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -58.08 -57.23 13.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.434 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 p -68.31 -32.83 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.936 0.398 . . . . 0.0 110.964 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.535 ' C ' ' H ' ' A' ' 58' ' ' ASP . 43.0 t0 -86.08 -13.03 48.51 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.812 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -72.04 15.42 0.16 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.056 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.535 ' H ' ' C ' ' A' ' 56' ' ' ASP . 38.7 p-10 -66.66 -23.55 66.16 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.39 -22.56 0.03 OUTLIER Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.625 ' C ' ' H ' ' A' ' 62' ' ' THR . 4.6 p30 179.31 146.55 0.19 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.76 33.71 0.18 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.625 ' H ' ' C ' ' A' ' 60' ' ' ASN . 80.6 p -132.15 143.93 50.33 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.88 135.12 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.057 0.456 . . . . 0.0 110.175 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.42 172.34 4.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.441 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.438 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -72.53 -49.59 8.56 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.761 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 53.2 Cg_exo -52.07 -43.26 53.95 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.87 1.714 . . . . 0.0 111.902 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.46 -37.43 77.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 110.867 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -60.42 -45.38 93.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.962 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.9 mt -62.39 -44.57 96.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.523 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.5 m -67.45 -45.43 76.03 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 111.242 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.4 ttp -61.17 -43.69 98.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.928 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 87.0 mmm -64.75 -39.36 93.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.206 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.435 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.89 -42.83 94.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.89 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -71.52 -41.78 68.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.237 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -64.76 -40.92 96.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.86 0.362 . . . . 0.0 110.422 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.435 ' O ' ' O ' ' A' ' 73' ' ' ALA . 14.2 mmt -95.21 129.82 42.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.129 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -86.84 142.8 27.8 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -50.35 168.77 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.425 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.0 p -75.15 -15.21 60.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.683 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.98 -16.5 64.08 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.908 0.385 . . . . 0.0 110.439 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 82' ' ' GLU . 1.1 m -60.41 -23.76 64.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.759 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 81' ' ' SER . 81.2 tt0 -36.75 -48.49 0.73 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.893 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -70.76 -43.52 68.62 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.262 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -63.88 -39.59 94.55 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.961 0.41 . . . . 0.0 110.025 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.5 mt -66.95 -21.92 28.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.287 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -57.97 -43.6 86.58 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 119.047 -1.061 . . . . 0.0 110.063 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -63.74 -34.76 78.61 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.846 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.8 -19.91 66.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.056 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -56.57 -48.75 76.7 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.261 0.553 . . . . 0.0 110.848 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -68.29 -44.71 74.86 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.462 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.7 t -66.3 -48.37 81.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -64.01 -47.11 81.58 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.654 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.405 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 18.4 t70 -120.35 100.14 6.99 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -66.74 -39.75 88.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.745 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -65.66 -40.59 92.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.102 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.62 -59.49 0.48 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -61.88 -17.44 56.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.986 0.422 . . . . 0.0 110.2 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.405 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.56 160.91 12.96 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -113.23 155.56 24.85 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.7 mt -95.74 118.25 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.966 0.412 . . . . 0.0 111.12 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.9 p -85.53 171.38 11.78 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.89 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.74 -35.73 78.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.551 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.5 -50.78 72.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.158 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -69.29 -37.36 77.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.922 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.03 -39.4 94.62 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.538 0.685 . . . . 0.0 111.07 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -54.22 -43.62 70.98 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.121 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -63.1 -39.49 94.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.3 t -61.82 -45.26 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.151 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 37.7 mmm -64.31 -37.94 89.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.562 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.0 m -60.58 -40.16 90.73 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -61.25 -38.12 85.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.204 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 tp -61.53 -44.09 97.69 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.907 0.385 . . . . 0.0 110.25 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.98 -154.71 25.68 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -139.02 23.35 2.6 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.722 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -62.66 -43.22 99.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 0.0 110.314 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.9 mt -99.95 169.07 9.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.525 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.55 ' HG1' ' H ' ' A' ' 117' ' ' THR . 0.8 OUTLIER -68.35 162.17 25.85 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.556 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -92.15 -22.28 19.94 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.434 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -87.26 -24.47 24.36 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.615 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.58 -66.06 0.21 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.254 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.615 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.7 m -65.19 -35.28 75.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.363 -178.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -60.51 -46.75 88.98 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.54 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -84.87 -40.4 17.12 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.3 tmm? -58.91 -47.21 85.79 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.2 mt -69.16 -18.37 22.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.553 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -77.4 -51.39 10.89 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.274 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 129' ' ' ASP . 34.9 tp10 -86.31 -68.67 0.72 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.341 -0.943 . . . . 0.0 111.456 -177.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.69 -21.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.877 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 127' ' ' GLU . 38.7 t0 -90.14 125.02 35.3 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.07 0.462 . . . . 0.0 110.657 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.494 ' H ' ' CD1' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.46 -32.09 56.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.018 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -72.19 -45.8 58.9 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.907 0.384 . . . . 0.0 110.347 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.68 -5.47 61.16 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 134' ' ' GLY . 35.2 p30 -89.94 -9.67 47.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.962 0.411 . . . . 0.0 109.934 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 58.22 117.93 0.01 OUTLIER Glycine 0 CA--C 1.519 0.294 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 8.2 pt20 -159.76 140.11 11.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.53 -0.335 . . . . 0.0 110.137 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.7 t -126.23 133.24 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.915 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.544 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.8 t30 -150.69 175.39 12.0 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.337 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -57.67 -52.1 66.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.761 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.544 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 57.2 mp0 -55.93 -35.02 66.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.668 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 79.4 mt-10 -69.55 -39.25 77.53 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.694 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -61.26 -45.33 94.97 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.753 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.1 t -58.01 -45.9 87.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -74.2 -30.84 62.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.413 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.4 ttp -60.08 -40.62 90.21 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.621 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.404 ' O ' ' OG1' ' A' ' 146' ' ' THR . 72.9 mtm -105.21 141.73 36.24 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.921 0.391 . . . . 0.0 110.589 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 145' ' ' MET . 63.1 m -167.3 72.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.119 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.58 -41.83 97.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.587 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 C--O 1.218 -0.561 0 CA-C-O 118.066 -0.968 . . . . 0.0 110.269 -179.89 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.065 0 CA-C-O 120.394 0.14 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -54.83 -50.58 68.24 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.997 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -63.74 -44.06 94.63 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.772 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -62.57 -45.94 90.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.484 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -69.69 -35.84 75.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.959 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -63.08 -37.79 88.59 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.492 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -58.47 -46.27 86.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.522 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -80.92 -18.82 45.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.735 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.49 -43.14 98.13 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.746 0.308 . . . . 0.0 111.283 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 83.0 m-85 -57.97 -49.27 77.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.586 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 6.3 t0 -73.15 -13.4 61.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.756 0.313 . . . . 0.0 111.27 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -44.49 -33.52 1.75 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.761 0.315 . . . . 0.0 110.959 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.414 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 7.2 p-10 -53.98 -45.69 71.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.86 0.362 . . . . 0.0 110.946 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.443 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . -149.01 -150.86 5.32 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 25.1 p-10 -70.2 -47.37 61.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.948 0.404 . . . . 0.0 111.006 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.527 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.81 107.81 0.3 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.444 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 6.2 m -166.21 139.46 4.09 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.139 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.2 mp -120.63 110.51 28.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.8 p -130.95 169.38 15.88 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.025 0.44 . . . . 0.0 110.566 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.2 p -63.07 -31.43 72.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.394 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -62.11 -42.35 99.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.99 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 26' ' ' THR . 81.5 mt-10 -66.74 -45.84 77.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.004 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.9 tp -63.93 -42.9 97.24 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.396 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.76 -25.11 28.42 Favored Glycine 0 C--O 1.226 -0.36 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.0 m -63.96 -44.1 93.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.934 0.397 . . . . 0.0 110.796 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.3 t -55.54 -20.49 7.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.527 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.509 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 87.4 mmm -48.9 -34.89 13.62 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.625 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -63.12 -46.4 87.5 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 118.005 -1.478 . . . . 0.0 111.851 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.503 ' HG ' ' N ' ' A' ' 39' ' ' LEU . 39.0 p -60.75 -30.89 70.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 41' ' ' GLN . 24.9 mt -96.75 2.13 51.62 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.974 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.92 -67.94 0.02 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 39' ' ' LEU . 86.1 mt-30 -143.59 110.07 5.47 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -123.72 75.03 55.56 Favored Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.461 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.577 ' O ' ' N ' ' A' ' 46' ' ' ALA . 99.5 Cg_exo -36.45 -35.69 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.732 1.621 . . . . 0.0 112.13 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.402 ' N ' ' HB3' ' A' ' 120' ' ' GLU . 5.9 m -37.83 -31.49 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.763 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.509 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.2 mt-10 -87.35 -36.03 18.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.316 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.47 -51.97 67.6 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.866 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -68.39 -47.21 67.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.304 0.573 . . . . 0.0 109.958 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 49' ' ' GLN . 84.7 mt -64.09 -26.81 68.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.917 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 48' ' ' LEU . 58.7 tp60 -38.82 -46.35 1.27 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.751 0.31 . . . . 0.0 110.566 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.17 -41.69 66.74 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.54 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 40.0 ttp -62.14 -41.73 98.55 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.076 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.444 HD11 HG23 ' A' ' 52' ' ' ILE . 96.6 mt -60.92 -51.99 66.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.39 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 57' ' ' ALA . 17.3 m120 -64.29 -40.03 95.13 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.71 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -55.61 -59.58 4.65 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.259 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.79 -34.43 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.99 0.424 . . . . 0.0 110.762 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 62' ' ' THR . 55.3 t0 -80.73 -13.59 58.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.533 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -72.13 16.11 0.14 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.274 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' A' ' 56' ' ' ASP . 21.5 p-10 -66.07 -24.61 66.75 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -154.54 -25.55 0.04 OUTLIER Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.631 ' C ' ' H ' ' A' ' 62' ' ' THR . 10.9 p30 179.96 150.84 0.39 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.403 ' C ' ' OD2' ' A' ' 56' ' ' ASP . . . -65.48 32.45 0.12 Allowed Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.631 ' H ' ' C ' ' A' ' 60' ' ' ASN . 66.5 p -130.39 148.91 52.26 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.0 mt -118.5 133.86 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.987 0.423 . . . . 0.0 110.514 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.32 169.08 18.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.475 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.436 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -67.29 -49.52 43.37 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.191 -179.027 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.8 Cg_exo -52.08 -45.31 39.77 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.995 1.797 . . . . 0.0 111.898 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.96 -37.02 72.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.694 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -60.69 -46.37 90.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.964 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.3 mt -62.22 -44.37 96.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.857 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.1 m -65.15 -44.63 87.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.904 0.383 . . . . 0.0 110.304 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 44.9 ttp -62.07 -41.83 98.57 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.853 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 76' ' ' MET . 60.3 mmm -63.35 -40.86 98.43 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.585 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.0 -35.84 77.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.739 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -87.71 -56.27 3.42 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.735 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -63.13 -43.31 98.74 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.123 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 72' ' ' MET . 50.8 mmm -108.88 131.51 54.94 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.863 0.363 . . . . 0.0 110.214 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 78' ' ' ASP . 29.0 tptt -83.12 150.07 26.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.764 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 77' ' ' LYS . 5.7 m-20 -55.51 -159.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.421 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.8 p -96.19 -0.27 50.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.916 0.388 . . . . 0.0 110.499 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -82.87 2.48 34.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.119 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 83' ' ' GLU . 1.6 m -62.09 -35.6 79.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.959 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -37.99 -29.61 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.861 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 81' ' ' SER . 71.5 mm-40 -74.17 -56.87 4.39 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -64.71 -38.73 91.99 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.154 0.502 . . . . 0.0 109.656 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.415 HD12 HG23 ' A' ' 85' ' ' ILE . 96.7 mt -58.7 -19.29 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.482 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.1 ttt-85 -57.69 -44.01 85.54 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.171 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -65.9 -33.02 74.87 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.785 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -63.0 -27.96 69.78 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -55.63 -46.0 77.47 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.38 0.609 . . . . 0.0 110.405 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -74.42 -51.08 15.97 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.757 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.21 -47.79 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.04 0.448 . . . . 0.0 110.553 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.443 ' CB ' ' O ' ' A' ' 88' ' ' ALA . 39.2 t80 -63.5 -45.83 88.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.239 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.48 ' OD2' ' N ' ' A' ' 96' ' ' GLY . 36.0 t70 -127.16 105.08 8.33 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.586 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -68.55 -42.12 78.82 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.897 0.379 . . . . 0.0 111.059 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 97' ' ' ASN . 1.5 p-10 -59.95 -46.62 88.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.846 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.48 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 73.77 -41.77 1.05 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 95' ' ' ASP . 77.1 m-20 -80.24 -13.55 59.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.929 0.395 . . . . 0.0 110.046 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.94 161.28 12.8 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -113.29 149.82 33.35 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.7 0.286 . . . . 0.0 110.511 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.7 mt -96.79 116.55 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.99 0.424 . . . . 0.0 111.191 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.9 p -84.39 170.76 13.24 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.3 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.57 -37.52 86.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.157 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.27 -47.16 84.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.978 0.418 . . . . 0.0 110.577 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.55 -35.99 75.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.495 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.6 tp -62.33 -40.15 95.41 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.63 0.728 . . . . 0.0 110.668 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -52.44 -45.02 65.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.649 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -61.64 -45.04 95.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.971 0.415 . . . . 0.0 110.396 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.9 t -63.91 -44.89 98.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.309 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 48.4 mmm -64.38 -37.12 86.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.514 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 83.1 m -61.04 -46.13 91.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -67.13 -24.54 65.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.216 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.1 tp -61.51 -44.89 96.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.893 0.378 . . . . 0.0 110.824 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.53 -148.79 15.54 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -140.36 25.84 2.21 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.502 0.192 . . . . 0.0 111.056 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -64.75 -45.34 86.84 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.979 0.418 . . . . 0.0 110.958 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.6 mt -113.54 170.67 8.07 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.943 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.491 ' H ' ' HG1' ' A' ' 117' ' ' THR . 0.8 OUTLIER -69.51 161.54 29.32 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.014 0.435 . . . . 0.0 110.952 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -92.1 -23.93 19.29 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.805 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -88.06 -20.39 25.81 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.578 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.7 -67.39 0.16 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.578 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 18.0 m -64.53 -35.15 73.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -57.68 -66.46 0.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -64.35 -43.79 93.48 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.465 ' C ' ' SD ' ' A' ' 124' ' ' MET . 16.1 tmm? -57.31 -48.69 78.3 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.832 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.22 -23.78 30.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.219 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -77.08 -46.86 22.17 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.499 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -85.38 -68.28 0.74 Allowed 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.486 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.01 -33.3 0.08 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.503 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -94.72 146.77 23.94 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.819 0.342 . . . . 0.0 110.702 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.433 ' H ' ' CD1' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -89.41 -17.37 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 133' ' ' ASP . 95.1 m-20 -65.46 -44.48 87.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.055 0.455 . . . . 0.0 110.531 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.37 -11.01 5.61 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 41.3 p-10 -89.12 -19.39 25.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.87 0.367 . . . . 0.0 110.483 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.549 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 55.36 106.24 0.01 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.477 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 11.1 pt20 -140.15 134.7 31.6 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.7 t -116.93 132.04 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.007 0.432 . . . . 0.0 110.225 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -142.74 175.44 9.81 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.579 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -58.22 -45.83 86.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.147 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.481 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 54.0 mp0 -63.66 -36.92 85.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.407 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.477 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 78.3 mt-10 -67.09 -33.85 76.38 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.137 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -62.09 -40.55 96.2 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.466 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.0 t -57.18 -45.78 84.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.516 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -82.86 -15.82 50.02 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.838 0.351 . . . . 0.0 111.224 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 43.8 ttp -60.99 -41.05 95.73 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.882 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 78.2 mtm -118.49 141.72 48.29 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.779 0.323 . . . . 0.0 110.683 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 81.5 m -159.56 84.5 0.76 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.798 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.58 -40.51 73.23 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.186 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.912 -1.042 . . . . 0.0 110.5 -179.563 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.06 0 CA-C-O 120.64 0.257 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -44.0 -48.21 8.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.852 0.358 . . . . 0.0 110.699 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -66.0 -39.8 90.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.582 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -65.38 -48.15 73.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.216 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -64.12 -34.03 77.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.476 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.57 -19.93 11.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.541 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -57.38 -49.3 76.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.865 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.8 m -60.95 -40.82 94.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.56 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.55 -42.86 99.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.003 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -59.33 -49.9 76.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.804 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.466 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.6 t0 -75.88 -15.61 60.18 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.682 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -43.6 -33.2 1.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.818 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.437 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 14.4 p-10 -53.4 -43.44 67.92 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.485 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -145.62 -153.7 5.95 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 26.7 p-10 -74.79 -47.27 31.7 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.59 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.69 107.27 0.28 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.445 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 8.4 m -166.7 149.93 6.86 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.128 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.8 mp -119.52 109.47 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.1 p -130.91 169.71 15.41 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.896 0.379 . . . . 0.0 110.506 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.464 ' CB ' HE22 ' A' ' 49' ' ' GLN . 82.5 p -63.51 -29.56 70.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.173 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -62.11 -41.28 98.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.236 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.445 ' OE2' ' O ' ' A' ' 26' ' ' THR . 89.6 mt-10 -66.99 -45.74 76.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.0 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.1 tp -65.92 -44.52 84.93 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.382 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.91 -22.49 4.52 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.3 m -67.03 -30.15 70.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.789 0.328 . . . . 0.0 110.478 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.6 t -62.34 -22.96 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 94.9 mmm -56.05 -37.11 68.83 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 120.199 -0.601 . . . . 0.0 109.701 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -63.17 -44.2 96.12 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 116.806 -1.958 . . . . 0.0 110.114 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 91.7 p -60.48 -37.87 82.43 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.16 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 41' ' ' GLN . 39.1 mt -94.74 5.05 53.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.302 0.572 . . . . 0.0 110.528 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.49 -67.62 0.26 Allowed Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 39' ' ' LEU . 84.1 mt-30 -147.86 104.99 3.63 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.431 ' O ' ' N ' ' A' ' 44' ' ' THR . 58.7 t30 -123.25 76.84 52.61 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.028 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' A' ' 46' ' ' ALA . 72.1 Cg_exo -36.74 -29.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.595 2.196 . . . . 0.0 112.603 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 42' ' ' ASN . 11.5 m -38.43 -31.93 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.418 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 49' ' ' GLN . 96.9 mt-10 -88.86 -36.14 16.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.117 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -55.08 -49.8 70.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.536 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -69.85 -49.21 54.69 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.174 0.511 . . . . 0.0 110.155 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.89 -21.35 65.94 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.663 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.464 HE22 ' CB ' ' A' ' 29' ' ' THR . 71.3 tp60 -45.5 -47.47 14.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.221 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 68.1 t0 -70.85 -38.63 73.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.519 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.468 ' CE ' ' HZ2' ' A' ' 75' ' ' LYS . 39.0 ttp -62.37 -42.78 99.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.914 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.411 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 87.5 mt -63.7 -46.22 95.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.488 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 57' ' ' ALA . 87.3 m-20 -63.95 -41.86 97.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.6 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -59.27 -59.17 5.89 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.477 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.8 p -66.1 -31.74 55.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.754 0.312 . . . . 0.0 110.834 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.541 ' OD2' ' N ' ' A' ' 62' ' ' THR . 45.5 t0 -87.38 -12.58 45.89 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.69 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -72.28 13.06 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.07 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 56' ' ' ASP . 16.8 p-10 -64.03 -33.83 76.63 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.44 -26.45 0.08 OUTLIER Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.625 ' C ' ' H ' ' A' ' 62' ' ' THR . 16.5 p30 -178.19 148.25 0.48 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.545 -0.327 . . . . 0.0 110.297 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.97 34.25 0.1 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.625 ' H ' ' C ' ' A' ' 60' ' ' ASN . 70.2 p -129.68 151.48 50.23 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.0 mt -119.59 134.15 64.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.82 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -77.05 -155.47 0.07 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.028 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.497 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -96.51 -47.89 0.24 Allowed Pre-proline 0 N--CA 1.469 0.496 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.824 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 42.9 Cg_exo -54.94 -36.01 91.01 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.107 1.872 . . . . 0.0 111.629 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -83.62 -28.66 28.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.795 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -59.44 -46.4 88.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.685 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.96 -43.5 95.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.854 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.9 m -63.64 -45.26 91.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.103 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 46.6 ttp -62.18 -44.41 96.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.806 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.415 ' O ' ' N ' ' A' ' 76' ' ' MET . 47.8 mmm -63.38 -42.23 98.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.767 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.72 -48.66 80.81 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.768 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -71.04 -50.15 37.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.554 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.468 ' HZ2' ' CE ' ' A' ' 51' ' ' MET . 69.2 mmtt -64.64 -41.78 95.9 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.396 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.415 ' N ' ' O ' ' A' ' 72' ' ' MET . 32.1 mmm -121.21 127.0 51.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.197 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -82.69 153.12 25.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.672 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -52.5 -179.96 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.263 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.4 p -80.99 -9.69 59.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.641 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -65.97 -21.69 66.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.39 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.3 m -50.59 -32.2 18.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.423 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -38.23 -45.72 1.0 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.685 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -69.1 -46.63 67.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.17 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -65.07 -49.43 70.07 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.939 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.6 mt -56.42 -21.13 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -57.94 -44.95 87.27 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 118.386 -1.326 . . . . 0.0 109.652 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -66.07 -26.02 67.3 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.62 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.74 -14.16 58.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.122 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -56.61 -50.62 71.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.292 0.568 . . . . 0.0 111.137 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -63.39 -44.52 94.47 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.164 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.58 -45.64 88.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.581 -0.447 . . . . 0.0 109.866 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.429 ' CE2' ' CD1' ' A' ' 100' ' ' ILE . 19.1 t80 -62.54 -47.17 85.05 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.697 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 37.3 t0 -119.94 106.53 12.13 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.208 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -68.1 -44.32 76.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.072 0.463 . . . . 0.0 110.648 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.0 OUTLIER -62.26 -44.59 96.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.752 -179.351 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.1 -47.38 1.05 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.419 ' H ' ' C ' ' A' ' 95' ' ' ASP . 62.6 m-20 -74.59 -14.43 60.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.016 0.436 . . . . 0.0 110.538 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.82 161.81 12.63 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -112.15 144.38 41.63 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.429 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 64.6 mt -74.95 129.49 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.861 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.6 p -83.09 168.79 16.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.293 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.88 97.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.857 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.11 -41.69 94.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.69 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -67.34 -37.33 83.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.084 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.2 tp -60.31 -43.17 96.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.192 0.52 . . . . 0.0 110.654 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -54.0 -40.76 67.26 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.789 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -59.05 -42.24 89.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.935 0.398 . . . . 0.0 109.987 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.02 -44.97 97.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.715 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 80.9 mmm -63.53 -35.47 80.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.562 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.3 m -61.21 -41.72 97.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.273 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -59.79 -39.15 83.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.663 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.1 tp -61.4 -44.33 97.33 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.534 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.77 -143.91 9.97 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -144.36 30.49 1.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.34 . . . . 0.0 110.775 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -62.85 -40.86 98.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.389 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.6 mt -105.19 165.93 10.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.788 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.486 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -65.16 161.58 18.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.877 0.37 . . . . 0.0 110.526 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.44 ' C ' ' OE1' ' A' ' 120' ' ' GLU . 83.8 m-20 -91.39 -20.25 22.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.851 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -89.34 -26.13 21.25 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.671 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -34.89 -65.17 0.23 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.565 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.671 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 31.0 m -68.65 -27.5 36.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 111.639 0.236 . . . . 0.0 111.639 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -63.21 -43.84 96.98 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.998 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -88.42 -41.02 13.07 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.47 ' C ' ' SD ' ' A' ' 124' ' ' MET . 15.0 tmm? -60.56 -42.72 97.19 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.858 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.02 -15.82 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -87.17 -66.76 0.88 Allowed 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.975 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -70.96 -68.53 0.43 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.949 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.3 -40.01 0.32 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.675 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -88.42 124.66 34.17 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.078 0.466 . . . . 0.0 110.466 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.483 ' H ' HD12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -72.25 -16.05 18.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.239 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 133' ' ' ASP . 51.0 m-20 -65.33 -45.65 83.4 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.994 0.426 . . . . 0.0 110.664 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.1 -11.56 2.67 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 42.0 p30 -88.45 -17.39 30.49 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.067 0.46 . . . . 0.0 110.14 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 58.33 120.7 0.01 OUTLIER Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.443 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 10.4 pt20 -160.97 137.87 8.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.711 0.291 . . . . 0.0 110.282 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.2 t -125.58 134.24 67.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.834 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.472 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.3 t30 -148.99 159.64 44.03 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.232 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -40.13 -35.34 0.38 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.289 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.472 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 53.0 mp0 -65.81 -42.29 90.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.177 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 80.2 mt-10 -71.75 -30.27 65.41 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.524 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -58.52 -45.5 88.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.21 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.3 -48.16 89.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.862 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -70.07 -32.15 70.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.778 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 37.6 ttp -56.62 -47.71 79.08 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.722 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 69.7 mtm -106.09 134.1 49.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 110.658 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 88.8 m -160.1 81.58 0.7 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.351 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.62 92.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.939 0.399 . . . . 0.0 110.607 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.632 -179.972 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.134 0 N-CA-C 111.482 0.178 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -41.25 -45.78 3.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.851 0.358 . . . . 0.0 110.963 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -66.78 -39.62 87.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.795 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -62.76 -43.22 99.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.484 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.06 -40.82 91.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.752 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.78 -20.42 49.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.652 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -49.36 -47.95 47.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.817 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.3 m -77.72 -20.36 53.66 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.019 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.6 tp -64.04 -40.69 96.87 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.837 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.468 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 76.3 m-85 -57.69 -45.41 85.7 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.354 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 9.7 t0 -86.16 -20.35 28.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -44.06 -33.17 1.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.806 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.41 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 4.5 p-10 -56.0 -46.14 78.81 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 110.82 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -140.25 -152.61 5.85 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 28.2 p-10 -74.4 -47.09 36.1 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.728 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.71 107.09 0.28 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 178.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 6.3 m -166.44 148.82 6.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.199 0.499 . . . . 0.0 111.436 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.73 74.02 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 p -86.96 166.18 15.3 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.541 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.444 ' HG1' ' N ' ' A' ' 30' ' ' LYS . 1.4 p -66.31 -28.55 68.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.961 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.444 ' N ' ' HG1' ' A' ' 29' ' ' THR . 59.2 mttp -61.91 -40.21 94.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.925 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.468 ' OE1' ' O ' ' A' ' 19' ' ' PHE . 86.7 mt-10 -66.76 -40.47 88.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.959 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.7 tp -62.8 -43.54 98.54 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.63 -33.22 47.94 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 m -64.58 -44.62 90.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.91 0.355 . . . . 0.0 110.857 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.4 t -55.95 -17.34 3.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.113 0.483 . . . . 0.0 110.287 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.545 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 88.9 mmm -52.72 -40.81 63.38 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.733 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.2 ttt85 -64.27 -46.01 85.57 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 118.202 -1.399 . . . . 0.0 110.2 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.8 p -64.3 -19.23 65.29 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.63 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 36.4 mt -94.41 6.6 48.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.682 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 43.75 78.67 0.07 OUTLIER Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 40' ' ' GLY . 85.7 mt-30 52.76 117.23 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.852 0.358 . . . . 0.0 110.723 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' A' ' 44' ' ' THR . 35.2 t-20 -148.85 68.76 9.84 Favored Pre-proline 0 C--O 1.235 0.303 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.657 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.582 ' O ' ' N ' ' A' ' 46' ' ' ALA . 86.7 Cg_exo -35.85 -31.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 122.533 2.156 . . . . 0.0 111.983 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.449 ' N ' ' O ' ' A' ' 42' ' ' ASN . 29.5 m -38.58 -27.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.299 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.545 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 87.7 mt-10 -89.52 -32.44 17.17 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.848 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.33 -51.88 67.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.994 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -67.5 -46.06 73.99 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.192 0.52 . . . . 0.0 109.661 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.8 mt -63.6 -27.6 69.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.403 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -39.51 -53.66 2.04 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.811 0.339 . . . . 0.0 110.85 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -65.9 -38.26 88.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.24 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.5 ttp -62.33 -40.18 95.51 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 97.8 mt -62.04 -46.42 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 57' ' ' ALA . 9.4 m120 -62.38 -42.43 99.41 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.666 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.68 -55.66 31.57 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.119 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.87 -34.88 62.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.891 0.377 . . . . 0.0 111.065 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.531 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.9 t0 -82.92 -13.43 56.09 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.408 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -72.12 9.0 1.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.778 0.323 . . . . 0.0 110.154 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 12.6 p30 -61.56 -25.18 67.15 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.484 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -157.83 -19.97 0.03 OUTLIER Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.647 ' C ' ' H ' ' A' ' 62' ' ' THR . 5.1 p30 177.08 141.82 0.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.72 32.25 0.08 OUTLIER Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.647 ' H ' ' C ' ' A' ' 60' ' ' ASN . 64.0 p -130.29 150.08 51.69 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-O 121.002 0.43 . . . . 0.0 110.273 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.433 HD12 HG22 ' A' ' 63' ' ' ILE . 91.3 mt -116.98 138.93 46.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.144 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.53 166.14 19.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.444 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.429 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -62.95 -50.52 76.59 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.761 -179.119 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.4 Cg_exo -50.92 -44.88 39.32 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.994 1.796 . . . . 0.0 111.778 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.95 -36.32 72.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.977 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -60.03 -45.85 91.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.224 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.08 -44.5 95.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.625 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.5 m -67.4 -44.45 78.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.194 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.0 ttp -61.42 -40.13 93.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.05 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 76.3 mmm -63.01 -38.6 91.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.848 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.07 96.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.02 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -68.43 -45.55 72.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.11 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.59 -41.78 83.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.924 0.393 . . . . 0.0 110.366 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.8 mmt -86.92 164.47 16.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.086 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -116.24 153.61 31.58 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.004 0.43 . . . . 0.0 110.145 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -59.29 160.46 6.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.26 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.4 p -64.17 -30.06 71.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.546 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.43 -10.05 22.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.206 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -57.04 -32.85 66.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.513 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -49.43 -50.23 41.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.735 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.02 -41.92 94.88 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.005 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -66.27 -45.74 79.45 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.476 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.3 mt -64.9 -20.59 27.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -59.74 -42.18 92.61 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 119.079 -1.048 . . . . 0.0 110.184 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -61.46 -35.88 78.87 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.496 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.18 -13.39 60.45 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -48.02 -51.05 25.59 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.981 0.419 . . . . 0.0 111.41 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -59.78 -46.86 87.89 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.784 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.86 -44.35 81.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.991 0.424 . . . . 0.0 110.451 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -59.46 -44.41 92.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.567 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.435 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 33.0 t70 -138.82 100.73 4.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.24 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.1 -39.96 82.71 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.175 0.512 . . . . 0.0 110.164 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.435 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.2 p-10 -60.22 -42.54 95.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.291 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.71 -56.99 0.51 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -70.78 -13.59 62.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.146 0.498 . . . . 0.0 110.28 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.66 161.12 12.86 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -115.0 150.89 35.13 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.7 mt -85.19 123.18 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.025 0.44 . . . . 0.0 110.343 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.2 p -80.02 168.14 19.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.026 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.48 82.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.62 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.21 -45.3 93.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.056 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.97 -37.68 75.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.251 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.7 tp -61.94 -42.96 99.7 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.263 0.554 . . . . 0.0 111.257 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -52.56 -43.25 65.1 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.012 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -55.4 -42.75 74.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.199 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.63 -42.43 95.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.279 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 58.3 mmm -57.56 -34.78 69.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.476 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 80.3 m -60.19 -42.34 94.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.458 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -58.6 -38.73 78.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.9 tp -61.29 -46.35 90.71 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.025 0.44 . . . . 0.0 110.117 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.85 -154.89 25.97 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.237 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -143.24 11.8 1.75 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.737 -0.231 . . . . 0.0 110.76 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -63.92 -44.01 94.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.102 0.477 . . . . 0.0 110.631 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.6 mt -79.75 160.29 26.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.978 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.48 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.6 OUTLIER -68.5 161.69 27.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.273 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -92.33 -21.03 20.5 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.098 0.475 . . . . 0.0 110.45 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -85.45 -26.93 26.03 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.24 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.612 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.59 -63.55 0.35 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.612 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 11.3 m -69.09 -31.32 49.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 121.236 -0.185 . . . . 0.0 111.497 -178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -58.94 -67.08 0.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.717 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.58 -45.15 72.79 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.469 ' C ' ' SD ' ' A' ' 124' ' ' MET . 13.3 tmm? -52.91 -50.3 64.2 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.62 -18.38 23.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.653 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -87.92 -57.88 2.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.297 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 128' ' ' ALA . 51.1 tp10 -81.92 -67.78 0.75 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.236 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 127' ' ' GLU . . . -36.78 -35.65 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 56.6 t0 -87.69 146.18 25.81 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.298 0.57 . . . . 0.0 110.519 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.523 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -89.39 -14.94 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.783 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 133' ' ' ASP . 44.8 m-20 -73.59 -45.27 54.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.016 0.436 . . . . 0.0 110.4 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.29 -10.29 3.65 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 131' ' ' ASP . 35.3 p30 -89.84 -10.42 45.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.233 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 62.28 122.93 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -161.7 119.61 2.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.859 0.362 . . . . 0.0 110.073 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.61 128.9 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.13 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.526 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 45.3 t30 -155.08 166.32 33.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.063 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.402 ' O ' ' CD1' ' A' ' 138' ' ' TYR . 2.6 t80 -48.82 -23.06 0.95 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.415 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 50.0 mp0 -66.4 -35.74 81.09 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.153 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -84.97 -20.83 29.97 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.582 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -61.94 -46.84 87.56 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.102 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 29.5 t -58.22 -45.95 88.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.105 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -71.4 -36.07 71.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.332 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 61.4 ttp -58.09 -43.03 86.83 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.128 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 70.6 mtm -112.76 129.28 56.48 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.84 0.353 . . . . 0.0 110.377 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 m -162.81 85.8 0.55 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.047 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.13 -43.93 93.75 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.645 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.55 179.846 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.574 0.226 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -54.68 -48.25 72.62 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.538 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -65.7 -40.81 92.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -61.95 -44.08 97.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.67 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -67.06 -37.51 84.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.01 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.481 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.02 -27.92 65.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.826 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -57.81 -46.91 83.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.537 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.7 m -77.92 -21.51 51.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.68 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.4 -42.76 99.68 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.436 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.481 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.1 m-85 -60.2 -50.96 71.61 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.478 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.1 t0 -76.93 -14.35 59.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.912 0.387 . . . . 0.0 111.335 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -45.59 -32.68 2.44 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.84 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 8.8 p-10 -53.72 -46.08 70.7 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.57 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -144.36 -151.58 5.47 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 30.8 p-10 -72.97 -47.25 47.01 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.09 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.72 107.36 0.28 Allowed Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 178.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 4.7 m -166.59 139.32 3.76 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.129 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 mp -115.04 109.19 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.6 p -128.68 170.31 13.43 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.847 0.356 . . . . 0.0 110.418 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.603 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.2 p -64.69 -33.12 75.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.805 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -61.62 -41.4 97.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.053 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 26' ' ' THR . 90.0 mt-10 -63.41 -45.69 89.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.915 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.1 tp -64.13 -43.36 95.5 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.113 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.77 -26.1 53.24 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.1 m -63.87 -41.46 97.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.85 0.357 . . . . 0.0 110.071 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.1 t -56.28 -23.52 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.352 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.48 ' O ' ' N ' ' A' ' 40' ' ' GLY . 62.1 mmm -48.17 -30.21 4.42 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.679 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -64.41 -45.65 86.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.003 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.1 p -63.91 -21.99 66.72 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.856 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 41' ' ' GLN . 16.8 mt -107.7 3.68 24.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.094 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.15 -71.19 0.02 OUTLIER Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 39' ' ' LEU . 87.8 mt-30 -145.46 109.44 4.83 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 44' ' ' THR . 41.4 t30 -125.58 70.88 65.34 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.149 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 46' ' ' ALA . 85.4 Cg_exo -32.92 -30.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 122.66 2.24 . . . . 0.0 112.785 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.542 ' N ' ' O ' ' A' ' 42' ' ' ASN . 26.2 m -39.27 -30.15 0.05 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.522 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' A' ' 49' ' ' GLN . 93.9 mt-10 -86.7 -34.86 19.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.27 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -59.12 -50.08 75.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.779 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.13 -46.15 71.65 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.166 0.508 . . . . 0.0 109.655 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 51' ' ' MET . 84.5 mt -64.79 -31.15 72.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.359 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.603 HE22 ' CB ' ' A' ' 29' ' ' THR . 61.1 tp60 -37.47 -51.3 1.13 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.72 0.295 . . . . 0.0 110.838 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.25 -40.35 90.14 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.27 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.463 ' N ' ' O ' ' A' ' 48' ' ' LEU . 33.1 ttp -62.45 -40.95 98.27 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.0 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 83.5 mt -62.04 -49.88 82.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.145 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' A' ' 57' ' ' ALA . 89.8 m-20 -63.0 -40.38 97.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.585 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -55.19 -61.54 2.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.193 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.9 -30.12 43.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.779 0.323 . . . . 0.0 111.285 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 62' ' ' THR . 50.6 t0 -84.68 -13.21 52.11 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.528 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -71.97 13.0 0.33 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.868 0.366 . . . . 0.0 110.295 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.7 p30 -65.57 -28.86 69.45 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.539 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -150.55 -22.4 0.06 OUTLIER Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.577 ' C ' ' H ' ' A' ' 62' ' ' THR . 3.3 p30 173.13 151.88 0.08 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.99 34.76 0.14 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.577 ' H ' ' C ' ' A' ' 60' ' ' ASN . 81.7 p -134.39 149.48 50.81 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.3 mt -121.02 134.52 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.14 162.44 28.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.416 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.471 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -64.65 -48.14 74.33 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.478 -179.096 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 50.3 Cg_exo -51.17 -37.36 58.49 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.171 1.914 . . . . 0.0 111.739 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -87.61 -22.3 24.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.35 -47.2 86.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.852 0.358 . . . . 0.0 111.028 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.5 -42.89 98.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.567 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.4 m -63.92 -46.11 86.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.668 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.7 ttp -61.76 -47.45 85.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.077 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 82.0 mmm -65.82 -37.79 87.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.271 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.62 -49.97 75.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.031 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -71.5 -43.76 65.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.196 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.72 -43.61 88.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.7 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 73' ' ' ALA . 22.3 mmm -104.31 127.46 51.96 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.07 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.7 tptt -84.97 141.11 30.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.931 0.396 . . . . 0.0 110.711 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 77' ' ' LYS . 95.0 m-20 -48.9 179.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.266 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.3 p -75.47 -6.77 51.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.456 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.47 -15.53 62.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.511 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.9 m -61.89 -19.91 63.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.527 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -48.2 -44.72 33.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.33 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.99 -39.49 79.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.894 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -65.89 -45.13 83.16 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.01 0.433 . . . . 0.0 110.197 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.3 mt -66.05 -19.09 25.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.494 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -58.43 -45.42 88.52 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 118.971 -1.092 . . . . 0.0 110.156 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.62 -31.79 73.01 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.923 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -72.08 -14.61 61.9 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.16 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -57.97 -48.98 78.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.328 0.585 . . . . 0.0 111.092 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -64.1 -45.57 88.05 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.358 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -76.2 -51.58 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 110.849 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.417 ' CE2' ' CD1' ' A' ' 100' ' ' ILE . 26.3 t80 -62.02 -47.17 85.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.625 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 18.2 t70 -108.98 94.24 4.94 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.29 -41.02 73.93 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 110.535 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 19.8 p-10 -62.52 -39.71 94.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.961 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.44 -67.29 0.97 Allowed Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.57 -16.56 63.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.009 0.433 . . . . 0.0 110.242 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.82 161.99 12.57 Favored Glycine 0 N--CA 1.465 0.575 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.28 155.33 24.24 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.775 0.321 . . . . 0.0 110.23 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.417 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 94.2 mt -79.66 125.99 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.974 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.4 p -82.39 168.94 17.0 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.128 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.51 -38.04 89.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.513 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.65 -47.3 84.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.916 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.67 -32.88 73.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.958 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.4 tp -61.52 -41.7 97.71 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.382 0.61 . . . . 0.0 110.706 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -56.43 -43.31 79.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.77 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -58.49 -41.88 86.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.3 t -66.68 -43.37 90.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.646 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.0 mmm -62.03 -35.59 79.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.642 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.2 m -61.09 -44.37 97.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.055 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -59.76 -35.0 73.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.378 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.0 tp -61.18 -46.73 89.28 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.081 0.467 . . . . 0.0 110.391 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.5 -160.71 33.43 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -140.53 23.35 2.31 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.603 0.24 . . . . 0.0 110.746 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -63.61 -42.79 98.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.962 0.41 . . . . 0.0 110.277 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.7 mt -92.88 175.8 6.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.972 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.467 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -72.85 161.29 30.9 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.668 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -91.66 -22.44 20.25 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.979 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -87.91 -25.32 23.29 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.174 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.641 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.41 -61.24 0.46 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.123 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.641 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 20.2 m -67.39 -40.21 84.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -56.73 -47.05 80.88 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.595 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -86.03 -40.28 15.95 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.7 tmm? -59.56 -46.53 88.63 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.081 0.467 . . . . 0.0 109.914 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 91.5 mt -69.1 -16.61 21.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.424 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -78.6 -50.51 11.38 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 119.394 -0.922 . . . . 0.0 112.148 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 129' ' ' ASP . 42.4 tp10 -87.69 -67.52 0.82 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.834 -178.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.33 -26.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.794 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 127' ' ' GLU . 25.4 t0 -87.95 128.26 35.37 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.058 0.456 . . . . 0.0 111.132 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.544 ' H ' ' CD1' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.48 -43.38 90.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.457 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -65.35 -40.33 93.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.19 0.519 . . . . 0.0 110.178 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.33 -1.97 58.84 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' GLY . 55.2 p-10 -89.49 -8.98 51.73 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 57.38 115.48 0.01 OUTLIER Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 20.3 pt20 -160.64 133.64 6.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.2 t -123.47 136.89 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.081 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -151.35 172.49 15.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.243 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -54.86 -46.78 74.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.13 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 55.2 mp0 -58.68 -44.36 90.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.657 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 93.4 mt-10 -72.0 -29.41 64.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.775 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.89 -43.98 77.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.586 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 94.1 t -59.16 -46.29 92.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.26 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.35 -29.09 66.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.124 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.8 ttp -59.7 -42.88 93.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.796 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.46 138.84 50.6 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.963 0.411 . . . . 0.0 110.731 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.2 m -163.24 77.72 0.43 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.661 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.16 -27.76 68.93 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.438 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 117.884 -1.055 . . . . 0.0 110.665 -179.864 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 120.776 0.322 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -54.18 -42.33 69.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.098 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -67.81 -41.71 82.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.375 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -62.63 -43.68 98.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.982 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -67.25 -35.75 80.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.437 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.414 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.49 -24.19 66.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.699 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -55.37 -46.51 76.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.79 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.3 m -80.65 -19.5 45.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.783 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.17 -41.96 96.92 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.052 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.425 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.3 m-85 -58.84 -46.1 88.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.871 0.367 . . . . 0.0 111.144 -178.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.448 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.3 t0 -79.57 -13.47 59.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.499 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -42.99 -32.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.915 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' CG ' ' OE2' ' A' ' 31' ' ' GLU . 10.9 p-10 -52.9 -45.13 67.41 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.481 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.436 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . -149.64 -151.21 5.44 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 21.2 p-10 -71.21 -46.9 60.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.685 0.278 . . . . 0.0 110.957 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.531 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.04 107.34 0.28 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.456 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 5.7 m -166.51 136.22 3.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.215 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.421 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.9 mp -110.53 118.3 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.0 p -134.76 167.05 21.56 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.897 0.38 . . . . 0.0 110.291 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.504 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.3 p -64.08 -33.69 76.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.31 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -62.57 -40.16 95.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.701 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.456 ' OE2' ' O ' ' A' ' 26' ' ' THR . 88.9 mt-10 -64.66 -48.56 74.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.313 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.38 -43.72 93.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.321 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.31 -24.72 17.09 Favored Glycine 0 C--O 1.224 -0.469 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -64.05 -40.99 97.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.873 0.368 . . . . 0.0 110.226 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.15 -22.37 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.205 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.6 mmm -48.87 -33.45 10.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.021 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -64.32 -45.47 87.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 118.152 -1.419 . . . . 0.0 110.278 -178.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.1 p -59.04 -30.67 68.2 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.301 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 41' ' ' GLN . 9.2 mt -102.3 5.45 39.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.974 0.416 . . . . 0.0 110.472 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.26 -69.79 0.03 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 39' ' ' LEU . 85.8 mt-30 -143.28 116.25 8.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.132 -0.534 . . . . 0.0 109.589 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.1 t30 -132.58 69.69 79.61 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.945 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.549 ' O ' ' N ' ' A' ' 46' ' ' ALA . 91.4 Cg_exo -33.0 -33.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 122.545 2.164 . . . . 0.0 112.476 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.477 ' N ' ' O ' ' A' ' 42' ' ' ASN . 12.7 m -39.07 -29.33 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.371 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 43' ' ' PRO . 90.6 mt-10 -87.67 -35.17 18.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.486 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -61.23 -49.22 78.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.998 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -68.09 -48.48 65.39 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.397 0.617 . . . . 0.0 109.951 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.72 -22.68 66.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.009 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.504 HE22 ' CB ' ' A' ' 29' ' ' THR . 48.0 tp60 -40.27 -49.6 2.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.87 0.367 . . . . 0.0 110.475 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.64 -39.85 73.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.478 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.1 ttp -61.56 -40.55 95.11 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.743 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.82 -46.91 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.586 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 57' ' ' ALA . 28.3 m120 -65.13 -39.91 93.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.358 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -58.03 -57.22 13.79 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.474 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 p -68.26 -32.85 57.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.923 0.392 . . . . 0.0 110.997 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.532 ' C ' ' H ' ' A' ' 58' ' ' ASP . 42.9 t0 -86.06 -13.08 48.43 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.805 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.561 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -72.06 15.43 0.16 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.532 ' H ' ' C ' ' A' ' 56' ' ' ASP . 38.7 p-10 -66.74 -23.48 66.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.4 -22.61 0.03 OUTLIER Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.621 ' C ' ' H ' ' A' ' 62' ' ' THR . 4.6 p30 179.34 146.51 0.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.75 33.78 0.18 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.621 ' H ' ' C ' ' A' ' 60' ' ' ASN . 80.6 p -132.2 143.94 50.3 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.92 135.15 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.034 0.445 . . . . 0.0 110.191 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.38 172.4 4.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.456 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.436 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -72.6 -49.57 8.38 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.764 -179.612 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 53.2 Cg_exo -52.03 -43.31 53.41 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.885 1.723 . . . . 0.0 111.88 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.45 -37.46 77.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.846 0.355 . . . . 0.0 110.898 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -60.34 -45.4 93.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.926 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.0 mt -62.39 -44.62 96.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.503 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.6 m -67.4 -45.49 76.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.736 0.303 . . . . 0.0 111.231 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.4 ttp -61.09 -43.72 98.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.977 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 87.0 mmm -64.75 -39.35 93.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.223 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.91 -42.88 94.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.838 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -71.51 -41.7 68.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.279 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -64.74 -40.94 96.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.804 0.335 . . . . 0.0 110.436 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 73' ' ' ALA . 14.2 mmt -95.27 129.84 42.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.079 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -86.81 142.81 27.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -50.41 168.87 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.379 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.3 p -75.24 -15.21 60.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.645 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.98 -16.46 64.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.449 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.1 m -60.46 -23.7 64.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.758 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -36.75 -48.45 0.73 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.931 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -70.79 -43.54 68.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.247 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -63.78 -39.63 94.73 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.012 0.434 . . . . 0.0 110.085 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.6 mt -66.98 -21.89 28.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.231 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -57.96 -43.65 86.56 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.085 -1.046 . . . . 0.0 110.053 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -63.7 -34.74 78.54 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.889 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.83 -19.85 66.03 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.081 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -56.64 -48.8 76.74 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.253 0.549 . . . . 0.0 110.817 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -68.19 -44.69 75.29 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.471 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.9 t -66.34 -48.39 81.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -63.96 -47.19 81.38 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.632 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.408 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 18.4 t70 -120.32 100.17 7.01 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -66.71 -39.75 88.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.812 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -65.67 -40.6 92.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.104 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.62 -59.48 0.48 Allowed Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -61.86 -17.41 56.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.978 0.418 . . . . 0.0 110.201 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.408 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.58 160.91 12.96 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -113.33 155.55 24.98 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.7 mt -95.77 118.22 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.04 0.448 . . . . 0.0 111.072 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.9 p -85.53 171.37 11.79 Favored 'General case' 0 C--N 1.335 -0.063 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.908 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.68 -35.76 78.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.572 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.43 -50.86 72.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.131 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.28 -37.37 77.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.919 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.06 -39.34 94.43 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.478 0.656 . . . . 0.0 111.089 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -54.18 -43.67 70.86 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.131 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -63.09 -39.49 94.87 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.85 -45.22 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.192 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 37.8 mmm -64.3 -38.05 89.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.483 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.8 m -60.57 -40.09 90.38 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -61.27 -38.11 85.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.175 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 tp -61.6 -44.07 97.68 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.868 0.366 . . . . 0.0 110.213 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.97 -154.78 25.78 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -138.97 23.42 2.6 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.577 -0.312 . . . . 0.0 110.728 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -62.67 -43.26 99.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.06 0.457 . . . . 0.0 110.309 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.9 mt -99.91 169.06 9.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.54 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.494 ' HG1' ' H ' ' A' ' 117' ' ' THR . 0.8 OUTLIER -68.34 162.11 25.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.86 0.362 . . . . 0.0 110.51 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -92.14 -22.21 19.99 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.421 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -87.29 -24.47 24.33 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.611 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.65 -66.06 0.21 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.196 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.611 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.6 m -65.09 -35.31 75.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.416 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -60.47 -46.8 88.75 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.558 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -84.92 -40.34 17.13 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.4 tmm? -58.92 -47.22 85.8 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.4 mt -69.18 -18.32 22.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.578 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -77.43 -51.37 10.89 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 119.044 -1.063 . . . . 0.0 111.307 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 129' ' ' ASP . 34.7 tp10 -86.32 -68.7 0.72 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.46 -177.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.64 -21.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 127' ' ' GLU . 38.7 t0 -90.16 125.06 35.33 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.139 0.495 . . . . 0.0 110.606 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.496 ' H ' ' CD1' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.5 -31.99 56.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.052 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -72.16 -45.84 58.81 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.93 0.395 . . . . 0.0 110.362 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.63 -5.41 61.15 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 134' ' ' GLY . 35.3 p30 -89.95 -9.69 47.85 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 58.24 117.92 0.01 OUTLIER Glycine 0 CA--C 1.519 0.335 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 8.2 pt20 -159.73 140.13 11.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.161 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.5 t -126.25 133.35 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.544 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.9 t30 -150.74 175.34 12.07 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.323 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -57.69 -52.09 66.85 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.766 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.544 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 57.2 mp0 -55.88 -35.04 66.07 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.736 -178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 79.3 mt-10 -69.46 -39.31 77.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.712 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -61.21 -45.38 94.83 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.0 t -57.94 -46.0 87.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -74.12 -30.92 62.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.397 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.4 ttp -60.03 -40.66 90.12 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.623 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.405 ' O ' ' OG1' ' A' ' 146' ' ' THR . 72.9 mtm -105.18 141.69 36.28 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.888 0.375 . . . . 0.0 110.631 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 145' ' ' MET . 62.9 m -167.23 72.06 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.104 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.61 -41.79 97.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.561 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 C--O 1.218 -0.559 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.263 -179.906 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.149 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -41.28 -45.7 3.02 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.819 0.342 . . . . 0.0 110.949 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -66.88 -39.62 87.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.724 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -62.74 -43.19 99.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.508 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.06 -40.84 91.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.767 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.79 -20.41 49.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.617 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -49.42 -47.94 47.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.793 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.0 m -77.74 -20.35 53.61 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.994 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.9 tp -64.06 -40.67 96.8 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.785 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.47 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 76.2 m-85 -57.67 -45.47 85.52 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.354 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 9.8 t0 -86.06 -20.42 28.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -44.04 -33.18 1.37 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.794 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.409 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 4.5 p-10 -55.91 -46.16 78.5 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.88 0.371 . . . . 0.0 110.839 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -140.32 -152.62 5.84 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 28.1 p-10 -74.48 -46.99 35.99 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.711 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.73 107.08 0.28 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 6.3 m -166.46 148.77 6.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.178 0.489 . . . . 0.0 111.445 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.66 74.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 p -86.93 166.16 15.33 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.998 0.428 . . . . 0.0 110.53 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.437 ' HG1' ' N ' ' A' ' 30' ' ' LYS . 1.4 p -66.28 -28.62 68.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.972 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.437 ' N ' ' HG1' ' A' ' 29' ' ' THR . 59.1 mttp -61.89 -40.21 94.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.914 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.47 ' OE1' ' O ' ' A' ' 19' ' ' PHE . 86.7 mt-10 -66.73 -40.44 88.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.977 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.7 tp -62.82 -43.56 98.47 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.61 -33.2 47.83 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 m -64.58 -44.64 90.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.949 0.374 . . . . 0.0 110.865 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.3 t -55.9 -17.36 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.297 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.544 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 88.9 mmm -52.73 -40.8 63.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.709 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.1 ttt85 -64.23 -46.05 85.5 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 118.165 -1.414 . . . . 0.0 110.229 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.2 p -64.28 -19.24 65.27 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.657 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 36.4 mt -94.34 6.54 48.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.731 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 43.72 78.78 0.07 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.491 ' O ' ' O ' ' A' ' 40' ' ' GLY . 85.7 mt-30 52.65 117.2 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.845 0.355 . . . . 0.0 110.783 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 44' ' ' THR . 35.2 t-20 -148.8 68.75 9.88 Favored Pre-proline 0 C--O 1.235 0.294 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.745 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.586 ' O ' ' N ' ' A' ' 46' ' ' ALA . 86.9 Cg_exo -35.85 -31.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.455 2.103 . . . . 0.0 111.978 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.451 ' N ' ' O ' ' A' ' 42' ' ' ASN . 29.9 m -38.57 -27.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.287 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.544 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 87.7 mt-10 -89.52 -32.43 17.18 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.818 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.41 -51.87 68.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.014 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -67.43 -46.07 74.21 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.18 0.514 . . . . 0.0 109.683 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.64 -27.64 69.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.344 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -39.54 -53.61 2.07 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.815 0.341 . . . . 0.0 110.804 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -65.94 -38.26 88.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.261 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.5 ttp -62.34 -40.18 95.52 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 98.0 mt -62.05 -46.4 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 57' ' ' ALA . 9.5 m120 -62.38 -42.38 99.37 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.679 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.73 -55.62 32.05 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.167 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 p -69.87 -34.89 62.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 120.894 0.378 . . . . 0.0 111.089 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.9 t0 -82.89 -13.45 56.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.404 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -72.08 8.92 1.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.819 0.342 . . . . 0.0 110.179 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 12.6 p30 -61.6 -25.09 67.12 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -157.83 -19.98 0.03 OUTLIER Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.645 ' C ' ' H ' ' A' ' 62' ' ' THR . 5.1 p30 177.07 141.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.73 32.24 0.08 OUTLIER Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.645 ' H ' ' C ' ' A' ' 60' ' ' ASN . 63.8 p -130.3 150.12 51.68 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-O 120.983 0.42 . . . . 0.0 110.266 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.434 HD12 HG22 ' A' ' 63' ' ' ILE . 91.6 mt -117.05 138.97 45.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.145 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.56 166.16 19.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.381 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.432 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -62.93 -50.55 76.52 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.756 -179.138 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.5 Cg_exo -50.89 -44.95 38.82 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.999 1.799 . . . . 0.0 111.788 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.94 -36.27 72.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.984 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -60.07 -45.83 91.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.194 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.08 -44.59 95.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.561 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.2 m -67.36 -44.39 79.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.27 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.9 ttp -61.47 -40.14 93.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.02 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 76.0 mmm -63.02 -38.58 91.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.805 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.11 96.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.008 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -68.43 -45.56 72.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.081 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.57 -41.79 83.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.976 0.417 . . . . 0.0 110.36 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.8 mmt -86.93 164.42 16.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.137 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -116.2 153.55 31.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.954 0.406 . . . . 0.0 110.154 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -59.26 160.44 6.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.31 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.6 p -64.14 -30.04 71.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.571 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -64.42 -10.04 22.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.182 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -57.08 -32.78 66.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.535 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -49.49 -50.23 42.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.712 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.02 -41.9 94.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.038 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -66.31 -45.71 79.4 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.469 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.4 mt -64.91 -20.61 27.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -59.67 -42.23 92.41 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.245 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -61.49 -35.89 78.94 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.468 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.13 -13.42 60.47 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -47.98 -51.1 25.13 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.013 0.435 . . . . 0.0 111.421 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -59.76 -46.82 87.97 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.822 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.87 -44.35 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.979 0.418 . . . . 0.0 110.451 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -59.44 -44.35 92.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.573 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 33.0 t70 -138.9 100.65 4.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.267 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.07 -39.98 82.83 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.209 0.528 . . . . 0.0 110.154 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.2 p-10 -60.18 -42.61 95.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.286 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.71 -56.98 0.51 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -70.69 -13.68 62.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.156 0.503 . . . . 0.0 110.286 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.63 161.12 12.87 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -115.04 150.93 35.11 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.5 mt -85.24 123.18 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.999 0.428 . . . . 0.0 110.375 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.2 p -80.01 168.12 19.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.049 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.3 -36.44 82.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.615 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.18 -45.24 94.26 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.082 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -70.08 -37.66 75.51 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.192 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.2 tp -62.0 -42.86 99.61 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.23 0.538 . . . . 0.0 111.248 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -52.62 -43.23 65.26 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.02 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -55.39 -42.73 74.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.914 0.388 . . . . 0.0 110.231 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.5 t -64.63 -42.44 95.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.259 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 58.3 mmm -57.56 -34.75 69.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.461 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.1 m -60.26 -42.37 95.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.37 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -58.57 -38.73 78.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.9 tp -61.35 -46.29 90.83 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 120.952 0.406 . . . . 0.0 110.126 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.9 -154.91 26.0 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -143.29 11.89 1.75 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.703 -0.249 . . . . 0.0 110.759 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -63.97 -43.99 94.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.114 0.483 . . . . 0.0 110.612 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.4 mt -79.77 160.3 26.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.99 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.475 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.6 OUTLIER -68.46 161.7 27.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.245 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -92.37 -21.07 20.45 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.063 0.458 . . . . 0.0 110.404 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -85.43 -26.93 26.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.234 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.611 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.59 -63.57 0.34 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -178.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.611 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 11.3 m -69.1 -31.35 49.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.457 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -58.86 -67.15 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.721 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.56 -45.19 72.75 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.468 ' C ' ' SD ' ' A' ' 124' ' ' MET . 13.3 tmm? -52.85 -50.27 64.1 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.6 -18.4 23.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.655 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -87.92 -57.86 2.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.306 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 128' ' ' ALA . 51.0 tp10 -81.96 -67.79 0.75 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.248 -178.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 127' ' ' GLU . . . -36.77 -35.64 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 56.7 t0 -87.69 146.15 25.82 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.258 0.551 . . . . 0.0 110.576 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.526 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -89.36 -15.02 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.778 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.47 ' C ' ' H ' ' A' ' 133' ' ' ASP . 44.9 m-20 -73.54 -45.29 54.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.994 0.426 . . . . 0.0 110.427 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.39 -10.3 3.75 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' A' ' 131' ' ' ASP . 35.2 p30 -89.88 -10.4 45.39 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.816 0.341 . . . . 0.0 110.172 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 62.18 122.99 0.01 OUTLIER Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -161.69 119.65 2.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.913 0.387 . . . . 0.0 110.08 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.65 128.91 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.128 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.525 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 45.3 t30 -155.07 166.26 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.064 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.4 ' O ' ' CD1' ' A' ' 138' ' ' TYR . 2.6 t80 -48.79 -23.04 0.93 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.444 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.539 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 50.1 mp0 -66.42 -35.75 81.08 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.151 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -84.95 -20.83 30.0 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.633 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.04 -46.68 88.1 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.141 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 29.8 t -58.28 -46.0 89.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.028 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -71.33 -36.12 71.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.305 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 61.5 ttp -57.99 -43.04 86.36 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.193 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 70.7 mtm -112.85 129.26 56.51 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.85 0.357 . . . . 0.0 110.328 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.6 m -162.78 85.82 0.55 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.064 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.15 -43.81 94.05 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.675 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.516 179.834 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.067 0 CA-C-O 120.586 0.231 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -47.63 -48.63 28.53 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.118 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -59.48 -44.87 92.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.83 0.347 . . . . 0.0 110.442 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -63.37 -39.68 95.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.693 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.31 -41.3 85.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.824 0.345 . . . . 0.0 111.158 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.47 -22.69 66.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.829 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -55.57 -47.89 75.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.2 m -81.37 -17.2 49.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.553 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.96 -43.72 98.03 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.423 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.417 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.5 m-85 -60.52 -50.36 73.86 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.553 -178.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.3 t0 -77.13 -14.56 59.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.188 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -45.11 -32.91 1.95 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.209 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.449 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 18.0 p-10 -54.73 -45.99 74.19 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.824 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -144.04 -151.1 5.38 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 32.2 p-10 -73.06 -47.08 47.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.675 0.274 . . . . 0.0 110.772 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.482 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.73 107.31 0.28 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.427 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 4.9 m -166.24 142.77 5.0 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.745 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.02 103.46 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.9 p -123.14 169.93 10.73 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.091 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.567 ' CB ' HE22 ' A' ' 49' ' ' GLN . 60.2 p -63.1 -35.35 79.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.833 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -60.34 -38.48 83.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.449 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 87.7 mt-10 -65.59 -43.12 90.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.097 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.76 -41.9 97.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.227 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.82 -28.67 17.21 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.1 m -64.58 -44.15 91.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 0.0 110.762 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.2 t -57.09 -17.6 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.194 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.543 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 87.6 mmm -53.01 -38.58 62.44 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.199 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.6 ttt85 -64.27 -46.04 85.44 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 117.412 -1.715 . . . . 0.0 110.668 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 93.5 p -63.4 -19.9 65.08 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.553 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 40' ' ' GLY . 52.5 mt -99.64 6.16 45.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.882 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 34.8 94.62 0.01 OUTLIER Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 40' ' ' GLY . 84.1 mt-30 52.3 110.1 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.599 0.238 . . . . 0.0 110.418 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 44' ' ' THR . 49.9 t30 -145.71 63.94 9.9 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.701 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 46' ' ' ALA . 88.7 Cg_exo -34.71 -30.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.56 2.173 . . . . 0.0 112.32 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.498 ' N ' ' O ' ' A' ' 42' ' ' ASN . 23.4 m -40.14 -29.51 0.08 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.123 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.543 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 90.7 mt-10 -89.73 -29.89 18.41 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.763 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -60.83 -49.15 78.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.82 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -72.17 -43.18 64.99 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.296 0.569 . . . . 0.0 109.755 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.3 mt -68.0 -25.05 65.22 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.212 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.567 HE22 ' CB ' ' A' ' 29' ' ' THR . 53.7 tp60 -40.85 -41.86 1.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.0 110.582 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -77.7 -36.75 50.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.5 ttp -59.98 -37.3 79.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.628 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.5 -44.78 98.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.043 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.451 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 19.5 m120 -62.57 -39.86 95.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.342 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -56.62 -56.44 21.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.273 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.0 p -74.14 -40.32 51.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.883 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.504 ' OD2' ' N ' ' A' ' 62' ' ' THR . 44.4 t0 -71.18 -13.3 61.88 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.52 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 53' ' ' ASN . . . -72.25 8.97 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.099 0.476 . . . . 0.0 110.346 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 56' ' ' ASP . 10.3 p-10 -59.73 -26.72 65.88 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -155.08 -24.42 0.03 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.578 ' C ' ' H ' ' A' ' 62' ' ' THR . 10.0 p30 176.15 151.17 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.29 36.32 0.09 OUTLIER Glycine 0 CA--C 1.535 1.306 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.578 ' H ' ' C ' ' A' ' 60' ' ' ASN . 44.2 p -137.38 153.34 50.21 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.5 mt -127.43 137.02 58.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.972 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -81.21 164.55 22.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.083 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.427 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -62.07 -50.13 81.87 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.232 -179.721 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.5 Cg_exo -50.12 -41.74 48.44 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.08 1.853 . . . . 0.0 112.046 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -80.77 -29.79 36.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.118 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -59.48 -45.07 92.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.989 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.42 -43.14 99.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.305 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.9 m -64.36 -44.92 89.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.869 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 46.9 ttp -60.08 -44.66 94.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.855 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 79.4 mmm -63.82 -40.86 97.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.266 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.408 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -61.27 -47.77 84.51 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.957 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -71.27 -46.28 61.29 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.458 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -66.72 -45.28 79.2 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.927 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.408 ' O ' ' O ' ' A' ' 73' ' ' ALA . 17.8 mmm -99.5 -176.68 3.35 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.054 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -128.51 152.15 48.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.153 0.501 . . . . 0.0 110.169 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -54.21 177.66 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.341 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.3 p -80.47 -15.81 55.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.582 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -66.38 -13.65 60.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.395 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 83' ' ' GLU . 72.7 m -53.38 -34.27 57.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.601 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.436 ' O ' ' OH ' ' A' ' 138' ' ' TYR . 74.6 tt0 -39.08 -28.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.381 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 81' ' ' SER . 75.8 mm-40 -85.35 -54.79 4.37 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.042 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -58.56 -36.29 73.69 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.905 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.55 -20.04 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -61.0 -45.09 96.24 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 118.409 -1.316 . . . . 0.0 109.588 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -64.61 -21.8 66.81 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.189 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.4 -17.54 48.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.439 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -57.01 -50.19 73.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.376 0.607 . . . . 0.0 110.572 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -68.62 -44.95 73.16 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.864 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.6 t -65.32 -49.07 80.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.069 0.462 . . . . 0.0 110.022 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -62.59 -45.19 94.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.905 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.411 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 22.2 t0 -120.53 104.52 10.03 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.119 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -66.36 -41.22 89.82 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.029 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -70.39 -41.66 72.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.063 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.89 -52.98 0.74 Allowed Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -64.02 -20.08 65.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.934 0.397 . . . . 0.0 110.297 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.411 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.66 161.01 12.9 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -113.34 148.31 35.96 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.7 mt -84.96 123.62 39.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.9 p -87.35 176.7 7.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.122 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.64 -36.49 83.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.963 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.57 -51.35 69.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.878 0.371 . . . . 0.0 110.977 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.39 -30.54 66.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 49.4 tp -61.69 -41.04 97.04 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.23 0.538 . . . . 0.0 111.106 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -54.22 -41.49 68.73 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.881 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -57.92 -42.69 85.33 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.3 t -65.57 -43.2 94.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.668 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 91.6 mmm -62.55 -37.23 85.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.476 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.8 m -59.43 -40.48 86.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.657 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -58.6 -38.73 78.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.724 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.0 tp -61.01 -45.1 96.2 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.547 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.09 -145.3 12.03 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -143.6 16.38 1.82 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.761 0.315 . . . . 0.0 110.679 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -61.86 -44.91 95.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.997 0.427 . . . . 0.0 110.468 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 82.8 mt -82.08 161.34 22.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.966 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.474 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -66.02 161.7 21.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.653 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -91.63 -19.62 22.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.866 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -87.67 -28.14 22.01 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.632 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.32 -66.85 0.17 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.632 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.4 m -64.05 -39.33 85.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 111.909 0.336 . . . . 0.0 111.909 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -54.27 -65.91 0.49 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.676 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 127' ' ' GLU . 80.6 mm-40 -70.42 -44.93 66.89 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.423 ' C ' ' SD ' ' A' ' 124' ' ' MET . 18.9 tmm? -53.0 -47.62 68.13 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 120.486 -0.486 . . . . 0.0 109.879 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 97.7 mt -67.19 -19.73 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.356 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -91.24 -66.84 0.89 Allowed 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.984 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 123' ' ' GLU . 24.9 tp10 -65.24 -68.53 0.36 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.21 -177.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.21 -37.67 0.18 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.48 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 66.0 t0 -87.5 138.23 31.65 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.207 0.527 . . . . 0.0 110.591 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.496 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -85.8 -16.09 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.335 -179.7 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -73.08 -46.54 50.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.121 0.486 . . . . 0.0 110.141 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.96 -2.59 54.92 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 52.1 p30 -88.67 -22.3 23.49 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 64.6 103.72 0.01 OUTLIER Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -147.77 140.77 24.95 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.784 0.326 . . . . 0.0 110.158 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.2 t -128.93 134.32 64.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.314 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.527 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 53.3 t30 -151.57 -179.09 7.11 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.624 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.436 ' OH ' ' O ' ' A' ' 82' ' ' GLU . 68.7 t80 -57.28 -48.15 79.63 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.267 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.527 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 55.9 mp0 -50.91 -43.66 59.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.352 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -67.69 -39.82 84.42 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.91 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -60.72 -43.65 97.61 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.598 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.3 t -54.19 -43.89 62.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.345 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -84.25 -19.38 33.99 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.064 -0.255 . . . . 0.0 111.223 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 41.1 ttp -65.07 -41.3 95.2 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.949 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.412 ' O ' ' OG1' ' A' ' 146' ' ' THR . 51.7 mtm -103.67 132.68 49.71 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.847 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 145' ' ' MET . 43.4 m -166.83 81.77 0.24 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.061 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.8 -37.19 75.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.342 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.1 mttm . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.458 179.948 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.883 0.373 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -51.5 -43.22 62.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.748 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -66.94 -46.38 74.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.874 0.368 . . . . 0.0 111.03 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -61.62 -44.81 96.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.792 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -67.96 -40.96 83.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.628 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.13 -28.42 67.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.022 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -55.58 -45.84 77.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.673 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.7 m -81.61 -17.83 46.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.723 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.7 tp -65.51 -42.36 92.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.918 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.403 ' O ' ' CD ' ' A' ' 31' ' ' GLU . 73.3 m-85 -61.06 -45.95 92.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.309 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 4.7 t0 -81.93 -15.66 53.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.357 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -42.82 -32.5 0.62 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.114 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.433 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 9.2 p-10 -53.67 -46.7 70.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.896 0.379 . . . . 0.0 110.712 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.433 ' N ' ' CG ' ' A' ' 22' ' ' ASP . . . -145.67 -147.33 4.58 Favored Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 20.5 p-10 -76.46 -47.57 22.51 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.898 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.01 106.97 0.27 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 95.7 m -166.72 143.13 4.64 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.968 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.05 117.06 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.849 0.357 . . . . 0.0 110.113 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.4 p -133.38 165.57 24.52 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.403 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.498 ' CB ' HE22 ' A' ' 49' ' ' GLN . 79.9 p -63.02 -35.13 79.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.33 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -61.26 -38.58 87.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.021 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.413 ' OE2' ' CG ' ' A' ' 22' ' ' ASP . 91.3 mt-10 -64.62 -49.13 72.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.359 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.37 -43.65 98.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.182 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.2 -23.94 4.47 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.3 m -64.9 -42.51 94.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.914 0.388 . . . . 0.0 110.545 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.405 ' O ' ' OG ' ' A' ' 38' ' ' SER . 54.3 t -54.59 -16.3 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.219 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.452 ' O ' ' N ' ' A' ' 40' ' ' GLY . 53.4 mmm -58.73 -37.27 75.8 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -62.48 -46.13 89.89 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 116.727 -1.989 . . . . 0.0 110.618 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 35' ' ' VAL . 23.7 p -60.12 -36.17 76.88 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.034 -178.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 41' ' ' GLN . 44.7 mt -95.87 2.08 53.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.701 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 66.2 -66.44 0.15 Allowed Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 39' ' ' LEU . 74.6 mt-30 -141.66 122.77 14.67 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.3 t-20 -141.5 71.15 26.19 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.636 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 46' ' ' ALA . 73.1 Cg_exo -37.42 -30.45 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.222 1.948 . . . . 0.0 112.136 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 42' ' ' ASN . 25.1 m -39.04 -27.62 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.488 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 49' ' ' GLN . 86.7 mt-10 -90.31 -36.92 14.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.011 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -56.27 -48.88 75.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.411 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -70.5 -45.08 66.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.289 0.566 . . . . 0.0 110.071 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.08 -20.05 63.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.82 -178.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 45' ' ' GLU . 67.3 tp60 -46.48 -46.22 18.84 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.608 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -75.06 -35.29 61.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.242 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 33.2 ttp -63.71 -43.03 97.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.016 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 96.7 mt -62.76 -46.21 96.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.753 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.465 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 24.1 m120 -64.65 -40.7 95.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.766 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -60.08 -56.84 16.72 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.42 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.68 -37.01 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.016 0.436 . . . . 0.0 110.94 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.549 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.5 t0 -79.06 -12.6 60.02 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.446 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 53' ' ' ASN . . . -72.15 15.43 0.16 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.314 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' A' ' 56' ' ' ASP . 10.5 p30 -65.76 -21.87 66.54 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -167.82 -9.56 0.03 OUTLIER Glycine 0 C--N 1.333 0.4 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.593 ' C ' ' H ' ' A' ' 62' ' ' THR . 1.9 p30 169.42 140.58 0.02 OUTLIER 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.02 35.77 0.11 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.593 ' H ' ' C ' ' A' ' 60' ' ' ASN . 69.5 p -135.94 155.0 50.93 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 90.9 mt -130.13 132.02 65.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.213 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.14 151.99 42.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.627 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.442 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -54.83 -51.24 80.75 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.778 -179.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 52.1 Cg_exo -49.17 -49.84 14.36 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.855 1.704 . . . . 0.0 112.059 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -68.56 -33.66 74.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.465 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -61.94 -43.82 98.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.96 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.8 mt -59.2 -45.58 90.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.753 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.3 m -63.83 -44.73 92.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.543 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 36.3 ttp -59.99 -45.34 93.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.578 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.3 mmm -64.64 -39.41 93.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.534 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.34 -39.05 78.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.743 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -77.92 -51.47 10.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.383 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -65.56 -44.27 87.27 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.498 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.2 mmm -99.74 126.46 45.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.348 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -86.76 143.89 27.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.537 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 80' ' ' ASP . 97.2 m-20 -49.35 158.58 0.38 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.418 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 35.8 p -54.9 -8.74 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.643 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.464 ' H ' ' C ' ' A' ' 78' ' ' ASP . 80.3 m-20 -67.11 -8.64 32.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.156 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.6 m -59.4 -29.51 67.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.688 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -37.85 -49.21 1.19 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.839 0.352 . . . . 0.0 110.994 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.73 -55.02 19.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.872 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -59.68 -32.31 70.38 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.055 0.455 . . . . 0.0 110.622 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 83.0 mt -69.23 -15.07 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.998 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -59.71 -48.93 79.71 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 117.546 -1.662 . . . . 0.0 110.395 -177.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.21 -32.55 74.28 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.471 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 92' ' ' PHE . . . -58.66 -36.04 73.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.731 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -50.58 -51.12 51.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.324 0.583 . . . . 0.0 110.928 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -69.3 -44.4 71.85 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.32 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.16 -51.44 48.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.132 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 88' ' ' ALA . 66.8 t80 -63.44 -47.42 81.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.389 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.463 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 17.9 t0 -107.83 105.33 15.1 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.131 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -71.67 -44.88 63.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.664 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 45.2 p-10 -67.07 -33.62 75.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.137 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.529 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 66.52 -74.87 0.15 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -53.66 -13.09 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.876 0.369 . . . . 0.0 110.343 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.422 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.52 161.77 12.67 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -112.34 155.91 23.34 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 94.6 mt -99.79 117.47 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.749 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.6 p -82.15 175.68 10.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.123 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.91 -37.06 85.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.838 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.54 -52.44 64.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.785 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -67.66 -31.18 70.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.67 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.1 tp -64.2 -41.35 97.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.451 0.644 . . . . 0.0 110.975 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -53.9 -39.2 65.57 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.002 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -63.83 -41.17 97.9 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.1 t -64.17 -42.66 96.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.44 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 54.0 mmm -62.4 -40.75 97.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.983 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.8 m -61.74 -40.22 94.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.564 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -58.82 -40.55 84.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.616 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.9 tp -61.33 -44.25 97.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.946 0.403 . . . . 0.0 110.528 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 161.85 -151.91 22.17 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -138.34 29.22 2.46 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.794 0.33 . . . . 0.0 110.619 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -67.46 -45.32 76.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.793 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.7 mt -100.68 166.94 10.63 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.853 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.52 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -69.49 161.57 29.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.188 -179.564 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -92.69 -21.54 19.94 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.902 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -87.41 -23.6 24.47 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.635 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -35.1 -68.08 0.13 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.603 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.498 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 9.8 m -63.87 -42.15 94.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.412 ' N ' ' CG2' ' A' ' 121' ' ' VAL . 87.6 m-20 -48.3 -67.06 0.3 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.752 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.459 ' O ' ' OE1' ' A' ' 127' ' ' GLU . 80.3 mm-40 -70.44 -40.02 74.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.404 ' SD ' ' C ' ' A' ' 124' ' ' MET . 17.7 tmm? -57.22 -38.94 74.49 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.684 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.407 HG21 HD12 ' A' ' 125' ' ' ILE . 93.9 mt -77.89 -23.79 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.929 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -77.5 -46.93 20.9 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 118.682 -1.207 . . . . 0.0 111.698 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 123' ' ' GLU . 19.6 mp0 -80.08 -68.45 0.67 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.667 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.56 -48.9 1.04 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.69 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -88.51 131.07 35.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.901 0.381 . . . . 0.0 110.27 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.439 ' H ' ' CD1' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -82.3 -10.7 12.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.129 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' A' ' 133' ' ' ASP . 89.2 m-20 -64.39 -40.42 95.76 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.099 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.65 -8.4 4.32 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' A' ' 131' ' ' ASP . 26.2 p-10 -88.32 -12.72 42.65 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 39.36 98.06 0.01 OUTLIER Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 13.3 pt20 -131.06 136.94 48.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.056 0.455 . . . . 0.0 110.311 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.0 t -115.29 134.82 57.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.097 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.515 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 53.1 t30 -152.64 176.74 11.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.605 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -58.84 -48.02 82.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.339 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.515 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 58.0 mp0 -57.42 -25.53 59.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.295 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 81.2 mt-10 -84.87 -33.64 22.78 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.08 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -65.72 -46.89 77.24 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.654 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 50.3 t -56.26 -44.57 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 120.792 0.33 . . . . 0.0 110.22 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -71.56 -38.05 71.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.202 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 50.2 ttp -60.43 -48.59 81.08 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.306 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 49.1 mtm -88.61 120.77 30.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.928 0.394 . . . . 0.0 110.782 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.0 m -165.77 99.14 0.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.729 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.94 -38.33 88.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.584 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.8 mttm . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.531 179.938 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.037 0 CA-C-O 120.598 0.237 . . . . 0.0 111.301 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -54.64 -48.25 72.5 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.556 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -65.74 -40.79 92.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.837 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -61.99 -44.1 97.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.633 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -66.99 -37.54 84.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.988 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.479 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.06 -27.9 65.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.803 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -57.83 -46.94 84.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.533 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.8 m -77.9 -21.5 51.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.65 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.36 -42.82 99.7 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.444 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.2 m-85 -60.21 -50.92 71.74 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.476 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.1 t0 -77.01 -14.26 59.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.83 0.347 . . . . 0.0 111.315 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -45.61 -32.69 2.45 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.831 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 8.8 p-10 -53.72 -46.11 70.69 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.557 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -144.34 -151.61 5.48 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 30.8 p-10 -72.95 -47.24 47.23 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.068 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.525 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.71 107.38 0.28 Allowed Glycine 0 CA--C 1.521 0.452 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 4.6 m -166.63 139.23 3.7 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.121 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 mp -115.02 109.18 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.6 p -128.65 170.32 13.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.824 0.345 . . . . 0.0 110.447 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.605 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.0 p -64.74 -33.05 75.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.801 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -61.63 -41.42 97.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.935 0.397 . . . . 0.0 109.998 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.425 ' OE1' ' O ' ' A' ' 26' ' ' THR . 90.1 mt-10 -63.45 -45.68 89.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.856 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.0 tp -64.2 -43.29 95.49 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.115 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.78 -26.16 53.42 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.2 m -63.87 -41.42 97.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.858 0.361 . . . . 0.0 110.143 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.3 t -56.18 -23.62 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.333 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.479 ' O ' ' N ' ' A' ' 40' ' ' GLY . 62.1 mmm -48.06 -30.33 4.33 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.721 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -64.34 -45.61 87.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 118.042 -1.463 . . . . 0.0 111.049 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 77.9 p -63.98 -21.95 66.71 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.136 -0.625 . . . . 0.0 109.808 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 41' ' ' GLN . 16.9 mt -107.8 3.75 24.79 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.04 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.16 -71.21 0.02 OUTLIER Glycine 0 N--CA 1.465 0.592 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 39' ' ' LEU . 87.8 mt-30 -145.45 109.46 4.83 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 44' ' ' THR . 41.4 t30 -125.59 70.93 65.52 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.12 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.551 ' O ' ' N ' ' A' ' 46' ' ' ALA . 85.3 Cg_exo -33.04 -30.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.595 2.196 . . . . 0.0 112.808 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 42' ' ' ASN . 26.2 m -39.31 -30.19 0.06 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.543 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 49' ' ' GLN . 93.9 mt-10 -86.64 -34.88 19.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.305 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -59.04 -50.04 75.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.821 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.15 -46.21 71.4 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 51' ' ' MET . 84.6 mt -64.79 -31.03 72.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.4 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.605 HE22 ' CB ' ' A' ' 29' ' ' THR . 61.1 tp60 -37.62 -51.2 1.19 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.732 0.301 . . . . 0.0 110.769 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.3 -40.34 89.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.232 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' LEU . 33.1 ttp -62.38 -41.05 98.33 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.981 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 83.9 mt -62.0 -49.95 82.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.114 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 57' ' ' ALA . 89.9 m-20 -62.89 -40.46 97.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.582 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -55.17 -61.5 2.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.206 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.93 -30.12 43.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.804 0.335 . . . . 0.0 111.241 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 62' ' ' THR . 50.7 t0 -84.71 -13.24 51.97 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.513 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -71.94 13.05 0.32 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.926 0.394 . . . . 0.0 110.339 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.8 p30 -65.56 -28.89 69.48 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.535 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -150.49 -22.49 0.06 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.58 ' C ' ' H ' ' A' ' 62' ' ' THR . 3.3 p30 173.19 151.88 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.95 34.7 0.14 Allowed Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.58 ' H ' ' C ' ' A' ' 60' ' ' ASN . 81.9 p -134.37 149.45 50.83 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.4 mt -120.99 134.52 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.933 0.397 . . . . 0.0 109.942 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.16 162.43 28.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.416 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.472 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -64.68 -48.05 74.37 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.467 -179.051 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 50.6 Cg_exo -51.28 -37.36 59.73 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.167 1.911 . . . . 0.0 111.692 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -87.55 -22.32 24.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.78 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.45 -47.11 87.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.021 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.54 -42.88 98.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.517 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 78.7 m -63.97 -46.09 86.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.648 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.7 ttp -61.71 -47.5 85.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.066 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.9 mmm -65.87 -37.76 87.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.265 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.61 -49.96 75.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.039 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -71.51 -43.8 65.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.159 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.72 -43.59 88.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.764 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.432 ' O ' ' O ' ' A' ' 73' ' ' ALA . 22.3 mmm -104.27 127.47 51.91 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.116 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.7 tptt -84.97 141.14 30.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.874 0.368 . . . . 0.0 110.748 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' LYS . 95.0 m-20 -48.87 179.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.262 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.5 p -75.51 -6.74 51.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.437 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.48 -15.52 62.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.545 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.9 m -61.89 -19.92 63.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.549 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -48.19 -44.69 32.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.358 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.96 -39.56 79.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.9 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.87 -45.12 83.25 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.989 0.423 . . . . 0.0 110.202 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.5 mt -66.12 -19.04 25.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.472 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -58.41 -45.44 88.4 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 118.97 -1.092 . . . . 0.0 110.19 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -65.56 -31.88 73.17 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.948 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.412 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -72.03 -14.64 61.93 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.185 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -57.98 -49.0 78.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.244 0.545 . . . . 0.0 111.061 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -64.09 -45.6 87.98 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.316 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -76.18 -51.54 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 0.0 110.908 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.418 ' CE2' ' CD1' ' A' ' 100' ' ' ILE . 26.2 t80 -61.99 -47.19 85.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.62 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.427 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 18.2 t70 -108.95 94.15 4.89 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.22 -40.97 74.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.965 0.412 . . . . 0.0 110.553 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 19.8 p-10 -62.61 -39.65 94.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.976 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.44 -67.3 0.97 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.58 -16.56 63.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.022 0.439 . . . . 0.0 110.247 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.76 162.04 12.56 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.23 155.39 24.09 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.713 0.292 . . . . 0.0 110.258 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.418 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 94.1 mt -79.75 126.02 39.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.938 0.399 . . . . 0.0 110.988 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.3 p -82.36 168.95 17.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.196 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.04 89.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.51 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.63 -47.38 84.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.863 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.67 -32.87 73.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.6 tp -61.58 -41.63 97.68 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.41 0.624 . . . . 0.0 110.712 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -56.46 -43.35 79.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.8 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -58.5 -41.88 86.35 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.67 -43.4 90.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.624 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.0 mmm -61.99 -35.68 79.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.605 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.6 m -61.04 -44.43 97.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.044 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -59.76 -34.98 73.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.376 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.0 tp -61.17 -46.73 89.31 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.051 0.453 . . . . 0.0 110.36 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.5 -160.74 33.47 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -140.51 23.35 2.32 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.64 0.257 . . . . 0.0 110.828 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -63.65 -42.8 98.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.963 0.411 . . . . 0.0 110.269 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.3 mt -92.84 175.79 6.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.006 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.469 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -72.83 161.29 30.91 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.695 179.844 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -91.66 -22.46 20.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.946 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -87.89 -25.37 23.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.126 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.642 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.4 -61.27 0.45 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.086 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.642 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 20.2 m -67.33 -40.2 84.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -56.81 -47.06 81.1 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.52 -178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -86.01 -40.32 15.92 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.7 tmm? -59.51 -46.51 88.61 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.094 0.473 . . . . 0.0 109.956 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 91.5 mt -69.15 -16.56 20.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.413 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -78.61 -50.56 11.29 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 119.389 -0.924 . . . . 0.0 112.13 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' ASP . 42.3 tp10 -87.61 -67.51 0.82 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.888 -178.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.43 -25.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.763 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' GLU . 25.4 t0 -88.06 128.26 35.41 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.062 0.458 . . . . 0.0 111.056 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.538 ' H ' ' CD1' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.46 -43.45 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.416 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -65.27 -40.4 93.86 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.136 0.493 . . . . 0.0 110.185 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.4 -2.03 58.94 Favored Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' GLY . 55.2 p-10 -89.44 -9.0 51.8 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 57.46 115.49 0.01 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.435 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 20.3 pt20 -160.69 133.6 6.44 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.46 136.92 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.056 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -151.36 172.43 15.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.23 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -54.78 -46.83 74.47 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.096 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -58.64 -44.35 90.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.709 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 93.4 mt-10 -72.05 -29.4 64.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.727 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.92 -43.91 77.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.605 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 93.8 t -59.22 -46.23 92.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.312 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.38 -29.1 66.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.128 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.7 ttp -59.71 -42.81 93.9 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.853 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.49 138.82 50.63 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.961 0.41 . . . . 0.0 110.756 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 81.9 m -163.22 77.77 0.43 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.671 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.15 -27.76 68.95 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.464 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.222 -0.391 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.624 -179.857 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.219 0 CA-C-O 120.75 0.31 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -54.22 -42.27 69.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.096 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -67.84 -41.73 82.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.34 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -62.62 -43.76 97.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.914 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -67.19 -35.71 80.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.431 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.413 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.57 -24.11 66.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.699 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -55.45 -46.46 76.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.783 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.4 m -80.66 -19.54 45.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.756 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.16 -41.95 96.95 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.013 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.42 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.1 m-85 -58.84 -46.11 88.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.831 0.348 . . . . 0.0 111.115 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.448 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.3 t0 -79.56 -13.49 59.5 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.468 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -42.97 -32.87 0.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.821 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.451 ' CG ' ' OE2' ' A' ' 31' ' ' GLU . 10.9 p-10 -52.93 -45.1 67.48 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.447 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.433 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . -149.68 -151.3 5.47 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 21.2 p-10 -71.1 -46.9 60.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.759 0.314 . . . . 0.0 111.009 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.534 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.02 107.4 0.28 Allowed Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.455 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 5.7 m -166.6 136.2 3.08 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.188 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.424 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.9 mp -110.55 118.33 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.0 p -134.78 167.04 21.59 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.863 0.363 . . . . 0.0 110.327 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.5 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.3 p -64.12 -33.64 76.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.296 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -62.51 -40.22 96.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.691 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.455 ' OE2' ' O ' ' A' ' 26' ' ' THR . 89.0 mt-10 -64.68 -48.46 74.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.373 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.6 tp -64.44 -43.72 93.42 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.296 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.29 -24.73 17.07 Favored Glycine 0 C--O 1.224 -0.487 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -64.09 -40.99 97.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.863 0.363 . . . . 0.0 110.197 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.3 t -57.05 -22.45 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.276 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.7 mmm -48.79 -33.53 10.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.992 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -64.33 -45.51 87.55 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 118.219 -1.392 . . . . 0.0 110.241 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.3 p -58.96 -30.68 68.09 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.367 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 41' ' ' GLN . 9.2 mt -102.34 5.47 39.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.99 0.424 . . . . 0.0 110.492 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.31 -69.83 0.03 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.481 ' N ' ' O ' ' A' ' 39' ' ' LEU . 85.8 mt-30 -143.27 116.21 8.82 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.1 t30 -132.61 69.71 79.55 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.934 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 46' ' ' ALA . 90.7 Cg_exo -32.98 -33.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.541 2.16 . . . . 0.0 112.463 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 42' ' ' ASN . 12.6 m -39.0 -29.35 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.398 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 43' ' ' PRO . 90.6 mt-10 -87.69 -35.21 18.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.449 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -61.22 -49.22 78.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.998 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -68.01 -48.6 65.27 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.437 0.637 . . . . 0.0 109.89 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.65 -22.75 66.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.012 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.5 HE22 ' CB ' ' A' ' 29' ' ' THR . 47.9 tp60 -40.25 -49.56 2.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.877 0.37 . . . . 0.0 110.519 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.69 -39.78 73.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.483 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.1 ttp -61.62 -40.54 95.21 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.73 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.85 -46.83 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.624 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.559 ' O ' ' N ' ' A' ' 57' ' ' ALA . 28.2 m120 -65.19 -39.83 93.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.342 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -58.1 -57.24 13.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.443 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.4 p -68.3 -32.83 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.949 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.534 ' C ' ' H ' ' A' ' 58' ' ' ASP . 42.9 t0 -86.02 -13.12 48.45 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.768 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -72.05 15.46 0.16 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.07 -179.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 56' ' ' ASP . 38.7 p-10 -66.75 -23.5 66.1 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.41 -22.54 0.03 OUTLIER Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.622 ' C ' ' H ' ' A' ' 62' ' ' THR . 4.6 p30 179.35 146.5 0.19 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.72 33.71 0.17 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.622 ' H ' ' C ' ' A' ' 60' ' ' ASN . 80.8 p -132.17 143.94 50.33 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.93 135.11 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.999 0.428 . . . . 0.0 110.172 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.39 172.39 4.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.486 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.436 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -72.59 -49.59 8.4 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.759 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 52.5 Cg_exo -52.01 -43.29 53.49 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.833 1.688 . . . . 0.0 111.931 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.45 -37.45 77.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 110.874 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -60.3 -45.45 93.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.967 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.2 mt -62.39 -44.63 95.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.487 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.2 m -67.38 -45.51 76.06 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.757 0.313 . . . . 0.0 111.223 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.4 ttp -61.13 -43.74 98.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.89 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 86.9 mmm -64.76 -39.33 93.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.215 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.91 -42.84 94.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.873 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -71.52 -41.77 68.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.268 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -64.72 -40.94 96.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.887 0.375 . . . . 0.0 110.412 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.434 ' O ' ' O ' ' A' ' 73' ' ' ALA . 14.2 mmt -95.22 129.85 42.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.074 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -86.87 142.82 27.77 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -50.35 168.86 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.414 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.8 p -75.23 -15.2 60.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.647 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.97 -16.49 64.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.424 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 82' ' ' GLU . 1.1 m -60.45 -23.67 64.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.717 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 81' ' ' SER . 81.2 tt0 -36.83 -48.45 0.74 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.62 0.248 . . . . 0.0 110.897 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -70.85 -43.47 68.44 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.181 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.87 -39.59 94.55 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.994 0.426 . . . . 0.0 110.086 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 81.0 mt -66.96 -21.91 28.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.242 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 -58.04 -43.61 86.93 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 119.031 -1.067 . . . . 0.0 110.014 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -63.65 -34.82 78.69 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.851 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.79 -19.9 66.06 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.039 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -56.6 -48.81 76.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.321 0.582 . . . . 0.0 110.838 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -68.23 -44.67 75.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.474 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.8 t -66.34 -48.34 81.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -64.04 -47.09 81.57 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.617 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.407 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 18.3 t70 -120.37 100.1 6.96 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -66.63 -39.84 88.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.182 0.515 . . . . 0.0 109.804 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -65.58 -40.66 92.97 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.105 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.67 -59.54 0.48 Allowed Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -61.78 -17.46 56.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.994 0.426 . . . . 0.0 110.228 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.407 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.55 160.9 12.96 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -113.31 155.57 24.92 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.7 mt -95.78 118.27 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.07 0.462 . . . . 0.0 111.108 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.0 p -85.52 171.41 11.77 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.898 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.72 -35.75 78.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.579 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.84 72.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.078 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.28 -37.36 77.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.928 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.02 -39.38 94.58 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.476 0.655 . . . . 0.0 111.07 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -54.24 -43.64 71.07 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.116 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -63.13 -39.47 94.77 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.702 -0.399 . . . . 0.0 109.937 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.1 t -61.84 -45.19 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.176 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 37.7 mmm -64.27 -38.02 89.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.553 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.0 m -60.58 -40.11 90.51 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -61.25 -38.08 85.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.22 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.3 tp -61.65 -44.0 97.8 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.862 0.363 . . . . 0.0 110.249 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.95 -154.71 25.68 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -139.02 23.33 2.6 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.624 -0.288 . . . . 0.0 110.763 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -62.57 -43.25 99.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.069 0.461 . . . . 0.0 110.386 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 29.0 mt -99.91 169.13 9.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.536 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.492 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -68.42 162.14 26.08 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.579 179.761 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -92.09 -22.27 20.0 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.432 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -87.26 -24.48 24.36 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.616 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.57 -66.09 0.21 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.241 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.616 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.7 m -65.17 -35.26 74.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.417 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -60.48 -46.81 88.72 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.586 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -84.85 -40.4 17.16 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.4 tmm? -58.89 -47.24 85.66 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.4 mt -69.13 -18.32 22.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.6 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -77.4 -51.4 10.87 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 119.016 -1.074 . . . . 0.0 111.317 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 129' ' ' ASP . 34.7 tp10 -86.3 -68.7 0.72 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.492 -177.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.63 -21.54 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 127' ' ' GLU . 38.7 t0 -90.12 125.12 35.33 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.135 0.493 . . . . 0.0 110.625 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.501 ' H ' ' CD1' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.58 -32.0 56.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.995 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -72.18 -45.83 58.77 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.95 0.405 . . . . 0.0 110.328 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.67 -5.45 61.19 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 134' ' ' GLY . 35.0 p30 -90.0 -9.69 47.75 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 58.26 117.9 0.01 OUTLIER Glycine 0 CA--C 1.519 0.323 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 8.2 pt20 -159.72 140.15 12.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.539 -0.331 . . . . 0.0 110.146 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.6 t -126.24 133.32 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.93 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.542 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.8 t30 -150.76 175.36 12.06 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.305 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -57.66 -52.1 66.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.765 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.542 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 57.3 mp0 -55.9 -35.04 66.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.708 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 79.4 mt-10 -69.51 -39.3 77.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.694 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -61.21 -45.39 94.78 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.0 t -57.94 -45.94 87.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -74.17 -30.83 62.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.442 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.4 ttp -60.07 -40.61 90.13 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.627 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.405 ' O ' ' OG1' ' A' ' 146' ' ' THR . 73.0 mtm -105.25 141.7 36.32 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.905 0.383 . . . . 0.0 110.635 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 145' ' ' MET . 63.0 m -167.23 72.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.146 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.8 97.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.617 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 C--O 1.219 -0.535 0 CA-C-O 118.105 -0.95 . . . . 0.0 110.228 -179.93 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.172 0 N-CA-C 111.487 0.18 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -41.21 -45.84 2.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.771 0.319 . . . . 0.0 110.929 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -66.82 -39.57 87.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.753 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -62.83 -43.12 99.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.539 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.09 -40.82 91.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.766 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.81 -20.33 49.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.654 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -49.43 -47.94 47.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.822 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.5 m -77.69 -20.38 53.74 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.035 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.8 tp -64.06 -40.69 96.83 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.802 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.471 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 76.2 m-85 -57.64 -45.49 85.39 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.339 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 9.7 t0 -86.1 -20.36 28.83 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -44.07 -33.13 1.37 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.821 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.415 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 4.4 p-10 -56.01 -46.12 78.85 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.888 0.375 . . . . 0.0 110.858 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -140.31 -152.62 5.84 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 28.1 p-10 -74.38 -47.1 36.2 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 122.679 -0.307 . . . . 0.0 110.74 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.498 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.72 107.13 0.28 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 6.2 m -166.44 148.82 6.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.123 0.462 . . . . 0.0 111.407 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.71 74.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 p -86.97 166.16 15.3 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.51 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.44 ' HG1' ' N ' ' A' ' 30' ' ' LYS . 1.4 p -66.3 -28.62 68.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.925 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.44 ' N ' ' HG1' ' A' ' 29' ' ' THR . 59.1 mttp -61.86 -40.19 94.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.961 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.471 ' OE1' ' O ' ' A' ' 19' ' ' PHE . 86.6 mt-10 -66.7 -40.51 88.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.954 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.7 tp -62.82 -43.55 98.5 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.61 -33.19 47.76 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 m -64.6 -44.69 89.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.922 0.361 . . . . 0.0 110.84 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.2 t -55.87 -17.36 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.331 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.542 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 88.9 mmm -52.71 -40.75 63.29 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.745 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.3 ttt85 -64.29 -46.01 85.5 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 118.159 -1.417 . . . . 0.0 110.181 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.0 p -64.33 -19.2 65.29 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.653 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 36.4 mt -94.4 6.57 48.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.727 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 43.76 78.69 0.07 OUTLIER Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 40' ' ' GLY . 85.7 mt-30 52.67 117.23 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.869 0.366 . . . . 0.0 110.733 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 44' ' ' THR . 35.3 t-20 -148.81 68.76 9.87 Favored Pre-proline 0 C--O 1.235 0.3 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.643 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.588 ' O ' ' N ' ' A' ' 46' ' ' ALA . 87.3 Cg_exo -35.77 -31.27 0.08 OUTLIER 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.507 2.138 . . . . 0.0 112.012 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 42' ' ' ASN . 29.5 m -38.49 -27.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.319 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.542 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 87.6 mt-10 -89.43 -32.4 17.26 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.588 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.46 -51.82 68.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.974 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -67.51 -46.04 74.04 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.6 -27.6 69.35 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.396 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 45' ' ' GLU . 63.1 tp60 -39.54 -53.65 2.06 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.818 0.342 . . . . 0.0 110.792 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -65.94 -38.25 88.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.197 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.5 ttp -62.42 -40.16 95.65 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 97.9 mt -61.99 -46.43 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 57' ' ' ALA . 9.5 m120 -62.31 -42.41 99.35 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.725 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.74 -55.6 32.3 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.134 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.9 -34.85 62.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.934 0.397 . . . . 0.0 111.123 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 62' ' ' THR . 44.0 t0 -82.94 -13.41 56.08 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.377 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -72.06 8.87 1.1 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.788 0.327 . . . . 0.0 110.151 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 12.7 p30 -61.54 -25.09 67.07 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -157.87 -19.94 0.03 OUTLIER Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.647 ' C ' ' H ' ' A' ' 62' ' ' THR . 5.1 p30 177.07 141.86 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.76 32.27 0.09 OUTLIER Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.647 ' H ' ' C ' ' A' ' 60' ' ' ASN . 64.2 p -130.29 150.14 51.66 Favored 'General case' 0 C--N 1.337 0.053 0 CA-C-O 120.973 0.416 . . . . 0.0 110.288 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.422 HG22 HD12 ' A' ' 63' ' ' ILE . 91.5 mt -117.08 138.96 46.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.138 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.51 166.13 19.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.436 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.431 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -62.97 -50.5 76.56 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.803 -179.19 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.5 Cg_exo -50.85 -44.94 38.7 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.984 1.79 . . . . 0.0 111.824 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.89 -36.35 72.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.924 0.393 . . . . 0.0 110.994 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -59.99 -45.86 91.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.246 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.08 -44.54 95.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.594 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.7 m -67.41 -44.4 78.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.254 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.9 ttp -61.43 -40.13 93.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.023 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 76.1 mmm -63.05 -38.55 91.64 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.841 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.09 96.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.028 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -68.48 -45.53 72.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.052 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.61 -41.78 83.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.955 0.407 . . . . 0.0 110.33 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.8 mmt -86.96 164.42 16.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.14 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -116.22 153.61 31.56 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.043 0.449 . . . . 0.0 110.154 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -59.26 160.47 6.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.302 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.8 p -64.13 -30.08 71.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.586 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -64.47 -10.01 22.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.158 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -57.08 -32.82 66.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.516 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -49.44 -50.22 41.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.723 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -65.08 -41.89 94.6 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.987 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -66.32 -45.66 79.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.497 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.4 mt -64.91 -20.6 27.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.8 ttt-85 -59.68 -42.19 92.39 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.206 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -61.48 -35.88 78.89 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.477 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.17 -13.4 60.46 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -47.96 -51.12 24.92 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.0 0.428 . . . . 0.0 111.424 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -59.75 -46.85 87.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.825 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 85.0 t -68.84 -44.34 81.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.958 0.409 . . . . 0.0 110.466 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -59.44 -44.43 92.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.529 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 33.0 t70 -138.84 100.67 4.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.231 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.04 -40.01 82.94 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.207 0.527 . . . . 0.0 110.198 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.3 p-10 -60.13 -42.6 95.14 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.327 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.67 -56.97 0.5 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -70.75 -13.63 62.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.078 0.466 . . . . 0.0 110.267 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.6 161.19 12.85 Favored Glycine 0 N--CA 1.464 0.541 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -115.13 150.92 35.26 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.8 mt -85.25 123.16 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 121.002 0.43 . . . . 0.0 110.339 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.2 p -79.99 168.13 19.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.034 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.25 -36.49 82.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.611 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.17 -45.31 93.97 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.095 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -69.99 -37.68 75.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.208 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.4 tp -62.01 -42.89 99.65 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.241 0.544 . . . . 0.0 111.276 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -52.57 -43.21 65.1 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.055 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -55.5 -42.73 74.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.164 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.4 t -64.58 -42.48 95.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.292 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 58.5 mmm -57.56 -34.74 69.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.467 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.7 m -60.24 -42.3 94.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.445 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -58.66 -38.68 78.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.824 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 40.0 tp -61.31 -46.34 90.7 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.048 0.451 . . . . 0.0 110.13 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.89 -154.91 26.0 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -143.22 11.81 1.76 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.693 -0.253 . . . . 0.0 110.78 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -63.93 -43.96 94.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.153 0.502 . . . . 0.0 110.657 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.5 mt -79.75 160.32 26.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.033 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.479 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -68.51 161.67 27.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.221 -179.71 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -92.33 -21.06 20.48 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.112 0.482 . . . . 0.0 110.448 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -85.45 -26.91 26.06 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.219 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.68 -63.49 0.35 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.808 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.61 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 11.3 m -69.09 -31.38 49.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 121.234 -0.186 . . . . 0.0 111.46 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -58.82 -67.15 0.39 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.699 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.58 -45.14 72.8 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.466 ' C ' ' SD ' ' A' ' 124' ' ' MET . 13.3 tmm? -52.93 -50.3 64.28 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.61 -18.37 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.669 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -87.92 -57.91 2.76 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 119.904 -0.718 . . . . 0.0 112.25 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 128' ' ' ALA . 51.0 tp10 -81.95 -67.7 0.76 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.271 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 127' ' ' GLU . . . -36.83 -35.65 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 56.6 t0 -87.71 146.11 25.83 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.277 0.56 . . . . 0.0 110.568 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.525 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -89.39 -14.85 9.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.809 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' A' ' 133' ' ' ASP . 44.8 m-20 -73.54 -45.36 54.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.032 0.444 . . . . 0.0 110.407 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.35 -10.28 3.73 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.472 ' H ' ' C ' ' A' ' 131' ' ' ASP . 35.4 p30 -89.88 -10.4 45.42 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.836 0.351 . . . . 0.0 110.195 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 62.25 123.0 0.01 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -161.72 119.61 2.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.889 0.376 . . . . 0.0 110.101 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.67 128.93 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.093 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.523 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 45.2 t30 -155.1 166.2 34.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.071 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.401 ' O ' ' CD1' ' A' ' 138' ' ' TYR . 2.6 t80 -48.79 -23.02 0.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.459 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 50.1 mp0 -66.42 -35.74 81.06 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.152 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -84.97 -20.78 30.04 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.56 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.04 -46.7 87.99 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 121.134 -0.227 . . . . 0.0 111.166 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 30.1 t -58.31 -45.98 89.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.005 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -71.36 -36.14 71.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.293 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 61.5 ttp -57.94 -43.09 86.14 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.207 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 70.7 mtm -112.72 129.33 56.45 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.818 0.342 . . . . 0.0 110.414 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.5 m -162.88 85.77 0.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.096 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.1 -43.91 93.9 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.676 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 C--O 1.219 -0.527 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.507 179.879 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.07 0 CA-C-O 120.525 0.203 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -47.67 -48.62 28.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.102 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -59.44 -44.86 92.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.89 0.376 . . . . 0.0 110.484 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -63.42 -39.66 95.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.664 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.29 -41.29 85.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.343 . . . . 0.0 111.143 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.44 -22.72 66.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.82 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -55.59 -47.81 75.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.21 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.9 m -81.47 -17.19 49.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.476 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.93 -43.77 97.9 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.435 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.416 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.7 m-85 -60.48 -50.39 73.75 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.565 -179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.3 t0 -77.08 -14.64 59.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.191 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -45.01 -32.93 1.84 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.228 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.447 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 18.0 p-10 -54.71 -46.01 74.12 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 120.966 -0.293 . . . . 0.0 110.875 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -144.0 -151.09 5.38 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 32.3 p-10 -73.08 -47.03 47.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.714 0.292 . . . . 0.0 110.81 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.494 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.77 107.29 0.28 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.428 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 4.9 m -166.2 142.79 5.04 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.771 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.03 103.42 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.9 p -123.11 169.96 10.69 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.1 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.568 ' CB ' HE22 ' A' ' 49' ' ' GLN . 61.1 p -63.14 -35.32 79.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.861 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -60.35 -38.46 83.88 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.447 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 87.7 mt-10 -65.64 -43.11 90.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.091 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.66 -41.96 98.14 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.258 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.71 -28.8 17.05 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.2 m -64.54 -44.15 91.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.95 0.405 . . . . 0.0 110.729 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.2 t -57.1 -17.61 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.175 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.541 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 87.7 mmm -53.03 -38.52 62.45 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.266 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.7 ttt85 -64.28 -45.97 85.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 117.444 -1.702 . . . . 0.0 110.722 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 92.8 p -63.41 -19.96 65.14 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.538 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 40' ' ' GLY . 52.4 mt -99.58 6.12 45.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.904 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 34.9 94.55 0.01 OUTLIER Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.487 ' O ' ' O ' ' A' ' 40' ' ' GLY . 84.1 mt-30 52.23 110.25 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.619 0.247 . . . . 0.0 110.369 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 44' ' ' THR . 49.9 t30 -145.82 63.98 9.81 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.704 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.574 ' O ' ' N ' ' A' ' 46' ' ' ALA . 89.3 Cg_exo -34.72 -29.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.612 2.208 . . . . 0.0 112.325 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 42' ' ' ASN . 23.3 m -40.13 -29.61 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.124 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.541 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 90.7 mt-10 -89.63 -29.93 18.49 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.802 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -60.84 -49.15 78.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.822 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -72.18 -43.18 64.96 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.25 0.548 . . . . 0.0 109.751 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.3 mt -67.97 -25.12 65.27 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.203 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.568 HE22 ' CB ' ' A' ' 29' ' ' THR . 53.8 tp60 -40.76 -41.89 1.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.603 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -77.64 -36.83 51.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.862 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.6 ttp -59.96 -37.28 79.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.677 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.44 -44.89 99.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.027 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 19.6 m120 -62.54 -39.84 94.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.37 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -56.62 -56.42 21.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.294 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.0 p -74.12 -40.38 51.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.851 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.502 ' OD2' ' N ' ' A' ' 62' ' ' THR . 44.4 t0 -71.2 -13.21 61.85 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.561 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 53' ' ' ASN . . . -72.35 8.98 1.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.31 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 56' ' ' ASP . 10.4 p-10 -59.67 -26.76 65.82 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -155.06 -24.41 0.03 OUTLIER Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.582 ' C ' ' H ' ' A' ' 62' ' ' THR . 9.9 p30 176.19 151.19 0.14 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.582 -0.309 . . . . 0.0 110.178 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.28 36.35 0.09 OUTLIER Glycine 0 CA--C 1.535 1.294 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.582 ' H ' ' C ' ' A' ' 60' ' ' ASN . 44.2 p -137.45 153.31 50.12 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.5 mt -127.38 136.98 59.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.971 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -81.18 164.59 22.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.137 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.431 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -62.13 -50.11 81.71 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.227 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.6 Cg_exo -50.07 -41.73 48.0 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.074 1.849 . . . . 0.0 112.065 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -80.78 -29.83 36.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.111 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -59.53 -45.0 93.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.026 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.39 -43.21 99.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.279 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.1 m -64.43 -44.83 89.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.85 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.0 ttp -60.1 -44.69 94.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.829 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 79.4 mmm -63.8 -40.91 97.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.258 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.407 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -61.21 -47.86 84.18 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.865 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -71.25 -46.25 61.43 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.496 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -66.79 -45.19 79.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.993 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.407 ' O ' ' O ' ' A' ' 73' ' ' ALA . 17.8 mmm -99.5 -176.69 3.36 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.057 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -128.49 152.19 48.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.112 0.482 . . . . 0.0 110.177 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -54.2 177.74 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.359 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.2 p -80.6 -15.74 55.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.544 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -66.39 -13.67 61.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.397 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 83' ' ' GLU . 72.8 m -53.35 -34.38 57.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.548 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.434 ' O ' ' OH ' ' A' ' 138' ' ' TYR . 74.7 tt0 -39.0 -28.83 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.365 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 81' ' ' SER . 75.8 mm-40 -85.36 -54.84 4.33 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.004 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -58.48 -36.3 73.53 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.984 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.58 -20.04 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.1 ttt-85 -60.99 -45.06 96.34 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 118.351 -1.34 . . . . 0.0 109.627 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -64.67 -21.74 66.81 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.172 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.41 -17.51 48.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.466 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -57.05 -50.19 73.52 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.305 0.574 . . . . 0.0 110.556 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -68.6 -44.92 73.29 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.898 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.2 t -65.33 -49.09 80.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.028 0.442 . . . . 0.0 109.986 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -62.61 -45.19 94.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.878 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.412 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 22.2 t0 -120.54 104.57 10.07 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.056 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -66.38 -41.21 89.71 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.037 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -70.49 -41.55 72.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.042 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.91 -53.04 0.75 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -64.04 -20.05 65.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.98 0.419 . . . . 0.0 110.315 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.412 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.67 161.0 12.9 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -113.34 148.29 35.99 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.7 mt -84.9 123.55 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.0 p -87.27 176.76 7.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.129 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.57 84.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.979 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.55 -51.32 69.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.886 0.374 . . . . 0.0 110.983 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -71.4 -30.51 66.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 49.6 tp -61.78 -41.02 97.18 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.235 0.54 . . . . 0.0 111.093 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -54.18 -41.49 68.59 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.918 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -57.94 -42.73 85.49 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.3 t -65.59 -43.1 94.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.691 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 91.6 mmm -62.59 -37.25 85.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.44 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.8 m -59.44 -40.49 86.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.639 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -58.59 -38.76 78.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.737 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.0 tp -61.07 -44.99 96.54 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.551 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.05 -145.37 12.16 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -143.52 16.3 1.83 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.827 0.346 . . . . 0.0 110.748 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -61.79 -44.93 95.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.014 0.435 . . . . 0.0 110.424 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 82.8 mt -82.12 161.38 22.86 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.981 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.471 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -66.13 161.73 21.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.685 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -91.58 -19.63 22.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.863 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -87.69 -28.11 22.01 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.632 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.34 -66.9 0.17 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.632 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.4 m -63.97 -39.32 85.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -54.33 -65.89 0.49 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.674 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 127' ' ' GLU . 80.6 mm-40 -70.42 -44.9 66.95 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.426 ' C ' ' SD ' ' A' ' 124' ' ' MET . 18.9 tmm? -53.04 -47.58 68.29 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.899 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 97.6 mt -67.18 -19.72 25.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.346 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -91.28 -66.72 0.9 Allowed 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.033 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 123' ' ' GLU . 25.0 tp10 -65.26 -68.62 0.35 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.161 -177.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.11 -37.72 0.17 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.481 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 66.1 t0 -87.52 138.29 31.6 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.246 0.546 . . . . 0.0 110.583 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.496 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -85.82 -16.14 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.319 -179.683 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -73.06 -46.53 51.12 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.126 0.488 . . . . 0.0 110.146 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.95 -2.58 54.93 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 52.1 p30 -88.66 -22.25 23.52 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 64.65 103.64 0.01 OUTLIER Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -147.76 140.82 24.99 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.788 0.328 . . . . 0.0 110.141 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.1 t -128.95 134.31 64.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.313 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.526 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 53.4 t30 -151.56 -179.12 7.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.603 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.434 ' OH ' ' O ' ' A' ' 82' ' ' GLU . 68.5 t80 -57.26 -48.14 79.63 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.259 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.526 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 55.8 mp0 -50.93 -43.66 60.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.353 -178.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -67.6 -39.84 84.76 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.967 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -60.71 -43.68 97.52 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.571 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.4 t -54.22 -43.92 62.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.239 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -84.29 -19.31 34.01 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.211 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 41.1 ttp -65.08 -41.32 95.15 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.94 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.412 ' O ' ' OG1' ' A' ' 146' ' ' THR . 51.7 mtm -103.71 132.7 49.73 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.867 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 145' ' ' MET . 43.6 m -166.83 81.79 0.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.053 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.77 -37.28 75.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.292 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.1 mttm . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.509 179.921 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.912 0.387 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -51.48 -43.23 62.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.738 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -66.97 -46.35 74.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.022 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -61.67 -44.78 96.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.795 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -67.98 -40.89 83.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.642 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.19 -28.42 67.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.971 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -55.56 -45.85 77.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.695 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.0 m -81.58 -17.88 46.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.733 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.5 tp -65.45 -42.36 92.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.952 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.401 ' O ' ' CD ' ' A' ' 31' ' ' GLU . 73.6 m-85 -61.05 -45.95 92.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.333 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 4.7 t0 -81.98 -15.65 53.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.341 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -42.84 -32.51 0.63 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.105 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.437 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 9.1 p-10 -53.59 -46.75 70.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.887 0.375 . . . . 0.0 110.72 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.437 ' N ' ' CG ' ' A' ' 22' ' ' ASP . . . -145.67 -147.3 4.58 Favored Glycine 0 N--CA 1.466 0.696 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 20.3 p-10 -76.53 -47.56 22.29 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.921 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.02 107.02 0.27 Allowed Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 177.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 96.0 m -166.73 143.14 4.64 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.936 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.06 117.09 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.831 0.348 . . . . 0.0 110.095 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.3 p -133.38 165.6 24.47 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.429 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.497 ' CB ' HE22 ' A' ' 49' ' ' GLN . 80.2 p -63.08 -35.14 79.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.274 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -61.27 -38.48 86.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.076 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.415 ' OE2' ' CG ' ' A' ' 22' ' ' ASP . 91.3 mt-10 -64.71 -49.16 71.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.336 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.32 -43.6 98.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.277 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.17 -24.02 4.48 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.7 m -64.91 -42.47 94.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.903 0.382 . . . . 0.0 110.509 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.401 ' O ' ' OG ' ' A' ' 38' ' ' SER . 54.5 t -54.55 -16.33 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.26 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.453 ' O ' ' N ' ' A' ' 40' ' ' GLY . 53.4 mmm -58.71 -37.27 75.77 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -62.46 -46.16 89.76 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 116.724 -1.99 . . . . 0.0 110.66 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 35' ' ' VAL . 23.9 p -60.11 -36.15 76.8 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.101 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 41' ' ' GLN . 44.6 mt -95.85 2.08 53.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.723 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 66.25 -66.47 0.15 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' A' ' 39' ' ' LEU . 74.6 mt-30 -141.7 122.75 14.61 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.5 t-20 -141.43 71.11 26.55 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.653 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' ALA . 73.2 Cg_exo -37.45 -30.41 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.172 1.915 . . . . 0.0 112.186 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 42' ' ' ASN . 25.2 m -39.05 -27.61 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.477 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 49' ' ' GLN . 86.7 mt-10 -90.31 -36.92 14.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.005 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -56.28 -48.89 75.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.399 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -70.5 -45.02 66.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.292 0.568 . . . . 0.0 110.133 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.06 -20.12 63.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.804 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 45' ' ' GLU . 67.4 tp60 -46.39 -46.23 18.37 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.67 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -75.08 -35.28 61.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.199 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 33.1 ttp -63.63 -43.05 97.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.077 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 96.7 mt -62.8 -46.19 96.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.752 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.465 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 24.0 m120 -64.66 -40.69 95.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.738 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.08 -56.84 16.74 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.421 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.7 -36.96 72.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.985 0.421 . . . . 0.0 110.95 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.551 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.4 t0 -79.03 -12.7 60.03 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.423 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 53' ' ' ASN . . . -72.12 15.46 0.16 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.349 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 56' ' ' ASP . 10.4 p30 -65.75 -21.91 66.55 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -167.81 -9.62 0.03 OUTLIER Glycine 0 C--N 1.333 0.392 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.597 ' C ' ' H ' ' A' ' 62' ' ' THR . 2.0 p30 169.37 140.46 0.02 OUTLIER 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.0 35.88 0.1 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.597 ' H ' ' C ' ' A' ' 60' ' ' ASN . 69.0 p -136.02 154.94 50.91 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 90.8 mt -130.05 132.08 65.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.219 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.14 151.99 42.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.612 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.445 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -54.87 -51.27 80.66 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.768 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 52.4 Cg_exo -49.12 -49.82 14.38 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.863 1.709 . . . . 0.0 112.106 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -68.6 -33.65 74.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.412 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -61.98 -43.77 98.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.997 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.2 mt -59.2 -45.61 90.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.789 0.328 . . . . 0.0 110.734 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.4 m -63.85 -44.73 92.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.463 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 36.4 ttp -60.01 -45.33 93.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.515 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.2 mmm -64.68 -39.33 93.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.565 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.32 -39.15 78.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.67 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -77.86 -51.46 10.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.424 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -65.6 -44.26 87.13 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.47 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.2 mmm -99.72 126.47 45.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.358 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.401 ' HB3' ' HG ' ' A' ' 81' ' ' SER . 48.5 tptt -86.74 143.87 27.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.501 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 80' ' ' ASP . 97.2 m-20 -49.42 158.59 0.4 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.431 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 35.7 p -54.88 -8.73 0.28 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.642 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 78' ' ' ASP . 80.1 m-20 -67.11 -8.66 32.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.109 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.401 ' HG ' ' HB3' ' A' ' 77' ' ' LYS . 20.4 m -59.37 -29.61 67.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.637 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -37.87 -49.15 1.19 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.006 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.66 -55.08 19.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.909 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -59.63 -32.36 70.36 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.083 0.468 . . . . 0.0 110.629 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 82.6 mt -69.2 -15.07 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -59.76 -48.88 79.91 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 117.508 -1.677 . . . . 0.0 110.377 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.2 -32.58 74.34 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.498 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 92' ' ' PHE . . . -58.63 -35.98 73.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.789 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -50.59 -51.12 51.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.341 0.591 . . . . 0.0 110.908 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -69.24 -44.54 71.79 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.292 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.09 -51.45 48.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.113 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 88' ' ' ALA . 66.6 t80 -63.45 -47.47 81.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.396 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.465 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 17.9 t0 -107.77 105.41 15.23 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.087 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -71.75 -44.87 63.32 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.598 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 44.9 p-10 -67.14 -33.64 75.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.054 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.526 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 66.56 -74.88 0.15 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -53.64 -13.07 0.58 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.922 0.391 . . . . 0.0 110.392 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.423 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.53 161.78 12.66 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -112.33 155.91 23.32 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 94.4 mt -99.78 117.43 44.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.7 p -82.1 175.69 10.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.151 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.95 -37.02 84.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.826 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.56 -52.43 64.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.791 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -67.7 -31.17 70.94 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.654 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.0 tp -64.15 -41.4 97.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.501 0.667 . . . . 0.0 110.997 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -53.86 -39.26 65.49 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.964 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -63.79 -41.23 97.98 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.1 -42.68 96.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.498 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 54.0 mmm -62.37 -40.75 97.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.979 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.4 m -61.69 -40.3 94.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.556 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -58.89 -40.45 84.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.614 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.9 tp -61.31 -44.27 97.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.964 0.411 . . . . 0.0 110.541 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 161.85 -151.91 22.16 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -138.31 29.15 2.47 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.806 0.336 . . . . 0.0 110.66 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -67.45 -45.32 76.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.824 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.6 mt -100.62 166.89 10.67 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.871 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.519 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -69.49 161.61 29.16 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.177 -179.595 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -92.71 -21.57 19.9 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.888 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -87.42 -23.56 24.47 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.637 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -35.09 -68.09 0.13 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.577 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.502 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 9.8 m -63.88 -42.09 94.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.415 ' N ' ' CG2' ' A' ' 121' ' ' VAL . 87.6 m-20 -48.33 -67.01 0.31 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.748 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.463 ' O ' ' OE1' ' A' ' 127' ' ' GLU . 80.3 mm-40 -70.54 -40.0 73.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.745 0.307 . . . . 0.0 111.801 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.404 ' SD ' ' C ' ' A' ' 124' ' ' MET . 17.7 tmm? -57.26 -38.93 74.62 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.669 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.413 HG21 HD12 ' A' ' 125' ' ' ILE . 93.8 mt -77.9 -23.76 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -77.61 -46.82 20.98 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 118.674 -1.211 . . . . 0.0 111.657 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 123' ' ' GLU . 19.6 mp0 -80.13 -68.41 0.68 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.661 -177.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.56 -49.02 1.05 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.629 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -88.46 131.07 35.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.896 0.379 . . . . 0.0 110.255 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.441 ' H ' ' CD1' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -82.31 -10.69 12.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.148 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.47 ' C ' ' H ' ' A' ' 133' ' ' ASP . 89.2 m-20 -64.35 -40.42 95.83 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.118 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.61 -8.4 4.28 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' A' ' 131' ' ' ASP . 26.1 p-10 -88.26 -12.72 42.84 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 39.39 98.07 0.01 OUTLIER Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.435 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 13.3 pt20 -131.09 136.94 48.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.021 0.439 . . . . 0.0 110.334 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.0 t -115.3 134.92 56.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.089 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.515 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 52.9 t30 -152.71 176.67 11.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.659 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -58.8 -47.97 82.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.406 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.515 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 58.0 mp0 -57.43 -25.54 59.79 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.293 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 81.1 mt-10 -84.82 -33.71 22.86 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.1 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -65.71 -46.84 77.44 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.634 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 50.3 t -56.35 -44.49 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 120.789 0.328 . . . . 0.0 110.253 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -71.63 -38.03 70.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.155 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 50.2 ttp -60.48 -48.55 81.26 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.291 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 49.1 mtm -88.62 120.81 30.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.945 0.402 . . . . 0.0 110.778 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.1 m -165.75 99.12 0.67 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.76 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.96 -38.31 88.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.582 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.8 mttm . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 117.821 -1.085 . . . . 0.0 110.509 179.982 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -88.71 117.41 27.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.476 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -82.74 -36.37 25.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.606 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 43.4 tp -99.28 122.69 42.78 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.137 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 p -137.9 158.9 43.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.328 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -67.76 -33.52 75.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.651 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -53.78 -44.12 69.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.826 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -57.65 -42.09 82.77 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.617 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.04 -43.16 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.575 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.97 -29.72 57.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.265 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -54.65 -48.32 72.45 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.528 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -65.62 -40.85 93.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.865 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -62.01 -44.05 97.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.659 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -66.98 -37.57 84.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.988 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.482 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.03 -27.9 65.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.806 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -57.81 -46.9 84.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.525 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 m -77.98 -21.41 50.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.691 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.0 tp -62.41 -42.83 99.73 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.419 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.482 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.3 m-85 -60.15 -51.02 71.4 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.439 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.2 t0 -76.9 -14.32 59.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.872 0.368 . . . . 0.0 111.366 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -45.59 -32.68 2.43 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.805 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 8.8 p-10 -53.72 -46.1 70.71 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.53 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.434 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -144.36 -151.6 5.47 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 30.8 p-10 -72.93 -47.28 47.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.733 0.301 . . . . 0.0 111.106 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.71 107.35 0.28 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 178.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.43 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 4.6 m -166.61 139.3 3.74 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.151 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 mp -115.13 109.23 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.6 p -128.72 170.24 13.53 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.882 0.373 . . . . 0.0 110.372 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.603 ' CB ' HE22 ' A' ' 49' ' ' GLN . 67.2 p -64.68 -33.05 75.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.789 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -61.69 -41.45 97.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.395 . . . . 0.0 109.983 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 26' ' ' THR . 90.0 mt-10 -63.4 -45.73 89.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.897 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.9 tp -64.16 -43.3 95.6 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.106 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.81 -26.07 53.5 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.1 m -63.9 -41.45 97.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.885 0.374 . . . . 0.0 110.098 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.1 t -56.23 -23.61 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.365 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.478 ' O ' ' N ' ' A' ' 40' ' ' GLY . 62.3 mmm -48.06 -30.27 4.29 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.667 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -64.36 -45.68 86.71 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 118.077 -1.449 . . . . 0.0 110.999 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -63.95 -21.96 66.71 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.837 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 41' ' ' GLN . 16.8 mt -107.73 3.7 24.87 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.097 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.2 -71.29 0.02 OUTLIER Glycine 0 N--CA 1.465 0.602 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 39' ' ' LEU . 87.8 mt-30 -145.44 109.45 4.83 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 44' ' ' THR . 41.4 t30 -125.56 70.88 65.21 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.091 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.551 ' O ' ' N ' ' A' ' 46' ' ' ALA . 84.7 Cg_exo -33.02 -30.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 122.63 2.22 . . . . 0.0 112.715 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 42' ' ' ASN . 26.3 m -39.27 -30.19 0.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.503 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.419 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.9 mt-10 -86.61 -34.96 19.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.291 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -59.07 -50.04 75.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.834 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.15 -46.07 71.78 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.176 0.512 . . . . 0.0 109.671 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 51' ' ' MET . 84.7 mt -64.87 -31.14 72.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.338 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.603 HE22 ' CB ' ' A' ' 29' ' ' THR . 61.1 tp60 -37.42 -51.29 1.11 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.879 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.31 -40.32 89.89 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.228 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 48' ' ' LEU . 33.1 ttp -62.44 -41.02 98.44 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.934 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.413 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 83.4 mt -61.98 -49.85 82.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.182 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.536 ' O ' ' N ' ' A' ' 57' ' ' ALA . 89.8 m-20 -62.95 -40.46 97.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.56 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -55.18 -61.5 2.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.238 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.92 -30.12 43.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.261 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 62' ' ' THR . 50.6 t0 -84.66 -13.2 52.19 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.568 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -72.02 13.06 0.33 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.859 0.362 . . . . 0.0 110.254 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.8 p30 -65.54 -28.9 69.5 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -150.53 -22.37 0.06 OUTLIER Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.578 ' C ' ' H ' ' A' ' 62' ' ' THR . 3.3 p30 173.17 151.84 0.08 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.93 34.64 0.14 Allowed Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.578 ' H ' ' C ' ' A' ' 60' ' ' ASN . 81.9 p -134.34 149.46 50.86 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.4 mt -120.98 134.48 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.14 162.36 28.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.461 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.473 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -64.61 -48.16 74.56 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.432 -179.045 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 50.2 Cg_exo -51.17 -37.44 58.72 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.195 1.93 . . . . 0.0 111.719 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -87.48 -22.33 24.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.31 -47.25 86.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.014 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.44 -42.94 98.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.543 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.1 m -63.97 -46.08 86.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.672 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.6 ttp -61.66 -47.57 84.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.062 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 82.0 mmm -65.75 -37.82 87.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.275 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.62 -49.97 75.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.01 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -71.46 -43.83 65.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.18 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.69 -43.64 88.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.681 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.434 ' O ' ' O ' ' A' ' 73' ' ' ALA . 22.4 mmm -104.3 127.47 51.94 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.08 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.7 tptt -84.99 141.18 30.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.893 0.378 . . . . 0.0 110.706 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.422 ' O ' ' O ' ' A' ' 77' ' ' LYS . 95.1 m-20 -48.93 179.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.239 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.6 p -75.5 -6.74 51.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.444 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.52 -15.43 62.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.567 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.1 m -61.94 -19.94 63.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.539 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -48.15 -44.71 32.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.374 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.97 -39.51 79.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.913 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.86 -45.15 83.22 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.023 0.439 . . . . 0.0 110.187 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.2 mt -66.1 -19.05 25.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.514 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -58.43 -45.41 88.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.205 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.63 -31.83 73.07 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.916 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -72.04 -14.62 61.92 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.212 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -58.04 -48.96 78.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.292 0.567 . . . . 0.0 111.046 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -64.1 -45.6 87.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.328 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.14 -51.59 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.897 0.379 . . . . 0.0 110.896 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.417 ' CE2' ' CD1' ' A' ' 100' ' ' ILE . 26.3 t80 -61.95 -47.2 85.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.628 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.422 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 18.1 t70 -108.97 94.21 4.93 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.24 -41.03 74.08 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.001 0.429 . . . . 0.0 110.536 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 20.1 p-10 -62.49 -39.75 94.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.021 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.51 -67.34 0.99 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.59 -16.53 63.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.93 0.395 . . . . 0.0 110.25 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.71 162.03 12.57 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.29 155.38 24.17 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.786 0.327 . . . . 0.0 110.247 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.417 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 94.2 mt -79.73 125.99 39.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.978 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.4 p -82.39 169.01 16.94 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.141 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.56 -37.98 89.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.499 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.72 -47.36 83.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.847 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.66 -32.83 72.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.955 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.5 tp -61.59 -41.7 97.81 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.405 0.622 . . . . 0.0 110.68 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -56.42 -43.3 79.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.816 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -58.48 -41.96 86.45 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.62 -43.39 90.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.692 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.1 mmm -62.02 -35.58 79.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.685 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.9 m -61.13 -44.37 97.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.014 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -59.8 -34.96 73.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.382 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.1 tp -61.18 -46.7 89.42 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.121 0.486 . . . . 0.0 110.384 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.47 -160.71 33.43 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -140.55 23.33 2.31 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.634 0.254 . . . . 0.0 110.78 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -63.57 -42.86 98.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.97 0.414 . . . . 0.0 110.24 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.6 mt -92.8 175.85 6.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.996 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.469 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -72.93 161.32 30.84 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.679 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -91.66 -22.5 20.23 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.928 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -87.92 -25.26 23.31 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.152 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.642 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.4 -61.28 0.45 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.141 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.642 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 20.3 m -67.39 -40.18 84.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -56.86 -47.0 81.43 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.521 -178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -86.02 -40.33 15.9 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.6 tmm? -59.57 -46.52 88.67 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.015 0.436 . . . . 0.0 109.896 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 91.9 mt -69.09 -16.58 20.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.475 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 -78.64 -50.53 11.31 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.085 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 129' ' ' ASP . 42.3 tp10 -87.65 -67.54 0.82 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.071 -0.651 . . . . 0.0 110.861 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.34 -26.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.745 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 127' ' ' GLU . 25.4 t0 -87.98 128.27 35.38 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.061 0.457 . . . . 0.0 111.091 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.536 ' H ' ' CD1' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.47 -43.36 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.442 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -65.4 -40.31 93.25 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.132 0.491 . . . . 0.0 110.15 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.37 -2.0 58.92 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' GLY . 55.2 p-10 -89.47 -8.97 51.78 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 57.44 115.47 0.01 OUTLIER Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.24 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.434 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 20.3 pt20 -160.65 133.6 6.47 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.0 t -123.46 136.96 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.04 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -151.41 172.42 15.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.252 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -54.77 -46.75 74.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.161 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 55.4 mp0 -58.73 -44.37 90.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.639 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 93.3 mt-10 -72.09 -29.33 64.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.753 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.86 -44.02 77.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.631 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 94.3 t -59.1 -46.34 91.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.289 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -69.37 -29.03 66.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.132 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.8 ttp -59.74 -42.82 94.03 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.832 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.49 138.87 50.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.912 0.387 . . . . 0.0 110.745 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 81.4 m -163.29 77.69 0.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.658 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.13 -27.75 68.95 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.451 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.695 -179.882 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -107.75 102.8 11.99 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.972 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -78.51 -8.58 58.71 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 49.8 tp -102.41 121.58 42.61 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.16 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.8 p -135.56 163.95 28.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.72 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -61.43 -31.44 71.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.369 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.89 -43.49 98.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.515 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -66.51 -41.15 89.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.931 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.431 HD12 HG23 ' A' ' 9' ' ' ILE . 95.1 mt -64.23 -42.83 96.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.81 79.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.083 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -54.78 -50.55 68.21 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.0 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -63.77 -44.08 94.47 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.715 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -62.57 -45.92 90.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.484 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -69.82 -35.72 75.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.923 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.506 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -63.13 -37.78 88.58 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.511 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -58.43 -46.29 86.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.535 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.4 m -80.87 -18.87 45.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.746 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.51 -43.08 98.26 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.792 0.329 . . . . 0.0 111.291 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.9 m-85 -58.06 -49.22 77.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.541 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 6.3 t0 -73.17 -13.43 61.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.693 0.282 . . . . 0.0 111.229 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -44.49 -33.48 1.74 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.965 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.413 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 7.2 p-10 -53.97 -45.67 71.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.858 0.361 . . . . 0.0 110.96 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -149.07 -150.89 5.34 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 24.9 p-10 -70.16 -47.4 61.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.901 0.382 . . . . 0.0 110.983 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.53 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.79 107.84 0.3 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.445 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 6.3 m -166.21 139.5 4.11 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.112 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.2 mp -120.66 110.6 28.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.8 p -130.99 169.33 15.98 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.978 0.418 . . . . 0.0 110.554 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.2 p -63.09 -31.45 72.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.304 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -62.14 -42.37 99.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.978 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.445 ' OE1' ' O ' ' A' ' 26' ' ' THR . 81.4 mt-10 -66.66 -45.9 77.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.004 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.92 -42.9 97.25 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.38 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.81 -25.04 28.52 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.9 m -63.96 -44.15 93.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.865 0.365 . . . . 0.0 110.743 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.2 t -55.54 -20.43 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.521 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.513 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 87.5 mmm -48.97 -34.86 13.85 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.613 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -63.12 -46.39 87.53 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 118.056 -1.458 . . . . 0.0 111.83 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.502 ' HG ' ' N ' ' A' ' 39' ' ' LEU . 39.5 p -60.85 -30.85 70.36 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 41' ' ' GLN . 24.8 mt -96.7 2.04 51.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.046 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.94 -67.91 0.02 OUTLIER Glycine 0 N--CA 1.467 0.743 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 39' ' ' LEU . 86.0 mt-30 -143.6 110.09 5.48 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -123.73 75.05 55.65 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.469 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 46' ' ' ALA . 99.3 Cg_exo -36.4 -35.74 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.743 1.629 . . . . 0.0 112.139 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.8 m -37.84 -31.51 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.734 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.513 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.2 mt-10 -87.34 -35.97 18.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.336 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.52 -51.96 67.68 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -68.4 -47.17 68.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.25 0.548 . . . . 0.0 109.969 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 49' ' ' GLN . 85.0 mt -64.08 -26.8 68.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.967 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 45' ' ' GLU . 58.7 tp60 -38.77 -46.42 1.26 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.72 0.295 . . . . 0.0 110.543 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.13 -41.72 66.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.536 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 40.1 ttp -62.17 -41.73 98.59 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.086 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.94 -51.97 67.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.354 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 57' ' ' ALA . 17.3 m120 -64.35 -40.08 95.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.668 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -55.53 -59.6 4.6 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.266 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.79 -34.42 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.012 0.434 . . . . 0.0 110.756 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 62' ' ' THR . 55.3 t0 -80.76 -13.56 58.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.53 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -72.2 16.12 0.14 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.294 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' A' ' 56' ' ' ASP . 21.5 p-10 -66.04 -24.61 66.77 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -154.58 -25.57 0.04 OUTLIER Glycine 0 C--N 1.337 0.637 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.627 ' C ' ' H ' ' A' ' 62' ' ' THR . 10.9 p30 -179.99 150.84 0.39 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.405 ' C ' ' OD2' ' A' ' 56' ' ' ASP . . . -65.55 32.5 0.13 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.627 ' H ' ' C ' ' A' ' 60' ' ' ASN . 65.7 p -130.46 148.86 52.32 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.1 mt -118.47 133.9 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.069 0.461 . . . . 0.0 110.45 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.34 169.09 18.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.48 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.435 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -67.3 -49.47 43.37 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.212 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.8 Cg_exo -52.08 -45.29 39.91 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.927 1.751 . . . . 0.0 111.925 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.03 -37.01 72.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.661 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -60.58 -46.46 90.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.007 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.8 mt -62.27 -44.29 96.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.861 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.0 m -65.22 -44.61 87.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.916 0.389 . . . . 0.0 110.287 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 44.8 ttp -62.05 -41.91 98.63 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.812 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 76' ' ' MET . 60.2 mmm -63.29 -40.9 98.66 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.598 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.97 -35.81 77.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.778 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -87.76 -56.24 3.43 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.752 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -63.15 -43.27 98.77 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.138 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 72' ' ' MET . 50.8 mmm -108.9 131.56 54.91 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.943 0.401 . . . . 0.0 110.162 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 78' ' ' ASP . 29.0 tptt -83.12 150.07 26.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.792 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 77' ' ' LYS . 5.7 m-20 -55.45 -159.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.481 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.8 p -96.16 -0.3 50.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.479 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -82.87 2.48 34.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.128 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 83' ' ' GLU . 1.6 m -62.07 -35.63 79.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.971 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -37.92 -29.69 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.839 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 81' ' ' SER . 71.5 mm-40 -74.15 -56.85 4.42 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.065 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -64.71 -38.76 92.08 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 85' ' ' ILE . 96.7 mt -58.67 -19.29 14.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.462 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.1 ttt-85 -57.65 -44.04 85.37 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 118.79 -1.164 . . . . 0.0 110.201 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -65.96 -32.99 74.79 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.745 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -63.02 -27.96 69.77 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -55.61 -46.0 77.39 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.358 0.599 . . . . 0.0 110.432 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -74.44 -51.12 15.82 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.779 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.0 t -64.06 -47.92 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.082 0.468 . . . . 0.0 110.57 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.445 ' CB ' ' O ' ' A' ' 88' ' ' ALA . 39.3 t80 -63.41 -45.9 88.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.246 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.487 ' OD2' ' N ' ' A' ' 96' ' ' GLY . 36.0 t70 -127.06 105.06 8.33 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.602 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -68.56 -42.09 78.85 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.935 0.398 . . . . 0.0 111.079 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 97' ' ' ASN . 1.5 p-10 -60.04 -46.59 89.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.801 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.487 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 73.78 -41.81 1.05 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.467 ' H ' ' C ' ' A' ' 95' ' ' ASP . 77.1 m-20 -80.25 -13.56 59.12 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.957 0.408 . . . . 0.0 110.002 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.96 161.22 12.81 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -113.25 149.9 33.17 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.694 0.283 . . . . 0.0 110.475 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.7 mt -96.87 116.55 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.954 0.407 . . . . 0.0 111.177 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.2 p -84.35 170.72 13.34 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.309 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.59 86.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.136 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.17 -47.21 84.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.917 0.389 . . . . 0.0 110.548 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.55 -36.04 75.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.487 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.35 -40.08 95.22 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.619 0.723 . . . . 0.0 110.68 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -52.44 -45.12 65.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.625 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -61.51 -45.13 95.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.057 0.456 . . . . 0.0 110.437 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.85 -44.94 98.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.321 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 48.3 mmm -64.41 -37.07 86.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.457 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 82.6 m -61.08 -46.18 91.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.846 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -67.08 -24.56 65.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.19 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.0 tp -61.47 -44.87 96.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.923 0.392 . . . . 0.0 110.846 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.52 -148.81 15.57 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -140.39 25.92 2.2 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.498 0.19 . . . . 0.0 111.048 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -64.79 -45.35 86.66 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.954 0.407 . . . . 0.0 110.926 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.8 mt -113.55 170.64 8.09 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.991 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.482 ' H ' ' HG1' ' A' ' 117' ' ' THR . 0.8 OUTLIER -69.43 161.54 29.23 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.934 0.397 . . . . 0.0 110.981 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -92.1 -24.0 19.27 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.806 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -88.06 -20.37 25.84 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.67 -67.42 0.16 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.576 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.9 m -64.48 -35.15 73.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -57.69 -66.52 0.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -64.37 -43.71 93.66 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.459 ' C ' ' SD ' ' A' ' 124' ' ' MET . 16.1 tmm? -57.32 -48.69 78.32 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.85 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.24 -23.79 30.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.209 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -77.17 -46.81 22.13 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 119.0 -1.08 . . . . 0.0 111.439 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -85.39 -68.22 0.74 Allowed 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.066 -0.653 . . . . 0.0 111.503 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.0 -33.37 0.08 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.45 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -94.66 146.73 23.94 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.826 0.346 . . . . 0.0 110.722 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.431 ' H ' ' CD1' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -89.36 -17.35 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 179.461 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 133' ' ' ASP . 95.1 m-20 -65.48 -44.47 87.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.051 0.453 . . . . 0.0 110.552 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.44 -11.11 5.64 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 41.1 p-10 -89.08 -19.36 25.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.923 0.392 . . . . 0.0 110.501 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.546 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 55.38 106.12 0.01 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.476 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 11.1 pt20 -140.12 134.75 31.71 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 92.3 t -116.97 132.06 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.96 0.41 . . . . 0.0 110.201 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -142.75 175.41 9.83 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.566 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -58.16 -45.87 86.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.162 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 54.2 mp0 -63.63 -36.87 85.24 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.442 -178.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.476 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 78.3 mt-10 -67.14 -33.92 76.46 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.073 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -61.98 -40.6 96.19 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.45 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.7 t -57.22 -45.74 84.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.513 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -82.84 -15.84 50.02 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.836 0.35 . . . . 0.0 111.217 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 43.8 ttp -60.97 -41.03 95.59 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.906 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 78.2 mtm -118.54 141.69 48.33 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.815 0.341 . . . . 0.0 110.694 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.6 m -159.55 84.51 0.77 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.809 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.7 -40.47 72.85 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.124 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.501 -179.548 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -92.3 105.12 17.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.98 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -73.69 -16.05 61.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.157 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 54.9 tp -89.56 123.74 33.92 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.391 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.8 p -142.74 152.9 42.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.152 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -61.25 -20.89 63.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.38 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -60.74 -41.49 95.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.747 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -61.63 -44.27 97.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.525 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.6 mt -64.5 -43.46 96.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.673 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.97 -19.8 0.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.965 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -57.89 -44.61 86.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.483 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -62.66 -45.8 91.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.841 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -63.86 -46.75 83.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.736 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.52 -34.52 77.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.444 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.51 -13.83 61.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.762 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -55.95 -48.96 74.81 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.642 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -71.78 -30.01 65.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.934 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.6 tp -61.31 -42.41 98.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.38 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -60.11 -49.86 75.97 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.032 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 3.5 t70 -76.58 -14.39 60.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.245 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -43.67 -32.79 1.06 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.985 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 24.2 p-10 -53.8 -43.1 69.04 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.196 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -143.81 -155.89 6.6 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 29.1 p-10 -75.29 -47.26 28.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.846 0.355 . . . . 0.0 111.066 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.92 107.36 0.28 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 23.6 m -166.63 155.72 10.88 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.164 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.79 91.1 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.069 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.3 p -98.09 173.02 7.24 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.414 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.4 p -63.55 -32.6 74.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.998 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -62.7 -41.48 99.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.912 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 26' ' ' THR . 83.9 mt-10 -66.73 -44.48 81.43 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.336 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.0 tp -63.19 -45.75 90.28 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.938 0.399 . . . . 0.0 110.66 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -45.96 -25.21 1.6 Allowed Glycine 0 C--O 1.226 -0.377 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.401 ' C ' ' N ' ' A' ' 36' ' ' MET . 14.7 m -63.23 -42.35 99.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.867 0.365 . . . . 0.0 110.026 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 82.6 t -49.46 -18.76 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.285 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.401 ' N ' ' C ' ' A' ' 34' ' ' THR . 89.2 mmm -59.62 -41.01 89.46 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.097 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.5 ttt85 -65.43 -43.87 89.13 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 118.185 -1.406 . . . . 0.0 111.133 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.3 p -58.14 -33.1 68.8 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.852 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 40' ' ' GLY . 91.2 mt -97.33 7.05 47.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.611 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 42.96 97.21 0.01 OUTLIER Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 40' ' ' GLY . 87.0 mt-30 41.12 94.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.687 0.28 . . . . 0.0 110.485 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 44' ' ' THR . 48.8 t30 -130.35 75.68 78.8 Favored Pre-proline 0 N--CA 1.464 0.275 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 46' ' ' ALA . 95.0 Cg_exo -33.93 -26.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.367 2.044 . . . . 0.0 112.668 178.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.58 ' N ' ' O ' ' A' ' 42' ' ' ASN . 80.4 m -38.65 -25.97 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.564 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' PRO . 84.4 mt-10 -89.44 -33.38 16.84 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.499 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -56.58 -53.41 57.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.212 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.414 ' OE1' ' O ' ' A' ' 115' ' ' LYS . 1.5 tm-20 -67.96 -41.39 82.52 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.2 mt -73.02 -14.09 61.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.741 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' A' ' 45' ' ' GLU . 73.4 tp60 -53.08 -47.3 68.64 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -67.05 -37.13 83.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.97 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.0 ttp -60.32 -40.79 91.84 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.27 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.402 HD11 HG23 ' A' ' 52' ' ' ILE . 96.6 mt -62.23 -48.15 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.653 0.263 . . . . 0.0 111.378 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 57' ' ' ALA . 93.6 m-20 -62.03 -39.58 92.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.301 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -55.8 -57.51 11.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.068 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 p -74.92 -29.35 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.274 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 62' ' ' THR . 42.8 t0 -85.15 -12.99 51.52 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.584 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -71.8 2.63 5.12 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.181 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.5 p-10 -52.51 -26.79 14.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -155.64 -27.69 0.03 OUTLIER Glycine 0 C--N 1.339 0.704 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.591 ' C ' ' H ' ' A' ' 62' ' ' THR . 17.7 p30 -177.51 145.71 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.18 36.02 0.09 OUTLIER Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.591 ' H ' ' C ' ' A' ' 60' ' ' ASN . 72.5 p -133.45 152.59 51.93 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.405 HG22 HD12 ' A' ' 63' ' ' ILE . 91.7 mt -122.39 136.39 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.99 0.424 . . . . 0.0 110.253 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.6 OUTLIER -72.64 172.47 10.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.189 -179.464 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.445 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -72.88 -48.73 8.07 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.28 -178.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.9 Cg_exo -53.89 -39.79 83.15 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.279 1.986 . . . . 0.0 111.849 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -76.4 -35.25 58.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.876 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -59.75 -50.29 74.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.066 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -66.27 -42.17 88.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.618 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.9 m -63.43 -48.34 78.2 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.996 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 45.6 ttp -62.82 -44.84 95.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.585 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 42.9 mmm -64.47 -39.54 94.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.703 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.16 -46.26 90.28 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.97 0.414 . . . . 0.0 110.255 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -72.33 -44.64 62.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.335 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -69.6 -46.39 66.41 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.869 0.366 . . . . 0.0 111.644 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 16.3 mmm -101.59 131.06 47.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.671 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 78' ' ' ASP . 48.2 tptt -84.68 148.2 26.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.885 0.374 . . . . 0.0 110.311 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 77' ' ' LYS . 85.7 m-20 -48.85 -179.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.289 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.6 p -80.93 -8.86 59.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.422 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.02 -8.95 49.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.415 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 82' ' ' GLU . 9.4 m -61.01 -25.42 66.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.419 ' O ' ' OH ' ' A' ' 138' ' ' TYR . 82.2 tt0 -37.2 -48.05 0.83 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.759 0.314 . . . . 0.0 110.833 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -71.14 -44.14 66.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.253 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -63.95 -39.01 93.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.019 0.438 . . . . 0.0 110.104 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.3 -23.33 33.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 56.1 ttt-85 -56.89 -43.17 81.03 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 118.698 -1.201 . . . . 0.0 109.848 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -63.11 -34.76 78.3 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.64 -22.28 64.42 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -56.91 -49.81 74.46 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.317 0.579 . . . . 0.0 110.971 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -63.69 -45.99 87.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.992 -1.003 . . . . 0.0 111.309 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.5 t -66.22 -48.39 81.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.975 0.417 . . . . 0.0 110.183 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -64.45 -48.33 75.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.615 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -102.19 102.3 12.71 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.892 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.57 -41.52 88.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.106 0.479 . . . . 0.0 109.893 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -73.25 -42.67 62.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.261 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.75 -51.29 3.06 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -76.39 -14.53 60.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.067 0.46 . . . . 0.0 110.114 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.16 162.42 12.42 Favored Glycine 0 N--CA 1.465 0.592 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -112.13 150.44 30.77 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 95.6 mt -88.42 122.52 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.065 0.46 . . . . 0.0 111.114 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.6 p -88.78 176.39 7.09 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.205 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.5 -36.44 82.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.808 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.71 -52.61 64.96 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.476 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -67.95 -37.44 81.59 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.198 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.8 tp -62.59 -41.29 98.86 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.57 0.7 . . . . 0.0 110.298 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -55.7 -43.5 76.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.711 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -55.84 -41.72 74.71 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.4 t -66.35 -42.55 90.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.651 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 63.7 mmm -60.97 -38.03 84.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.617 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.3 m -61.17 -39.84 91.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.654 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -57.55 -40.21 78.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.558 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.4 tp -62.14 -43.68 98.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 0.0 110.138 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 146.31 -144.77 13.21 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -137.32 28.81 2.76 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.647 0.26 . . . . 0.0 110.403 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.414 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 48.7 mtmt -62.39 -42.06 99.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.218 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.2 mt -95.83 168.26 10.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.154 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.535 ' H ' ' HG1' ' A' ' 117' ' ' THR . 0.2 OUTLIER -63.76 161.7 14.72 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.819 0.342 . . . . 0.0 110.326 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -91.72 -22.42 20.22 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.539 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 120' ' ' GLU . 78.0 tt0 -86.17 -23.95 26.33 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.418 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.606 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -35.78 -64.38 0.31 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.566 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 14.4 m -63.93 -36.74 77.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.544 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -55.88 -66.67 0.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.596 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -69.69 -37.88 76.79 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.434 ' C ' ' SD ' ' A' ' 124' ' ' MET . 16.1 tmm? -59.07 -47.34 85.6 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.598 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.411 HD12 HG21 ' A' ' 125' ' ' ILE . 94.4 mt -70.18 -20.42 22.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.896 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -89.66 -60.24 1.99 Allowed 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.592 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -63.68 -68.34 0.35 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 119.519 -0.873 . . . . 0.0 111.405 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.13 -26.98 0.53 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.42 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -87.76 126.12 34.82 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.028 0.442 . . . . 0.0 111.15 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.413 ' H ' HD11 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -77.31 -23.45 14.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.422 179.255 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -74.95 -41.8 58.89 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.153 0.502 . . . . 0.0 110.004 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.79 2.24 56.44 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 41.7 p-10 -88.13 -18.54 28.57 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.36 111.15 0.04 OUTLIER Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -162.81 139.46 7.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.756 0.312 . . . . 0.0 110.26 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.9 t -126.22 132.98 69.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.182 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -146.73 166.76 25.65 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.187 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.419 ' OH ' ' O ' ' A' ' 82' ' ' GLU . 60.1 t80 -49.35 -37.42 24.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.649 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -59.77 -33.94 72.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.015 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -75.5 -37.06 60.41 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -61.29 -49.77 75.71 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.8 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.5 t -49.39 -48.24 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.42 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -68.91 -39.43 79.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.9 ttp -60.61 -44.73 95.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.768 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.412 ' O ' ' OG1' ' A' ' 146' ' ' THR . 67.1 mtt -89.18 121.18 31.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.898 0.38 . . . . 0.0 110.43 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 145' ' ' MET . 12.1 m -167.36 82.81 0.21 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.47 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.43 -46.2 89.65 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.815 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.456 -179.851 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -65.98 133.04 50.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.319 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.58 -25.54 45.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.457 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 53.3 tp -95.24 128.18 41.88 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.124 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.8 p -136.71 149.91 48.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.968 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -68.91 -20.25 64.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.247 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -59.16 -42.46 90.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.346 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.89 -45.04 91.16 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.915 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.8 mt -64.97 -42.9 95.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.799 0.333 . . . . 0.0 110.837 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -48.56 -26.7 2.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.183 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.41 -45.14 55.41 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.488 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -63.05 -44.01 97.07 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.907 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -63.84 -46.52 84.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.293 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -67.38 -43.58 81.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.904 0.383 . . . . 0.0 111.174 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.34 -36.48 80.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.409 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -55.72 -51.07 68.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.975 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -72.77 -23.45 60.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.735 0.302 . . . . 0.0 110.763 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.08 -42.24 99.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.705 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.406 ' O ' ' CD ' ' A' ' 31' ' ' GLU . 79.4 m-85 -59.55 -49.0 79.47 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.169 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.7 t0 -74.81 -13.67 60.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.528 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -43.09 -32.64 0.72 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.998 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 10.9 p-10 -53.3 -45.6 69.04 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.65 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -148.79 -149.18 4.91 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 32.2 p-10 -72.09 -46.89 55.03 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.698 0.285 . . . . 0.0 111.208 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.99 107.57 0.29 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 m -166.0 142.61 5.18 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.099 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.61 108.05 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.4 p -128.39 169.82 13.82 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.965 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.606 ' CG2' HE22 ' A' ' 49' ' ' GLN . 75.7 p -64.77 -32.38 74.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.985 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -62.35 -41.42 98.58 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.579 -0.449 . . . . 0.0 109.901 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.406 ' CD ' ' O ' ' A' ' 19' ' ' PHE . 89.2 mt-10 -63.49 -45.82 88.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.808 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.8 tp -63.87 -45.0 91.39 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.122 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.87 -24.24 7.98 Favored Glycine 0 C--O 1.224 -0.493 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.5 m -64.98 -42.95 94.08 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.256 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.8 t -53.86 -18.23 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.291 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.43 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 91.3 mmm -57.36 -35.35 69.84 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.389 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -63.62 -43.94 95.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 118.004 -1.478 . . . . 0.0 110.148 -178.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.8 p -61.06 -35.76 77.8 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.844 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 41' ' ' GLN . 25.7 mt -96.36 3.61 52.8 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.944 0.402 . . . . 0.0 110.314 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.51 -66.9 0.02 OUTLIER Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 39' ' ' LEU . 80.8 mt-30 -145.05 104.8 4.01 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' A' ' 44' ' ' THR . 50.2 t30 -123.61 73.75 52.87 Favored Pre-proline 0 N--CA 1.466 0.371 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.159 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' A' ' 46' ' ' ALA . 80.4 Cg_exo -35.05 -32.61 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.58 2.186 . . . . 0.0 112.504 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 42' ' ' ASN . 29.1 m -38.25 -31.04 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.593 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 92.5 mt-10 -86.8 -35.89 18.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.327 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -57.44 -49.98 74.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.694 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -70.47 -45.72 65.18 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.141 0.496 . . . . 0.0 109.666 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.62 -31.43 72.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.948 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.606 HE22 ' CG2' ' A' ' 29' ' ' THR . 67.3 tp60 -40.17 -54.79 2.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.681 0.276 . . . . 0.0 110.997 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -63.6 -41.52 98.32 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.722 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.6 ttp -61.26 -38.95 88.55 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.201 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.5 mt -62.94 -46.61 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.329 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 57' ' ' ALA . 92.3 m-20 -62.81 -41.28 99.24 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.838 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -57.88 -57.16 14.01 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.644 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 p -70.45 -29.31 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.156 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 62' ' ' THR . 38.7 t0 -89.13 -12.48 40.93 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.849 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -71.62 13.46 0.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.484 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' A' ' 56' ' ' ASP . 38.9 p-10 -66.81 -28.79 68.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -149.62 -32.12 0.05 OUTLIER Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.643 ' C ' ' H ' ' A' ' 62' ' ' THR . 11.3 p30 -177.11 153.04 0.94 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.551 -0.324 . . . . 0.0 110.202 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.39 30.93 0.1 OUTLIER Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.643 ' H ' ' C ' ' A' ' 60' ' ' ASN . 57.9 p -127.56 146.07 50.64 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.4 mt -116.66 139.74 42.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.652 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.35 176.08 2.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.604 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.516 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -85.67 -46.68 0.6 Allowed Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.667 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 32.4 Cg_exo -55.89 -45.02 41.85 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.272 1.981 . . . . 0.0 111.756 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -70.05 -36.98 75.41 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -57.45 -41.77 81.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.458 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.17 -43.87 98.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.59 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.8 m -64.14 -43.19 96.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.875 0.369 . . . . 0.0 110.365 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 62.1 ttp -59.13 -43.62 92.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.527 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 88.5 mmm -64.83 -38.13 89.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.78 -46.3 84.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -72.88 -45.67 56.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.841 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -64.72 -45.06 88.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.056 0.455 . . . . 0.0 110.537 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 28.6 mmt -93.91 128.07 40.01 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.79 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -85.18 148.26 26.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.307 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -52.96 164.77 0.36 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.357 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 75.4 p -67.19 -21.5 65.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.634 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.13 -7.23 8.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.038 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.6 m -53.47 -34.73 59.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.447 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -38.17 -45.13 0.91 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -69.28 -44.87 70.97 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.008 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.56 -36.48 81.03 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.0 0.428 . . . . 0.0 110.296 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.47 -20.98 24.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -55.58 -45.19 77.43 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 118.758 -1.177 . . . . 0.0 109.539 -177.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -68.07 -33.09 73.89 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.195 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.96 -27.71 69.59 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -57.31 -51.39 69.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.294 0.568 . . . . 0.0 110.94 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -69.36 -45.22 69.9 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.699 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.6 t -68.13 -50.58 57.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.918 0.389 . . . . 0.0 110.769 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -63.39 -47.43 82.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.223 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.408 ' OD2' ' N ' ' A' ' 96' ' ' GLY . 22.5 t0 -110.07 107.63 17.55 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.801 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -68.91 -41.24 78.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.173 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 97' ' ' ASN . 1.1 p-10 -68.63 -37.39 79.68 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.257 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.408 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 67.69 -64.88 0.3 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 95' ' ' ASP . 56.0 m-80 -63.1 -14.38 47.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.958 0.409 . . . . 0.0 110.41 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.57 162.01 12.59 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -112.16 145.64 39.48 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 75.7 mt -83.72 125.08 40.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.038 0.447 . . . . 0.0 111.087 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.7 p -83.68 172.15 12.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.043 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.14 -39.07 92.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.012 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.62 76.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.869 0.366 . . . . 0.0 111.108 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.3 -33.18 74.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.652 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.6 tp -61.91 -43.11 99.52 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.408 0.623 . . . . 0.0 111.257 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -55.52 -43.22 75.54 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.883 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -60.35 -43.96 96.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.102 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 84.2 t -63.2 -45.22 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.695 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 86.7 mmm -63.61 -37.46 87.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.337 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 m -60.75 -41.02 94.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.603 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -55.5 -28.38 54.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.011 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.8 tp -60.88 -43.39 98.5 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.035 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 152.8 -141.76 8.71 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -137.58 27.23 2.78 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.7 0.286 . . . . 0.0 110.522 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -62.69 -43.43 98.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.013 0.435 . . . . 0.0 110.356 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 56.3 mt -108.9 -178.67 3.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.689 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.483 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -76.85 161.76 28.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.66 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -92.15 -22.12 20.03 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.099 0.476 . . . . 0.0 110.526 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -86.99 -24.17 24.78 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.14 -67.57 0.14 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.309 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.581 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 19.3 m -64.46 -34.24 68.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -57.08 -67.43 0.32 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.589 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -68.88 -38.01 79.41 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.418 ' C ' ' SD ' ' A' ' 124' ' ' MET . 15.2 tmm? -59.88 -47.09 87.18 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.035 0.445 . . . . 0.0 110.103 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 97.6 mt -68.84 -16.86 21.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.144 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -80.18 -51.61 8.76 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.08 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 129' ' ' ASP . 44.1 tp10 -86.2 -68.2 0.76 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 118.978 -1.089 . . . . 0.0 111.362 -177.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 127' ' ' GLU . . . -37.44 -25.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.635 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 127' ' ' GLU . 40.0 t0 -88.57 126.71 35.4 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.165 0.507 . . . . 0.0 110.849 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.529 ' H ' ' CD1' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -65.46 -41.19 90.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.95 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.97 -42.87 99.61 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.755 0.312 . . . . 0.0 110.501 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.45 -0.92 62.83 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 50.2 p-10 -94.26 -18.57 21.53 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.894 0.378 . . . . 0.0 110.097 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.513 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 64.84 121.22 0.01 OUTLIER Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -164.45 144.5 7.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.57 -0.315 . . . . 0.0 110.272 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 72.7 t -128.62 134.36 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.39 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -150.98 176.3 11.25 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.105 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -56.15 -46.75 79.14 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.338 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -55.53 -37.92 68.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.579 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -69.16 -39.68 78.62 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.446 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -61.92 -43.12 99.5 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.0 t -58.03 -45.93 88.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.769 0.319 . . . . 0.0 110.657 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -77.07 -24.32 51.92 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.684 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 44.5 ttp -63.88 -41.14 97.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.727 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.438 ' O ' ' OG1' ' A' ' 146' ' ' THR . 64.6 mtt -91.36 130.38 37.22 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.929 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 145' ' ' MET . 36.0 m -167.44 67.8 0.09 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.583 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.42 87.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.32 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 66.4 mttm . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.913 179.606 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -81.88 115.42 21.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.444 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -81.42 -4.56 56.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.54 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 36.4 tp -84.77 123.55 30.55 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.15 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.5 p -79.83 156.17 27.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.136 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -75.84 -23.15 55.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.955 0.407 . . . . 0.0 110.216 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -62.03 -43.69 98.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.798 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -64.31 -41.99 96.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.881 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 91.3 mt -64.24 -43.54 97.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.722 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.82 -41.28 64.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.84 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -43.95 -48.24 8.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.653 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -65.97 -39.8 90.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.67 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -65.36 -48.14 73.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.237 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -64.14 -33.96 76.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.512 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.64 -19.88 12.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.543 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -57.45 -49.25 76.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.823 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.4 m -60.93 -40.84 94.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.552 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.55 -42.85 99.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.982 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -59.31 -49.84 76.27 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.849 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.466 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.5 t0 -75.97 -15.62 60.13 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.644 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -43.58 -33.25 1.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.787 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.433 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 14.5 p-10 -53.43 -43.45 68.02 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.466 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -145.57 -153.69 5.95 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 26.7 p-10 -74.79 -47.26 31.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 110.59 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.71 107.22 0.28 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 178.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 8.4 m -166.65 149.91 6.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.143 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.8 mp -119.52 109.49 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.1 p -130.98 169.68 15.5 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.908 0.385 . . . . 0.0 110.473 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.465 ' CB ' HE22 ' A' ' 49' ' ' GLN . 82.4 p -63.43 -29.57 70.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.182 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -62.16 -41.25 98.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.252 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.448 ' OE2' ' O ' ' A' ' 26' ' ' THR . 89.6 mt-10 -67.0 -45.72 76.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.98 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.3 tp -65.96 -44.43 85.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.409 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.93 -22.5 4.57 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.5 m -67.06 -30.2 70.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.78 0.324 . . . . 0.0 110.446 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.4 t -62.24 -22.99 30.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.809 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.0 mmm -56.0 -37.14 68.74 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.702 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -63.19 -44.2 96.05 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 116.771 -1.971 . . . . 0.0 110.06 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 91.6 p -60.45 -37.9 82.44 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.166 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.1 mt -94.71 5.05 53.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.28 0.562 . . . . 0.0 110.505 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.46 -67.62 0.26 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -147.87 104.98 3.63 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 44' ' ' THR . 58.7 t30 -123.24 76.8 52.48 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.06 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' A' ' 46' ' ' ALA . 72.0 Cg_exo -36.63 -29.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.582 2.188 . . . . 0.0 112.653 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 42' ' ' ASN . 11.4 m -38.46 -31.98 0.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.358 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 49' ' ' GLN . 96.8 mt-10 -88.77 -36.19 16.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.195 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -55.01 -49.8 70.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.558 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -69.85 -49.14 55.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.26 0.552 . . . . 0.0 110.258 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.91 -21.36 65.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.683 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.465 HE22 ' CB ' ' A' ' 29' ' ' THR . 71.2 tp60 -45.55 -47.44 14.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.209 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 68.1 t0 -70.89 -38.6 73.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.492 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.465 ' CE ' ' HZ2' ' A' ' 75' ' ' LYS . 39.1 ttp -62.38 -42.83 99.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.922 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 87.1 mt -63.53 -46.28 95.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.541 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 57' ' ' ALA . 87.3 m-20 -64.02 -41.79 97.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.62 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -59.27 -59.15 5.92 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.491 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.8 p -66.07 -31.82 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.0 110.847 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.546 ' OD2' ' N ' ' A' ' 62' ' ' THR . 45.5 t0 -87.28 -12.6 46.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.737 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -72.24 13.01 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.048 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 56' ' ' ASP . 16.7 p-10 -63.98 -33.84 76.65 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.47 -26.41 0.08 OUTLIER Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.622 ' C ' ' H ' ' A' ' 62' ' ' THR . 16.5 p30 -178.25 148.21 0.47 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.513 -0.343 . . . . 0.0 110.262 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.92 34.23 0.1 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.622 ' H ' ' C ' ' A' ' 60' ' ' ASN . 70.7 p -129.68 151.49 50.21 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.0 mt -119.62 134.12 64.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.821 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -77.09 -155.43 0.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.042 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.49 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -96.52 -47.86 0.24 Allowed Pre-proline 0 N--CA 1.469 0.485 0 CA-C-O 120.501 0.191 . . . . 0.0 110.845 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 42.6 Cg_exo -54.93 -36.06 91.07 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.115 1.877 . . . . 0.0 111.606 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -83.61 -28.69 28.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.794 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -59.38 -46.42 88.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.7 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.0 -43.48 95.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.822 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.7 m -63.6 -45.29 91.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.113 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 46.8 ttp -62.18 -44.44 96.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.782 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 47.8 mmm -63.39 -42.2 98.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.718 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.77 -48.65 80.82 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.686 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -71.03 -50.13 37.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.565 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.465 ' HZ2' ' CE ' ' A' ' 51' ' ' MET . 69.3 mmtt -64.67 -41.8 95.82 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.371 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 32.1 mmm -121.17 127.02 51.13 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.219 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -82.77 153.14 25.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.675 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -52.54 -179.96 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.282 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.0 p -80.97 -9.74 59.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.651 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -65.95 -21.65 66.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.419 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.7 m -50.58 -32.25 18.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.407 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -38.19 -45.71 0.98 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.716 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -69.12 -46.6 67.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.145 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -65.02 -49.52 69.89 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.9 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.5 mt -56.37 -21.14 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -57.94 -44.94 87.24 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 118.466 -1.294 . . . . 0.0 109.649 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -66.16 -25.95 67.19 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.6 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.81 -14.14 58.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.071 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -56.56 -50.68 71.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.298 0.57 . . . . 0.0 111.121 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -63.37 -44.49 94.64 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.203 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.6 t -66.64 -45.63 87.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.807 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.429 ' CE2' ' CD1' ' A' ' 100' ' ' ILE . 19.3 t80 -62.55 -47.23 84.79 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.643 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.431 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 37.3 t0 -119.94 106.56 12.16 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.242 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -68.14 -44.29 76.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.011 0.434 . . . . 0.0 110.58 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.431 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 0.9 OUTLIER -62.36 -44.47 96.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.779 -179.312 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.1 -47.41 1.05 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 95' ' ' ASP . 62.6 m-20 -74.6 -14.44 60.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.017 0.437 . . . . 0.0 110.541 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.79 161.79 12.64 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -112.19 144.38 41.68 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.429 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 64.7 mt -74.95 129.49 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.902 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.5 p -83.05 168.79 16.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.284 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.86 97.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.85 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.14 -41.7 94.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.701 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -67.32 -37.36 83.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.086 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.2 tp -60.21 -43.19 96.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.2 0.524 . . . . 0.0 110.682 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -54.07 -40.68 67.39 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.846 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -59.09 -42.2 89.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.893 0.377 . . . . 0.0 110.002 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.11 -44.92 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.745 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 80.9 mmm -63.51 -35.48 80.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.568 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.4 m -61.23 -41.71 97.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.251 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -59.8 -39.16 84.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.634 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.39 -44.29 97.4 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.582 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.69 -143.95 10.03 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -144.33 30.49 1.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.817 0.342 . . . . 0.0 110.766 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -62.87 -40.8 98.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.414 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.5 mt -105.25 165.94 10.76 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.485 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -65.15 161.52 18.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 0.0 110.51 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.445 ' C ' ' OE1' ' A' ' 120' ' ' GLU . 83.8 m-20 -91.28 -20.37 21.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 178.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -89.3 -26.11 21.31 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.674 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -34.91 -65.18 0.23 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.559 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.674 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 31.0 m -68.6 -27.46 36.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -178.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -63.25 -43.78 97.03 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.614 -0.435 . . . . 0.0 112.002 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -88.46 -41.07 13.0 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.467 ' C ' ' SD ' ' A' ' 124' ' ' MET . 15.0 tmm? -60.57 -42.67 97.11 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.898 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.98 -15.88 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -87.2 -66.69 0.88 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 118.971 -1.092 . . . . 0.0 112.003 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 128' ' ' ALA . 50.9 tp10 -70.97 -68.5 0.43 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.304 -0.959 . . . . 0.0 111.939 -176.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 127' ' ' GLU . . . -37.31 -40.01 0.32 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.699 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -88.42 124.64 34.15 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.066 0.46 . . . . 0.0 110.436 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.484 ' H ' HD12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -72.24 -16.03 18.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.281 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 133' ' ' ASP . 51.0 m-20 -65.36 -45.65 83.28 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.623 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.07 -11.48 2.67 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 42.0 p30 -88.51 -17.41 30.35 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.097 0.475 . . . . 0.0 110.15 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 58.35 120.73 0.01 OUTLIER Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.443 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 10.4 pt20 -161.02 137.88 8.77 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.4 t -125.59 134.17 67.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.874 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.468 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.4 t30 -148.98 159.56 44.1 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.232 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -40.04 -35.36 0.37 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.334 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.468 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 53.1 mp0 -65.8 -42.32 90.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.17 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 80.3 mt-10 -71.83 -30.18 65.2 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.538 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -58.5 -45.57 88.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.248 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 58.9 t -60.19 -48.2 89.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.914 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -70.05 -32.13 70.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.833 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.483 ' SD ' ' C37' ' A' ' 205' ' ' 4DY . 37.6 ttp -56.62 -47.69 79.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.696 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 69.7 mtm -106.1 134.1 49.76 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.844 0.354 . . . . 0.0 110.613 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 88.7 m -160.14 81.69 0.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.325 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.95 -40.52 91.41 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.885 0.374 . . . . 0.0 110.571 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.627 179.997 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' 4DY . . . . . 0.483 ' C37' ' SD ' ' A' ' 144' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -88.73 117.49 27.74 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.43 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -82.8 -36.34 25.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.607 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 43.3 tp -99.24 122.67 42.72 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.178 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 p -137.92 158.88 43.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.327 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -67.75 -33.58 75.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.582 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -53.73 -44.15 69.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.843 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -57.67 -42.09 82.86 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.6 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.99 -43.22 96.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.577 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.87 -29.79 56.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.288 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -54.7 -48.23 72.72 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.537 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -65.67 -40.84 92.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.824 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -62.04 -44.03 97.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.631 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -66.96 -37.58 84.54 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.998 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.482 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.0 -27.99 65.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.779 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -57.77 -46.95 83.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.526 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 m -77.9 -21.51 51.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.693 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.37 -42.81 99.7 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.431 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.482 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.2 m-85 -60.17 -51.01 71.43 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.462 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.1 t0 -76.89 -14.35 59.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.893 0.377 . . . . 0.0 111.358 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -45.56 -32.67 2.39 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.893 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 8.8 p-10 -53.73 -46.11 70.73 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.542 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -144.37 -151.62 5.48 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 30.7 p-10 -72.97 -47.19 47.54 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.074 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.7 107.37 0.28 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 178.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 4.5 m -166.62 139.28 3.72 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.38 -0.482 . . . . 0.0 111.179 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 mp -115.13 109.23 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.6 p -128.66 170.31 13.42 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.817 0.342 . . . . 0.0 110.442 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.602 ' CB ' HE22 ' A' ' 49' ' ' GLN . 67.3 p -64.66 -33.11 75.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.788 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -61.71 -41.32 97.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.011 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 26' ' ' THR . 90.1 mt-10 -63.49 -45.71 89.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.863 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.2 tp -64.1 -43.35 95.61 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.149 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.78 -26.1 53.29 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.2 m -63.93 -41.41 97.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.843 0.354 . . . . 0.0 110.084 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.7 t -56.24 -23.56 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.363 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.483 ' O ' ' N ' ' A' ' 40' ' ' GLY . 62.1 mmm -48.14 -30.27 4.41 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.671 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -64.38 -45.64 86.81 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 118.042 -1.463 . . . . 0.0 110.975 -178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -63.94 -21.98 66.72 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.852 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 41' ' ' GLN . 16.8 mt -107.75 3.7 24.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.086 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.19 -71.2 0.02 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.512 ' N ' ' O ' ' A' ' 39' ' ' LEU . 87.8 mt-30 -145.43 109.47 4.84 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 44' ' ' THR . 41.3 t30 -125.61 70.87 65.55 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.552 ' O ' ' N ' ' A' ' 46' ' ' ALA . 84.8 Cg_exo -32.94 -30.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.65 2.233 . . . . 0.0 112.792 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.542 ' N ' ' O ' ' A' ' 42' ' ' ASN . 26.1 m -39.29 -30.15 0.06 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.545 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 49' ' ' GLN . 93.9 mt-10 -86.67 -34.85 19.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.332 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -59.04 -50.14 75.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.799 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.15 -46.13 71.63 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 51' ' ' MET . 84.5 mt -64.81 -31.07 72.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.382 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.602 HE22 ' CB ' ' A' ' 29' ' ' THR . 61.1 tp60 -37.5 -51.36 1.14 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.74 0.305 . . . . 0.0 110.761 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.22 -40.33 90.22 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.259 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 48' ' ' LEU . 33.1 ttp -62.45 -40.98 98.37 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.948 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.415 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 83.5 mt -61.99 -49.9 82.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.142 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.536 ' O ' ' N ' ' A' ' 57' ' ' ALA . 89.9 m-20 -62.99 -40.36 97.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.597 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -55.19 -61.52 2.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.213 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.87 -30.21 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.341 . . . . 0.0 111.28 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 62' ' ' THR . 50.6 t0 -84.63 -13.24 52.15 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.574 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -71.99 13.07 0.33 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.871 0.367 . . . . 0.0 110.284 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.5 p30 -65.58 -28.92 69.49 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.535 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -150.48 -22.34 0.06 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.581 ' C ' ' H ' ' A' ' 62' ' ' THR . 3.3 p30 173.14 151.87 0.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.99 34.71 0.15 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.581 ' H ' ' C ' ' A' ' 60' ' ' ASN . 81.7 p -134.33 149.49 50.87 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.6 mt -120.98 134.57 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.26 162.4 28.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.41 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.471 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -64.56 -48.12 74.99 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.513 -179.076 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 50.5 Cg_exo -51.3 -37.29 59.76 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.195 1.93 . . . . 0.0 111.71 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -87.59 -22.3 24.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.836 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.42 -47.14 87.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.048 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.54 -42.89 98.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.549 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.8 m -63.95 -46.08 86.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.647 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.6 ttp -61.69 -47.56 84.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.077 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.9 mmm -65.76 -37.85 87.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.282 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.53 -50.01 75.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.031 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -71.51 -43.75 65.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.203 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.73 -43.56 88.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.733 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.431 ' O ' ' O ' ' A' ' 73' ' ' ALA . 22.4 mmm -104.35 127.44 52.01 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.094 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.7 tptt -84.96 141.17 30.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.38 . . . . 0.0 110.712 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' LYS . 95.0 m-20 -48.92 179.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.226 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.8 p -75.53 -6.76 51.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.418 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.44 -15.54 62.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.509 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.0 m -61.92 -19.87 63.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.548 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -48.19 -44.76 33.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.342 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.95 -39.52 79.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.905 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.82 -45.22 83.11 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.006 0.431 . . . . 0.0 110.152 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.2 mt -66.04 -19.04 25.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.525 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -58.47 -45.38 88.73 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.218 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.64 -31.81 73.04 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.928 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.406 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -72.03 -14.69 61.94 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.138 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -57.94 -48.99 78.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.297 0.57 . . . . 0.0 111.116 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -64.09 -45.58 88.07 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.36 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.7 t -76.17 -51.54 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.381 . . . . 0.0 110.894 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.416 ' CE2' ' CD1' ' A' ' 100' ' ' ILE . 26.3 t80 -61.98 -47.22 85.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.598 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.43 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 18.2 t70 -108.95 94.15 4.89 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.21 -41.04 74.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.02 0.438 . . . . 0.0 110.578 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 19.9 p-10 -62.48 -39.74 94.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.969 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.44 -67.33 0.97 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.56 -16.52 63.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.917 0.389 . . . . 0.0 110.228 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.78 162.0 12.57 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.2 155.4 24.04 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.811 0.338 . . . . 0.0 110.237 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.416 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 94.0 mt -79.76 126.04 39.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.965 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.3 p -82.45 168.94 16.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.181 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.07 89.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.557 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.59 -47.4 83.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.65 -32.8 72.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.5 tp -61.57 -41.69 97.77 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.423 0.63 . . . . 0.0 110.691 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -56.51 -43.23 79.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.845 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -58.47 -41.96 86.42 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.7 t -66.64 -43.35 90.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.656 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.0 mmm -62.01 -35.65 79.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.634 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.4 m -61.04 -44.39 97.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.071 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -59.8 -34.99 73.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.348 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.0 tp -61.12 -46.75 89.29 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.068 0.461 . . . . 0.0 110.375 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.46 -160.71 33.42 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -140.53 23.38 2.31 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.654 0.264 . . . . 0.0 110.835 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -63.66 -42.82 98.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.983 0.42 . . . . 0.0 110.237 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.7 mt -92.8 175.8 6.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.965 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.468 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -72.87 161.33 30.84 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.672 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -91.69 -22.5 20.2 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.945 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -87.88 -25.35 23.31 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.167 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.641 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.44 -61.19 0.46 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.114 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.641 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 20.4 m -67.4 -40.21 84.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -56.76 -47.1 80.86 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.51 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -86.0 -40.3 15.95 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.6 tmm? -59.52 -46.49 88.69 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.061 0.458 . . . . 0.0 109.954 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 91.3 mt -69.2 -16.49 20.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.409 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -78.62 -50.61 11.19 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 119.397 -0.921 . . . . 0.0 112.09 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' ASP . 42.4 tp10 -87.64 -67.47 0.82 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.897 -178.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.37 -26.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.784 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' GLU . 25.4 t0 -88.02 128.32 35.4 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.092 0.472 . . . . 0.0 111.073 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.538 ' H ' ' CD1' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.51 -43.42 90.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.404 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -65.35 -40.28 93.41 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.122 0.487 . . . . 0.0 110.164 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.3 -1.98 58.67 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.334 -1.107 . . . . 0.0 110.334 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 134' ' ' GLY . 55.3 p-10 -89.53 -8.96 51.66 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 57.44 115.43 0.01 OUTLIER Glycine 0 CA--C 1.522 0.525 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.229 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 20.3 pt20 -160.62 133.59 6.5 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.4 t -123.45 136.92 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.066 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -151.36 172.5 15.82 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.221 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -54.8 -46.82 74.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.152 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -58.65 -44.32 90.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.71 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 93.3 mt-10 -72.09 -29.34 64.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.763 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.9 -43.99 77.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.587 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 94.7 t -59.1 -46.32 91.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.301 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.33 -29.13 66.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.136 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.7 ttp -59.69 -42.87 93.91 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.841 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.48 138.81 50.64 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.913 0.387 . . . . 0.0 110.754 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 80.8 m -163.19 77.73 0.43 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.664 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.19 -27.74 68.9 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.414 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.86 -1.067 . . . . 0.0 110.625 -179.853 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 4' ' ' LEU . 43.5 t0 -88.7 115.92 26.59 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.699 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -78.81 -25.38 44.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.547 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.419 ' O ' ' OD1' ' A' ' 2' ' ' ASP . 37.1 tp -109.52 120.29 42.03 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.024 0.44 . . . . 0.0 110.33 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.2 p -139.05 158.8 43.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.043 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -68.7 -20.9 64.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -56.59 -39.29 73.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.15 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.28 -40.28 95.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.624 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.26 -43.59 97.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 121.074 -0.251 . . . . 0.0 110.863 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.25 -18.81 6.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.216 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -54.33 -42.25 69.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.044 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -67.78 -41.79 82.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.381 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -62.57 -43.76 98.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.956 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -67.2 -35.77 80.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.398 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.51 -24.17 66.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.768 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -55.4 -46.5 76.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.777 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.4 m -80.68 -19.41 45.26 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.808 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.18 -41.95 96.89 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.019 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.421 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.2 m-85 -58.84 -46.13 88.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.852 0.358 . . . . 0.0 111.107 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.3 t0 -79.58 -13.47 59.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.461 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -43.02 -32.77 0.71 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.867 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' CG ' ' OE2' ' A' ' 31' ' ' GLU . 10.9 p-10 -52.91 -45.13 67.44 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.49 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.433 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . -149.66 -151.26 5.46 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 21.3 p-10 -71.2 -46.86 60.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.712 0.292 . . . . 0.0 111.005 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.03 107.39 0.28 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.457 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 5.8 m -166.59 136.22 3.09 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.191 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.419 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.9 mp -110.58 118.27 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.0 p -134.73 167.08 21.5 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.881 0.372 . . . . 0.0 110.285 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.497 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.3 p -64.13 -33.65 76.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.283 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -62.56 -40.16 95.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.707 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.457 ' OE2' ' O ' ' A' ' 26' ' ' THR . 88.9 mt-10 -64.68 -48.51 74.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.366 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.8 tp -64.42 -43.75 93.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.252 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.31 -24.69 17.01 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -64.08 -41.04 97.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.851 0.358 . . . . 0.0 110.151 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.04 -22.47 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.207 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.6 mmm -48.78 -33.56 10.6 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.969 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -64.3 -45.5 87.69 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 118.163 -1.415 . . . . 0.0 110.272 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.3 p -59.0 -30.65 68.14 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.356 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 41' ' ' GLN . 9.3 mt -102.33 5.47 39.89 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.966 0.412 . . . . 0.0 110.443 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.27 -69.79 0.03 OUTLIER Glycine 0 N--CA 1.465 0.588 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 39' ' ' LEU . 85.7 mt-30 -143.25 116.29 8.88 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.1 t30 -132.66 69.75 79.45 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.906 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 46' ' ' ALA . 92.0 Cg_exo -33.1 -33.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 122.527 2.151 . . . . 0.0 112.49 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 42' ' ' ASN . 12.4 m -38.99 -29.35 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.476 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 43' ' ' PRO . 90.6 mt-10 -87.65 -35.22 18.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.463 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -61.26 -49.17 78.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.027 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -68.03 -48.61 65.18 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.403 0.621 . . . . 0.0 109.889 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.62 -22.75 66.64 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.018 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.497 HE22 ' CB ' ' A' ' 29' ' ' THR . 47.9 tp60 -40.21 -49.58 2.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 110.532 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.69 -39.8 73.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.472 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.1 ttp -61.54 -40.59 95.23 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.765 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.78 -46.93 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.658 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 57' ' ' ALA . 28.3 m120 -65.17 -39.84 93.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.333 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -58.08 -57.23 13.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.434 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 p -68.31 -32.83 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.936 0.398 . . . . 0.0 110.964 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.535 ' C ' ' H ' ' A' ' 58' ' ' ASP . 43.0 t0 -86.08 -13.03 48.51 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.812 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -72.04 15.42 0.16 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.056 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.535 ' H ' ' C ' ' A' ' 56' ' ' ASP . 38.7 p-10 -66.66 -23.55 66.16 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.39 -22.56 0.03 OUTLIER Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.625 ' C ' ' H ' ' A' ' 62' ' ' THR . 4.6 p30 179.31 146.55 0.19 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.76 33.71 0.18 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.625 ' H ' ' C ' ' A' ' 60' ' ' ASN . 80.6 p -132.15 143.93 50.33 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.88 135.12 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.057 0.456 . . . . 0.0 110.175 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.42 172.34 4.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.441 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.438 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -72.53 -49.59 8.56 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.761 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 53.2 Cg_exo -52.07 -43.26 53.95 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.87 1.714 . . . . 0.0 111.902 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.46 -37.43 77.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 110.867 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -60.42 -45.38 93.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.962 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.9 mt -62.39 -44.57 96.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.523 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.5 m -67.45 -45.43 76.03 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 111.242 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.4 ttp -61.17 -43.69 98.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.928 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 87.0 mmm -64.75 -39.36 93.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.206 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.435 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.89 -42.83 94.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.89 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -71.52 -41.78 68.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.237 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -64.76 -40.92 96.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.86 0.362 . . . . 0.0 110.422 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.435 ' O ' ' O ' ' A' ' 73' ' ' ALA . 14.2 mmt -95.21 129.82 42.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.129 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -86.84 142.8 27.8 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -50.35 168.77 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.425 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.0 p -75.15 -15.21 60.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.683 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.98 -16.5 64.08 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.908 0.385 . . . . 0.0 110.439 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 82' ' ' GLU . 1.1 m -60.41 -23.76 64.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.759 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 81' ' ' SER . 81.2 tt0 -36.75 -48.49 0.73 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.893 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -70.76 -43.52 68.62 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.262 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -63.88 -39.59 94.55 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.961 0.41 . . . . 0.0 110.025 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.5 mt -66.95 -21.92 28.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.287 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -57.97 -43.6 86.58 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 119.047 -1.061 . . . . 0.0 110.063 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -63.74 -34.76 78.61 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.846 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.8 -19.91 66.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.056 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -56.57 -48.75 76.7 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.261 0.553 . . . . 0.0 110.848 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -68.29 -44.71 74.86 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.462 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.7 t -66.3 -48.37 81.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -64.01 -47.11 81.58 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.654 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.405 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 18.4 t70 -120.35 100.14 6.99 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -66.74 -39.75 88.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.745 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -65.66 -40.59 92.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.102 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.62 -59.49 0.48 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -61.88 -17.44 56.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.986 0.422 . . . . 0.0 110.2 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.405 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.56 160.91 12.96 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -113.23 155.56 24.85 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.7 mt -95.74 118.25 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.966 0.412 . . . . 0.0 111.12 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.9 p -85.53 171.38 11.78 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.89 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.74 -35.73 78.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.551 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.5 -50.78 72.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.158 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -69.29 -37.36 77.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.922 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.03 -39.4 94.62 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.538 0.685 . . . . 0.0 111.07 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -54.22 -43.62 70.98 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.121 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -63.1 -39.49 94.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.3 t -61.82 -45.26 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.151 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 37.7 mmm -64.31 -37.94 89.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.562 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.0 m -60.58 -40.16 90.73 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -61.25 -38.12 85.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.204 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 tp -61.53 -44.09 97.69 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.907 0.385 . . . . 0.0 110.25 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.98 -154.71 25.68 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -139.02 23.35 2.6 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.722 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -62.66 -43.22 99.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 0.0 110.314 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.9 mt -99.95 169.07 9.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.525 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.55 ' HG1' ' H ' ' A' ' 117' ' ' THR . 0.8 OUTLIER -68.35 162.17 25.85 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.556 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -92.15 -22.28 19.94 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.434 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -87.26 -24.47 24.36 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.615 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.58 -66.06 0.21 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.254 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.615 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.7 m -65.19 -35.28 75.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.363 -178.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -60.51 -46.75 88.98 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.54 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -84.87 -40.4 17.12 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.3 tmm? -58.91 -47.21 85.79 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.2 mt -69.16 -18.37 22.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.553 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -77.4 -51.39 10.89 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.274 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 129' ' ' ASP . 34.9 tp10 -86.31 -68.67 0.72 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.341 -0.943 . . . . 0.0 111.456 -177.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.69 -21.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.877 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 127' ' ' GLU . 38.7 t0 -90.14 125.02 35.3 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.07 0.462 . . . . 0.0 110.657 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.494 ' H ' ' CD1' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.46 -32.09 56.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.018 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -72.19 -45.8 58.9 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.907 0.384 . . . . 0.0 110.347 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.68 -5.47 61.16 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 134' ' ' GLY . 35.2 p30 -89.94 -9.67 47.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.962 0.411 . . . . 0.0 109.934 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 58.22 117.93 0.01 OUTLIER Glycine 0 CA--C 1.519 0.294 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 8.2 pt20 -159.76 140.11 11.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.53 -0.335 . . . . 0.0 110.137 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.7 t -126.23 133.24 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.915 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.544 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.8 t30 -150.69 175.39 12.0 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.337 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -57.67 -52.1 66.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.761 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.544 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 57.2 mp0 -55.93 -35.02 66.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.668 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 79.4 mt-10 -69.55 -39.25 77.53 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.694 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -61.26 -45.33 94.97 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.753 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.1 t -58.01 -45.9 87.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -74.2 -30.84 62.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.413 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.4 ttp -60.08 -40.62 90.21 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.621 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.404 ' O ' ' OG1' ' A' ' 146' ' ' THR . 72.9 mtm -105.21 141.73 36.24 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.921 0.391 . . . . 0.0 110.589 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 145' ' ' MET . 63.1 m -167.3 72.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.119 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.58 -41.83 97.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.587 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 C--O 1.218 -0.561 0 CA-C-O 118.066 -0.968 . . . . 0.0 110.269 -179.89 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -107.79 102.8 11.98 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.974 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -78.48 -8.58 58.68 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 50.0 tp -102.46 121.59 42.64 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.167 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.2 p -135.52 163.96 28.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.685 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -61.39 -31.51 71.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.372 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.86 -43.55 98.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.472 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -66.57 -41.08 89.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.868 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.22 -42.92 96.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.048 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.36 -36.78 78.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.155 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -54.83 -50.58 68.24 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.997 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -63.74 -44.06 94.63 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.772 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -62.57 -45.94 90.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.484 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -69.69 -35.84 75.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.959 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -63.08 -37.79 88.59 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.492 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -58.47 -46.27 86.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.522 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -80.92 -18.82 45.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.735 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.49 -43.14 98.13 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.746 0.308 . . . . 0.0 111.283 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 83.0 m-85 -57.97 -49.27 77.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.586 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 6.3 t0 -73.15 -13.4 61.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.756 0.313 . . . . 0.0 111.27 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -44.49 -33.52 1.75 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.761 0.315 . . . . 0.0 110.959 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.414 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 7.2 p-10 -53.98 -45.69 71.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.86 0.362 . . . . 0.0 110.946 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.443 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . -149.01 -150.86 5.32 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 25.1 p-10 -70.2 -47.37 61.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.948 0.404 . . . . 0.0 111.006 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.527 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.81 107.81 0.3 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.444 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 6.2 m -166.21 139.46 4.09 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.139 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.2 mp -120.63 110.51 28.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.8 p -130.95 169.38 15.88 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.025 0.44 . . . . 0.0 110.566 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.2 p -63.07 -31.43 72.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.394 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -62.11 -42.35 99.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.99 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 26' ' ' THR . 81.5 mt-10 -66.74 -45.84 77.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.004 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.9 tp -63.93 -42.9 97.24 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.396 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.76 -25.11 28.42 Favored Glycine 0 C--O 1.226 -0.36 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.0 m -63.96 -44.1 93.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.934 0.397 . . . . 0.0 110.796 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.3 t -55.54 -20.49 7.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.527 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.509 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 87.4 mmm -48.9 -34.89 13.62 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.625 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -63.12 -46.4 87.5 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 118.005 -1.478 . . . . 0.0 111.851 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.503 ' HG ' ' N ' ' A' ' 39' ' ' LEU . 39.0 p -60.75 -30.89 70.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 41' ' ' GLN . 24.9 mt -96.75 2.13 51.62 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.974 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.92 -67.94 0.02 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 39' ' ' LEU . 86.1 mt-30 -143.59 110.07 5.47 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -123.72 75.03 55.56 Favored Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.461 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.577 ' O ' ' N ' ' A' ' 46' ' ' ALA . 99.5 Cg_exo -36.45 -35.69 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.732 1.621 . . . . 0.0 112.13 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.402 ' N ' ' HB3' ' A' ' 120' ' ' GLU . 5.9 m -37.83 -31.49 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.763 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.509 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.2 mt-10 -87.35 -36.03 18.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.316 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.47 -51.97 67.6 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.866 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -68.39 -47.21 67.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.304 0.573 . . . . 0.0 109.958 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 49' ' ' GLN . 84.7 mt -64.09 -26.81 68.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.917 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 48' ' ' LEU . 58.7 tp60 -38.82 -46.35 1.27 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.751 0.31 . . . . 0.0 110.566 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.17 -41.69 66.74 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.54 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 40.0 ttp -62.14 -41.73 98.55 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.076 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.444 HD11 HG23 ' A' ' 52' ' ' ILE . 96.6 mt -60.92 -51.99 66.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.39 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 57' ' ' ALA . 17.3 m120 -64.29 -40.03 95.13 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.71 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -55.61 -59.58 4.65 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.259 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.79 -34.43 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.99 0.424 . . . . 0.0 110.762 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 62' ' ' THR . 55.3 t0 -80.73 -13.59 58.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.533 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -72.13 16.11 0.14 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.274 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' A' ' 56' ' ' ASP . 21.5 p-10 -66.07 -24.61 66.75 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -154.54 -25.55 0.04 OUTLIER Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.631 ' C ' ' H ' ' A' ' 62' ' ' THR . 10.9 p30 179.96 150.84 0.39 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.403 ' C ' ' OD2' ' A' ' 56' ' ' ASP . . . -65.48 32.45 0.12 Allowed Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.631 ' H ' ' C ' ' A' ' 60' ' ' ASN . 66.5 p -130.39 148.91 52.26 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.0 mt -118.5 133.86 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.987 0.423 . . . . 0.0 110.514 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.32 169.08 18.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.475 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.436 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -67.29 -49.52 43.37 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.191 -179.027 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.8 Cg_exo -52.08 -45.31 39.77 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.995 1.797 . . . . 0.0 111.898 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.96 -37.02 72.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.694 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -60.69 -46.37 90.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.964 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.3 mt -62.22 -44.37 96.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.857 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.1 m -65.15 -44.63 87.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.904 0.383 . . . . 0.0 110.304 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 44.9 ttp -62.07 -41.83 98.57 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.853 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 76' ' ' MET . 60.3 mmm -63.35 -40.86 98.43 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.585 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.0 -35.84 77.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.739 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -87.71 -56.27 3.42 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.735 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -63.13 -43.31 98.74 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.123 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 72' ' ' MET . 50.8 mmm -108.88 131.51 54.94 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.863 0.363 . . . . 0.0 110.214 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 78' ' ' ASP . 29.0 tptt -83.12 150.07 26.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.764 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 77' ' ' LYS . 5.7 m-20 -55.51 -159.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.421 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.8 p -96.19 -0.27 50.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.916 0.388 . . . . 0.0 110.499 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -82.87 2.48 34.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.119 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 83' ' ' GLU . 1.6 m -62.09 -35.6 79.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.959 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -37.99 -29.61 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.861 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 81' ' ' SER . 71.5 mm-40 -74.17 -56.87 4.39 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -64.71 -38.73 91.99 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.154 0.502 . . . . 0.0 109.656 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.415 HD12 HG23 ' A' ' 85' ' ' ILE . 96.7 mt -58.7 -19.29 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.482 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.1 ttt-85 -57.69 -44.01 85.54 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.171 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -65.9 -33.02 74.87 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.785 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -63.0 -27.96 69.78 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -55.63 -46.0 77.47 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.38 0.609 . . . . 0.0 110.405 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -74.42 -51.08 15.97 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.757 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.21 -47.79 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.04 0.448 . . . . 0.0 110.553 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.443 ' CB ' ' O ' ' A' ' 88' ' ' ALA . 39.2 t80 -63.5 -45.83 88.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.239 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.48 ' OD2' ' N ' ' A' ' 96' ' ' GLY . 36.0 t70 -127.16 105.08 8.33 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.586 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -68.55 -42.12 78.82 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.897 0.379 . . . . 0.0 111.059 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 97' ' ' ASN . 1.5 p-10 -59.95 -46.62 88.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.846 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.48 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 73.77 -41.77 1.05 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 95' ' ' ASP . 77.1 m-20 -80.24 -13.55 59.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.929 0.395 . . . . 0.0 110.046 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.94 161.28 12.8 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -113.29 149.82 33.35 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.7 0.286 . . . . 0.0 110.511 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.7 mt -96.79 116.55 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.99 0.424 . . . . 0.0 111.191 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.9 p -84.39 170.76 13.24 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.3 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.57 -37.52 86.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.157 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.27 -47.16 84.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.978 0.418 . . . . 0.0 110.577 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.55 -35.99 75.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.495 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.6 tp -62.33 -40.15 95.41 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.63 0.728 . . . . 0.0 110.668 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -52.44 -45.02 65.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.649 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -61.64 -45.04 95.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.971 0.415 . . . . 0.0 110.396 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.9 t -63.91 -44.89 98.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.309 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 48.4 mmm -64.38 -37.12 86.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.514 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 83.1 m -61.04 -46.13 91.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -67.13 -24.54 65.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.216 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.1 tp -61.51 -44.89 96.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.893 0.378 . . . . 0.0 110.824 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.53 -148.79 15.54 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -140.36 25.84 2.21 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.502 0.192 . . . . 0.0 111.056 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -64.75 -45.34 86.84 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.979 0.418 . . . . 0.0 110.958 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.6 mt -113.54 170.67 8.07 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.943 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.491 ' H ' ' HG1' ' A' ' 117' ' ' THR . 0.8 OUTLIER -69.51 161.54 29.32 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.014 0.435 . . . . 0.0 110.952 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -92.1 -23.93 19.29 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.805 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -88.06 -20.39 25.81 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.578 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.7 -67.39 0.16 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.578 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 18.0 m -64.53 -35.15 73.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -57.68 -66.46 0.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -64.35 -43.79 93.48 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.465 ' C ' ' SD ' ' A' ' 124' ' ' MET . 16.1 tmm? -57.31 -48.69 78.3 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.832 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.22 -23.78 30.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.219 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -77.08 -46.86 22.17 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.499 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -85.38 -68.28 0.74 Allowed 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.486 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.01 -33.3 0.08 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.503 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -94.72 146.77 23.94 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.819 0.342 . . . . 0.0 110.702 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.433 ' H ' ' CD1' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -89.41 -17.37 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 133' ' ' ASP . 95.1 m-20 -65.46 -44.48 87.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.055 0.455 . . . . 0.0 110.531 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.37 -11.01 5.61 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 41.3 p-10 -89.12 -19.39 25.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.87 0.367 . . . . 0.0 110.483 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.549 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 55.36 106.24 0.01 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.477 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 11.1 pt20 -140.15 134.7 31.6 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.7 t -116.93 132.04 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.007 0.432 . . . . 0.0 110.225 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -142.74 175.44 9.81 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.579 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -58.22 -45.83 86.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.147 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.481 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 54.0 mp0 -63.66 -36.92 85.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.407 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.477 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 78.3 mt-10 -67.09 -33.85 76.38 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.137 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -62.09 -40.55 96.2 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.466 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.0 t -57.18 -45.78 84.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.516 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -82.86 -15.82 50.02 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.838 0.351 . . . . 0.0 111.224 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 43.8 ttp -60.99 -41.05 95.73 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.882 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 78.2 mtm -118.49 141.72 48.29 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.779 0.323 . . . . 0.0 110.683 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 81.5 m -159.56 84.5 0.76 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.798 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.58 -40.51 73.23 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.186 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.912 -1.042 . . . . 0.0 110.5 -179.563 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -81.83 115.42 21.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.451 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -81.41 -4.56 56.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.549 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 36.3 tp -84.78 123.52 30.52 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.16 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.5 p -79.74 156.19 27.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.132 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -75.89 -23.12 55.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.258 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -62.08 -43.7 98.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.782 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -64.25 -42.07 96.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.787 0.327 . . . . 0.0 110.847 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 91.4 mt -64.25 -43.49 97.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.719 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.86 -41.24 64.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -44.0 -48.21 8.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.852 0.358 . . . . 0.0 110.699 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -66.0 -39.8 90.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.582 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -65.38 -48.15 73.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.216 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -64.12 -34.03 77.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.476 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.57 -19.93 11.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.541 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -57.38 -49.3 76.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.865 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.8 m -60.95 -40.82 94.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.56 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.55 -42.86 99.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.003 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -59.33 -49.9 76.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.804 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.466 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.6 t0 -75.88 -15.61 60.18 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.682 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -43.6 -33.2 1.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.818 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.437 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 14.4 p-10 -53.4 -43.44 67.92 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.485 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -145.62 -153.7 5.95 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 26.7 p-10 -74.79 -47.27 31.7 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.59 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.69 107.27 0.28 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.445 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 8.4 m -166.7 149.93 6.86 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.128 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.8 mp -119.52 109.47 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.1 p -130.91 169.71 15.41 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.896 0.379 . . . . 0.0 110.506 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.464 ' CB ' HE22 ' A' ' 49' ' ' GLN . 82.5 p -63.51 -29.56 70.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.173 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -62.11 -41.28 98.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.236 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.445 ' OE2' ' O ' ' A' ' 26' ' ' THR . 89.6 mt-10 -66.99 -45.74 76.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.0 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.1 tp -65.92 -44.52 84.93 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.382 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.91 -22.49 4.52 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.3 m -67.03 -30.15 70.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.789 0.328 . . . . 0.0 110.478 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.6 t -62.34 -22.96 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 94.9 mmm -56.05 -37.11 68.83 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 120.199 -0.601 . . . . 0.0 109.701 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -63.17 -44.2 96.12 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 116.806 -1.958 . . . . 0.0 110.114 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 91.7 p -60.48 -37.87 82.43 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.16 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 41' ' ' GLN . 39.1 mt -94.74 5.05 53.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.302 0.572 . . . . 0.0 110.528 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.49 -67.62 0.26 Allowed Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 39' ' ' LEU . 84.1 mt-30 -147.86 104.99 3.63 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.431 ' O ' ' N ' ' A' ' 44' ' ' THR . 58.7 t30 -123.25 76.84 52.61 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.028 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' A' ' 46' ' ' ALA . 72.1 Cg_exo -36.74 -29.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.595 2.196 . . . . 0.0 112.603 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 42' ' ' ASN . 11.5 m -38.43 -31.93 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.418 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 49' ' ' GLN . 96.9 mt-10 -88.86 -36.14 16.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.117 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -55.08 -49.8 70.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.536 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -69.85 -49.21 54.69 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.174 0.511 . . . . 0.0 110.155 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.89 -21.35 65.94 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.663 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.464 HE22 ' CB ' ' A' ' 29' ' ' THR . 71.3 tp60 -45.5 -47.47 14.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.221 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 68.1 t0 -70.85 -38.63 73.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.519 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.468 ' CE ' ' HZ2' ' A' ' 75' ' ' LYS . 39.0 ttp -62.37 -42.78 99.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.914 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.411 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 87.5 mt -63.7 -46.22 95.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.488 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 57' ' ' ALA . 87.3 m-20 -63.95 -41.86 97.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.6 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -59.27 -59.17 5.89 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.477 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.8 p -66.1 -31.74 55.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.754 0.312 . . . . 0.0 110.834 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.541 ' OD2' ' N ' ' A' ' 62' ' ' THR . 45.5 t0 -87.38 -12.58 45.89 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.69 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -72.28 13.06 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.07 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 56' ' ' ASP . 16.8 p-10 -64.03 -33.83 76.63 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.44 -26.45 0.08 OUTLIER Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.625 ' C ' ' H ' ' A' ' 62' ' ' THR . 16.5 p30 -178.19 148.25 0.48 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.545 -0.327 . . . . 0.0 110.297 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.97 34.25 0.1 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.625 ' H ' ' C ' ' A' ' 60' ' ' ASN . 70.2 p -129.68 151.48 50.23 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.0 mt -119.59 134.15 64.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.82 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -77.05 -155.47 0.07 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.028 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.497 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -96.51 -47.89 0.24 Allowed Pre-proline 0 N--CA 1.469 0.496 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.824 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 42.9 Cg_exo -54.94 -36.01 91.01 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.107 1.872 . . . . 0.0 111.629 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -83.62 -28.66 28.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.795 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -59.44 -46.4 88.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.685 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.96 -43.5 95.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.854 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.9 m -63.64 -45.26 91.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.103 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 46.6 ttp -62.18 -44.41 96.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.806 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.415 ' O ' ' N ' ' A' ' 76' ' ' MET . 47.8 mmm -63.38 -42.23 98.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.767 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.72 -48.66 80.81 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.768 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -71.04 -50.15 37.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.554 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.468 ' HZ2' ' CE ' ' A' ' 51' ' ' MET . 69.2 mmtt -64.64 -41.78 95.9 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.396 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.415 ' N ' ' O ' ' A' ' 72' ' ' MET . 32.1 mmm -121.21 127.0 51.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.197 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -82.69 153.12 25.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.672 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -52.5 -179.96 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.263 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.4 p -80.99 -9.69 59.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.641 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -65.97 -21.69 66.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.39 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.3 m -50.59 -32.2 18.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.423 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -38.23 -45.72 1.0 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.685 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -69.1 -46.63 67.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.17 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -65.07 -49.43 70.07 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.939 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.6 mt -56.42 -21.13 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -57.94 -44.95 87.27 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 118.386 -1.326 . . . . 0.0 109.652 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -66.07 -26.02 67.3 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.62 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.74 -14.16 58.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.122 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -56.61 -50.62 71.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.292 0.568 . . . . 0.0 111.137 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -63.39 -44.52 94.47 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.164 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.58 -45.64 88.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.581 -0.447 . . . . 0.0 109.866 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.429 ' CE2' ' CD1' ' A' ' 100' ' ' ILE . 19.1 t80 -62.54 -47.17 85.05 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.697 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 37.3 t0 -119.94 106.53 12.13 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.208 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -68.1 -44.32 76.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.072 0.463 . . . . 0.0 110.648 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.0 OUTLIER -62.26 -44.59 96.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.752 -179.351 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.1 -47.38 1.05 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.419 ' H ' ' C ' ' A' ' 95' ' ' ASP . 62.6 m-20 -74.59 -14.43 60.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.016 0.436 . . . . 0.0 110.538 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.82 161.81 12.63 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -112.15 144.38 41.63 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.429 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 64.6 mt -74.95 129.49 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.861 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.6 p -83.09 168.79 16.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.293 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.88 97.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.857 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.11 -41.69 94.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.69 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -67.34 -37.33 83.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.084 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.2 tp -60.31 -43.17 96.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.192 0.52 . . . . 0.0 110.654 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -54.0 -40.76 67.26 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.789 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -59.05 -42.24 89.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.935 0.398 . . . . 0.0 109.987 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.02 -44.97 97.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.715 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 80.9 mmm -63.53 -35.47 80.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.562 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.3 m -61.21 -41.72 97.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.273 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -59.79 -39.15 83.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.663 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.1 tp -61.4 -44.33 97.33 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.534 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.77 -143.91 9.97 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -144.36 30.49 1.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.34 . . . . 0.0 110.775 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -62.85 -40.86 98.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.389 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.6 mt -105.19 165.93 10.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.788 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.486 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -65.16 161.58 18.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.877 0.37 . . . . 0.0 110.526 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.44 ' C ' ' OE1' ' A' ' 120' ' ' GLU . 83.8 m-20 -91.39 -20.25 22.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.851 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -89.34 -26.13 21.25 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.671 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -34.89 -65.17 0.23 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.565 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.671 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 31.0 m -68.65 -27.5 36.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 111.639 0.236 . . . . 0.0 111.639 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -63.21 -43.84 96.98 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.998 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -88.42 -41.02 13.07 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.47 ' C ' ' SD ' ' A' ' 124' ' ' MET . 15.0 tmm? -60.56 -42.72 97.19 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.858 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.02 -15.82 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -87.17 -66.76 0.88 Allowed 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.975 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -70.96 -68.53 0.43 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.949 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.3 -40.01 0.32 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.675 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -88.42 124.66 34.17 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.078 0.466 . . . . 0.0 110.466 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.483 ' H ' HD12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -72.25 -16.05 18.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.239 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 133' ' ' ASP . 51.0 m-20 -65.33 -45.65 83.4 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.994 0.426 . . . . 0.0 110.664 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.1 -11.56 2.67 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 42.0 p30 -88.45 -17.39 30.49 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.067 0.46 . . . . 0.0 110.14 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 58.33 120.7 0.01 OUTLIER Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.443 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 10.4 pt20 -160.97 137.87 8.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.711 0.291 . . . . 0.0 110.282 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.2 t -125.58 134.24 67.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.834 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.472 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.3 t30 -148.99 159.64 44.03 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.232 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -40.13 -35.34 0.38 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.289 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.472 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 53.0 mp0 -65.81 -42.29 90.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.177 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 80.2 mt-10 -71.75 -30.27 65.41 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.524 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -58.52 -45.5 88.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.21 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.3 -48.16 89.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.862 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -70.07 -32.15 70.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.778 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.486 ' SD ' ' C37' ' A' ' 205' ' ' 4DY . 37.6 ttp -56.62 -47.71 79.08 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.722 -178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 69.7 mtm -106.09 134.1 49.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 110.658 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 88.8 m -160.1 81.58 0.7 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.351 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.62 92.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.939 0.399 . . . . 0.0 110.607 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.632 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' 4DY . . . . . 0.486 ' C37' ' SD ' ' A' ' 144' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -88.49 114.0 24.65 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.649 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -81.21 -16.87 51.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.417 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 32.4 tp -113.03 117.71 32.79 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.914 0.388 . . . . 0.0 110.034 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.2 p -139.12 157.52 45.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.171 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -71.33 -22.1 61.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.996 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.05 -43.08 77.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.077 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -62.37 -44.19 97.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.467 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.424 HG23 HD13 ' A' ' 9' ' ' ILE . 92.1 mt -64.34 -43.3 97.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.8 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.4 -45.35 69.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.482 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -41.25 -45.78 3.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.851 0.358 . . . . 0.0 110.963 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -66.78 -39.62 87.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.795 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -62.76 -43.22 99.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.484 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.06 -40.82 91.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.752 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.78 -20.42 49.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.652 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -49.36 -47.95 47.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.817 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.3 m -77.72 -20.36 53.66 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.019 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.6 tp -64.04 -40.69 96.87 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.837 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.468 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 76.3 m-85 -57.69 -45.41 85.7 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.354 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 9.7 t0 -86.16 -20.35 28.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -44.06 -33.17 1.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.806 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.41 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 4.5 p-10 -56.0 -46.14 78.81 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 110.82 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -140.25 -152.61 5.85 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 28.2 p-10 -74.4 -47.09 36.1 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.728 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.71 107.09 0.28 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 178.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 6.3 m -166.44 148.82 6.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.199 0.499 . . . . 0.0 111.436 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.73 74.02 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 p -86.96 166.18 15.3 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.541 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.444 ' HG1' ' N ' ' A' ' 30' ' ' LYS . 1.4 p -66.31 -28.55 68.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.961 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.444 ' N ' ' HG1' ' A' ' 29' ' ' THR . 59.2 mttp -61.91 -40.21 94.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.925 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.468 ' OE1' ' O ' ' A' ' 19' ' ' PHE . 86.7 mt-10 -66.76 -40.47 88.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.959 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.7 tp -62.8 -43.54 98.54 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.63 -33.22 47.94 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 m -64.58 -44.62 90.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.91 0.355 . . . . 0.0 110.857 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.4 t -55.95 -17.34 3.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.113 0.483 . . . . 0.0 110.287 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.545 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 88.9 mmm -52.72 -40.81 63.38 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.733 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.2 ttt85 -64.27 -46.01 85.57 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 118.202 -1.399 . . . . 0.0 110.2 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.8 p -64.3 -19.23 65.29 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.63 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 36.4 mt -94.41 6.6 48.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.682 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 43.75 78.67 0.07 OUTLIER Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 40' ' ' GLY . 85.7 mt-30 52.76 117.23 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.852 0.358 . . . . 0.0 110.723 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' A' ' 44' ' ' THR . 35.2 t-20 -148.85 68.76 9.84 Favored Pre-proline 0 C--O 1.235 0.303 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.657 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.582 ' O ' ' N ' ' A' ' 46' ' ' ALA . 86.7 Cg_exo -35.85 -31.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 122.533 2.156 . . . . 0.0 111.983 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.449 ' N ' ' O ' ' A' ' 42' ' ' ASN . 29.5 m -38.58 -27.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.299 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.545 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 87.7 mt-10 -89.52 -32.44 17.17 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.848 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.33 -51.88 67.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.994 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -67.5 -46.06 73.99 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.192 0.52 . . . . 0.0 109.661 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.8 mt -63.6 -27.6 69.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.403 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -39.51 -53.66 2.04 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.811 0.339 . . . . 0.0 110.85 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -65.9 -38.26 88.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.24 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.5 ttp -62.33 -40.18 95.51 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 97.8 mt -62.04 -46.42 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 57' ' ' ALA . 9.4 m120 -62.38 -42.43 99.41 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.666 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.68 -55.66 31.57 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.119 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.87 -34.88 62.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.891 0.377 . . . . 0.0 111.065 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.531 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.9 t0 -82.92 -13.43 56.09 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.408 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -72.12 9.0 1.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.778 0.323 . . . . 0.0 110.154 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 12.6 p30 -61.56 -25.18 67.15 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.484 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -157.83 -19.97 0.03 OUTLIER Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.647 ' C ' ' H ' ' A' ' 62' ' ' THR . 5.1 p30 177.08 141.82 0.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.72 32.25 0.08 OUTLIER Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.647 ' H ' ' C ' ' A' ' 60' ' ' ASN . 64.0 p -130.29 150.08 51.69 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-O 121.002 0.43 . . . . 0.0 110.273 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.433 HD12 HG22 ' A' ' 63' ' ' ILE . 91.3 mt -116.98 138.93 46.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.144 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.53 166.14 19.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.444 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.429 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -62.95 -50.52 76.59 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.761 -179.119 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.4 Cg_exo -50.92 -44.88 39.32 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.994 1.796 . . . . 0.0 111.778 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.95 -36.32 72.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.977 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -60.03 -45.85 91.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.224 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.08 -44.5 95.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.625 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.5 m -67.4 -44.45 78.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.194 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.0 ttp -61.42 -40.13 93.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.05 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 76.3 mmm -63.01 -38.6 91.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.848 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.07 96.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.02 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -68.43 -45.55 72.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.11 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.59 -41.78 83.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.924 0.393 . . . . 0.0 110.366 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.8 mmt -86.92 164.47 16.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.086 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -116.24 153.61 31.58 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.004 0.43 . . . . 0.0 110.145 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -59.29 160.46 6.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.26 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.4 p -64.17 -30.06 71.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.546 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.43 -10.05 22.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.206 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -57.04 -32.85 66.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.513 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -49.43 -50.23 41.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.735 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.02 -41.92 94.88 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.005 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -66.27 -45.74 79.45 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.476 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.3 mt -64.9 -20.59 27.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -59.74 -42.18 92.61 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 119.079 -1.048 . . . . 0.0 110.184 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -61.46 -35.88 78.87 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.496 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.18 -13.39 60.45 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -48.02 -51.05 25.59 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.981 0.419 . . . . 0.0 111.41 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -59.78 -46.86 87.89 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.784 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.86 -44.35 81.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.991 0.424 . . . . 0.0 110.451 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -59.46 -44.41 92.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.567 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.435 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 33.0 t70 -138.82 100.73 4.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.24 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.1 -39.96 82.71 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.175 0.512 . . . . 0.0 110.164 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.435 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.2 p-10 -60.22 -42.54 95.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.291 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.71 -56.99 0.51 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -70.78 -13.59 62.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.146 0.498 . . . . 0.0 110.28 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.66 161.12 12.86 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -115.0 150.89 35.13 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.7 mt -85.19 123.18 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.025 0.44 . . . . 0.0 110.343 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.2 p -80.02 168.14 19.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.026 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.48 82.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.62 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.21 -45.3 93.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.056 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.97 -37.68 75.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.251 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.7 tp -61.94 -42.96 99.7 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.263 0.554 . . . . 0.0 111.257 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -52.56 -43.25 65.1 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.012 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -55.4 -42.75 74.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.199 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.63 -42.43 95.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.279 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 58.3 mmm -57.56 -34.78 69.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.476 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 80.3 m -60.19 -42.34 94.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.458 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -58.6 -38.73 78.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.9 tp -61.29 -46.35 90.71 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.025 0.44 . . . . 0.0 110.117 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.85 -154.89 25.97 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.237 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -143.24 11.8 1.75 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.737 -0.231 . . . . 0.0 110.76 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -63.92 -44.01 94.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.102 0.477 . . . . 0.0 110.631 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.6 mt -79.75 160.29 26.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.978 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.48 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.6 OUTLIER -68.5 161.69 27.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.273 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -92.33 -21.03 20.5 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.098 0.475 . . . . 0.0 110.45 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -85.45 -26.93 26.03 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.24 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.612 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.59 -63.55 0.35 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.612 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 11.3 m -69.09 -31.32 49.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 121.236 -0.185 . . . . 0.0 111.497 -178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -58.94 -67.08 0.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.717 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.58 -45.15 72.79 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.469 ' C ' ' SD ' ' A' ' 124' ' ' MET . 13.3 tmm? -52.91 -50.3 64.2 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.62 -18.38 23.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.653 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -87.92 -57.88 2.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.297 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 128' ' ' ALA . 51.1 tp10 -81.92 -67.78 0.75 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.236 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 127' ' ' GLU . . . -36.78 -35.65 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 56.6 t0 -87.69 146.18 25.81 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.298 0.57 . . . . 0.0 110.519 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.523 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -89.39 -14.94 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.783 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 133' ' ' ASP . 44.8 m-20 -73.59 -45.27 54.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.016 0.436 . . . . 0.0 110.4 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.29 -10.29 3.65 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 131' ' ' ASP . 35.3 p30 -89.84 -10.42 45.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.233 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 62.28 122.93 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -161.7 119.61 2.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.859 0.362 . . . . 0.0 110.073 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.61 128.9 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.13 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.526 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 45.3 t30 -155.08 166.32 33.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.063 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.402 ' O ' ' CD1' ' A' ' 138' ' ' TYR . 2.6 t80 -48.82 -23.06 0.95 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.415 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 50.0 mp0 -66.4 -35.74 81.09 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.153 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -84.97 -20.83 29.97 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.582 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -61.94 -46.84 87.56 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.102 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 29.5 t -58.22 -45.95 88.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.105 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -71.4 -36.07 71.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.332 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.471 ' SD ' ' H38' ' A' ' 205' ' ' 4DY . 61.4 ttp -58.09 -43.03 86.83 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.128 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 70.6 mtm -112.76 129.28 56.48 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.84 0.353 . . . . 0.0 110.377 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 m -162.81 85.8 0.55 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.047 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.13 -43.93 93.75 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.645 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.55 179.846 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' 4DY . . . . . 0.471 ' H38' ' SD ' ' A' ' 144' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -88.72 117.43 27.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.416 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -82.77 -36.37 25.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.596 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 43.4 tp -99.29 122.6 42.67 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.146 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 p -137.87 158.95 43.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.348 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -67.78 -33.57 75.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.599 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -53.73 -44.13 69.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.857 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -57.63 -42.05 82.57 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.67 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.09 -43.15 95.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.57 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.93 -29.73 56.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.281 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -54.68 -48.25 72.62 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.538 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -65.7 -40.81 92.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -61.95 -44.08 97.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.67 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -67.06 -37.51 84.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.01 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.481 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.02 -27.92 65.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.826 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -57.81 -46.91 83.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.537 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.7 m -77.92 -21.51 51.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.68 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.4 -42.76 99.68 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.436 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.481 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.1 m-85 -60.2 -50.96 71.61 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.478 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.1 t0 -76.93 -14.35 59.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.912 0.387 . . . . 0.0 111.335 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -45.59 -32.68 2.44 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.84 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 8.8 p-10 -53.72 -46.08 70.7 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.57 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -144.36 -151.58 5.47 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 30.8 p-10 -72.97 -47.25 47.01 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.09 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.72 107.36 0.28 Allowed Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 178.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 4.7 m -166.59 139.32 3.76 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.129 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 mp -115.04 109.19 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.6 p -128.68 170.31 13.43 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.847 0.356 . . . . 0.0 110.418 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.603 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.2 p -64.69 -33.12 75.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.805 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -61.62 -41.4 97.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.053 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 26' ' ' THR . 90.0 mt-10 -63.41 -45.69 89.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.915 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.1 tp -64.13 -43.36 95.5 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.113 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.77 -26.1 53.24 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.1 m -63.87 -41.46 97.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.85 0.357 . . . . 0.0 110.071 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.1 t -56.28 -23.52 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.352 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.48 ' O ' ' N ' ' A' ' 40' ' ' GLY . 62.1 mmm -48.17 -30.21 4.42 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.679 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -64.41 -45.65 86.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.003 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.1 p -63.91 -21.99 66.72 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.856 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 41' ' ' GLN . 16.8 mt -107.7 3.68 24.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.094 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.15 -71.19 0.02 OUTLIER Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 39' ' ' LEU . 87.8 mt-30 -145.46 109.44 4.83 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 44' ' ' THR . 41.4 t30 -125.58 70.88 65.34 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.149 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 46' ' ' ALA . 85.4 Cg_exo -32.92 -30.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 122.66 2.24 . . . . 0.0 112.785 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.542 ' N ' ' O ' ' A' ' 42' ' ' ASN . 26.2 m -39.27 -30.15 0.05 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.522 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' A' ' 49' ' ' GLN . 93.9 mt-10 -86.7 -34.86 19.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.27 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -59.12 -50.08 75.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.779 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.13 -46.15 71.65 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.166 0.508 . . . . 0.0 109.655 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 51' ' ' MET . 84.5 mt -64.79 -31.15 72.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.359 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.603 HE22 ' CB ' ' A' ' 29' ' ' THR . 61.1 tp60 -37.47 -51.3 1.13 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.72 0.295 . . . . 0.0 110.838 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.25 -40.35 90.14 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.27 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.463 ' N ' ' O ' ' A' ' 48' ' ' LEU . 33.1 ttp -62.45 -40.95 98.27 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.0 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 83.5 mt -62.04 -49.88 82.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.145 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' A' ' 57' ' ' ALA . 89.8 m-20 -63.0 -40.38 97.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.585 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -55.19 -61.54 2.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.193 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.9 -30.12 43.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.779 0.323 . . . . 0.0 111.285 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 62' ' ' THR . 50.6 t0 -84.68 -13.21 52.11 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.528 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -71.97 13.0 0.33 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.868 0.366 . . . . 0.0 110.295 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.7 p30 -65.57 -28.86 69.45 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.539 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -150.55 -22.4 0.06 OUTLIER Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.577 ' C ' ' H ' ' A' ' 62' ' ' THR . 3.3 p30 173.13 151.88 0.08 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.99 34.76 0.14 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.577 ' H ' ' C ' ' A' ' 60' ' ' ASN . 81.7 p -134.39 149.48 50.81 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.3 mt -121.02 134.52 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.14 162.44 28.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.416 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.471 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -64.65 -48.14 74.33 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.478 -179.096 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 50.3 Cg_exo -51.17 -37.36 58.49 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.171 1.914 . . . . 0.0 111.739 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -87.61 -22.3 24.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.35 -47.2 86.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.852 0.358 . . . . 0.0 111.028 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.5 -42.89 98.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.567 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.4 m -63.92 -46.11 86.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.668 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.7 ttp -61.76 -47.45 85.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.077 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 82.0 mmm -65.82 -37.79 87.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.271 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.62 -49.97 75.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.031 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -71.5 -43.76 65.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.196 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.72 -43.61 88.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.7 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 73' ' ' ALA . 22.3 mmm -104.31 127.46 51.96 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.07 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.7 tptt -84.97 141.11 30.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.931 0.396 . . . . 0.0 110.711 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 77' ' ' LYS . 95.0 m-20 -48.9 179.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.266 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.3 p -75.47 -6.77 51.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.456 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.47 -15.53 62.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.511 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.9 m -61.89 -19.91 63.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.527 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -48.2 -44.72 33.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.33 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.99 -39.49 79.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.894 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -65.89 -45.13 83.16 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.01 0.433 . . . . 0.0 110.197 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.3 mt -66.05 -19.09 25.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.494 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -58.43 -45.42 88.52 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 118.971 -1.092 . . . . 0.0 110.156 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.62 -31.79 73.01 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.923 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -72.08 -14.61 61.9 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.16 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -57.97 -48.98 78.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.328 0.585 . . . . 0.0 111.092 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -64.1 -45.57 88.05 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.358 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -76.2 -51.58 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 110.849 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.417 ' CE2' ' CD1' ' A' ' 100' ' ' ILE . 26.3 t80 -62.02 -47.17 85.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.625 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 18.2 t70 -108.98 94.24 4.94 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.29 -41.02 73.93 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 110.535 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 19.8 p-10 -62.52 -39.71 94.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.961 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.44 -67.29 0.97 Allowed Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.57 -16.56 63.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.009 0.433 . . . . 0.0 110.242 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.82 161.99 12.57 Favored Glycine 0 N--CA 1.465 0.575 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.28 155.33 24.24 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.775 0.321 . . . . 0.0 110.23 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.417 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 94.2 mt -79.66 125.99 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.974 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.4 p -82.39 168.94 17.0 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.128 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.51 -38.04 89.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.513 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.65 -47.3 84.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.916 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.67 -32.88 73.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.958 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.4 tp -61.52 -41.7 97.71 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.382 0.61 . . . . 0.0 110.706 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -56.43 -43.31 79.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.77 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -58.49 -41.88 86.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.3 t -66.68 -43.37 90.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.646 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.0 mmm -62.03 -35.59 79.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.642 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.2 m -61.09 -44.37 97.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.055 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -59.76 -35.0 73.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.378 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.0 tp -61.18 -46.73 89.28 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.081 0.467 . . . . 0.0 110.391 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.5 -160.71 33.43 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -140.53 23.35 2.31 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.603 0.24 . . . . 0.0 110.746 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -63.61 -42.79 98.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.962 0.41 . . . . 0.0 110.277 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.7 mt -92.88 175.8 6.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.972 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.467 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -72.85 161.29 30.9 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.668 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -91.66 -22.44 20.25 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.979 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -87.91 -25.32 23.29 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.174 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.641 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.41 -61.24 0.46 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.123 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.641 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 20.2 m -67.39 -40.21 84.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -56.73 -47.05 80.88 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.595 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -86.03 -40.28 15.95 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.7 tmm? -59.56 -46.53 88.63 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.081 0.467 . . . . 0.0 109.914 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 91.5 mt -69.1 -16.61 21.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.424 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -78.6 -50.51 11.38 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 119.394 -0.922 . . . . 0.0 112.148 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 129' ' ' ASP . 42.4 tp10 -87.69 -67.52 0.82 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.834 -178.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.33 -26.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.794 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 127' ' ' GLU . 25.4 t0 -87.95 128.26 35.37 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.058 0.456 . . . . 0.0 111.132 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.544 ' H ' ' CD1' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.48 -43.38 90.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.457 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -65.35 -40.33 93.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.19 0.519 . . . . 0.0 110.178 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.33 -1.97 58.84 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' GLY . 55.2 p-10 -89.49 -8.98 51.73 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 57.38 115.48 0.01 OUTLIER Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 20.3 pt20 -160.64 133.64 6.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.2 t -123.47 136.89 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.081 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -151.35 172.49 15.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.243 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -54.86 -46.78 74.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.13 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 55.2 mp0 -58.68 -44.36 90.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.657 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 93.4 mt-10 -72.0 -29.41 64.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.775 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.89 -43.98 77.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.586 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 94.1 t -59.16 -46.29 92.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.26 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.35 -29.09 66.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.124 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.8 ttp -59.7 -42.88 93.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.796 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.46 138.84 50.6 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.963 0.411 . . . . 0.0 110.731 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.2 m -163.24 77.72 0.43 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.661 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.16 -27.76 68.93 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.438 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 117.884 -1.055 . . . . 0.0 110.665 -179.864 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 4' ' ' LEU . 43.6 t0 -88.76 115.87 26.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.71 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -78.81 -25.32 44.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.573 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.419 ' O ' ' OD1' ' A' ' 2' ' ' ASP . 37.3 tp -109.52 120.28 42.0 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.953 0.406 . . . . 0.0 110.352 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.4 p -139.09 158.75 43.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.045 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -68.65 -20.88 64.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.801 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -56.59 -39.23 73.19 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.221 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.38 -40.24 95.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.584 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.26 -43.51 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 121.049 -0.261 . . . . 0.0 110.905 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.3 -18.89 7.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.143 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -54.18 -42.33 69.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.098 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -67.81 -41.71 82.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.375 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -62.63 -43.68 98.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.982 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -67.25 -35.75 80.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.437 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.414 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.49 -24.19 66.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.699 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -55.37 -46.51 76.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.79 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.3 m -80.65 -19.5 45.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.783 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.17 -41.96 96.92 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.052 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.425 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.3 m-85 -58.84 -46.1 88.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.871 0.367 . . . . 0.0 111.144 -178.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.448 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.3 t0 -79.57 -13.47 59.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.499 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -42.99 -32.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.915 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' CG ' ' OE2' ' A' ' 31' ' ' GLU . 10.9 p-10 -52.9 -45.13 67.41 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.481 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.436 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . -149.64 -151.21 5.44 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 21.2 p-10 -71.21 -46.9 60.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.685 0.278 . . . . 0.0 110.957 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.531 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.04 107.34 0.28 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.456 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 5.7 m -166.51 136.22 3.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.215 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.421 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.9 mp -110.53 118.3 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.0 p -134.76 167.05 21.56 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.897 0.38 . . . . 0.0 110.291 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.504 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.3 p -64.08 -33.69 76.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.31 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -62.57 -40.16 95.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.701 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.456 ' OE2' ' O ' ' A' ' 26' ' ' THR . 88.9 mt-10 -64.66 -48.56 74.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.313 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.38 -43.72 93.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.321 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.31 -24.72 17.09 Favored Glycine 0 C--O 1.224 -0.469 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -64.05 -40.99 97.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.873 0.368 . . . . 0.0 110.226 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.15 -22.37 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.205 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.6 mmm -48.87 -33.45 10.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.021 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -64.32 -45.47 87.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 118.152 -1.419 . . . . 0.0 110.278 -178.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.1 p -59.04 -30.67 68.2 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.301 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 41' ' ' GLN . 9.2 mt -102.3 5.45 39.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.974 0.416 . . . . 0.0 110.472 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.26 -69.79 0.03 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 39' ' ' LEU . 85.8 mt-30 -143.28 116.25 8.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.132 -0.534 . . . . 0.0 109.589 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.1 t30 -132.58 69.69 79.61 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.945 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.549 ' O ' ' N ' ' A' ' 46' ' ' ALA . 91.4 Cg_exo -33.0 -33.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 122.545 2.164 . . . . 0.0 112.476 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.477 ' N ' ' O ' ' A' ' 42' ' ' ASN . 12.7 m -39.07 -29.33 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.371 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 43' ' ' PRO . 90.6 mt-10 -87.67 -35.17 18.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.486 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -61.23 -49.22 78.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.998 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -68.09 -48.48 65.39 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.397 0.617 . . . . 0.0 109.951 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.72 -22.68 66.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.009 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.504 HE22 ' CB ' ' A' ' 29' ' ' THR . 48.0 tp60 -40.27 -49.6 2.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.87 0.367 . . . . 0.0 110.475 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.64 -39.85 73.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.478 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.1 ttp -61.56 -40.55 95.11 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.743 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.82 -46.91 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.586 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 57' ' ' ALA . 28.3 m120 -65.13 -39.91 93.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.358 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -58.03 -57.22 13.79 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.474 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 p -68.26 -32.85 57.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.923 0.392 . . . . 0.0 110.997 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.532 ' C ' ' H ' ' A' ' 58' ' ' ASP . 42.9 t0 -86.06 -13.08 48.43 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.805 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.561 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -72.06 15.43 0.16 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.532 ' H ' ' C ' ' A' ' 56' ' ' ASP . 38.7 p-10 -66.74 -23.48 66.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.4 -22.61 0.03 OUTLIER Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.621 ' C ' ' H ' ' A' ' 62' ' ' THR . 4.6 p30 179.34 146.51 0.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.75 33.78 0.18 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.621 ' H ' ' C ' ' A' ' 60' ' ' ASN . 80.6 p -132.2 143.94 50.3 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.92 135.15 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.034 0.445 . . . . 0.0 110.191 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.38 172.4 4.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.456 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.436 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -72.6 -49.57 8.38 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.764 -179.612 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 53.2 Cg_exo -52.03 -43.31 53.41 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.885 1.723 . . . . 0.0 111.88 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.45 -37.46 77.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.846 0.355 . . . . 0.0 110.898 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -60.34 -45.4 93.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.926 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.0 mt -62.39 -44.62 96.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.503 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.6 m -67.4 -45.49 76.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.736 0.303 . . . . 0.0 111.231 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.4 ttp -61.09 -43.72 98.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.977 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 87.0 mmm -64.75 -39.35 93.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.223 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.91 -42.88 94.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.838 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -71.51 -41.7 68.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.279 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -64.74 -40.94 96.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.804 0.335 . . . . 0.0 110.436 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 73' ' ' ALA . 14.2 mmt -95.27 129.84 42.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.079 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -86.81 142.81 27.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -50.41 168.87 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.379 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.3 p -75.24 -15.21 60.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.645 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.98 -16.46 64.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.449 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.1 m -60.46 -23.7 64.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.758 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -36.75 -48.45 0.73 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.931 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -70.79 -43.54 68.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.247 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -63.78 -39.63 94.73 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.012 0.434 . . . . 0.0 110.085 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.6 mt -66.98 -21.89 28.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.231 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -57.96 -43.65 86.56 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.085 -1.046 . . . . 0.0 110.053 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -63.7 -34.74 78.54 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.889 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.83 -19.85 66.03 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.081 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -56.64 -48.8 76.74 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.253 0.549 . . . . 0.0 110.817 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -68.19 -44.69 75.29 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.471 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.9 t -66.34 -48.39 81.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -63.96 -47.19 81.38 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.632 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.408 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 18.4 t70 -120.32 100.17 7.01 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -66.71 -39.75 88.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.812 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -65.67 -40.6 92.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.104 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.62 -59.48 0.48 Allowed Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -61.86 -17.41 56.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.978 0.418 . . . . 0.0 110.201 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.408 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.58 160.91 12.96 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -113.33 155.55 24.98 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.7 mt -95.77 118.22 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.04 0.448 . . . . 0.0 111.072 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.9 p -85.53 171.37 11.79 Favored 'General case' 0 C--N 1.335 -0.063 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.908 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.68 -35.76 78.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.572 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.43 -50.86 72.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.131 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.28 -37.37 77.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.919 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.06 -39.34 94.43 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.478 0.656 . . . . 0.0 111.089 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -54.18 -43.67 70.86 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.131 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -63.09 -39.49 94.87 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.85 -45.22 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.192 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 37.8 mmm -64.3 -38.05 89.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.483 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.8 m -60.57 -40.09 90.38 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -61.27 -38.11 85.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.175 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 tp -61.6 -44.07 97.68 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.868 0.366 . . . . 0.0 110.213 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.97 -154.78 25.78 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -138.97 23.42 2.6 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.577 -0.312 . . . . 0.0 110.728 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -62.67 -43.26 99.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.06 0.457 . . . . 0.0 110.309 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.9 mt -99.91 169.06 9.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.54 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.494 ' HG1' ' H ' ' A' ' 117' ' ' THR . 0.8 OUTLIER -68.34 162.11 25.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.86 0.362 . . . . 0.0 110.51 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -92.14 -22.21 19.99 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.421 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -87.29 -24.47 24.33 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.611 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.65 -66.06 0.21 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.196 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.611 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.6 m -65.09 -35.31 75.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.416 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -60.47 -46.8 88.75 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.558 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -84.92 -40.34 17.13 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.4 tmm? -58.92 -47.22 85.8 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.4 mt -69.18 -18.32 22.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.578 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -77.43 -51.37 10.89 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 119.044 -1.063 . . . . 0.0 111.307 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 129' ' ' ASP . 34.7 tp10 -86.32 -68.7 0.72 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.46 -177.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.64 -21.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 127' ' ' GLU . 38.7 t0 -90.16 125.06 35.33 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.139 0.495 . . . . 0.0 110.606 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.496 ' H ' ' CD1' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.5 -31.99 56.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.052 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -72.16 -45.84 58.81 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.93 0.395 . . . . 0.0 110.362 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.63 -5.41 61.15 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 134' ' ' GLY . 35.3 p30 -89.95 -9.69 47.85 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 58.24 117.92 0.01 OUTLIER Glycine 0 CA--C 1.519 0.335 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 8.2 pt20 -159.73 140.13 11.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.161 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.5 t -126.25 133.35 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.544 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.9 t30 -150.74 175.34 12.07 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.323 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -57.69 -52.09 66.85 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.766 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.544 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 57.2 mp0 -55.88 -35.04 66.07 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.736 -178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 79.3 mt-10 -69.46 -39.31 77.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.712 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -61.21 -45.38 94.83 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.0 t -57.94 -46.0 87.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -74.12 -30.92 62.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.397 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.4 ttp -60.03 -40.66 90.12 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.623 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.405 ' O ' ' OG1' ' A' ' 146' ' ' THR . 72.9 mtm -105.18 141.69 36.28 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.888 0.375 . . . . 0.0 110.631 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 145' ' ' MET . 62.9 m -167.23 72.06 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.104 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.61 -41.79 97.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.561 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 C--O 1.218 -0.559 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.263 -179.906 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 4' ' ' LEU . 66.7 t0 -88.49 113.95 24.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.643 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -81.16 -16.86 51.68 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.386 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.408 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 32.3 tp -113.0 117.64 32.61 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.929 0.395 . . . . 0.0 110.068 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.4 p -139.14 157.5 45.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.168 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -71.3 -22.1 61.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.016 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.06 -43.07 77.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.058 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -62.37 -44.26 96.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.464 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.43 HG23 HD13 ' A' ' 9' ' ' ILE . 92.3 mt -64.26 -43.37 97.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.779 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.37 69.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.518 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -41.28 -45.7 3.02 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.819 0.342 . . . . 0.0 110.949 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -66.88 -39.62 87.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.724 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -62.74 -43.19 99.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.508 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.06 -40.84 91.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.767 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.79 -20.41 49.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.617 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -49.42 -47.94 47.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.793 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.0 m -77.74 -20.35 53.61 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.994 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.9 tp -64.06 -40.67 96.8 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.785 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.47 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 76.2 m-85 -57.67 -45.47 85.52 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.354 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 9.8 t0 -86.06 -20.42 28.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -44.04 -33.18 1.37 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.794 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.409 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 4.5 p-10 -55.91 -46.16 78.5 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.88 0.371 . . . . 0.0 110.839 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -140.32 -152.62 5.84 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 28.1 p-10 -74.48 -46.99 35.99 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.711 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.73 107.08 0.28 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 6.3 m -166.46 148.77 6.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.178 0.489 . . . . 0.0 111.445 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.66 74.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 p -86.93 166.16 15.33 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.998 0.428 . . . . 0.0 110.53 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.437 ' HG1' ' N ' ' A' ' 30' ' ' LYS . 1.4 p -66.28 -28.62 68.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.972 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.437 ' N ' ' HG1' ' A' ' 29' ' ' THR . 59.1 mttp -61.89 -40.21 94.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.914 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.47 ' OE1' ' O ' ' A' ' 19' ' ' PHE . 86.7 mt-10 -66.73 -40.44 88.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.977 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.7 tp -62.82 -43.56 98.47 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.61 -33.2 47.83 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 m -64.58 -44.64 90.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.949 0.374 . . . . 0.0 110.865 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.3 t -55.9 -17.36 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.297 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.544 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 88.9 mmm -52.73 -40.8 63.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.709 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.1 ttt85 -64.23 -46.05 85.5 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 118.165 -1.414 . . . . 0.0 110.229 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.2 p -64.28 -19.24 65.27 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.657 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 36.4 mt -94.34 6.54 48.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.731 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 43.72 78.78 0.07 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.491 ' O ' ' O ' ' A' ' 40' ' ' GLY . 85.7 mt-30 52.65 117.2 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.845 0.355 . . . . 0.0 110.783 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 44' ' ' THR . 35.2 t-20 -148.8 68.75 9.88 Favored Pre-proline 0 C--O 1.235 0.294 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.745 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.586 ' O ' ' N ' ' A' ' 46' ' ' ALA . 86.9 Cg_exo -35.85 -31.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.455 2.103 . . . . 0.0 111.978 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.451 ' N ' ' O ' ' A' ' 42' ' ' ASN . 29.9 m -38.57 -27.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.287 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.544 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 87.7 mt-10 -89.52 -32.43 17.18 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.818 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.41 -51.87 68.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.014 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -67.43 -46.07 74.21 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.18 0.514 . . . . 0.0 109.683 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.64 -27.64 69.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.344 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -39.54 -53.61 2.07 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.815 0.341 . . . . 0.0 110.804 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -65.94 -38.26 88.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.261 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.5 ttp -62.34 -40.18 95.52 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 98.0 mt -62.05 -46.4 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 57' ' ' ALA . 9.5 m120 -62.38 -42.38 99.37 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.679 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.73 -55.62 32.05 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.167 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 p -69.87 -34.89 62.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 120.894 0.378 . . . . 0.0 111.089 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.9 t0 -82.89 -13.45 56.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.404 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -72.08 8.92 1.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.819 0.342 . . . . 0.0 110.179 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 12.6 p30 -61.6 -25.09 67.12 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -157.83 -19.98 0.03 OUTLIER Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.645 ' C ' ' H ' ' A' ' 62' ' ' THR . 5.1 p30 177.07 141.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.73 32.24 0.08 OUTLIER Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.645 ' H ' ' C ' ' A' ' 60' ' ' ASN . 63.8 p -130.3 150.12 51.68 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-O 120.983 0.42 . . . . 0.0 110.266 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.434 HD12 HG22 ' A' ' 63' ' ' ILE . 91.6 mt -117.05 138.97 45.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.145 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.56 166.16 19.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.381 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.432 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -62.93 -50.55 76.52 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.756 -179.138 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.5 Cg_exo -50.89 -44.95 38.82 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.999 1.799 . . . . 0.0 111.788 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.94 -36.27 72.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.984 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -60.07 -45.83 91.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.194 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.08 -44.59 95.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.561 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.2 m -67.36 -44.39 79.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.27 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.9 ttp -61.47 -40.14 93.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.02 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 76.0 mmm -63.02 -38.58 91.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.805 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.11 96.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.008 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -68.43 -45.56 72.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.081 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.57 -41.79 83.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.976 0.417 . . . . 0.0 110.36 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.8 mmt -86.93 164.42 16.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.137 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -116.2 153.55 31.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.954 0.406 . . . . 0.0 110.154 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -59.26 160.44 6.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.31 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.6 p -64.14 -30.04 71.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.571 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -64.42 -10.04 22.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.182 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -57.08 -32.78 66.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.535 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -49.49 -50.23 42.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.712 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.02 -41.9 94.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.038 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -66.31 -45.71 79.4 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.469 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.4 mt -64.91 -20.61 27.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -59.67 -42.23 92.41 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.245 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -61.49 -35.89 78.94 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.468 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.13 -13.42 60.47 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -47.98 -51.1 25.13 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.013 0.435 . . . . 0.0 111.421 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -59.76 -46.82 87.97 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.822 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.87 -44.35 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.979 0.418 . . . . 0.0 110.451 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -59.44 -44.35 92.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.573 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 33.0 t70 -138.9 100.65 4.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.267 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.07 -39.98 82.83 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.209 0.528 . . . . 0.0 110.154 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.2 p-10 -60.18 -42.61 95.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.286 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.71 -56.98 0.51 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -70.69 -13.68 62.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.156 0.503 . . . . 0.0 110.286 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.63 161.12 12.87 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -115.04 150.93 35.11 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.5 mt -85.24 123.18 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.999 0.428 . . . . 0.0 110.375 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.2 p -80.01 168.12 19.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.049 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.3 -36.44 82.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.615 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.18 -45.24 94.26 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.082 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -70.08 -37.66 75.51 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.192 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.2 tp -62.0 -42.86 99.61 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.23 0.538 . . . . 0.0 111.248 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -52.62 -43.23 65.26 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.02 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -55.39 -42.73 74.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.914 0.388 . . . . 0.0 110.231 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.5 t -64.63 -42.44 95.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.259 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 58.3 mmm -57.56 -34.75 69.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.461 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.1 m -60.26 -42.37 95.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.37 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -58.57 -38.73 78.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.9 tp -61.35 -46.29 90.83 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 120.952 0.406 . . . . 0.0 110.126 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.9 -154.91 26.0 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -143.29 11.89 1.75 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.703 -0.249 . . . . 0.0 110.759 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -63.97 -43.99 94.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.114 0.483 . . . . 0.0 110.612 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.4 mt -79.77 160.3 26.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.99 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.475 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.6 OUTLIER -68.46 161.7 27.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.245 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -92.37 -21.07 20.45 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.063 0.458 . . . . 0.0 110.404 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -85.43 -26.93 26.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.234 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.611 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.59 -63.57 0.34 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -178.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.611 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 11.3 m -69.1 -31.35 49.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.457 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -58.86 -67.15 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.721 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.56 -45.19 72.75 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.468 ' C ' ' SD ' ' A' ' 124' ' ' MET . 13.3 tmm? -52.85 -50.27 64.1 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.6 -18.4 23.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.655 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -87.92 -57.86 2.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.306 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 128' ' ' ALA . 51.0 tp10 -81.96 -67.79 0.75 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.248 -178.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 127' ' ' GLU . . . -36.77 -35.64 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 56.7 t0 -87.69 146.15 25.82 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.258 0.551 . . . . 0.0 110.576 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.526 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -89.36 -15.02 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.778 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.47 ' C ' ' H ' ' A' ' 133' ' ' ASP . 44.9 m-20 -73.54 -45.29 54.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.994 0.426 . . . . 0.0 110.427 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.39 -10.3 3.75 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' A' ' 131' ' ' ASP . 35.2 p30 -89.88 -10.4 45.39 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.816 0.341 . . . . 0.0 110.172 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 62.18 122.99 0.01 OUTLIER Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -161.69 119.65 2.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.913 0.387 . . . . 0.0 110.08 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.65 128.91 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.128 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.525 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 45.3 t30 -155.07 166.26 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.064 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.4 ' O ' ' CD1' ' A' ' 138' ' ' TYR . 2.6 t80 -48.79 -23.04 0.93 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.444 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.539 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 50.1 mp0 -66.42 -35.75 81.08 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.151 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -84.95 -20.83 30.0 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.633 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.04 -46.68 88.1 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.141 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 29.8 t -58.28 -46.0 89.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.028 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -71.33 -36.12 71.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.305 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.472 ' SD ' ' H38' ' A' ' 205' ' ' 4DY . 61.5 ttp -57.99 -43.04 86.36 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.193 -178.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 70.7 mtm -112.85 129.26 56.51 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.85 0.357 . . . . 0.0 110.328 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.6 m -162.78 85.82 0.55 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.064 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.15 -43.81 94.05 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.675 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.516 179.834 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' 4DY . . . . . 0.472 ' H38' ' SD ' ' A' ' 144' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.411 ' OD2' ' O ' ' A' ' 4' ' ' LEU . 67.3 t0 -92.55 115.91 28.53 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.034 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -68.81 -30.01 68.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.192 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.411 ' O ' ' OD2' ' A' ' 2' ' ' ASP . 46.8 tp -102.03 128.17 48.59 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.648 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.5 p -134.61 158.43 44.05 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.354 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -66.16 -21.97 66.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.707 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -63.15 -44.2 96.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.531 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.88 -41.58 91.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.966 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 89.6 mt -64.62 -43.03 96.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.472 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.77 -39.9 68.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.233 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -47.63 -48.63 28.53 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.118 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -59.48 -44.87 92.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.83 0.347 . . . . 0.0 110.442 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -63.37 -39.68 95.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.693 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.31 -41.3 85.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.824 0.345 . . . . 0.0 111.158 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.47 -22.69 66.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.829 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -55.57 -47.89 75.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.2 m -81.37 -17.2 49.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.553 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.96 -43.72 98.03 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.423 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.417 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.5 m-85 -60.52 -50.36 73.86 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.553 -178.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.3 t0 -77.13 -14.56 59.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.188 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -45.11 -32.91 1.95 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.209 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.449 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 18.0 p-10 -54.73 -45.99 74.19 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.824 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -144.04 -151.1 5.38 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 32.2 p-10 -73.06 -47.08 47.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.675 0.274 . . . . 0.0 110.772 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.482 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.73 107.31 0.28 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.427 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 4.9 m -166.24 142.77 5.0 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.745 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.02 103.46 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.9 p -123.14 169.93 10.73 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.091 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.567 ' CB ' HE22 ' A' ' 49' ' ' GLN . 60.2 p -63.1 -35.35 79.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.833 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -60.34 -38.48 83.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 87.7 mt-10 -65.59 -43.12 90.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.097 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.76 -41.9 97.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.227 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.82 -28.67 17.21 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.1 m -64.58 -44.15 91.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 0.0 110.762 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.2 t -57.09 -17.6 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.194 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.543 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 87.6 mmm -53.01 -38.58 62.44 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.199 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.6 ttt85 -64.27 -46.04 85.44 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 117.412 -1.715 . . . . 0.0 110.668 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 93.5 p -63.4 -19.9 65.08 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.553 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 40' ' ' GLY . 52.5 mt -99.64 6.16 45.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.882 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 34.8 94.62 0.01 OUTLIER Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 40' ' ' GLY . 84.1 mt-30 52.3 110.1 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.599 0.238 . . . . 0.0 110.418 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 44' ' ' THR . 49.9 t30 -145.71 63.94 9.9 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.701 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 46' ' ' ALA . 88.7 Cg_exo -34.71 -30.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.56 2.173 . . . . 0.0 112.32 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.498 ' N ' ' O ' ' A' ' 42' ' ' ASN . 23.4 m -40.14 -29.51 0.08 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.123 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.543 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 90.7 mt-10 -89.73 -29.89 18.41 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.763 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -60.83 -49.15 78.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.82 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -72.17 -43.18 64.99 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.296 0.569 . . . . 0.0 109.755 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.3 mt -68.0 -25.05 65.22 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.212 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.567 HE22 ' CB ' ' A' ' 29' ' ' THR . 53.7 tp60 -40.85 -41.86 1.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.0 110.582 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -77.7 -36.75 50.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.5 ttp -59.98 -37.3 79.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.628 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.5 -44.78 98.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.043 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.451 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 19.5 m120 -62.57 -39.86 95.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.342 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -56.62 -56.44 21.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.273 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.0 p -74.14 -40.32 51.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.883 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.504 ' OD2' ' N ' ' A' ' 62' ' ' THR . 44.4 t0 -71.18 -13.3 61.88 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.52 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 53' ' ' ASN . . . -72.25 8.97 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.099 0.476 . . . . 0.0 110.346 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 56' ' ' ASP . 10.3 p-10 -59.73 -26.72 65.88 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -155.08 -24.42 0.03 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.578 ' C ' ' H ' ' A' ' 62' ' ' THR . 10.0 p30 176.15 151.17 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.29 36.32 0.09 OUTLIER Glycine 0 CA--C 1.535 1.306 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.578 ' H ' ' C ' ' A' ' 60' ' ' ASN . 44.2 p -137.38 153.34 50.21 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.5 mt -127.43 137.02 58.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.972 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -81.21 164.55 22.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.083 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.427 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -62.07 -50.13 81.87 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.232 -179.721 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.5 Cg_exo -50.12 -41.74 48.44 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.08 1.853 . . . . 0.0 112.046 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -80.77 -29.79 36.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.118 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -59.48 -45.07 92.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.989 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.42 -43.14 99.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.305 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.9 m -64.36 -44.92 89.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.869 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 46.9 ttp -60.08 -44.66 94.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.855 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 79.4 mmm -63.82 -40.86 97.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.266 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.408 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -61.27 -47.77 84.51 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.957 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -71.27 -46.28 61.29 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.458 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -66.72 -45.28 79.2 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.927 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.408 ' O ' ' O ' ' A' ' 73' ' ' ALA . 17.8 mmm -99.5 -176.68 3.35 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.054 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -128.51 152.15 48.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.153 0.501 . . . . 0.0 110.169 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -54.21 177.66 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.341 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.3 p -80.47 -15.81 55.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.582 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -66.38 -13.65 60.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.395 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 83' ' ' GLU . 72.7 m -53.38 -34.27 57.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.601 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.436 ' O ' ' OH ' ' A' ' 138' ' ' TYR . 74.6 tt0 -39.08 -28.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.381 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 81' ' ' SER . 75.8 mm-40 -85.35 -54.79 4.37 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.042 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -58.56 -36.29 73.69 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.905 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.55 -20.04 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -61.0 -45.09 96.24 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 118.409 -1.316 . . . . 0.0 109.588 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -64.61 -21.8 66.81 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.189 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.4 -17.54 48.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.439 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -57.01 -50.19 73.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.376 0.607 . . . . 0.0 110.572 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -68.62 -44.95 73.16 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.864 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.6 t -65.32 -49.07 80.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.069 0.462 . . . . 0.0 110.022 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -62.59 -45.19 94.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.905 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.411 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 22.2 t0 -120.53 104.52 10.03 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.119 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -66.36 -41.22 89.82 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.029 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -70.39 -41.66 72.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.063 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.89 -52.98 0.74 Allowed Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -64.02 -20.08 65.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.934 0.397 . . . . 0.0 110.297 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.411 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.66 161.01 12.9 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -113.34 148.31 35.96 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.7 mt -84.96 123.62 39.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.9 p -87.35 176.7 7.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.122 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.64 -36.49 83.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.963 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.57 -51.35 69.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.878 0.371 . . . . 0.0 110.977 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.39 -30.54 66.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 49.4 tp -61.69 -41.04 97.04 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.23 0.538 . . . . 0.0 111.106 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -54.22 -41.49 68.73 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.881 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -57.92 -42.69 85.33 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.3 t -65.57 -43.2 94.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.668 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 91.6 mmm -62.55 -37.23 85.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.476 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.8 m -59.43 -40.48 86.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.657 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -58.6 -38.73 78.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.724 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.0 tp -61.01 -45.1 96.2 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.547 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.09 -145.3 12.03 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -143.6 16.38 1.82 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.761 0.315 . . . . 0.0 110.679 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -61.86 -44.91 95.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.997 0.427 . . . . 0.0 110.468 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 82.8 mt -82.08 161.34 22.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.966 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.474 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -66.02 161.7 21.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.653 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -91.63 -19.62 22.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.866 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -87.67 -28.14 22.01 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.632 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.32 -66.85 0.17 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.632 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.4 m -64.05 -39.33 85.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 111.909 0.336 . . . . 0.0 111.909 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -54.27 -65.91 0.49 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.676 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 127' ' ' GLU . 80.6 mm-40 -70.42 -44.93 66.89 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.423 ' C ' ' SD ' ' A' ' 124' ' ' MET . 18.9 tmm? -53.0 -47.62 68.13 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 120.486 -0.486 . . . . 0.0 109.879 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 97.7 mt -67.19 -19.73 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.356 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -91.24 -66.84 0.89 Allowed 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.984 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 123' ' ' GLU . 24.9 tp10 -65.24 -68.53 0.36 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.21 -177.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.21 -37.67 0.18 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.48 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 66.0 t0 -87.5 138.23 31.65 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.207 0.527 . . . . 0.0 110.591 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.496 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -85.8 -16.09 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.335 -179.7 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -73.08 -46.54 50.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.121 0.486 . . . . 0.0 110.141 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.96 -2.59 54.92 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 52.1 p30 -88.67 -22.3 23.49 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 64.6 103.72 0.01 OUTLIER Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -147.77 140.77 24.95 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.784 0.326 . . . . 0.0 110.158 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.2 t -128.93 134.32 64.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.314 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.527 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 53.3 t30 -151.57 -179.09 7.11 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.624 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.436 ' OH ' ' O ' ' A' ' 82' ' ' GLU . 68.7 t80 -57.28 -48.15 79.63 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.267 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.527 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 55.9 mp0 -50.91 -43.66 59.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.352 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -67.69 -39.82 84.42 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.91 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -60.72 -43.65 97.61 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.598 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.3 t -54.19 -43.89 62.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.345 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -84.25 -19.38 33.99 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.064 -0.255 . . . . 0.0 111.223 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 41.1 ttp -65.07 -41.3 95.2 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.949 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.412 ' O ' ' OG1' ' A' ' 146' ' ' THR . 51.7 mtm -103.67 132.68 49.71 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.847 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 145' ' ' MET . 43.4 m -166.83 81.77 0.24 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.061 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.8 -37.19 75.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.342 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.1 mttm . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.458 179.948 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -91.92 107.58 19.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.128 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -135.58 166.37 23.38 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.014 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 36.8 tp -96.11 126.57 41.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.245 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.1 p -127.27 160.05 32.5 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.611 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.63 -19.23 62.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.564 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -67.14 -42.0 85.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.063 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -62.98 -42.09 99.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.872 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.4 HG23 HD12 ' A' ' 9' ' ' ILE . 64.2 mt -69.75 -31.39 48.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.679 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.19 -29.55 70.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.881 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -51.5 -43.22 62.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.748 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -66.94 -46.38 74.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.874 0.368 . . . . 0.0 111.03 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -61.62 -44.81 96.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.792 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -67.96 -40.96 83.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.628 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.13 -28.42 67.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.022 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -55.58 -45.84 77.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.673 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.7 m -81.61 -17.83 46.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.723 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.7 tp -65.51 -42.36 92.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.918 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.403 ' O ' ' CD ' ' A' ' 31' ' ' GLU . 73.3 m-85 -61.06 -45.95 92.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.309 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 4.7 t0 -81.93 -15.66 53.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.357 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -42.82 -32.5 0.62 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.114 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.433 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 9.2 p-10 -53.67 -46.7 70.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.896 0.379 . . . . 0.0 110.712 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.433 ' N ' ' CG ' ' A' ' 22' ' ' ASP . . . -145.67 -147.33 4.58 Favored Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 20.5 p-10 -76.46 -47.57 22.51 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.898 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.01 106.97 0.27 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 95.7 m -166.72 143.13 4.64 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.968 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.05 117.06 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.849 0.357 . . . . 0.0 110.113 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.4 p -133.38 165.57 24.52 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.403 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.498 ' CB ' HE22 ' A' ' 49' ' ' GLN . 79.9 p -63.02 -35.13 79.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.33 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -61.26 -38.58 87.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.021 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.413 ' OE2' ' CG ' ' A' ' 22' ' ' ASP . 91.3 mt-10 -64.62 -49.13 72.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.359 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.37 -43.65 98.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.182 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.2 -23.94 4.47 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.3 m -64.9 -42.51 94.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.914 0.388 . . . . 0.0 110.545 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.405 ' O ' ' OG ' ' A' ' 38' ' ' SER . 54.3 t -54.59 -16.3 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.219 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.452 ' O ' ' N ' ' A' ' 40' ' ' GLY . 53.4 mmm -58.73 -37.27 75.8 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -62.48 -46.13 89.89 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 116.727 -1.989 . . . . 0.0 110.618 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 35' ' ' VAL . 23.7 p -60.12 -36.17 76.88 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.034 -178.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 41' ' ' GLN . 44.7 mt -95.87 2.08 53.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.701 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 66.2 -66.44 0.15 Allowed Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 39' ' ' LEU . 74.6 mt-30 -141.66 122.77 14.67 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.3 t-20 -141.5 71.15 26.19 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.636 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 46' ' ' ALA . 73.1 Cg_exo -37.42 -30.45 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.222 1.948 . . . . 0.0 112.136 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 42' ' ' ASN . 25.1 m -39.04 -27.62 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.488 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 49' ' ' GLN . 86.7 mt-10 -90.31 -36.92 14.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.011 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -56.27 -48.88 75.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.411 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -70.5 -45.08 66.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.289 0.566 . . . . 0.0 110.071 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.08 -20.05 63.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.82 -178.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 45' ' ' GLU . 67.3 tp60 -46.48 -46.22 18.84 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.608 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -75.06 -35.29 61.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.242 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 33.2 ttp -63.71 -43.03 97.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.016 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 96.7 mt -62.76 -46.21 96.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.753 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.465 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 24.1 m120 -64.65 -40.7 95.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.766 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -60.08 -56.84 16.72 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.42 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.68 -37.01 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.016 0.436 . . . . 0.0 110.94 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.549 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.5 t0 -79.06 -12.6 60.02 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.446 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 53' ' ' ASN . . . -72.15 15.43 0.16 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.314 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' A' ' 56' ' ' ASP . 10.5 p30 -65.76 -21.87 66.54 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -167.82 -9.56 0.03 OUTLIER Glycine 0 C--N 1.333 0.4 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.593 ' C ' ' H ' ' A' ' 62' ' ' THR . 1.9 p30 169.42 140.58 0.02 OUTLIER 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.02 35.77 0.11 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.593 ' H ' ' C ' ' A' ' 60' ' ' ASN . 69.5 p -135.94 155.0 50.93 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 90.9 mt -130.13 132.02 65.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.213 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.14 151.99 42.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.627 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.442 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -54.83 -51.24 80.75 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.778 -179.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 52.1 Cg_exo -49.17 -49.84 14.36 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.855 1.704 . . . . 0.0 112.059 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -68.56 -33.66 74.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.465 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -61.94 -43.82 98.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.96 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.8 mt -59.2 -45.58 90.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.753 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.3 m -63.83 -44.73 92.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.543 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 36.3 ttp -59.99 -45.34 93.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.578 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.3 mmm -64.64 -39.41 93.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.534 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.34 -39.05 78.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.743 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -77.92 -51.47 10.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.383 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -65.56 -44.27 87.27 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.498 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.2 mmm -99.74 126.46 45.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.348 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -86.76 143.89 27.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.537 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 80' ' ' ASP . 97.2 m-20 -49.35 158.58 0.38 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.418 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 35.8 p -54.9 -8.74 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.643 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.464 ' H ' ' C ' ' A' ' 78' ' ' ASP . 80.3 m-20 -67.11 -8.64 32.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.156 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.6 m -59.4 -29.51 67.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.688 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -37.85 -49.21 1.19 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.839 0.352 . . . . 0.0 110.994 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.73 -55.02 19.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.872 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -59.68 -32.31 70.38 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.055 0.455 . . . . 0.0 110.622 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 83.0 mt -69.23 -15.07 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.998 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -59.71 -48.93 79.71 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 117.546 -1.662 . . . . 0.0 110.395 -177.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.21 -32.55 74.28 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.471 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 92' ' ' PHE . . . -58.66 -36.04 73.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.731 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -50.58 -51.12 51.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.324 0.583 . . . . 0.0 110.928 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -69.3 -44.4 71.85 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.32 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.16 -51.44 48.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.132 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 88' ' ' ALA . 66.8 t80 -63.44 -47.42 81.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.389 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.463 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 17.9 t0 -107.83 105.33 15.1 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.131 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -71.67 -44.88 63.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.664 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 45.2 p-10 -67.07 -33.62 75.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.137 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.529 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 66.52 -74.87 0.15 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -53.66 -13.09 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.876 0.369 . . . . 0.0 110.343 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.422 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.52 161.77 12.67 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -112.34 155.91 23.34 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 94.6 mt -99.79 117.47 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.749 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.6 p -82.15 175.68 10.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.123 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.91 -37.06 85.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.838 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.54 -52.44 64.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.785 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -67.66 -31.18 70.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.67 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.1 tp -64.2 -41.35 97.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.451 0.644 . . . . 0.0 110.975 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -53.9 -39.2 65.57 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.002 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -63.83 -41.17 97.9 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.1 t -64.17 -42.66 96.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.44 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 54.0 mmm -62.4 -40.75 97.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.983 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.8 m -61.74 -40.22 94.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.564 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -58.82 -40.55 84.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.616 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.9 tp -61.33 -44.25 97.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.946 0.403 . . . . 0.0 110.528 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 161.85 -151.91 22.17 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -138.34 29.22 2.46 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.794 0.33 . . . . 0.0 110.619 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -67.46 -45.32 76.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.793 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.7 mt -100.68 166.94 10.63 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.853 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.52 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -69.49 161.57 29.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.188 -179.564 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -92.69 -21.54 19.94 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.902 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -87.41 -23.6 24.47 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.635 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -35.1 -68.08 0.13 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.603 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.498 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 9.8 m -63.87 -42.15 94.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.412 ' N ' ' CG2' ' A' ' 121' ' ' VAL . 87.6 m-20 -48.3 -67.06 0.3 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.752 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.459 ' O ' ' OE1' ' A' ' 127' ' ' GLU . 80.3 mm-40 -70.44 -40.02 74.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.404 ' SD ' ' C ' ' A' ' 124' ' ' MET . 17.7 tmm? -57.22 -38.94 74.49 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.684 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.407 HG21 HD12 ' A' ' 125' ' ' ILE . 93.9 mt -77.89 -23.79 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.929 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -77.5 -46.93 20.9 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 118.682 -1.207 . . . . 0.0 111.698 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 123' ' ' GLU . 19.6 mp0 -80.08 -68.45 0.67 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.667 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.56 -48.9 1.04 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.69 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -88.51 131.07 35.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.901 0.381 . . . . 0.0 110.27 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.439 ' H ' ' CD1' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -82.3 -10.7 12.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.129 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' A' ' 133' ' ' ASP . 89.2 m-20 -64.39 -40.42 95.76 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.099 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.65 -8.4 4.32 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' A' ' 131' ' ' ASP . 26.2 p-10 -88.32 -12.72 42.65 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 39.36 98.06 0.01 OUTLIER Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 13.3 pt20 -131.06 136.94 48.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.056 0.455 . . . . 0.0 110.311 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.0 t -115.29 134.82 57.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.097 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.515 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 53.1 t30 -152.64 176.74 11.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.605 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -58.84 -48.02 82.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.339 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.515 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 58.0 mp0 -57.42 -25.53 59.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.295 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 81.2 mt-10 -84.87 -33.64 22.78 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.08 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -65.72 -46.89 77.24 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.654 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 50.3 t -56.26 -44.57 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 120.792 0.33 . . . . 0.0 110.22 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -71.56 -38.05 71.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.202 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 50.2 ttp -60.43 -48.59 81.08 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.306 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 49.1 mtm -88.61 120.77 30.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.928 0.394 . . . . 0.0 110.782 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.0 m -165.77 99.14 0.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.729 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.94 -38.33 88.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.584 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.8 mttm . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.531 179.938 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -88.69 117.48 27.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.398 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -82.82 -36.35 25.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.602 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 43.3 tp -99.27 122.66 42.74 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.16 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 p -137.94 158.87 43.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.295 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -67.72 -33.57 75.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.633 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -53.69 -44.15 69.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.871 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -57.64 -42.16 82.86 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.572 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.98 -43.18 96.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.606 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.92 -29.77 56.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.301 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -54.64 -48.25 72.5 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.556 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -65.74 -40.79 92.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.837 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -61.99 -44.1 97.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.633 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -66.99 -37.54 84.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.988 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.479 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.06 -27.9 65.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.803 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -57.83 -46.94 84.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.533 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.8 m -77.9 -21.5 51.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.65 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.36 -42.82 99.7 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.444 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.2 m-85 -60.21 -50.92 71.74 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.476 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.1 t0 -77.01 -14.26 59.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.83 0.347 . . . . 0.0 111.315 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -45.61 -32.69 2.45 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.831 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 8.8 p-10 -53.72 -46.11 70.69 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.557 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -144.34 -151.61 5.48 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 30.8 p-10 -72.95 -47.24 47.23 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.068 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.525 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.71 107.38 0.28 Allowed Glycine 0 CA--C 1.521 0.452 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.425 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 4.6 m -166.63 139.23 3.7 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.121 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 mp -115.02 109.18 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.6 p -128.65 170.32 13.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.824 0.345 . . . . 0.0 110.447 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.605 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.0 p -64.74 -33.05 75.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.801 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -61.63 -41.42 97.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.935 0.397 . . . . 0.0 109.998 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.425 ' OE1' ' O ' ' A' ' 26' ' ' THR . 90.1 mt-10 -63.45 -45.68 89.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.856 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.0 tp -64.2 -43.29 95.49 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.115 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.78 -26.16 53.42 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.2 m -63.87 -41.42 97.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.858 0.361 . . . . 0.0 110.143 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.3 t -56.18 -23.62 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.333 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.479 ' O ' ' N ' ' A' ' 40' ' ' GLY . 62.1 mmm -48.06 -30.33 4.33 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.721 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -64.34 -45.61 87.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 118.042 -1.463 . . . . 0.0 111.049 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 77.9 p -63.98 -21.95 66.71 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.136 -0.625 . . . . 0.0 109.808 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 41' ' ' GLN . 16.9 mt -107.8 3.75 24.79 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.04 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.16 -71.21 0.02 OUTLIER Glycine 0 N--CA 1.465 0.592 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 39' ' ' LEU . 87.8 mt-30 -145.45 109.46 4.83 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 44' ' ' THR . 41.4 t30 -125.59 70.93 65.52 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.12 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.551 ' O ' ' N ' ' A' ' 46' ' ' ALA . 85.3 Cg_exo -33.04 -30.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.595 2.196 . . . . 0.0 112.808 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 42' ' ' ASN . 26.2 m -39.31 -30.19 0.06 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.543 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 49' ' ' GLN . 93.9 mt-10 -86.64 -34.88 19.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.305 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -59.04 -50.04 75.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.821 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.15 -46.21 71.4 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 51' ' ' MET . 84.6 mt -64.79 -31.03 72.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.4 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.605 HE22 ' CB ' ' A' ' 29' ' ' THR . 61.1 tp60 -37.62 -51.2 1.19 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.732 0.301 . . . . 0.0 110.769 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.3 -40.34 89.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.232 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' LEU . 33.1 ttp -62.38 -41.05 98.33 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.981 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 83.9 mt -62.0 -49.95 82.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.114 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 57' ' ' ALA . 89.9 m-20 -62.89 -40.46 97.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.582 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -55.17 -61.5 2.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.206 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.93 -30.12 43.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.804 0.335 . . . . 0.0 111.241 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 62' ' ' THR . 50.7 t0 -84.71 -13.24 51.97 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.513 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -71.94 13.05 0.32 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.926 0.394 . . . . 0.0 110.339 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.8 p30 -65.56 -28.89 69.48 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.535 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -150.49 -22.49 0.06 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.58 ' C ' ' H ' ' A' ' 62' ' ' THR . 3.3 p30 173.19 151.88 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.95 34.7 0.14 Allowed Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.58 ' H ' ' C ' ' A' ' 60' ' ' ASN . 81.9 p -134.37 149.45 50.83 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.4 mt -120.99 134.52 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.933 0.397 . . . . 0.0 109.942 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.16 162.43 28.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.416 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.472 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -64.68 -48.05 74.37 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.467 -179.051 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 50.6 Cg_exo -51.28 -37.36 59.73 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.167 1.911 . . . . 0.0 111.692 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -87.55 -22.32 24.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.78 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.45 -47.11 87.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.021 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.54 -42.88 98.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.517 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 78.7 m -63.97 -46.09 86.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.648 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.7 ttp -61.71 -47.5 85.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.066 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.9 mmm -65.87 -37.76 87.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.265 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.61 -49.96 75.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.039 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -71.51 -43.8 65.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.159 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.72 -43.59 88.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.764 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.432 ' O ' ' O ' ' A' ' 73' ' ' ALA . 22.3 mmm -104.27 127.47 51.91 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.116 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.7 tptt -84.97 141.14 30.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.874 0.368 . . . . 0.0 110.748 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' LYS . 95.0 m-20 -48.87 179.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.262 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.5 p -75.51 -6.74 51.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.437 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.48 -15.52 62.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.545 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.9 m -61.89 -19.92 63.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.549 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -48.19 -44.69 32.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.358 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.96 -39.56 79.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.9 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.87 -45.12 83.25 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.989 0.423 . . . . 0.0 110.202 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.5 mt -66.12 -19.04 25.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.472 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -58.41 -45.44 88.4 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 118.97 -1.092 . . . . 0.0 110.19 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -65.56 -31.88 73.17 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.948 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.412 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -72.03 -14.64 61.93 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.185 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -57.98 -49.0 78.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.244 0.545 . . . . 0.0 111.061 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -64.09 -45.6 87.98 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.316 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -76.18 -51.54 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 0.0 110.908 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.418 ' CE2' ' CD1' ' A' ' 100' ' ' ILE . 26.2 t80 -61.99 -47.19 85.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.62 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.427 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 18.2 t70 -108.95 94.15 4.89 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.22 -40.97 74.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.965 0.412 . . . . 0.0 110.553 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 19.8 p-10 -62.61 -39.65 94.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.976 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.44 -67.3 0.97 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.58 -16.56 63.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.022 0.439 . . . . 0.0 110.247 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.76 162.04 12.56 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.23 155.39 24.09 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.713 0.292 . . . . 0.0 110.258 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.418 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 94.1 mt -79.75 126.02 39.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.938 0.399 . . . . 0.0 110.988 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.3 p -82.36 168.95 17.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.196 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.04 89.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.51 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.63 -47.38 84.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.863 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.67 -32.87 73.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.6 tp -61.58 -41.63 97.68 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.41 0.624 . . . . 0.0 110.712 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -56.46 -43.35 79.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.8 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -58.5 -41.88 86.35 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.67 -43.4 90.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.624 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.0 mmm -61.99 -35.68 79.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.605 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.6 m -61.04 -44.43 97.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.044 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -59.76 -34.98 73.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.376 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.0 tp -61.17 -46.73 89.31 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.051 0.453 . . . . 0.0 110.36 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.5 -160.74 33.47 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -140.51 23.35 2.32 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.64 0.257 . . . . 0.0 110.828 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -63.65 -42.8 98.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.963 0.411 . . . . 0.0 110.269 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.3 mt -92.84 175.79 6.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.006 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.469 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -72.83 161.29 30.91 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.695 179.844 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -91.66 -22.46 20.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.946 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -87.89 -25.37 23.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.126 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.642 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.4 -61.27 0.45 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.086 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.642 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 20.2 m -67.33 -40.2 84.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -56.81 -47.06 81.1 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.52 -178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -86.01 -40.32 15.92 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.7 tmm? -59.51 -46.51 88.61 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.094 0.473 . . . . 0.0 109.956 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 91.5 mt -69.15 -16.56 20.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.413 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -78.61 -50.56 11.29 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 119.389 -0.924 . . . . 0.0 112.13 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' ASP . 42.3 tp10 -87.61 -67.51 0.82 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.888 -178.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.43 -25.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.763 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' GLU . 25.4 t0 -88.06 128.26 35.41 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.062 0.458 . . . . 0.0 111.056 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.538 ' H ' ' CD1' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.46 -43.45 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.416 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -65.27 -40.4 93.86 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.136 0.493 . . . . 0.0 110.185 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.4 -2.03 58.94 Favored Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' GLY . 55.2 p-10 -89.44 -9.0 51.8 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 57.46 115.49 0.01 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.435 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 20.3 pt20 -160.69 133.6 6.44 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.46 136.92 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.056 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -151.36 172.43 15.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.23 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -54.78 -46.83 74.47 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.096 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -58.64 -44.35 90.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.709 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 93.4 mt-10 -72.05 -29.4 64.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.727 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.92 -43.91 77.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.605 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 93.8 t -59.22 -46.23 92.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.312 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.38 -29.1 66.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.128 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.7 ttp -59.71 -42.81 93.9 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.853 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.49 138.82 50.63 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.961 0.41 . . . . 0.0 110.756 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 81.9 m -163.22 77.77 0.43 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.671 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.15 -27.76 68.95 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.464 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.222 -0.391 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.624 -179.857 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 4' ' ' LEU . 43.6 t0 -88.72 115.92 26.61 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.745 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -78.81 -25.38 44.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.532 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.415 ' O ' ' OD1' ' A' ' 2' ' ' ASP . 37.5 tp -109.5 120.22 41.84 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.024 0.44 . . . . 0.0 110.339 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.4 p -139.04 158.74 43.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.095 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -68.66 -20.89 64.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.823 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -56.55 -39.35 73.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.21 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.25 -40.27 95.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.621 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.26 -43.59 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.883 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.25 -18.89 6.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.157 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -54.22 -42.27 69.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.096 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -67.84 -41.73 82.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.34 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -62.62 -43.76 97.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.914 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -67.19 -35.71 80.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.431 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.413 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.57 -24.11 66.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.699 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -55.45 -46.46 76.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.783 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.4 m -80.66 -19.54 45.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.756 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.16 -41.95 96.95 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.013 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.42 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.1 m-85 -58.84 -46.11 88.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.831 0.348 . . . . 0.0 111.115 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.448 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.3 t0 -79.56 -13.49 59.5 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.468 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -42.97 -32.87 0.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.821 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.451 ' CG ' ' OE2' ' A' ' 31' ' ' GLU . 10.9 p-10 -52.93 -45.1 67.48 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.447 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.433 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . -149.68 -151.3 5.47 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 21.2 p-10 -71.1 -46.9 60.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.759 0.314 . . . . 0.0 111.009 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.534 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.02 107.4 0.28 Allowed Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.455 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 5.7 m -166.6 136.2 3.08 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.188 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.424 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.9 mp -110.55 118.33 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.0 p -134.78 167.04 21.59 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.863 0.363 . . . . 0.0 110.327 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.5 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.3 p -64.12 -33.64 76.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.296 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -62.51 -40.22 96.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.691 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.455 ' OE2' ' O ' ' A' ' 26' ' ' THR . 89.0 mt-10 -64.68 -48.46 74.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.373 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.6 tp -64.44 -43.72 93.42 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.296 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.29 -24.73 17.07 Favored Glycine 0 C--O 1.224 -0.487 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -64.09 -40.99 97.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.863 0.363 . . . . 0.0 110.197 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.3 t -57.05 -22.45 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.276 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.7 mmm -48.79 -33.53 10.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.992 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -64.33 -45.51 87.55 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 118.219 -1.392 . . . . 0.0 110.241 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.3 p -58.96 -30.68 68.09 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.367 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 41' ' ' GLN . 9.2 mt -102.34 5.47 39.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.99 0.424 . . . . 0.0 110.492 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.31 -69.83 0.03 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.481 ' N ' ' O ' ' A' ' 39' ' ' LEU . 85.8 mt-30 -143.27 116.21 8.82 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.1 t30 -132.61 69.71 79.55 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.934 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 46' ' ' ALA . 90.7 Cg_exo -32.98 -33.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.541 2.16 . . . . 0.0 112.463 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 42' ' ' ASN . 12.6 m -39.0 -29.35 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.398 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 43' ' ' PRO . 90.6 mt-10 -87.69 -35.21 18.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.449 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -61.22 -49.22 78.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.998 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -68.01 -48.6 65.27 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.437 0.637 . . . . 0.0 109.89 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.65 -22.75 66.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.012 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.5 HE22 ' CB ' ' A' ' 29' ' ' THR . 47.9 tp60 -40.25 -49.56 2.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.877 0.37 . . . . 0.0 110.519 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.69 -39.78 73.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.483 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.1 ttp -61.62 -40.54 95.21 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.73 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.85 -46.83 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.624 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.559 ' O ' ' N ' ' A' ' 57' ' ' ALA . 28.2 m120 -65.19 -39.83 93.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.342 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -58.1 -57.24 13.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.443 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.4 p -68.3 -32.83 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.949 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.534 ' C ' ' H ' ' A' ' 58' ' ' ASP . 42.9 t0 -86.02 -13.12 48.45 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.768 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -72.05 15.46 0.16 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.07 -179.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 56' ' ' ASP . 38.7 p-10 -66.75 -23.5 66.1 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.41 -22.54 0.03 OUTLIER Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.622 ' C ' ' H ' ' A' ' 62' ' ' THR . 4.6 p30 179.35 146.5 0.19 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.72 33.71 0.17 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.622 ' H ' ' C ' ' A' ' 60' ' ' ASN . 80.8 p -132.17 143.94 50.33 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.93 135.11 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.999 0.428 . . . . 0.0 110.172 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.39 172.39 4.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.486 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.436 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -72.59 -49.59 8.4 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.759 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 52.5 Cg_exo -52.01 -43.29 53.49 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.833 1.688 . . . . 0.0 111.931 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.45 -37.45 77.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 110.874 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -60.3 -45.45 93.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.967 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.2 mt -62.39 -44.63 95.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.487 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.2 m -67.38 -45.51 76.06 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.757 0.313 . . . . 0.0 111.223 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.4 ttp -61.13 -43.74 98.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.89 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 86.9 mmm -64.76 -39.33 93.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.215 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.91 -42.84 94.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.873 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -71.52 -41.77 68.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.268 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -64.72 -40.94 96.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.887 0.375 . . . . 0.0 110.412 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.434 ' O ' ' O ' ' A' ' 73' ' ' ALA . 14.2 mmt -95.22 129.85 42.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.074 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -86.87 142.82 27.77 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -50.35 168.86 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.414 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.8 p -75.23 -15.2 60.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.647 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.97 -16.49 64.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.424 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 82' ' ' GLU . 1.1 m -60.45 -23.67 64.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.717 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 81' ' ' SER . 81.2 tt0 -36.83 -48.45 0.74 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.62 0.248 . . . . 0.0 110.897 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -70.85 -43.47 68.44 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.181 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.87 -39.59 94.55 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.994 0.426 . . . . 0.0 110.086 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 81.0 mt -66.96 -21.91 28.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.242 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 -58.04 -43.61 86.93 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 119.031 -1.067 . . . . 0.0 110.014 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -63.65 -34.82 78.69 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.851 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.79 -19.9 66.06 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.039 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -56.6 -48.81 76.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.321 0.582 . . . . 0.0 110.838 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -68.23 -44.67 75.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.474 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.8 t -66.34 -48.34 81.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -64.04 -47.09 81.57 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.617 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.407 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 18.3 t70 -120.37 100.1 6.96 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -66.63 -39.84 88.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.182 0.515 . . . . 0.0 109.804 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -65.58 -40.66 92.97 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.105 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.67 -59.54 0.48 Allowed Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -61.78 -17.46 56.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.994 0.426 . . . . 0.0 110.228 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.407 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.55 160.9 12.96 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -113.31 155.57 24.92 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.7 mt -95.78 118.27 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.07 0.462 . . . . 0.0 111.108 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.0 p -85.52 171.41 11.77 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.898 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.72 -35.75 78.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.579 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.84 72.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.078 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.28 -37.36 77.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.928 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.02 -39.38 94.58 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.476 0.655 . . . . 0.0 111.07 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -54.24 -43.64 71.07 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.116 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -63.13 -39.47 94.77 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.702 -0.399 . . . . 0.0 109.937 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.1 t -61.84 -45.19 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.176 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 37.7 mmm -64.27 -38.02 89.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.553 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.0 m -60.58 -40.11 90.51 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -61.25 -38.08 85.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.22 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.3 tp -61.65 -44.0 97.8 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.862 0.363 . . . . 0.0 110.249 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.95 -154.71 25.68 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -139.02 23.33 2.6 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.624 -0.288 . . . . 0.0 110.763 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -62.57 -43.25 99.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.069 0.461 . . . . 0.0 110.386 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 29.0 mt -99.91 169.13 9.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.536 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.492 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -68.42 162.14 26.08 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.579 179.761 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -92.09 -22.27 20.0 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.432 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -87.26 -24.48 24.36 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.616 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.57 -66.09 0.21 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.241 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.616 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.7 m -65.17 -35.26 74.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.417 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -60.48 -46.81 88.72 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.586 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -84.85 -40.4 17.16 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.4 tmm? -58.89 -47.24 85.66 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.4 mt -69.13 -18.32 22.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.6 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -77.4 -51.4 10.87 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 119.016 -1.074 . . . . 0.0 111.317 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 129' ' ' ASP . 34.7 tp10 -86.3 -68.7 0.72 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.492 -177.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.63 -21.54 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 127' ' ' GLU . 38.7 t0 -90.12 125.12 35.33 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.135 0.493 . . . . 0.0 110.625 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.501 ' H ' ' CD1' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.58 -32.0 56.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.995 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -72.18 -45.83 58.77 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.95 0.405 . . . . 0.0 110.328 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.67 -5.45 61.19 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 134' ' ' GLY . 35.0 p30 -90.0 -9.69 47.75 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 58.26 117.9 0.01 OUTLIER Glycine 0 CA--C 1.519 0.323 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 8.2 pt20 -159.72 140.15 12.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.539 -0.331 . . . . 0.0 110.146 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.6 t -126.24 133.32 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.93 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.542 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.8 t30 -150.76 175.36 12.06 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.305 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -57.66 -52.1 66.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.765 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.542 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 57.3 mp0 -55.9 -35.04 66.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.708 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 79.4 mt-10 -69.51 -39.3 77.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.694 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -61.21 -45.39 94.78 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.0 t -57.94 -45.94 87.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -74.17 -30.83 62.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.442 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.4 ttp -60.07 -40.61 90.13 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.627 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.405 ' O ' ' OG1' ' A' ' 146' ' ' THR . 73.0 mtm -105.25 141.7 36.32 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.905 0.383 . . . . 0.0 110.635 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 145' ' ' MET . 63.0 m -167.23 72.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.146 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.8 97.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.617 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 C--O 1.219 -0.535 0 CA-C-O 118.105 -0.95 . . . . 0.0 110.228 -179.93 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 4' ' ' LEU . 66.8 t0 -88.44 113.97 24.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.651 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -81.16 -16.93 51.52 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.398 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.405 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 32.3 tp -112.96 117.66 32.68 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.908 0.385 . . . . 0.0 110.074 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.1 p -139.08 157.46 45.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.223 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -71.24 -22.11 62.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.021 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.12 -43.04 77.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.031 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -62.4 -44.19 97.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.454 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.3 mt -64.3 -43.29 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.842 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.4 -45.36 69.29 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.487 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -41.21 -45.84 2.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.771 0.319 . . . . 0.0 110.929 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -66.82 -39.57 87.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.753 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -62.83 -43.12 99.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.539 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.09 -40.82 91.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.766 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.81 -20.33 49.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.654 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -49.43 -47.94 47.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.822 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.5 m -77.69 -20.38 53.74 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.035 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.8 tp -64.06 -40.69 96.83 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.802 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.471 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 76.2 m-85 -57.64 -45.49 85.39 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.339 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 9.7 t0 -86.1 -20.36 28.83 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -44.07 -33.13 1.37 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.821 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.415 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 4.4 p-10 -56.01 -46.12 78.85 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.888 0.375 . . . . 0.0 110.858 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -140.31 -152.62 5.84 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 28.1 p-10 -74.38 -47.1 36.2 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 122.679 -0.307 . . . . 0.0 110.74 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.498 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.72 107.13 0.28 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 6.2 m -166.44 148.82 6.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.123 0.462 . . . . 0.0 111.407 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.71 74.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 p -86.97 166.16 15.3 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.51 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.44 ' HG1' ' N ' ' A' ' 30' ' ' LYS . 1.4 p -66.3 -28.62 68.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.925 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.44 ' N ' ' HG1' ' A' ' 29' ' ' THR . 59.1 mttp -61.86 -40.19 94.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.961 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.471 ' OE1' ' O ' ' A' ' 19' ' ' PHE . 86.6 mt-10 -66.7 -40.51 88.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.954 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.7 tp -62.82 -43.55 98.5 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.61 -33.19 47.76 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 m -64.6 -44.69 89.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.922 0.361 . . . . 0.0 110.84 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.2 t -55.87 -17.36 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.331 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.542 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 88.9 mmm -52.71 -40.75 63.29 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.745 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.3 ttt85 -64.29 -46.01 85.5 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 118.159 -1.417 . . . . 0.0 110.181 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.0 p -64.33 -19.2 65.29 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.653 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 36.4 mt -94.4 6.57 48.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.727 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 43.76 78.69 0.07 OUTLIER Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 40' ' ' GLY . 85.7 mt-30 52.67 117.23 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.869 0.366 . . . . 0.0 110.733 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 44' ' ' THR . 35.3 t-20 -148.81 68.76 9.87 Favored Pre-proline 0 C--O 1.235 0.3 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.643 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.588 ' O ' ' N ' ' A' ' 46' ' ' ALA . 87.3 Cg_exo -35.77 -31.27 0.08 OUTLIER 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.507 2.138 . . . . 0.0 112.012 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 42' ' ' ASN . 29.5 m -38.49 -27.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.319 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.542 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 87.6 mt-10 -89.43 -32.4 17.26 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.588 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.46 -51.82 68.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.974 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -67.51 -46.04 74.04 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.6 -27.6 69.35 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.396 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 45' ' ' GLU . 63.1 tp60 -39.54 -53.65 2.06 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.818 0.342 . . . . 0.0 110.792 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -65.94 -38.25 88.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.197 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.5 ttp -62.42 -40.16 95.65 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 97.9 mt -61.99 -46.43 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 57' ' ' ALA . 9.5 m120 -62.31 -42.41 99.35 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.725 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.74 -55.6 32.3 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.134 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.9 -34.85 62.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.934 0.397 . . . . 0.0 111.123 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 62' ' ' THR . 44.0 t0 -82.94 -13.41 56.08 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.377 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . -72.06 8.87 1.1 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.788 0.327 . . . . 0.0 110.151 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 12.7 p30 -61.54 -25.09 67.07 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -157.87 -19.94 0.03 OUTLIER Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.647 ' C ' ' H ' ' A' ' 62' ' ' THR . 5.1 p30 177.07 141.86 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.76 32.27 0.09 OUTLIER Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.647 ' H ' ' C ' ' A' ' 60' ' ' ASN . 64.2 p -130.29 150.14 51.66 Favored 'General case' 0 C--N 1.337 0.053 0 CA-C-O 120.973 0.416 . . . . 0.0 110.288 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.422 HG22 HD12 ' A' ' 63' ' ' ILE . 91.5 mt -117.08 138.96 46.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.138 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.51 166.13 19.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.436 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.431 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -62.97 -50.5 76.56 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.803 -179.19 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.5 Cg_exo -50.85 -44.94 38.7 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.984 1.79 . . . . 0.0 111.824 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.89 -36.35 72.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.924 0.393 . . . . 0.0 110.994 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -59.99 -45.86 91.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.246 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.08 -44.54 95.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.594 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.7 m -67.41 -44.4 78.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.254 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.9 ttp -61.43 -40.13 93.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.023 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 76.1 mmm -63.05 -38.55 91.64 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.841 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.09 96.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.028 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -68.48 -45.53 72.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.052 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.61 -41.78 83.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.955 0.407 . . . . 0.0 110.33 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.8 mmt -86.96 164.42 16.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.14 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -116.22 153.61 31.56 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.043 0.449 . . . . 0.0 110.154 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -59.26 160.47 6.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.302 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.8 p -64.13 -30.08 71.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.586 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -64.47 -10.01 22.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.158 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -57.08 -32.82 66.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.516 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -49.44 -50.22 41.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.723 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -65.08 -41.89 94.6 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.987 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -66.32 -45.66 79.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.497 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.4 mt -64.91 -20.6 27.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.8 ttt-85 -59.68 -42.19 92.39 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.206 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -61.48 -35.88 78.89 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.477 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.17 -13.4 60.46 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -47.96 -51.12 24.92 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.0 0.428 . . . . 0.0 111.424 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -59.75 -46.85 87.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.825 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 85.0 t -68.84 -44.34 81.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.958 0.409 . . . . 0.0 110.466 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -59.44 -44.43 92.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.529 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 33.0 t70 -138.84 100.67 4.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.231 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.04 -40.01 82.94 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.207 0.527 . . . . 0.0 110.198 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.3 p-10 -60.13 -42.6 95.14 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.327 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.67 -56.97 0.5 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -70.75 -13.63 62.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.078 0.466 . . . . 0.0 110.267 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.6 161.19 12.85 Favored Glycine 0 N--CA 1.464 0.541 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -115.13 150.92 35.26 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.8 mt -85.25 123.16 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 121.002 0.43 . . . . 0.0 110.339 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.2 p -79.99 168.13 19.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.034 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.25 -36.49 82.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.611 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.17 -45.31 93.97 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.095 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -69.99 -37.68 75.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.208 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.4 tp -62.01 -42.89 99.65 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.241 0.544 . . . . 0.0 111.276 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -52.57 -43.21 65.1 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.055 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -55.5 -42.73 74.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.164 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.4 t -64.58 -42.48 95.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.292 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 58.5 mmm -57.56 -34.74 69.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.467 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.7 m -60.24 -42.3 94.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.445 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -58.66 -38.68 78.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.824 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 40.0 tp -61.31 -46.34 90.7 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.048 0.451 . . . . 0.0 110.13 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.89 -154.91 26.0 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -143.22 11.81 1.76 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.693 -0.253 . . . . 0.0 110.78 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -63.93 -43.96 94.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.153 0.502 . . . . 0.0 110.657 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.5 mt -79.75 160.32 26.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.033 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.479 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -68.51 161.67 27.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.221 -179.71 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -92.33 -21.06 20.48 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.112 0.482 . . . . 0.0 110.448 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -85.45 -26.91 26.06 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.219 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.68 -63.49 0.35 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.808 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.61 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 11.3 m -69.09 -31.38 49.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 121.234 -0.186 . . . . 0.0 111.46 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -58.82 -67.15 0.39 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.699 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.58 -45.14 72.8 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.466 ' C ' ' SD ' ' A' ' 124' ' ' MET . 13.3 tmm? -52.93 -50.3 64.28 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.61 -18.37 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.669 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -87.92 -57.91 2.76 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 119.904 -0.718 . . . . 0.0 112.25 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 128' ' ' ALA . 51.0 tp10 -81.95 -67.7 0.76 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.271 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 127' ' ' GLU . . . -36.83 -35.65 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 56.6 t0 -87.71 146.11 25.83 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.277 0.56 . . . . 0.0 110.568 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.525 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -89.39 -14.85 9.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.809 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' A' ' 133' ' ' ASP . 44.8 m-20 -73.54 -45.36 54.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.032 0.444 . . . . 0.0 110.407 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.35 -10.28 3.73 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.472 ' H ' ' C ' ' A' ' 131' ' ' ASP . 35.4 p30 -89.88 -10.4 45.42 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.836 0.351 . . . . 0.0 110.195 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 62.25 123.0 0.01 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -161.72 119.61 2.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.889 0.376 . . . . 0.0 110.101 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.67 128.93 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.093 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.523 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 45.2 t30 -155.1 166.2 34.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.071 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.401 ' O ' ' CD1' ' A' ' 138' ' ' TYR . 2.6 t80 -48.79 -23.02 0.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.459 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 50.1 mp0 -66.42 -35.74 81.06 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.152 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -84.97 -20.78 30.04 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.56 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.04 -46.7 87.99 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 121.134 -0.227 . . . . 0.0 111.166 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 30.1 t -58.31 -45.98 89.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.005 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -71.36 -36.14 71.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.293 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.467 ' SD ' ' H38' ' A' ' 205' ' ' 4DY . 61.5 ttp -57.94 -43.09 86.14 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.207 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 70.7 mtm -112.72 129.33 56.45 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.818 0.342 . . . . 0.0 110.414 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.5 m -162.88 85.77 0.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.096 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.1 -43.91 93.9 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.676 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 C--O 1.219 -0.527 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.507 179.879 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' 4DY . . . . . 0.467 ' H38' ' SD ' ' A' ' 144' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.413 ' OD2' ' O ' ' A' ' 4' ' ' LEU . 67.3 t0 -92.62 115.95 28.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.016 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -68.81 -30.08 68.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.195 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.413 ' O ' ' OD2' ' A' ' 2' ' ' ASP . 46.9 tp -102.0 128.18 48.55 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.675 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.0 p -134.58 158.39 44.12 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.382 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -66.15 -21.98 66.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.713 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -63.13 -44.21 96.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.531 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -65.9 -41.49 91.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.031 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 89.7 mt -64.58 -43.11 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.484 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.74 -39.93 68.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.181 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -47.67 -48.62 28.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.102 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -59.44 -44.86 92.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.89 0.376 . . . . 0.0 110.484 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -63.42 -39.66 95.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.664 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.29 -41.29 85.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.343 . . . . 0.0 111.143 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.44 -22.72 66.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.82 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -55.59 -47.81 75.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.21 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.9 m -81.47 -17.19 49.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.476 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.93 -43.77 97.9 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.435 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.416 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.7 m-85 -60.48 -50.39 73.75 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.565 -179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.3 t0 -77.08 -14.64 59.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.191 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -45.01 -32.93 1.84 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.228 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.447 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 18.0 p-10 -54.71 -46.01 74.12 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 120.966 -0.293 . . . . 0.0 110.875 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -144.0 -151.09 5.38 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 32.3 p-10 -73.08 -47.03 47.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.714 0.292 . . . . 0.0 110.81 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.494 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.77 107.29 0.28 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.428 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 4.9 m -166.2 142.79 5.04 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.771 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.03 103.42 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.9 p -123.11 169.96 10.69 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.1 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.568 ' CB ' HE22 ' A' ' 49' ' ' GLN . 61.1 p -63.14 -35.32 79.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.861 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -60.35 -38.46 83.88 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.447 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 87.7 mt-10 -65.64 -43.11 90.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.091 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.66 -41.96 98.14 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.258 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.71 -28.8 17.05 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.2 m -64.54 -44.15 91.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.95 0.405 . . . . 0.0 110.729 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.2 t -57.1 -17.61 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.175 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.541 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 87.7 mmm -53.03 -38.52 62.45 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.266 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.7 ttt85 -64.28 -45.97 85.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 117.444 -1.702 . . . . 0.0 110.722 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 92.8 p -63.41 -19.96 65.14 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.538 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 40' ' ' GLY . 52.4 mt -99.58 6.12 45.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.904 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 34.9 94.55 0.01 OUTLIER Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.487 ' O ' ' O ' ' A' ' 40' ' ' GLY . 84.1 mt-30 52.23 110.25 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.619 0.247 . . . . 0.0 110.369 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 44' ' ' THR . 49.9 t30 -145.82 63.98 9.81 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.704 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.574 ' O ' ' N ' ' A' ' 46' ' ' ALA . 89.3 Cg_exo -34.72 -29.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.612 2.208 . . . . 0.0 112.325 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 42' ' ' ASN . 23.3 m -40.13 -29.61 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.124 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.541 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 90.7 mt-10 -89.63 -29.93 18.49 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.802 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -60.84 -49.15 78.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.822 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -72.18 -43.18 64.96 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.25 0.548 . . . . 0.0 109.751 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.3 mt -67.97 -25.12 65.27 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.203 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.568 HE22 ' CB ' ' A' ' 29' ' ' THR . 53.8 tp60 -40.76 -41.89 1.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.603 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -77.64 -36.83 51.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.862 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.6 ttp -59.96 -37.28 79.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.677 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.44 -44.89 99.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.027 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 19.6 m120 -62.54 -39.84 94.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.37 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -56.62 -56.42 21.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.294 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.0 p -74.12 -40.38 51.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.851 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.502 ' OD2' ' N ' ' A' ' 62' ' ' THR . 44.4 t0 -71.2 -13.21 61.85 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.561 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 53' ' ' ASN . . . -72.35 8.98 1.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.31 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 56' ' ' ASP . 10.4 p-10 -59.67 -26.76 65.82 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -155.06 -24.41 0.03 OUTLIER Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.582 ' C ' ' H ' ' A' ' 62' ' ' THR . 9.9 p30 176.19 151.19 0.14 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.582 -0.309 . . . . 0.0 110.178 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.28 36.35 0.09 OUTLIER Glycine 0 CA--C 1.535 1.294 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.582 ' H ' ' C ' ' A' ' 60' ' ' ASN . 44.2 p -137.45 153.31 50.12 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.5 mt -127.38 136.98 59.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.971 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -81.18 164.59 22.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.137 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.431 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -62.13 -50.11 81.71 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.227 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.6 Cg_exo -50.07 -41.73 48.0 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.074 1.849 . . . . 0.0 112.065 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -80.78 -29.83 36.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.111 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -59.53 -45.0 93.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.026 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.39 -43.21 99.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.279 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.1 m -64.43 -44.83 89.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.85 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.0 ttp -60.1 -44.69 94.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.829 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 79.4 mmm -63.8 -40.91 97.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.258 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.407 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -61.21 -47.86 84.18 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.865 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -71.25 -46.25 61.43 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.496 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -66.79 -45.19 79.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.993 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.407 ' O ' ' O ' ' A' ' 73' ' ' ALA . 17.8 mmm -99.5 -176.69 3.36 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.057 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -128.49 152.19 48.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.112 0.482 . . . . 0.0 110.177 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -54.2 177.74 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.359 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.2 p -80.6 -15.74 55.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.544 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -66.39 -13.67 61.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.397 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 83' ' ' GLU . 72.8 m -53.35 -34.38 57.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.548 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.434 ' O ' ' OH ' ' A' ' 138' ' ' TYR . 74.7 tt0 -39.0 -28.83 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.365 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 81' ' ' SER . 75.8 mm-40 -85.36 -54.84 4.33 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.004 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -58.48 -36.3 73.53 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.984 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.58 -20.04 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.1 ttt-85 -60.99 -45.06 96.34 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 118.351 -1.34 . . . . 0.0 109.627 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -64.67 -21.74 66.81 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.172 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.41 -17.51 48.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.466 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -57.05 -50.19 73.52 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.305 0.574 . . . . 0.0 110.556 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -68.6 -44.92 73.29 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.898 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.2 t -65.33 -49.09 80.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.028 0.442 . . . . 0.0 109.986 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -62.61 -45.19 94.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.878 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.412 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 22.2 t0 -120.54 104.57 10.07 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.056 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -66.38 -41.21 89.71 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.037 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -70.49 -41.55 72.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.042 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.91 -53.04 0.75 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -64.04 -20.05 65.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.98 0.419 . . . . 0.0 110.315 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.412 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.67 161.0 12.9 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -113.34 148.29 35.99 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.7 mt -84.9 123.55 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.0 p -87.27 176.76 7.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.129 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.57 84.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.979 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.55 -51.32 69.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.886 0.374 . . . . 0.0 110.983 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -71.4 -30.51 66.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 49.6 tp -61.78 -41.02 97.18 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.235 0.54 . . . . 0.0 111.093 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -54.18 -41.49 68.59 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.918 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -57.94 -42.73 85.49 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.3 t -65.59 -43.1 94.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.691 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 91.6 mmm -62.59 -37.25 85.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.44 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.8 m -59.44 -40.49 86.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.639 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -58.59 -38.76 78.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.737 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.0 tp -61.07 -44.99 96.54 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.551 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.05 -145.37 12.16 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -143.52 16.3 1.83 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.827 0.346 . . . . 0.0 110.748 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -61.79 -44.93 95.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.014 0.435 . . . . 0.0 110.424 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 82.8 mt -82.12 161.38 22.86 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.981 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.471 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -66.13 161.73 21.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.685 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -91.58 -19.63 22.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.863 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -87.69 -28.11 22.01 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.632 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.34 -66.9 0.17 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.632 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.4 m -63.97 -39.32 85.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -54.33 -65.89 0.49 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.674 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 127' ' ' GLU . 80.6 mm-40 -70.42 -44.9 66.95 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.426 ' C ' ' SD ' ' A' ' 124' ' ' MET . 18.9 tmm? -53.04 -47.58 68.29 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.899 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 97.6 mt -67.18 -19.72 25.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.346 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -91.28 -66.72 0.9 Allowed 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.033 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 123' ' ' GLU . 25.0 tp10 -65.26 -68.62 0.35 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.161 -177.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.11 -37.72 0.17 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.481 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 66.1 t0 -87.52 138.29 31.6 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.246 0.546 . . . . 0.0 110.583 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.496 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -85.82 -16.14 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.319 -179.683 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -73.06 -46.53 51.12 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.126 0.488 . . . . 0.0 110.146 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.95 -2.58 54.93 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 52.1 p30 -88.66 -22.25 23.52 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 64.65 103.64 0.01 OUTLIER Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -147.76 140.82 24.99 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.788 0.328 . . . . 0.0 110.141 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.1 t -128.95 134.31 64.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.313 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.526 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 53.4 t30 -151.56 -179.12 7.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.603 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.434 ' OH ' ' O ' ' A' ' 82' ' ' GLU . 68.5 t80 -57.26 -48.14 79.63 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.259 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.526 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 55.8 mp0 -50.93 -43.66 60.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.353 -178.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -67.6 -39.84 84.76 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.967 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -60.71 -43.68 97.52 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.571 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.4 t -54.22 -43.92 62.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.239 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -84.29 -19.31 34.01 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.211 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 41.1 ttp -65.08 -41.32 95.15 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.94 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.412 ' O ' ' OG1' ' A' ' 146' ' ' THR . 51.7 mtm -103.71 132.7 49.73 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.867 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 145' ' ' MET . 43.6 m -166.83 81.79 0.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.053 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.77 -37.28 75.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.292 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.1 mttm . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.509 179.921 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -91.98 107.58 19.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.08 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -135.53 166.38 23.34 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.093 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 36.7 tp -96.1 126.55 41.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.263 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.2 p -127.26 160.04 32.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.668 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.59 -19.27 62.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.565 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -67.21 -42.03 84.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.967 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -62.97 -42.01 99.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.906 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.408 HG23 HD12 ' A' ' 9' ' ' ILE . 64.4 mt -69.83 -31.39 48.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.608 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.2 -29.56 70.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -51.48 -43.23 62.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.738 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -66.97 -46.35 74.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.022 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -61.67 -44.78 96.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.795 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -67.98 -40.89 83.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.642 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.19 -28.42 67.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.971 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -55.56 -45.85 77.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.695 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.0 m -81.58 -17.88 46.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.733 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.5 tp -65.45 -42.36 92.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.952 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.401 ' O ' ' CD ' ' A' ' 31' ' ' GLU . 73.6 m-85 -61.05 -45.95 92.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.333 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 4.7 t0 -81.98 -15.65 53.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.341 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -42.84 -32.51 0.63 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.105 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.437 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 9.1 p-10 -53.59 -46.75 70.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.887 0.375 . . . . 0.0 110.72 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.437 ' N ' ' CG ' ' A' ' 22' ' ' ASP . . . -145.67 -147.3 4.58 Favored Glycine 0 N--CA 1.466 0.696 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 20.3 p-10 -76.53 -47.56 22.29 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.921 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.02 107.02 0.27 Allowed Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 177.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 96.0 m -166.73 143.14 4.64 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.936 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.06 117.09 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.831 0.348 . . . . 0.0 110.095 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.3 p -133.38 165.6 24.47 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.429 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.497 ' CB ' HE22 ' A' ' 49' ' ' GLN . 80.2 p -63.08 -35.14 79.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.274 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -61.27 -38.48 86.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.076 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.415 ' OE2' ' CG ' ' A' ' 22' ' ' ASP . 91.3 mt-10 -64.71 -49.16 71.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.336 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.32 -43.6 98.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.277 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.17 -24.02 4.48 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.7 m -64.91 -42.47 94.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.903 0.382 . . . . 0.0 110.509 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.401 ' O ' ' OG ' ' A' ' 38' ' ' SER . 54.5 t -54.55 -16.33 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.26 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.453 ' O ' ' N ' ' A' ' 40' ' ' GLY . 53.4 mmm -58.71 -37.27 75.77 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -62.46 -46.16 89.76 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 116.724 -1.99 . . . . 0.0 110.66 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 35' ' ' VAL . 23.9 p -60.11 -36.15 76.8 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.101 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 41' ' ' GLN . 44.6 mt -95.85 2.08 53.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.723 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 66.25 -66.47 0.15 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' A' ' 39' ' ' LEU . 74.6 mt-30 -141.7 122.75 14.61 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.5 t-20 -141.43 71.11 26.55 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.653 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' ALA . 73.2 Cg_exo -37.45 -30.41 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.172 1.915 . . . . 0.0 112.186 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 42' ' ' ASN . 25.2 m -39.05 -27.61 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.477 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 49' ' ' GLN . 86.7 mt-10 -90.31 -36.92 14.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.005 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -56.28 -48.89 75.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.399 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -70.5 -45.02 66.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.292 0.568 . . . . 0.0 110.133 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.06 -20.12 63.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.804 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 45' ' ' GLU . 67.4 tp60 -46.39 -46.23 18.37 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.67 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -75.08 -35.28 61.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.199 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 33.1 ttp -63.63 -43.05 97.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.077 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 96.7 mt -62.8 -46.19 96.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.752 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.465 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 24.0 m120 -64.66 -40.69 95.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.738 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.08 -56.84 16.74 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.421 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.7 -36.96 72.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.985 0.421 . . . . 0.0 110.95 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.551 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.4 t0 -79.03 -12.7 60.03 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.423 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 53' ' ' ASN . . . -72.12 15.46 0.16 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.349 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 56' ' ' ASP . 10.4 p30 -65.75 -21.91 66.55 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -167.81 -9.62 0.03 OUTLIER Glycine 0 C--N 1.333 0.392 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.597 ' C ' ' H ' ' A' ' 62' ' ' THR . 2.0 p30 169.37 140.46 0.02 OUTLIER 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.0 35.88 0.1 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.597 ' H ' ' C ' ' A' ' 60' ' ' ASN . 69.0 p -136.02 154.94 50.91 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 90.8 mt -130.05 132.08 65.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.219 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.14 151.99 42.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.612 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.445 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -54.87 -51.27 80.66 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.768 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 52.4 Cg_exo -49.12 -49.82 14.38 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.863 1.709 . . . . 0.0 112.106 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -68.6 -33.65 74.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.412 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -61.98 -43.77 98.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.997 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.2 mt -59.2 -45.61 90.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.789 0.328 . . . . 0.0 110.734 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.4 m -63.85 -44.73 92.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.463 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 36.4 ttp -60.01 -45.33 93.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.515 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.2 mmm -64.68 -39.33 93.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.565 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.32 -39.15 78.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.67 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -77.86 -51.46 10.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.424 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -65.6 -44.26 87.13 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.47 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.2 mmm -99.72 126.47 45.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.358 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.401 ' HB3' ' HG ' ' A' ' 81' ' ' SER . 48.5 tptt -86.74 143.87 27.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.501 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 80' ' ' ASP . 97.2 m-20 -49.42 158.59 0.4 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.431 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 35.7 p -54.88 -8.73 0.28 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.642 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 78' ' ' ASP . 80.1 m-20 -67.11 -8.66 32.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.109 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.401 ' HG ' ' HB3' ' A' ' 77' ' ' LYS . 20.4 m -59.37 -29.61 67.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.637 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -37.87 -49.15 1.19 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.006 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.66 -55.08 19.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.909 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -59.63 -32.36 70.36 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.083 0.468 . . . . 0.0 110.629 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 82.6 mt -69.2 -15.07 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -59.76 -48.88 79.91 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 117.508 -1.677 . . . . 0.0 110.377 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.2 -32.58 74.34 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.498 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 92' ' ' PHE . . . -58.63 -35.98 73.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.789 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -50.59 -51.12 51.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.341 0.591 . . . . 0.0 110.908 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -69.24 -44.54 71.79 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.292 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.09 -51.45 48.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.113 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 88' ' ' ALA . 66.6 t80 -63.45 -47.47 81.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.396 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.465 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 17.9 t0 -107.77 105.41 15.23 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.087 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -71.75 -44.87 63.32 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.598 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 44.9 p-10 -67.14 -33.64 75.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.054 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.526 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 66.56 -74.88 0.15 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -53.64 -13.07 0.58 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.922 0.391 . . . . 0.0 110.392 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.423 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.53 161.78 12.66 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -112.33 155.91 23.32 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 94.4 mt -99.78 117.43 44.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.7 p -82.1 175.69 10.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.151 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.95 -37.02 84.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.826 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.56 -52.43 64.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.791 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -67.7 -31.17 70.94 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.654 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.0 tp -64.15 -41.4 97.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.501 0.667 . . . . 0.0 110.997 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -53.86 -39.26 65.49 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.964 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -63.79 -41.23 97.98 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.1 -42.68 96.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.498 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 54.0 mmm -62.37 -40.75 97.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.979 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.4 m -61.69 -40.3 94.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.556 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -58.89 -40.45 84.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.614 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.9 tp -61.31 -44.27 97.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.964 0.411 . . . . 0.0 110.541 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 161.85 -151.91 22.16 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -138.31 29.15 2.47 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.806 0.336 . . . . 0.0 110.66 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -67.45 -45.32 76.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.824 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.6 mt -100.62 166.89 10.67 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.871 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.519 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -69.49 161.61 29.16 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.177 -179.595 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -92.71 -21.57 19.9 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.888 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -87.42 -23.56 24.47 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.637 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -35.09 -68.09 0.13 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.577 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.502 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 9.8 m -63.88 -42.09 94.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.415 ' N ' ' CG2' ' A' ' 121' ' ' VAL . 87.6 m-20 -48.33 -67.01 0.31 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.748 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.463 ' O ' ' OE1' ' A' ' 127' ' ' GLU . 80.3 mm-40 -70.54 -40.0 73.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.745 0.307 . . . . 0.0 111.801 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.404 ' SD ' ' C ' ' A' ' 124' ' ' MET . 17.7 tmm? -57.26 -38.93 74.62 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.669 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.413 HG21 HD12 ' A' ' 125' ' ' ILE . 93.8 mt -77.9 -23.76 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -77.61 -46.82 20.98 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 118.674 -1.211 . . . . 0.0 111.657 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 123' ' ' GLU . 19.6 mp0 -80.13 -68.41 0.68 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.661 -177.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.56 -49.02 1.05 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.629 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -88.46 131.07 35.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.896 0.379 . . . . 0.0 110.255 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.441 ' H ' ' CD1' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -82.31 -10.69 12.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.148 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.47 ' C ' ' H ' ' A' ' 133' ' ' ASP . 89.2 m-20 -64.35 -40.42 95.83 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.118 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.61 -8.4 4.28 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' A' ' 131' ' ' ASP . 26.1 p-10 -88.26 -12.72 42.84 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 39.39 98.07 0.01 OUTLIER Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.435 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 13.3 pt20 -131.09 136.94 48.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.021 0.439 . . . . 0.0 110.334 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.0 t -115.3 134.92 56.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.089 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.515 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 52.9 t30 -152.71 176.67 11.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.659 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -58.8 -47.97 82.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.406 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.515 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 58.0 mp0 -57.43 -25.54 59.79 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.293 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 81.1 mt-10 -84.82 -33.71 22.86 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.1 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -65.71 -46.84 77.44 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.634 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 50.3 t -56.35 -44.49 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 120.789 0.328 . . . . 0.0 110.253 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -71.63 -38.03 70.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.155 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 50.2 ttp -60.48 -48.55 81.26 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.291 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 49.1 mtm -88.62 120.81 30.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.945 0.402 . . . . 0.0 110.778 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.1 m -165.75 99.12 0.67 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.76 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.96 -38.31 88.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.582 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.8 mttm . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 117.821 -1.085 . . . . 0.0 110.509 179.982 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.544 0.212 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -54.65 -48.32 72.45 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.528 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -65.62 -40.85 93.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.865 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -62.01 -44.05 97.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.659 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -66.98 -37.57 84.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.988 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.482 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.03 -27.9 65.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.806 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -57.81 -46.9 84.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.525 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 m -77.98 -21.41 50.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.691 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.0 tp -62.41 -42.83 99.73 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.419 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.482 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.3 m-85 -60.15 -51.02 71.4 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.439 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.2 t0 -76.9 -14.32 59.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.872 0.368 . . . . 0.0 111.366 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -45.59 -32.68 2.43 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.805 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 8.8 p-10 -53.72 -46.1 70.71 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.53 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.434 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -144.36 -151.6 5.47 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 30.8 p-10 -72.93 -47.28 47.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.733 0.301 . . . . 0.0 111.106 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.71 107.35 0.28 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 178.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.43 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 4.6 m -166.61 139.3 3.74 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.151 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 27' ' ' ILE . 5.2 mp -115.13 109.23 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.594 HG22 HG22 ' A' ' 62' ' ' THR . 2.6 p -128.72 170.24 13.53 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.882 0.373 . . . . 0.0 110.372 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.66 ' HB ' HE22 ' A' ' 49' ' ' GLN . 67.2 p -64.68 -33.05 75.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.789 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -61.69 -41.45 97.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.395 . . . . 0.0 109.983 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 26' ' ' THR . 90.0 mt-10 -63.4 -45.73 89.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.897 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.9 tp -64.16 -43.3 95.6 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.106 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.81 -26.07 53.5 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.1 m -63.9 -41.45 97.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.885 0.374 . . . . 0.0 110.098 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.1 t -56.23 -23.61 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.365 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.478 ' O ' ' N ' ' A' ' 40' ' ' GLY . 62.3 mmm -48.06 -30.27 4.29 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.667 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -64.36 -45.68 86.71 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 118.077 -1.449 . . . . 0.0 110.999 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -63.95 -21.96 66.71 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.837 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 41' ' ' GLN . 16.8 mt -107.73 3.7 24.87 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.097 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.2 -71.29 0.02 OUTLIER Glycine 0 N--CA 1.465 0.602 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 39' ' ' LEU . 87.8 mt-30 -145.44 109.45 4.83 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 44' ' ' THR . 41.4 t30 -125.56 70.88 65.21 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.091 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.551 ' O ' ' N ' ' A' ' 46' ' ' ALA . 84.7 Cg_exo -33.02 -30.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 122.63 2.22 . . . . 0.0 112.715 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 42' ' ' ASN . 26.3 m -39.27 -30.19 0.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.503 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.419 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.9 mt-10 -86.61 -34.96 19.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.291 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -59.07 -50.04 75.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.834 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.15 -46.07 71.78 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.176 0.512 . . . . 0.0 109.671 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 51' ' ' MET . 84.7 mt -64.87 -31.14 72.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.338 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.66 HE22 ' HB ' ' A' ' 29' ' ' THR . 8.7 tp-100 -37.42 -51.29 1.11 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.879 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.31 -40.32 89.89 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.228 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 48' ' ' LEU . 33.1 ttp -62.44 -41.02 98.44 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.934 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.413 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 83.4 mt -61.98 -49.85 82.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.182 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.604 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 89.8 m-20 -62.95 -40.46 97.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.56 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -55.18 -61.5 2.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.238 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.92 -30.12 43.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.261 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 62' ' ' THR . 50.6 t0 -84.66 -13.2 52.19 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.568 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.02 13.06 0.33 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.859 0.362 . . . . 0.0 110.254 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.8 p30 -65.54 -28.9 69.5 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -150.53 -22.37 0.06 OUTLIER Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 62' ' ' THR . 3.3 p30 173.17 151.84 0.08 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.93 34.64 0.14 Allowed Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.594 HG22 HG22 ' A' ' 28' ' ' THR . 81.9 p -134.34 149.46 50.86 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.4 mt -120.98 134.48 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.14 162.36 28.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.461 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.473 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -64.61 -48.16 74.56 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.432 -179.045 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 50.2 Cg_exo -51.17 -37.44 58.72 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.195 1.93 . . . . 0.0 111.719 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -87.48 -22.33 24.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.31 -47.25 86.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.014 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.44 -42.94 98.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.543 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.1 m -63.97 -46.08 86.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.672 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.6 ttp -61.66 -47.57 84.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.062 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 82.0 mmm -65.75 -37.82 87.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.275 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.62 -49.97 75.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.01 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -71.46 -43.83 65.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.18 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.69 -43.64 88.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.681 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.434 ' O ' ' O ' ' A' ' 73' ' ' ALA . 22.4 mmm -104.3 127.47 51.94 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.08 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.7 tptt -84.99 141.18 30.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.893 0.378 . . . . 0.0 110.706 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.422 ' O ' ' O ' ' A' ' 77' ' ' LYS . 95.1 m-20 -48.93 179.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.239 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.6 p -75.5 -6.74 51.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.444 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.52 -15.43 62.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.567 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.1 m -61.94 -19.94 63.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.539 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -48.15 -44.71 32.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.374 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.97 -39.51 79.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.913 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.86 -45.15 83.22 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.023 0.439 . . . . 0.0 110.187 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.2 mt -66.1 -19.05 25.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.514 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -58.43 -45.41 88.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.205 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.63 -31.83 73.07 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.916 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -72.04 -14.62 61.92 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.212 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -58.04 -48.96 78.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.292 0.567 . . . . 0.0 111.046 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -64.1 -45.6 87.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.328 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.14 -51.59 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.897 0.379 . . . . 0.0 110.896 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.441 ' CE2' HD12 ' A' ' 100' ' ' ILE . 26.3 t80 -61.95 -47.2 85.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.628 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.422 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 18.1 t70 -108.97 94.21 4.93 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.24 -41.03 74.08 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.001 0.429 . . . . 0.0 110.536 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 20.1 p-10 -62.49 -39.75 94.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.021 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.51 -67.34 0.99 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.59 -16.53 63.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.93 0.395 . . . . 0.0 110.25 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.71 162.03 12.57 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.29 155.38 24.17 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.786 0.327 . . . . 0.0 110.247 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.441 HD12 ' CE2' ' A' ' 92' ' ' PHE . 94.2 mt -79.73 125.99 39.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.978 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.4 p -82.39 169.01 16.94 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.141 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.56 -37.98 89.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.499 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.72 -47.36 83.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.847 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.66 -32.83 72.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.955 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.5 tp -61.59 -41.7 97.81 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.405 0.622 . . . . 0.0 110.68 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -56.42 -43.3 79.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.816 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -58.48 -41.96 86.45 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.62 -43.39 90.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.692 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.1 mmm -62.02 -35.58 79.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.685 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.9 m -61.13 -44.37 97.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.014 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -59.8 -34.96 73.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.382 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.1 tp -61.18 -46.7 89.42 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.121 0.486 . . . . 0.0 110.384 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.47 -160.71 33.43 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -140.55 23.33 2.31 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.634 0.254 . . . . 0.0 110.78 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -63.57 -42.86 98.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.97 0.414 . . . . 0.0 110.24 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.6 mt -92.8 175.85 6.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.996 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.469 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -72.93 161.32 30.84 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.679 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -91.66 -22.5 20.23 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.928 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -87.92 -25.26 23.31 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.152 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.638 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.4 -61.28 0.45 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.141 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.638 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 20.3 m -67.39 -40.18 84.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.486 ' N ' HG23 ' A' ' 121' ' ' VAL . 81.2 m-20 -56.86 -47.0 81.43 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.521 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -86.02 -40.33 15.9 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.6 tmm? -59.57 -46.52 88.67 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.015 0.436 . . . . 0.0 109.896 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 125' ' ' ILE . 91.9 mt -69.09 -16.58 20.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.475 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 -78.64 -50.53 11.31 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.085 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 129' ' ' ASP . 42.3 tp10 -87.65 -67.54 0.82 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.071 -0.651 . . . . 0.0 110.861 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.34 -26.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.745 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 127' ' ' GLU . 25.4 t0 -87.98 128.27 35.38 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.061 0.457 . . . . 0.0 111.091 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.673 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.47 -43.36 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.442 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -65.4 -40.31 93.25 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.132 0.491 . . . . 0.0 110.15 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.37 -2.0 58.92 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' GLY . 55.2 p-10 -89.47 -8.97 51.78 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 57.44 115.47 0.01 OUTLIER Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.24 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.434 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 20.3 pt20 -160.65 133.6 6.47 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.0 t -123.46 136.96 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.04 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -151.41 172.42 15.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.252 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -54.77 -46.75 74.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.161 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 139' ' ' GLU . 55.4 mp0 -58.73 -44.37 90.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.639 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 93.3 mt-10 -72.09 -29.33 64.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.753 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.86 -44.02 77.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.631 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 94.3 t -59.1 -46.34 91.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.289 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -69.37 -29.03 66.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.132 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.8 ttp -59.74 -42.82 94.03 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.832 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.49 138.87 50.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.912 0.387 . . . . 0.0 110.745 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 81.4 m -163.29 77.69 0.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.658 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.13 -27.75 68.95 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.451 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.695 -179.882 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.067 0 CA-C-O 120.433 0.159 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -54.78 -50.55 68.21 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.0 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -63.77 -44.08 94.47 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.715 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -62.57 -45.92 90.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.484 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -69.82 -35.72 75.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.923 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.506 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -63.13 -37.78 88.58 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.511 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -58.43 -46.29 86.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.535 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.4 m -80.87 -18.87 45.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.746 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.51 -43.08 98.26 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.792 0.329 . . . . 0.0 111.291 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.9 m-85 -58.06 -49.22 77.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.541 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 6.3 t0 -73.17 -13.43 61.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.693 0.282 . . . . 0.0 111.229 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -44.49 -33.48 1.74 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.965 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.413 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 7.2 p-10 -53.97 -45.67 71.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.858 0.361 . . . . 0.0 110.96 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -149.07 -150.89 5.34 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 24.9 p-10 -70.16 -47.4 61.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.901 0.382 . . . . 0.0 110.983 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.53 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.79 107.84 0.3 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.445 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 6.3 m -166.21 139.5 4.11 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.112 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.2 mp -120.66 110.6 28.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.553 ' CG2' HG22 ' A' ' 62' ' ' THR . 2.8 p -130.99 169.33 15.98 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.978 0.418 . . . . 0.0 110.554 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.424 HG22 HG21 ' A' ' 52' ' ' ILE . 51.2 p -63.09 -31.45 72.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.304 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -62.14 -42.37 99.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.978 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.445 ' OE1' ' O ' ' A' ' 26' ' ' THR . 81.4 mt-10 -66.66 -45.9 77.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.004 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.92 -42.9 97.25 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.38 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.81 -25.04 28.52 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.9 m -63.96 -44.15 93.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.865 0.365 . . . . 0.0 110.743 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.414 ' H ' HG23 ' A' ' 35' ' ' VAL . 5.2 t -55.54 -20.43 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.521 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.513 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 87.5 mmm -48.97 -34.86 13.85 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.613 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -63.12 -46.39 87.53 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 118.056 -1.458 . . . . 0.0 111.83 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.5 p -60.85 -30.85 70.36 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 41' ' ' GLN . 24.8 mt -96.7 2.04 51.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.046 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.94 -67.91 0.02 OUTLIER Glycine 0 N--CA 1.467 0.743 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 39' ' ' LEU . 86.0 mt-30 -143.6 110.09 5.48 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -123.73 75.05 55.65 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.469 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 46' ' ' ALA . 99.3 Cg_exo -36.4 -35.74 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.743 1.629 . . . . 0.0 112.139 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.418 ' N ' ' HB3' ' A' ' 120' ' ' GLU . 5.8 m -37.84 -31.51 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.734 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.513 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.2 mt-10 -87.34 -35.97 18.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.336 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.52 -51.96 67.68 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -68.4 -47.17 68.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.25 0.548 . . . . 0.0 109.969 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.507 HD22 ' CE ' ' A' ' 51' ' ' MET . 85.0 mt -64.08 -26.8 68.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.967 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 45' ' ' GLU . 8.3 tp-100 -38.77 -46.42 1.26 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.72 0.295 . . . . 0.0 110.543 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.13 -41.72 66.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.536 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.507 ' CE ' HD22 ' A' ' 48' ' ' LEU . 40.1 ttp -62.17 -41.73 98.59 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.086 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.424 HG21 HG22 ' A' ' 29' ' ' THR . 96.6 mt -60.94 -51.97 67.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.354 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.621 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 85.8 m-20 -64.35 -40.08 95.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.668 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -55.53 -59.6 4.6 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.266 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.79 -34.42 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.012 0.434 . . . . 0.0 110.756 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 62' ' ' THR . 55.3 t0 -80.76 -13.56 58.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.53 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.2 16.12 0.14 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.294 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 56' ' ' ASP . 21.5 p-10 -66.04 -24.61 66.77 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -154.58 -25.57 0.04 OUTLIER Glycine 0 C--N 1.337 0.637 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.6 ' C ' ' H ' ' A' ' 62' ' ' THR . 10.9 p30 -179.99 150.84 0.39 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.405 ' C ' ' OD2' ' A' ' 56' ' ' ASP . . . -65.55 32.5 0.13 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.6 ' H ' ' C ' ' A' ' 60' ' ' ASN . 65.7 p -130.46 148.86 52.32 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.1 mt -118.47 133.9 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.069 0.461 . . . . 0.0 110.45 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.34 169.09 18.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.48 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.435 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -67.3 -49.47 43.37 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.212 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.8 Cg_exo -52.08 -45.29 39.91 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.927 1.751 . . . . 0.0 111.925 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.03 -37.01 72.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.661 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -60.58 -46.46 90.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.007 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.8 mt -62.27 -44.29 96.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.861 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.0 m -65.22 -44.61 87.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.916 0.389 . . . . 0.0 110.287 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 44.8 ttp -62.05 -41.91 98.63 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.812 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 76' ' ' MET . 60.2 mmm -63.29 -40.9 98.66 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.598 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.97 -35.81 77.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.778 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -87.76 -56.24 3.43 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.752 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -63.15 -43.27 98.77 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.138 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 72' ' ' MET . 50.8 mmm -108.9 131.56 54.91 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.943 0.401 . . . . 0.0 110.162 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 78' ' ' ASP . 29.0 tptt -83.12 150.07 26.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.792 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 77' ' ' LYS . 5.7 m-20 -55.45 -159.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.481 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.8 p -96.16 -0.3 50.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.479 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -82.87 2.48 34.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.128 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 83' ' ' GLU . 1.6 m -62.07 -35.63 79.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.971 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -37.92 -29.69 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.839 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 81' ' ' SER . 71.5 mm-40 -74.15 -56.85 4.42 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.065 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -64.71 -38.76 92.08 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.67 -19.29 14.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.462 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.1 ttt-85 -57.65 -44.04 85.37 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 118.79 -1.164 . . . . 0.0 110.201 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -65.96 -32.99 74.79 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.745 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -63.02 -27.96 69.77 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -55.61 -46.0 77.39 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.358 0.599 . . . . 0.0 110.432 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -74.44 -51.12 15.82 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.779 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.0 t -64.06 -47.92 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.082 0.468 . . . . 0.0 110.57 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.476 ' CE2' HD12 ' A' ' 100' ' ' ILE . 39.3 t80 -63.41 -45.9 88.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.246 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.479 ' OD2' ' N ' ' A' ' 96' ' ' GLY . 36.0 t70 -127.06 105.06 8.33 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.602 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -68.56 -42.09 78.85 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.935 0.398 . . . . 0.0 111.079 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 97' ' ' ASN . 1.5 p-10 -60.04 -46.59 89.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.801 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.479 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 73.78 -41.81 1.05 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.432 ' H ' ' C ' ' A' ' 95' ' ' ASP . 77.1 m-20 -80.25 -13.56 59.12 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.957 0.408 . . . . 0.0 110.002 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.96 161.22 12.81 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -113.25 149.9 33.17 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.694 0.283 . . . . 0.0 110.475 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.476 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -96.87 116.55 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.954 0.407 . . . . 0.0 111.177 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.2 p -84.35 170.72 13.34 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.309 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.59 86.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.136 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.17 -47.21 84.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.917 0.389 . . . . 0.0 110.548 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.55 -36.04 75.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.487 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.35 -40.08 95.22 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.619 0.723 . . . . 0.0 110.68 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -52.44 -45.12 65.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.625 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -61.51 -45.13 95.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.057 0.456 . . . . 0.0 110.437 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.85 -44.94 98.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.321 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 48.3 mmm -64.41 -37.07 86.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.457 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 82.6 m -61.08 -46.18 91.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.846 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -67.08 -24.56 65.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.19 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.0 tp -61.47 -44.87 96.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.923 0.392 . . . . 0.0 110.846 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.52 -148.81 15.57 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -140.39 25.92 2.2 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.498 0.19 . . . . 0.0 111.048 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -64.79 -45.35 86.66 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.954 0.407 . . . . 0.0 110.926 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.8 mt -113.55 170.64 8.09 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.991 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.482 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -69.43 161.54 29.23 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.934 0.397 . . . . 0.0 110.981 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -92.1 -24.0 19.27 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.806 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -88.06 -20.37 25.84 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.579 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.67 -67.42 0.16 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.579 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.9 m -64.48 -35.15 73.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -57.69 -66.52 0.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -64.37 -43.71 93.66 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.459 ' C ' ' SD ' ' A' ' 124' ' ' MET . 16.1 tmm? -57.32 -48.69 78.32 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.85 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.24 -23.79 30.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.209 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -77.17 -46.81 22.13 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 119.0 -1.08 . . . . 0.0 111.439 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -85.39 -68.22 0.74 Allowed 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.066 -0.653 . . . . 0.0 111.503 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.0 -33.37 0.08 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.45 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -94.66 146.73 23.94 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.826 0.346 . . . . 0.0 110.722 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.665 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -89.36 -17.35 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 179.461 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -65.48 -44.47 87.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.051 0.453 . . . . 0.0 110.552 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.44 -11.11 5.64 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 41.1 p-10 -89.08 -19.36 25.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.923 0.392 . . . . 0.0 110.501 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.546 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 55.38 106.12 0.01 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.476 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 11.1 pt20 -140.12 134.75 31.71 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 92.3 t -116.97 132.06 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.96 0.41 . . . . 0.0 110.201 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -142.75 175.41 9.83 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.566 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -58.16 -45.87 86.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.162 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 54.2 mp0 -63.63 -36.87 85.24 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.442 -178.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.476 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 78.3 mt-10 -67.14 -33.92 76.46 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.073 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -61.98 -40.6 96.19 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.45 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.7 t -57.22 -45.74 84.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.513 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -82.84 -15.84 50.02 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.836 0.35 . . . . 0.0 111.217 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 43.8 ttp -60.97 -41.03 95.59 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.906 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 78.2 mtm -118.54 141.69 48.33 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.815 0.341 . . . . 0.0 110.694 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.6 m -159.55 84.51 0.77 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.809 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.7 -40.47 72.85 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.124 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.501 -179.548 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.085 0 CA-C-O 120.766 0.317 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -57.89 -44.61 86.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.483 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -62.66 -45.8 91.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.841 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -63.86 -46.75 83.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.736 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.52 -34.52 77.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.444 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.51 -13.83 61.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.762 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -55.95 -48.96 74.81 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.642 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -71.78 -30.01 65.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.934 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.6 tp -61.31 -42.41 98.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.38 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -60.11 -49.86 75.97 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.032 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 3.5 t70 -76.58 -14.39 60.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.245 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -43.67 -32.79 1.06 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.985 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 24.2 p-10 -53.8 -43.1 69.04 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.196 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -143.81 -155.89 6.6 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 29.1 p-10 -75.29 -47.26 28.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.846 0.355 . . . . 0.0 111.066 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.92 107.36 0.28 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 23.6 m -166.63 155.72 10.88 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.164 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.429 ' N ' HG22 ' A' ' 26' ' ' THR . 5.2 mp -122.79 91.1 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.069 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.3 p -98.09 173.02 7.24 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.414 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.4 p -63.55 -32.6 74.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.998 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -62.7 -41.48 99.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.912 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 26' ' ' THR . 83.9 mt-10 -66.73 -44.48 81.43 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.336 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.0 tp -63.19 -45.75 90.28 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.938 0.399 . . . . 0.0 110.66 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -45.96 -25.21 1.6 Allowed Glycine 0 C--O 1.226 -0.377 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.401 ' C ' ' N ' ' A' ' 36' ' ' MET . 14.7 m -63.23 -42.35 99.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.867 0.365 . . . . 0.0 110.026 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 82.6 t -49.46 -18.76 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.285 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.401 ' N ' ' C ' ' A' ' 34' ' ' THR . 89.2 mmm -59.62 -41.01 89.46 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.097 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.5 ttt85 -65.43 -43.87 89.13 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 118.185 -1.406 . . . . 0.0 111.133 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.3 p -58.14 -33.1 68.8 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.852 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.639 HD13 HD22 ' A' ' 42' ' ' ASN . 91.2 mt -97.33 7.05 47.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.611 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 42.96 97.21 0.01 OUTLIER Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 40' ' ' GLY . 87.0 mt-30 41.12 94.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.687 0.28 . . . . 0.0 110.485 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.639 HD22 HD13 ' A' ' 39' ' ' LEU . 48.8 t30 -130.35 75.68 78.8 Favored Pre-proline 0 N--CA 1.464 0.275 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 46' ' ' ALA . 95.0 Cg_exo -33.93 -26.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.367 2.044 . . . . 0.0 112.668 178.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.58 ' N ' ' O ' ' A' ' 42' ' ' ASN . 80.4 m -38.65 -25.97 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.564 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' PRO . 84.4 mt-10 -89.44 -33.38 16.84 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.499 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -56.58 -53.41 57.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.212 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.414 ' OE1' ' O ' ' A' ' 115' ' ' LYS . 1.5 tm-20 -67.96 -41.39 82.52 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.47 HD12 ' O ' ' A' ' 44' ' ' THR . 96.2 mt -73.02 -14.09 61.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.741 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' A' ' 45' ' ' GLU . 11.8 tp-100 -53.08 -47.3 68.64 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -67.05 -37.13 83.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.97 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.0 ttp -60.32 -40.79 91.84 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.27 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.23 -48.15 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.653 0.263 . . . . 0.0 111.378 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.609 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 93.6 m-20 -62.03 -39.58 92.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.301 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -55.8 -57.51 11.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.068 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 p -74.92 -29.35 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.274 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 62' ' ' THR . 42.8 t0 -85.15 -12.99 51.52 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.584 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -71.8 2.63 5.12 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.181 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.5 p-10 -52.51 -26.79 14.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -155.64 -27.69 0.03 OUTLIER Glycine 0 C--N 1.339 0.704 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.571 ' C ' ' H ' ' A' ' 62' ' ' THR . 17.7 p30 -177.51 145.71 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.18 36.02 0.09 OUTLIER Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.571 ' H ' ' C ' ' A' ' 60' ' ' ASN . 72.5 p -133.45 152.59 51.93 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.7 mt -122.39 136.39 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.99 0.424 . . . . 0.0 110.253 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.6 OUTLIER -72.64 172.47 10.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.189 -179.464 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.445 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -72.88 -48.73 8.07 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.28 -178.912 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.9 Cg_exo -53.89 -39.79 83.15 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.279 1.986 . . . . 0.0 111.849 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -76.4 -35.25 58.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.876 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -59.75 -50.29 74.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.066 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -66.27 -42.17 88.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.618 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.9 m -63.43 -48.34 78.2 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.996 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 45.6 ttp -62.82 -44.84 95.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.585 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 42.9 mmm -64.47 -39.54 94.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.703 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.16 -46.26 90.28 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.97 0.414 . . . . 0.0 110.255 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -72.33 -44.64 62.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.335 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -69.6 -46.39 66.41 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.869 0.366 . . . . 0.0 111.644 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 16.3 mmm -101.59 131.06 47.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.671 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 78' ' ' ASP . 48.2 tptt -84.68 148.2 26.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.885 0.374 . . . . 0.0 110.311 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 77' ' ' LYS . 85.7 m-20 -48.85 -179.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.289 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.43 HG22 HG23 ' A' ' 146' ' ' THR . 3.6 p -80.93 -8.86 59.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.422 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.02 -8.95 49.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.415 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 82' ' ' GLU . 9.4 m -61.01 -25.42 66.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 81' ' ' SER . 82.2 tt0 -37.2 -48.05 0.83 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.759 0.314 . . . . 0.0 110.833 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -71.14 -44.14 66.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.253 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -63.95 -39.01 93.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.019 0.438 . . . . 0.0 110.104 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.3 -23.33 33.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 56.1 ttt-85 -56.89 -43.17 81.03 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 118.698 -1.201 . . . . 0.0 109.848 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -63.11 -34.76 78.3 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.64 -22.28 64.42 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -56.91 -49.81 74.46 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.317 0.579 . . . . 0.0 110.971 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -63.69 -45.99 87.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.992 -1.003 . . . . 0.0 111.309 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.5 t -66.22 -48.39 81.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.975 0.417 . . . . 0.0 110.183 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -64.45 -48.33 75.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.615 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 96' ' ' GLY . 42.4 t0 -102.19 102.3 12.71 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.892 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.57 -41.52 88.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.106 0.479 . . . . 0.0 109.893 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -73.25 -42.67 62.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.261 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.456 ' H ' ' CG ' ' A' ' 93' ' ' ASP . . . 76.75 -51.29 3.06 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -76.39 -14.53 60.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.067 0.46 . . . . 0.0 110.114 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.16 162.42 12.42 Favored Glycine 0 N--CA 1.465 0.592 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -112.13 150.44 30.77 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 95.6 mt -88.42 122.52 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.065 0.46 . . . . 0.0 111.114 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.6 p -88.78 176.39 7.09 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.205 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.5 -36.44 82.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.808 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.71 -52.61 64.96 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.476 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -67.95 -37.44 81.59 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.198 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.8 tp -62.59 -41.29 98.86 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.57 0.7 . . . . 0.0 110.298 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -55.7 -43.5 76.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.711 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -55.84 -41.72 74.71 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.4 t -66.35 -42.55 90.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.651 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 63.7 mmm -60.97 -38.03 84.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.617 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.3 m -61.17 -39.84 91.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.654 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -57.55 -40.21 78.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.558 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.4 tp -62.14 -43.68 98.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 0.0 110.138 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 146.31 -144.77 13.21 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -137.32 28.81 2.76 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.647 0.26 . . . . 0.0 110.403 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.414 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 48.7 mtmt -62.39 -42.06 99.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.218 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.468 HD22 HD21 ' A' ' 48' ' ' LEU . 14.2 mt -95.83 168.26 10.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.154 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.472 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -63.76 161.7 14.72 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.819 0.342 . . . . 0.0 110.326 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -91.72 -22.42 20.22 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.539 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 120' ' ' GLU . 78.0 tt0 -86.17 -23.95 26.33 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.418 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.606 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -35.78 -64.38 0.31 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.564 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 14.4 m -63.93 -36.74 77.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.544 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.401 ' N ' HG23 ' A' ' 121' ' ' VAL . 43.8 m-20 -55.88 -66.67 0.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.596 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -69.69 -37.88 76.79 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.434 ' C ' ' SD ' ' A' ' 124' ' ' MET . 16.1 tmm? -59.07 -47.34 85.6 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.598 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.4 mt -70.18 -20.42 22.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.896 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -89.66 -60.24 1.99 Allowed 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.592 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -63.68 -68.34 0.35 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 119.519 -0.873 . . . . 0.0 111.405 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 39' ' ' LEU . . . -45.13 -26.98 0.53 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.42 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -87.76 126.12 34.82 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.028 0.442 . . . . 0.0 111.15 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.618 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -77.31 -23.45 14.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.422 179.255 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -74.95 -41.8 58.89 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.153 0.502 . . . . 0.0 110.004 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.79 2.24 56.44 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 41.7 p-10 -88.13 -18.54 28.57 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.36 111.15 0.04 OUTLIER Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -162.81 139.46 7.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.756 0.312 . . . . 0.0 110.26 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.9 t -126.22 132.98 69.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.182 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -146.73 166.76 25.65 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.187 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -49.35 -37.42 24.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.649 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -59.77 -33.94 72.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.015 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -75.5 -37.06 60.41 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -61.29 -49.77 75.71 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.8 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.5 t -49.39 -48.24 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.42 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -68.91 -39.43 79.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.9 ttp -60.61 -44.73 95.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.768 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.412 ' O ' ' OG1' ' A' ' 146' ' ' THR . 67.1 mtt -89.18 121.18 31.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.898 0.38 . . . . 0.0 110.43 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.43 HG23 HG22 ' A' ' 79' ' ' THR . 12.1 m -167.36 82.81 0.21 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.47 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.43 -46.2 89.65 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.815 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.456 -179.851 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.592 0.234 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.41 -45.14 55.41 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.488 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -63.05 -44.01 97.07 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.907 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -63.84 -46.52 84.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.293 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -67.38 -43.58 81.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.904 0.383 . . . . 0.0 111.174 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.34 -36.48 80.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.409 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -55.72 -51.07 68.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.975 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -72.77 -23.45 60.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.735 0.302 . . . . 0.0 110.763 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.08 -42.24 99.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.705 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.406 ' O ' ' CD ' ' A' ' 31' ' ' GLU . 79.4 m-85 -59.55 -49.0 79.47 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.169 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.7 t0 -74.81 -13.67 60.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.528 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -43.09 -32.64 0.72 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.998 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 10.9 p-10 -53.3 -45.6 69.04 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.65 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -148.79 -149.18 4.91 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 32.2 p-10 -72.09 -46.89 55.03 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.698 0.285 . . . . 0.0 111.208 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.99 107.57 0.29 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 m -166.0 142.61 5.18 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.099 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.61 108.05 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.536 HG22 HG22 ' A' ' 62' ' ' THR . 2.4 p -128.39 169.82 13.82 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.965 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.788 ' HB ' HE22 ' A' ' 49' ' ' GLN . 75.7 p -64.77 -32.38 74.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.985 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -62.35 -41.42 98.58 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.579 -0.449 . . . . 0.0 109.901 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.406 ' CD ' ' O ' ' A' ' 19' ' ' PHE . 89.2 mt-10 -63.49 -45.82 88.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.808 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.8 tp -63.87 -45.0 91.39 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.122 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.87 -24.24 7.98 Favored Glycine 0 C--O 1.224 -0.493 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.5 m -64.98 -42.95 94.08 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.256 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.8 t -53.86 -18.23 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.291 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.43 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 91.3 mmm -57.36 -35.35 69.84 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.389 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -63.62 -43.94 95.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 118.004 -1.478 . . . . 0.0 110.148 -178.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.8 p -61.06 -35.76 77.8 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.844 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 41' ' ' GLN . 25.7 mt -96.36 3.61 52.8 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.944 0.402 . . . . 0.0 110.314 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.51 -66.9 0.02 OUTLIER Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 39' ' ' LEU . 80.8 mt-30 -145.05 104.8 4.01 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' A' ' 44' ' ' THR . 50.2 t30 -123.61 73.75 52.87 Favored Pre-proline 0 N--CA 1.466 0.371 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.159 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' A' ' 46' ' ' ALA . 80.4 Cg_exo -35.05 -32.61 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.58 2.186 . . . . 0.0 112.504 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.457 ' O ' HD12 ' A' ' 48' ' ' LEU . 29.1 m -38.25 -31.04 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.593 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 92.5 mt-10 -86.8 -35.89 18.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.327 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -57.44 -49.98 74.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.694 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.505 ' HB2' HG23 ' A' ' 117' ' ' THR . 1.4 tm-20 -70.47 -45.72 65.18 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.141 0.496 . . . . 0.0 109.666 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 44' ' ' THR . 86.6 mt -63.62 -31.43 72.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.948 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.788 HE22 ' HB ' ' A' ' 29' ' ' THR . 10.8 tp-100 -40.17 -54.79 2.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.681 0.276 . . . . 0.0 110.997 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -63.6 -41.52 98.32 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.722 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.6 ttp -61.26 -38.95 88.55 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.201 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.5 mt -62.94 -46.61 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.329 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.626 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 92.3 m-20 -62.81 -41.28 99.24 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.838 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -57.88 -57.16 14.01 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.644 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 p -70.45 -29.31 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.156 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 62' ' ' THR . 38.7 t0 -89.13 -12.48 40.93 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.849 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -71.62 13.46 0.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.484 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.472 ' H ' ' C ' ' A' ' 56' ' ' ASP . 38.9 p-10 -66.81 -28.79 68.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -149.62 -32.12 0.05 OUTLIER Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.628 ' C ' ' H ' ' A' ' 62' ' ' THR . 11.3 p30 -177.11 153.04 0.94 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.551 -0.324 . . . . 0.0 110.202 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.39 30.93 0.1 OUTLIER Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.628 ' H ' ' C ' ' A' ' 60' ' ' ASN . 57.9 p -127.56 146.07 50.64 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.4 mt -116.66 139.74 42.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.652 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.35 176.08 2.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.604 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.516 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -85.67 -46.68 0.6 Allowed Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.667 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 32.4 Cg_exo -55.89 -45.02 41.85 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.272 1.981 . . . . 0.0 111.756 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -70.05 -36.98 75.41 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -57.45 -41.77 81.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.458 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.17 -43.87 98.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.59 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.8 m -64.14 -43.19 96.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.875 0.369 . . . . 0.0 110.365 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 62.1 ttp -59.13 -43.62 92.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.527 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 88.5 mmm -64.83 -38.13 89.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.78 -46.3 84.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -72.88 -45.67 56.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.841 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -64.72 -45.06 88.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.056 0.455 . . . . 0.0 110.537 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 28.6 mmt -93.91 128.07 40.01 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.79 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -85.18 148.26 26.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.307 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -52.96 164.77 0.36 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.357 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 75.4 p -67.19 -21.5 65.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.634 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.13 -7.23 8.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.038 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.6 m -53.47 -34.73 59.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.447 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -38.17 -45.13 0.91 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -69.28 -44.87 70.97 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.008 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.56 -36.48 81.03 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.0 0.428 . . . . 0.0 110.296 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.47 -20.98 24.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -55.58 -45.19 77.43 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 118.758 -1.177 . . . . 0.0 109.539 -177.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -68.07 -33.09 73.89 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.195 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.96 -27.71 69.59 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -57.31 -51.39 69.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.294 0.568 . . . . 0.0 110.94 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -69.36 -45.22 69.9 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.699 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.6 t -68.13 -50.58 57.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.918 0.389 . . . . 0.0 110.769 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -63.39 -47.43 82.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.223 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.408 ' OD2' ' N ' ' A' ' 96' ' ' GLY . 22.5 t0 -110.07 107.63 17.55 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.801 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -68.91 -41.24 78.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.173 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 97' ' ' ASN . 1.1 p-10 -68.63 -37.39 79.68 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.257 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.408 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 67.69 -64.88 0.3 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 95' ' ' ASP . 56.0 m-80 -63.1 -14.38 47.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.958 0.409 . . . . 0.0 110.41 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.57 162.01 12.59 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -112.16 145.64 39.48 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 75.7 mt -83.72 125.08 40.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.038 0.447 . . . . 0.0 111.087 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.7 p -83.68 172.15 12.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.043 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.14 -39.07 92.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.012 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.62 76.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.869 0.366 . . . . 0.0 111.108 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.3 -33.18 74.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.652 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.6 tp -61.91 -43.11 99.52 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.408 0.623 . . . . 0.0 111.257 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -55.52 -43.22 75.54 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.883 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -60.35 -43.96 96.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.102 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 84.2 t -63.2 -45.22 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.695 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 86.7 mmm -63.61 -37.46 87.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.337 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 m -60.75 -41.02 94.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.603 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -55.5 -28.38 54.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.011 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.8 tp -60.88 -43.39 98.5 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.035 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 152.8 -141.76 8.71 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -137.58 27.23 2.78 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.7 0.286 . . . . 0.0 110.522 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -62.69 -43.43 98.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.013 0.435 . . . . 0.0 110.356 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 56.3 mt -108.9 -178.67 3.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.689 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.505 HG23 ' HB2' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -76.85 161.76 28.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.66 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -92.15 -22.12 20.03 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.099 0.476 . . . . 0.0 110.526 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -86.99 -24.17 24.78 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.14 -67.57 0.14 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.309 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.581 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 19.3 m -64.46 -34.24 68.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -57.08 -67.43 0.32 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.589 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -68.88 -38.01 79.41 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.418 ' C ' ' SD ' ' A' ' 124' ' ' MET . 15.2 tmm? -59.88 -47.09 87.18 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.035 0.445 . . . . 0.0 110.103 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 125' ' ' ILE . 97.6 mt -68.84 -16.86 21.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.144 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -80.18 -51.61 8.76 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.08 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 129' ' ' ASP . 44.1 tp10 -86.2 -68.2 0.76 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 118.978 -1.089 . . . . 0.0 111.362 -177.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 124' ' ' MET . . . -37.44 -25.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.635 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 127' ' ' GLU . 40.0 t0 -88.57 126.71 35.4 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.165 0.507 . . . . 0.0 110.849 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -65.46 -41.19 90.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.95 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.97 -42.87 99.61 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.755 0.312 . . . . 0.0 110.501 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.45 -0.92 62.83 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 50.2 p-10 -94.26 -18.57 21.53 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.894 0.378 . . . . 0.0 110.097 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.513 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 64.84 121.22 0.01 OUTLIER Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -164.45 144.5 7.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.57 -0.315 . . . . 0.0 110.272 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 72.7 t -128.62 134.36 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.39 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -150.98 176.3 11.25 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.105 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -56.15 -46.75 79.14 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.338 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -55.53 -37.92 68.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.579 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -69.16 -39.68 78.62 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.446 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -61.92 -43.12 99.5 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.0 t -58.03 -45.93 88.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.769 0.319 . . . . 0.0 110.657 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -77.07 -24.32 51.92 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.684 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 44.5 ttp -63.88 -41.14 97.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.727 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.415 ' O ' ' OG1' ' A' ' 146' ' ' THR . 64.6 mtt -91.36 130.38 37.22 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.929 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 145' ' ' MET . 36.0 m -167.44 67.8 0.09 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.583 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.42 87.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.32 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 66.4 mttm . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.913 179.606 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.057 0 CA-C-O 120.626 0.251 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -43.95 -48.24 8.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.653 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -65.97 -39.8 90.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.67 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -65.36 -48.14 73.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.237 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -64.14 -33.96 76.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.512 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.64 -19.88 12.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.543 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -57.45 -49.25 76.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.823 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.4 m -60.93 -40.84 94.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.552 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.55 -42.85 99.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.982 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -59.31 -49.84 76.27 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.849 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.466 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.5 t0 -75.97 -15.62 60.13 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.644 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -43.58 -33.25 1.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.787 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.433 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 14.5 p-10 -53.43 -43.45 68.02 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.466 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -145.57 -153.69 5.95 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 26.7 p-10 -74.79 -47.26 31.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 110.59 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.71 107.22 0.28 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 178.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.629 ' C ' HD12 ' A' ' 27' ' ' ILE . 8.4 m -166.65 149.91 6.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.143 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.629 HD12 ' C ' ' A' ' 26' ' ' THR . 2.8 mp -119.52 109.49 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.505 HG22 HG22 ' A' ' 62' ' ' THR . 4.1 p -130.98 169.68 15.5 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.908 0.385 . . . . 0.0 110.473 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.4 p -63.43 -29.57 70.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.182 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -62.16 -41.25 98.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.252 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.448 ' OE2' ' O ' ' A' ' 26' ' ' THR . 89.6 mt-10 -67.0 -45.72 76.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.98 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.3 tp -65.96 -44.43 85.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.409 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.93 -22.5 4.57 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.5 m -67.06 -30.2 70.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.78 0.324 . . . . 0.0 110.446 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.4 t -62.24 -22.99 30.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.809 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.0 mmm -56.0 -37.14 68.74 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.702 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -63.19 -44.2 96.05 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 116.771 -1.971 . . . . 0.0 110.06 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 91.6 p -60.45 -37.9 82.44 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.166 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 41' ' ' GLN . 39.1 mt -94.71 5.05 53.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.28 0.562 . . . . 0.0 110.505 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.46 -67.62 0.26 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 39' ' ' LEU . 84.1 mt-30 -147.87 104.98 3.63 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 44' ' ' THR . 58.7 t30 -123.24 76.8 52.48 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.06 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' A' ' 46' ' ' ALA . 72.0 Cg_exo -36.63 -29.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.582 2.188 . . . . 0.0 112.653 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.434 ' N ' ' HB3' ' A' ' 120' ' ' GLU . 11.4 m -38.46 -31.98 0.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.358 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 49' ' ' GLN . 96.8 mt-10 -88.77 -36.19 16.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.195 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -55.01 -49.8 70.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.558 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -69.85 -49.14 55.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.26 0.552 . . . . 0.0 110.258 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.91 -21.36 65.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.683 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 45' ' ' GLU . 10.8 tp-100 -45.55 -47.44 14.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.209 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 68.1 t0 -70.89 -38.6 73.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.492 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.1 ttp -62.38 -42.83 99.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.922 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 87.1 mt -63.53 -46.28 95.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.541 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.669 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 87.3 m-20 -64.02 -41.79 97.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.62 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -59.27 -59.15 5.92 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.491 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.8 p -66.07 -31.82 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.0 110.847 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.546 ' OD2' ' N ' ' A' ' 62' ' ' THR . 45.5 t0 -87.28 -12.6 46.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.737 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.24 13.01 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.048 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 56' ' ' ASP . 16.7 p-10 -63.98 -33.84 76.65 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.47 -26.41 0.08 OUTLIER Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.591 ' C ' ' H ' ' A' ' 62' ' ' THR . 16.5 p30 -178.25 148.21 0.47 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.513 -0.343 . . . . 0.0 110.262 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.92 34.23 0.1 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.591 ' H ' ' C ' ' A' ' 60' ' ' ASN . 70.7 p -129.68 151.49 50.21 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.0 mt -119.62 134.12 64.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.821 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -77.09 -155.43 0.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.042 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.49 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -96.52 -47.86 0.24 Allowed Pre-proline 0 N--CA 1.469 0.485 0 CA-C-O 120.501 0.191 . . . . 0.0 110.845 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 42.6 Cg_exo -54.93 -36.06 91.07 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.115 1.877 . . . . 0.0 111.606 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -83.61 -28.69 28.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.794 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -59.38 -46.42 88.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.7 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.0 -43.48 95.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.822 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.7 m -63.6 -45.29 91.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.113 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 46.8 ttp -62.18 -44.44 96.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.782 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 47.8 mmm -63.39 -42.2 98.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.718 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.77 -48.65 80.82 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.686 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -71.03 -50.13 37.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.565 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -64.67 -41.8 95.82 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.371 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.505 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 32.1 mmm -121.17 127.02 51.13 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.219 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -82.77 153.14 25.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.675 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -52.54 -179.96 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.282 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.0 p -80.97 -9.74 59.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.651 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -65.95 -21.65 66.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.419 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.7 m -50.58 -32.25 18.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.407 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -38.19 -45.71 0.98 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.716 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -69.12 -46.6 67.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.145 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -65.02 -49.52 69.89 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.9 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.5 mt -56.37 -21.14 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -57.94 -44.94 87.24 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 118.466 -1.294 . . . . 0.0 109.649 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -66.16 -25.95 67.19 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.6 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.81 -14.14 58.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.071 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -56.56 -50.68 71.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.298 0.57 . . . . 0.0 111.121 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -63.37 -44.49 94.64 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.203 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.6 t -66.64 -45.63 87.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.807 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.429 ' CE2' ' CD1' ' A' ' 100' ' ' ILE . 19.3 t80 -62.55 -47.23 84.79 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.643 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.431 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 37.3 t0 -119.94 106.56 12.16 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.242 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -68.14 -44.29 76.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.011 0.434 . . . . 0.0 110.58 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.431 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 0.9 OUTLIER -62.36 -44.47 96.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.779 -179.312 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.1 -47.41 1.05 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -74.6 -14.44 60.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.017 0.437 . . . . 0.0 110.541 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.79 161.79 12.64 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -112.19 144.38 41.68 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.429 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 64.7 mt -74.95 129.49 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.902 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.5 p -83.05 168.79 16.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.284 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.86 97.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.85 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.14 -41.7 94.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.701 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -67.32 -37.36 83.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.086 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.2 tp -60.21 -43.19 96.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.2 0.524 . . . . 0.0 110.682 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -54.07 -40.68 67.39 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.846 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -59.09 -42.2 89.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.893 0.377 . . . . 0.0 110.002 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.11 -44.92 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.745 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 80.9 mmm -63.51 -35.48 80.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.568 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.4 m -61.23 -41.71 97.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.251 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -59.8 -39.16 84.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.634 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.39 -44.29 97.4 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.582 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.69 -143.95 10.03 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -144.33 30.49 1.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.817 0.342 . . . . 0.0 110.766 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -62.87 -40.8 98.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.414 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.5 mt -105.25 165.94 10.76 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.485 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -65.15 161.52 18.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 0.0 110.51 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.445 ' C ' ' OE1' ' A' ' 120' ' ' GLU . 83.8 m-20 -91.28 -20.37 21.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 178.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -89.3 -26.11 21.31 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.684 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -34.91 -65.18 0.23 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.559 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.684 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 31.0 m -68.6 -27.46 36.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -178.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -63.25 -43.78 97.03 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.614 -0.435 . . . . 0.0 112.002 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -88.46 -41.07 13.0 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.471 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 15.0 tmm? -60.57 -42.67 97.11 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.898 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 125' ' ' ILE . 96.6 mt -69.98 -15.88 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -87.2 -66.69 0.88 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 118.971 -1.092 . . . . 0.0 112.003 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 128' ' ' ALA . 50.9 tp10 -70.97 -68.5 0.43 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.304 -0.959 . . . . 0.0 111.939 -176.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 124' ' ' MET . . . -37.31 -40.01 0.32 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.699 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -88.42 124.64 34.15 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.066 0.46 . . . . 0.0 110.436 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.697 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -72.24 -16.03 18.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.281 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.461 ' C ' ' H ' ' A' ' 133' ' ' ASP . 51.0 m-20 -65.36 -45.65 83.28 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.623 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.07 -11.48 2.67 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 42.0 p30 -88.51 -17.41 30.35 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.097 0.475 . . . . 0.0 110.15 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 58.35 120.73 0.01 OUTLIER Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.443 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 10.4 pt20 -161.02 137.88 8.77 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.4 t -125.59 134.17 67.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.874 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.468 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.4 t30 -148.98 159.56 44.1 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.232 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -40.04 -35.36 0.37 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.334 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.468 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 53.1 mp0 -65.8 -42.32 90.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.17 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 80.3 mt-10 -71.83 -30.18 65.2 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.538 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -58.5 -45.57 88.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.248 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 58.9 t -60.19 -48.2 89.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.914 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -70.05 -32.13 70.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.833 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 37.6 ttp -56.62 -47.69 79.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.696 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 69.7 mtm -106.1 134.1 49.76 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.844 0.354 . . . . 0.0 110.613 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 88.7 m -160.14 81.69 0.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.325 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 76' ' ' MET . . . -65.95 -40.52 91.41 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.885 0.374 . . . . 0.0 110.571 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.627 179.997 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.035 0 CA-C-O 120.571 0.224 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -54.7 -48.23 72.72 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.537 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -65.67 -40.84 92.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.824 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -62.04 -44.03 97.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.631 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -66.96 -37.58 84.54 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.998 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.482 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.0 -27.99 65.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.779 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -57.77 -46.95 83.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.526 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 m -77.9 -21.51 51.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.693 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.37 -42.81 99.7 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.431 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.482 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.2 m-85 -60.17 -51.01 71.43 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.462 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.1 t0 -76.89 -14.35 59.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.893 0.377 . . . . 0.0 111.358 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -45.56 -32.67 2.39 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.893 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 8.8 p-10 -53.73 -46.11 70.73 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.542 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -144.37 -151.62 5.48 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 30.7 p-10 -72.97 -47.19 47.54 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.074 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.7 107.37 0.28 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 178.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.425 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 4.5 m -166.62 139.28 3.72 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.38 -0.482 . . . . 0.0 111.179 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 27' ' ' ILE . 5.2 mp -115.13 109.23 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.596 HG22 HG22 ' A' ' 62' ' ' THR . 2.6 p -128.66 170.31 13.42 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.817 0.342 . . . . 0.0 110.442 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.66 ' HB ' HE22 ' A' ' 49' ' ' GLN . 67.3 p -64.66 -33.11 75.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.788 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -61.71 -41.32 97.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.011 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 26' ' ' THR . 90.1 mt-10 -63.49 -45.71 89.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.863 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.2 tp -64.1 -43.35 95.61 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.149 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.78 -26.1 53.29 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.2 m -63.93 -41.41 97.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.843 0.354 . . . . 0.0 110.084 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.7 t -56.24 -23.56 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.363 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.483 ' O ' ' N ' ' A' ' 40' ' ' GLY . 62.1 mmm -48.14 -30.27 4.41 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.671 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -64.38 -45.64 86.81 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 118.042 -1.463 . . . . 0.0 110.975 -178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -63.94 -21.98 66.72 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.852 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 41' ' ' GLN . 16.8 mt -107.75 3.7 24.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.086 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.19 -71.2 0.02 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 39' ' ' LEU . 87.8 mt-30 -145.43 109.47 4.84 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 44' ' ' THR . 41.3 t30 -125.61 70.87 65.55 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.552 ' O ' ' N ' ' A' ' 46' ' ' ALA . 84.8 Cg_exo -32.94 -30.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.65 2.233 . . . . 0.0 112.792 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.542 ' N ' ' O ' ' A' ' 42' ' ' ASN . 26.1 m -39.29 -30.15 0.06 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.545 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.417 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.9 mt-10 -86.67 -34.85 19.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.332 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -59.04 -50.14 75.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.799 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.15 -46.13 71.63 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 51' ' ' MET . 84.5 mt -64.81 -31.07 72.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.382 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.66 HE22 ' HB ' ' A' ' 29' ' ' THR . 8.7 tp-100 -37.5 -51.36 1.14 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.74 0.305 . . . . 0.0 110.761 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.22 -40.33 90.22 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.259 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 48' ' ' LEU . 33.1 ttp -62.45 -40.98 98.37 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.948 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.415 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 83.5 mt -61.99 -49.9 82.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.142 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.603 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 89.9 m-20 -62.99 -40.36 97.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.597 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -55.19 -61.52 2.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.213 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.87 -30.21 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.341 . . . . 0.0 111.28 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 62' ' ' THR . 50.6 t0 -84.63 -13.24 52.15 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.574 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -71.99 13.07 0.33 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.871 0.367 . . . . 0.0 110.284 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.5 p30 -65.58 -28.92 69.49 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.535 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -150.48 -22.34 0.06 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.552 ' C ' ' H ' ' A' ' 62' ' ' THR . 3.3 p30 173.14 151.87 0.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.99 34.71 0.15 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.596 HG22 HG22 ' A' ' 28' ' ' THR . 81.7 p -134.33 149.49 50.87 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.6 mt -120.98 134.57 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.26 162.4 28.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.41 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.471 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -64.56 -48.12 74.99 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.513 -179.076 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 50.5 Cg_exo -51.3 -37.29 59.76 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.195 1.93 . . . . 0.0 111.71 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -87.59 -22.3 24.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.836 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.42 -47.14 87.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.048 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.54 -42.89 98.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.549 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.8 m -63.95 -46.08 86.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.647 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.6 ttp -61.69 -47.56 84.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.077 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.9 mmm -65.76 -37.85 87.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.282 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.53 -50.01 75.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.031 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -71.51 -43.75 65.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.203 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.73 -43.56 88.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.733 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.431 ' O ' ' O ' ' A' ' 73' ' ' ALA . 22.4 mmm -104.35 127.44 52.01 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.094 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.7 tptt -84.96 141.17 30.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.38 . . . . 0.0 110.712 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' LYS . 95.0 m-20 -48.92 179.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.226 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.8 p -75.53 -6.76 51.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.418 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.44 -15.54 62.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.509 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.0 m -61.92 -19.87 63.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.548 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -48.19 -44.76 33.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.342 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.95 -39.52 79.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.905 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.82 -45.22 83.11 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.006 0.431 . . . . 0.0 110.152 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.2 mt -66.04 -19.04 25.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.525 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -58.47 -45.38 88.73 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.218 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.64 -31.81 73.04 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.928 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.406 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -72.03 -14.69 61.94 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.138 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -57.94 -48.99 78.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.297 0.57 . . . . 0.0 111.116 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -64.09 -45.58 88.07 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.36 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.7 t -76.17 -51.54 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.381 . . . . 0.0 110.894 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.446 ' CE2' HD12 ' A' ' 100' ' ' ILE . 26.3 t80 -61.98 -47.22 85.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.598 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.43 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 18.2 t70 -108.95 94.15 4.89 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.21 -41.04 74.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.02 0.438 . . . . 0.0 110.578 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 19.9 p-10 -62.48 -39.74 94.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.969 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.44 -67.33 0.97 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.56 -16.52 63.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.917 0.389 . . . . 0.0 110.228 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.78 162.0 12.57 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.2 155.4 24.04 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.811 0.338 . . . . 0.0 110.237 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.446 HD12 ' CE2' ' A' ' 92' ' ' PHE . 94.0 mt -79.76 126.04 39.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.965 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.3 p -82.45 168.94 16.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.181 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.07 89.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.557 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.59 -47.4 83.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.65 -32.8 72.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.5 tp -61.57 -41.69 97.77 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.423 0.63 . . . . 0.0 110.691 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -56.51 -43.23 79.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.845 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -58.47 -41.96 86.42 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.7 t -66.64 -43.35 90.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.656 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.0 mmm -62.01 -35.65 79.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.634 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.4 m -61.04 -44.39 97.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.071 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -59.8 -34.99 73.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.348 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.0 tp -61.12 -46.75 89.29 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.068 0.461 . . . . 0.0 110.375 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.46 -160.71 33.42 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -140.53 23.38 2.31 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.654 0.264 . . . . 0.0 110.835 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -63.66 -42.82 98.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.983 0.42 . . . . 0.0 110.237 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.7 mt -92.8 175.8 6.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.965 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.468 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -72.87 161.33 30.84 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.672 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -91.69 -22.5 20.2 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.945 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -87.88 -25.35 23.31 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.167 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.637 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.44 -61.19 0.46 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.114 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.637 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 20.4 m -67.4 -40.21 84.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.492 ' N ' HG23 ' A' ' 121' ' ' VAL . 81.2 m-20 -56.76 -47.1 80.86 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.51 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -86.0 -40.3 15.95 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.6 tmm? -59.52 -46.49 88.69 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.061 0.458 . . . . 0.0 109.954 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 125' ' ' ILE . 91.3 mt -69.2 -16.49 20.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.409 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -78.62 -50.61 11.19 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 119.397 -0.921 . . . . 0.0 112.09 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' ASP . 42.4 tp10 -87.64 -67.47 0.82 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.897 -178.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.37 -26.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.784 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' GLU . 25.4 t0 -88.02 128.32 35.4 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.092 0.472 . . . . 0.0 111.073 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.666 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.51 -43.42 90.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.404 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -65.35 -40.28 93.41 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.122 0.487 . . . . 0.0 110.164 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.3 -1.98 58.67 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.334 -1.107 . . . . 0.0 110.334 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 134' ' ' GLY . 55.3 p-10 -89.53 -8.96 51.66 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 57.44 115.43 0.01 OUTLIER Glycine 0 CA--C 1.522 0.525 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.229 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 20.3 pt20 -160.62 133.59 6.5 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.4 t -123.45 136.92 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.066 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -151.36 172.5 15.82 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.221 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -54.8 -46.82 74.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.152 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 139' ' ' GLU . 55.5 mp0 -58.65 -44.32 90.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.71 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 93.3 mt-10 -72.09 -29.34 64.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.763 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.9 -43.99 77.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.587 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 94.7 t -59.1 -46.32 91.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.301 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.33 -29.13 66.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.136 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.7 ttp -59.69 -42.87 93.91 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.841 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.48 138.81 50.64 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.913 0.387 . . . . 0.0 110.754 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 80.8 m -163.19 77.73 0.43 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.664 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.19 -27.74 68.9 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.414 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.86 -1.067 . . . . 0.0 110.625 -179.853 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.163 0 CA-C-O 120.81 0.338 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -54.33 -42.25 69.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.044 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -67.78 -41.79 82.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.381 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -62.57 -43.76 98.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.956 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -67.2 -35.77 80.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.398 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.51 -24.17 66.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.768 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -55.4 -46.5 76.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.777 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.4 m -80.68 -19.41 45.26 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.808 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.18 -41.95 96.89 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.019 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.421 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.2 m-85 -58.84 -46.13 88.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.852 0.358 . . . . 0.0 111.107 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.3 t0 -79.58 -13.47 59.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.461 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -43.02 -32.77 0.71 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.867 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' CG ' ' OE2' ' A' ' 31' ' ' GLU . 10.9 p-10 -52.91 -45.13 67.44 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.49 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.433 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . -149.66 -151.26 5.46 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 21.3 p-10 -71.2 -46.86 60.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.712 0.292 . . . . 0.0 111.005 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.03 107.39 0.28 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.595 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.8 m -166.59 136.22 3.09 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.191 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 27' ' ' ILE . 1.9 mp -110.58 118.27 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.464 HG22 HG22 ' A' ' 62' ' ' THR . 2.0 p -134.73 167.08 21.5 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.881 0.372 . . . . 0.0 110.285 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.536 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.3 p -64.13 -33.65 76.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.283 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -62.56 -40.16 95.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.707 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.457 ' OE2' ' O ' ' A' ' 26' ' ' THR . 88.9 mt-10 -64.68 -48.51 74.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.366 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.8 tp -64.42 -43.75 93.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.252 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.31 -24.69 17.01 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -64.08 -41.04 97.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.851 0.358 . . . . 0.0 110.151 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.04 -22.47 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.207 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.6 mmm -48.78 -33.56 10.6 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.969 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -64.3 -45.5 87.69 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 118.163 -1.415 . . . . 0.0 110.272 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.3 p -59.0 -30.65 68.14 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.356 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 41' ' ' GLN . 9.3 mt -102.33 5.47 39.89 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.966 0.412 . . . . 0.0 110.443 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.27 -69.79 0.03 OUTLIER Glycine 0 N--CA 1.465 0.588 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 39' ' ' LEU . 85.7 mt-30 -143.25 116.29 8.88 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.1 t30 -132.66 69.75 79.45 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.906 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 46' ' ' ALA . 92.0 Cg_exo -33.1 -33.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 122.527 2.151 . . . . 0.0 112.49 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 42' ' ' ASN . 12.4 m -38.99 -29.35 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.476 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 43' ' ' PRO . 90.6 mt-10 -87.65 -35.22 18.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.463 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -61.26 -49.17 78.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.027 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.434 ' HB2' HG23 ' A' ' 117' ' ' THR . 3.1 tm-20 -68.03 -48.61 65.18 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.403 0.621 . . . . 0.0 109.889 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.515 HD22 ' CE ' ' A' ' 51' ' ' MET . 87.4 mt -62.62 -22.75 66.64 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.018 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.536 HE22 ' CB ' ' A' ' 29' ' ' THR . 47.9 tp60 -40.21 -49.58 2.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 110.532 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.69 -39.8 73.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.472 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.515 ' CE ' HD22 ' A' ' 48' ' ' LEU . 36.1 ttp -61.54 -40.59 95.23 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.765 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.78 -46.93 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.658 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.653 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 28.3 m120 -65.17 -39.84 93.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.333 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -58.08 -57.23 13.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.434 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 p -68.31 -32.83 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.936 0.398 . . . . 0.0 110.964 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.0 t0 -86.08 -13.03 48.51 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.812 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.653 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.04 15.42 0.16 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.056 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 56' ' ' ASP . 38.7 p-10 -66.66 -23.55 66.16 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.39 -22.56 0.03 OUTLIER Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.588 ' C ' ' H ' ' A' ' 62' ' ' THR . 4.6 p30 179.31 146.55 0.19 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.76 33.71 0.18 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.588 ' H ' ' C ' ' A' ' 60' ' ' ASN . 80.6 p -132.15 143.93 50.33 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.88 135.12 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.057 0.456 . . . . 0.0 110.175 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.42 172.34 4.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.441 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.438 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -72.53 -49.59 8.56 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.761 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 53.2 Cg_exo -52.07 -43.26 53.95 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.87 1.714 . . . . 0.0 111.902 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.46 -37.43 77.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 110.867 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -60.42 -45.38 93.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.962 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.9 mt -62.39 -44.57 96.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.523 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.5 m -67.45 -45.43 76.03 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 111.242 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.4 ttp -61.17 -43.69 98.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.928 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 87.0 mmm -64.75 -39.36 93.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.206 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.435 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.89 -42.83 94.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.89 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -71.52 -41.78 68.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.237 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -64.76 -40.92 96.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.86 0.362 . . . . 0.0 110.422 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.435 ' O ' ' O ' ' A' ' 73' ' ' ALA . 14.2 mmt -95.21 129.82 42.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.129 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -86.84 142.8 27.8 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -50.35 168.77 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.425 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.0 p -75.15 -15.21 60.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.683 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.98 -16.5 64.08 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.908 0.385 . . . . 0.0 110.439 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 82' ' ' GLU . 1.1 m -60.41 -23.76 64.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.759 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 81' ' ' SER . 81.2 tt0 -36.75 -48.49 0.73 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.893 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -70.76 -43.52 68.62 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.262 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -63.88 -39.59 94.55 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.961 0.41 . . . . 0.0 110.025 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.5 mt -66.95 -21.92 28.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.287 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -57.97 -43.6 86.58 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 119.047 -1.061 . . . . 0.0 110.063 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -63.74 -34.76 78.61 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.846 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.8 -19.91 66.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.056 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -56.57 -48.75 76.7 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.261 0.553 . . . . 0.0 110.848 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -68.29 -44.71 74.86 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.462 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.7 t -66.3 -48.37 81.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.443 ' CE2' HD12 ' A' ' 100' ' ' ILE . 23.4 t80 -64.01 -47.11 81.58 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.654 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.405 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 18.4 t70 -120.35 100.14 6.99 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -66.74 -39.75 88.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.745 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' ASN . 2.0 p-10 -65.66 -40.59 92.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.102 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.62 -59.49 0.48 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 95' ' ' ASP . 54.0 m-80 -61.88 -17.44 56.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.986 0.422 . . . . 0.0 110.2 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.405 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.56 160.91 12.96 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -113.23 155.56 24.85 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.443 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -95.74 118.25 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.966 0.412 . . . . 0.0 111.12 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.9 p -85.53 171.38 11.78 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.89 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.74 -35.73 78.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.551 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.5 -50.78 72.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.158 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -69.29 -37.36 77.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.922 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.03 -39.4 94.62 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.538 0.685 . . . . 0.0 111.07 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -54.22 -43.62 70.98 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.121 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -63.1 -39.49 94.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.3 t -61.82 -45.26 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.151 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 37.7 mmm -64.31 -37.94 89.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.562 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.0 m -60.58 -40.16 90.73 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -61.25 -38.12 85.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.204 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 tp -61.53 -44.09 97.69 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.907 0.385 . . . . 0.0 110.25 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.98 -154.71 25.68 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -139.02 23.35 2.6 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.722 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -62.66 -43.22 99.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 0.0 110.314 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.9 mt -99.95 169.07 9.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.525 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.493 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -68.35 162.17 25.85 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.556 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -92.15 -22.28 19.94 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.434 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -87.26 -24.47 24.36 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.58 -66.06 0.21 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.254 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.626 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.7 m -65.19 -35.28 75.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.363 -178.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -60.51 -46.75 88.98 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.54 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -84.87 -40.4 17.12 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.3 tmm? -58.91 -47.21 85.79 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 125' ' ' ILE . 94.2 mt -69.16 -18.37 22.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.553 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -77.4 -51.39 10.89 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.274 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 129' ' ' ASP . 34.9 tp10 -86.31 -68.67 0.72 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.341 -0.943 . . . . 0.0 111.456 -177.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.69 -21.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.877 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 127' ' ' GLU . 38.7 t0 -90.14 125.02 35.3 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.07 0.462 . . . . 0.0 110.657 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.643 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.46 -32.09 56.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.018 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -72.19 -45.8 58.9 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.907 0.384 . . . . 0.0 110.347 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.68 -5.47 61.16 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 134' ' ' GLY . 35.2 p30 -89.94 -9.67 47.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.962 0.411 . . . . 0.0 109.934 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 58.22 117.93 0.01 OUTLIER Glycine 0 CA--C 1.519 0.294 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 8.2 pt20 -159.76 140.11 11.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.53 -0.335 . . . . 0.0 110.137 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.7 t -126.23 133.24 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.915 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.544 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.8 t30 -150.69 175.39 12.0 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.337 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -57.67 -52.1 66.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.761 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.544 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 57.2 mp0 -55.93 -35.02 66.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.668 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 79.4 mt-10 -69.55 -39.25 77.53 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.694 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -61.26 -45.33 94.97 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.753 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.1 t -58.01 -45.9 87.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -74.2 -30.84 62.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.413 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.4 ttp -60.08 -40.62 90.21 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.621 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 72.9 mtm -105.21 141.73 36.24 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.921 0.391 . . . . 0.0 110.589 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.1 m -167.3 72.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.119 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.58 -41.83 97.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.587 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 C--O 1.218 -0.561 0 CA-C-O 118.066 -0.968 . . . . 0.0 110.269 -179.89 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.065 0 CA-C-O 120.394 0.14 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -54.83 -50.58 68.24 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.997 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -63.74 -44.06 94.63 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.772 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -62.57 -45.94 90.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.484 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -69.69 -35.84 75.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.959 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -63.08 -37.79 88.59 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.492 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -58.47 -46.27 86.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.522 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -80.92 -18.82 45.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.735 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.49 -43.14 98.13 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.746 0.308 . . . . 0.0 111.283 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 83.0 m-85 -57.97 -49.27 77.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.586 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 6.3 t0 -73.15 -13.4 61.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.756 0.313 . . . . 0.0 111.27 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -44.49 -33.52 1.75 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.761 0.315 . . . . 0.0 110.959 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.414 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 7.2 p-10 -53.98 -45.69 71.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.86 0.362 . . . . 0.0 110.946 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.443 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . -149.01 -150.86 5.32 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 25.1 p-10 -70.2 -47.37 61.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.948 0.404 . . . . 0.0 111.006 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.527 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.81 107.81 0.3 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.444 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 6.2 m -166.21 139.46 4.09 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.139 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.2 mp -120.63 110.51 28.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.552 ' CG2' HG22 ' A' ' 62' ' ' THR . 2.8 p -130.95 169.38 15.88 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.025 0.44 . . . . 0.0 110.566 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.421 HG22 HG21 ' A' ' 52' ' ' ILE . 51.2 p -63.07 -31.43 72.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.394 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -62.11 -42.35 99.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.99 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 26' ' ' THR . 81.5 mt-10 -66.74 -45.84 77.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.004 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.9 tp -63.93 -42.9 97.24 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.396 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.76 -25.11 28.42 Favored Glycine 0 C--O 1.226 -0.36 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.0 m -63.96 -44.1 93.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.934 0.397 . . . . 0.0 110.796 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.3 t -55.54 -20.49 7.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.527 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.509 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 87.4 mmm -48.9 -34.89 13.62 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.625 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -63.12 -46.4 87.5 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 118.005 -1.478 . . . . 0.0 111.851 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.0 p -60.75 -30.89 70.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 41' ' ' GLN . 24.9 mt -96.75 2.13 51.62 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.974 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.92 -67.94 0.02 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.532 ' N ' ' O ' ' A' ' 39' ' ' LEU . 86.1 mt-30 -143.59 110.07 5.47 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -123.72 75.03 55.56 Favored Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.461 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.577 ' O ' ' N ' ' A' ' 46' ' ' ALA . 99.5 Cg_exo -36.45 -35.69 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.732 1.621 . . . . 0.0 112.13 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.421 ' N ' ' HB3' ' A' ' 120' ' ' GLU . 5.9 m -37.83 -31.49 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.763 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.509 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.2 mt-10 -87.35 -36.03 18.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.316 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.47 -51.97 67.6 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.866 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -68.39 -47.21 67.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.304 0.573 . . . . 0.0 109.958 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.51 HD22 ' CE ' ' A' ' 51' ' ' MET . 84.7 mt -64.09 -26.81 68.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.917 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 48' ' ' LEU . 8.3 tp-100 -38.82 -46.35 1.27 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.751 0.31 . . . . 0.0 110.566 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.17 -41.69 66.74 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.54 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.51 ' CE ' HD22 ' A' ' 48' ' ' LEU . 40.0 ttp -62.14 -41.73 98.55 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.076 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.421 HG21 HG22 ' A' ' 29' ' ' THR . 96.6 mt -60.92 -51.99 66.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.39 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.625 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 85.8 m-20 -64.29 -40.03 95.13 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.71 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -55.61 -59.58 4.65 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.259 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.79 -34.43 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.99 0.424 . . . . 0.0 110.762 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 62' ' ' THR . 55.3 t0 -80.73 -13.59 58.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.533 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.13 16.11 0.14 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.274 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 56' ' ' ASP . 21.5 p-10 -66.07 -24.61 66.75 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -154.54 -25.55 0.04 OUTLIER Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.604 ' C ' ' H ' ' A' ' 62' ' ' THR . 10.9 p30 179.96 150.84 0.39 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.403 ' C ' ' OD2' ' A' ' 56' ' ' ASP . . . -65.48 32.45 0.12 Allowed Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.604 ' H ' ' C ' ' A' ' 60' ' ' ASN . 66.5 p -130.39 148.91 52.26 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.0 mt -118.5 133.86 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.987 0.423 . . . . 0.0 110.514 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.32 169.08 18.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.475 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.436 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -67.29 -49.52 43.37 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.191 -179.027 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.8 Cg_exo -52.08 -45.31 39.77 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.995 1.797 . . . . 0.0 111.898 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.96 -37.02 72.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.694 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -60.69 -46.37 90.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.964 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.3 mt -62.22 -44.37 96.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.857 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.1 m -65.15 -44.63 87.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.904 0.383 . . . . 0.0 110.304 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 44.9 ttp -62.07 -41.83 98.57 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.853 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 76' ' ' MET . 60.3 mmm -63.35 -40.86 98.43 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.585 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.0 -35.84 77.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.739 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -87.71 -56.27 3.42 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.735 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -63.13 -43.31 98.74 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.123 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 72' ' ' MET . 50.8 mmm -108.88 131.51 54.94 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.863 0.363 . . . . 0.0 110.214 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 78' ' ' ASP . 29.0 tptt -83.12 150.07 26.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.764 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 77' ' ' LYS . 5.7 m-20 -55.51 -159.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.421 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.8 p -96.19 -0.27 50.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.916 0.388 . . . . 0.0 110.499 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -82.87 2.48 34.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.119 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 83' ' ' GLU . 1.6 m -62.09 -35.6 79.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.959 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -37.99 -29.61 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.861 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 81' ' ' SER . 71.5 mm-40 -74.17 -56.87 4.39 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -64.71 -38.73 91.99 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.154 0.502 . . . . 0.0 109.656 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.7 -19.29 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.482 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.1 ttt-85 -57.69 -44.01 85.54 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.171 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -65.9 -33.02 74.87 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.785 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -63.0 -27.96 69.78 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -55.63 -46.0 77.47 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.38 0.609 . . . . 0.0 110.405 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -74.42 -51.08 15.97 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.757 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.21 -47.79 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.04 0.448 . . . . 0.0 110.553 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.473 ' CE2' HD12 ' A' ' 100' ' ' ILE . 39.2 t80 -63.5 -45.83 88.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.239 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.48 ' OD2' ' N ' ' A' ' 96' ' ' GLY . 36.0 t70 -127.16 105.08 8.33 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.586 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -68.55 -42.12 78.82 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.897 0.379 . . . . 0.0 111.059 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' A' ' 97' ' ' ASN . 1.5 p-10 -59.95 -46.62 88.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.846 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.48 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 73.77 -41.77 1.05 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.43 ' H ' ' C ' ' A' ' 95' ' ' ASP . 77.1 m-20 -80.24 -13.55 59.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.929 0.395 . . . . 0.0 110.046 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.94 161.28 12.8 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -113.29 149.82 33.35 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.7 0.286 . . . . 0.0 110.511 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.473 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -96.79 116.55 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.99 0.424 . . . . 0.0 111.191 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.9 p -84.39 170.76 13.24 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.3 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.57 -37.52 86.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.157 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.27 -47.16 84.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.978 0.418 . . . . 0.0 110.577 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.55 -35.99 75.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.495 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.6 tp -62.33 -40.15 95.41 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.63 0.728 . . . . 0.0 110.668 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -52.44 -45.02 65.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.649 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -61.64 -45.04 95.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.971 0.415 . . . . 0.0 110.396 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.9 t -63.91 -44.89 98.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.309 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 48.4 mmm -64.38 -37.12 86.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.514 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 83.1 m -61.04 -46.13 91.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -67.13 -24.54 65.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.216 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.1 tp -61.51 -44.89 96.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.893 0.378 . . . . 0.0 110.824 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.53 -148.79 15.54 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -140.36 25.84 2.21 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.502 0.192 . . . . 0.0 111.056 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -64.75 -45.34 86.84 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.979 0.418 . . . . 0.0 110.958 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.6 mt -113.54 170.67 8.07 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.943 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.48 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -69.51 161.54 29.32 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.014 0.435 . . . . 0.0 110.952 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -92.1 -23.93 19.29 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.805 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -88.06 -20.39 25.81 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.58 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.7 -67.39 0.16 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.58 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 18.0 m -64.53 -35.15 73.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -57.68 -66.46 0.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -64.35 -43.79 93.48 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.465 ' C ' ' SD ' ' A' ' 124' ' ' MET . 16.1 tmm? -57.31 -48.69 78.3 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.832 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.22 -23.78 30.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.219 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -77.08 -46.86 22.17 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.499 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -85.38 -68.28 0.74 Allowed 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.486 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.01 -33.3 0.08 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.503 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -94.72 146.77 23.94 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.819 0.342 . . . . 0.0 110.702 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.662 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -89.41 -17.37 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -65.46 -44.48 87.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.055 0.455 . . . . 0.0 110.531 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.37 -11.01 5.61 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 41.3 p-10 -89.12 -19.39 25.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.87 0.367 . . . . 0.0 110.483 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.549 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 55.36 106.24 0.01 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.477 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 11.1 pt20 -140.15 134.7 31.6 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.7 t -116.93 132.04 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.007 0.432 . . . . 0.0 110.225 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -142.74 175.44 9.81 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.579 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -58.22 -45.83 86.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.147 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.481 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 54.0 mp0 -63.66 -36.92 85.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.407 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.477 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 78.3 mt-10 -67.09 -33.85 76.38 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.137 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -62.09 -40.55 96.2 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.466 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.0 t -57.18 -45.78 84.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.516 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -82.86 -15.82 50.02 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.838 0.351 . . . . 0.0 111.224 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 43.8 ttp -60.99 -41.05 95.73 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.882 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 78.2 mtm -118.49 141.72 48.29 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.779 0.323 . . . . 0.0 110.683 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 81.5 m -159.56 84.5 0.76 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.798 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.58 -40.51 73.23 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.186 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.912 -1.042 . . . . 0.0 110.5 -179.563 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.06 0 CA-C-O 120.64 0.257 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -44.0 -48.21 8.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.852 0.358 . . . . 0.0 110.699 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -66.0 -39.8 90.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.582 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -65.38 -48.15 73.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.216 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -64.12 -34.03 77.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.476 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.57 -19.93 11.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.541 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -57.38 -49.3 76.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.865 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.8 m -60.95 -40.82 94.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.56 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.55 -42.86 99.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.003 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -59.33 -49.9 76.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.804 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.466 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.6 t0 -75.88 -15.61 60.18 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.682 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -43.6 -33.2 1.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.818 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.437 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 14.4 p-10 -53.4 -43.44 67.92 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.485 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -145.62 -153.7 5.95 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 26.7 p-10 -74.79 -47.27 31.7 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.59 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.69 107.27 0.28 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.638 ' C ' HD12 ' A' ' 27' ' ' ILE . 8.4 m -166.7 149.93 6.86 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.128 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.638 HD12 ' C ' ' A' ' 26' ' ' THR . 2.8 mp -119.52 109.47 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.503 HG22 HG22 ' A' ' 62' ' ' THR . 4.1 p -130.91 169.71 15.41 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.896 0.379 . . . . 0.0 110.506 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.5 p -63.51 -29.56 70.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.173 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -62.11 -41.28 98.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.236 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.445 ' OE2' ' O ' ' A' ' 26' ' ' THR . 89.6 mt-10 -66.99 -45.74 76.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.0 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.1 tp -65.92 -44.52 84.93 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.382 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.91 -22.49 4.52 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.3 m -67.03 -30.15 70.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.789 0.328 . . . . 0.0 110.478 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.6 t -62.34 -22.96 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 94.9 mmm -56.05 -37.11 68.83 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 120.199 -0.601 . . . . 0.0 109.701 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -63.17 -44.2 96.12 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 116.806 -1.958 . . . . 0.0 110.114 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 91.7 p -60.48 -37.87 82.43 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.16 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.413 ' O ' ' N ' ' A' ' 41' ' ' GLN . 39.1 mt -94.74 5.05 53.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.302 0.572 . . . . 0.0 110.528 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.49 -67.62 0.26 Allowed Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 39' ' ' LEU . 84.1 mt-30 -147.86 104.99 3.63 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.431 ' O ' ' N ' ' A' ' 44' ' ' THR . 58.7 t30 -123.25 76.84 52.61 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.028 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' A' ' 46' ' ' ALA . 72.1 Cg_exo -36.74 -29.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.595 2.196 . . . . 0.0 112.603 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.437 ' N ' ' HB3' ' A' ' 120' ' ' GLU . 11.5 m -38.43 -31.93 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.418 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 49' ' ' GLN . 96.9 mt-10 -88.86 -36.14 16.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.117 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -55.08 -49.8 70.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.536 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -69.85 -49.21 54.69 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.174 0.511 . . . . 0.0 110.155 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.89 -21.35 65.94 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.663 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 45' ' ' GLU . 10.8 tp-100 -45.5 -47.47 14.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.221 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 68.1 t0 -70.85 -38.63 73.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.519 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.0 ttp -62.37 -42.78 99.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.914 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.411 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 87.5 mt -63.7 -46.22 95.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.488 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.667 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 87.3 m-20 -63.95 -41.86 97.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.6 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -59.27 -59.17 5.89 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.477 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.8 p -66.1 -31.74 55.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.754 0.312 . . . . 0.0 110.834 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.541 ' OD2' ' N ' ' A' ' 62' ' ' THR . 45.5 t0 -87.38 -12.58 45.89 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.69 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.28 13.06 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.07 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' A' ' 56' ' ' ASP . 16.8 p-10 -64.03 -33.83 76.63 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.44 -26.45 0.08 OUTLIER Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.594 ' C ' ' H ' ' A' ' 62' ' ' THR . 16.5 p30 -178.19 148.25 0.48 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.545 -0.327 . . . . 0.0 110.297 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.97 34.25 0.1 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.594 ' H ' ' C ' ' A' ' 60' ' ' ASN . 70.2 p -129.68 151.48 50.23 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.0 mt -119.59 134.15 64.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.82 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -77.05 -155.47 0.07 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.028 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.497 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -96.51 -47.89 0.24 Allowed Pre-proline 0 N--CA 1.469 0.496 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.824 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 42.9 Cg_exo -54.94 -36.01 91.01 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.107 1.872 . . . . 0.0 111.629 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -83.62 -28.66 28.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.795 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -59.44 -46.4 88.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.685 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.96 -43.5 95.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.854 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.9 m -63.64 -45.26 91.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.103 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 46.6 ttp -62.18 -44.41 96.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.806 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 47.8 mmm -63.38 -42.23 98.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.767 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.72 -48.66 80.81 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.768 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -71.04 -50.15 37.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.554 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -64.64 -41.78 95.9 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.396 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.505 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 32.1 mmm -121.21 127.0 51.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.197 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -82.69 153.12 25.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.672 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -52.5 -179.96 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.263 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.4 p -80.99 -9.69 59.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.641 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -65.97 -21.69 66.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.39 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.3 m -50.59 -32.2 18.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.423 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -38.23 -45.72 1.0 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.685 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -69.1 -46.63 67.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.17 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -65.07 -49.43 70.07 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.939 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.6 mt -56.42 -21.13 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -57.94 -44.95 87.27 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 118.386 -1.326 . . . . 0.0 109.652 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -66.07 -26.02 67.3 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.62 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.74 -14.16 58.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.122 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -56.61 -50.62 71.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.292 0.568 . . . . 0.0 111.137 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -63.39 -44.52 94.47 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.164 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.58 -45.64 88.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.581 -0.447 . . . . 0.0 109.866 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.429 ' CE2' ' CD1' ' A' ' 100' ' ' ILE . 19.1 t80 -62.54 -47.17 85.05 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.697 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 37.3 t0 -119.94 106.53 12.13 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.208 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -68.1 -44.32 76.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.072 0.463 . . . . 0.0 110.648 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.0 OUTLIER -62.26 -44.59 96.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.752 -179.351 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.1 -47.38 1.05 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -74.59 -14.43 60.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.016 0.436 . . . . 0.0 110.538 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.82 161.81 12.63 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -112.15 144.38 41.63 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.429 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 64.6 mt -74.95 129.49 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.861 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.6 p -83.09 168.79 16.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.293 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.88 97.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.857 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.11 -41.69 94.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.69 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -67.34 -37.33 83.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.084 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.2 tp -60.31 -43.17 96.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.192 0.52 . . . . 0.0 110.654 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -54.0 -40.76 67.26 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.789 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -59.05 -42.24 89.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.935 0.398 . . . . 0.0 109.987 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.02 -44.97 97.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.715 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 80.9 mmm -63.53 -35.47 80.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.562 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.3 m -61.21 -41.72 97.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.273 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -59.79 -39.15 83.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.663 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.1 tp -61.4 -44.33 97.33 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.534 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.77 -143.91 9.97 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -144.36 30.49 1.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.34 . . . . 0.0 110.775 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -62.85 -40.86 98.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.389 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.6 mt -105.19 165.93 10.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.788 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.486 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -65.16 161.58 18.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.877 0.37 . . . . 0.0 110.526 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.44 ' C ' ' OE1' ' A' ' 120' ' ' GLU . 83.8 m-20 -91.39 -20.25 22.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.851 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -89.34 -26.13 21.25 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.682 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -34.89 -65.17 0.23 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.565 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.682 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 31.0 m -68.65 -27.5 36.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 111.639 0.236 . . . . 0.0 111.639 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -63.21 -43.84 96.98 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.998 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -88.42 -41.02 13.07 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.47 ' C ' ' SD ' ' A' ' 124' ' ' MET . 15.0 tmm? -60.56 -42.72 97.19 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.858 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 125' ' ' ILE . 96.6 mt -70.02 -15.82 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -87.17 -66.76 0.88 Allowed 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.975 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -70.96 -68.53 0.43 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.949 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 124' ' ' MET . . . -37.3 -40.01 0.32 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.675 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -88.42 124.66 34.17 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.078 0.466 . . . . 0.0 110.466 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -72.25 -16.05 18.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.239 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 133' ' ' ASP . 51.0 m-20 -65.33 -45.65 83.4 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.994 0.426 . . . . 0.0 110.664 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.1 -11.56 2.67 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 42.0 p30 -88.45 -17.39 30.49 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.067 0.46 . . . . 0.0 110.14 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 58.33 120.7 0.01 OUTLIER Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.443 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 10.4 pt20 -160.97 137.87 8.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.711 0.291 . . . . 0.0 110.282 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.2 t -125.58 134.24 67.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.834 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.472 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.3 t30 -148.99 159.64 44.03 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.232 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -40.13 -35.34 0.38 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.289 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.472 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 53.0 mp0 -65.81 -42.29 90.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.177 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 80.2 mt-10 -71.75 -30.27 65.41 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.524 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -58.52 -45.5 88.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.21 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.3 -48.16 89.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.862 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -70.07 -32.15 70.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.778 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 37.6 ttp -56.62 -47.71 79.08 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.722 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 69.7 mtm -106.09 134.1 49.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 110.658 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 88.8 m -160.1 81.58 0.7 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.351 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 76' ' ' MET . . . -65.79 -40.62 92.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.939 0.399 . . . . 0.0 110.607 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.632 -179.972 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.134 0 N-CA-C 111.482 0.178 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -41.25 -45.78 3.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.851 0.358 . . . . 0.0 110.963 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -66.78 -39.62 87.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.795 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -62.76 -43.22 99.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.484 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.06 -40.82 91.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.752 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.78 -20.42 49.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.652 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -49.36 -47.95 47.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.817 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.3 m -77.72 -20.36 53.66 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.019 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.6 tp -64.04 -40.69 96.87 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.837 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.468 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 76.3 m-85 -57.69 -45.41 85.7 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.354 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 9.7 t0 -86.16 -20.35 28.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -44.06 -33.17 1.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.806 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.41 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 4.5 p-10 -56.0 -46.14 78.81 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 110.82 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -140.25 -152.61 5.85 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 28.2 p-10 -74.4 -47.09 36.1 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.728 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.71 107.09 0.28 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 178.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 6.3 m -166.44 148.82 6.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.199 0.499 . . . . 0.0 111.436 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.73 74.02 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.504 HG22 HG22 ' A' ' 62' ' ' THR . 9.7 p -86.96 166.18 15.3 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.541 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -66.31 -28.55 68.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.961 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -61.91 -40.21 94.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.925 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.468 ' OE1' ' O ' ' A' ' 19' ' ' PHE . 86.7 mt-10 -66.76 -40.47 88.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.959 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.7 tp -62.8 -43.54 98.54 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.63 -33.22 47.94 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 m -64.58 -44.62 90.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.91 0.355 . . . . 0.0 110.857 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.4 t -55.95 -17.34 3.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.113 0.483 . . . . 0.0 110.287 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.545 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 88.9 mmm -52.72 -40.81 63.38 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.733 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.2 ttt85 -64.27 -46.01 85.57 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 118.202 -1.399 . . . . 0.0 110.2 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.8 p -64.3 -19.23 65.29 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.63 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.812 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 36.4 mt -94.41 6.6 48.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.682 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 43.75 78.67 0.07 OUTLIER Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 40' ' ' GLY . 85.7 mt-30 52.76 117.23 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.852 0.358 . . . . 0.0 110.723 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' A' ' 44' ' ' THR . 35.2 t-20 -148.85 68.76 9.84 Favored Pre-proline 0 C--O 1.235 0.303 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.657 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.582 ' O ' ' N ' ' A' ' 46' ' ' ALA . 86.7 Cg_exo -35.85 -31.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 122.533 2.156 . . . . 0.0 111.983 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.449 ' N ' ' O ' ' A' ' 42' ' ' ASN . 29.5 m -38.58 -27.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.299 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.545 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 87.7 mt-10 -89.52 -32.44 17.17 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.848 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.33 -51.88 67.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.994 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.456 ' HB2' HG23 ' A' ' 117' ' ' THR . 2.2 tm-20 -67.5 -46.06 73.99 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.192 0.52 . . . . 0.0 109.661 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 44' ' ' THR . 96.8 mt -63.6 -27.6 69.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.403 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -39.51 -53.66 2.04 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.811 0.339 . . . . 0.0 110.85 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -65.9 -38.26 88.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.24 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.5 ttp -62.33 -40.18 95.51 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 97.8 mt -62.04 -46.42 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.649 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 9.4 m120 -62.38 -42.43 99.41 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.666 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.68 -55.66 31.57 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.119 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.87 -34.88 62.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.891 0.377 . . . . 0.0 111.065 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.531 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.9 t0 -82.92 -13.43 56.09 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.408 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.12 9.0 1.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.778 0.323 . . . . 0.0 110.154 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 12.6 p30 -61.56 -25.18 67.15 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.484 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -157.83 -19.97 0.03 OUTLIER Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.623 ' C ' ' H ' ' A' ' 62' ' ' THR . 5.1 p30 177.08 141.82 0.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.72 32.25 0.08 OUTLIER Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.623 ' H ' ' C ' ' A' ' 60' ' ' ASN . 64.0 p -130.29 150.08 51.69 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-O 121.002 0.43 . . . . 0.0 110.273 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.3 mt -116.98 138.93 46.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.144 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.53 166.14 19.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.444 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.429 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -62.95 -50.52 76.59 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.761 -179.119 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.4 Cg_exo -50.92 -44.88 39.32 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.994 1.796 . . . . 0.0 111.778 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.95 -36.32 72.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.977 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -60.03 -45.85 91.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.224 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.08 -44.5 95.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.625 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.5 m -67.4 -44.45 78.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.194 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.0 ttp -61.42 -40.13 93.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.05 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 76.3 mmm -63.01 -38.6 91.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.848 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.07 96.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.02 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -68.43 -45.55 72.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.11 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.59 -41.78 83.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.924 0.393 . . . . 0.0 110.366 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.8 mmt -86.92 164.47 16.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.086 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -116.24 153.61 31.58 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.004 0.43 . . . . 0.0 110.145 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -59.29 160.46 6.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.26 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.4 p -64.17 -30.06 71.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.546 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.43 -10.05 22.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.206 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -57.04 -32.85 66.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.513 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -49.43 -50.23 41.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.735 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.02 -41.92 94.88 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.005 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -66.27 -45.74 79.45 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.476 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.3 mt -64.9 -20.59 27.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -59.74 -42.18 92.61 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 119.079 -1.048 . . . . 0.0 110.184 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -61.46 -35.88 78.87 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.496 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.18 -13.39 60.45 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -48.02 -51.05 25.59 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.981 0.419 . . . . 0.0 111.41 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -59.78 -46.86 87.89 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.784 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.86 -44.35 81.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.991 0.424 . . . . 0.0 110.451 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -59.46 -44.41 92.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.567 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.435 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 33.0 t70 -138.82 100.73 4.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.24 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.1 -39.96 82.71 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.175 0.512 . . . . 0.0 110.164 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.435 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.2 p-10 -60.22 -42.54 95.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.291 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.71 -56.99 0.51 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -70.78 -13.59 62.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.146 0.498 . . . . 0.0 110.28 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.66 161.12 12.86 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -115.0 150.89 35.13 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.7 mt -85.19 123.18 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.025 0.44 . . . . 0.0 110.343 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.2 p -80.02 168.14 19.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.026 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.48 82.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.62 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.21 -45.3 93.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.056 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.97 -37.68 75.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.251 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.7 tp -61.94 -42.96 99.7 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.263 0.554 . . . . 0.0 111.257 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -52.56 -43.25 65.1 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.012 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -55.4 -42.75 74.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.199 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.63 -42.43 95.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.279 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 58.3 mmm -57.56 -34.78 69.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.476 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 80.3 m -60.19 -42.34 94.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.458 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -58.6 -38.73 78.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.9 tp -61.29 -46.35 90.71 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.025 0.44 . . . . 0.0 110.117 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.85 -154.89 25.97 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.237 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -143.24 11.8 1.75 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.737 -0.231 . . . . 0.0 110.76 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -63.92 -44.01 94.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.102 0.477 . . . . 0.0 110.631 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.6 mt -79.75 160.29 26.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.978 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.48 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.6 OUTLIER -68.5 161.69 27.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.273 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -92.33 -21.03 20.5 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.098 0.475 . . . . 0.0 110.45 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -85.45 -26.93 26.03 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.24 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.613 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.59 -63.55 0.35 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.863 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.613 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 11.3 m -69.09 -31.32 49.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 121.236 -0.185 . . . . 0.0 111.497 -178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -58.94 -67.08 0.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.717 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.58 -45.15 72.79 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.517 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 13.3 tmm? -52.91 -50.3 64.2 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 125' ' ' ILE . 95.9 mt -64.62 -18.38 23.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.653 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -87.92 -57.88 2.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.297 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 128' ' ' ALA . 51.1 tp10 -81.92 -67.78 0.75 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.236 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.812 ' HB2' ' O ' ' A' ' 39' ' ' LEU . . . -36.78 -35.65 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 56.6 t0 -87.69 146.18 25.81 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.298 0.57 . . . . 0.0 110.519 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.567 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -89.39 -14.94 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.783 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 133' ' ' ASP . 44.8 m-20 -73.59 -45.27 54.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.016 0.436 . . . . 0.0 110.4 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.29 -10.29 3.65 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 131' ' ' ASP . 35.3 p30 -89.84 -10.42 45.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.233 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 62.28 122.93 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -161.7 119.61 2.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.859 0.362 . . . . 0.0 110.073 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.61 128.9 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.13 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.526 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 45.3 t30 -155.08 166.32 33.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.063 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.402 ' O ' ' CD1' ' A' ' 138' ' ' TYR . 2.6 t80 -48.82 -23.06 0.95 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.415 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 50.0 mp0 -66.4 -35.74 81.09 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.153 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -84.97 -20.83 29.97 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.582 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -61.94 -46.84 87.56 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.102 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 29.5 t -58.22 -45.95 88.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.105 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -71.4 -36.07 71.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.332 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 61.4 ttp -58.09 -43.03 86.83 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.128 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 70.6 mtm -112.76 129.28 56.48 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.84 0.353 . . . . 0.0 110.377 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 m -162.81 85.8 0.55 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.047 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.13 -43.93 93.75 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.645 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.55 179.846 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.574 0.226 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -54.68 -48.25 72.62 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.538 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -65.7 -40.81 92.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -61.95 -44.08 97.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.67 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -67.06 -37.51 84.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.01 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.481 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.02 -27.92 65.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.826 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -57.81 -46.91 83.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.537 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.7 m -77.92 -21.51 51.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.68 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.4 -42.76 99.68 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.436 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.481 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.1 m-85 -60.2 -50.96 71.61 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.478 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.1 t0 -76.93 -14.35 59.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.912 0.387 . . . . 0.0 111.335 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -45.59 -32.68 2.44 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.84 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 8.8 p-10 -53.72 -46.08 70.7 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.57 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -144.36 -151.58 5.47 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 30.8 p-10 -72.97 -47.25 47.01 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.09 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.72 107.36 0.28 Allowed Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 178.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.426 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 4.7 m -166.59 139.32 3.76 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.129 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 27' ' ' ILE . 5.2 mp -115.04 109.19 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.594 HG22 HG22 ' A' ' 62' ' ' THR . 2.6 p -128.68 170.31 13.43 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.847 0.356 . . . . 0.0 110.418 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.659 ' HB ' HE22 ' A' ' 49' ' ' GLN . 68.2 p -64.69 -33.12 75.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.805 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -61.62 -41.4 97.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.053 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 26' ' ' THR . 90.0 mt-10 -63.41 -45.69 89.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.915 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.1 tp -64.13 -43.36 95.5 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.113 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.77 -26.1 53.24 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.1 m -63.87 -41.46 97.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.85 0.357 . . . . 0.0 110.071 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.1 t -56.28 -23.52 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.352 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.48 ' O ' ' N ' ' A' ' 40' ' ' GLY . 62.1 mmm -48.17 -30.21 4.42 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.679 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -64.41 -45.65 86.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.003 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.1 p -63.91 -21.99 66.72 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.856 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 41' ' ' GLN . 16.8 mt -107.7 3.68 24.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.094 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.15 -71.19 0.02 OUTLIER Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 39' ' ' LEU . 87.8 mt-30 -145.46 109.44 4.83 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 44' ' ' THR . 41.4 t30 -125.58 70.88 65.34 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.149 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 46' ' ' ALA . 85.4 Cg_exo -32.92 -30.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 122.66 2.24 . . . . 0.0 112.785 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.542 ' N ' ' O ' ' A' ' 42' ' ' ASN . 26.2 m -39.27 -30.15 0.05 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.522 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.418 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.9 mt-10 -86.7 -34.86 19.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.27 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -59.12 -50.08 75.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.779 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.13 -46.15 71.65 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.166 0.508 . . . . 0.0 109.655 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 51' ' ' MET . 84.5 mt -64.79 -31.15 72.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.359 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.659 HE22 ' HB ' ' A' ' 29' ' ' THR . 8.7 tp-100 -37.47 -51.3 1.13 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.72 0.295 . . . . 0.0 110.838 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.25 -40.35 90.14 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.27 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.463 ' N ' ' O ' ' A' ' 48' ' ' LEU . 33.1 ttp -62.45 -40.95 98.27 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.0 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 83.5 mt -62.04 -49.88 82.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.145 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.602 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 89.8 m-20 -63.0 -40.38 97.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.585 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -55.19 -61.54 2.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.193 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.9 -30.12 43.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.779 0.323 . . . . 0.0 111.285 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 62' ' ' THR . 50.6 t0 -84.68 -13.21 52.11 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.528 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -71.97 13.0 0.33 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.868 0.366 . . . . 0.0 110.295 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.7 p30 -65.57 -28.86 69.45 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.539 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -150.55 -22.4 0.06 OUTLIER Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.557 ' C ' ' H ' ' A' ' 62' ' ' THR . 3.3 p30 173.13 151.88 0.08 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.99 34.76 0.14 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.594 HG22 HG22 ' A' ' 28' ' ' THR . 81.7 p -134.39 149.48 50.81 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.3 mt -121.02 134.52 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.14 162.44 28.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.416 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.471 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -64.65 -48.14 74.33 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.478 -179.096 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 50.3 Cg_exo -51.17 -37.36 58.49 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.171 1.914 . . . . 0.0 111.739 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -87.61 -22.3 24.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.35 -47.2 86.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.852 0.358 . . . . 0.0 111.028 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.5 -42.89 98.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.567 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.4 m -63.92 -46.11 86.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.668 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.7 ttp -61.76 -47.45 85.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.077 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 82.0 mmm -65.82 -37.79 87.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.271 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.62 -49.97 75.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.031 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -71.5 -43.76 65.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.196 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.72 -43.61 88.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.7 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 73' ' ' ALA . 22.3 mmm -104.31 127.46 51.96 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.07 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.7 tptt -84.97 141.11 30.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.931 0.396 . . . . 0.0 110.711 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 77' ' ' LYS . 95.0 m-20 -48.9 179.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.266 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.3 p -75.47 -6.77 51.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.456 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.47 -15.53 62.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.511 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.9 m -61.89 -19.91 63.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.527 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -48.2 -44.72 33.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.33 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.99 -39.49 79.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.894 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -65.89 -45.13 83.16 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.01 0.433 . . . . 0.0 110.197 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.3 mt -66.05 -19.09 25.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.494 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -58.43 -45.42 88.52 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 118.971 -1.092 . . . . 0.0 110.156 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.62 -31.79 73.01 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.923 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -72.08 -14.61 61.9 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.16 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -57.97 -48.98 78.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.328 0.585 . . . . 0.0 111.092 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -64.1 -45.57 88.05 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.358 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -76.2 -51.58 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 110.849 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.443 ' CE2' HD12 ' A' ' 100' ' ' ILE . 26.3 t80 -62.02 -47.17 85.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.625 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 18.2 t70 -108.98 94.24 4.94 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.29 -41.02 73.93 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 110.535 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 19.8 p-10 -62.52 -39.71 94.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.961 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.44 -67.29 0.97 Allowed Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.57 -16.56 63.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.009 0.433 . . . . 0.0 110.242 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.82 161.99 12.57 Favored Glycine 0 N--CA 1.465 0.575 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.28 155.33 24.24 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.775 0.321 . . . . 0.0 110.23 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.443 HD12 ' CE2' ' A' ' 92' ' ' PHE . 94.2 mt -79.66 125.99 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.974 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.4 p -82.39 168.94 17.0 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.128 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.51 -38.04 89.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.513 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.65 -47.3 84.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.916 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.67 -32.88 73.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.958 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.4 tp -61.52 -41.7 97.71 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.382 0.61 . . . . 0.0 110.706 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -56.43 -43.31 79.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.77 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -58.49 -41.88 86.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.3 t -66.68 -43.37 90.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.646 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.0 mmm -62.03 -35.59 79.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.642 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.2 m -61.09 -44.37 97.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.055 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -59.76 -35.0 73.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.378 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.0 tp -61.18 -46.73 89.28 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.081 0.467 . . . . 0.0 110.391 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.5 -160.71 33.43 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -140.53 23.35 2.31 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.603 0.24 . . . . 0.0 110.746 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -63.61 -42.79 98.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.962 0.41 . . . . 0.0 110.277 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.7 mt -92.88 175.8 6.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.972 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.467 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -72.85 161.29 30.9 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.668 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -91.66 -22.44 20.25 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.979 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -87.91 -25.32 23.29 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.174 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.639 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.41 -61.24 0.46 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.123 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.639 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 20.2 m -67.39 -40.21 84.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.509 ' N ' HG23 ' A' ' 121' ' ' VAL . 81.2 m-20 -56.73 -47.05 80.88 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.595 -178.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -86.03 -40.28 15.95 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.7 tmm? -59.56 -46.53 88.63 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.081 0.467 . . . . 0.0 109.914 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 125' ' ' ILE . 91.5 mt -69.1 -16.61 21.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.424 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -78.6 -50.51 11.38 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 119.394 -0.922 . . . . 0.0 112.148 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 129' ' ' ASP . 42.4 tp10 -87.69 -67.52 0.82 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.834 -178.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.33 -26.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.794 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 127' ' ' GLU . 25.4 t0 -87.95 128.26 35.37 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.058 0.456 . . . . 0.0 111.132 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.664 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.48 -43.38 90.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.457 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -65.35 -40.33 93.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.19 0.519 . . . . 0.0 110.178 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.33 -1.97 58.84 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' GLY . 55.2 p-10 -89.49 -8.98 51.73 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 57.38 115.48 0.01 OUTLIER Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 20.3 pt20 -160.64 133.64 6.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.2 t -123.47 136.89 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.081 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -151.35 172.49 15.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.243 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -54.86 -46.78 74.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.13 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 139' ' ' GLU . 55.2 mp0 -58.68 -44.36 90.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.657 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 93.4 mt-10 -72.0 -29.41 64.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.775 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.89 -43.98 77.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.586 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 94.1 t -59.16 -46.29 92.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.26 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.35 -29.09 66.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.124 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.8 ttp -59.7 -42.88 93.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.796 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.46 138.84 50.6 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.963 0.411 . . . . 0.0 110.731 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.2 m -163.24 77.72 0.43 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.661 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.16 -27.76 68.93 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.438 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 117.884 -1.055 . . . . 0.0 110.665 -179.864 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 120.776 0.322 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -54.18 -42.33 69.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.098 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -67.81 -41.71 82.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.375 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -62.63 -43.68 98.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.982 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -67.25 -35.75 80.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.437 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.414 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.49 -24.19 66.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.699 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -55.37 -46.51 76.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.79 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.3 m -80.65 -19.5 45.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.783 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.17 -41.96 96.92 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.052 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.425 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.3 m-85 -58.84 -46.1 88.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.871 0.367 . . . . 0.0 111.144 -178.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.448 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.3 t0 -79.57 -13.47 59.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.499 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -42.99 -32.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.915 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' CG ' ' OE2' ' A' ' 31' ' ' GLU . 10.9 p-10 -52.9 -45.13 67.41 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.481 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.436 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . -149.64 -151.21 5.44 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 21.2 p-10 -71.21 -46.9 60.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.685 0.278 . . . . 0.0 110.957 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.531 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.04 107.34 0.28 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.593 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.7 m -166.51 136.22 3.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.215 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.608 HD12 ' N ' ' A' ' 27' ' ' ILE . 1.9 mp -110.53 118.3 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.459 HG22 HG22 ' A' ' 62' ' ' THR . 2.0 p -134.76 167.05 21.56 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.897 0.38 . . . . 0.0 110.291 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.541 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.3 p -64.08 -33.69 76.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.31 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -62.57 -40.16 95.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.701 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.456 ' OE2' ' O ' ' A' ' 26' ' ' THR . 88.9 mt-10 -64.66 -48.56 74.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.313 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.38 -43.72 93.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.321 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.31 -24.72 17.09 Favored Glycine 0 C--O 1.224 -0.469 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -64.05 -40.99 97.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.873 0.368 . . . . 0.0 110.226 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.15 -22.37 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.205 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.6 mmm -48.87 -33.45 10.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.021 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -64.32 -45.47 87.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 118.152 -1.419 . . . . 0.0 110.278 -178.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.1 p -59.04 -30.67 68.2 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.301 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 41' ' ' GLN . 9.2 mt -102.3 5.45 39.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.974 0.416 . . . . 0.0 110.472 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.26 -69.79 0.03 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 39' ' ' LEU . 85.8 mt-30 -143.28 116.25 8.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.132 -0.534 . . . . 0.0 109.589 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.1 t30 -132.58 69.69 79.61 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.945 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.549 ' O ' ' N ' ' A' ' 46' ' ' ALA . 91.4 Cg_exo -33.0 -33.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 122.545 2.164 . . . . 0.0 112.476 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.477 ' N ' ' O ' ' A' ' 42' ' ' ASN . 12.7 m -39.07 -29.33 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.371 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 43' ' ' PRO . 90.6 mt-10 -87.67 -35.17 18.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.486 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -61.23 -49.22 78.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.998 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.433 ' HB2' HG23 ' A' ' 117' ' ' THR . 3.1 tm-20 -68.09 -48.48 65.39 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.397 0.617 . . . . 0.0 109.951 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.513 HD22 ' CE ' ' A' ' 51' ' ' MET . 87.3 mt -62.72 -22.68 66.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.009 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.541 HE22 ' CB ' ' A' ' 29' ' ' THR . 48.0 tp60 -40.27 -49.6 2.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.87 0.367 . . . . 0.0 110.475 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.64 -39.85 73.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.478 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.513 ' CE ' HD22 ' A' ' 48' ' ' LEU . 36.1 ttp -61.56 -40.55 95.11 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.743 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.82 -46.91 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.586 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.652 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 28.3 m120 -65.13 -39.91 93.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.358 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -58.03 -57.22 13.79 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.474 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 p -68.26 -32.85 57.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.923 0.392 . . . . 0.0 110.997 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.511 ' OD2' ' N ' ' A' ' 62' ' ' THR . 42.9 t0 -86.06 -13.08 48.43 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.805 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.06 15.43 0.16 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 56' ' ' ASP . 38.7 p-10 -66.74 -23.48 66.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.4 -22.61 0.03 OUTLIER Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.591 ' C ' ' H ' ' A' ' 62' ' ' THR . 4.6 p30 179.34 146.51 0.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.75 33.78 0.18 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.591 ' H ' ' C ' ' A' ' 60' ' ' ASN . 80.6 p -132.2 143.94 50.3 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.92 135.15 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.034 0.445 . . . . 0.0 110.191 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.38 172.4 4.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.456 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.436 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -72.6 -49.57 8.38 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.764 -179.612 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 53.2 Cg_exo -52.03 -43.31 53.41 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.885 1.723 . . . . 0.0 111.88 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.45 -37.46 77.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.846 0.355 . . . . 0.0 110.898 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -60.34 -45.4 93.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.926 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.0 mt -62.39 -44.62 96.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.503 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.6 m -67.4 -45.49 76.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.736 0.303 . . . . 0.0 111.231 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.4 ttp -61.09 -43.72 98.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.977 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 87.0 mmm -64.75 -39.35 93.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.223 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.91 -42.88 94.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.838 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -71.51 -41.7 68.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.279 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -64.74 -40.94 96.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.804 0.335 . . . . 0.0 110.436 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 73' ' ' ALA . 14.2 mmt -95.27 129.84 42.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.079 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -86.81 142.81 27.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -50.41 168.87 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.379 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.3 p -75.24 -15.21 60.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.645 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.98 -16.46 64.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.449 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.1 m -60.46 -23.7 64.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.758 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -36.75 -48.45 0.73 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.931 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -70.79 -43.54 68.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.247 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -63.78 -39.63 94.73 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.012 0.434 . . . . 0.0 110.085 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.6 mt -66.98 -21.89 28.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.231 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -57.96 -43.65 86.56 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.085 -1.046 . . . . 0.0 110.053 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -63.7 -34.74 78.54 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.889 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.83 -19.85 66.03 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.081 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -56.64 -48.8 76.74 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.253 0.549 . . . . 0.0 110.817 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -68.19 -44.69 75.29 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.471 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.9 t -66.34 -48.39 81.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.441 ' CE2' HD12 ' A' ' 100' ' ' ILE . 23.4 t80 -63.96 -47.19 81.38 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.632 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.408 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 18.4 t70 -120.32 100.17 7.01 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -66.71 -39.75 88.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.812 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 97' ' ' ASN . 2.0 p-10 -65.67 -40.6 92.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.104 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.62 -59.48 0.48 Allowed Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 95' ' ' ASP . 54.0 m-80 -61.86 -17.41 56.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.978 0.418 . . . . 0.0 110.201 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.408 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.58 160.91 12.96 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -113.33 155.55 24.98 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.441 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -95.77 118.22 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.04 0.448 . . . . 0.0 111.072 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.9 p -85.53 171.37 11.79 Favored 'General case' 0 C--N 1.335 -0.063 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.908 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.68 -35.76 78.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.572 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.43 -50.86 72.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.131 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.28 -37.37 77.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.919 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.06 -39.34 94.43 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.478 0.656 . . . . 0.0 111.089 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -54.18 -43.67 70.86 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.131 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -63.09 -39.49 94.87 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.85 -45.22 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.192 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 37.8 mmm -64.3 -38.05 89.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.483 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.8 m -60.57 -40.09 90.38 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -61.27 -38.11 85.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.175 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 tp -61.6 -44.07 97.68 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.868 0.366 . . . . 0.0 110.213 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.97 -154.78 25.78 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -138.97 23.42 2.6 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.577 -0.312 . . . . 0.0 110.728 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -62.67 -43.26 99.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.06 0.457 . . . . 0.0 110.309 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.9 mt -99.91 169.06 9.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.54 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.49 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -68.34 162.11 25.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.86 0.362 . . . . 0.0 110.51 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -92.14 -22.21 19.99 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.421 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -87.29 -24.47 24.33 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.625 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.65 -66.06 0.21 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.196 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.625 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.6 m -65.09 -35.31 75.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.416 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -60.47 -46.8 88.75 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.558 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -84.92 -40.34 17.13 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.4 tmm? -58.92 -47.22 85.8 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 125' ' ' ILE . 94.4 mt -69.18 -18.32 22.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.578 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -77.43 -51.37 10.89 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 119.044 -1.063 . . . . 0.0 111.307 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 129' ' ' ASP . 34.7 tp10 -86.32 -68.7 0.72 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.46 -177.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.64 -21.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 127' ' ' GLU . 38.7 t0 -90.16 125.06 35.33 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.139 0.495 . . . . 0.0 110.606 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.647 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.5 -31.99 56.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.052 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -72.16 -45.84 58.81 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.93 0.395 . . . . 0.0 110.362 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.63 -5.41 61.15 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 134' ' ' GLY . 35.3 p30 -89.95 -9.69 47.85 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 58.24 117.92 0.01 OUTLIER Glycine 0 CA--C 1.519 0.335 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 8.2 pt20 -159.73 140.13 11.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.161 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.5 t -126.25 133.35 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.544 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.9 t30 -150.74 175.34 12.07 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.323 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -57.69 -52.09 66.85 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.766 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.544 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 57.2 mp0 -55.88 -35.04 66.07 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.736 -178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 79.3 mt-10 -69.46 -39.31 77.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.712 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -61.21 -45.38 94.83 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.0 t -57.94 -46.0 87.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -74.12 -30.92 62.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.397 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.4 ttp -60.03 -40.66 90.12 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.623 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.403 ' O ' ' OG1' ' A' ' 146' ' ' THR . 72.9 mtm -105.18 141.69 36.28 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.888 0.375 . . . . 0.0 110.631 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 145' ' ' MET . 62.9 m -167.23 72.06 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.104 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.61 -41.79 97.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.561 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 C--O 1.218 -0.559 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.263 -179.906 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.149 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -41.28 -45.7 3.02 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.819 0.342 . . . . 0.0 110.949 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -66.88 -39.62 87.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.724 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -62.74 -43.19 99.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.508 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.06 -40.84 91.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.767 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.79 -20.41 49.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.617 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -49.42 -47.94 47.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.793 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.0 m -77.74 -20.35 53.61 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.994 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.9 tp -64.06 -40.67 96.8 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.785 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.47 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 76.2 m-85 -57.67 -45.47 85.52 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.354 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 9.8 t0 -86.06 -20.42 28.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -44.04 -33.18 1.37 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.794 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.409 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 4.5 p-10 -55.91 -46.16 78.5 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.88 0.371 . . . . 0.0 110.839 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -140.32 -152.62 5.84 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 28.1 p-10 -74.48 -46.99 35.99 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.711 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.73 107.08 0.28 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 6.3 m -166.46 148.77 6.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.178 0.489 . . . . 0.0 111.445 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.66 74.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.507 HG22 HG22 ' A' ' 62' ' ' THR . 9.7 p -86.93 166.16 15.33 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.998 0.428 . . . . 0.0 110.53 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -66.28 -28.62 68.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.972 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -61.89 -40.21 94.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.914 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.47 ' OE1' ' O ' ' A' ' 19' ' ' PHE . 86.7 mt-10 -66.73 -40.44 88.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.977 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.7 tp -62.82 -43.56 98.47 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.61 -33.2 47.83 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 m -64.58 -44.64 90.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.949 0.374 . . . . 0.0 110.865 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.3 t -55.9 -17.36 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.297 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.544 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 88.9 mmm -52.73 -40.8 63.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.709 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.1 ttt85 -64.23 -46.05 85.5 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 118.165 -1.414 . . . . 0.0 110.229 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.2 p -64.28 -19.24 65.27 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.657 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.81 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 36.4 mt -94.34 6.54 48.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.731 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 43.72 78.78 0.07 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.491 ' O ' ' O ' ' A' ' 40' ' ' GLY . 85.7 mt-30 52.65 117.2 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.845 0.355 . . . . 0.0 110.783 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 44' ' ' THR . 35.2 t-20 -148.8 68.75 9.88 Favored Pre-proline 0 C--O 1.235 0.294 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.745 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.586 ' O ' ' N ' ' A' ' 46' ' ' ALA . 86.9 Cg_exo -35.85 -31.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.455 2.103 . . . . 0.0 111.978 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.451 ' N ' ' O ' ' A' ' 42' ' ' ASN . 29.9 m -38.57 -27.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.287 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.544 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 87.7 mt-10 -89.52 -32.43 17.18 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.818 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.41 -51.87 68.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.014 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.451 ' HB2' HG23 ' A' ' 117' ' ' THR . 2.2 tm-20 -67.43 -46.07 74.21 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.18 0.514 . . . . 0.0 109.683 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 44' ' ' THR . 96.9 mt -63.64 -27.64 69.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.344 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -39.54 -53.61 2.07 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.815 0.341 . . . . 0.0 110.804 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -65.94 -38.26 88.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.261 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.5 ttp -62.34 -40.18 95.52 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 98.0 mt -62.05 -46.4 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.646 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 9.5 m120 -62.38 -42.38 99.37 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.679 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.73 -55.62 32.05 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.167 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 p -69.87 -34.89 62.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 120.894 0.378 . . . . 0.0 111.089 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.9 t0 -82.89 -13.45 56.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.404 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.646 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.08 8.92 1.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.819 0.342 . . . . 0.0 110.179 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 12.6 p30 -61.6 -25.09 67.12 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -157.83 -19.98 0.03 OUTLIER Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.619 ' C ' ' H ' ' A' ' 62' ' ' THR . 5.1 p30 177.07 141.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.73 32.24 0.08 OUTLIER Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.619 ' H ' ' C ' ' A' ' 60' ' ' ASN . 63.8 p -130.3 150.12 51.68 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-O 120.983 0.42 . . . . 0.0 110.266 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.6 mt -117.05 138.97 45.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.145 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.56 166.16 19.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.381 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.432 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -62.93 -50.55 76.52 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.756 -179.138 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.5 Cg_exo -50.89 -44.95 38.82 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.999 1.799 . . . . 0.0 111.788 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.94 -36.27 72.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.984 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -60.07 -45.83 91.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.194 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.08 -44.59 95.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.561 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.2 m -67.36 -44.39 79.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.27 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.9 ttp -61.47 -40.14 93.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.02 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 76.0 mmm -63.02 -38.58 91.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.805 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.11 96.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.008 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -68.43 -45.56 72.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.081 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.57 -41.79 83.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.976 0.417 . . . . 0.0 110.36 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.8 mmt -86.93 164.42 16.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.137 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -116.2 153.55 31.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.954 0.406 . . . . 0.0 110.154 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -59.26 160.44 6.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.31 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.6 p -64.14 -30.04 71.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.571 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -64.42 -10.04 22.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.182 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -57.08 -32.78 66.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.535 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -49.49 -50.23 42.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.712 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.02 -41.9 94.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.038 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -66.31 -45.71 79.4 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.469 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.4 mt -64.91 -20.61 27.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -59.67 -42.23 92.41 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.245 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -61.49 -35.89 78.94 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.468 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.13 -13.42 60.47 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -47.98 -51.1 25.13 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.013 0.435 . . . . 0.0 111.421 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -59.76 -46.82 87.97 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.822 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.87 -44.35 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.979 0.418 . . . . 0.0 110.451 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -59.44 -44.35 92.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.573 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 33.0 t70 -138.9 100.65 4.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.267 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.07 -39.98 82.83 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.209 0.528 . . . . 0.0 110.154 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.2 p-10 -60.18 -42.61 95.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.286 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.71 -56.98 0.51 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -70.69 -13.68 62.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.156 0.503 . . . . 0.0 110.286 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.63 161.12 12.87 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -115.04 150.93 35.11 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.5 mt -85.24 123.18 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.999 0.428 . . . . 0.0 110.375 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.2 p -80.01 168.12 19.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.049 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.3 -36.44 82.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.615 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.18 -45.24 94.26 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.082 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -70.08 -37.66 75.51 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.192 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.2 tp -62.0 -42.86 99.61 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.23 0.538 . . . . 0.0 111.248 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -52.62 -43.23 65.26 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.02 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -55.39 -42.73 74.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.914 0.388 . . . . 0.0 110.231 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.5 t -64.63 -42.44 95.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.259 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 58.3 mmm -57.56 -34.75 69.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.461 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.1 m -60.26 -42.37 95.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.37 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -58.57 -38.73 78.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.9 tp -61.35 -46.29 90.83 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 120.952 0.406 . . . . 0.0 110.126 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.9 -154.91 26.0 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -143.29 11.89 1.75 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.703 -0.249 . . . . 0.0 110.759 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -63.97 -43.99 94.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.114 0.483 . . . . 0.0 110.612 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.4 mt -79.77 160.3 26.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.99 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.475 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.6 OUTLIER -68.46 161.7 27.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.245 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -92.37 -21.07 20.45 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.063 0.458 . . . . 0.0 110.404 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -85.43 -26.93 26.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.234 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.59 -63.57 0.34 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -178.85 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.61 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 11.3 m -69.1 -31.35 49.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.457 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -58.86 -67.15 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.721 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.56 -45.19 72.75 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.519 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 13.3 tmm? -52.85 -50.27 64.1 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.419 HG22 ' O ' ' A' ' 125' ' ' ILE . 95.9 mt -64.6 -18.4 23.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.655 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -87.92 -57.86 2.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.306 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 128' ' ' ALA . 51.0 tp10 -81.96 -67.79 0.75 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.248 -178.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.81 ' HB2' ' O ' ' A' ' 39' ' ' LEU . . . -36.77 -35.64 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 56.7 t0 -87.69 146.15 25.82 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.258 0.551 . . . . 0.0 110.576 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.566 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -89.36 -15.02 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.778 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 133' ' ' ASP . 44.9 m-20 -73.54 -45.29 54.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.994 0.426 . . . . 0.0 110.427 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.39 -10.3 3.75 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 131' ' ' ASP . 35.2 p30 -89.88 -10.4 45.39 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.816 0.341 . . . . 0.0 110.172 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 62.18 122.99 0.01 OUTLIER Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -161.69 119.65 2.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.913 0.387 . . . . 0.0 110.08 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.65 128.91 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.128 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.525 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 45.3 t30 -155.07 166.26 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.064 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.4 ' O ' ' CD1' ' A' ' 138' ' ' TYR . 2.6 t80 -48.79 -23.04 0.93 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.444 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.539 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 50.1 mp0 -66.42 -35.75 81.08 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.151 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -84.95 -20.83 30.0 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.633 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.04 -46.68 88.1 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.141 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 29.8 t -58.28 -46.0 89.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.028 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -71.33 -36.12 71.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.305 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 61.5 ttp -57.99 -43.04 86.36 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.193 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 70.7 mtm -112.85 129.26 56.51 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.85 0.357 . . . . 0.0 110.328 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.6 m -162.78 85.82 0.55 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.064 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.15 -43.81 94.05 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.675 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.516 179.834 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.067 0 CA-C-O 120.586 0.231 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -47.63 -48.63 28.53 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.118 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -59.48 -44.87 92.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.83 0.347 . . . . 0.0 110.442 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -63.37 -39.68 95.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.693 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.31 -41.3 85.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.824 0.345 . . . . 0.0 111.158 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.47 -22.69 66.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.829 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -55.57 -47.89 75.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.2 m -81.37 -17.2 49.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.553 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.96 -43.72 98.03 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.423 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.417 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.5 m-85 -60.52 -50.36 73.86 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.553 -178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.3 t0 -77.13 -14.56 59.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.188 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -45.11 -32.91 1.95 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.209 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.449 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 18.0 p-10 -54.73 -45.99 74.19 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.824 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -144.04 -151.1 5.38 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 32.2 p-10 -73.06 -47.08 47.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.675 0.274 . . . . 0.0 110.772 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.73 107.31 0.28 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.427 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 4.9 m -166.24 142.77 5.0 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.745 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.02 103.46 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.405 HG22 HG22 ' A' ' 62' ' ' THR . 2.9 p -123.14 169.93 10.73 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.091 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.606 ' CB ' HE22 ' A' ' 49' ' ' GLN . 60.2 p -63.1 -35.35 79.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.833 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -60.34 -38.48 83.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.449 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 87.7 mt-10 -65.59 -43.12 90.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.097 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.76 -41.9 97.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.227 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.82 -28.67 17.21 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.1 m -64.58 -44.15 91.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 0.0 110.762 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.2 t -57.09 -17.6 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.194 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.543 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 87.6 mmm -53.01 -38.58 62.44 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.199 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.6 ttt85 -64.27 -46.04 85.44 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 117.412 -1.715 . . . . 0.0 110.668 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 93.5 p -63.4 -19.9 65.08 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.553 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.882 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 52.5 mt -99.64 6.16 45.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.882 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 34.8 94.62 0.01 OUTLIER Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 40' ' ' GLY . 84.1 mt-30 52.3 110.1 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.599 0.238 . . . . 0.0 110.418 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 44' ' ' THR . 49.9 t30 -145.71 63.94 9.9 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.701 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 46' ' ' ALA . 88.7 Cg_exo -34.71 -30.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.56 2.173 . . . . 0.0 112.32 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.498 ' N ' ' O ' ' A' ' 42' ' ' ASN . 23.4 m -40.14 -29.51 0.08 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.123 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.543 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 90.7 mt-10 -89.73 -29.89 18.41 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.763 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -60.83 -49.15 78.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.82 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.47 ' HB2' HG23 ' A' ' 117' ' ' THR . 2.2 tm-20 -72.17 -43.18 64.99 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.296 0.569 . . . . 0.0 109.755 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.591 HD21 HD21 ' A' ' 116' ' ' LEU . 96.3 mt -68.0 -25.05 65.22 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.212 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.606 HE22 ' CB ' ' A' ' 29' ' ' THR . 53.7 tp60 -40.85 -41.86 1.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.0 110.582 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -77.7 -36.75 50.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.492 ' CE ' HD22 ' A' ' 48' ' ' LEU . 32.5 ttp -59.98 -37.3 79.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.628 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.589 HG21 HG22 ' A' ' 29' ' ' THR . 96.8 mt -63.5 -44.78 98.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.043 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.675 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 51.0 m-80 -62.57 -39.86 95.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.342 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -56.62 -56.44 21.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.273 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.471 HG13 ' N ' ' A' ' 56' ' ' ASP . 15.0 p -74.14 -40.32 51.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.883 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.504 ' OD2' ' N ' ' A' ' 62' ' ' THR . 44.4 t0 -71.18 -13.3 61.88 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.52 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.675 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.25 8.97 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.099 0.476 . . . . 0.0 110.346 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 56' ' ' ASP . 10.3 p-10 -59.73 -26.72 65.88 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -155.08 -24.42 0.03 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.549 ' C ' ' H ' ' A' ' 62' ' ' THR . 10.0 p30 176.15 151.17 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.29 36.32 0.09 OUTLIER Glycine 0 CA--C 1.535 1.306 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.549 ' H ' ' C ' ' A' ' 60' ' ' ASN . 44.2 p -137.38 153.34 50.21 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.5 mt -127.43 137.02 58.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.972 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -81.21 164.55 22.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.083 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.427 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -62.07 -50.13 81.87 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.232 -179.721 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.5 Cg_exo -50.12 -41.74 48.44 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.08 1.853 . . . . 0.0 112.046 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -80.77 -29.79 36.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.118 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -59.48 -45.07 92.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.989 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.42 -43.14 99.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.305 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.9 m -64.36 -44.92 89.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.869 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 46.9 ttp -60.08 -44.66 94.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.855 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 79.4 mmm -63.82 -40.86 97.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.266 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.408 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -61.27 -47.77 84.51 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.957 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -71.27 -46.28 61.29 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.458 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -66.72 -45.28 79.2 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.927 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.408 ' O ' ' O ' ' A' ' 73' ' ' ALA . 17.8 mmm -99.5 -176.68 3.35 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.054 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -128.51 152.15 48.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.153 0.501 . . . . 0.0 110.169 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -54.21 177.66 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.341 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.3 p -80.47 -15.81 55.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.582 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -66.38 -13.65 60.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.395 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 83' ' ' GLU . 72.7 m -53.38 -34.27 57.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.601 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -39.08 -28.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.381 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 81' ' ' SER . 75.8 mm-40 -85.35 -54.79 4.37 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.042 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -58.56 -36.29 73.69 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.905 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.427 ' O ' HG22 ' A' ' 85' ' ' ILE . 96.6 mt -63.55 -20.04 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -61.0 -45.09 96.24 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 118.409 -1.316 . . . . 0.0 109.588 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -64.61 -21.8 66.81 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.189 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.4 -17.54 48.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.439 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -57.01 -50.19 73.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.376 0.607 . . . . 0.0 110.572 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -68.62 -44.95 73.16 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.864 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.6 t -65.32 -49.07 80.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.069 0.462 . . . . 0.0 110.022 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.683 ' CE2' HD12 ' A' ' 100' ' ' ILE . 51.6 t80 -62.59 -45.19 94.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.905 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.411 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 22.2 t0 -120.53 104.52 10.03 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.119 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -66.36 -41.22 89.82 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.029 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -70.39 -41.66 72.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.063 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.89 -52.98 0.74 Allowed Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -64.02 -20.08 65.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.934 0.397 . . . . 0.0 110.297 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.411 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.66 161.01 12.9 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -113.34 148.31 35.96 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.683 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -84.96 123.62 39.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.9 p -87.35 176.7 7.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.122 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.64 -36.49 83.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.963 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.57 -51.35 69.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.878 0.371 . . . . 0.0 110.977 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.39 -30.54 66.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 49.4 tp -61.69 -41.04 97.04 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.23 0.538 . . . . 0.0 111.106 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -54.22 -41.49 68.73 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.881 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -57.92 -42.69 85.33 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.3 t -65.57 -43.2 94.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.668 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 91.6 mmm -62.55 -37.23 85.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.476 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.8 m -59.43 -40.48 86.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.657 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -58.6 -38.73 78.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.724 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.0 tp -61.01 -45.1 96.2 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.547 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.09 -145.3 12.03 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -143.6 16.38 1.82 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.761 0.315 . . . . 0.0 110.679 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -61.86 -44.91 95.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.997 0.427 . . . . 0.0 110.468 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.591 HD21 HD21 ' A' ' 48' ' ' LEU . 82.8 mt -82.08 161.34 22.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.966 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.474 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -66.02 161.7 21.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.653 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -91.63 -19.62 22.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.866 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -87.67 -28.14 22.01 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.622 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.32 -66.85 0.17 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.804 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.622 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.4 m -64.05 -39.33 85.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 111.909 0.336 . . . . 0.0 111.909 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.469 ' N ' HG23 ' A' ' 121' ' ' VAL . 84.8 m-20 -54.27 -65.91 0.49 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.676 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 127' ' ' GLU . 80.6 mm-40 -70.42 -44.93 66.89 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.661 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 18.9 tmm? -53.0 -47.62 68.13 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 120.486 -0.486 . . . . 0.0 109.879 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.403 ' O ' HG22 ' A' ' 125' ' ' ILE . 97.7 mt -67.19 -19.73 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.356 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -91.24 -66.84 0.89 Allowed 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.984 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 123' ' ' GLU . 24.9 tp10 -65.24 -68.53 0.36 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.21 -177.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.882 ' HB2' ' O ' ' A' ' 39' ' ' LEU . . . -37.21 -37.67 0.18 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.48 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 66.0 t0 -87.5 138.23 31.65 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.207 0.527 . . . . 0.0 110.591 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.59 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -85.8 -16.09 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.335 -179.7 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -73.08 -46.54 50.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.121 0.486 . . . . 0.0 110.141 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.96 -2.59 54.92 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 52.1 p30 -88.67 -22.3 23.49 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 64.6 103.72 0.01 OUTLIER Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -147.77 140.77 24.95 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.784 0.326 . . . . 0.0 110.158 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.2 t -128.93 134.32 64.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.314 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.527 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 53.3 t30 -151.57 -179.09 7.11 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.624 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -57.28 -48.15 79.63 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.267 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.527 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 55.9 mp0 -50.91 -43.66 59.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.352 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -67.69 -39.82 84.42 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.91 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -60.72 -43.65 97.61 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.598 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.3 t -54.19 -43.89 62.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.345 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -84.25 -19.38 33.99 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.064 -0.255 . . . . 0.0 111.223 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 41.1 ttp -65.07 -41.3 95.2 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.949 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 51.7 mtm -103.67 132.68 49.71 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.847 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.4 m -166.83 81.77 0.24 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.061 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.8 -37.19 75.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.342 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.1 mttm . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.458 179.948 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.883 0.373 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -51.5 -43.22 62.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.748 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -66.94 -46.38 74.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.874 0.368 . . . . 0.0 111.03 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -61.62 -44.81 96.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.792 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -67.96 -40.96 83.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.628 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.13 -28.42 67.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.022 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -55.58 -45.84 77.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.673 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.7 m -81.61 -17.83 46.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.723 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.7 tp -65.51 -42.36 92.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.918 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.403 ' O ' ' CD ' ' A' ' 31' ' ' GLU . 73.3 m-85 -61.06 -45.95 92.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.309 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 4.7 t0 -81.93 -15.66 53.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.357 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -42.82 -32.5 0.62 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.114 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.433 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 9.2 p-10 -53.67 -46.7 70.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.896 0.379 . . . . 0.0 110.712 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.433 ' N ' ' CG ' ' A' ' 22' ' ' ASP . . . -145.67 -147.33 4.58 Favored Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 20.5 p-10 -76.46 -47.57 22.51 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.898 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.01 106.97 0.27 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 95.7 m -166.72 143.13 4.64 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.968 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.05 117.06 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.849 0.357 . . . . 0.0 110.113 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.691 HG22 HG22 ' A' ' 62' ' ' THR . 12.4 p -133.38 165.57 24.52 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.403 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.424 ' HB ' HE22 ' A' ' 49' ' ' GLN . 79.9 p -63.02 -35.13 79.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.33 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -61.26 -38.58 87.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.021 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.413 ' OE2' ' CG ' ' A' ' 22' ' ' ASP . 91.3 mt-10 -64.62 -49.13 72.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.359 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.37 -43.65 98.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.182 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.2 -23.94 4.47 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.3 m -64.9 -42.51 94.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.914 0.388 . . . . 0.0 110.545 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.3 t -54.59 -16.3 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.219 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.452 ' O ' ' N ' ' A' ' 40' ' ' GLY . 53.4 mmm -58.73 -37.27 75.8 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -62.48 -46.13 89.89 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 116.727 -1.989 . . . . 0.0 110.618 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.7 p -60.12 -36.17 76.88 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.034 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 41' ' ' GLN . 44.7 mt -95.87 2.08 53.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.701 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 66.2 -66.44 0.15 Allowed Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 39' ' ' LEU . 74.6 mt-30 -141.66 122.77 14.67 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.3 t-20 -141.5 71.15 26.19 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.636 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 46' ' ' ALA . 73.1 Cg_exo -37.42 -30.45 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.222 1.948 . . . . 0.0 112.136 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 42' ' ' ASN . 25.1 m -39.04 -27.62 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.488 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 49' ' ' GLN . 86.7 mt-10 -90.31 -36.92 14.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.011 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -56.27 -48.88 75.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.411 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -70.5 -45.08 66.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.289 0.566 . . . . 0.0 110.071 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.521 HD21 HD22 ' A' ' 116' ' ' LEU . 96.0 mt -70.08 -20.05 63.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.82 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 45' ' ' GLU . 11.7 tp-100 -46.48 -46.22 18.84 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.608 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -75.06 -35.29 61.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.242 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.433 ' CE ' HD22 ' A' ' 48' ' ' LEU . 33.2 ttp -63.71 -43.03 97.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.016 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 96.7 mt -62.76 -46.21 96.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.753 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.697 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 81.3 m-20 -64.65 -40.7 95.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.766 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -60.08 -56.84 16.72 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.42 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 56' ' ' ASP . 11.3 p -69.68 -37.01 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.016 0.436 . . . . 0.0 110.94 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.549 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.5 t0 -79.06 -12.6 60.02 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.446 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.697 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.15 15.43 0.16 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.314 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 10.5 p30 -65.76 -21.87 66.54 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.412 ' H ' ' H ' ' A' ' 60' ' ' ASN . . . -167.82 -9.56 0.03 OUTLIER Glycine 0 C--N 1.333 0.4 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.576 ' C ' ' H ' ' A' ' 62' ' ' THR . 1.9 p30 169.42 140.58 0.02 OUTLIER 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.02 35.77 0.11 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.691 HG22 HG22 ' A' ' 28' ' ' THR . 69.5 p -135.94 155.0 50.93 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 90.9 mt -130.13 132.02 65.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.213 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.14 151.99 42.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.627 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.442 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -54.83 -51.24 80.75 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.778 -179.703 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 52.1 Cg_exo -49.17 -49.84 14.36 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.855 1.704 . . . . 0.0 112.059 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -68.56 -33.66 74.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.465 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -61.94 -43.82 98.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.96 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.8 mt -59.2 -45.58 90.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.753 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.3 m -63.83 -44.73 92.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.543 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 36.3 ttp -59.99 -45.34 93.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.578 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.3 mmm -64.64 -39.41 93.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.534 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.34 -39.05 78.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.743 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -77.92 -51.47 10.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.383 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -65.56 -44.27 87.27 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.498 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.2 mmm -99.74 126.46 45.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.348 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -86.76 143.89 27.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.537 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 80' ' ' ASP . 97.2 m-20 -49.35 158.58 0.38 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.418 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 35.8 p -54.9 -8.74 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.643 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 78' ' ' ASP . 80.3 m-20 -67.11 -8.64 32.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.156 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.6 m -59.4 -29.51 67.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.688 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -37.85 -49.21 1.19 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.839 0.352 . . . . 0.0 110.994 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.73 -55.02 19.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.872 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -59.68 -32.31 70.38 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.055 0.455 . . . . 0.0 110.622 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 85' ' ' ILE . 83.0 mt -69.23 -15.07 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.998 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -59.71 -48.93 79.71 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 117.546 -1.662 . . . . 0.0 110.395 -177.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.21 -32.55 74.28 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.471 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.66 -36.04 73.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.731 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -50.58 -51.12 51.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.324 0.583 . . . . 0.0 110.928 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -69.3 -44.4 71.85 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.32 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.16 -51.44 48.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.132 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.555 ' CE2' HD12 ' A' ' 100' ' ' ILE . 66.8 t80 -63.44 -47.42 81.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.389 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.463 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 17.9 t0 -107.83 105.33 15.1 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.131 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -71.67 -44.88 63.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.664 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 45.2 p-10 -67.07 -33.62 75.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.137 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.529 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 66.52 -74.87 0.15 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -53.66 -13.09 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.876 0.369 . . . . 0.0 110.343 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.422 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.52 161.77 12.67 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -112.34 155.91 23.34 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.555 HD12 ' CE2' ' A' ' 92' ' ' PHE . 94.6 mt -99.79 117.47 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.749 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.6 p -82.15 175.68 10.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.123 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.91 -37.06 85.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.838 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.54 -52.44 64.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.785 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -67.66 -31.18 70.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.67 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.1 tp -64.2 -41.35 97.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.451 0.644 . . . . 0.0 110.975 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -53.9 -39.2 65.57 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.002 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -63.83 -41.17 97.9 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.1 t -64.17 -42.66 96.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.44 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 54.0 mmm -62.4 -40.75 97.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.983 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.8 m -61.74 -40.22 94.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.564 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -58.82 -40.55 84.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.616 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.9 tp -61.33 -44.25 97.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.946 0.403 . . . . 0.0 110.528 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 161.85 -151.91 22.17 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -138.34 29.22 2.46 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.794 0.33 . . . . 0.0 110.619 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -67.46 -45.32 76.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.793 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.521 HD22 HD21 ' A' ' 48' ' ' LEU . 19.7 mt -100.68 166.94 10.63 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.853 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.52 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -69.49 161.57 29.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.188 -179.564 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -92.69 -21.54 19.94 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.902 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -87.41 -23.6 24.47 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.635 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -35.1 -68.08 0.13 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.603 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.521 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 9.8 m -63.87 -42.15 94.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.517 ' N ' HG23 ' A' ' 121' ' ' VAL . 87.6 m-20 -48.3 -67.06 0.3 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.752 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.459 ' O ' ' OE1' ' A' ' 127' ' ' GLU . 80.3 mm-40 -70.44 -40.02 74.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.404 ' SD ' ' C ' ' A' ' 124' ' ' MET . 17.7 tmm? -57.22 -38.94 74.49 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.684 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.9 mt -77.89 -23.79 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.929 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -77.5 -46.93 20.9 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 118.682 -1.207 . . . . 0.0 111.698 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 123' ' ' GLU . 19.6 mp0 -80.08 -68.45 0.67 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.667 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.56 -48.9 1.04 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.69 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -88.51 131.07 35.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.901 0.381 . . . . 0.0 110.27 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.549 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -82.3 -10.7 12.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.129 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 133' ' ' ASP . 89.2 m-20 -64.39 -40.42 95.76 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.099 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.65 -8.4 4.32 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 134' ' ' GLY . 26.2 p-10 -88.32 -12.72 42.65 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 39.36 98.06 0.01 OUTLIER Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 13.3 pt20 -131.06 136.94 48.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.056 0.455 . . . . 0.0 110.311 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.0 t -115.29 134.82 57.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.097 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.515 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 53.1 t30 -152.64 176.74 11.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.605 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -58.84 -48.02 82.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.339 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.515 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 58.0 mp0 -57.42 -25.53 59.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.295 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 81.2 mt-10 -84.87 -33.64 22.78 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.08 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -65.72 -46.89 77.24 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.654 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 50.3 t -56.26 -44.57 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 120.792 0.33 . . . . 0.0 110.22 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -71.56 -38.05 71.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.202 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 50.2 ttp -60.43 -48.59 81.08 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.306 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 49.1 mtm -88.61 120.77 30.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.928 0.394 . . . . 0.0 110.782 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.0 m -165.77 99.14 0.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.729 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.94 -38.33 88.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.584 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.8 mttm . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.531 179.938 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.037 0 CA-C-O 120.598 0.237 . . . . 0.0 111.301 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -54.64 -48.25 72.5 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.556 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -65.74 -40.79 92.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.837 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -61.99 -44.1 97.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.633 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -66.99 -37.54 84.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.988 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.479 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.06 -27.9 65.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.803 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -57.83 -46.94 84.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.533 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.8 m -77.9 -21.5 51.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.65 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.36 -42.82 99.7 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.444 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.2 m-85 -60.21 -50.92 71.74 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.476 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.1 t0 -77.01 -14.26 59.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.83 0.347 . . . . 0.0 111.315 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -45.61 -32.69 2.45 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.831 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 8.8 p-10 -53.72 -46.11 70.69 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.557 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -144.34 -151.61 5.48 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 30.8 p-10 -72.95 -47.24 47.23 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.068 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.525 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.71 107.38 0.28 Allowed Glycine 0 CA--C 1.521 0.452 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.425 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 4.6 m -166.63 139.23 3.7 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.121 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 27' ' ' ILE . 5.2 mp -115.02 109.18 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.593 HG22 HG22 ' A' ' 62' ' ' THR . 2.6 p -128.65 170.32 13.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.824 0.345 . . . . 0.0 110.447 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.651 ' HB ' HE22 ' A' ' 49' ' ' GLN . 68.0 p -64.74 -33.05 75.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.801 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -61.63 -41.42 97.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.935 0.397 . . . . 0.0 109.998 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.425 ' OE1' ' O ' ' A' ' 26' ' ' THR . 90.1 mt-10 -63.45 -45.68 89.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.856 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.0 tp -64.2 -43.29 95.49 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.115 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.78 -26.16 53.42 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.2 m -63.87 -41.42 97.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.858 0.361 . . . . 0.0 110.143 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.3 t -56.18 -23.62 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.333 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.479 ' O ' ' N ' ' A' ' 40' ' ' GLY . 62.1 mmm -48.06 -30.33 4.33 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.721 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -64.34 -45.61 87.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 118.042 -1.463 . . . . 0.0 111.049 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 77.9 p -63.98 -21.95 66.71 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.136 -0.625 . . . . 0.0 109.808 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 41' ' ' GLN . 16.9 mt -107.8 3.75 24.79 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.04 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.16 -71.21 0.02 OUTLIER Glycine 0 N--CA 1.465 0.592 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 39' ' ' LEU . 87.8 mt-30 -145.45 109.46 4.83 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 44' ' ' THR . 41.4 t30 -125.59 70.93 65.52 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.12 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.551 ' O ' ' N ' ' A' ' 46' ' ' ALA . 85.3 Cg_exo -33.04 -30.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.595 2.196 . . . . 0.0 112.808 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 42' ' ' ASN . 26.2 m -39.31 -30.19 0.06 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.543 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.417 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.9 mt-10 -86.64 -34.88 19.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.305 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -59.04 -50.04 75.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.821 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.15 -46.21 71.4 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 51' ' ' MET . 84.6 mt -64.79 -31.03 72.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.4 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.651 HE22 ' HB ' ' A' ' 29' ' ' THR . 8.7 tp-100 -37.62 -51.2 1.19 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.732 0.301 . . . . 0.0 110.769 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.3 -40.34 89.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.232 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' LEU . 33.1 ttp -62.38 -41.05 98.33 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.981 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 83.9 mt -62.0 -49.95 82.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.114 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.61 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 89.9 m-20 -62.89 -40.46 97.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.582 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -55.17 -61.5 2.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.206 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.93 -30.12 43.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.804 0.335 . . . . 0.0 111.241 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 62' ' ' THR . 50.7 t0 -84.71 -13.24 51.97 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.513 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -71.94 13.05 0.32 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.926 0.394 . . . . 0.0 110.339 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.8 p30 -65.56 -28.89 69.48 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.535 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -150.49 -22.49 0.06 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.558 ' C ' ' H ' ' A' ' 62' ' ' THR . 3.3 p30 173.19 151.88 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.95 34.7 0.14 Allowed Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.593 HG22 HG22 ' A' ' 28' ' ' THR . 81.9 p -134.37 149.45 50.83 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.4 mt -120.99 134.52 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.933 0.397 . . . . 0.0 109.942 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.16 162.43 28.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.416 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.472 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -64.68 -48.05 74.37 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.467 -179.051 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 50.6 Cg_exo -51.28 -37.36 59.73 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.167 1.911 . . . . 0.0 111.692 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -87.55 -22.32 24.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.78 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.45 -47.11 87.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.021 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.54 -42.88 98.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.517 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 78.7 m -63.97 -46.09 86.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.648 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.7 ttp -61.71 -47.5 85.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.066 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.9 mmm -65.87 -37.76 87.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.265 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.61 -49.96 75.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.039 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -71.51 -43.8 65.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.159 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.72 -43.59 88.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.764 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.432 ' O ' ' O ' ' A' ' 73' ' ' ALA . 22.3 mmm -104.27 127.47 51.91 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.116 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.7 tptt -84.97 141.14 30.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.874 0.368 . . . . 0.0 110.748 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' LYS . 95.0 m-20 -48.87 179.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.262 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.5 p -75.51 -6.74 51.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.437 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.48 -15.52 62.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.545 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.9 m -61.89 -19.92 63.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.549 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -48.19 -44.69 32.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.358 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.96 -39.56 79.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.9 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.87 -45.12 83.25 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.989 0.423 . . . . 0.0 110.202 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.5 mt -66.12 -19.04 25.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.472 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -58.41 -45.44 88.4 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 118.97 -1.092 . . . . 0.0 110.19 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -65.56 -31.88 73.17 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.948 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.412 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -72.03 -14.64 61.93 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.185 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -57.98 -49.0 78.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.244 0.545 . . . . 0.0 111.061 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -64.09 -45.6 87.98 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.316 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -76.18 -51.54 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 0.0 110.908 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.442 ' CE2' HD12 ' A' ' 100' ' ' ILE . 26.2 t80 -61.99 -47.19 85.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.62 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.427 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 18.2 t70 -108.95 94.15 4.89 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.22 -40.97 74.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.965 0.412 . . . . 0.0 110.553 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 19.8 p-10 -62.61 -39.65 94.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.976 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.44 -67.3 0.97 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.58 -16.56 63.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.022 0.439 . . . . 0.0 110.247 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.76 162.04 12.56 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.23 155.39 24.09 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.713 0.292 . . . . 0.0 110.258 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.442 HD12 ' CE2' ' A' ' 92' ' ' PHE . 94.1 mt -79.75 126.02 39.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.938 0.399 . . . . 0.0 110.988 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.3 p -82.36 168.95 17.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.196 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.04 89.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.51 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.63 -47.38 84.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.863 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.67 -32.87 73.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.6 tp -61.58 -41.63 97.68 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.41 0.624 . . . . 0.0 110.712 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -56.46 -43.35 79.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.8 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -58.5 -41.88 86.35 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.67 -43.4 90.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.624 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.0 mmm -61.99 -35.68 79.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.605 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.6 m -61.04 -44.43 97.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.044 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -59.76 -34.98 73.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.376 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.0 tp -61.17 -46.73 89.31 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.051 0.453 . . . . 0.0 110.36 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.5 -160.74 33.47 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -140.51 23.35 2.32 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.64 0.257 . . . . 0.0 110.828 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -63.65 -42.8 98.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.963 0.411 . . . . 0.0 110.269 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.3 mt -92.84 175.79 6.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.006 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.469 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -72.83 161.29 30.91 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.695 179.844 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -91.66 -22.46 20.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.946 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -87.89 -25.37 23.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.126 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.64 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.4 -61.27 0.45 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.086 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.64 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 20.2 m -67.33 -40.2 84.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.492 ' N ' HG23 ' A' ' 121' ' ' VAL . 81.2 m-20 -56.81 -47.06 81.1 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.52 -178.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -86.01 -40.32 15.92 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.7 tmm? -59.51 -46.51 88.61 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.094 0.473 . . . . 0.0 109.956 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 125' ' ' ILE . 91.5 mt -69.15 -16.56 20.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.413 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -78.61 -50.56 11.29 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 119.389 -0.924 . . . . 0.0 112.13 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' ASP . 42.3 tp10 -87.61 -67.51 0.82 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.888 -178.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.43 -25.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.763 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' GLU . 25.4 t0 -88.06 128.26 35.41 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.062 0.458 . . . . 0.0 111.056 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.668 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.46 -43.45 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.416 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -65.27 -40.4 93.86 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.136 0.493 . . . . 0.0 110.185 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.4 -2.03 58.94 Favored Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' GLY . 55.2 p-10 -89.44 -9.0 51.8 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 57.46 115.49 0.01 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.435 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 20.3 pt20 -160.69 133.6 6.44 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.46 136.92 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.056 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -151.36 172.43 15.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.23 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -54.78 -46.83 74.47 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.096 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 139' ' ' GLU . 55.3 mp0 -58.64 -44.35 90.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.709 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 93.4 mt-10 -72.05 -29.4 64.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.727 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.92 -43.91 77.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.605 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 93.8 t -59.22 -46.23 92.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.312 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.38 -29.1 66.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.128 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.7 ttp -59.71 -42.81 93.9 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.853 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.49 138.82 50.63 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.961 0.41 . . . . 0.0 110.756 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 81.9 m -163.22 77.77 0.43 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.671 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.15 -27.76 68.95 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.464 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.222 -0.391 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.624 -179.857 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.219 0 CA-C-O 120.75 0.31 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -54.22 -42.27 69.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.096 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -67.84 -41.73 82.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.34 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -62.62 -43.76 97.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.914 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -67.19 -35.71 80.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.431 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.413 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.57 -24.11 66.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.699 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -55.45 -46.46 76.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.783 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.4 m -80.66 -19.54 45.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.756 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.16 -41.95 96.95 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.013 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.42 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.1 m-85 -58.84 -46.11 88.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.831 0.348 . . . . 0.0 111.115 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.448 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.3 t0 -79.56 -13.49 59.5 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.468 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -42.97 -32.87 0.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.821 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.451 ' CG ' ' OE2' ' A' ' 31' ' ' GLU . 10.9 p-10 -52.93 -45.1 67.48 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.447 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.433 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . -149.68 -151.3 5.47 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 21.2 p-10 -71.1 -46.9 60.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.759 0.314 . . . . 0.0 111.009 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.534 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.02 107.4 0.28 Allowed Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.592 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.7 m -166.6 136.2 3.08 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.188 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.608 HD12 ' N ' ' A' ' 27' ' ' ILE . 1.9 mp -110.55 118.33 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.457 HG22 HG22 ' A' ' 62' ' ' THR . 2.0 p -134.78 167.04 21.59 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.863 0.363 . . . . 0.0 110.327 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.538 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.3 p -64.12 -33.64 76.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.296 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -62.51 -40.22 96.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.691 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.455 ' OE2' ' O ' ' A' ' 26' ' ' THR . 89.0 mt-10 -64.68 -48.46 74.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.373 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.6 tp -64.44 -43.72 93.42 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.296 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.29 -24.73 17.07 Favored Glycine 0 C--O 1.224 -0.487 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -64.09 -40.99 97.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.863 0.363 . . . . 0.0 110.197 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.3 t -57.05 -22.45 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.276 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.7 mmm -48.79 -33.53 10.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.992 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -64.33 -45.51 87.55 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 118.219 -1.392 . . . . 0.0 110.241 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.3 p -58.96 -30.68 68.09 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.367 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 41' ' ' GLN . 9.2 mt -102.34 5.47 39.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.99 0.424 . . . . 0.0 110.492 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.31 -69.83 0.03 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 39' ' ' LEU . 85.8 mt-30 -143.27 116.21 8.82 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.1 t30 -132.61 69.71 79.55 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.934 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 46' ' ' ALA . 90.7 Cg_exo -32.98 -33.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.541 2.16 . . . . 0.0 112.463 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 42' ' ' ASN . 12.6 m -39.0 -29.35 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.398 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 43' ' ' PRO . 90.6 mt-10 -87.69 -35.21 18.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.449 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -61.22 -49.22 78.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.998 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.437 ' HB2' HG23 ' A' ' 117' ' ' THR . 3.1 tm-20 -68.01 -48.6 65.27 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.437 0.637 . . . . 0.0 109.89 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.511 HD22 ' CE ' ' A' ' 51' ' ' MET . 87.2 mt -62.65 -22.75 66.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.012 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.538 HE22 ' CB ' ' A' ' 29' ' ' THR . 47.9 tp60 -40.25 -49.56 2.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.877 0.37 . . . . 0.0 110.519 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.69 -39.78 73.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.483 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.511 ' CE ' HD22 ' A' ' 48' ' ' LEU . 36.1 ttp -61.62 -40.54 95.21 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.73 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.85 -46.83 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.624 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.655 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 28.2 m120 -65.19 -39.83 93.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.342 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -58.1 -57.24 13.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.443 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.4 p -68.3 -32.83 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.949 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 62' ' ' THR . 42.9 t0 -86.02 -13.12 48.45 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.768 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.05 15.46 0.16 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.07 -179.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 56' ' ' ASP . 38.7 p-10 -66.75 -23.5 66.1 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.41 -22.54 0.03 OUTLIER Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.591 ' C ' ' H ' ' A' ' 62' ' ' THR . 4.6 p30 179.35 146.5 0.19 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.72 33.71 0.17 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.591 ' H ' ' C ' ' A' ' 60' ' ' ASN . 80.8 p -132.17 143.94 50.33 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.93 135.11 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.999 0.428 . . . . 0.0 110.172 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.39 172.39 4.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.486 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.436 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -72.59 -49.59 8.4 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.759 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 52.5 Cg_exo -52.01 -43.29 53.49 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.833 1.688 . . . . 0.0 111.931 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.45 -37.45 77.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 110.874 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -60.3 -45.45 93.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.967 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.2 mt -62.39 -44.63 95.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.487 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.2 m -67.38 -45.51 76.06 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.757 0.313 . . . . 0.0 111.223 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.4 ttp -61.13 -43.74 98.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.89 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 86.9 mmm -64.76 -39.33 93.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.215 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.91 -42.84 94.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.873 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -71.52 -41.77 68.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.268 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -64.72 -40.94 96.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.887 0.375 . . . . 0.0 110.412 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.434 ' O ' ' O ' ' A' ' 73' ' ' ALA . 14.2 mmt -95.22 129.85 42.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.074 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -86.87 142.82 27.77 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -50.35 168.86 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.414 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.8 p -75.23 -15.2 60.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.647 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.97 -16.49 64.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.424 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 82' ' ' GLU . 1.1 m -60.45 -23.67 64.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.717 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 81' ' ' SER . 81.2 tt0 -36.83 -48.45 0.74 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.62 0.248 . . . . 0.0 110.897 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -70.85 -43.47 68.44 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.181 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.87 -39.59 94.55 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.994 0.426 . . . . 0.0 110.086 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 81.0 mt -66.96 -21.91 28.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.242 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 -58.04 -43.61 86.93 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 119.031 -1.067 . . . . 0.0 110.014 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -63.65 -34.82 78.69 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.851 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.79 -19.9 66.06 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.039 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -56.6 -48.81 76.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.321 0.582 . . . . 0.0 110.838 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -68.23 -44.67 75.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.474 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.8 t -66.34 -48.34 81.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.442 ' CE2' HD12 ' A' ' 100' ' ' ILE . 23.7 t80 -64.04 -47.09 81.57 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.617 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.407 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 18.3 t70 -120.37 100.1 6.96 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -66.63 -39.84 88.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.182 0.515 . . . . 0.0 109.804 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 97' ' ' ASN . 2.0 p-10 -65.58 -40.66 92.97 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.105 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.67 -59.54 0.48 Allowed Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 95' ' ' ASP . 54.0 m-80 -61.78 -17.46 56.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.994 0.426 . . . . 0.0 110.228 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.407 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.55 160.9 12.96 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -113.31 155.57 24.92 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.442 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -95.78 118.27 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.07 0.462 . . . . 0.0 111.108 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.0 p -85.52 171.41 11.77 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.898 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.72 -35.75 78.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.579 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.84 72.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.078 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.28 -37.36 77.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.928 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.02 -39.38 94.58 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.476 0.655 . . . . 0.0 111.07 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -54.24 -43.64 71.07 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.116 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -63.13 -39.47 94.77 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.702 -0.399 . . . . 0.0 109.937 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.1 t -61.84 -45.19 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.176 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 37.7 mmm -64.27 -38.02 89.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.553 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.0 m -60.58 -40.11 90.51 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -61.25 -38.08 85.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.22 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.3 tp -61.65 -44.0 97.8 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.862 0.363 . . . . 0.0 110.249 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.95 -154.71 25.68 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -139.02 23.33 2.6 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.624 -0.288 . . . . 0.0 110.763 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -62.57 -43.25 99.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.069 0.461 . . . . 0.0 110.386 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.402 ' CD2' HD21 ' A' ' 48' ' ' LEU . 29.0 mt -99.91 169.13 9.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.536 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.492 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -68.42 162.14 26.08 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.579 179.761 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -92.09 -22.27 20.0 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.432 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -87.26 -24.48 24.36 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.618 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.57 -66.09 0.21 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.241 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.618 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.7 m -65.17 -35.26 74.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.417 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -60.48 -46.81 88.72 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.586 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -84.85 -40.4 17.16 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.4 tmm? -58.89 -47.24 85.66 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 125' ' ' ILE . 94.4 mt -69.13 -18.32 22.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.6 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -77.4 -51.4 10.87 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 119.016 -1.074 . . . . 0.0 111.317 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 129' ' ' ASP . 34.7 tp10 -86.3 -68.7 0.72 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.492 -177.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.63 -21.54 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 127' ' ' GLU . 38.7 t0 -90.12 125.12 35.33 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.135 0.493 . . . . 0.0 110.625 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.644 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.58 -32.0 56.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.995 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -72.18 -45.83 58.77 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.95 0.405 . . . . 0.0 110.328 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.67 -5.45 61.19 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 134' ' ' GLY . 35.0 p30 -90.0 -9.69 47.75 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 58.26 117.9 0.01 OUTLIER Glycine 0 CA--C 1.519 0.323 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 8.2 pt20 -159.72 140.15 12.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.539 -0.331 . . . . 0.0 110.146 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.6 t -126.24 133.32 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.93 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.542 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.8 t30 -150.76 175.36 12.06 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.305 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -57.66 -52.1 66.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.765 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.542 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 57.3 mp0 -55.9 -35.04 66.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.708 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 79.4 mt-10 -69.51 -39.3 77.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.694 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -61.21 -45.39 94.78 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.0 t -57.94 -45.94 87.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -74.17 -30.83 62.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.442 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.4 ttp -60.07 -40.61 90.13 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.627 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.405 ' O ' ' OG1' ' A' ' 146' ' ' THR . 73.0 mtm -105.25 141.7 36.32 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.905 0.383 . . . . 0.0 110.635 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 145' ' ' MET . 63.0 m -167.23 72.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.146 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.8 97.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.617 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 C--O 1.219 -0.535 0 CA-C-O 118.105 -0.95 . . . . 0.0 110.228 -179.93 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.172 0 N-CA-C 111.487 0.18 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -41.21 -45.84 2.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.771 0.319 . . . . 0.0 110.929 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -66.82 -39.57 87.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.753 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -62.83 -43.12 99.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.539 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.09 -40.82 91.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.766 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.81 -20.33 49.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.654 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -49.43 -47.94 47.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.822 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.5 m -77.69 -20.38 53.74 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.035 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.8 tp -64.06 -40.69 96.83 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.802 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.471 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 76.2 m-85 -57.64 -45.49 85.39 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.339 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 9.7 t0 -86.1 -20.36 28.83 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -44.07 -33.13 1.37 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.821 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.415 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 4.4 p-10 -56.01 -46.12 78.85 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.888 0.375 . . . . 0.0 110.858 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -140.31 -152.62 5.84 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 28.1 p-10 -74.38 -47.1 36.2 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 122.679 -0.307 . . . . 0.0 110.74 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.498 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.72 107.13 0.28 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 6.2 m -166.44 148.82 6.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.123 0.462 . . . . 0.0 111.407 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.71 74.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.508 HG22 HG22 ' A' ' 62' ' ' THR . 9.7 p -86.97 166.16 15.3 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.51 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -66.3 -28.62 68.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.925 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -61.86 -40.19 94.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.961 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.471 ' OE1' ' O ' ' A' ' 19' ' ' PHE . 86.6 mt-10 -66.7 -40.51 88.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.954 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.7 tp -62.82 -43.55 98.5 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.61 -33.19 47.76 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 m -64.6 -44.69 89.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.922 0.361 . . . . 0.0 110.84 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.2 t -55.87 -17.36 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.331 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.542 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 88.9 mmm -52.71 -40.75 63.29 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.745 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.3 ttt85 -64.29 -46.01 85.5 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 118.159 -1.417 . . . . 0.0 110.181 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.0 p -64.33 -19.2 65.29 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.653 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.815 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 36.4 mt -94.4 6.57 48.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.727 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 43.76 78.69 0.07 OUTLIER Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 40' ' ' GLY . 85.7 mt-30 52.67 117.23 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.869 0.366 . . . . 0.0 110.733 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 44' ' ' THR . 35.3 t-20 -148.81 68.76 9.87 Favored Pre-proline 0 C--O 1.235 0.3 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.643 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.588 ' O ' ' N ' ' A' ' 46' ' ' ALA . 87.3 Cg_exo -35.77 -31.27 0.08 OUTLIER 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.507 2.138 . . . . 0.0 112.012 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 42' ' ' ASN . 29.5 m -38.49 -27.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.319 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.542 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 87.6 mt-10 -89.43 -32.4 17.26 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.588 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.46 -51.82 68.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.974 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.449 ' HB2' HG23 ' A' ' 117' ' ' THR . 2.2 tm-20 -67.51 -46.04 74.04 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 44' ' ' THR . 97.0 mt -63.6 -27.6 69.35 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.396 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -39.54 -53.65 2.06 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.818 0.342 . . . . 0.0 110.792 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -65.94 -38.25 88.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.197 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.5 ttp -62.42 -40.16 95.65 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 97.9 mt -61.99 -46.43 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.644 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 9.5 m120 -62.31 -42.41 99.35 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.725 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.74 -55.6 32.3 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.134 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.9 -34.85 62.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.934 0.397 . . . . 0.0 111.123 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 62' ' ' THR . 44.0 t0 -82.94 -13.41 56.08 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.377 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.06 8.87 1.1 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.788 0.327 . . . . 0.0 110.151 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 12.7 p30 -61.54 -25.09 67.07 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -157.87 -19.94 0.03 OUTLIER Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.62 ' C ' ' H ' ' A' ' 62' ' ' THR . 5.1 p30 177.07 141.86 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.76 32.27 0.09 OUTLIER Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.62 ' H ' ' C ' ' A' ' 60' ' ' ASN . 64.2 p -130.29 150.14 51.66 Favored 'General case' 0 C--N 1.337 0.053 0 CA-C-O 120.973 0.416 . . . . 0.0 110.288 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.5 mt -117.08 138.96 46.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.138 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.51 166.13 19.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.436 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.431 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -62.97 -50.5 76.56 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.803 -179.19 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.5 Cg_exo -50.85 -44.94 38.7 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.984 1.79 . . . . 0.0 111.824 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.89 -36.35 72.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.924 0.393 . . . . 0.0 110.994 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -59.99 -45.86 91.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.246 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.08 -44.54 95.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.594 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.7 m -67.41 -44.4 78.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.254 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.9 ttp -61.43 -40.13 93.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.023 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 76.1 mmm -63.05 -38.55 91.64 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.841 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.09 96.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.028 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -68.48 -45.53 72.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.052 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.61 -41.78 83.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.955 0.407 . . . . 0.0 110.33 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.8 mmt -86.96 164.42 16.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.14 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -116.22 153.61 31.56 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.043 0.449 . . . . 0.0 110.154 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -59.26 160.47 6.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.302 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.8 p -64.13 -30.08 71.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.586 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -64.47 -10.01 22.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.158 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -57.08 -32.82 66.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.516 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -49.44 -50.22 41.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.723 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -65.08 -41.89 94.6 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.987 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -66.32 -45.66 79.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.497 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.4 mt -64.91 -20.6 27.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.8 ttt-85 -59.68 -42.19 92.39 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.206 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -61.48 -35.88 78.89 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.477 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.17 -13.4 60.46 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -47.96 -51.12 24.92 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.0 0.428 . . . . 0.0 111.424 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -59.75 -46.85 87.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.825 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 85.0 t -68.84 -44.34 81.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.958 0.409 . . . . 0.0 110.466 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -59.44 -44.43 92.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.529 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 33.0 t70 -138.84 100.67 4.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.231 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.04 -40.01 82.94 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.207 0.527 . . . . 0.0 110.198 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.3 p-10 -60.13 -42.6 95.14 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.327 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.67 -56.97 0.5 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -70.75 -13.63 62.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.078 0.466 . . . . 0.0 110.267 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.6 161.19 12.85 Favored Glycine 0 N--CA 1.464 0.541 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -115.13 150.92 35.26 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.8 mt -85.25 123.16 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 121.002 0.43 . . . . 0.0 110.339 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.2 p -79.99 168.13 19.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.034 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.25 -36.49 82.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.611 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.17 -45.31 93.97 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.095 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -69.99 -37.68 75.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.208 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.4 tp -62.01 -42.89 99.65 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.241 0.544 . . . . 0.0 111.276 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -52.57 -43.21 65.1 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.055 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -55.5 -42.73 74.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.164 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.4 t -64.58 -42.48 95.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.292 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 58.5 mmm -57.56 -34.74 69.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.467 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.7 m -60.24 -42.3 94.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.445 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -58.66 -38.68 78.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.824 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 40.0 tp -61.31 -46.34 90.7 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.048 0.451 . . . . 0.0 110.13 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.89 -154.91 26.0 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -143.22 11.81 1.76 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.693 -0.253 . . . . 0.0 110.78 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -63.93 -43.96 94.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.153 0.502 . . . . 0.0 110.657 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.5 mt -79.75 160.32 26.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.033 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.479 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -68.51 161.67 27.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.221 -179.71 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -92.33 -21.06 20.48 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.112 0.482 . . . . 0.0 110.448 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -85.45 -26.91 26.06 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.219 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.612 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.68 -63.49 0.35 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.808 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.612 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 11.3 m -69.09 -31.38 49.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 121.234 -0.186 . . . . 0.0 111.46 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -58.82 -67.15 0.39 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.699 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.58 -45.14 72.8 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.521 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 13.3 tmm? -52.93 -50.3 64.28 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 125' ' ' ILE . 95.9 mt -64.61 -18.37 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.669 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -87.92 -57.91 2.76 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 119.904 -0.718 . . . . 0.0 112.25 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 128' ' ' ALA . 51.0 tp10 -81.95 -67.7 0.76 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.271 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.815 ' HB2' ' O ' ' A' ' 39' ' ' LEU . . . -36.83 -35.65 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 56.6 t0 -87.71 146.11 25.83 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.277 0.56 . . . . 0.0 110.568 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.566 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -89.39 -14.85 9.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.809 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 133' ' ' ASP . 44.8 m-20 -73.54 -45.36 54.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.032 0.444 . . . . 0.0 110.407 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.35 -10.28 3.73 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 131' ' ' ASP . 35.4 p30 -89.88 -10.4 45.42 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.836 0.351 . . . . 0.0 110.195 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 62.25 123.0 0.01 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -161.72 119.61 2.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.889 0.376 . . . . 0.0 110.101 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.67 128.93 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.093 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.523 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 45.2 t30 -155.1 166.2 34.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.071 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.401 ' O ' ' CD1' ' A' ' 138' ' ' TYR . 2.6 t80 -48.79 -23.02 0.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.459 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 50.1 mp0 -66.42 -35.74 81.06 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.152 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -84.97 -20.78 30.04 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.56 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.04 -46.7 87.99 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 121.134 -0.227 . . . . 0.0 111.166 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 30.1 t -58.31 -45.98 89.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.005 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -71.36 -36.14 71.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.293 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 61.5 ttp -57.94 -43.09 86.14 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.207 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 70.7 mtm -112.72 129.33 56.45 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.818 0.342 . . . . 0.0 110.414 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.5 m -162.88 85.77 0.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.096 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.1 -43.91 93.9 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.676 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 C--O 1.219 -0.527 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.507 179.879 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.07 0 CA-C-O 120.525 0.203 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -47.67 -48.62 28.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.102 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -59.44 -44.86 92.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.89 0.376 . . . . 0.0 110.484 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -63.42 -39.66 95.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.664 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.29 -41.29 85.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.343 . . . . 0.0 111.143 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.44 -22.72 66.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.82 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -55.59 -47.81 75.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.21 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.9 m -81.47 -17.19 49.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.476 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.93 -43.77 97.9 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.435 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.416 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.7 m-85 -60.48 -50.39 73.75 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.565 -179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.3 t0 -77.08 -14.64 59.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.191 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -45.01 -32.93 1.84 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.228 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.447 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 18.0 p-10 -54.71 -46.01 74.12 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 120.966 -0.293 . . . . 0.0 110.875 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -144.0 -151.09 5.38 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 32.3 p-10 -73.08 -47.03 47.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.714 0.292 . . . . 0.0 110.81 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.77 107.29 0.28 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.428 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 4.9 m -166.2 142.79 5.04 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.771 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.03 103.42 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.404 HG22 HG22 ' A' ' 62' ' ' THR . 2.9 p -123.11 169.96 10.69 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.1 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.605 ' CB ' HE22 ' A' ' 49' ' ' GLN . 61.1 p -63.14 -35.32 79.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.861 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -60.35 -38.46 83.88 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.447 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 87.7 mt-10 -65.64 -43.11 90.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.091 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.66 -41.96 98.14 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.258 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.71 -28.8 17.05 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.2 m -64.54 -44.15 91.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.95 0.405 . . . . 0.0 110.729 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.2 t -57.1 -17.61 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.175 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.541 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 87.7 mmm -53.03 -38.52 62.45 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.266 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.7 ttt85 -64.28 -45.97 85.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 117.444 -1.702 . . . . 0.0 110.722 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 92.8 p -63.41 -19.96 65.14 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.538 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.882 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 52.4 mt -99.58 6.12 45.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.904 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 34.9 94.55 0.01 OUTLIER Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.487 ' O ' ' O ' ' A' ' 40' ' ' GLY . 84.1 mt-30 52.23 110.25 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.619 0.247 . . . . 0.0 110.369 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 44' ' ' THR . 49.9 t30 -145.82 63.98 9.81 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.704 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.574 ' O ' ' N ' ' A' ' 46' ' ' ALA . 89.3 Cg_exo -34.72 -29.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.612 2.208 . . . . 0.0 112.325 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 42' ' ' ASN . 23.3 m -40.13 -29.61 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.124 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.541 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 90.7 mt-10 -89.63 -29.93 18.49 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.802 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -60.84 -49.15 78.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.822 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.469 ' HB2' HG23 ' A' ' 117' ' ' THR . 2.2 tm-20 -72.18 -43.18 64.96 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.25 0.548 . . . . 0.0 109.751 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.585 HD21 HD21 ' A' ' 116' ' ' LEU . 96.3 mt -67.97 -25.12 65.27 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.203 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.605 HE22 ' CB ' ' A' ' 29' ' ' THR . 53.8 tp60 -40.76 -41.89 1.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.603 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -77.64 -36.83 51.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.862 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.492 ' CE ' HD22 ' A' ' 48' ' ' LEU . 32.6 ttp -59.96 -37.28 79.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.677 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.59 HG21 HG22 ' A' ' 29' ' ' THR . 96.8 mt -63.44 -44.89 99.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.027 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.673 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 51.0 m-80 -62.54 -39.84 94.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.37 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -56.62 -56.42 21.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.294 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.476 HG13 ' N ' ' A' ' 56' ' ' ASP . 15.0 p -74.12 -40.38 51.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.851 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.502 ' OD2' ' N ' ' A' ' 62' ' ' THR . 44.4 t0 -71.2 -13.21 61.85 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.561 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.673 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.35 8.98 1.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.31 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 56' ' ' ASP . 10.4 p-10 -59.67 -26.76 65.82 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -155.06 -24.41 0.03 OUTLIER Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.551 ' C ' ' H ' ' A' ' 62' ' ' THR . 9.9 p30 176.19 151.19 0.14 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.582 -0.309 . . . . 0.0 110.178 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.28 36.35 0.09 OUTLIER Glycine 0 CA--C 1.535 1.294 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.551 ' H ' ' C ' ' A' ' 60' ' ' ASN . 44.2 p -137.45 153.31 50.12 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.5 mt -127.38 136.98 59.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.971 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -81.18 164.59 22.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.137 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.431 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -62.13 -50.11 81.71 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.227 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.6 Cg_exo -50.07 -41.73 48.0 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.074 1.849 . . . . 0.0 112.065 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -80.78 -29.83 36.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.111 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -59.53 -45.0 93.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.026 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.39 -43.21 99.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.279 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.1 m -64.43 -44.83 89.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.85 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.0 ttp -60.1 -44.69 94.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.829 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 79.4 mmm -63.8 -40.91 97.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.258 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.407 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -61.21 -47.86 84.18 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.865 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -71.25 -46.25 61.43 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.496 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -66.79 -45.19 79.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.993 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.407 ' O ' ' O ' ' A' ' 73' ' ' ALA . 17.8 mmm -99.5 -176.69 3.36 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.057 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -128.49 152.19 48.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.112 0.482 . . . . 0.0 110.177 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -54.2 177.74 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.359 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.2 p -80.6 -15.74 55.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.544 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -66.39 -13.67 61.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.397 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 83' ' ' GLU . 72.8 m -53.35 -34.38 57.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.548 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -39.0 -28.83 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.365 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 81' ' ' SER . 75.8 mm-40 -85.36 -54.84 4.33 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.004 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -58.48 -36.3 73.53 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.984 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.431 ' O ' HG22 ' A' ' 85' ' ' ILE . 96.7 mt -63.58 -20.04 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.1 ttt-85 -60.99 -45.06 96.34 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 118.351 -1.34 . . . . 0.0 109.627 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -64.67 -21.74 66.81 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.172 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.41 -17.51 48.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.466 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -57.05 -50.19 73.52 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.305 0.574 . . . . 0.0 110.556 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -68.6 -44.92 73.29 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.898 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.2 t -65.33 -49.09 80.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.028 0.442 . . . . 0.0 109.986 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.679 ' CE2' HD12 ' A' ' 100' ' ' ILE . 51.7 t80 -62.61 -45.19 94.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.878 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.412 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 22.2 t0 -120.54 104.57 10.07 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.056 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -66.38 -41.21 89.71 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.037 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -70.49 -41.55 72.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.042 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.91 -53.04 0.75 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -64.04 -20.05 65.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.98 0.419 . . . . 0.0 110.315 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.412 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.67 161.0 12.9 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -113.34 148.29 35.99 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.679 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -84.9 123.55 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.0 p -87.27 176.76 7.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.129 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.57 84.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.979 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.55 -51.32 69.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.886 0.374 . . . . 0.0 110.983 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -71.4 -30.51 66.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 49.6 tp -61.78 -41.02 97.18 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.235 0.54 . . . . 0.0 111.093 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -54.18 -41.49 68.59 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.918 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -57.94 -42.73 85.49 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.3 t -65.59 -43.1 94.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.691 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 91.6 mmm -62.59 -37.25 85.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.44 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.8 m -59.44 -40.49 86.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.639 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -58.59 -38.76 78.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.737 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.0 tp -61.07 -44.99 96.54 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.551 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.05 -145.37 12.16 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -143.52 16.3 1.83 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.827 0.346 . . . . 0.0 110.748 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -61.79 -44.93 95.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.014 0.435 . . . . 0.0 110.424 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.585 HD21 HD21 ' A' ' 48' ' ' LEU . 82.8 mt -82.12 161.38 22.86 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.981 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.471 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -66.13 161.73 21.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.685 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -91.58 -19.63 22.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.863 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -87.69 -28.11 22.01 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.63 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.34 -66.9 0.17 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.802 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.63 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.4 m -63.97 -39.32 85.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.468 ' N ' HG23 ' A' ' 121' ' ' VAL . 84.9 m-20 -54.33 -65.89 0.49 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.674 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 127' ' ' GLU . 80.6 mm-40 -70.42 -44.9 66.95 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.656 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 18.9 tmm? -53.04 -47.58 68.29 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.899 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 97.6 mt -67.18 -19.72 25.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.346 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -91.28 -66.72 0.9 Allowed 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.033 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 123' ' ' GLU . 25.0 tp10 -65.26 -68.62 0.35 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.161 -177.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.882 ' HB2' ' O ' ' A' ' 39' ' ' LEU . . . -37.11 -37.72 0.17 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.481 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 66.1 t0 -87.52 138.29 31.6 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.246 0.546 . . . . 0.0 110.583 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.592 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -85.82 -16.14 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.319 -179.683 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -73.06 -46.53 51.12 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.126 0.488 . . . . 0.0 110.146 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.95 -2.58 54.93 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 52.1 p30 -88.66 -22.25 23.52 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 64.65 103.64 0.01 OUTLIER Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -147.76 140.82 24.99 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.788 0.328 . . . . 0.0 110.141 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.1 t -128.95 134.31 64.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.313 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.526 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 53.4 t30 -151.56 -179.12 7.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.603 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -57.26 -48.14 79.63 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.259 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.526 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 55.8 mp0 -50.93 -43.66 60.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.353 -178.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -67.6 -39.84 84.76 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.967 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -60.71 -43.68 97.52 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.571 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.4 t -54.22 -43.92 62.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.239 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -84.29 -19.31 34.01 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.211 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 41.1 ttp -65.08 -41.32 95.15 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.94 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.404 ' O ' ' OG1' ' A' ' 146' ' ' THR . 51.7 mtm -103.71 132.7 49.73 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.867 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 145' ' ' MET . 43.6 m -166.83 81.79 0.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.053 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.77 -37.28 75.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.292 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.1 mttm . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.509 179.921 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.912 0.387 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -51.48 -43.23 62.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.738 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -66.97 -46.35 74.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.022 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -61.67 -44.78 96.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.795 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -67.98 -40.89 83.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.642 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.19 -28.42 67.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.971 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -55.56 -45.85 77.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.695 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.0 m -81.58 -17.88 46.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.733 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.5 tp -65.45 -42.36 92.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.952 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.401 ' O ' ' CD ' ' A' ' 31' ' ' GLU . 73.6 m-85 -61.05 -45.95 92.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.333 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 4.7 t0 -81.98 -15.65 53.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.341 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -42.84 -32.51 0.63 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.105 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.437 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 9.1 p-10 -53.59 -46.75 70.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.887 0.375 . . . . 0.0 110.72 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.437 ' N ' ' CG ' ' A' ' 22' ' ' ASP . . . -145.67 -147.3 4.58 Favored Glycine 0 N--CA 1.466 0.696 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 20.3 p-10 -76.53 -47.56 22.29 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.921 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.02 107.02 0.27 Allowed Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 177.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 96.0 m -166.73 143.14 4.64 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.936 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.06 117.09 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.831 0.348 . . . . 0.0 110.095 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.689 HG22 HG22 ' A' ' 62' ' ' THR . 12.3 p -133.38 165.6 24.47 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.429 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.429 ' HB ' HE22 ' A' ' 49' ' ' GLN . 80.2 p -63.08 -35.14 79.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.274 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -61.27 -38.48 86.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.076 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.415 ' OE2' ' CG ' ' A' ' 22' ' ' ASP . 91.3 mt-10 -64.71 -49.16 71.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.336 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.32 -43.6 98.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.277 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.17 -24.02 4.48 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.7 m -64.91 -42.47 94.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.903 0.382 . . . . 0.0 110.509 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.5 t -54.55 -16.33 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.26 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.453 ' O ' ' N ' ' A' ' 40' ' ' GLY . 53.4 mmm -58.71 -37.27 75.77 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -62.46 -46.16 89.76 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 116.724 -1.99 . . . . 0.0 110.66 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.9 p -60.11 -36.15 76.8 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.101 -178.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 41' ' ' GLN . 44.6 mt -95.85 2.08 53.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.723 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 66.25 -66.47 0.15 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' A' ' 39' ' ' LEU . 74.6 mt-30 -141.7 122.75 14.61 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.5 t-20 -141.43 71.11 26.55 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.653 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' ALA . 73.2 Cg_exo -37.45 -30.41 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.172 1.915 . . . . 0.0 112.186 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 42' ' ' ASN . 25.2 m -39.05 -27.61 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.477 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 49' ' ' GLN . 86.7 mt-10 -90.31 -36.92 14.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.005 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -56.28 -48.89 75.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.399 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -70.5 -45.02 66.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.292 0.568 . . . . 0.0 110.133 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.516 HD21 HD22 ' A' ' 116' ' ' LEU . 96.0 mt -70.06 -20.12 63.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.804 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 45' ' ' GLU . 11.7 tp-100 -46.39 -46.23 18.37 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.67 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -75.08 -35.28 61.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.199 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.431 ' CE ' HD22 ' A' ' 48' ' ' LEU . 33.1 ttp -63.63 -43.05 97.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.077 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 96.7 mt -62.8 -46.19 96.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.752 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.693 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 81.3 m-20 -64.66 -40.69 95.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.738 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.08 -56.84 16.74 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.421 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 56' ' ' ASP . 11.3 p -69.7 -36.96 72.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.985 0.421 . . . . 0.0 110.95 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.551 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.4 t0 -79.03 -12.7 60.03 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.423 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.693 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.12 15.46 0.16 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.349 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 10.4 p30 -65.75 -21.91 66.55 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.415 ' H ' ' H ' ' A' ' 60' ' ' ASN . . . -167.81 -9.62 0.03 OUTLIER Glycine 0 C--N 1.333 0.392 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.579 ' C ' ' H ' ' A' ' 62' ' ' THR . 2.0 p30 169.37 140.46 0.02 OUTLIER 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.0 35.88 0.1 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.689 HG22 HG22 ' A' ' 28' ' ' THR . 69.0 p -136.02 154.94 50.91 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 90.8 mt -130.05 132.08 65.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.219 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.14 151.99 42.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.612 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.445 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -54.87 -51.27 80.66 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.768 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 52.4 Cg_exo -49.12 -49.82 14.38 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.863 1.709 . . . . 0.0 112.106 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -68.6 -33.65 74.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.412 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -61.98 -43.77 98.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.997 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.2 mt -59.2 -45.61 90.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.789 0.328 . . . . 0.0 110.734 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.4 m -63.85 -44.73 92.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.463 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 36.4 ttp -60.01 -45.33 93.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.515 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.2 mmm -64.68 -39.33 93.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.565 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.32 -39.15 78.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.67 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -77.86 -51.46 10.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.424 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -65.6 -44.26 87.13 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.47 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.2 mmm -99.72 126.47 45.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.358 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -86.74 143.87 27.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.501 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 80' ' ' ASP . 97.2 m-20 -49.42 158.59 0.4 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.431 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 35.7 p -54.88 -8.73 0.28 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.642 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 78' ' ' ASP . 80.1 m-20 -67.11 -8.66 32.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.109 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.4 m -59.37 -29.61 67.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.637 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -37.87 -49.15 1.19 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.006 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.66 -55.08 19.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.909 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -59.63 -32.36 70.36 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.083 0.468 . . . . 0.0 110.629 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 85' ' ' ILE . 82.6 mt -69.2 -15.07 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -59.76 -48.88 79.91 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 117.508 -1.677 . . . . 0.0 110.377 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.2 -32.58 74.34 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.498 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.63 -35.98 73.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.789 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -50.59 -51.12 51.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.341 0.591 . . . . 0.0 110.908 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -69.24 -44.54 71.79 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.292 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.09 -51.45 48.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.113 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.558 ' CE2' HD12 ' A' ' 100' ' ' ILE . 66.6 t80 -63.45 -47.47 81.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.396 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.465 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 17.9 t0 -107.77 105.41 15.23 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.087 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -71.75 -44.87 63.32 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.598 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 44.9 p-10 -67.14 -33.64 75.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.054 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.526 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 66.56 -74.88 0.15 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -53.64 -13.07 0.58 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.922 0.391 . . . . 0.0 110.392 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.423 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.53 161.78 12.66 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -112.33 155.91 23.32 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.558 HD12 ' CE2' ' A' ' 92' ' ' PHE . 94.4 mt -99.78 117.43 44.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.7 p -82.1 175.69 10.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.151 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.95 -37.02 84.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.826 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.56 -52.43 64.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.791 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -67.7 -31.17 70.94 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.654 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.0 tp -64.15 -41.4 97.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.501 0.667 . . . . 0.0 110.997 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -53.86 -39.26 65.49 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.964 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -63.79 -41.23 97.98 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.1 -42.68 96.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.498 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 54.0 mmm -62.37 -40.75 97.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.979 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.4 m -61.69 -40.3 94.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.556 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -58.89 -40.45 84.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.614 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.9 tp -61.31 -44.27 97.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.964 0.411 . . . . 0.0 110.541 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 161.85 -151.91 22.16 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -138.31 29.15 2.47 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.806 0.336 . . . . 0.0 110.66 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -67.45 -45.32 76.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.824 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.516 HD22 HD21 ' A' ' 48' ' ' LEU . 19.6 mt -100.62 166.89 10.67 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.871 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.519 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -69.49 161.61 29.16 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.177 -179.595 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -92.71 -21.57 19.9 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.888 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -87.42 -23.56 24.47 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.637 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -35.09 -68.09 0.13 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.577 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.523 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 9.8 m -63.88 -42.09 94.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.517 ' N ' HG23 ' A' ' 121' ' ' VAL . 87.6 m-20 -48.33 -67.01 0.31 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.748 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.463 ' O ' ' OE1' ' A' ' 127' ' ' GLU . 80.3 mm-40 -70.54 -40.0 73.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.745 0.307 . . . . 0.0 111.801 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.404 ' SD ' ' C ' ' A' ' 124' ' ' MET . 17.7 tmm? -57.26 -38.93 74.62 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.669 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.8 mt -77.9 -23.76 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -77.61 -46.82 20.98 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 118.674 -1.211 . . . . 0.0 111.657 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 123' ' ' GLU . 19.6 mp0 -80.13 -68.41 0.68 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.661 -177.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.56 -49.02 1.05 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.629 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -88.46 131.07 35.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.896 0.379 . . . . 0.0 110.255 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.546 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -82.31 -10.69 12.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.148 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 133' ' ' ASP . 89.2 m-20 -64.35 -40.42 95.83 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.118 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.61 -8.4 4.28 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' A' ' 134' ' ' GLY . 26.1 p-10 -88.26 -12.72 42.84 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 39.39 98.07 0.01 OUTLIER Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.435 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 13.3 pt20 -131.09 136.94 48.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.021 0.439 . . . . 0.0 110.334 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.0 t -115.3 134.92 56.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.089 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.515 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 52.9 t30 -152.71 176.67 11.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.659 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -58.8 -47.97 82.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.406 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.515 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 58.0 mp0 -57.43 -25.54 59.79 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.293 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 81.1 mt-10 -84.82 -33.71 22.86 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.1 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -65.71 -46.84 77.44 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.634 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 50.3 t -56.35 -44.49 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 120.789 0.328 . . . . 0.0 110.253 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -71.63 -38.03 70.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.155 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 50.2 ttp -60.48 -48.55 81.26 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.291 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 49.1 mtm -88.62 120.81 30.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.945 0.402 . . . . 0.0 110.778 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.1 m -165.75 99.12 0.67 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.76 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.96 -38.31 88.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.582 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.8 mttm . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 117.821 -1.085 . . . . 0.0 110.509 179.982 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -88.71 117.41 27.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.476 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -82.74 -36.37 25.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.606 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 43.4 tp -99.28 122.69 42.78 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.137 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 p -137.9 158.9 43.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.328 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -67.76 -33.52 75.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.651 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -53.78 -44.12 69.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.826 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -57.65 -42.09 82.77 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.617 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.04 -43.16 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.575 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.97 -29.72 57.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.265 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -54.65 -48.32 72.45 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.528 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -65.62 -40.85 93.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.865 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -62.01 -44.05 97.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.659 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -66.98 -37.57 84.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.988 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.482 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.03 -27.9 65.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.806 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -57.81 -46.9 84.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.525 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 m -77.98 -21.41 50.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.691 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.0 tp -62.41 -42.83 99.73 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.419 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.482 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.3 m-85 -60.15 -51.02 71.4 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.439 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.2 t0 -76.9 -14.32 59.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.872 0.368 . . . . 0.0 111.366 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -45.59 -32.68 2.43 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.805 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 8.8 p-10 -53.72 -46.1 70.71 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.53 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.434 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -144.36 -151.6 5.47 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 30.8 p-10 -72.93 -47.28 47.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.733 0.301 . . . . 0.0 111.106 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.71 107.35 0.28 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 178.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.43 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 4.6 m -166.61 139.3 3.74 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.151 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 27' ' ' ILE . 5.2 mp -115.13 109.23 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.594 HG22 HG22 ' A' ' 62' ' ' THR . 2.6 p -128.72 170.24 13.53 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.882 0.373 . . . . 0.0 110.372 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.66 ' HB ' HE22 ' A' ' 49' ' ' GLN . 67.2 p -64.68 -33.05 75.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.789 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -61.69 -41.45 97.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.395 . . . . 0.0 109.983 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 26' ' ' THR . 90.0 mt-10 -63.4 -45.73 89.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.897 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.9 tp -64.16 -43.3 95.6 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.106 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.81 -26.07 53.5 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.1 m -63.9 -41.45 97.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.885 0.374 . . . . 0.0 110.098 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.1 t -56.23 -23.61 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.365 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.478 ' O ' ' N ' ' A' ' 40' ' ' GLY . 62.3 mmm -48.06 -30.27 4.29 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.667 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -64.36 -45.68 86.71 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 118.077 -1.449 . . . . 0.0 110.999 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -63.95 -21.96 66.71 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.837 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 41' ' ' GLN . 16.8 mt -107.73 3.7 24.87 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.097 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.2 -71.29 0.02 OUTLIER Glycine 0 N--CA 1.465 0.602 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 39' ' ' LEU . 87.8 mt-30 -145.44 109.45 4.83 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 44' ' ' THR . 41.4 t30 -125.56 70.88 65.21 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.091 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.551 ' O ' ' N ' ' A' ' 46' ' ' ALA . 84.7 Cg_exo -33.02 -30.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 122.63 2.22 . . . . 0.0 112.715 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 42' ' ' ASN . 26.3 m -39.27 -30.19 0.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.503 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.419 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.9 mt-10 -86.61 -34.96 19.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.291 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -59.07 -50.04 75.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.834 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.15 -46.07 71.78 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.176 0.512 . . . . 0.0 109.671 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 51' ' ' MET . 84.7 mt -64.87 -31.14 72.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.338 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.66 HE22 ' HB ' ' A' ' 29' ' ' THR . 8.7 tp-100 -37.42 -51.29 1.11 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.879 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.31 -40.32 89.89 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.228 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 48' ' ' LEU . 33.1 ttp -62.44 -41.02 98.44 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.934 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.413 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 83.4 mt -61.98 -49.85 82.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.182 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.604 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 89.8 m-20 -62.95 -40.46 97.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.56 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -55.18 -61.5 2.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.238 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.92 -30.12 43.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.261 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 62' ' ' THR . 50.6 t0 -84.66 -13.2 52.19 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.568 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.02 13.06 0.33 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.859 0.362 . . . . 0.0 110.254 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.8 p30 -65.54 -28.9 69.5 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -150.53 -22.37 0.06 OUTLIER Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 62' ' ' THR . 3.3 p30 173.17 151.84 0.08 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.93 34.64 0.14 Allowed Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.594 HG22 HG22 ' A' ' 28' ' ' THR . 81.9 p -134.34 149.46 50.86 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.4 mt -120.98 134.48 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.14 162.36 28.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.461 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.473 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -64.61 -48.16 74.56 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.432 -179.045 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 50.2 Cg_exo -51.17 -37.44 58.72 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.195 1.93 . . . . 0.0 111.719 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -87.48 -22.33 24.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.31 -47.25 86.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.014 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.44 -42.94 98.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.543 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.1 m -63.97 -46.08 86.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.672 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.6 ttp -61.66 -47.57 84.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.062 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 82.0 mmm -65.75 -37.82 87.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.275 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.62 -49.97 75.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.01 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -71.46 -43.83 65.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.18 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.69 -43.64 88.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.681 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.434 ' O ' ' O ' ' A' ' 73' ' ' ALA . 22.4 mmm -104.3 127.47 51.94 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.08 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.7 tptt -84.99 141.18 30.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.893 0.378 . . . . 0.0 110.706 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.422 ' O ' ' O ' ' A' ' 77' ' ' LYS . 95.1 m-20 -48.93 179.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.239 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.6 p -75.5 -6.74 51.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.444 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.52 -15.43 62.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.567 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.1 m -61.94 -19.94 63.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.539 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -48.15 -44.71 32.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.374 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.97 -39.51 79.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.913 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.86 -45.15 83.22 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.023 0.439 . . . . 0.0 110.187 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.2 mt -66.1 -19.05 25.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.514 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -58.43 -45.41 88.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.205 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.63 -31.83 73.07 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.916 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -72.04 -14.62 61.92 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.212 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -58.04 -48.96 78.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.292 0.567 . . . . 0.0 111.046 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -64.1 -45.6 87.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.328 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.14 -51.59 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.897 0.379 . . . . 0.0 110.896 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.441 ' CE2' HD12 ' A' ' 100' ' ' ILE . 26.3 t80 -61.95 -47.2 85.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.628 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.422 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 18.1 t70 -108.97 94.21 4.93 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.24 -41.03 74.08 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.001 0.429 . . . . 0.0 110.536 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 20.1 p-10 -62.49 -39.75 94.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.021 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.51 -67.34 0.99 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.59 -16.53 63.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.93 0.395 . . . . 0.0 110.25 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.71 162.03 12.57 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.29 155.38 24.17 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.786 0.327 . . . . 0.0 110.247 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.441 HD12 ' CE2' ' A' ' 92' ' ' PHE . 94.2 mt -79.73 125.99 39.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.978 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.4 p -82.39 169.01 16.94 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.141 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.56 -37.98 89.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.499 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.72 -47.36 83.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.847 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.66 -32.83 72.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.955 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.5 tp -61.59 -41.7 97.81 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.405 0.622 . . . . 0.0 110.68 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -56.42 -43.3 79.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.816 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -58.48 -41.96 86.45 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.62 -43.39 90.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.692 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.1 mmm -62.02 -35.58 79.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.685 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.9 m -61.13 -44.37 97.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.014 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -59.8 -34.96 73.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.382 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.1 tp -61.18 -46.7 89.42 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.121 0.486 . . . . 0.0 110.384 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.47 -160.71 33.43 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -140.55 23.33 2.31 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.634 0.254 . . . . 0.0 110.78 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -63.57 -42.86 98.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.97 0.414 . . . . 0.0 110.24 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.6 mt -92.8 175.85 6.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.996 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.469 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -72.93 161.32 30.84 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.679 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -91.66 -22.5 20.23 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.928 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -87.92 -25.26 23.31 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.152 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.638 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.4 -61.28 0.45 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.141 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.638 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 20.3 m -67.39 -40.18 84.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.486 ' N ' HG23 ' A' ' 121' ' ' VAL . 81.2 m-20 -56.86 -47.0 81.43 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.521 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -86.02 -40.33 15.9 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.6 tmm? -59.57 -46.52 88.67 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.015 0.436 . . . . 0.0 109.896 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 125' ' ' ILE . 91.9 mt -69.09 -16.58 20.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.475 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 -78.64 -50.53 11.31 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.085 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 129' ' ' ASP . 42.3 tp10 -87.65 -67.54 0.82 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.071 -0.651 . . . . 0.0 110.861 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.34 -26.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.745 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 127' ' ' GLU . 25.4 t0 -87.98 128.27 35.38 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.061 0.457 . . . . 0.0 111.091 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.673 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.47 -43.36 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.442 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -65.4 -40.31 93.25 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.132 0.491 . . . . 0.0 110.15 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.37 -2.0 58.92 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' GLY . 55.2 p-10 -89.47 -8.97 51.78 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 57.44 115.47 0.01 OUTLIER Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.24 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.434 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 20.3 pt20 -160.65 133.6 6.47 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.0 t -123.46 136.96 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.04 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -151.41 172.42 15.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.252 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -54.77 -46.75 74.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.161 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 139' ' ' GLU . 55.4 mp0 -58.73 -44.37 90.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.639 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 93.3 mt-10 -72.09 -29.33 64.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.753 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.86 -44.02 77.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.631 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 94.3 t -59.1 -46.34 91.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.289 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -69.37 -29.03 66.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.132 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.8 ttp -59.74 -42.82 94.03 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.832 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.49 138.87 50.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.912 0.387 . . . . 0.0 110.745 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 81.4 m -163.29 77.69 0.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.658 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.13 -27.75 68.95 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.451 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.695 -179.882 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -107.75 102.8 11.99 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.972 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -78.51 -8.58 58.71 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 49.8 tp -102.41 121.58 42.61 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.16 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.8 p -135.56 163.95 28.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.72 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -61.43 -31.44 71.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.369 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.89 -43.49 98.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.515 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -66.51 -41.15 89.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.931 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.23 -42.83 96.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.81 79.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.083 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -54.78 -50.55 68.21 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.0 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -63.77 -44.08 94.47 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.715 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -62.57 -45.92 90.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.484 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -69.82 -35.72 75.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.923 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.506 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -63.13 -37.78 88.58 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.511 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -58.43 -46.29 86.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.535 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.4 m -80.87 -18.87 45.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.746 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.51 -43.08 98.26 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.792 0.329 . . . . 0.0 111.291 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.9 m-85 -58.06 -49.22 77.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.541 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 6.3 t0 -73.17 -13.43 61.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.693 0.282 . . . . 0.0 111.229 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -44.49 -33.48 1.74 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.965 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.413 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 7.2 p-10 -53.97 -45.67 71.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.858 0.361 . . . . 0.0 110.96 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -149.07 -150.89 5.34 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 24.9 p-10 -70.16 -47.4 61.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.901 0.382 . . . . 0.0 110.983 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.53 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.79 107.84 0.3 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.445 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 6.3 m -166.21 139.5 4.11 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.112 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.2 mp -120.66 110.6 28.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.553 ' CG2' HG22 ' A' ' 62' ' ' THR . 2.8 p -130.99 169.33 15.98 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.978 0.418 . . . . 0.0 110.554 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.424 HG22 HG21 ' A' ' 52' ' ' ILE . 51.2 p -63.09 -31.45 72.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.304 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -62.14 -42.37 99.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.978 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.445 ' OE1' ' O ' ' A' ' 26' ' ' THR . 81.4 mt-10 -66.66 -45.9 77.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.004 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.92 -42.9 97.25 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.38 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.81 -25.04 28.52 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.9 m -63.96 -44.15 93.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.865 0.365 . . . . 0.0 110.743 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.414 ' H ' HG23 ' A' ' 35' ' ' VAL . 5.2 t -55.54 -20.43 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.521 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.513 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 87.5 mmm -48.97 -34.86 13.85 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.613 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -63.12 -46.39 87.53 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 118.056 -1.458 . . . . 0.0 111.83 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.5 p -60.85 -30.85 70.36 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 41' ' ' GLN . 24.8 mt -96.7 2.04 51.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.046 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.94 -67.91 0.02 OUTLIER Glycine 0 N--CA 1.467 0.743 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 39' ' ' LEU . 86.0 mt-30 -143.6 110.09 5.48 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -123.73 75.05 55.65 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.469 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 46' ' ' ALA . 99.3 Cg_exo -36.4 -35.74 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.743 1.629 . . . . 0.0 112.139 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.418 ' N ' ' HB3' ' A' ' 120' ' ' GLU . 5.8 m -37.84 -31.51 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.734 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.513 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.2 mt-10 -87.34 -35.97 18.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.336 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.52 -51.96 67.68 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -68.4 -47.17 68.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.25 0.548 . . . . 0.0 109.969 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.507 HD22 ' CE ' ' A' ' 51' ' ' MET . 85.0 mt -64.08 -26.8 68.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.967 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 45' ' ' GLU . 8.3 tp-100 -38.77 -46.42 1.26 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.72 0.295 . . . . 0.0 110.543 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.13 -41.72 66.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.536 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.507 ' CE ' HD22 ' A' ' 48' ' ' LEU . 40.1 ttp -62.17 -41.73 98.59 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.086 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.424 HG21 HG22 ' A' ' 29' ' ' THR . 96.6 mt -60.94 -51.97 67.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.354 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.621 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 85.8 m-20 -64.35 -40.08 95.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.668 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -55.53 -59.6 4.6 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.266 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.79 -34.42 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.012 0.434 . . . . 0.0 110.756 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 62' ' ' THR . 55.3 t0 -80.76 -13.56 58.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.53 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.2 16.12 0.14 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.294 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 56' ' ' ASP . 21.5 p-10 -66.04 -24.61 66.77 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -154.58 -25.57 0.04 OUTLIER Glycine 0 C--N 1.337 0.637 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.6 ' C ' ' H ' ' A' ' 62' ' ' THR . 10.9 p30 -179.99 150.84 0.39 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.405 ' C ' ' OD2' ' A' ' 56' ' ' ASP . . . -65.55 32.5 0.13 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.6 ' H ' ' C ' ' A' ' 60' ' ' ASN . 65.7 p -130.46 148.86 52.32 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.1 mt -118.47 133.9 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.069 0.461 . . . . 0.0 110.45 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.34 169.09 18.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.48 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.435 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -67.3 -49.47 43.37 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.212 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.8 Cg_exo -52.08 -45.29 39.91 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.927 1.751 . . . . 0.0 111.925 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.03 -37.01 72.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.661 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -60.58 -46.46 90.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.007 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.8 mt -62.27 -44.29 96.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.861 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.0 m -65.22 -44.61 87.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.916 0.389 . . . . 0.0 110.287 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 44.8 ttp -62.05 -41.91 98.63 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.812 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 76' ' ' MET . 60.2 mmm -63.29 -40.9 98.66 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.598 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.97 -35.81 77.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.778 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -87.76 -56.24 3.43 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.752 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -63.15 -43.27 98.77 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.138 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 72' ' ' MET . 50.8 mmm -108.9 131.56 54.91 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.943 0.401 . . . . 0.0 110.162 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 78' ' ' ASP . 29.0 tptt -83.12 150.07 26.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.792 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 77' ' ' LYS . 5.7 m-20 -55.45 -159.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.481 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.8 p -96.16 -0.3 50.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.479 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -82.87 2.48 34.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.128 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 83' ' ' GLU . 1.6 m -62.07 -35.63 79.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.971 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -37.92 -29.69 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.839 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 81' ' ' SER . 71.5 mm-40 -74.15 -56.85 4.42 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.065 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -64.71 -38.76 92.08 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.67 -19.29 14.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.462 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.1 ttt-85 -57.65 -44.04 85.37 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 118.79 -1.164 . . . . 0.0 110.201 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -65.96 -32.99 74.79 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.745 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -63.02 -27.96 69.77 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -55.61 -46.0 77.39 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.358 0.599 . . . . 0.0 110.432 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -74.44 -51.12 15.82 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.779 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.0 t -64.06 -47.92 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.082 0.468 . . . . 0.0 110.57 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.476 ' CE2' HD12 ' A' ' 100' ' ' ILE . 39.3 t80 -63.41 -45.9 88.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.246 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.479 ' OD2' ' N ' ' A' ' 96' ' ' GLY . 36.0 t70 -127.06 105.06 8.33 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.602 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -68.56 -42.09 78.85 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.935 0.398 . . . . 0.0 111.079 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 97' ' ' ASN . 1.5 p-10 -60.04 -46.59 89.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.801 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.479 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 73.78 -41.81 1.05 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.432 ' H ' ' C ' ' A' ' 95' ' ' ASP . 77.1 m-20 -80.25 -13.56 59.12 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.957 0.408 . . . . 0.0 110.002 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.96 161.22 12.81 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -113.25 149.9 33.17 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.694 0.283 . . . . 0.0 110.475 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.476 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -96.87 116.55 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.954 0.407 . . . . 0.0 111.177 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.2 p -84.35 170.72 13.34 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.309 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.59 86.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.136 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.17 -47.21 84.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.917 0.389 . . . . 0.0 110.548 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.55 -36.04 75.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.487 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.35 -40.08 95.22 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.619 0.723 . . . . 0.0 110.68 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -52.44 -45.12 65.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.625 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -61.51 -45.13 95.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.057 0.456 . . . . 0.0 110.437 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.85 -44.94 98.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.321 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 48.3 mmm -64.41 -37.07 86.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.457 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 82.6 m -61.08 -46.18 91.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.846 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -67.08 -24.56 65.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.19 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.0 tp -61.47 -44.87 96.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.923 0.392 . . . . 0.0 110.846 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.52 -148.81 15.57 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -140.39 25.92 2.2 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.498 0.19 . . . . 0.0 111.048 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -64.79 -45.35 86.66 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.954 0.407 . . . . 0.0 110.926 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.8 mt -113.55 170.64 8.09 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.991 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.482 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -69.43 161.54 29.23 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.934 0.397 . . . . 0.0 110.981 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -92.1 -24.0 19.27 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.806 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -88.06 -20.37 25.84 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.579 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.67 -67.42 0.16 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.579 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.9 m -64.48 -35.15 73.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -57.69 -66.52 0.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -64.37 -43.71 93.66 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.459 ' C ' ' SD ' ' A' ' 124' ' ' MET . 16.1 tmm? -57.32 -48.69 78.32 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.85 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.24 -23.79 30.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.209 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -77.17 -46.81 22.13 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 119.0 -1.08 . . . . 0.0 111.439 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -85.39 -68.22 0.74 Allowed 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.066 -0.653 . . . . 0.0 111.503 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.0 -33.37 0.08 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.45 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -94.66 146.73 23.94 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.826 0.346 . . . . 0.0 110.722 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.665 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -89.36 -17.35 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 179.461 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -65.48 -44.47 87.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.051 0.453 . . . . 0.0 110.552 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.44 -11.11 5.64 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 41.1 p-10 -89.08 -19.36 25.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.923 0.392 . . . . 0.0 110.501 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.546 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 55.38 106.12 0.01 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.476 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 11.1 pt20 -140.12 134.75 31.71 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 92.3 t -116.97 132.06 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.96 0.41 . . . . 0.0 110.201 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -142.75 175.41 9.83 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.566 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -58.16 -45.87 86.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.162 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 54.2 mp0 -63.63 -36.87 85.24 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.442 -178.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.476 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 78.3 mt-10 -67.14 -33.92 76.46 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.073 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -61.98 -40.6 96.19 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.45 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.7 t -57.22 -45.74 84.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.513 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -82.84 -15.84 50.02 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.836 0.35 . . . . 0.0 111.217 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 43.8 ttp -60.97 -41.03 95.59 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.906 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 78.2 mtm -118.54 141.69 48.33 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.815 0.341 . . . . 0.0 110.694 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.6 m -159.55 84.51 0.77 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.809 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.7 -40.47 72.85 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.124 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.501 -179.548 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -92.3 105.12 17.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.98 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -73.69 -16.05 61.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.157 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 54.9 tp -89.56 123.74 33.92 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.391 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.8 p -142.74 152.9 42.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.152 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -61.25 -20.89 63.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.38 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -60.74 -41.49 95.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.747 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -61.63 -44.27 97.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.525 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.6 mt -64.5 -43.46 96.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.673 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.97 -19.8 0.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.965 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -57.89 -44.61 86.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.483 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -62.66 -45.8 91.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.841 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -63.86 -46.75 83.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.736 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.52 -34.52 77.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.444 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.51 -13.83 61.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.762 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -55.95 -48.96 74.81 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.642 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -71.78 -30.01 65.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.934 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.6 tp -61.31 -42.41 98.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.38 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -60.11 -49.86 75.97 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.032 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 3.5 t70 -76.58 -14.39 60.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.245 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -43.67 -32.79 1.06 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.985 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 24.2 p-10 -53.8 -43.1 69.04 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.196 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -143.81 -155.89 6.6 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 29.1 p-10 -75.29 -47.26 28.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.846 0.355 . . . . 0.0 111.066 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.92 107.36 0.28 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 23.6 m -166.63 155.72 10.88 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.164 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.429 ' N ' HG22 ' A' ' 26' ' ' THR . 5.2 mp -122.79 91.1 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.069 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.3 p -98.09 173.02 7.24 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.414 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.4 p -63.55 -32.6 74.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.998 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -62.7 -41.48 99.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.912 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 26' ' ' THR . 83.9 mt-10 -66.73 -44.48 81.43 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.336 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.0 tp -63.19 -45.75 90.28 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.938 0.399 . . . . 0.0 110.66 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -45.96 -25.21 1.6 Allowed Glycine 0 C--O 1.226 -0.377 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.401 ' C ' ' N ' ' A' ' 36' ' ' MET . 14.7 m -63.23 -42.35 99.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.867 0.365 . . . . 0.0 110.026 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 82.6 t -49.46 -18.76 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.285 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.401 ' N ' ' C ' ' A' ' 34' ' ' THR . 89.2 mmm -59.62 -41.01 89.46 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.097 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.5 ttt85 -65.43 -43.87 89.13 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 118.185 -1.406 . . . . 0.0 111.133 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.3 p -58.14 -33.1 68.8 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.852 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.639 HD13 HD22 ' A' ' 42' ' ' ASN . 91.2 mt -97.33 7.05 47.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.611 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 42.96 97.21 0.01 OUTLIER Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 40' ' ' GLY . 87.0 mt-30 41.12 94.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.687 0.28 . . . . 0.0 110.485 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.639 HD22 HD13 ' A' ' 39' ' ' LEU . 48.8 t30 -130.35 75.68 78.8 Favored Pre-proline 0 N--CA 1.464 0.275 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 46' ' ' ALA . 95.0 Cg_exo -33.93 -26.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.367 2.044 . . . . 0.0 112.668 178.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.58 ' N ' ' O ' ' A' ' 42' ' ' ASN . 80.4 m -38.65 -25.97 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.564 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' PRO . 84.4 mt-10 -89.44 -33.38 16.84 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.499 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -56.58 -53.41 57.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.212 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.414 ' OE1' ' O ' ' A' ' 115' ' ' LYS . 1.5 tm-20 -67.96 -41.39 82.52 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.47 HD12 ' O ' ' A' ' 44' ' ' THR . 96.2 mt -73.02 -14.09 61.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.741 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' A' ' 45' ' ' GLU . 11.8 tp-100 -53.08 -47.3 68.64 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -67.05 -37.13 83.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.97 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.0 ttp -60.32 -40.79 91.84 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.27 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.23 -48.15 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.653 0.263 . . . . 0.0 111.378 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.609 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 93.6 m-20 -62.03 -39.58 92.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.301 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -55.8 -57.51 11.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.068 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 p -74.92 -29.35 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.274 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 62' ' ' THR . 42.8 t0 -85.15 -12.99 51.52 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.584 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -71.8 2.63 5.12 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.181 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.5 p-10 -52.51 -26.79 14.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -155.64 -27.69 0.03 OUTLIER Glycine 0 C--N 1.339 0.704 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.571 ' C ' ' H ' ' A' ' 62' ' ' THR . 17.7 p30 -177.51 145.71 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.18 36.02 0.09 OUTLIER Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.571 ' H ' ' C ' ' A' ' 60' ' ' ASN . 72.5 p -133.45 152.59 51.93 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.7 mt -122.39 136.39 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.99 0.424 . . . . 0.0 110.253 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.6 OUTLIER -72.64 172.47 10.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.189 -179.464 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.445 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -72.88 -48.73 8.07 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.28 -178.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.9 Cg_exo -53.89 -39.79 83.15 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.279 1.986 . . . . 0.0 111.849 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -76.4 -35.25 58.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.876 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -59.75 -50.29 74.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.066 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -66.27 -42.17 88.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.618 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.9 m -63.43 -48.34 78.2 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.996 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 45.6 ttp -62.82 -44.84 95.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.585 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 42.9 mmm -64.47 -39.54 94.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.703 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.16 -46.26 90.28 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.97 0.414 . . . . 0.0 110.255 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -72.33 -44.64 62.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.335 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -69.6 -46.39 66.41 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.869 0.366 . . . . 0.0 111.644 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 16.3 mmm -101.59 131.06 47.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.671 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 78' ' ' ASP . 48.2 tptt -84.68 148.2 26.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.885 0.374 . . . . 0.0 110.311 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 77' ' ' LYS . 85.7 m-20 -48.85 -179.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.289 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.43 HG22 HG23 ' A' ' 146' ' ' THR . 3.6 p -80.93 -8.86 59.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.422 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.02 -8.95 49.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.415 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 82' ' ' GLU . 9.4 m -61.01 -25.42 66.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 81' ' ' SER . 82.2 tt0 -37.2 -48.05 0.83 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.759 0.314 . . . . 0.0 110.833 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -71.14 -44.14 66.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.253 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -63.95 -39.01 93.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.019 0.438 . . . . 0.0 110.104 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.3 -23.33 33.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 56.1 ttt-85 -56.89 -43.17 81.03 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 118.698 -1.201 . . . . 0.0 109.848 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -63.11 -34.76 78.3 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.64 -22.28 64.42 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -56.91 -49.81 74.46 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.317 0.579 . . . . 0.0 110.971 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -63.69 -45.99 87.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.992 -1.003 . . . . 0.0 111.309 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.5 t -66.22 -48.39 81.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.975 0.417 . . . . 0.0 110.183 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -64.45 -48.33 75.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.615 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 96' ' ' GLY . 42.4 t0 -102.19 102.3 12.71 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.892 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.57 -41.52 88.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.106 0.479 . . . . 0.0 109.893 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -73.25 -42.67 62.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.261 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.456 ' H ' ' CG ' ' A' ' 93' ' ' ASP . . . 76.75 -51.29 3.06 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -76.39 -14.53 60.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.067 0.46 . . . . 0.0 110.114 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.16 162.42 12.42 Favored Glycine 0 N--CA 1.465 0.592 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -112.13 150.44 30.77 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 95.6 mt -88.42 122.52 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.065 0.46 . . . . 0.0 111.114 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.6 p -88.78 176.39 7.09 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.205 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.5 -36.44 82.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.808 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.71 -52.61 64.96 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.476 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -67.95 -37.44 81.59 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.198 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.8 tp -62.59 -41.29 98.86 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.57 0.7 . . . . 0.0 110.298 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -55.7 -43.5 76.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.711 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -55.84 -41.72 74.71 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.4 t -66.35 -42.55 90.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.651 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 63.7 mmm -60.97 -38.03 84.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.617 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.3 m -61.17 -39.84 91.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.654 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -57.55 -40.21 78.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.558 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.4 tp -62.14 -43.68 98.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 0.0 110.138 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 146.31 -144.77 13.21 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -137.32 28.81 2.76 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.647 0.26 . . . . 0.0 110.403 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.414 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 48.7 mtmt -62.39 -42.06 99.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.218 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.468 HD22 HD21 ' A' ' 48' ' ' LEU . 14.2 mt -95.83 168.26 10.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.154 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.472 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -63.76 161.7 14.72 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.819 0.342 . . . . 0.0 110.326 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -91.72 -22.42 20.22 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.539 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 120' ' ' GLU . 78.0 tt0 -86.17 -23.95 26.33 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.418 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.606 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -35.78 -64.38 0.31 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.564 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 14.4 m -63.93 -36.74 77.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.544 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.401 ' N ' HG23 ' A' ' 121' ' ' VAL . 43.8 m-20 -55.88 -66.67 0.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.596 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -69.69 -37.88 76.79 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.434 ' C ' ' SD ' ' A' ' 124' ' ' MET . 16.1 tmm? -59.07 -47.34 85.6 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.598 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.4 mt -70.18 -20.42 22.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.896 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -89.66 -60.24 1.99 Allowed 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.592 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -63.68 -68.34 0.35 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 119.519 -0.873 . . . . 0.0 111.405 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 39' ' ' LEU . . . -45.13 -26.98 0.53 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.42 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -87.76 126.12 34.82 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.028 0.442 . . . . 0.0 111.15 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.618 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -77.31 -23.45 14.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.422 179.255 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -74.95 -41.8 58.89 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.153 0.502 . . . . 0.0 110.004 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.79 2.24 56.44 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 41.7 p-10 -88.13 -18.54 28.57 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.36 111.15 0.04 OUTLIER Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -162.81 139.46 7.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.756 0.312 . . . . 0.0 110.26 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.9 t -126.22 132.98 69.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.182 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -146.73 166.76 25.65 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.187 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -49.35 -37.42 24.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.649 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -59.77 -33.94 72.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.015 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -75.5 -37.06 60.41 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -61.29 -49.77 75.71 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.8 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.5 t -49.39 -48.24 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.42 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -68.91 -39.43 79.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.9 ttp -60.61 -44.73 95.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.768 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.412 ' O ' ' OG1' ' A' ' 146' ' ' THR . 67.1 mtt -89.18 121.18 31.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.898 0.38 . . . . 0.0 110.43 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.43 HG23 HG22 ' A' ' 79' ' ' THR . 12.1 m -167.36 82.81 0.21 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.47 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.43 -46.2 89.65 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.815 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.456 -179.851 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -65.98 133.04 50.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.319 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.58 -25.54 45.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.457 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 53.3 tp -95.24 128.18 41.88 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.124 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.8 p -136.71 149.91 48.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.968 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -68.91 -20.25 64.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.247 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -59.16 -42.46 90.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.346 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.89 -45.04 91.16 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.915 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.8 mt -64.97 -42.9 95.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.799 0.333 . . . . 0.0 110.837 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -48.56 -26.7 2.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.183 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.41 -45.14 55.41 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.488 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -63.05 -44.01 97.07 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.907 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -63.84 -46.52 84.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.293 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -67.38 -43.58 81.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.904 0.383 . . . . 0.0 111.174 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.34 -36.48 80.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.409 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -55.72 -51.07 68.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.975 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -72.77 -23.45 60.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.735 0.302 . . . . 0.0 110.763 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.08 -42.24 99.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.705 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.406 ' O ' ' CD ' ' A' ' 31' ' ' GLU . 79.4 m-85 -59.55 -49.0 79.47 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.169 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.7 t0 -74.81 -13.67 60.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.528 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -43.09 -32.64 0.72 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.998 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 10.9 p-10 -53.3 -45.6 69.04 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.65 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -148.79 -149.18 4.91 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 32.2 p-10 -72.09 -46.89 55.03 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.698 0.285 . . . . 0.0 111.208 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.99 107.57 0.29 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 m -166.0 142.61 5.18 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.099 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.61 108.05 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.536 HG22 HG22 ' A' ' 62' ' ' THR . 2.4 p -128.39 169.82 13.82 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.965 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.788 ' HB ' HE22 ' A' ' 49' ' ' GLN . 75.7 p -64.77 -32.38 74.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.985 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -62.35 -41.42 98.58 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.579 -0.449 . . . . 0.0 109.901 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.406 ' CD ' ' O ' ' A' ' 19' ' ' PHE . 89.2 mt-10 -63.49 -45.82 88.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.808 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.8 tp -63.87 -45.0 91.39 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.122 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.87 -24.24 7.98 Favored Glycine 0 C--O 1.224 -0.493 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.5 m -64.98 -42.95 94.08 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.256 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.8 t -53.86 -18.23 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.291 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.43 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 91.3 mmm -57.36 -35.35 69.84 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.389 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -63.62 -43.94 95.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 118.004 -1.478 . . . . 0.0 110.148 -178.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.8 p -61.06 -35.76 77.8 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.844 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 41' ' ' GLN . 25.7 mt -96.36 3.61 52.8 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.944 0.402 . . . . 0.0 110.314 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.51 -66.9 0.02 OUTLIER Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 39' ' ' LEU . 80.8 mt-30 -145.05 104.8 4.01 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' A' ' 44' ' ' THR . 50.2 t30 -123.61 73.75 52.87 Favored Pre-proline 0 N--CA 1.466 0.371 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.159 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' A' ' 46' ' ' ALA . 80.4 Cg_exo -35.05 -32.61 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.58 2.186 . . . . 0.0 112.504 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.457 ' O ' HD12 ' A' ' 48' ' ' LEU . 29.1 m -38.25 -31.04 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.593 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 92.5 mt-10 -86.8 -35.89 18.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.327 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -57.44 -49.98 74.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.694 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.505 ' HB2' HG23 ' A' ' 117' ' ' THR . 1.4 tm-20 -70.47 -45.72 65.18 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.141 0.496 . . . . 0.0 109.666 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 44' ' ' THR . 86.6 mt -63.62 -31.43 72.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.948 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.788 HE22 ' HB ' ' A' ' 29' ' ' THR . 10.8 tp-100 -40.17 -54.79 2.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.681 0.276 . . . . 0.0 110.997 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -63.6 -41.52 98.32 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.722 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.6 ttp -61.26 -38.95 88.55 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.201 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.5 mt -62.94 -46.61 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.329 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.626 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 92.3 m-20 -62.81 -41.28 99.24 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.838 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -57.88 -57.16 14.01 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.644 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 p -70.45 -29.31 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.156 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 62' ' ' THR . 38.7 t0 -89.13 -12.48 40.93 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.849 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -71.62 13.46 0.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.484 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.472 ' H ' ' C ' ' A' ' 56' ' ' ASP . 38.9 p-10 -66.81 -28.79 68.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -149.62 -32.12 0.05 OUTLIER Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.628 ' C ' ' H ' ' A' ' 62' ' ' THR . 11.3 p30 -177.11 153.04 0.94 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.551 -0.324 . . . . 0.0 110.202 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.39 30.93 0.1 OUTLIER Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.628 ' H ' ' C ' ' A' ' 60' ' ' ASN . 57.9 p -127.56 146.07 50.64 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.4 mt -116.66 139.74 42.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.652 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.35 176.08 2.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.604 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.516 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -85.67 -46.68 0.6 Allowed Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.667 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 32.4 Cg_exo -55.89 -45.02 41.85 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.272 1.981 . . . . 0.0 111.756 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -70.05 -36.98 75.41 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -57.45 -41.77 81.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.458 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.17 -43.87 98.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.59 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.8 m -64.14 -43.19 96.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.875 0.369 . . . . 0.0 110.365 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 62.1 ttp -59.13 -43.62 92.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.527 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 88.5 mmm -64.83 -38.13 89.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.78 -46.3 84.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -72.88 -45.67 56.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.841 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -64.72 -45.06 88.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.056 0.455 . . . . 0.0 110.537 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 28.6 mmt -93.91 128.07 40.01 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.79 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -85.18 148.26 26.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.307 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -52.96 164.77 0.36 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.357 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 75.4 p -67.19 -21.5 65.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.634 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.13 -7.23 8.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.038 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.6 m -53.47 -34.73 59.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.447 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -38.17 -45.13 0.91 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -69.28 -44.87 70.97 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.008 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.56 -36.48 81.03 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.0 0.428 . . . . 0.0 110.296 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.47 -20.98 24.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -55.58 -45.19 77.43 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 118.758 -1.177 . . . . 0.0 109.539 -177.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -68.07 -33.09 73.89 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.195 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.96 -27.71 69.59 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -57.31 -51.39 69.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.294 0.568 . . . . 0.0 110.94 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -69.36 -45.22 69.9 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.699 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.6 t -68.13 -50.58 57.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.918 0.389 . . . . 0.0 110.769 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -63.39 -47.43 82.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.223 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.408 ' OD2' ' N ' ' A' ' 96' ' ' GLY . 22.5 t0 -110.07 107.63 17.55 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.801 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -68.91 -41.24 78.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.173 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 97' ' ' ASN . 1.1 p-10 -68.63 -37.39 79.68 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.257 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.408 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 67.69 -64.88 0.3 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 95' ' ' ASP . 56.0 m-80 -63.1 -14.38 47.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.958 0.409 . . . . 0.0 110.41 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.57 162.01 12.59 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -112.16 145.64 39.48 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 75.7 mt -83.72 125.08 40.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.038 0.447 . . . . 0.0 111.087 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.7 p -83.68 172.15 12.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.043 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.14 -39.07 92.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.012 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.62 76.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.869 0.366 . . . . 0.0 111.108 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.3 -33.18 74.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.652 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.6 tp -61.91 -43.11 99.52 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.408 0.623 . . . . 0.0 111.257 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -55.52 -43.22 75.54 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.883 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -60.35 -43.96 96.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.102 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 84.2 t -63.2 -45.22 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.695 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 86.7 mmm -63.61 -37.46 87.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.337 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 m -60.75 -41.02 94.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.603 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -55.5 -28.38 54.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.011 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.8 tp -60.88 -43.39 98.5 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.035 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 152.8 -141.76 8.71 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -137.58 27.23 2.78 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.7 0.286 . . . . 0.0 110.522 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -62.69 -43.43 98.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.013 0.435 . . . . 0.0 110.356 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 56.3 mt -108.9 -178.67 3.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.689 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.505 HG23 ' HB2' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -76.85 161.76 28.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.66 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -92.15 -22.12 20.03 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.099 0.476 . . . . 0.0 110.526 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -86.99 -24.17 24.78 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.14 -67.57 0.14 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.309 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.581 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 19.3 m -64.46 -34.24 68.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -57.08 -67.43 0.32 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.589 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -68.88 -38.01 79.41 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.418 ' C ' ' SD ' ' A' ' 124' ' ' MET . 15.2 tmm? -59.88 -47.09 87.18 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.035 0.445 . . . . 0.0 110.103 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 125' ' ' ILE . 97.6 mt -68.84 -16.86 21.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.144 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -80.18 -51.61 8.76 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.08 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 129' ' ' ASP . 44.1 tp10 -86.2 -68.2 0.76 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 118.978 -1.089 . . . . 0.0 111.362 -177.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 124' ' ' MET . . . -37.44 -25.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.635 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 127' ' ' GLU . 40.0 t0 -88.57 126.71 35.4 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.165 0.507 . . . . 0.0 110.849 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -65.46 -41.19 90.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.95 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.97 -42.87 99.61 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.755 0.312 . . . . 0.0 110.501 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.45 -0.92 62.83 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 50.2 p-10 -94.26 -18.57 21.53 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.894 0.378 . . . . 0.0 110.097 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.513 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 64.84 121.22 0.01 OUTLIER Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -164.45 144.5 7.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.57 -0.315 . . . . 0.0 110.272 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 72.7 t -128.62 134.36 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.39 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -150.98 176.3 11.25 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.105 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -56.15 -46.75 79.14 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.338 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -55.53 -37.92 68.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.579 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -69.16 -39.68 78.62 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.446 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -61.92 -43.12 99.5 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.0 t -58.03 -45.93 88.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.769 0.319 . . . . 0.0 110.657 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -77.07 -24.32 51.92 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.684 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 44.5 ttp -63.88 -41.14 97.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.727 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.415 ' O ' ' OG1' ' A' ' 146' ' ' THR . 64.6 mtt -91.36 130.38 37.22 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.929 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 145' ' ' MET . 36.0 m -167.44 67.8 0.09 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.583 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.42 87.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.32 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 66.4 mttm . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.913 179.606 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -81.88 115.42 21.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.444 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -81.42 -4.56 56.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.54 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 36.4 tp -84.77 123.55 30.55 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.15 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.5 p -79.83 156.17 27.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.136 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -75.84 -23.15 55.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.955 0.407 . . . . 0.0 110.216 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -62.03 -43.69 98.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.798 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -64.31 -41.99 96.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.881 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 91.3 mt -64.24 -43.54 97.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.722 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.82 -41.28 64.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.84 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -43.95 -48.24 8.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.653 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -65.97 -39.8 90.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.67 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -65.36 -48.14 73.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.237 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -64.14 -33.96 76.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.512 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.64 -19.88 12.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.543 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -57.45 -49.25 76.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.823 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.4 m -60.93 -40.84 94.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.552 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.55 -42.85 99.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.982 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -59.31 -49.84 76.27 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.849 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.466 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.5 t0 -75.97 -15.62 60.13 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.644 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -43.58 -33.25 1.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.787 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.433 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 14.5 p-10 -53.43 -43.45 68.02 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.466 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -145.57 -153.69 5.95 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 26.7 p-10 -74.79 -47.26 31.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 110.59 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.71 107.22 0.28 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 178.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.629 ' C ' HD12 ' A' ' 27' ' ' ILE . 8.4 m -166.65 149.91 6.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.143 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.629 HD12 ' C ' ' A' ' 26' ' ' THR . 2.8 mp -119.52 109.49 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.505 HG22 HG22 ' A' ' 62' ' ' THR . 4.1 p -130.98 169.68 15.5 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.908 0.385 . . . . 0.0 110.473 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.4 p -63.43 -29.57 70.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.182 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -62.16 -41.25 98.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.252 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.448 ' OE2' ' O ' ' A' ' 26' ' ' THR . 89.6 mt-10 -67.0 -45.72 76.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.98 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.3 tp -65.96 -44.43 85.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.409 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.93 -22.5 4.57 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.5 m -67.06 -30.2 70.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.78 0.324 . . . . 0.0 110.446 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.4 t -62.24 -22.99 30.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.809 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.0 mmm -56.0 -37.14 68.74 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.702 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -63.19 -44.2 96.05 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 116.771 -1.971 . . . . 0.0 110.06 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 91.6 p -60.45 -37.9 82.44 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.166 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 41' ' ' GLN . 39.1 mt -94.71 5.05 53.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.28 0.562 . . . . 0.0 110.505 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.46 -67.62 0.26 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 39' ' ' LEU . 84.1 mt-30 -147.87 104.98 3.63 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 44' ' ' THR . 58.7 t30 -123.24 76.8 52.48 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.06 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' A' ' 46' ' ' ALA . 72.0 Cg_exo -36.63 -29.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.582 2.188 . . . . 0.0 112.653 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.434 ' N ' ' HB3' ' A' ' 120' ' ' GLU . 11.4 m -38.46 -31.98 0.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.358 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 49' ' ' GLN . 96.8 mt-10 -88.77 -36.19 16.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.195 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -55.01 -49.8 70.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.558 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -69.85 -49.14 55.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.26 0.552 . . . . 0.0 110.258 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.91 -21.36 65.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.683 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 45' ' ' GLU . 10.8 tp-100 -45.55 -47.44 14.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.209 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 68.1 t0 -70.89 -38.6 73.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.492 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.1 ttp -62.38 -42.83 99.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.922 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 87.1 mt -63.53 -46.28 95.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.541 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.669 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 87.3 m-20 -64.02 -41.79 97.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.62 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -59.27 -59.15 5.92 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.491 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.8 p -66.07 -31.82 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.0 110.847 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.546 ' OD2' ' N ' ' A' ' 62' ' ' THR . 45.5 t0 -87.28 -12.6 46.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.737 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.24 13.01 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.048 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 56' ' ' ASP . 16.7 p-10 -63.98 -33.84 76.65 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.47 -26.41 0.08 OUTLIER Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.591 ' C ' ' H ' ' A' ' 62' ' ' THR . 16.5 p30 -178.25 148.21 0.47 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.513 -0.343 . . . . 0.0 110.262 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.92 34.23 0.1 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.591 ' H ' ' C ' ' A' ' 60' ' ' ASN . 70.7 p -129.68 151.49 50.21 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.0 mt -119.62 134.12 64.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.821 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -77.09 -155.43 0.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.042 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.49 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -96.52 -47.86 0.24 Allowed Pre-proline 0 N--CA 1.469 0.485 0 CA-C-O 120.501 0.191 . . . . 0.0 110.845 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 42.6 Cg_exo -54.93 -36.06 91.07 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.115 1.877 . . . . 0.0 111.606 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -83.61 -28.69 28.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.794 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -59.38 -46.42 88.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.7 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.0 -43.48 95.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.822 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.7 m -63.6 -45.29 91.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.113 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 46.8 ttp -62.18 -44.44 96.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.782 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 47.8 mmm -63.39 -42.2 98.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.718 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.77 -48.65 80.82 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.686 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -71.03 -50.13 37.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.565 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -64.67 -41.8 95.82 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.371 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.505 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 32.1 mmm -121.17 127.02 51.13 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.219 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -82.77 153.14 25.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.675 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -52.54 -179.96 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.282 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.0 p -80.97 -9.74 59.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.651 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -65.95 -21.65 66.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.419 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.7 m -50.58 -32.25 18.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.407 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -38.19 -45.71 0.98 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.716 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -69.12 -46.6 67.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.145 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -65.02 -49.52 69.89 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.9 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.5 mt -56.37 -21.14 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -57.94 -44.94 87.24 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 118.466 -1.294 . . . . 0.0 109.649 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -66.16 -25.95 67.19 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.6 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.81 -14.14 58.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.071 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -56.56 -50.68 71.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.298 0.57 . . . . 0.0 111.121 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -63.37 -44.49 94.64 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.203 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.6 t -66.64 -45.63 87.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.807 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.429 ' CE2' ' CD1' ' A' ' 100' ' ' ILE . 19.3 t80 -62.55 -47.23 84.79 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.643 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.431 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 37.3 t0 -119.94 106.56 12.16 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.242 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -68.14 -44.29 76.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.011 0.434 . . . . 0.0 110.58 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.431 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 0.9 OUTLIER -62.36 -44.47 96.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.779 -179.312 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.1 -47.41 1.05 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -74.6 -14.44 60.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.017 0.437 . . . . 0.0 110.541 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.79 161.79 12.64 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -112.19 144.38 41.68 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.429 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 64.7 mt -74.95 129.49 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.902 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.5 p -83.05 168.79 16.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.284 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.86 97.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.85 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.14 -41.7 94.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.701 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -67.32 -37.36 83.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.086 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.2 tp -60.21 -43.19 96.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.2 0.524 . . . . 0.0 110.682 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -54.07 -40.68 67.39 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.846 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -59.09 -42.2 89.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.893 0.377 . . . . 0.0 110.002 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.11 -44.92 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.745 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 80.9 mmm -63.51 -35.48 80.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.568 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.4 m -61.23 -41.71 97.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.251 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -59.8 -39.16 84.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.634 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.39 -44.29 97.4 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.582 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.69 -143.95 10.03 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -144.33 30.49 1.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.817 0.342 . . . . 0.0 110.766 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -62.87 -40.8 98.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.414 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.5 mt -105.25 165.94 10.76 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.485 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -65.15 161.52 18.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 0.0 110.51 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.445 ' C ' ' OE1' ' A' ' 120' ' ' GLU . 83.8 m-20 -91.28 -20.37 21.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 178.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -89.3 -26.11 21.31 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.684 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -34.91 -65.18 0.23 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.559 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.684 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 31.0 m -68.6 -27.46 36.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -178.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -63.25 -43.78 97.03 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.614 -0.435 . . . . 0.0 112.002 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -88.46 -41.07 13.0 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.471 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 15.0 tmm? -60.57 -42.67 97.11 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.898 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 125' ' ' ILE . 96.6 mt -69.98 -15.88 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -87.2 -66.69 0.88 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 118.971 -1.092 . . . . 0.0 112.003 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 128' ' ' ALA . 50.9 tp10 -70.97 -68.5 0.43 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.304 -0.959 . . . . 0.0 111.939 -176.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 124' ' ' MET . . . -37.31 -40.01 0.32 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.699 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -88.42 124.64 34.15 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.066 0.46 . . . . 0.0 110.436 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.697 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -72.24 -16.03 18.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.281 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.461 ' C ' ' H ' ' A' ' 133' ' ' ASP . 51.0 m-20 -65.36 -45.65 83.28 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.623 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.07 -11.48 2.67 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 42.0 p30 -88.51 -17.41 30.35 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.097 0.475 . . . . 0.0 110.15 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 58.35 120.73 0.01 OUTLIER Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.443 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 10.4 pt20 -161.02 137.88 8.77 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.4 t -125.59 134.17 67.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.874 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.468 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.4 t30 -148.98 159.56 44.1 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.232 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -40.04 -35.36 0.37 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.334 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.468 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 53.1 mp0 -65.8 -42.32 90.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.17 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 80.3 mt-10 -71.83 -30.18 65.2 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.538 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -58.5 -45.57 88.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.248 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 58.9 t -60.19 -48.2 89.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.914 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -70.05 -32.13 70.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.833 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.483 ' SD ' ' C37' ' A' ' 205' ' ' 4DY . 37.6 ttp -56.62 -47.69 79.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.696 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 69.7 mtm -106.1 134.1 49.76 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.844 0.354 . . . . 0.0 110.613 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 88.7 m -160.14 81.69 0.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.325 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 76' ' ' MET . . . -65.95 -40.52 91.41 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.885 0.374 . . . . 0.0 110.571 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.627 179.997 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 205' ' ' 4DY . . . . . 0.483 ' C37' ' SD ' ' A' ' 144' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -88.73 117.49 27.74 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.43 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -82.8 -36.34 25.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.607 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 43.3 tp -99.24 122.67 42.72 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.178 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 p -137.92 158.88 43.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.327 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -67.75 -33.58 75.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.582 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -53.73 -44.15 69.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.843 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -57.67 -42.09 82.86 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.6 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.99 -43.22 96.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.577 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.87 -29.79 56.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.288 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -54.7 -48.23 72.72 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.537 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -65.67 -40.84 92.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.824 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -62.04 -44.03 97.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.631 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -66.96 -37.58 84.54 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.998 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.482 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.0 -27.99 65.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.779 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -57.77 -46.95 83.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.526 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 m -77.9 -21.51 51.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.693 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.37 -42.81 99.7 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.431 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.482 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.2 m-85 -60.17 -51.01 71.43 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.462 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.1 t0 -76.89 -14.35 59.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.893 0.377 . . . . 0.0 111.358 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -45.56 -32.67 2.39 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.893 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 8.8 p-10 -53.73 -46.11 70.73 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.542 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -144.37 -151.62 5.48 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 30.7 p-10 -72.97 -47.19 47.54 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.074 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.7 107.37 0.28 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 178.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 4.5 m -166.62 139.28 3.72 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.38 -0.482 . . . . 0.0 111.179 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 27' ' ' ILE . 5.2 mp -115.13 109.23 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.596 HG22 HG22 ' A' ' 62' ' ' THR . 2.6 p -128.66 170.31 13.42 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.817 0.342 . . . . 0.0 110.442 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.66 ' HB ' HE22 ' A' ' 49' ' ' GLN . 67.3 p -64.66 -33.11 75.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.788 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -61.71 -41.32 97.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.011 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 26' ' ' THR . 90.1 mt-10 -63.49 -45.71 89.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.863 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.2 tp -64.1 -43.35 95.61 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.149 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.78 -26.1 53.29 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.2 m -63.93 -41.41 97.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.843 0.354 . . . . 0.0 110.084 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.7 t -56.24 -23.56 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.363 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.483 ' O ' ' N ' ' A' ' 40' ' ' GLY . 62.1 mmm -48.14 -30.27 4.41 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.671 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -64.38 -45.64 86.81 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 118.042 -1.463 . . . . 0.0 110.975 -178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -63.94 -21.98 66.72 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.852 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 41' ' ' GLN . 16.8 mt -107.75 3.7 24.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.086 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.19 -71.2 0.02 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 39' ' ' LEU . 87.8 mt-30 -145.43 109.47 4.84 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 44' ' ' THR . 41.3 t30 -125.61 70.87 65.55 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.552 ' O ' ' N ' ' A' ' 46' ' ' ALA . 84.8 Cg_exo -32.94 -30.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.65 2.233 . . . . 0.0 112.792 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.542 ' N ' ' O ' ' A' ' 42' ' ' ASN . 26.1 m -39.29 -30.15 0.06 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.545 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.417 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.9 mt-10 -86.67 -34.85 19.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.332 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -59.04 -50.14 75.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.799 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.15 -46.13 71.63 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 51' ' ' MET . 84.5 mt -64.81 -31.07 72.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.382 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.66 HE22 ' HB ' ' A' ' 29' ' ' THR . 8.7 tp-100 -37.5 -51.36 1.14 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.74 0.305 . . . . 0.0 110.761 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.22 -40.33 90.22 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.259 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 48' ' ' LEU . 33.1 ttp -62.45 -40.98 98.37 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.948 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.415 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 83.5 mt -61.99 -49.9 82.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.142 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.603 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 89.9 m-20 -62.99 -40.36 97.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.597 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -55.19 -61.52 2.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.213 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.87 -30.21 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.341 . . . . 0.0 111.28 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 62' ' ' THR . 50.6 t0 -84.63 -13.24 52.15 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.574 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -71.99 13.07 0.33 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.871 0.367 . . . . 0.0 110.284 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.5 p30 -65.58 -28.92 69.49 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.535 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -150.48 -22.34 0.06 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.552 ' C ' ' H ' ' A' ' 62' ' ' THR . 3.3 p30 173.14 151.87 0.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.99 34.71 0.15 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.596 HG22 HG22 ' A' ' 28' ' ' THR . 81.7 p -134.33 149.49 50.87 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.6 mt -120.98 134.57 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.26 162.4 28.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.41 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.471 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -64.56 -48.12 74.99 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.513 -179.076 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 50.5 Cg_exo -51.3 -37.29 59.76 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.195 1.93 . . . . 0.0 111.71 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -87.59 -22.3 24.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.836 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.42 -47.14 87.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.048 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.54 -42.89 98.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.549 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.8 m -63.95 -46.08 86.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.647 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.6 ttp -61.69 -47.56 84.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.077 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.9 mmm -65.76 -37.85 87.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.282 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.53 -50.01 75.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.031 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -71.51 -43.75 65.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.203 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.73 -43.56 88.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.733 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.431 ' O ' ' O ' ' A' ' 73' ' ' ALA . 22.4 mmm -104.35 127.44 52.01 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.094 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.7 tptt -84.96 141.17 30.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.38 . . . . 0.0 110.712 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' LYS . 95.0 m-20 -48.92 179.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.226 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.8 p -75.53 -6.76 51.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.418 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.44 -15.54 62.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.509 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.0 m -61.92 -19.87 63.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.548 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -48.19 -44.76 33.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.342 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.95 -39.52 79.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.905 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.82 -45.22 83.11 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.006 0.431 . . . . 0.0 110.152 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.2 mt -66.04 -19.04 25.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.525 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -58.47 -45.38 88.73 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.218 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.64 -31.81 73.04 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.928 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.406 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -72.03 -14.69 61.94 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.138 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -57.94 -48.99 78.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.297 0.57 . . . . 0.0 111.116 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -64.09 -45.58 88.07 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.36 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.7 t -76.17 -51.54 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.381 . . . . 0.0 110.894 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.446 ' CE2' HD12 ' A' ' 100' ' ' ILE . 26.3 t80 -61.98 -47.22 85.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.598 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.43 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 18.2 t70 -108.95 94.15 4.89 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.21 -41.04 74.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.02 0.438 . . . . 0.0 110.578 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 19.9 p-10 -62.48 -39.74 94.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.969 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.44 -67.33 0.97 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.56 -16.52 63.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.917 0.389 . . . . 0.0 110.228 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.78 162.0 12.57 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.2 155.4 24.04 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.811 0.338 . . . . 0.0 110.237 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.446 HD12 ' CE2' ' A' ' 92' ' ' PHE . 94.0 mt -79.76 126.04 39.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.965 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.3 p -82.45 168.94 16.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.181 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.07 89.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.557 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.59 -47.4 83.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.65 -32.8 72.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.5 tp -61.57 -41.69 97.77 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.423 0.63 . . . . 0.0 110.691 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -56.51 -43.23 79.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.845 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -58.47 -41.96 86.42 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.7 t -66.64 -43.35 90.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.656 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.0 mmm -62.01 -35.65 79.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.634 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.4 m -61.04 -44.39 97.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.071 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -59.8 -34.99 73.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.348 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.0 tp -61.12 -46.75 89.29 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.068 0.461 . . . . 0.0 110.375 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.46 -160.71 33.42 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -140.53 23.38 2.31 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.654 0.264 . . . . 0.0 110.835 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -63.66 -42.82 98.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.983 0.42 . . . . 0.0 110.237 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.7 mt -92.8 175.8 6.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.965 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.468 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -72.87 161.33 30.84 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.672 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -91.69 -22.5 20.2 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.945 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -87.88 -25.35 23.31 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.167 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.637 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.44 -61.19 0.46 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.114 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.637 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 20.4 m -67.4 -40.21 84.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.492 ' N ' HG23 ' A' ' 121' ' ' VAL . 81.2 m-20 -56.76 -47.1 80.86 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.51 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -86.0 -40.3 15.95 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.6 tmm? -59.52 -46.49 88.69 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.061 0.458 . . . . 0.0 109.954 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 125' ' ' ILE . 91.3 mt -69.2 -16.49 20.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.409 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -78.62 -50.61 11.19 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 119.397 -0.921 . . . . 0.0 112.09 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' ASP . 42.4 tp10 -87.64 -67.47 0.82 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.897 -178.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.37 -26.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.784 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' GLU . 25.4 t0 -88.02 128.32 35.4 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.092 0.472 . . . . 0.0 111.073 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.666 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.51 -43.42 90.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.404 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -65.35 -40.28 93.41 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.122 0.487 . . . . 0.0 110.164 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.3 -1.98 58.67 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.334 -1.107 . . . . 0.0 110.334 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 134' ' ' GLY . 55.3 p-10 -89.53 -8.96 51.66 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 57.44 115.43 0.01 OUTLIER Glycine 0 CA--C 1.522 0.525 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.229 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 20.3 pt20 -160.62 133.59 6.5 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.4 t -123.45 136.92 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.066 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -151.36 172.5 15.82 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.221 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -54.8 -46.82 74.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.152 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 139' ' ' GLU . 55.5 mp0 -58.65 -44.32 90.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.71 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 93.3 mt-10 -72.09 -29.34 64.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.763 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.9 -43.99 77.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.587 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 94.7 t -59.1 -46.32 91.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.301 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.33 -29.13 66.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.136 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.7 ttp -59.69 -42.87 93.91 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.841 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.48 138.81 50.64 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.913 0.387 . . . . 0.0 110.754 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 80.8 m -163.19 77.73 0.43 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.664 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.19 -27.74 68.9 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.414 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.86 -1.067 . . . . 0.0 110.625 -179.853 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 4' ' ' LEU . 43.5 t0 -88.7 115.92 26.59 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.699 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -78.81 -25.38 44.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.547 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.419 ' O ' ' OD1' ' A' ' 2' ' ' ASP . 37.1 tp -109.52 120.29 42.03 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.024 0.44 . . . . 0.0 110.33 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.2 p -139.05 158.8 43.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.043 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -68.7 -20.9 64.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -56.59 -39.29 73.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.15 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.28 -40.28 95.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.624 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.26 -43.59 97.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 121.074 -0.251 . . . . 0.0 110.863 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.25 -18.81 6.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.216 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -54.33 -42.25 69.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.044 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -67.78 -41.79 82.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.381 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -62.57 -43.76 98.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.956 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -67.2 -35.77 80.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.398 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.51 -24.17 66.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.768 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -55.4 -46.5 76.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.777 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.4 m -80.68 -19.41 45.26 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.808 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.18 -41.95 96.89 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.019 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.421 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.2 m-85 -58.84 -46.13 88.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.852 0.358 . . . . 0.0 111.107 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.3 t0 -79.58 -13.47 59.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.461 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -43.02 -32.77 0.71 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.867 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' CG ' ' OE2' ' A' ' 31' ' ' GLU . 10.9 p-10 -52.91 -45.13 67.44 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.49 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.433 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . -149.66 -151.26 5.46 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 21.3 p-10 -71.2 -46.86 60.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.712 0.292 . . . . 0.0 111.005 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.03 107.39 0.28 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.595 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.8 m -166.59 136.22 3.09 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.191 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 27' ' ' ILE . 1.9 mp -110.58 118.27 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.464 HG22 HG22 ' A' ' 62' ' ' THR . 2.0 p -134.73 167.08 21.5 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.881 0.372 . . . . 0.0 110.285 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.536 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.3 p -64.13 -33.65 76.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.283 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -62.56 -40.16 95.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.707 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.457 ' OE2' ' O ' ' A' ' 26' ' ' THR . 88.9 mt-10 -64.68 -48.51 74.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.366 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.8 tp -64.42 -43.75 93.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.252 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.31 -24.69 17.01 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -64.08 -41.04 97.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.851 0.358 . . . . 0.0 110.151 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.04 -22.47 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.207 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.6 mmm -48.78 -33.56 10.6 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.969 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -64.3 -45.5 87.69 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 118.163 -1.415 . . . . 0.0 110.272 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.3 p -59.0 -30.65 68.14 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.356 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 41' ' ' GLN . 9.3 mt -102.33 5.47 39.89 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.966 0.412 . . . . 0.0 110.443 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.27 -69.79 0.03 OUTLIER Glycine 0 N--CA 1.465 0.588 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 39' ' ' LEU . 85.7 mt-30 -143.25 116.29 8.88 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.1 t30 -132.66 69.75 79.45 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.906 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 46' ' ' ALA . 92.0 Cg_exo -33.1 -33.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 122.527 2.151 . . . . 0.0 112.49 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 42' ' ' ASN . 12.4 m -38.99 -29.35 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.476 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 43' ' ' PRO . 90.6 mt-10 -87.65 -35.22 18.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.463 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -61.26 -49.17 78.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.027 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.434 ' HB2' HG23 ' A' ' 117' ' ' THR . 3.1 tm-20 -68.03 -48.61 65.18 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.403 0.621 . . . . 0.0 109.889 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.515 HD22 ' CE ' ' A' ' 51' ' ' MET . 87.4 mt -62.62 -22.75 66.64 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.018 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.536 HE22 ' CB ' ' A' ' 29' ' ' THR . 47.9 tp60 -40.21 -49.58 2.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 110.532 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.69 -39.8 73.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.472 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.515 ' CE ' HD22 ' A' ' 48' ' ' LEU . 36.1 ttp -61.54 -40.59 95.23 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.765 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.78 -46.93 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.658 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.653 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 28.3 m120 -65.17 -39.84 93.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.333 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -58.08 -57.23 13.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.434 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 p -68.31 -32.83 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.936 0.398 . . . . 0.0 110.964 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.0 t0 -86.08 -13.03 48.51 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.812 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.653 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.04 15.42 0.16 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.056 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 56' ' ' ASP . 38.7 p-10 -66.66 -23.55 66.16 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.39 -22.56 0.03 OUTLIER Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.588 ' C ' ' H ' ' A' ' 62' ' ' THR . 4.6 p30 179.31 146.55 0.19 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.76 33.71 0.18 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.588 ' H ' ' C ' ' A' ' 60' ' ' ASN . 80.6 p -132.15 143.93 50.33 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.88 135.12 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.057 0.456 . . . . 0.0 110.175 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.42 172.34 4.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.441 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.438 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -72.53 -49.59 8.56 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.761 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 53.2 Cg_exo -52.07 -43.26 53.95 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.87 1.714 . . . . 0.0 111.902 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.46 -37.43 77.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 110.867 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -60.42 -45.38 93.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.962 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.9 mt -62.39 -44.57 96.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.523 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.5 m -67.45 -45.43 76.03 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 111.242 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.4 ttp -61.17 -43.69 98.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.928 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 87.0 mmm -64.75 -39.36 93.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.206 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.435 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.89 -42.83 94.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.89 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -71.52 -41.78 68.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.237 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -64.76 -40.92 96.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.86 0.362 . . . . 0.0 110.422 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.435 ' O ' ' O ' ' A' ' 73' ' ' ALA . 14.2 mmt -95.21 129.82 42.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.129 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -86.84 142.8 27.8 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -50.35 168.77 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.425 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.0 p -75.15 -15.21 60.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.683 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.98 -16.5 64.08 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.908 0.385 . . . . 0.0 110.439 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 82' ' ' GLU . 1.1 m -60.41 -23.76 64.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.759 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 81' ' ' SER . 81.2 tt0 -36.75 -48.49 0.73 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.893 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -70.76 -43.52 68.62 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.262 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -63.88 -39.59 94.55 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.961 0.41 . . . . 0.0 110.025 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.5 mt -66.95 -21.92 28.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.287 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -57.97 -43.6 86.58 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 119.047 -1.061 . . . . 0.0 110.063 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -63.74 -34.76 78.61 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.846 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.8 -19.91 66.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.056 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -56.57 -48.75 76.7 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.261 0.553 . . . . 0.0 110.848 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -68.29 -44.71 74.86 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.462 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.7 t -66.3 -48.37 81.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.443 ' CE2' HD12 ' A' ' 100' ' ' ILE . 23.4 t80 -64.01 -47.11 81.58 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.654 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.405 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 18.4 t70 -120.35 100.14 6.99 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -66.74 -39.75 88.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.745 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' ASN . 2.0 p-10 -65.66 -40.59 92.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.102 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.62 -59.49 0.48 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 95' ' ' ASP . 54.0 m-80 -61.88 -17.44 56.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.986 0.422 . . . . 0.0 110.2 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.405 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.56 160.91 12.96 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -113.23 155.56 24.85 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.443 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -95.74 118.25 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.966 0.412 . . . . 0.0 111.12 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.9 p -85.53 171.38 11.78 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.89 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.74 -35.73 78.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.551 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.5 -50.78 72.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.158 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -69.29 -37.36 77.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.922 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.03 -39.4 94.62 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.538 0.685 . . . . 0.0 111.07 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -54.22 -43.62 70.98 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.121 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -63.1 -39.49 94.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.3 t -61.82 -45.26 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.151 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 37.7 mmm -64.31 -37.94 89.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.562 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.0 m -60.58 -40.16 90.73 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -61.25 -38.12 85.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.204 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 tp -61.53 -44.09 97.69 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.907 0.385 . . . . 0.0 110.25 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.98 -154.71 25.68 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -139.02 23.35 2.6 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.722 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -62.66 -43.22 99.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 0.0 110.314 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.9 mt -99.95 169.07 9.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.525 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.493 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -68.35 162.17 25.85 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.556 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -92.15 -22.28 19.94 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.434 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -87.26 -24.47 24.36 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.58 -66.06 0.21 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.254 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.626 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.7 m -65.19 -35.28 75.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.363 -178.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -60.51 -46.75 88.98 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.54 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -84.87 -40.4 17.12 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.3 tmm? -58.91 -47.21 85.79 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 125' ' ' ILE . 94.2 mt -69.16 -18.37 22.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.553 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -77.4 -51.39 10.89 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.274 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 129' ' ' ASP . 34.9 tp10 -86.31 -68.67 0.72 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.341 -0.943 . . . . 0.0 111.456 -177.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.69 -21.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.877 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 127' ' ' GLU . 38.7 t0 -90.14 125.02 35.3 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.07 0.462 . . . . 0.0 110.657 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.643 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.46 -32.09 56.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.018 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -72.19 -45.8 58.9 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.907 0.384 . . . . 0.0 110.347 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.68 -5.47 61.16 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 134' ' ' GLY . 35.2 p30 -89.94 -9.67 47.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.962 0.411 . . . . 0.0 109.934 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 58.22 117.93 0.01 OUTLIER Glycine 0 CA--C 1.519 0.294 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 8.2 pt20 -159.76 140.11 11.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.53 -0.335 . . . . 0.0 110.137 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.7 t -126.23 133.24 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.915 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.544 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.8 t30 -150.69 175.39 12.0 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.337 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -57.67 -52.1 66.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.761 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.544 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 57.2 mp0 -55.93 -35.02 66.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.668 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 79.4 mt-10 -69.55 -39.25 77.53 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.694 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -61.26 -45.33 94.97 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.753 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.1 t -58.01 -45.9 87.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -74.2 -30.84 62.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.413 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.4 ttp -60.08 -40.62 90.21 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.621 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 72.9 mtm -105.21 141.73 36.24 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.921 0.391 . . . . 0.0 110.589 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.1 m -167.3 72.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.119 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.58 -41.83 97.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.587 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 C--O 1.218 -0.561 0 CA-C-O 118.066 -0.968 . . . . 0.0 110.269 -179.89 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -107.79 102.8 11.98 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.974 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -78.48 -8.58 58.68 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 50.0 tp -102.46 121.59 42.64 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.167 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.2 p -135.52 163.96 28.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.685 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -61.39 -31.51 71.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.372 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.86 -43.55 98.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.472 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -66.57 -41.08 89.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.868 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.22 -42.92 96.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.048 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.36 -36.78 78.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.155 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -54.83 -50.58 68.24 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.997 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -63.74 -44.06 94.63 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.772 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -62.57 -45.94 90.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.484 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -69.69 -35.84 75.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.959 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -63.08 -37.79 88.59 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.492 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -58.47 -46.27 86.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.522 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -80.92 -18.82 45.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.735 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.49 -43.14 98.13 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.746 0.308 . . . . 0.0 111.283 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 83.0 m-85 -57.97 -49.27 77.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.586 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 6.3 t0 -73.15 -13.4 61.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.756 0.313 . . . . 0.0 111.27 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -44.49 -33.52 1.75 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.761 0.315 . . . . 0.0 110.959 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.414 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 7.2 p-10 -53.98 -45.69 71.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.86 0.362 . . . . 0.0 110.946 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.443 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . -149.01 -150.86 5.32 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 25.1 p-10 -70.2 -47.37 61.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.948 0.404 . . . . 0.0 111.006 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.527 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.81 107.81 0.3 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.444 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 6.2 m -166.21 139.46 4.09 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.139 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.2 mp -120.63 110.51 28.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.552 ' CG2' HG22 ' A' ' 62' ' ' THR . 2.8 p -130.95 169.38 15.88 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.025 0.44 . . . . 0.0 110.566 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.421 HG22 HG21 ' A' ' 52' ' ' ILE . 51.2 p -63.07 -31.43 72.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.394 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -62.11 -42.35 99.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.99 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 26' ' ' THR . 81.5 mt-10 -66.74 -45.84 77.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.004 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.9 tp -63.93 -42.9 97.24 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.396 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.76 -25.11 28.42 Favored Glycine 0 C--O 1.226 -0.36 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.0 m -63.96 -44.1 93.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.934 0.397 . . . . 0.0 110.796 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.3 t -55.54 -20.49 7.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.527 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.509 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 87.4 mmm -48.9 -34.89 13.62 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.625 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -63.12 -46.4 87.5 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 118.005 -1.478 . . . . 0.0 111.851 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.0 p -60.75 -30.89 70.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 41' ' ' GLN . 24.9 mt -96.75 2.13 51.62 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.974 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.92 -67.94 0.02 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.532 ' N ' ' O ' ' A' ' 39' ' ' LEU . 86.1 mt-30 -143.59 110.07 5.47 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -123.72 75.03 55.56 Favored Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.461 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.577 ' O ' ' N ' ' A' ' 46' ' ' ALA . 99.5 Cg_exo -36.45 -35.69 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.732 1.621 . . . . 0.0 112.13 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.421 ' N ' ' HB3' ' A' ' 120' ' ' GLU . 5.9 m -37.83 -31.49 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.763 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.509 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.2 mt-10 -87.35 -36.03 18.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.316 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.47 -51.97 67.6 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.866 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -68.39 -47.21 67.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.304 0.573 . . . . 0.0 109.958 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.51 HD22 ' CE ' ' A' ' 51' ' ' MET . 84.7 mt -64.09 -26.81 68.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.917 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 48' ' ' LEU . 8.3 tp-100 -38.82 -46.35 1.27 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.751 0.31 . . . . 0.0 110.566 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.17 -41.69 66.74 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.54 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.51 ' CE ' HD22 ' A' ' 48' ' ' LEU . 40.0 ttp -62.14 -41.73 98.55 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.076 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.421 HG21 HG22 ' A' ' 29' ' ' THR . 96.6 mt -60.92 -51.99 66.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.39 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.625 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 85.8 m-20 -64.29 -40.03 95.13 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.71 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -55.61 -59.58 4.65 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.259 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.79 -34.43 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.99 0.424 . . . . 0.0 110.762 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 62' ' ' THR . 55.3 t0 -80.73 -13.59 58.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.533 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.13 16.11 0.14 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.274 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 56' ' ' ASP . 21.5 p-10 -66.07 -24.61 66.75 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -154.54 -25.55 0.04 OUTLIER Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.604 ' C ' ' H ' ' A' ' 62' ' ' THR . 10.9 p30 179.96 150.84 0.39 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.403 ' C ' ' OD2' ' A' ' 56' ' ' ASP . . . -65.48 32.45 0.12 Allowed Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.604 ' H ' ' C ' ' A' ' 60' ' ' ASN . 66.5 p -130.39 148.91 52.26 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.0 mt -118.5 133.86 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.987 0.423 . . . . 0.0 110.514 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.32 169.08 18.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.475 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.436 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -67.29 -49.52 43.37 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.191 -179.027 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.8 Cg_exo -52.08 -45.31 39.77 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.995 1.797 . . . . 0.0 111.898 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.96 -37.02 72.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.694 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -60.69 -46.37 90.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.964 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.3 mt -62.22 -44.37 96.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.857 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.1 m -65.15 -44.63 87.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.904 0.383 . . . . 0.0 110.304 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 44.9 ttp -62.07 -41.83 98.57 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.853 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 76' ' ' MET . 60.3 mmm -63.35 -40.86 98.43 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.585 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.0 -35.84 77.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.739 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -87.71 -56.27 3.42 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.735 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -63.13 -43.31 98.74 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.123 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 72' ' ' MET . 50.8 mmm -108.88 131.51 54.94 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.863 0.363 . . . . 0.0 110.214 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 78' ' ' ASP . 29.0 tptt -83.12 150.07 26.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.764 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 77' ' ' LYS . 5.7 m-20 -55.51 -159.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.421 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.8 p -96.19 -0.27 50.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.916 0.388 . . . . 0.0 110.499 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -82.87 2.48 34.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.119 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 83' ' ' GLU . 1.6 m -62.09 -35.6 79.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.959 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -37.99 -29.61 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.861 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 81' ' ' SER . 71.5 mm-40 -74.17 -56.87 4.39 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -64.71 -38.73 91.99 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.154 0.502 . . . . 0.0 109.656 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.7 -19.29 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.482 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.1 ttt-85 -57.69 -44.01 85.54 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.171 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -65.9 -33.02 74.87 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.785 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -63.0 -27.96 69.78 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -55.63 -46.0 77.47 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.38 0.609 . . . . 0.0 110.405 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -74.42 -51.08 15.97 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.757 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.21 -47.79 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.04 0.448 . . . . 0.0 110.553 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.473 ' CE2' HD12 ' A' ' 100' ' ' ILE . 39.2 t80 -63.5 -45.83 88.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.239 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.48 ' OD2' ' N ' ' A' ' 96' ' ' GLY . 36.0 t70 -127.16 105.08 8.33 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.586 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -68.55 -42.12 78.82 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.897 0.379 . . . . 0.0 111.059 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' A' ' 97' ' ' ASN . 1.5 p-10 -59.95 -46.62 88.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.846 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.48 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 73.77 -41.77 1.05 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.43 ' H ' ' C ' ' A' ' 95' ' ' ASP . 77.1 m-20 -80.24 -13.55 59.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.929 0.395 . . . . 0.0 110.046 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.94 161.28 12.8 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -113.29 149.82 33.35 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.7 0.286 . . . . 0.0 110.511 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.473 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -96.79 116.55 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.99 0.424 . . . . 0.0 111.191 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.9 p -84.39 170.76 13.24 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.3 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.57 -37.52 86.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.157 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.27 -47.16 84.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.978 0.418 . . . . 0.0 110.577 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.55 -35.99 75.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.495 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.6 tp -62.33 -40.15 95.41 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.63 0.728 . . . . 0.0 110.668 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -52.44 -45.02 65.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.649 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -61.64 -45.04 95.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.971 0.415 . . . . 0.0 110.396 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.9 t -63.91 -44.89 98.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.309 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 48.4 mmm -64.38 -37.12 86.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.514 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 83.1 m -61.04 -46.13 91.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -67.13 -24.54 65.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.216 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.1 tp -61.51 -44.89 96.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.893 0.378 . . . . 0.0 110.824 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.53 -148.79 15.54 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -140.36 25.84 2.21 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.502 0.192 . . . . 0.0 111.056 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -64.75 -45.34 86.84 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.979 0.418 . . . . 0.0 110.958 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.6 mt -113.54 170.67 8.07 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.943 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.48 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -69.51 161.54 29.32 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.014 0.435 . . . . 0.0 110.952 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -92.1 -23.93 19.29 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.805 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -88.06 -20.39 25.81 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.58 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.7 -67.39 0.16 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.58 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 18.0 m -64.53 -35.15 73.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -57.68 -66.46 0.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -64.35 -43.79 93.48 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.465 ' C ' ' SD ' ' A' ' 124' ' ' MET . 16.1 tmm? -57.31 -48.69 78.3 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.832 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.22 -23.78 30.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.219 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -77.08 -46.86 22.17 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.499 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -85.38 -68.28 0.74 Allowed 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.486 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.01 -33.3 0.08 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.503 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -94.72 146.77 23.94 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.819 0.342 . . . . 0.0 110.702 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.662 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -89.41 -17.37 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -65.46 -44.48 87.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.055 0.455 . . . . 0.0 110.531 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.37 -11.01 5.61 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 41.3 p-10 -89.12 -19.39 25.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.87 0.367 . . . . 0.0 110.483 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.549 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 55.36 106.24 0.01 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.477 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 11.1 pt20 -140.15 134.7 31.6 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.7 t -116.93 132.04 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.007 0.432 . . . . 0.0 110.225 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -142.74 175.44 9.81 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.579 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -58.22 -45.83 86.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.147 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.481 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 54.0 mp0 -63.66 -36.92 85.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.407 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.477 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 78.3 mt-10 -67.09 -33.85 76.38 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.137 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -62.09 -40.55 96.2 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.466 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.0 t -57.18 -45.78 84.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.516 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -82.86 -15.82 50.02 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.838 0.351 . . . . 0.0 111.224 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 43.8 ttp -60.99 -41.05 95.73 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.882 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 78.2 mtm -118.49 141.72 48.29 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.779 0.323 . . . . 0.0 110.683 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 81.5 m -159.56 84.5 0.76 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.798 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.58 -40.51 73.23 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.186 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.912 -1.042 . . . . 0.0 110.5 -179.563 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -81.83 115.42 21.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.451 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -81.41 -4.56 56.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.549 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 36.3 tp -84.78 123.52 30.52 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.16 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.5 p -79.74 156.19 27.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.132 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -75.89 -23.12 55.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.258 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -62.08 -43.7 98.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.782 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -64.25 -42.07 96.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.787 0.327 . . . . 0.0 110.847 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 91.4 mt -64.25 -43.49 97.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.719 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.86 -41.24 64.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -44.0 -48.21 8.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.852 0.358 . . . . 0.0 110.699 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -66.0 -39.8 90.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.582 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -65.38 -48.15 73.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.216 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -64.12 -34.03 77.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.476 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.57 -19.93 11.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.541 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -57.38 -49.3 76.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.865 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.8 m -60.95 -40.82 94.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.56 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.55 -42.86 99.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.003 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -59.33 -49.9 76.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.804 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.466 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.6 t0 -75.88 -15.61 60.18 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.682 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -43.6 -33.2 1.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.818 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.437 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 14.4 p-10 -53.4 -43.44 67.92 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.485 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -145.62 -153.7 5.95 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 26.7 p-10 -74.79 -47.27 31.7 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.59 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.69 107.27 0.28 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.638 ' C ' HD12 ' A' ' 27' ' ' ILE . 8.4 m -166.7 149.93 6.86 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.128 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.638 HD12 ' C ' ' A' ' 26' ' ' THR . 2.8 mp -119.52 109.47 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.503 HG22 HG22 ' A' ' 62' ' ' THR . 4.1 p -130.91 169.71 15.41 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.896 0.379 . . . . 0.0 110.506 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.5 p -63.51 -29.56 70.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.173 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -62.11 -41.28 98.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.236 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.445 ' OE2' ' O ' ' A' ' 26' ' ' THR . 89.6 mt-10 -66.99 -45.74 76.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.0 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.1 tp -65.92 -44.52 84.93 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.382 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.91 -22.49 4.52 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.3 m -67.03 -30.15 70.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.789 0.328 . . . . 0.0 110.478 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.6 t -62.34 -22.96 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 94.9 mmm -56.05 -37.11 68.83 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 120.199 -0.601 . . . . 0.0 109.701 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -63.17 -44.2 96.12 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 116.806 -1.958 . . . . 0.0 110.114 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 91.7 p -60.48 -37.87 82.43 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.16 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.413 ' O ' ' N ' ' A' ' 41' ' ' GLN . 39.1 mt -94.74 5.05 53.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.302 0.572 . . . . 0.0 110.528 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.49 -67.62 0.26 Allowed Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 39' ' ' LEU . 84.1 mt-30 -147.86 104.99 3.63 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.431 ' O ' ' N ' ' A' ' 44' ' ' THR . 58.7 t30 -123.25 76.84 52.61 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.028 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' A' ' 46' ' ' ALA . 72.1 Cg_exo -36.74 -29.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.595 2.196 . . . . 0.0 112.603 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.437 ' N ' ' HB3' ' A' ' 120' ' ' GLU . 11.5 m -38.43 -31.93 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.418 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 49' ' ' GLN . 96.9 mt-10 -88.86 -36.14 16.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.117 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -55.08 -49.8 70.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.536 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -69.85 -49.21 54.69 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.174 0.511 . . . . 0.0 110.155 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.89 -21.35 65.94 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.663 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 45' ' ' GLU . 10.8 tp-100 -45.5 -47.47 14.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.221 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 68.1 t0 -70.85 -38.63 73.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.519 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.0 ttp -62.37 -42.78 99.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.914 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.411 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 87.5 mt -63.7 -46.22 95.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.488 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.667 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 87.3 m-20 -63.95 -41.86 97.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.6 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -59.27 -59.17 5.89 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.477 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.8 p -66.1 -31.74 55.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.754 0.312 . . . . 0.0 110.834 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.541 ' OD2' ' N ' ' A' ' 62' ' ' THR . 45.5 t0 -87.38 -12.58 45.89 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.69 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.28 13.06 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.07 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' A' ' 56' ' ' ASP . 16.8 p-10 -64.03 -33.83 76.63 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.44 -26.45 0.08 OUTLIER Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.594 ' C ' ' H ' ' A' ' 62' ' ' THR . 16.5 p30 -178.19 148.25 0.48 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.545 -0.327 . . . . 0.0 110.297 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.97 34.25 0.1 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.594 ' H ' ' C ' ' A' ' 60' ' ' ASN . 70.2 p -129.68 151.48 50.23 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.0 mt -119.59 134.15 64.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.82 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -77.05 -155.47 0.07 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.028 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.497 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -96.51 -47.89 0.24 Allowed Pre-proline 0 N--CA 1.469 0.496 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.824 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 42.9 Cg_exo -54.94 -36.01 91.01 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.107 1.872 . . . . 0.0 111.629 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -83.62 -28.66 28.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.795 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -59.44 -46.4 88.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.685 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.96 -43.5 95.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.854 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.9 m -63.64 -45.26 91.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.103 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 46.6 ttp -62.18 -44.41 96.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.806 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 47.8 mmm -63.38 -42.23 98.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.767 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.72 -48.66 80.81 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.768 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -71.04 -50.15 37.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.554 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -64.64 -41.78 95.9 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.396 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.505 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 32.1 mmm -121.21 127.0 51.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.197 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -82.69 153.12 25.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.672 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -52.5 -179.96 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.263 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.4 p -80.99 -9.69 59.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.641 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -65.97 -21.69 66.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.39 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.3 m -50.59 -32.2 18.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.423 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -38.23 -45.72 1.0 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.685 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -69.1 -46.63 67.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.17 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -65.07 -49.43 70.07 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.939 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.6 mt -56.42 -21.13 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -57.94 -44.95 87.27 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 118.386 -1.326 . . . . 0.0 109.652 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -66.07 -26.02 67.3 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.62 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.74 -14.16 58.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.122 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -56.61 -50.62 71.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.292 0.568 . . . . 0.0 111.137 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -63.39 -44.52 94.47 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.164 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.58 -45.64 88.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.581 -0.447 . . . . 0.0 109.866 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.429 ' CE2' ' CD1' ' A' ' 100' ' ' ILE . 19.1 t80 -62.54 -47.17 85.05 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.697 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 37.3 t0 -119.94 106.53 12.13 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.208 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -68.1 -44.32 76.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.072 0.463 . . . . 0.0 110.648 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.0 OUTLIER -62.26 -44.59 96.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.752 -179.351 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.1 -47.38 1.05 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -74.59 -14.43 60.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.016 0.436 . . . . 0.0 110.538 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.82 161.81 12.63 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -112.15 144.38 41.63 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.429 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 64.6 mt -74.95 129.49 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.861 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.6 p -83.09 168.79 16.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.293 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.88 97.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.857 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.11 -41.69 94.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.69 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -67.34 -37.33 83.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.084 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.2 tp -60.31 -43.17 96.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.192 0.52 . . . . 0.0 110.654 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -54.0 -40.76 67.26 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.789 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -59.05 -42.24 89.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.935 0.398 . . . . 0.0 109.987 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.02 -44.97 97.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.715 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 80.9 mmm -63.53 -35.47 80.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.562 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.3 m -61.21 -41.72 97.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.273 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -59.79 -39.15 83.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.663 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.1 tp -61.4 -44.33 97.33 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.534 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.77 -143.91 9.97 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -144.36 30.49 1.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.34 . . . . 0.0 110.775 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -62.85 -40.86 98.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.389 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.6 mt -105.19 165.93 10.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.788 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.486 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -65.16 161.58 18.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.877 0.37 . . . . 0.0 110.526 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.44 ' C ' ' OE1' ' A' ' 120' ' ' GLU . 83.8 m-20 -91.39 -20.25 22.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.851 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -89.34 -26.13 21.25 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.682 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -34.89 -65.17 0.23 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.565 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.682 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 31.0 m -68.65 -27.5 36.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 111.639 0.236 . . . . 0.0 111.639 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -63.21 -43.84 96.98 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.998 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -88.42 -41.02 13.07 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.47 ' C ' ' SD ' ' A' ' 124' ' ' MET . 15.0 tmm? -60.56 -42.72 97.19 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.858 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 125' ' ' ILE . 96.6 mt -70.02 -15.82 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -87.17 -66.76 0.88 Allowed 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.975 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -70.96 -68.53 0.43 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.949 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 124' ' ' MET . . . -37.3 -40.01 0.32 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.675 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -88.42 124.66 34.17 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.078 0.466 . . . . 0.0 110.466 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -72.25 -16.05 18.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.239 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 133' ' ' ASP . 51.0 m-20 -65.33 -45.65 83.4 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.994 0.426 . . . . 0.0 110.664 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.1 -11.56 2.67 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 42.0 p30 -88.45 -17.39 30.49 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.067 0.46 . . . . 0.0 110.14 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 58.33 120.7 0.01 OUTLIER Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.443 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 10.4 pt20 -160.97 137.87 8.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.711 0.291 . . . . 0.0 110.282 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.2 t -125.58 134.24 67.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.834 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.472 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.3 t30 -148.99 159.64 44.03 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.232 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -40.13 -35.34 0.38 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.289 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.472 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 53.0 mp0 -65.81 -42.29 90.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.177 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 80.2 mt-10 -71.75 -30.27 65.41 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.524 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -58.52 -45.5 88.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.21 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.3 -48.16 89.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.862 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -70.07 -32.15 70.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.778 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.486 ' SD ' ' C37' ' A' ' 205' ' ' 4DY . 37.6 ttp -56.62 -47.71 79.08 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.722 -178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 69.7 mtm -106.09 134.1 49.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 110.658 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 88.8 m -160.1 81.58 0.7 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.351 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 76' ' ' MET . . . -65.79 -40.62 92.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.939 0.399 . . . . 0.0 110.607 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.632 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 205' ' ' 4DY . . . . . 0.486 ' C37' ' SD ' ' A' ' 144' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -88.49 114.0 24.65 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.649 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -81.21 -16.87 51.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.417 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 32.4 tp -113.03 117.71 32.79 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.914 0.388 . . . . 0.0 110.034 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.2 p -139.12 157.52 45.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.171 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -71.33 -22.1 61.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.996 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.05 -43.08 77.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.077 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -62.37 -44.19 97.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.467 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.1 mt -64.34 -43.3 97.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.8 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.4 -45.35 69.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.482 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -41.25 -45.78 3.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.851 0.358 . . . . 0.0 110.963 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -66.78 -39.62 87.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.795 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -62.76 -43.22 99.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.484 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.06 -40.82 91.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.752 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.78 -20.42 49.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.652 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -49.36 -47.95 47.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.817 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.3 m -77.72 -20.36 53.66 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.019 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.6 tp -64.04 -40.69 96.87 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.837 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.468 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 76.3 m-85 -57.69 -45.41 85.7 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.354 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 9.7 t0 -86.16 -20.35 28.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -44.06 -33.17 1.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.806 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.41 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 4.5 p-10 -56.0 -46.14 78.81 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 110.82 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -140.25 -152.61 5.85 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 28.2 p-10 -74.4 -47.09 36.1 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.728 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.71 107.09 0.28 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 178.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 6.3 m -166.44 148.82 6.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.199 0.499 . . . . 0.0 111.436 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.73 74.02 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.504 HG22 HG22 ' A' ' 62' ' ' THR . 9.7 p -86.96 166.18 15.3 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.541 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -66.31 -28.55 68.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.961 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -61.91 -40.21 94.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.925 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.468 ' OE1' ' O ' ' A' ' 19' ' ' PHE . 86.7 mt-10 -66.76 -40.47 88.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.959 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.7 tp -62.8 -43.54 98.54 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.63 -33.22 47.94 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 m -64.58 -44.62 90.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.91 0.355 . . . . 0.0 110.857 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.4 t -55.95 -17.34 3.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.113 0.483 . . . . 0.0 110.287 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.545 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 88.9 mmm -52.72 -40.81 63.38 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.733 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.2 ttt85 -64.27 -46.01 85.57 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 118.202 -1.399 . . . . 0.0 110.2 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.8 p -64.3 -19.23 65.29 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.63 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.812 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 36.4 mt -94.41 6.6 48.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.682 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 43.75 78.67 0.07 OUTLIER Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 40' ' ' GLY . 85.7 mt-30 52.76 117.23 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.852 0.358 . . . . 0.0 110.723 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' A' ' 44' ' ' THR . 35.2 t-20 -148.85 68.76 9.84 Favored Pre-proline 0 C--O 1.235 0.303 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.657 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.582 ' O ' ' N ' ' A' ' 46' ' ' ALA . 86.7 Cg_exo -35.85 -31.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 122.533 2.156 . . . . 0.0 111.983 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.449 ' N ' ' O ' ' A' ' 42' ' ' ASN . 29.5 m -38.58 -27.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.299 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.545 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 87.7 mt-10 -89.52 -32.44 17.17 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.848 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.33 -51.88 67.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.994 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.456 ' HB2' HG23 ' A' ' 117' ' ' THR . 2.2 tm-20 -67.5 -46.06 73.99 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.192 0.52 . . . . 0.0 109.661 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 44' ' ' THR . 96.8 mt -63.6 -27.6 69.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.403 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -39.51 -53.66 2.04 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.811 0.339 . . . . 0.0 110.85 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -65.9 -38.26 88.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.24 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.5 ttp -62.33 -40.18 95.51 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 97.8 mt -62.04 -46.42 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.649 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 9.4 m120 -62.38 -42.43 99.41 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.666 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.68 -55.66 31.57 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.119 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.87 -34.88 62.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.891 0.377 . . . . 0.0 111.065 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.531 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.9 t0 -82.92 -13.43 56.09 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.408 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.12 9.0 1.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.778 0.323 . . . . 0.0 110.154 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 12.6 p30 -61.56 -25.18 67.15 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.484 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -157.83 -19.97 0.03 OUTLIER Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.623 ' C ' ' H ' ' A' ' 62' ' ' THR . 5.1 p30 177.08 141.82 0.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.72 32.25 0.08 OUTLIER Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.623 ' H ' ' C ' ' A' ' 60' ' ' ASN . 64.0 p -130.29 150.08 51.69 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-O 121.002 0.43 . . . . 0.0 110.273 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.3 mt -116.98 138.93 46.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.144 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.53 166.14 19.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.444 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.429 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -62.95 -50.52 76.59 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.761 -179.119 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.4 Cg_exo -50.92 -44.88 39.32 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.994 1.796 . . . . 0.0 111.778 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.95 -36.32 72.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.977 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -60.03 -45.85 91.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.224 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.08 -44.5 95.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.625 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.5 m -67.4 -44.45 78.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.194 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.0 ttp -61.42 -40.13 93.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.05 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 76.3 mmm -63.01 -38.6 91.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.848 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.07 96.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.02 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -68.43 -45.55 72.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.11 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.59 -41.78 83.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.924 0.393 . . . . 0.0 110.366 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.8 mmt -86.92 164.47 16.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.086 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -116.24 153.61 31.58 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.004 0.43 . . . . 0.0 110.145 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -59.29 160.46 6.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.26 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.4 p -64.17 -30.06 71.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.546 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.43 -10.05 22.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.206 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -57.04 -32.85 66.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.513 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -49.43 -50.23 41.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.735 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.02 -41.92 94.88 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.005 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -66.27 -45.74 79.45 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.476 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.3 mt -64.9 -20.59 27.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -59.74 -42.18 92.61 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 119.079 -1.048 . . . . 0.0 110.184 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -61.46 -35.88 78.87 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.496 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.18 -13.39 60.45 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -48.02 -51.05 25.59 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.981 0.419 . . . . 0.0 111.41 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -59.78 -46.86 87.89 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.784 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.86 -44.35 81.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.991 0.424 . . . . 0.0 110.451 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -59.46 -44.41 92.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.567 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.435 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 33.0 t70 -138.82 100.73 4.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.24 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.1 -39.96 82.71 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.175 0.512 . . . . 0.0 110.164 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.435 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.2 p-10 -60.22 -42.54 95.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.291 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.71 -56.99 0.51 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -70.78 -13.59 62.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.146 0.498 . . . . 0.0 110.28 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.66 161.12 12.86 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -115.0 150.89 35.13 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.7 mt -85.19 123.18 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.025 0.44 . . . . 0.0 110.343 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.2 p -80.02 168.14 19.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.026 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.48 82.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.62 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.21 -45.3 93.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.056 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.97 -37.68 75.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.251 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.7 tp -61.94 -42.96 99.7 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.263 0.554 . . . . 0.0 111.257 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -52.56 -43.25 65.1 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.012 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -55.4 -42.75 74.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.199 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.63 -42.43 95.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.279 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 58.3 mmm -57.56 -34.78 69.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.476 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 80.3 m -60.19 -42.34 94.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.458 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -58.6 -38.73 78.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.9 tp -61.29 -46.35 90.71 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.025 0.44 . . . . 0.0 110.117 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.85 -154.89 25.97 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.237 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -143.24 11.8 1.75 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.737 -0.231 . . . . 0.0 110.76 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -63.92 -44.01 94.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.102 0.477 . . . . 0.0 110.631 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.6 mt -79.75 160.29 26.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.978 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.48 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.6 OUTLIER -68.5 161.69 27.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.273 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -92.33 -21.03 20.5 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.098 0.475 . . . . 0.0 110.45 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -85.45 -26.93 26.03 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.24 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.613 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.59 -63.55 0.35 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.613 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 11.3 m -69.09 -31.32 49.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 121.236 -0.185 . . . . 0.0 111.497 -178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -58.94 -67.08 0.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.717 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.58 -45.15 72.79 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.517 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 13.3 tmm? -52.91 -50.3 64.2 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 125' ' ' ILE . 95.9 mt -64.62 -18.38 23.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.653 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -87.92 -57.88 2.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.297 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 128' ' ' ALA . 51.1 tp10 -81.92 -67.78 0.75 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.236 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.812 ' HB2' ' O ' ' A' ' 39' ' ' LEU . . . -36.78 -35.65 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 56.6 t0 -87.69 146.18 25.81 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.298 0.57 . . . . 0.0 110.519 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.567 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -89.39 -14.94 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.783 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 133' ' ' ASP . 44.8 m-20 -73.59 -45.27 54.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.016 0.436 . . . . 0.0 110.4 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.29 -10.29 3.65 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 131' ' ' ASP . 35.3 p30 -89.84 -10.42 45.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.233 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 62.28 122.93 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -161.7 119.61 2.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.859 0.362 . . . . 0.0 110.073 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.61 128.9 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.13 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.526 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 45.3 t30 -155.08 166.32 33.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.063 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.402 ' O ' ' CD1' ' A' ' 138' ' ' TYR . 2.6 t80 -48.82 -23.06 0.95 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.415 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 50.0 mp0 -66.4 -35.74 81.09 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.153 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -84.97 -20.83 29.97 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.582 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -61.94 -46.84 87.56 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.102 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 29.5 t -58.22 -45.95 88.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.105 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -71.4 -36.07 71.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.332 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 61.4 ttp -58.09 -43.03 86.83 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.128 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 70.6 mtm -112.76 129.28 56.48 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.84 0.353 . . . . 0.0 110.377 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 m -162.81 85.8 0.55 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.047 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.13 -43.93 93.75 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.645 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.55 179.846 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -88.72 117.43 27.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.416 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -82.77 -36.37 25.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.596 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 43.4 tp -99.29 122.6 42.67 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.146 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 p -137.87 158.95 43.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.348 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -67.78 -33.57 75.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.599 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -53.73 -44.13 69.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.857 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -57.63 -42.05 82.57 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.67 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.09 -43.15 95.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.57 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.93 -29.73 56.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.281 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -54.68 -48.25 72.62 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.538 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -65.7 -40.81 92.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -61.95 -44.08 97.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.67 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -67.06 -37.51 84.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.01 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.481 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.02 -27.92 65.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.826 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -57.81 -46.91 83.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.537 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.7 m -77.92 -21.51 51.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.68 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.4 -42.76 99.68 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.436 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.481 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.1 m-85 -60.2 -50.96 71.61 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.478 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.1 t0 -76.93 -14.35 59.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.912 0.387 . . . . 0.0 111.335 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -45.59 -32.68 2.44 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.84 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 8.8 p-10 -53.72 -46.08 70.7 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.57 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -144.36 -151.58 5.47 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 30.8 p-10 -72.97 -47.25 47.01 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.09 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.72 107.36 0.28 Allowed Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 178.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 4.7 m -166.59 139.32 3.76 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.129 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 27' ' ' ILE . 5.2 mp -115.04 109.19 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.594 HG22 HG22 ' A' ' 62' ' ' THR . 2.6 p -128.68 170.31 13.43 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.847 0.356 . . . . 0.0 110.418 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.659 ' HB ' HE22 ' A' ' 49' ' ' GLN . 68.2 p -64.69 -33.12 75.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.805 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -61.62 -41.4 97.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.053 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 26' ' ' THR . 90.0 mt-10 -63.41 -45.69 89.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.915 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.1 tp -64.13 -43.36 95.5 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.113 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.77 -26.1 53.24 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.1 m -63.87 -41.46 97.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.85 0.357 . . . . 0.0 110.071 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.1 t -56.28 -23.52 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.352 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.48 ' O ' ' N ' ' A' ' 40' ' ' GLY . 62.1 mmm -48.17 -30.21 4.42 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.679 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -64.41 -45.65 86.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.003 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.1 p -63.91 -21.99 66.72 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.856 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 41' ' ' GLN . 16.8 mt -107.7 3.68 24.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.094 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.15 -71.19 0.02 OUTLIER Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 39' ' ' LEU . 87.8 mt-30 -145.46 109.44 4.83 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 44' ' ' THR . 41.4 t30 -125.58 70.88 65.34 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.149 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 46' ' ' ALA . 85.4 Cg_exo -32.92 -30.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 122.66 2.24 . . . . 0.0 112.785 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.542 ' N ' ' O ' ' A' ' 42' ' ' ASN . 26.2 m -39.27 -30.15 0.05 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.522 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.418 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.9 mt-10 -86.7 -34.86 19.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.27 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -59.12 -50.08 75.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.779 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.13 -46.15 71.65 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.166 0.508 . . . . 0.0 109.655 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 51' ' ' MET . 84.5 mt -64.79 -31.15 72.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.359 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.659 HE22 ' HB ' ' A' ' 29' ' ' THR . 8.7 tp-100 -37.47 -51.3 1.13 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.72 0.295 . . . . 0.0 110.838 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.25 -40.35 90.14 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.27 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.463 ' N ' ' O ' ' A' ' 48' ' ' LEU . 33.1 ttp -62.45 -40.95 98.27 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.0 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 83.5 mt -62.04 -49.88 82.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.145 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.602 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 89.8 m-20 -63.0 -40.38 97.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.585 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -55.19 -61.54 2.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.193 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.9 -30.12 43.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.779 0.323 . . . . 0.0 111.285 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 62' ' ' THR . 50.6 t0 -84.68 -13.21 52.11 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.528 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -71.97 13.0 0.33 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.868 0.366 . . . . 0.0 110.295 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.7 p30 -65.57 -28.86 69.45 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.539 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -150.55 -22.4 0.06 OUTLIER Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.557 ' C ' ' H ' ' A' ' 62' ' ' THR . 3.3 p30 173.13 151.88 0.08 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.99 34.76 0.14 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.594 HG22 HG22 ' A' ' 28' ' ' THR . 81.7 p -134.39 149.48 50.81 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.3 mt -121.02 134.52 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.14 162.44 28.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.416 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.471 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -64.65 -48.14 74.33 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.478 -179.096 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 50.3 Cg_exo -51.17 -37.36 58.49 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.171 1.914 . . . . 0.0 111.739 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -87.61 -22.3 24.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.35 -47.2 86.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.852 0.358 . . . . 0.0 111.028 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.5 -42.89 98.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.567 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.4 m -63.92 -46.11 86.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.668 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.7 ttp -61.76 -47.45 85.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.077 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 82.0 mmm -65.82 -37.79 87.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.271 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.62 -49.97 75.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.031 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -71.5 -43.76 65.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.196 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.72 -43.61 88.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.7 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 73' ' ' ALA . 22.3 mmm -104.31 127.46 51.96 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.07 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.7 tptt -84.97 141.11 30.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.931 0.396 . . . . 0.0 110.711 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 77' ' ' LYS . 95.0 m-20 -48.9 179.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.266 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.3 p -75.47 -6.77 51.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.456 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.47 -15.53 62.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.511 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.9 m -61.89 -19.91 63.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.527 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -48.2 -44.72 33.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.33 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.99 -39.49 79.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.894 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -65.89 -45.13 83.16 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.01 0.433 . . . . 0.0 110.197 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.3 mt -66.05 -19.09 25.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.494 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -58.43 -45.42 88.52 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 118.971 -1.092 . . . . 0.0 110.156 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.62 -31.79 73.01 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.923 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -72.08 -14.61 61.9 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.16 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -57.97 -48.98 78.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.328 0.585 . . . . 0.0 111.092 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -64.1 -45.57 88.05 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.358 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -76.2 -51.58 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 110.849 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.443 ' CE2' HD12 ' A' ' 100' ' ' ILE . 26.3 t80 -62.02 -47.17 85.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.625 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 18.2 t70 -108.98 94.24 4.94 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.29 -41.02 73.93 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 110.535 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 19.8 p-10 -62.52 -39.71 94.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.961 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.44 -67.29 0.97 Allowed Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.57 -16.56 63.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.009 0.433 . . . . 0.0 110.242 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.82 161.99 12.57 Favored Glycine 0 N--CA 1.465 0.575 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.28 155.33 24.24 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.775 0.321 . . . . 0.0 110.23 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.443 HD12 ' CE2' ' A' ' 92' ' ' PHE . 94.2 mt -79.66 125.99 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.974 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.4 p -82.39 168.94 17.0 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.128 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.51 -38.04 89.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.513 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.65 -47.3 84.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.916 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.67 -32.88 73.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.958 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.4 tp -61.52 -41.7 97.71 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.382 0.61 . . . . 0.0 110.706 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -56.43 -43.31 79.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.77 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -58.49 -41.88 86.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.3 t -66.68 -43.37 90.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.646 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.0 mmm -62.03 -35.59 79.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.642 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.2 m -61.09 -44.37 97.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.055 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -59.76 -35.0 73.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.378 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.0 tp -61.18 -46.73 89.28 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.081 0.467 . . . . 0.0 110.391 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.5 -160.71 33.43 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -140.53 23.35 2.31 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.603 0.24 . . . . 0.0 110.746 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -63.61 -42.79 98.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.962 0.41 . . . . 0.0 110.277 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.7 mt -92.88 175.8 6.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.972 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.467 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -72.85 161.29 30.9 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.668 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -91.66 -22.44 20.25 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.979 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -87.91 -25.32 23.29 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.174 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.639 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.41 -61.24 0.46 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.123 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.639 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 20.2 m -67.39 -40.21 84.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.509 ' N ' HG23 ' A' ' 121' ' ' VAL . 81.2 m-20 -56.73 -47.05 80.88 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.595 -178.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -86.03 -40.28 15.95 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.7 tmm? -59.56 -46.53 88.63 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.081 0.467 . . . . 0.0 109.914 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 125' ' ' ILE . 91.5 mt -69.1 -16.61 21.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.424 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -78.6 -50.51 11.38 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 119.394 -0.922 . . . . 0.0 112.148 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 129' ' ' ASP . 42.4 tp10 -87.69 -67.52 0.82 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.834 -178.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.33 -26.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.794 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 127' ' ' GLU . 25.4 t0 -87.95 128.26 35.37 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.058 0.456 . . . . 0.0 111.132 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.664 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.48 -43.38 90.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.457 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -65.35 -40.33 93.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.19 0.519 . . . . 0.0 110.178 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.33 -1.97 58.84 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' GLY . 55.2 p-10 -89.49 -8.98 51.73 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 57.38 115.48 0.01 OUTLIER Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 20.3 pt20 -160.64 133.64 6.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.2 t -123.47 136.89 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.081 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -151.35 172.49 15.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.243 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -54.86 -46.78 74.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.13 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 139' ' ' GLU . 55.2 mp0 -58.68 -44.36 90.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.657 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 93.4 mt-10 -72.0 -29.41 64.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.775 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.89 -43.98 77.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.586 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 94.1 t -59.16 -46.29 92.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.26 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.35 -29.09 66.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.124 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.8 ttp -59.7 -42.88 93.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.796 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.46 138.84 50.6 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.963 0.411 . . . . 0.0 110.731 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.2 m -163.24 77.72 0.43 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.661 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.16 -27.76 68.93 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.438 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 117.884 -1.055 . . . . 0.0 110.665 -179.864 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 4' ' ' LEU . 43.6 t0 -88.76 115.87 26.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.71 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -78.81 -25.32 44.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.573 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.419 ' O ' ' OD1' ' A' ' 2' ' ' ASP . 37.3 tp -109.52 120.28 42.0 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.953 0.406 . . . . 0.0 110.352 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.4 p -139.09 158.75 43.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.045 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -68.65 -20.88 64.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.801 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -56.59 -39.23 73.19 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.221 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.38 -40.24 95.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.584 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.26 -43.51 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 121.049 -0.261 . . . . 0.0 110.905 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.3 -18.89 7.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.143 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -54.18 -42.33 69.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.098 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -67.81 -41.71 82.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.375 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -62.63 -43.68 98.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.982 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -67.25 -35.75 80.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.437 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.414 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.49 -24.19 66.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.699 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -55.37 -46.51 76.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.79 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.3 m -80.65 -19.5 45.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.783 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.17 -41.96 96.92 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.052 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.425 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.3 m-85 -58.84 -46.1 88.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.871 0.367 . . . . 0.0 111.144 -178.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.448 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.3 t0 -79.57 -13.47 59.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.499 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -42.99 -32.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.915 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' CG ' ' OE2' ' A' ' 31' ' ' GLU . 10.9 p-10 -52.9 -45.13 67.41 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.481 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.436 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . -149.64 -151.21 5.44 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 21.2 p-10 -71.21 -46.9 60.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.685 0.278 . . . . 0.0 110.957 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.531 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.04 107.34 0.28 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.593 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.7 m -166.51 136.22 3.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.215 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.608 HD12 ' N ' ' A' ' 27' ' ' ILE . 1.9 mp -110.53 118.3 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.459 HG22 HG22 ' A' ' 62' ' ' THR . 2.0 p -134.76 167.05 21.56 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.897 0.38 . . . . 0.0 110.291 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.541 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.3 p -64.08 -33.69 76.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.31 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -62.57 -40.16 95.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.701 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.456 ' OE2' ' O ' ' A' ' 26' ' ' THR . 88.9 mt-10 -64.66 -48.56 74.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.313 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.38 -43.72 93.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.321 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.31 -24.72 17.09 Favored Glycine 0 C--O 1.224 -0.469 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -64.05 -40.99 97.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.873 0.368 . . . . 0.0 110.226 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.15 -22.37 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.205 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.6 mmm -48.87 -33.45 10.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.021 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -64.32 -45.47 87.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 118.152 -1.419 . . . . 0.0 110.278 -178.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.1 p -59.04 -30.67 68.2 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.301 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 41' ' ' GLN . 9.2 mt -102.3 5.45 39.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.974 0.416 . . . . 0.0 110.472 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.26 -69.79 0.03 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 39' ' ' LEU . 85.8 mt-30 -143.28 116.25 8.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.132 -0.534 . . . . 0.0 109.589 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.1 t30 -132.58 69.69 79.61 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.945 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.549 ' O ' ' N ' ' A' ' 46' ' ' ALA . 91.4 Cg_exo -33.0 -33.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 122.545 2.164 . . . . 0.0 112.476 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.477 ' N ' ' O ' ' A' ' 42' ' ' ASN . 12.7 m -39.07 -29.33 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.371 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 43' ' ' PRO . 90.6 mt-10 -87.67 -35.17 18.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.486 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -61.23 -49.22 78.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.998 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.433 ' HB2' HG23 ' A' ' 117' ' ' THR . 3.1 tm-20 -68.09 -48.48 65.39 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.397 0.617 . . . . 0.0 109.951 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.513 HD22 ' CE ' ' A' ' 51' ' ' MET . 87.3 mt -62.72 -22.68 66.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.009 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.541 HE22 ' CB ' ' A' ' 29' ' ' THR . 48.0 tp60 -40.27 -49.6 2.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.87 0.367 . . . . 0.0 110.475 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.64 -39.85 73.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.478 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.513 ' CE ' HD22 ' A' ' 48' ' ' LEU . 36.1 ttp -61.56 -40.55 95.11 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.743 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.82 -46.91 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.586 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.652 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 28.3 m120 -65.13 -39.91 93.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.358 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -58.03 -57.22 13.79 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.474 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 p -68.26 -32.85 57.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.923 0.392 . . . . 0.0 110.997 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.511 ' OD2' ' N ' ' A' ' 62' ' ' THR . 42.9 t0 -86.06 -13.08 48.43 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.805 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.06 15.43 0.16 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 56' ' ' ASP . 38.7 p-10 -66.74 -23.48 66.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.4 -22.61 0.03 OUTLIER Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.591 ' C ' ' H ' ' A' ' 62' ' ' THR . 4.6 p30 179.34 146.51 0.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.75 33.78 0.18 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.591 ' H ' ' C ' ' A' ' 60' ' ' ASN . 80.6 p -132.2 143.94 50.3 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.92 135.15 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.034 0.445 . . . . 0.0 110.191 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.38 172.4 4.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.456 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.436 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -72.6 -49.57 8.38 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.764 -179.612 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 53.2 Cg_exo -52.03 -43.31 53.41 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.885 1.723 . . . . 0.0 111.88 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.45 -37.46 77.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.846 0.355 . . . . 0.0 110.898 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -60.34 -45.4 93.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.926 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.0 mt -62.39 -44.62 96.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.503 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.6 m -67.4 -45.49 76.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.736 0.303 . . . . 0.0 111.231 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.4 ttp -61.09 -43.72 98.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.977 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 87.0 mmm -64.75 -39.35 93.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.223 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.91 -42.88 94.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.838 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -71.51 -41.7 68.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.279 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -64.74 -40.94 96.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.804 0.335 . . . . 0.0 110.436 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 73' ' ' ALA . 14.2 mmt -95.27 129.84 42.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.079 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -86.81 142.81 27.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -50.41 168.87 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.379 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.3 p -75.24 -15.21 60.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.645 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.98 -16.46 64.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.449 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.1 m -60.46 -23.7 64.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.758 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -36.75 -48.45 0.73 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.931 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -70.79 -43.54 68.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.247 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -63.78 -39.63 94.73 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.012 0.434 . . . . 0.0 110.085 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.6 mt -66.98 -21.89 28.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.231 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -57.96 -43.65 86.56 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.085 -1.046 . . . . 0.0 110.053 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -63.7 -34.74 78.54 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.889 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.83 -19.85 66.03 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.081 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -56.64 -48.8 76.74 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.253 0.549 . . . . 0.0 110.817 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -68.19 -44.69 75.29 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.471 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.9 t -66.34 -48.39 81.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.441 ' CE2' HD12 ' A' ' 100' ' ' ILE . 23.4 t80 -63.96 -47.19 81.38 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.632 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.408 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 18.4 t70 -120.32 100.17 7.01 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -66.71 -39.75 88.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.812 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 97' ' ' ASN . 2.0 p-10 -65.67 -40.6 92.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.104 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.62 -59.48 0.48 Allowed Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 95' ' ' ASP . 54.0 m-80 -61.86 -17.41 56.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.978 0.418 . . . . 0.0 110.201 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.408 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.58 160.91 12.96 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -113.33 155.55 24.98 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.441 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -95.77 118.22 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.04 0.448 . . . . 0.0 111.072 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.9 p -85.53 171.37 11.79 Favored 'General case' 0 C--N 1.335 -0.063 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.908 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.68 -35.76 78.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.572 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.43 -50.86 72.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.131 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.28 -37.37 77.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.919 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.06 -39.34 94.43 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.478 0.656 . . . . 0.0 111.089 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -54.18 -43.67 70.86 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.131 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -63.09 -39.49 94.87 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.85 -45.22 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.192 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 37.8 mmm -64.3 -38.05 89.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.483 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.8 m -60.57 -40.09 90.38 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -61.27 -38.11 85.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.175 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 tp -61.6 -44.07 97.68 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.868 0.366 . . . . 0.0 110.213 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.97 -154.78 25.78 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -138.97 23.42 2.6 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.577 -0.312 . . . . 0.0 110.728 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -62.67 -43.26 99.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.06 0.457 . . . . 0.0 110.309 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.9 mt -99.91 169.06 9.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.54 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.49 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -68.34 162.11 25.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.86 0.362 . . . . 0.0 110.51 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -92.14 -22.21 19.99 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.421 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -87.29 -24.47 24.33 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.625 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.65 -66.06 0.21 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.196 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.625 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.6 m -65.09 -35.31 75.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.416 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -60.47 -46.8 88.75 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.558 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -84.92 -40.34 17.13 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.4 tmm? -58.92 -47.22 85.8 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 125' ' ' ILE . 94.4 mt -69.18 -18.32 22.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.578 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -77.43 -51.37 10.89 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 119.044 -1.063 . . . . 0.0 111.307 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 129' ' ' ASP . 34.7 tp10 -86.32 -68.7 0.72 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.46 -177.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.64 -21.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 127' ' ' GLU . 38.7 t0 -90.16 125.06 35.33 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.139 0.495 . . . . 0.0 110.606 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.647 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.5 -31.99 56.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.052 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -72.16 -45.84 58.81 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.93 0.395 . . . . 0.0 110.362 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.63 -5.41 61.15 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 134' ' ' GLY . 35.3 p30 -89.95 -9.69 47.85 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 58.24 117.92 0.01 OUTLIER Glycine 0 CA--C 1.519 0.335 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 8.2 pt20 -159.73 140.13 11.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.161 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.5 t -126.25 133.35 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.544 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.9 t30 -150.74 175.34 12.07 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.323 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -57.69 -52.09 66.85 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.766 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.544 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 57.2 mp0 -55.88 -35.04 66.07 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.736 -178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 79.3 mt-10 -69.46 -39.31 77.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.712 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -61.21 -45.38 94.83 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.0 t -57.94 -46.0 87.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -74.12 -30.92 62.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.397 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.4 ttp -60.03 -40.66 90.12 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.623 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.403 ' O ' ' OG1' ' A' ' 146' ' ' THR . 72.9 mtm -105.18 141.69 36.28 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.888 0.375 . . . . 0.0 110.631 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 145' ' ' MET . 62.9 m -167.23 72.06 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.104 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.61 -41.79 97.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.561 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 C--O 1.218 -0.559 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.263 -179.906 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 4' ' ' LEU . 66.7 t0 -88.49 113.95 24.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.643 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -81.16 -16.86 51.68 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.386 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.408 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 32.3 tp -113.0 117.64 32.61 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.929 0.395 . . . . 0.0 110.068 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.4 p -139.14 157.5 45.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.168 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -71.3 -22.1 61.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.016 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.06 -43.07 77.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.058 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -62.37 -44.26 96.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.464 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.3 mt -64.26 -43.37 97.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.779 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.37 69.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.518 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -41.28 -45.7 3.02 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.819 0.342 . . . . 0.0 110.949 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -66.88 -39.62 87.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.724 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -62.74 -43.19 99.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.508 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.06 -40.84 91.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.767 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.79 -20.41 49.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.617 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -49.42 -47.94 47.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.793 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.0 m -77.74 -20.35 53.61 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.994 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.9 tp -64.06 -40.67 96.8 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.785 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.47 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 76.2 m-85 -57.67 -45.47 85.52 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.354 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 9.8 t0 -86.06 -20.42 28.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -44.04 -33.18 1.37 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.794 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.409 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 4.5 p-10 -55.91 -46.16 78.5 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.88 0.371 . . . . 0.0 110.839 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -140.32 -152.62 5.84 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 28.1 p-10 -74.48 -46.99 35.99 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.711 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.73 107.08 0.28 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 6.3 m -166.46 148.77 6.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.178 0.489 . . . . 0.0 111.445 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.66 74.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.507 HG22 HG22 ' A' ' 62' ' ' THR . 9.7 p -86.93 166.16 15.33 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.998 0.428 . . . . 0.0 110.53 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -66.28 -28.62 68.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.972 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -61.89 -40.21 94.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.914 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.47 ' OE1' ' O ' ' A' ' 19' ' ' PHE . 86.7 mt-10 -66.73 -40.44 88.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.977 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.7 tp -62.82 -43.56 98.47 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.61 -33.2 47.83 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 m -64.58 -44.64 90.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.949 0.374 . . . . 0.0 110.865 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.3 t -55.9 -17.36 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.297 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.544 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 88.9 mmm -52.73 -40.8 63.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.709 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.1 ttt85 -64.23 -46.05 85.5 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 118.165 -1.414 . . . . 0.0 110.229 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.2 p -64.28 -19.24 65.27 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.657 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.81 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 36.4 mt -94.34 6.54 48.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.731 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 43.72 78.78 0.07 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.491 ' O ' ' O ' ' A' ' 40' ' ' GLY . 85.7 mt-30 52.65 117.2 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.845 0.355 . . . . 0.0 110.783 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 44' ' ' THR . 35.2 t-20 -148.8 68.75 9.88 Favored Pre-proline 0 C--O 1.235 0.294 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.745 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.586 ' O ' ' N ' ' A' ' 46' ' ' ALA . 86.9 Cg_exo -35.85 -31.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.455 2.103 . . . . 0.0 111.978 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.451 ' N ' ' O ' ' A' ' 42' ' ' ASN . 29.9 m -38.57 -27.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.287 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.544 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 87.7 mt-10 -89.52 -32.43 17.18 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.818 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.41 -51.87 68.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.014 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.451 ' HB2' HG23 ' A' ' 117' ' ' THR . 2.2 tm-20 -67.43 -46.07 74.21 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.18 0.514 . . . . 0.0 109.683 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 44' ' ' THR . 96.9 mt -63.64 -27.64 69.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.344 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -39.54 -53.61 2.07 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.815 0.341 . . . . 0.0 110.804 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -65.94 -38.26 88.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.261 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.5 ttp -62.34 -40.18 95.52 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 98.0 mt -62.05 -46.4 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.646 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 9.5 m120 -62.38 -42.38 99.37 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.679 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.73 -55.62 32.05 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.167 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 p -69.87 -34.89 62.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 120.894 0.378 . . . . 0.0 111.089 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.9 t0 -82.89 -13.45 56.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.404 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.646 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.08 8.92 1.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.819 0.342 . . . . 0.0 110.179 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 12.6 p30 -61.6 -25.09 67.12 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -157.83 -19.98 0.03 OUTLIER Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.619 ' C ' ' H ' ' A' ' 62' ' ' THR . 5.1 p30 177.07 141.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.73 32.24 0.08 OUTLIER Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.619 ' H ' ' C ' ' A' ' 60' ' ' ASN . 63.8 p -130.3 150.12 51.68 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-O 120.983 0.42 . . . . 0.0 110.266 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.6 mt -117.05 138.97 45.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.145 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.56 166.16 19.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.381 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.432 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -62.93 -50.55 76.52 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.756 -179.138 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.5 Cg_exo -50.89 -44.95 38.82 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.999 1.799 . . . . 0.0 111.788 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.94 -36.27 72.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.984 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -60.07 -45.83 91.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.194 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.08 -44.59 95.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.561 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.2 m -67.36 -44.39 79.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.27 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.9 ttp -61.47 -40.14 93.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.02 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 76.0 mmm -63.02 -38.58 91.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.805 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.11 96.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.008 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -68.43 -45.56 72.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.081 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.57 -41.79 83.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.976 0.417 . . . . 0.0 110.36 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.8 mmt -86.93 164.42 16.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.137 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -116.2 153.55 31.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.954 0.406 . . . . 0.0 110.154 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -59.26 160.44 6.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.31 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.6 p -64.14 -30.04 71.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.571 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -64.42 -10.04 22.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.182 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -57.08 -32.78 66.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.535 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -49.49 -50.23 42.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.712 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.02 -41.9 94.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.038 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -66.31 -45.71 79.4 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.469 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.4 mt -64.91 -20.61 27.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -59.67 -42.23 92.41 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.245 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -61.49 -35.89 78.94 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.468 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.13 -13.42 60.47 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -47.98 -51.1 25.13 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.013 0.435 . . . . 0.0 111.421 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -59.76 -46.82 87.97 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.822 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.87 -44.35 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.979 0.418 . . . . 0.0 110.451 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -59.44 -44.35 92.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.573 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 33.0 t70 -138.9 100.65 4.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.267 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.07 -39.98 82.83 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.209 0.528 . . . . 0.0 110.154 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.2 p-10 -60.18 -42.61 95.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.286 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.71 -56.98 0.51 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -70.69 -13.68 62.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.156 0.503 . . . . 0.0 110.286 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.63 161.12 12.87 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -115.04 150.93 35.11 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.5 mt -85.24 123.18 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.999 0.428 . . . . 0.0 110.375 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.2 p -80.01 168.12 19.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.049 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.3 -36.44 82.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.615 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.18 -45.24 94.26 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.082 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -70.08 -37.66 75.51 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.192 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.2 tp -62.0 -42.86 99.61 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.23 0.538 . . . . 0.0 111.248 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -52.62 -43.23 65.26 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.02 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -55.39 -42.73 74.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.914 0.388 . . . . 0.0 110.231 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.5 t -64.63 -42.44 95.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.259 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 58.3 mmm -57.56 -34.75 69.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.461 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.1 m -60.26 -42.37 95.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.37 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -58.57 -38.73 78.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.9 tp -61.35 -46.29 90.83 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 120.952 0.406 . . . . 0.0 110.126 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.9 -154.91 26.0 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -143.29 11.89 1.75 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.703 -0.249 . . . . 0.0 110.759 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -63.97 -43.99 94.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.114 0.483 . . . . 0.0 110.612 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.4 mt -79.77 160.3 26.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.99 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.475 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.6 OUTLIER -68.46 161.7 27.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.245 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -92.37 -21.07 20.45 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.063 0.458 . . . . 0.0 110.404 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -85.43 -26.93 26.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.234 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.59 -63.57 0.34 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -178.85 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.61 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 11.3 m -69.1 -31.35 49.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.457 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -58.86 -67.15 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.721 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.56 -45.19 72.75 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.519 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 13.3 tmm? -52.85 -50.27 64.1 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.419 HG22 ' O ' ' A' ' 125' ' ' ILE . 95.9 mt -64.6 -18.4 23.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.655 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -87.92 -57.86 2.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.306 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 128' ' ' ALA . 51.0 tp10 -81.96 -67.79 0.75 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.248 -178.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.81 ' HB2' ' O ' ' A' ' 39' ' ' LEU . . . -36.77 -35.64 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 56.7 t0 -87.69 146.15 25.82 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.258 0.551 . . . . 0.0 110.576 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.566 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -89.36 -15.02 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.778 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 133' ' ' ASP . 44.9 m-20 -73.54 -45.29 54.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.994 0.426 . . . . 0.0 110.427 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.39 -10.3 3.75 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 131' ' ' ASP . 35.2 p30 -89.88 -10.4 45.39 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.816 0.341 . . . . 0.0 110.172 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 62.18 122.99 0.01 OUTLIER Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -161.69 119.65 2.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.913 0.387 . . . . 0.0 110.08 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.65 128.91 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.128 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.525 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 45.3 t30 -155.07 166.26 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.064 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.4 ' O ' ' CD1' ' A' ' 138' ' ' TYR . 2.6 t80 -48.79 -23.04 0.93 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.444 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.539 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 50.1 mp0 -66.42 -35.75 81.08 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.151 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -84.95 -20.83 30.0 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.633 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.04 -46.68 88.1 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.141 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 29.8 t -58.28 -46.0 89.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.028 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -71.33 -36.12 71.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.305 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 61.5 ttp -57.99 -43.04 86.36 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.193 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 70.7 mtm -112.85 129.26 56.51 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.85 0.357 . . . . 0.0 110.328 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.6 m -162.78 85.82 0.55 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.064 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.15 -43.81 94.05 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.675 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.516 179.834 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.411 ' OD2' ' O ' ' A' ' 4' ' ' LEU . 67.3 t0 -92.55 115.91 28.53 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.034 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -68.81 -30.01 68.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.192 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.411 ' O ' ' OD2' ' A' ' 2' ' ' ASP . 46.8 tp -102.03 128.17 48.59 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.648 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.5 p -134.61 158.43 44.05 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.354 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -66.16 -21.97 66.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.707 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -63.15 -44.2 96.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.531 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.88 -41.58 91.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.966 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 89.6 mt -64.62 -43.03 96.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.472 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.77 -39.9 68.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.233 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -47.63 -48.63 28.53 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.118 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -59.48 -44.87 92.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.83 0.347 . . . . 0.0 110.442 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -63.37 -39.68 95.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.693 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.31 -41.3 85.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.824 0.345 . . . . 0.0 111.158 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.47 -22.69 66.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.829 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -55.57 -47.89 75.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.2 m -81.37 -17.2 49.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.553 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.96 -43.72 98.03 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.423 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.417 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.5 m-85 -60.52 -50.36 73.86 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.553 -178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.3 t0 -77.13 -14.56 59.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.188 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -45.11 -32.91 1.95 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.209 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.449 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 18.0 p-10 -54.73 -45.99 74.19 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.824 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -144.04 -151.1 5.38 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 32.2 p-10 -73.06 -47.08 47.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.675 0.274 . . . . 0.0 110.772 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.73 107.31 0.28 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.427 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 4.9 m -166.24 142.77 5.0 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.745 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.02 103.46 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.405 HG22 HG22 ' A' ' 62' ' ' THR . 2.9 p -123.14 169.93 10.73 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.091 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.606 ' CB ' HE22 ' A' ' 49' ' ' GLN . 60.2 p -63.1 -35.35 79.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.833 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -60.34 -38.48 83.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 87.7 mt-10 -65.59 -43.12 90.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.097 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.76 -41.9 97.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.227 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.82 -28.67 17.21 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.1 m -64.58 -44.15 91.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 0.0 110.762 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.2 t -57.09 -17.6 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.194 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.543 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 87.6 mmm -53.01 -38.58 62.44 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.199 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.6 ttt85 -64.27 -46.04 85.44 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 117.412 -1.715 . . . . 0.0 110.668 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 93.5 p -63.4 -19.9 65.08 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.553 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.882 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 52.5 mt -99.64 6.16 45.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.882 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 34.8 94.62 0.01 OUTLIER Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 40' ' ' GLY . 84.1 mt-30 52.3 110.1 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.599 0.238 . . . . 0.0 110.418 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 44' ' ' THR . 49.9 t30 -145.71 63.94 9.9 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.701 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 46' ' ' ALA . 88.7 Cg_exo -34.71 -30.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.56 2.173 . . . . 0.0 112.32 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.498 ' N ' ' O ' ' A' ' 42' ' ' ASN . 23.4 m -40.14 -29.51 0.08 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.123 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.543 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 90.7 mt-10 -89.73 -29.89 18.41 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.763 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -60.83 -49.15 78.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.82 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.47 ' HB2' HG23 ' A' ' 117' ' ' THR . 2.2 tm-20 -72.17 -43.18 64.99 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.296 0.569 . . . . 0.0 109.755 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.591 HD21 HD21 ' A' ' 116' ' ' LEU . 96.3 mt -68.0 -25.05 65.22 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.212 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.606 HE22 ' CB ' ' A' ' 29' ' ' THR . 53.7 tp60 -40.85 -41.86 1.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.0 110.582 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -77.7 -36.75 50.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.492 ' CE ' HD22 ' A' ' 48' ' ' LEU . 32.5 ttp -59.98 -37.3 79.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.628 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.589 HG21 HG22 ' A' ' 29' ' ' THR . 96.8 mt -63.5 -44.78 98.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.043 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.675 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 51.0 m-80 -62.57 -39.86 95.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.342 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -56.62 -56.44 21.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.273 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.471 HG13 ' N ' ' A' ' 56' ' ' ASP . 15.0 p -74.14 -40.32 51.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.883 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.504 ' OD2' ' N ' ' A' ' 62' ' ' THR . 44.4 t0 -71.18 -13.3 61.88 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.52 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.675 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.25 8.97 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.099 0.476 . . . . 0.0 110.346 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 56' ' ' ASP . 10.3 p-10 -59.73 -26.72 65.88 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -155.08 -24.42 0.03 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.549 ' C ' ' H ' ' A' ' 62' ' ' THR . 10.0 p30 176.15 151.17 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.29 36.32 0.09 OUTLIER Glycine 0 CA--C 1.535 1.306 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.549 ' H ' ' C ' ' A' ' 60' ' ' ASN . 44.2 p -137.38 153.34 50.21 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.5 mt -127.43 137.02 58.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.972 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -81.21 164.55 22.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.083 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.427 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -62.07 -50.13 81.87 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.232 -179.721 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.5 Cg_exo -50.12 -41.74 48.44 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.08 1.853 . . . . 0.0 112.046 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -80.77 -29.79 36.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.118 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -59.48 -45.07 92.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.989 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.42 -43.14 99.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.305 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.9 m -64.36 -44.92 89.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.869 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 46.9 ttp -60.08 -44.66 94.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.855 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 79.4 mmm -63.82 -40.86 97.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.266 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.408 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -61.27 -47.77 84.51 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.957 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -71.27 -46.28 61.29 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.458 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -66.72 -45.28 79.2 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.927 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.408 ' O ' ' O ' ' A' ' 73' ' ' ALA . 17.8 mmm -99.5 -176.68 3.35 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.054 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -128.51 152.15 48.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.153 0.501 . . . . 0.0 110.169 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -54.21 177.66 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.341 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.3 p -80.47 -15.81 55.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.582 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -66.38 -13.65 60.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.395 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 83' ' ' GLU . 72.7 m -53.38 -34.27 57.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.601 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -39.08 -28.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.381 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 81' ' ' SER . 75.8 mm-40 -85.35 -54.79 4.37 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.042 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -58.56 -36.29 73.69 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.905 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.427 ' O ' HG22 ' A' ' 85' ' ' ILE . 96.6 mt -63.55 -20.04 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -61.0 -45.09 96.24 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 118.409 -1.316 . . . . 0.0 109.588 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -64.61 -21.8 66.81 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.189 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.4 -17.54 48.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.439 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -57.01 -50.19 73.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.376 0.607 . . . . 0.0 110.572 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -68.62 -44.95 73.16 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.864 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.6 t -65.32 -49.07 80.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.069 0.462 . . . . 0.0 110.022 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.683 ' CE2' HD12 ' A' ' 100' ' ' ILE . 51.6 t80 -62.59 -45.19 94.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.905 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.411 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 22.2 t0 -120.53 104.52 10.03 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.119 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -66.36 -41.22 89.82 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.029 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -70.39 -41.66 72.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.063 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.89 -52.98 0.74 Allowed Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -64.02 -20.08 65.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.934 0.397 . . . . 0.0 110.297 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.411 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.66 161.01 12.9 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -113.34 148.31 35.96 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.683 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -84.96 123.62 39.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.9 p -87.35 176.7 7.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.122 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.64 -36.49 83.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.963 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.57 -51.35 69.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.878 0.371 . . . . 0.0 110.977 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.39 -30.54 66.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 49.4 tp -61.69 -41.04 97.04 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.23 0.538 . . . . 0.0 111.106 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -54.22 -41.49 68.73 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.881 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -57.92 -42.69 85.33 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.3 t -65.57 -43.2 94.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.668 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 91.6 mmm -62.55 -37.23 85.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.476 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.8 m -59.43 -40.48 86.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.657 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -58.6 -38.73 78.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.724 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.0 tp -61.01 -45.1 96.2 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.547 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.09 -145.3 12.03 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -143.6 16.38 1.82 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.761 0.315 . . . . 0.0 110.679 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -61.86 -44.91 95.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.997 0.427 . . . . 0.0 110.468 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.591 HD21 HD21 ' A' ' 48' ' ' LEU . 82.8 mt -82.08 161.34 22.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.966 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.474 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -66.02 161.7 21.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.653 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -91.63 -19.62 22.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.866 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -87.67 -28.14 22.01 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.622 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.32 -66.85 0.17 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.804 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.622 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.4 m -64.05 -39.33 85.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 111.909 0.336 . . . . 0.0 111.909 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.469 ' N ' HG23 ' A' ' 121' ' ' VAL . 84.8 m-20 -54.27 -65.91 0.49 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.676 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 127' ' ' GLU . 80.6 mm-40 -70.42 -44.93 66.89 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.661 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 18.9 tmm? -53.0 -47.62 68.13 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 120.486 -0.486 . . . . 0.0 109.879 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.403 ' O ' HG22 ' A' ' 125' ' ' ILE . 97.7 mt -67.19 -19.73 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.356 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -91.24 -66.84 0.89 Allowed 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.984 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 123' ' ' GLU . 24.9 tp10 -65.24 -68.53 0.36 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.21 -177.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.882 ' HB2' ' O ' ' A' ' 39' ' ' LEU . . . -37.21 -37.67 0.18 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.48 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 66.0 t0 -87.5 138.23 31.65 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.207 0.527 . . . . 0.0 110.591 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.59 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -85.8 -16.09 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.335 -179.7 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -73.08 -46.54 50.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.121 0.486 . . . . 0.0 110.141 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.96 -2.59 54.92 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 52.1 p30 -88.67 -22.3 23.49 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 64.6 103.72 0.01 OUTLIER Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -147.77 140.77 24.95 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.784 0.326 . . . . 0.0 110.158 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.2 t -128.93 134.32 64.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.314 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.527 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 53.3 t30 -151.57 -179.09 7.11 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.624 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -57.28 -48.15 79.63 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.267 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.527 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 55.9 mp0 -50.91 -43.66 59.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.352 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -67.69 -39.82 84.42 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.91 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -60.72 -43.65 97.61 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.598 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.3 t -54.19 -43.89 62.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.345 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -84.25 -19.38 33.99 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.064 -0.255 . . . . 0.0 111.223 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 41.1 ttp -65.07 -41.3 95.2 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.949 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 51.7 mtm -103.67 132.68 49.71 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.847 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.4 m -166.83 81.77 0.24 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.061 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.8 -37.19 75.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.342 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.1 mttm . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.458 179.948 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -91.92 107.58 19.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.128 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -135.58 166.37 23.38 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.014 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 36.8 tp -96.11 126.57 41.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.245 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.1 p -127.27 160.05 32.5 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.611 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.63 -19.23 62.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.564 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -67.14 -42.0 85.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.063 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -62.98 -42.09 99.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.872 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.2 mt -69.75 -31.39 48.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.679 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.19 -29.55 70.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.881 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -51.5 -43.22 62.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.748 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -66.94 -46.38 74.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.874 0.368 . . . . 0.0 111.03 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -61.62 -44.81 96.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.792 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -67.96 -40.96 83.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.628 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.13 -28.42 67.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.022 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -55.58 -45.84 77.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.673 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.7 m -81.61 -17.83 46.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.723 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.7 tp -65.51 -42.36 92.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.918 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.403 ' O ' ' CD ' ' A' ' 31' ' ' GLU . 73.3 m-85 -61.06 -45.95 92.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.309 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 4.7 t0 -81.93 -15.66 53.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.357 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -42.82 -32.5 0.62 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.114 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.433 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 9.2 p-10 -53.67 -46.7 70.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.896 0.379 . . . . 0.0 110.712 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.433 ' N ' ' CG ' ' A' ' 22' ' ' ASP . . . -145.67 -147.33 4.58 Favored Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 20.5 p-10 -76.46 -47.57 22.51 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.898 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.01 106.97 0.27 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 95.7 m -166.72 143.13 4.64 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.968 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.05 117.06 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.849 0.357 . . . . 0.0 110.113 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.691 HG22 HG22 ' A' ' 62' ' ' THR . 12.4 p -133.38 165.57 24.52 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.403 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.424 ' HB ' HE22 ' A' ' 49' ' ' GLN . 79.9 p -63.02 -35.13 79.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.33 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -61.26 -38.58 87.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.021 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.413 ' OE2' ' CG ' ' A' ' 22' ' ' ASP . 91.3 mt-10 -64.62 -49.13 72.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.359 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.37 -43.65 98.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.182 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.2 -23.94 4.47 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.3 m -64.9 -42.51 94.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.914 0.388 . . . . 0.0 110.545 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.3 t -54.59 -16.3 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.219 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.452 ' O ' ' N ' ' A' ' 40' ' ' GLY . 53.4 mmm -58.73 -37.27 75.8 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -62.48 -46.13 89.89 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 116.727 -1.989 . . . . 0.0 110.618 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.7 p -60.12 -36.17 76.88 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.034 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 41' ' ' GLN . 44.7 mt -95.87 2.08 53.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.701 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 66.2 -66.44 0.15 Allowed Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 39' ' ' LEU . 74.6 mt-30 -141.66 122.77 14.67 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.3 t-20 -141.5 71.15 26.19 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.636 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 46' ' ' ALA . 73.1 Cg_exo -37.42 -30.45 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.222 1.948 . . . . 0.0 112.136 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 42' ' ' ASN . 25.1 m -39.04 -27.62 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.488 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 49' ' ' GLN . 86.7 mt-10 -90.31 -36.92 14.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.011 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -56.27 -48.88 75.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.411 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -70.5 -45.08 66.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.289 0.566 . . . . 0.0 110.071 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.521 HD21 HD22 ' A' ' 116' ' ' LEU . 96.0 mt -70.08 -20.05 63.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.82 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 45' ' ' GLU . 11.7 tp-100 -46.48 -46.22 18.84 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.608 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -75.06 -35.29 61.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.242 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.433 ' CE ' HD22 ' A' ' 48' ' ' LEU . 33.2 ttp -63.71 -43.03 97.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.016 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 96.7 mt -62.76 -46.21 96.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.753 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.697 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 81.3 m-20 -64.65 -40.7 95.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.766 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -60.08 -56.84 16.72 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.42 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 56' ' ' ASP . 11.3 p -69.68 -37.01 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.016 0.436 . . . . 0.0 110.94 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.549 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.5 t0 -79.06 -12.6 60.02 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.446 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.697 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.15 15.43 0.16 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.314 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 10.5 p30 -65.76 -21.87 66.54 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.412 ' H ' ' H ' ' A' ' 60' ' ' ASN . . . -167.82 -9.56 0.03 OUTLIER Glycine 0 C--N 1.333 0.4 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.576 ' C ' ' H ' ' A' ' 62' ' ' THR . 1.9 p30 169.42 140.58 0.02 OUTLIER 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.02 35.77 0.11 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.691 HG22 HG22 ' A' ' 28' ' ' THR . 69.5 p -135.94 155.0 50.93 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 90.9 mt -130.13 132.02 65.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.213 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.14 151.99 42.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.627 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.442 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -54.83 -51.24 80.75 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.778 -179.703 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 52.1 Cg_exo -49.17 -49.84 14.36 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.855 1.704 . . . . 0.0 112.059 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -68.56 -33.66 74.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.465 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -61.94 -43.82 98.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.96 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.8 mt -59.2 -45.58 90.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.753 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.3 m -63.83 -44.73 92.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.543 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 36.3 ttp -59.99 -45.34 93.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.578 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.3 mmm -64.64 -39.41 93.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.534 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.34 -39.05 78.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.743 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -77.92 -51.47 10.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.383 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -65.56 -44.27 87.27 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.498 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.2 mmm -99.74 126.46 45.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.348 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -86.76 143.89 27.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.537 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 80' ' ' ASP . 97.2 m-20 -49.35 158.58 0.38 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.418 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 35.8 p -54.9 -8.74 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.643 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 78' ' ' ASP . 80.3 m-20 -67.11 -8.64 32.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.156 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.6 m -59.4 -29.51 67.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.688 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -37.85 -49.21 1.19 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.839 0.352 . . . . 0.0 110.994 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.73 -55.02 19.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.872 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -59.68 -32.31 70.38 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.055 0.455 . . . . 0.0 110.622 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 85' ' ' ILE . 83.0 mt -69.23 -15.07 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.998 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -59.71 -48.93 79.71 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 117.546 -1.662 . . . . 0.0 110.395 -177.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.21 -32.55 74.28 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.471 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.66 -36.04 73.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.731 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -50.58 -51.12 51.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.324 0.583 . . . . 0.0 110.928 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -69.3 -44.4 71.85 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.32 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.16 -51.44 48.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.132 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.555 ' CE2' HD12 ' A' ' 100' ' ' ILE . 66.8 t80 -63.44 -47.42 81.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.389 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.463 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 17.9 t0 -107.83 105.33 15.1 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.131 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -71.67 -44.88 63.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.664 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 45.2 p-10 -67.07 -33.62 75.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.137 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.529 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 66.52 -74.87 0.15 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -53.66 -13.09 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.876 0.369 . . . . 0.0 110.343 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.422 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.52 161.77 12.67 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -112.34 155.91 23.34 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.555 HD12 ' CE2' ' A' ' 92' ' ' PHE . 94.6 mt -99.79 117.47 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.749 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.6 p -82.15 175.68 10.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.123 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.91 -37.06 85.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.838 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.54 -52.44 64.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.785 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -67.66 -31.18 70.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.67 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.1 tp -64.2 -41.35 97.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.451 0.644 . . . . 0.0 110.975 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -53.9 -39.2 65.57 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.002 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -63.83 -41.17 97.9 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.1 t -64.17 -42.66 96.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.44 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 54.0 mmm -62.4 -40.75 97.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.983 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.8 m -61.74 -40.22 94.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.564 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -58.82 -40.55 84.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.616 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.9 tp -61.33 -44.25 97.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.946 0.403 . . . . 0.0 110.528 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 161.85 -151.91 22.17 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -138.34 29.22 2.46 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.794 0.33 . . . . 0.0 110.619 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -67.46 -45.32 76.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.793 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.521 HD22 HD21 ' A' ' 48' ' ' LEU . 19.7 mt -100.68 166.94 10.63 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.853 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.52 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -69.49 161.57 29.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.188 -179.564 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -92.69 -21.54 19.94 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.902 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -87.41 -23.6 24.47 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.635 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -35.1 -68.08 0.13 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.603 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.521 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 9.8 m -63.87 -42.15 94.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.517 ' N ' HG23 ' A' ' 121' ' ' VAL . 87.6 m-20 -48.3 -67.06 0.3 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.752 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.459 ' O ' ' OE1' ' A' ' 127' ' ' GLU . 80.3 mm-40 -70.44 -40.02 74.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.404 ' SD ' ' C ' ' A' ' 124' ' ' MET . 17.7 tmm? -57.22 -38.94 74.49 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.684 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.9 mt -77.89 -23.79 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.929 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -77.5 -46.93 20.9 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 118.682 -1.207 . . . . 0.0 111.698 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 123' ' ' GLU . 19.6 mp0 -80.08 -68.45 0.67 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.667 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.56 -48.9 1.04 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.69 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -88.51 131.07 35.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.901 0.381 . . . . 0.0 110.27 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.549 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -82.3 -10.7 12.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.129 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 133' ' ' ASP . 89.2 m-20 -64.39 -40.42 95.76 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.099 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.65 -8.4 4.32 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 134' ' ' GLY . 26.2 p-10 -88.32 -12.72 42.65 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 39.36 98.06 0.01 OUTLIER Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 13.3 pt20 -131.06 136.94 48.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.056 0.455 . . . . 0.0 110.311 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.0 t -115.29 134.82 57.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.097 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.515 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 53.1 t30 -152.64 176.74 11.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.605 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -58.84 -48.02 82.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.339 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.515 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 58.0 mp0 -57.42 -25.53 59.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.295 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 81.2 mt-10 -84.87 -33.64 22.78 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.08 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -65.72 -46.89 77.24 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.654 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 50.3 t -56.26 -44.57 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 120.792 0.33 . . . . 0.0 110.22 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -71.56 -38.05 71.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.202 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 50.2 ttp -60.43 -48.59 81.08 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.306 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 49.1 mtm -88.61 120.77 30.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.928 0.394 . . . . 0.0 110.782 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.0 m -165.77 99.14 0.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.729 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.94 -38.33 88.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.584 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.8 mttm . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.531 179.938 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -88.69 117.48 27.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.398 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -82.82 -36.35 25.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.602 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 43.3 tp -99.27 122.66 42.74 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.16 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 p -137.94 158.87 43.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.295 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -67.72 -33.57 75.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.633 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -53.69 -44.15 69.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.871 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -57.64 -42.16 82.86 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.572 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.98 -43.18 96.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.606 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.92 -29.77 56.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.301 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -54.64 -48.25 72.5 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.556 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -65.74 -40.79 92.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.837 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -61.99 -44.1 97.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.633 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -66.99 -37.54 84.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.988 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.479 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.06 -27.9 65.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.803 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -57.83 -46.94 84.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.533 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.8 m -77.9 -21.5 51.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.65 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.36 -42.82 99.7 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.444 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.2 m-85 -60.21 -50.92 71.74 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.476 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.1 t0 -77.01 -14.26 59.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.83 0.347 . . . . 0.0 111.315 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -45.61 -32.69 2.45 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.831 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 8.8 p-10 -53.72 -46.11 70.69 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.557 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -144.34 -151.61 5.48 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 30.8 p-10 -72.95 -47.24 47.23 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.068 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.525 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.71 107.38 0.28 Allowed Glycine 0 CA--C 1.521 0.452 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.425 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 4.6 m -166.63 139.23 3.7 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.121 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 27' ' ' ILE . 5.2 mp -115.02 109.18 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.593 HG22 HG22 ' A' ' 62' ' ' THR . 2.6 p -128.65 170.32 13.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.824 0.345 . . . . 0.0 110.447 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.651 ' HB ' HE22 ' A' ' 49' ' ' GLN . 68.0 p -64.74 -33.05 75.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.801 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -61.63 -41.42 97.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.935 0.397 . . . . 0.0 109.998 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.425 ' OE1' ' O ' ' A' ' 26' ' ' THR . 90.1 mt-10 -63.45 -45.68 89.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.856 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.0 tp -64.2 -43.29 95.49 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.115 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.78 -26.16 53.42 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.2 m -63.87 -41.42 97.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.858 0.361 . . . . 0.0 110.143 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.3 t -56.18 -23.62 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.333 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.479 ' O ' ' N ' ' A' ' 40' ' ' GLY . 62.1 mmm -48.06 -30.33 4.33 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.721 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -64.34 -45.61 87.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 118.042 -1.463 . . . . 0.0 111.049 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 77.9 p -63.98 -21.95 66.71 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.136 -0.625 . . . . 0.0 109.808 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 41' ' ' GLN . 16.9 mt -107.8 3.75 24.79 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.04 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.16 -71.21 0.02 OUTLIER Glycine 0 N--CA 1.465 0.592 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 39' ' ' LEU . 87.8 mt-30 -145.45 109.46 4.83 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 44' ' ' THR . 41.4 t30 -125.59 70.93 65.52 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.12 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.551 ' O ' ' N ' ' A' ' 46' ' ' ALA . 85.3 Cg_exo -33.04 -30.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.595 2.196 . . . . 0.0 112.808 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 42' ' ' ASN . 26.2 m -39.31 -30.19 0.06 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.543 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.417 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.9 mt-10 -86.64 -34.88 19.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.305 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -59.04 -50.04 75.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.821 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.15 -46.21 71.4 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 51' ' ' MET . 84.6 mt -64.79 -31.03 72.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.4 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.651 HE22 ' HB ' ' A' ' 29' ' ' THR . 8.7 tp-100 -37.62 -51.2 1.19 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.732 0.301 . . . . 0.0 110.769 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.3 -40.34 89.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.232 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' LEU . 33.1 ttp -62.38 -41.05 98.33 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.981 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 83.9 mt -62.0 -49.95 82.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.114 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.61 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 89.9 m-20 -62.89 -40.46 97.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.582 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -55.17 -61.5 2.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.206 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.93 -30.12 43.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.804 0.335 . . . . 0.0 111.241 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 62' ' ' THR . 50.7 t0 -84.71 -13.24 51.97 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.513 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -71.94 13.05 0.32 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.926 0.394 . . . . 0.0 110.339 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.8 p30 -65.56 -28.89 69.48 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.535 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -150.49 -22.49 0.06 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.558 ' C ' ' H ' ' A' ' 62' ' ' THR . 3.3 p30 173.19 151.88 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.95 34.7 0.14 Allowed Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.593 HG22 HG22 ' A' ' 28' ' ' THR . 81.9 p -134.37 149.45 50.83 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.4 mt -120.99 134.52 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.933 0.397 . . . . 0.0 109.942 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.16 162.43 28.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.416 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.472 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -64.68 -48.05 74.37 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.467 -179.051 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 50.6 Cg_exo -51.28 -37.36 59.73 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.167 1.911 . . . . 0.0 111.692 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -87.55 -22.32 24.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.78 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.45 -47.11 87.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.021 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.54 -42.88 98.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.517 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 78.7 m -63.97 -46.09 86.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.648 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.7 ttp -61.71 -47.5 85.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.066 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.9 mmm -65.87 -37.76 87.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.265 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.61 -49.96 75.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.039 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -71.51 -43.8 65.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.159 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.72 -43.59 88.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.764 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.432 ' O ' ' O ' ' A' ' 73' ' ' ALA . 22.3 mmm -104.27 127.47 51.91 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.116 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.7 tptt -84.97 141.14 30.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.874 0.368 . . . . 0.0 110.748 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' LYS . 95.0 m-20 -48.87 179.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.262 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.5 p -75.51 -6.74 51.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.437 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.48 -15.52 62.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.545 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.9 m -61.89 -19.92 63.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.549 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -48.19 -44.69 32.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.358 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.96 -39.56 79.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.9 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.87 -45.12 83.25 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.989 0.423 . . . . 0.0 110.202 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.5 mt -66.12 -19.04 25.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.472 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -58.41 -45.44 88.4 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 118.97 -1.092 . . . . 0.0 110.19 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -65.56 -31.88 73.17 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.948 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.412 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -72.03 -14.64 61.93 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.185 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -57.98 -49.0 78.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.244 0.545 . . . . 0.0 111.061 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -64.09 -45.6 87.98 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.316 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -76.18 -51.54 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 0.0 110.908 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.442 ' CE2' HD12 ' A' ' 100' ' ' ILE . 26.2 t80 -61.99 -47.19 85.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.62 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.427 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 18.2 t70 -108.95 94.15 4.89 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.22 -40.97 74.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.965 0.412 . . . . 0.0 110.553 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 19.8 p-10 -62.61 -39.65 94.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.976 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.44 -67.3 0.97 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.58 -16.56 63.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.022 0.439 . . . . 0.0 110.247 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.76 162.04 12.56 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.23 155.39 24.09 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.713 0.292 . . . . 0.0 110.258 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.442 HD12 ' CE2' ' A' ' 92' ' ' PHE . 94.1 mt -79.75 126.02 39.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.938 0.399 . . . . 0.0 110.988 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.3 p -82.36 168.95 17.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.196 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.04 89.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.51 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.63 -47.38 84.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.863 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.67 -32.87 73.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.6 tp -61.58 -41.63 97.68 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.41 0.624 . . . . 0.0 110.712 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -56.46 -43.35 79.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.8 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -58.5 -41.88 86.35 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.67 -43.4 90.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.624 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.0 mmm -61.99 -35.68 79.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.605 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.6 m -61.04 -44.43 97.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.044 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -59.76 -34.98 73.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.376 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.0 tp -61.17 -46.73 89.31 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.051 0.453 . . . . 0.0 110.36 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.5 -160.74 33.47 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -140.51 23.35 2.32 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.64 0.257 . . . . 0.0 110.828 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -63.65 -42.8 98.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.963 0.411 . . . . 0.0 110.269 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.3 mt -92.84 175.79 6.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.006 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.469 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -72.83 161.29 30.91 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.695 179.844 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -91.66 -22.46 20.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.946 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -87.89 -25.37 23.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.126 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.64 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.4 -61.27 0.45 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.086 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.64 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 20.2 m -67.33 -40.2 84.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.492 ' N ' HG23 ' A' ' 121' ' ' VAL . 81.2 m-20 -56.81 -47.06 81.1 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.52 -178.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -86.01 -40.32 15.92 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.7 tmm? -59.51 -46.51 88.61 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.094 0.473 . . . . 0.0 109.956 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 125' ' ' ILE . 91.5 mt -69.15 -16.56 20.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.413 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -78.61 -50.56 11.29 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 119.389 -0.924 . . . . 0.0 112.13 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' ASP . 42.3 tp10 -87.61 -67.51 0.82 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.888 -178.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.43 -25.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.763 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' GLU . 25.4 t0 -88.06 128.26 35.41 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.062 0.458 . . . . 0.0 111.056 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.668 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.46 -43.45 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.416 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -65.27 -40.4 93.86 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.136 0.493 . . . . 0.0 110.185 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.4 -2.03 58.94 Favored Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' GLY . 55.2 p-10 -89.44 -9.0 51.8 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 57.46 115.49 0.01 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.435 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 20.3 pt20 -160.69 133.6 6.44 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.46 136.92 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.056 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -151.36 172.43 15.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.23 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -54.78 -46.83 74.47 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.096 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 139' ' ' GLU . 55.3 mp0 -58.64 -44.35 90.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.709 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 93.4 mt-10 -72.05 -29.4 64.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.727 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.92 -43.91 77.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.605 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 93.8 t -59.22 -46.23 92.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.312 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.38 -29.1 66.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.128 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.7 ttp -59.71 -42.81 93.9 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.853 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.49 138.82 50.63 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.961 0.41 . . . . 0.0 110.756 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 81.9 m -163.22 77.77 0.43 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.671 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.15 -27.76 68.95 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.464 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.222 -0.391 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.624 -179.857 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 4' ' ' LEU . 43.6 t0 -88.72 115.92 26.61 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.745 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -78.81 -25.38 44.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.532 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.415 ' O ' ' OD1' ' A' ' 2' ' ' ASP . 37.5 tp -109.5 120.22 41.84 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.024 0.44 . . . . 0.0 110.339 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.4 p -139.04 158.74 43.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.095 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -68.66 -20.89 64.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.823 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -56.55 -39.35 73.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.21 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.25 -40.27 95.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.621 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.26 -43.59 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.883 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.25 -18.89 6.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.157 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -54.22 -42.27 69.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.096 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -67.84 -41.73 82.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.34 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -62.62 -43.76 97.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.914 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -67.19 -35.71 80.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.431 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.413 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.57 -24.11 66.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.699 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -55.45 -46.46 76.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.783 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.4 m -80.66 -19.54 45.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.756 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.16 -41.95 96.95 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.013 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.42 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.1 m-85 -58.84 -46.11 88.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.831 0.348 . . . . 0.0 111.115 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.448 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.3 t0 -79.56 -13.49 59.5 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.468 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -42.97 -32.87 0.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.821 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.451 ' CG ' ' OE2' ' A' ' 31' ' ' GLU . 10.9 p-10 -52.93 -45.1 67.48 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.447 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.433 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . -149.68 -151.3 5.47 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 21.2 p-10 -71.1 -46.9 60.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.759 0.314 . . . . 0.0 111.009 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.534 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.02 107.4 0.28 Allowed Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.592 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.7 m -166.6 136.2 3.08 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.188 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.608 HD12 ' N ' ' A' ' 27' ' ' ILE . 1.9 mp -110.55 118.33 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.457 HG22 HG22 ' A' ' 62' ' ' THR . 2.0 p -134.78 167.04 21.59 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.863 0.363 . . . . 0.0 110.327 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.538 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.3 p -64.12 -33.64 76.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.296 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -62.51 -40.22 96.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.691 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.455 ' OE2' ' O ' ' A' ' 26' ' ' THR . 89.0 mt-10 -64.68 -48.46 74.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.373 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.6 tp -64.44 -43.72 93.42 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.296 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.29 -24.73 17.07 Favored Glycine 0 C--O 1.224 -0.487 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -64.09 -40.99 97.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.863 0.363 . . . . 0.0 110.197 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.3 t -57.05 -22.45 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.276 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.7 mmm -48.79 -33.53 10.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.992 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -64.33 -45.51 87.55 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 118.219 -1.392 . . . . 0.0 110.241 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.3 p -58.96 -30.68 68.09 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.367 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 41' ' ' GLN . 9.2 mt -102.34 5.47 39.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.99 0.424 . . . . 0.0 110.492 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.31 -69.83 0.03 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 39' ' ' LEU . 85.8 mt-30 -143.27 116.21 8.82 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.1 t30 -132.61 69.71 79.55 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.934 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 46' ' ' ALA . 90.7 Cg_exo -32.98 -33.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.541 2.16 . . . . 0.0 112.463 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 42' ' ' ASN . 12.6 m -39.0 -29.35 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.398 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 43' ' ' PRO . 90.6 mt-10 -87.69 -35.21 18.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.449 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -61.22 -49.22 78.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.998 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.437 ' HB2' HG23 ' A' ' 117' ' ' THR . 3.1 tm-20 -68.01 -48.6 65.27 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.437 0.637 . . . . 0.0 109.89 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.511 HD22 ' CE ' ' A' ' 51' ' ' MET . 87.2 mt -62.65 -22.75 66.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.012 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.538 HE22 ' CB ' ' A' ' 29' ' ' THR . 47.9 tp60 -40.25 -49.56 2.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.877 0.37 . . . . 0.0 110.519 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.69 -39.78 73.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.483 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.511 ' CE ' HD22 ' A' ' 48' ' ' LEU . 36.1 ttp -61.62 -40.54 95.21 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.73 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.85 -46.83 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.624 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.655 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 28.2 m120 -65.19 -39.83 93.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.342 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -58.1 -57.24 13.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.443 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.4 p -68.3 -32.83 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.949 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 62' ' ' THR . 42.9 t0 -86.02 -13.12 48.45 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.768 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.05 15.46 0.16 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.07 -179.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 56' ' ' ASP . 38.7 p-10 -66.75 -23.5 66.1 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.41 -22.54 0.03 OUTLIER Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.591 ' C ' ' H ' ' A' ' 62' ' ' THR . 4.6 p30 179.35 146.5 0.19 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.72 33.71 0.17 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.591 ' H ' ' C ' ' A' ' 60' ' ' ASN . 80.8 p -132.17 143.94 50.33 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.93 135.11 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.999 0.428 . . . . 0.0 110.172 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.39 172.39 4.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.486 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.436 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -72.59 -49.59 8.4 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.759 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 52.5 Cg_exo -52.01 -43.29 53.49 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.833 1.688 . . . . 0.0 111.931 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.45 -37.45 77.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 110.874 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -60.3 -45.45 93.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.967 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.2 mt -62.39 -44.63 95.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.487 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.2 m -67.38 -45.51 76.06 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.757 0.313 . . . . 0.0 111.223 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.4 ttp -61.13 -43.74 98.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.89 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 86.9 mmm -64.76 -39.33 93.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.215 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.91 -42.84 94.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.873 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -71.52 -41.77 68.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.268 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -64.72 -40.94 96.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.887 0.375 . . . . 0.0 110.412 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.434 ' O ' ' O ' ' A' ' 73' ' ' ALA . 14.2 mmt -95.22 129.85 42.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.074 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -86.87 142.82 27.77 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -50.35 168.86 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.414 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.8 p -75.23 -15.2 60.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.647 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.97 -16.49 64.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.424 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 82' ' ' GLU . 1.1 m -60.45 -23.67 64.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.717 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 81' ' ' SER . 81.2 tt0 -36.83 -48.45 0.74 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.62 0.248 . . . . 0.0 110.897 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -70.85 -43.47 68.44 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.181 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.87 -39.59 94.55 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.994 0.426 . . . . 0.0 110.086 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 81.0 mt -66.96 -21.91 28.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.242 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 -58.04 -43.61 86.93 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 119.031 -1.067 . . . . 0.0 110.014 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -63.65 -34.82 78.69 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.851 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.79 -19.9 66.06 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.039 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -56.6 -48.81 76.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.321 0.582 . . . . 0.0 110.838 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -68.23 -44.67 75.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.474 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.8 t -66.34 -48.34 81.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.442 ' CE2' HD12 ' A' ' 100' ' ' ILE . 23.7 t80 -64.04 -47.09 81.57 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.617 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.407 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 18.3 t70 -120.37 100.1 6.96 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -66.63 -39.84 88.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.182 0.515 . . . . 0.0 109.804 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 97' ' ' ASN . 2.0 p-10 -65.58 -40.66 92.97 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.105 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.67 -59.54 0.48 Allowed Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 95' ' ' ASP . 54.0 m-80 -61.78 -17.46 56.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.994 0.426 . . . . 0.0 110.228 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.407 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.55 160.9 12.96 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -113.31 155.57 24.92 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.442 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -95.78 118.27 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.07 0.462 . . . . 0.0 111.108 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.0 p -85.52 171.41 11.77 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.898 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.72 -35.75 78.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.579 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.84 72.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.078 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.28 -37.36 77.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.928 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.02 -39.38 94.58 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.476 0.655 . . . . 0.0 111.07 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -54.24 -43.64 71.07 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.116 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -63.13 -39.47 94.77 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.702 -0.399 . . . . 0.0 109.937 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.1 t -61.84 -45.19 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.176 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 37.7 mmm -64.27 -38.02 89.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.553 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.0 m -60.58 -40.11 90.51 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -61.25 -38.08 85.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.22 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.3 tp -61.65 -44.0 97.8 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.862 0.363 . . . . 0.0 110.249 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.95 -154.71 25.68 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -139.02 23.33 2.6 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.624 -0.288 . . . . 0.0 110.763 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -62.57 -43.25 99.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.069 0.461 . . . . 0.0 110.386 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.402 ' CD2' HD21 ' A' ' 48' ' ' LEU . 29.0 mt -99.91 169.13 9.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.536 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.492 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -68.42 162.14 26.08 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.579 179.761 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -92.09 -22.27 20.0 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.432 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -87.26 -24.48 24.36 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.618 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.57 -66.09 0.21 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.241 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.618 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.7 m -65.17 -35.26 74.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.417 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -60.48 -46.81 88.72 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.586 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -84.85 -40.4 17.16 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.4 tmm? -58.89 -47.24 85.66 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 125' ' ' ILE . 94.4 mt -69.13 -18.32 22.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.6 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -77.4 -51.4 10.87 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 119.016 -1.074 . . . . 0.0 111.317 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 129' ' ' ASP . 34.7 tp10 -86.3 -68.7 0.72 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.492 -177.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.63 -21.54 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 127' ' ' GLU . 38.7 t0 -90.12 125.12 35.33 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.135 0.493 . . . . 0.0 110.625 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.644 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.58 -32.0 56.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.995 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -72.18 -45.83 58.77 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.95 0.405 . . . . 0.0 110.328 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.67 -5.45 61.19 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 134' ' ' GLY . 35.0 p30 -90.0 -9.69 47.75 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 58.26 117.9 0.01 OUTLIER Glycine 0 CA--C 1.519 0.323 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 8.2 pt20 -159.72 140.15 12.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.539 -0.331 . . . . 0.0 110.146 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.6 t -126.24 133.32 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.93 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.542 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.8 t30 -150.76 175.36 12.06 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.305 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -57.66 -52.1 66.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.765 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.542 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 57.3 mp0 -55.9 -35.04 66.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.708 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 79.4 mt-10 -69.51 -39.3 77.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.694 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -61.21 -45.39 94.78 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.0 t -57.94 -45.94 87.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -74.17 -30.83 62.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.442 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.4 ttp -60.07 -40.61 90.13 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.627 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.405 ' O ' ' OG1' ' A' ' 146' ' ' THR . 73.0 mtm -105.25 141.7 36.32 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.905 0.383 . . . . 0.0 110.635 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 145' ' ' MET . 63.0 m -167.23 72.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.146 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.8 97.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.617 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 C--O 1.219 -0.535 0 CA-C-O 118.105 -0.95 . . . . 0.0 110.228 -179.93 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 4' ' ' LEU . 66.8 t0 -88.44 113.97 24.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.651 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -81.16 -16.93 51.52 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.398 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.405 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 32.3 tp -112.96 117.66 32.68 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.908 0.385 . . . . 0.0 110.074 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.1 p -139.08 157.46 45.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.223 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -71.24 -22.11 62.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.021 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.12 -43.04 77.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.031 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -62.4 -44.19 97.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.454 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.3 mt -64.3 -43.29 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.842 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.4 -45.36 69.29 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.487 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -41.21 -45.84 2.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.771 0.319 . . . . 0.0 110.929 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -66.82 -39.57 87.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.753 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -62.83 -43.12 99.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.539 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.09 -40.82 91.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.766 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.81 -20.33 49.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.654 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -49.43 -47.94 47.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.822 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.5 m -77.69 -20.38 53.74 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.035 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.8 tp -64.06 -40.69 96.83 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.802 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.471 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 76.2 m-85 -57.64 -45.49 85.39 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.339 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 9.7 t0 -86.1 -20.36 28.83 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -44.07 -33.13 1.37 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.821 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.415 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 4.4 p-10 -56.01 -46.12 78.85 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.888 0.375 . . . . 0.0 110.858 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -140.31 -152.62 5.84 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 28.1 p-10 -74.38 -47.1 36.2 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 122.679 -0.307 . . . . 0.0 110.74 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.498 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.72 107.13 0.28 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 6.2 m -166.44 148.82 6.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.123 0.462 . . . . 0.0 111.407 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.71 74.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.508 HG22 HG22 ' A' ' 62' ' ' THR . 9.7 p -86.97 166.16 15.3 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.51 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -66.3 -28.62 68.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.925 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -61.86 -40.19 94.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.961 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.471 ' OE1' ' O ' ' A' ' 19' ' ' PHE . 86.6 mt-10 -66.7 -40.51 88.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.954 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.7 tp -62.82 -43.55 98.5 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.61 -33.19 47.76 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 m -64.6 -44.69 89.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.922 0.361 . . . . 0.0 110.84 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.2 t -55.87 -17.36 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.331 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.542 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 88.9 mmm -52.71 -40.75 63.29 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.745 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.3 ttt85 -64.29 -46.01 85.5 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 118.159 -1.417 . . . . 0.0 110.181 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.0 p -64.33 -19.2 65.29 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.653 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.815 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 36.4 mt -94.4 6.57 48.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.727 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 43.76 78.69 0.07 OUTLIER Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 40' ' ' GLY . 85.7 mt-30 52.67 117.23 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.869 0.366 . . . . 0.0 110.733 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 44' ' ' THR . 35.3 t-20 -148.81 68.76 9.87 Favored Pre-proline 0 C--O 1.235 0.3 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.643 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.588 ' O ' ' N ' ' A' ' 46' ' ' ALA . 87.3 Cg_exo -35.77 -31.27 0.08 OUTLIER 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.507 2.138 . . . . 0.0 112.012 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 42' ' ' ASN . 29.5 m -38.49 -27.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.319 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.542 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 87.6 mt-10 -89.43 -32.4 17.26 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.588 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.46 -51.82 68.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.974 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.449 ' HB2' HG23 ' A' ' 117' ' ' THR . 2.2 tm-20 -67.51 -46.04 74.04 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 44' ' ' THR . 97.0 mt -63.6 -27.6 69.35 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.396 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -39.54 -53.65 2.06 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.818 0.342 . . . . 0.0 110.792 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -65.94 -38.25 88.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.197 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.5 ttp -62.42 -40.16 95.65 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 97.9 mt -61.99 -46.43 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.644 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 9.5 m120 -62.31 -42.41 99.35 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.725 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.74 -55.6 32.3 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.134 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.9 -34.85 62.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.934 0.397 . . . . 0.0 111.123 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 62' ' ' THR . 44.0 t0 -82.94 -13.41 56.08 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.377 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.06 8.87 1.1 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.788 0.327 . . . . 0.0 110.151 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 12.7 p30 -61.54 -25.09 67.07 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -157.87 -19.94 0.03 OUTLIER Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.62 ' C ' ' H ' ' A' ' 62' ' ' THR . 5.1 p30 177.07 141.86 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.76 32.27 0.09 OUTLIER Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.62 ' H ' ' C ' ' A' ' 60' ' ' ASN . 64.2 p -130.29 150.14 51.66 Favored 'General case' 0 C--N 1.337 0.053 0 CA-C-O 120.973 0.416 . . . . 0.0 110.288 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.5 mt -117.08 138.96 46.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.138 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.51 166.13 19.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.436 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.431 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -62.97 -50.5 76.56 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.803 -179.19 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.5 Cg_exo -50.85 -44.94 38.7 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.984 1.79 . . . . 0.0 111.824 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.89 -36.35 72.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.924 0.393 . . . . 0.0 110.994 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -59.99 -45.86 91.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.246 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.08 -44.54 95.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.594 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.7 m -67.41 -44.4 78.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.254 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.9 ttp -61.43 -40.13 93.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.023 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 76.1 mmm -63.05 -38.55 91.64 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.841 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.09 96.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.028 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -68.48 -45.53 72.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.052 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.61 -41.78 83.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.955 0.407 . . . . 0.0 110.33 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.8 mmt -86.96 164.42 16.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.14 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -116.22 153.61 31.56 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.043 0.449 . . . . 0.0 110.154 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -59.26 160.47 6.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.302 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.8 p -64.13 -30.08 71.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.586 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -64.47 -10.01 22.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.158 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -57.08 -32.82 66.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.516 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -49.44 -50.22 41.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.723 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -65.08 -41.89 94.6 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.987 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -66.32 -45.66 79.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.497 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.4 mt -64.91 -20.6 27.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.8 ttt-85 -59.68 -42.19 92.39 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.206 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -61.48 -35.88 78.89 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.477 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.17 -13.4 60.46 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -47.96 -51.12 24.92 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.0 0.428 . . . . 0.0 111.424 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -59.75 -46.85 87.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.825 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 85.0 t -68.84 -44.34 81.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.958 0.409 . . . . 0.0 110.466 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -59.44 -44.43 92.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.529 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 33.0 t70 -138.84 100.67 4.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.231 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.04 -40.01 82.94 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.207 0.527 . . . . 0.0 110.198 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.3 p-10 -60.13 -42.6 95.14 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.327 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.67 -56.97 0.5 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -70.75 -13.63 62.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.078 0.466 . . . . 0.0 110.267 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.6 161.19 12.85 Favored Glycine 0 N--CA 1.464 0.541 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -115.13 150.92 35.26 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.8 mt -85.25 123.16 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 121.002 0.43 . . . . 0.0 110.339 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.2 p -79.99 168.13 19.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.034 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.25 -36.49 82.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.611 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.17 -45.31 93.97 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.095 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -69.99 -37.68 75.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.208 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.4 tp -62.01 -42.89 99.65 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.241 0.544 . . . . 0.0 111.276 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -52.57 -43.21 65.1 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.055 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -55.5 -42.73 74.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.164 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.4 t -64.58 -42.48 95.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.292 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 58.5 mmm -57.56 -34.74 69.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.467 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.7 m -60.24 -42.3 94.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.445 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -58.66 -38.68 78.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.824 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 40.0 tp -61.31 -46.34 90.7 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.048 0.451 . . . . 0.0 110.13 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.89 -154.91 26.0 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -143.22 11.81 1.76 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.693 -0.253 . . . . 0.0 110.78 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -63.93 -43.96 94.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.153 0.502 . . . . 0.0 110.657 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.5 mt -79.75 160.32 26.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.033 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.479 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -68.51 161.67 27.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.221 -179.71 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -92.33 -21.06 20.48 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.112 0.482 . . . . 0.0 110.448 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -85.45 -26.91 26.06 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.219 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.612 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.68 -63.49 0.35 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.808 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.612 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 11.3 m -69.09 -31.38 49.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 121.234 -0.186 . . . . 0.0 111.46 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -58.82 -67.15 0.39 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.699 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.58 -45.14 72.8 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.521 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 13.3 tmm? -52.93 -50.3 64.28 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 125' ' ' ILE . 95.9 mt -64.61 -18.37 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.669 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -87.92 -57.91 2.76 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 119.904 -0.718 . . . . 0.0 112.25 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 128' ' ' ALA . 51.0 tp10 -81.95 -67.7 0.76 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.271 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.815 ' HB2' ' O ' ' A' ' 39' ' ' LEU . . . -36.83 -35.65 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 56.6 t0 -87.71 146.11 25.83 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.277 0.56 . . . . 0.0 110.568 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.566 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -89.39 -14.85 9.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.809 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 133' ' ' ASP . 44.8 m-20 -73.54 -45.36 54.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.032 0.444 . . . . 0.0 110.407 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.35 -10.28 3.73 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 131' ' ' ASP . 35.4 p30 -89.88 -10.4 45.42 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.836 0.351 . . . . 0.0 110.195 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 62.25 123.0 0.01 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -161.72 119.61 2.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.889 0.376 . . . . 0.0 110.101 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.67 128.93 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.093 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.523 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 45.2 t30 -155.1 166.2 34.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.071 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.401 ' O ' ' CD1' ' A' ' 138' ' ' TYR . 2.6 t80 -48.79 -23.02 0.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.459 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 50.1 mp0 -66.42 -35.74 81.06 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.152 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -84.97 -20.78 30.04 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.56 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.04 -46.7 87.99 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 121.134 -0.227 . . . . 0.0 111.166 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 30.1 t -58.31 -45.98 89.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.005 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -71.36 -36.14 71.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.293 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 61.5 ttp -57.94 -43.09 86.14 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.207 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 70.7 mtm -112.72 129.33 56.45 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.818 0.342 . . . . 0.0 110.414 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.5 m -162.88 85.77 0.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.096 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.1 -43.91 93.9 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.676 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 C--O 1.219 -0.527 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.507 179.879 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.413 ' OD2' ' O ' ' A' ' 4' ' ' LEU . 67.3 t0 -92.62 115.95 28.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.016 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -68.81 -30.08 68.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.195 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.413 ' O ' ' OD2' ' A' ' 2' ' ' ASP . 46.9 tp -102.0 128.18 48.55 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.675 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.0 p -134.58 158.39 44.12 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.382 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -66.15 -21.98 66.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.713 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -63.13 -44.21 96.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.531 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -65.9 -41.49 91.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.031 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 89.7 mt -64.58 -43.11 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.484 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.74 -39.93 68.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.181 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -47.67 -48.62 28.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.102 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -59.44 -44.86 92.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.89 0.376 . . . . 0.0 110.484 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -63.42 -39.66 95.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.664 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.29 -41.29 85.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.343 . . . . 0.0 111.143 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.44 -22.72 66.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.82 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -55.59 -47.81 75.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.21 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.9 m -81.47 -17.19 49.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.476 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.93 -43.77 97.9 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.435 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.416 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.7 m-85 -60.48 -50.39 73.75 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.565 -179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.3 t0 -77.08 -14.64 59.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.191 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -45.01 -32.93 1.84 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.228 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.447 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 18.0 p-10 -54.71 -46.01 74.12 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 120.966 -0.293 . . . . 0.0 110.875 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -144.0 -151.09 5.38 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 32.3 p-10 -73.08 -47.03 47.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.714 0.292 . . . . 0.0 110.81 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.77 107.29 0.28 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.428 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 4.9 m -166.2 142.79 5.04 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.771 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.03 103.42 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.404 HG22 HG22 ' A' ' 62' ' ' THR . 2.9 p -123.11 169.96 10.69 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.1 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.605 ' CB ' HE22 ' A' ' 49' ' ' GLN . 61.1 p -63.14 -35.32 79.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.861 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -60.35 -38.46 83.88 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.447 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 87.7 mt-10 -65.64 -43.11 90.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.091 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.66 -41.96 98.14 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.258 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.71 -28.8 17.05 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.2 m -64.54 -44.15 91.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.95 0.405 . . . . 0.0 110.729 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.2 t -57.1 -17.61 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.175 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.541 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 87.7 mmm -53.03 -38.52 62.45 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.266 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.7 ttt85 -64.28 -45.97 85.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 117.444 -1.702 . . . . 0.0 110.722 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 92.8 p -63.41 -19.96 65.14 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.538 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.882 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 52.4 mt -99.58 6.12 45.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.904 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 34.9 94.55 0.01 OUTLIER Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.487 ' O ' ' O ' ' A' ' 40' ' ' GLY . 84.1 mt-30 52.23 110.25 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.619 0.247 . . . . 0.0 110.369 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 44' ' ' THR . 49.9 t30 -145.82 63.98 9.81 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.704 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.574 ' O ' ' N ' ' A' ' 46' ' ' ALA . 89.3 Cg_exo -34.72 -29.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.612 2.208 . . . . 0.0 112.325 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 42' ' ' ASN . 23.3 m -40.13 -29.61 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.124 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.541 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 90.7 mt-10 -89.63 -29.93 18.49 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.802 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -60.84 -49.15 78.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.822 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.469 ' HB2' HG23 ' A' ' 117' ' ' THR . 2.2 tm-20 -72.18 -43.18 64.96 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.25 0.548 . . . . 0.0 109.751 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.585 HD21 HD21 ' A' ' 116' ' ' LEU . 96.3 mt -67.97 -25.12 65.27 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.203 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.605 HE22 ' CB ' ' A' ' 29' ' ' THR . 53.8 tp60 -40.76 -41.89 1.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.603 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -77.64 -36.83 51.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.862 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.492 ' CE ' HD22 ' A' ' 48' ' ' LEU . 32.6 ttp -59.96 -37.28 79.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.677 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.59 HG21 HG22 ' A' ' 29' ' ' THR . 96.8 mt -63.44 -44.89 99.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.027 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.673 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 51.0 m-80 -62.54 -39.84 94.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.37 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -56.62 -56.42 21.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.294 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.476 HG13 ' N ' ' A' ' 56' ' ' ASP . 15.0 p -74.12 -40.38 51.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.851 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.502 ' OD2' ' N ' ' A' ' 62' ' ' THR . 44.4 t0 -71.2 -13.21 61.85 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.561 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.673 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.35 8.98 1.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.31 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 56' ' ' ASP . 10.4 p-10 -59.67 -26.76 65.82 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -155.06 -24.41 0.03 OUTLIER Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.551 ' C ' ' H ' ' A' ' 62' ' ' THR . 9.9 p30 176.19 151.19 0.14 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.582 -0.309 . . . . 0.0 110.178 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.28 36.35 0.09 OUTLIER Glycine 0 CA--C 1.535 1.294 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.551 ' H ' ' C ' ' A' ' 60' ' ' ASN . 44.2 p -137.45 153.31 50.12 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.5 mt -127.38 136.98 59.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.971 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -81.18 164.59 22.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.137 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.431 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -62.13 -50.11 81.71 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.227 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.6 Cg_exo -50.07 -41.73 48.0 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.074 1.849 . . . . 0.0 112.065 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -80.78 -29.83 36.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.111 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -59.53 -45.0 93.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.026 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.39 -43.21 99.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.279 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.1 m -64.43 -44.83 89.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.85 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.0 ttp -60.1 -44.69 94.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.829 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 79.4 mmm -63.8 -40.91 97.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.258 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.407 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -61.21 -47.86 84.18 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.865 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -71.25 -46.25 61.43 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.496 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -66.79 -45.19 79.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.993 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.407 ' O ' ' O ' ' A' ' 73' ' ' ALA . 17.8 mmm -99.5 -176.69 3.36 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.057 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -128.49 152.19 48.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.112 0.482 . . . . 0.0 110.177 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -54.2 177.74 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.359 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.2 p -80.6 -15.74 55.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.544 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -66.39 -13.67 61.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.397 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 83' ' ' GLU . 72.8 m -53.35 -34.38 57.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.548 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -39.0 -28.83 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.365 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 81' ' ' SER . 75.8 mm-40 -85.36 -54.84 4.33 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.004 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -58.48 -36.3 73.53 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.984 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.431 ' O ' HG22 ' A' ' 85' ' ' ILE . 96.7 mt -63.58 -20.04 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.1 ttt-85 -60.99 -45.06 96.34 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 118.351 -1.34 . . . . 0.0 109.627 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -64.67 -21.74 66.81 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.172 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.41 -17.51 48.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.466 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -57.05 -50.19 73.52 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.305 0.574 . . . . 0.0 110.556 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -68.6 -44.92 73.29 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.898 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.2 t -65.33 -49.09 80.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.028 0.442 . . . . 0.0 109.986 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.679 ' CE2' HD12 ' A' ' 100' ' ' ILE . 51.7 t80 -62.61 -45.19 94.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.878 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.412 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 22.2 t0 -120.54 104.57 10.07 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.056 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -66.38 -41.21 89.71 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.037 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -70.49 -41.55 72.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.042 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.91 -53.04 0.75 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -64.04 -20.05 65.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.98 0.419 . . . . 0.0 110.315 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.412 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.67 161.0 12.9 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -113.34 148.29 35.99 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.679 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -84.9 123.55 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.0 p -87.27 176.76 7.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.129 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.57 84.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.979 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.55 -51.32 69.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.886 0.374 . . . . 0.0 110.983 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -71.4 -30.51 66.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 49.6 tp -61.78 -41.02 97.18 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.235 0.54 . . . . 0.0 111.093 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -54.18 -41.49 68.59 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.918 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -57.94 -42.73 85.49 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.3 t -65.59 -43.1 94.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.691 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 91.6 mmm -62.59 -37.25 85.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.44 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.8 m -59.44 -40.49 86.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.639 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -58.59 -38.76 78.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.737 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.0 tp -61.07 -44.99 96.54 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.551 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.05 -145.37 12.16 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -143.52 16.3 1.83 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.827 0.346 . . . . 0.0 110.748 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -61.79 -44.93 95.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.014 0.435 . . . . 0.0 110.424 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.585 HD21 HD21 ' A' ' 48' ' ' LEU . 82.8 mt -82.12 161.38 22.86 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.981 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.471 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -66.13 161.73 21.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.685 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -91.58 -19.63 22.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.863 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -87.69 -28.11 22.01 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.63 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.34 -66.9 0.17 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.802 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.63 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.4 m -63.97 -39.32 85.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.468 ' N ' HG23 ' A' ' 121' ' ' VAL . 84.9 m-20 -54.33 -65.89 0.49 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.674 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 127' ' ' GLU . 80.6 mm-40 -70.42 -44.9 66.95 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.656 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 18.9 tmm? -53.04 -47.58 68.29 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.899 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 97.6 mt -67.18 -19.72 25.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.346 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -91.28 -66.72 0.9 Allowed 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.033 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 123' ' ' GLU . 25.0 tp10 -65.26 -68.62 0.35 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.161 -177.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.882 ' HB2' ' O ' ' A' ' 39' ' ' LEU . . . -37.11 -37.72 0.17 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.481 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 66.1 t0 -87.52 138.29 31.6 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.246 0.546 . . . . 0.0 110.583 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.592 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -85.82 -16.14 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.319 -179.683 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -73.06 -46.53 51.12 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.126 0.488 . . . . 0.0 110.146 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.95 -2.58 54.93 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 52.1 p30 -88.66 -22.25 23.52 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 64.65 103.64 0.01 OUTLIER Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -147.76 140.82 24.99 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.788 0.328 . . . . 0.0 110.141 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.1 t -128.95 134.31 64.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.313 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.526 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 53.4 t30 -151.56 -179.12 7.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.603 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -57.26 -48.14 79.63 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.259 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.526 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 55.8 mp0 -50.93 -43.66 60.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.353 -178.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -67.6 -39.84 84.76 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.967 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -60.71 -43.68 97.52 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.571 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.4 t -54.22 -43.92 62.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.239 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -84.29 -19.31 34.01 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.211 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 41.1 ttp -65.08 -41.32 95.15 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.94 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.404 ' O ' ' OG1' ' A' ' 146' ' ' THR . 51.7 mtm -103.71 132.7 49.73 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.867 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 145' ' ' MET . 43.6 m -166.83 81.79 0.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.053 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.77 -37.28 75.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.292 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.1 mttm . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.509 179.921 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -91.98 107.58 19.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.08 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -135.53 166.38 23.34 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.093 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 36.7 tp -96.1 126.55 41.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.263 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.2 p -127.26 160.04 32.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.668 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.59 -19.27 62.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.565 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -67.21 -42.03 84.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.967 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -62.97 -42.01 99.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.906 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.4 mt -69.83 -31.39 48.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.608 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.2 -29.56 70.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -51.48 -43.23 62.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.738 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -66.97 -46.35 74.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.022 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -61.67 -44.78 96.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.795 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -67.98 -40.89 83.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.642 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.19 -28.42 67.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.971 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -55.56 -45.85 77.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.695 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.0 m -81.58 -17.88 46.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.733 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.5 tp -65.45 -42.36 92.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.952 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.401 ' O ' ' CD ' ' A' ' 31' ' ' GLU . 73.6 m-85 -61.05 -45.95 92.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.333 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 4.7 t0 -81.98 -15.65 53.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.341 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -42.84 -32.51 0.63 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.105 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.437 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 9.1 p-10 -53.59 -46.75 70.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.887 0.375 . . . . 0.0 110.72 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.437 ' N ' ' CG ' ' A' ' 22' ' ' ASP . . . -145.67 -147.3 4.58 Favored Glycine 0 N--CA 1.466 0.696 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 20.3 p-10 -76.53 -47.56 22.29 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.921 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.02 107.02 0.27 Allowed Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 177.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 96.0 m -166.73 143.14 4.64 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.936 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.06 117.09 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.831 0.348 . . . . 0.0 110.095 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.689 HG22 HG22 ' A' ' 62' ' ' THR . 12.3 p -133.38 165.6 24.47 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.429 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.429 ' HB ' HE22 ' A' ' 49' ' ' GLN . 80.2 p -63.08 -35.14 79.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.274 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -61.27 -38.48 86.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.076 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.415 ' OE2' ' CG ' ' A' ' 22' ' ' ASP . 91.3 mt-10 -64.71 -49.16 71.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.336 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.32 -43.6 98.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.277 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.17 -24.02 4.48 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.7 m -64.91 -42.47 94.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.903 0.382 . . . . 0.0 110.509 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.5 t -54.55 -16.33 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.26 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.453 ' O ' ' N ' ' A' ' 40' ' ' GLY . 53.4 mmm -58.71 -37.27 75.77 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -62.46 -46.16 89.76 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 116.724 -1.99 . . . . 0.0 110.66 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.9 p -60.11 -36.15 76.8 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.101 -178.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 41' ' ' GLN . 44.6 mt -95.85 2.08 53.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.723 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 66.25 -66.47 0.15 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' A' ' 39' ' ' LEU . 74.6 mt-30 -141.7 122.75 14.61 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.5 t-20 -141.43 71.11 26.55 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.653 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' ALA . 73.2 Cg_exo -37.45 -30.41 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.172 1.915 . . . . 0.0 112.186 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 42' ' ' ASN . 25.2 m -39.05 -27.61 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.477 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 49' ' ' GLN . 86.7 mt-10 -90.31 -36.92 14.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.005 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -56.28 -48.89 75.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.399 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -70.5 -45.02 66.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.292 0.568 . . . . 0.0 110.133 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.516 HD21 HD22 ' A' ' 116' ' ' LEU . 96.0 mt -70.06 -20.12 63.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.804 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 45' ' ' GLU . 11.7 tp-100 -46.39 -46.23 18.37 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.67 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -75.08 -35.28 61.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.199 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.431 ' CE ' HD22 ' A' ' 48' ' ' LEU . 33.1 ttp -63.63 -43.05 97.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.077 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 96.7 mt -62.8 -46.19 96.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.752 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.693 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 81.3 m-20 -64.66 -40.69 95.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.738 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.08 -56.84 16.74 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.421 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 56' ' ' ASP . 11.3 p -69.7 -36.96 72.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.985 0.421 . . . . 0.0 110.95 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.551 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.4 t0 -79.03 -12.7 60.03 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.423 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.693 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.12 15.46 0.16 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.349 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 10.4 p30 -65.75 -21.91 66.55 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.415 ' H ' ' H ' ' A' ' 60' ' ' ASN . . . -167.81 -9.62 0.03 OUTLIER Glycine 0 C--N 1.333 0.392 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.579 ' C ' ' H ' ' A' ' 62' ' ' THR . 2.0 p30 169.37 140.46 0.02 OUTLIER 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.0 35.88 0.1 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.689 HG22 HG22 ' A' ' 28' ' ' THR . 69.0 p -136.02 154.94 50.91 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 90.8 mt -130.05 132.08 65.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.219 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.14 151.99 42.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.612 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.445 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -54.87 -51.27 80.66 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.768 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 52.4 Cg_exo -49.12 -49.82 14.38 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.863 1.709 . . . . 0.0 112.106 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -68.6 -33.65 74.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.412 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -61.98 -43.77 98.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.997 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.2 mt -59.2 -45.61 90.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.789 0.328 . . . . 0.0 110.734 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.4 m -63.85 -44.73 92.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.463 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 36.4 ttp -60.01 -45.33 93.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.515 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.2 mmm -64.68 -39.33 93.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.565 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.32 -39.15 78.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.67 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -77.86 -51.46 10.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.424 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -65.6 -44.26 87.13 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.47 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.2 mmm -99.72 126.47 45.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.358 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -86.74 143.87 27.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.501 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 80' ' ' ASP . 97.2 m-20 -49.42 158.59 0.4 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.431 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 35.7 p -54.88 -8.73 0.28 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.642 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 78' ' ' ASP . 80.1 m-20 -67.11 -8.66 32.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.109 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.4 m -59.37 -29.61 67.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.637 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -37.87 -49.15 1.19 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.006 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.66 -55.08 19.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.909 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -59.63 -32.36 70.36 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.083 0.468 . . . . 0.0 110.629 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 85' ' ' ILE . 82.6 mt -69.2 -15.07 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -59.76 -48.88 79.91 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 117.508 -1.677 . . . . 0.0 110.377 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.2 -32.58 74.34 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.498 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.63 -35.98 73.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.789 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -50.59 -51.12 51.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.341 0.591 . . . . 0.0 110.908 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -69.24 -44.54 71.79 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.292 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.09 -51.45 48.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.113 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.558 ' CE2' HD12 ' A' ' 100' ' ' ILE . 66.6 t80 -63.45 -47.47 81.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.396 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.465 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 17.9 t0 -107.77 105.41 15.23 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.087 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -71.75 -44.87 63.32 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.598 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 44.9 p-10 -67.14 -33.64 75.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.054 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.526 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 66.56 -74.88 0.15 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -53.64 -13.07 0.58 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.922 0.391 . . . . 0.0 110.392 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.423 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.53 161.78 12.66 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -112.33 155.91 23.32 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.558 HD12 ' CE2' ' A' ' 92' ' ' PHE . 94.4 mt -99.78 117.43 44.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.7 p -82.1 175.69 10.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.151 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.95 -37.02 84.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.826 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.56 -52.43 64.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.791 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -67.7 -31.17 70.94 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.654 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.0 tp -64.15 -41.4 97.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.501 0.667 . . . . 0.0 110.997 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -53.86 -39.26 65.49 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.964 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -63.79 -41.23 97.98 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.1 -42.68 96.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.498 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 54.0 mmm -62.37 -40.75 97.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.979 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.4 m -61.69 -40.3 94.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.556 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -58.89 -40.45 84.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.614 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.9 tp -61.31 -44.27 97.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.964 0.411 . . . . 0.0 110.541 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 161.85 -151.91 22.16 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -138.31 29.15 2.47 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.806 0.336 . . . . 0.0 110.66 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -67.45 -45.32 76.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.824 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.516 HD22 HD21 ' A' ' 48' ' ' LEU . 19.6 mt -100.62 166.89 10.67 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.871 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.519 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -69.49 161.61 29.16 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.177 -179.595 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -92.71 -21.57 19.9 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.888 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -87.42 -23.56 24.47 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.637 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -35.09 -68.09 0.13 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.577 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.523 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 9.8 m -63.88 -42.09 94.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.517 ' N ' HG23 ' A' ' 121' ' ' VAL . 87.6 m-20 -48.33 -67.01 0.31 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.748 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.463 ' O ' ' OE1' ' A' ' 127' ' ' GLU . 80.3 mm-40 -70.54 -40.0 73.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.745 0.307 . . . . 0.0 111.801 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.404 ' SD ' ' C ' ' A' ' 124' ' ' MET . 17.7 tmm? -57.26 -38.93 74.62 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.669 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.8 mt -77.9 -23.76 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -77.61 -46.82 20.98 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 118.674 -1.211 . . . . 0.0 111.657 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 123' ' ' GLU . 19.6 mp0 -80.13 -68.41 0.68 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.661 -177.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.56 -49.02 1.05 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.629 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -88.46 131.07 35.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.896 0.379 . . . . 0.0 110.255 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.546 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -82.31 -10.69 12.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.148 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 133' ' ' ASP . 89.2 m-20 -64.35 -40.42 95.83 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.118 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.61 -8.4 4.28 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' A' ' 134' ' ' GLY . 26.1 p-10 -88.26 -12.72 42.84 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 39.39 98.07 0.01 OUTLIER Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.435 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 13.3 pt20 -131.09 136.94 48.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.021 0.439 . . . . 0.0 110.334 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.0 t -115.3 134.92 56.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.089 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.515 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 52.9 t30 -152.71 176.67 11.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.659 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -58.8 -47.97 82.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.406 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.515 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 58.0 mp0 -57.43 -25.54 59.79 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.293 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 81.1 mt-10 -84.82 -33.71 22.86 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.1 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -65.71 -46.84 77.44 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.634 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 50.3 t -56.35 -44.49 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 120.789 0.328 . . . . 0.0 110.253 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -71.63 -38.03 70.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.155 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 50.2 ttp -60.48 -48.55 81.26 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.291 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 49.1 mtm -88.62 120.81 30.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.945 0.402 . . . . 0.0 110.778 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.1 m -165.75 99.12 0.67 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.76 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.96 -38.31 88.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.582 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.8 mttm . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 117.821 -1.085 . . . . 0.0 110.509 179.982 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.544 0.212 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -54.65 -48.32 72.45 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.528 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -65.62 -40.85 93.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.865 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -62.01 -44.05 97.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.659 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -66.98 -37.57 84.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.988 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.482 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.03 -27.9 65.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.806 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -57.81 -46.9 84.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.525 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 m -77.98 -21.41 50.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.691 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.0 tp -62.41 -42.83 99.73 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.419 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.482 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.3 m-85 -60.15 -51.02 71.4 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.439 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.2 t0 -76.9 -14.32 59.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.872 0.368 . . . . 0.0 111.366 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -45.59 -32.68 2.43 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.805 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 8.8 p-10 -53.72 -46.1 70.71 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.53 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.434 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -144.36 -151.6 5.47 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 30.8 p-10 -72.93 -47.28 47.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.733 0.301 . . . . 0.0 111.106 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.71 107.35 0.28 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 178.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.43 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 4.6 m -166.61 139.3 3.74 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.151 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 27' ' ' ILE . 5.2 mp -115.13 109.23 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.594 HG22 HG22 ' A' ' 62' ' ' THR . 2.6 p -128.72 170.24 13.53 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.882 0.373 . . . . 0.0 110.372 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.638 ' CB ' HE22 ' A' ' 49' ' ' GLN . 67.2 p -64.68 -33.05 75.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.789 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -61.69 -41.45 97.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.395 . . . . 0.0 109.983 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 26' ' ' THR . 90.0 mt-10 -63.4 -45.73 89.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.897 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.9 tp -64.16 -43.3 95.6 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.106 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.81 -26.07 53.5 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.1 m -63.9 -41.45 97.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.885 0.374 . . . . 0.0 110.098 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.1 t -56.23 -23.61 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.365 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.478 ' O ' ' N ' ' A' ' 40' ' ' GLY . 62.3 mmm -48.06 -30.27 4.29 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.667 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -64.36 -45.68 86.71 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 118.077 -1.449 . . . . 0.0 110.999 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -63.95 -21.96 66.71 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.837 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 41' ' ' GLN . 16.8 mt -107.73 3.7 24.87 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.097 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.2 -71.29 0.02 OUTLIER Glycine 0 N--CA 1.465 0.602 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 39' ' ' LEU . 87.8 mt-30 -145.44 109.45 4.83 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 44' ' ' THR . 41.4 t30 -125.56 70.88 65.21 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.091 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.551 ' O ' ' N ' ' A' ' 46' ' ' ALA . 84.7 Cg_exo -33.02 -30.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 122.63 2.22 . . . . 0.0 112.715 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 42' ' ' ASN . 26.3 m -39.27 -30.19 0.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.503 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.419 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.9 mt-10 -86.61 -34.96 19.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.291 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -59.07 -50.04 75.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.834 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.15 -46.07 71.78 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.176 0.512 . . . . 0.0 109.671 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 51' ' ' MET . 84.7 mt -64.87 -31.14 72.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.338 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.638 HE22 ' CB ' ' A' ' 29' ' ' THR . 61.1 tp60 -37.42 -51.29 1.11 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.879 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.31 -40.32 89.89 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.228 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 48' ' ' LEU . 33.1 ttp -62.44 -41.02 98.44 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.934 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.413 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 83.4 mt -61.98 -49.85 82.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.182 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.604 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 89.8 m-20 -62.95 -40.46 97.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.56 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -55.18 -61.5 2.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.238 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.92 -30.12 43.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.261 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 62' ' ' THR . 50.6 t0 -84.66 -13.2 52.19 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.568 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.02 13.06 0.33 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.859 0.362 . . . . 0.0 110.254 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.8 p30 -65.54 -28.9 69.5 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -150.53 -22.37 0.06 OUTLIER Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 62' ' ' THR . 3.3 p30 173.17 151.84 0.08 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.93 34.64 0.14 Allowed Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.594 HG22 HG22 ' A' ' 28' ' ' THR . 81.9 p -134.34 149.46 50.86 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.4 mt -120.98 134.48 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.14 162.36 28.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.461 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.473 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -64.61 -48.16 74.56 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.432 -179.045 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 50.2 Cg_exo -51.17 -37.44 58.72 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.195 1.93 . . . . 0.0 111.719 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -87.48 -22.33 24.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.31 -47.25 86.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.014 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.44 -42.94 98.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.543 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.1 m -63.97 -46.08 86.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.672 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.6 ttp -61.66 -47.57 84.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.062 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 82.0 mmm -65.75 -37.82 87.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.275 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.62 -49.97 75.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.01 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -71.46 -43.83 65.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.18 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.69 -43.64 88.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.681 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.434 ' O ' ' O ' ' A' ' 73' ' ' ALA . 22.4 mmm -104.3 127.47 51.94 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.08 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.7 tptt -84.99 141.18 30.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.893 0.378 . . . . 0.0 110.706 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.422 ' O ' ' O ' ' A' ' 77' ' ' LYS . 95.1 m-20 -48.93 179.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.239 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.6 p -75.5 -6.74 51.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.444 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.52 -15.43 62.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.567 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.1 m -61.94 -19.94 63.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.539 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -48.15 -44.71 32.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.374 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.97 -39.51 79.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.913 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.86 -45.15 83.22 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.023 0.439 . . . . 0.0 110.187 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.2 mt -66.1 -19.05 25.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.514 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -58.43 -45.41 88.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.205 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.63 -31.83 73.07 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.916 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -72.04 -14.62 61.92 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.212 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -58.04 -48.96 78.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.292 0.567 . . . . 0.0 111.046 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -64.1 -45.6 87.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.328 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.14 -51.59 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.897 0.379 . . . . 0.0 110.896 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.441 ' CE2' HD12 ' A' ' 100' ' ' ILE . 26.3 t80 -61.95 -47.2 85.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.628 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.422 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 18.1 t70 -108.97 94.21 4.93 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.24 -41.03 74.08 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.001 0.429 . . . . 0.0 110.536 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 20.1 p-10 -62.49 -39.75 94.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.021 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.51 -67.34 0.99 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.59 -16.53 63.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.93 0.395 . . . . 0.0 110.25 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.71 162.03 12.57 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.29 155.38 24.17 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.786 0.327 . . . . 0.0 110.247 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.441 HD12 ' CE2' ' A' ' 92' ' ' PHE . 94.2 mt -79.73 125.99 39.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.978 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.4 p -82.39 169.01 16.94 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.141 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.56 -37.98 89.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.499 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.72 -47.36 83.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.847 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.66 -32.83 72.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.955 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.5 tp -61.59 -41.7 97.81 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.405 0.622 . . . . 0.0 110.68 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -56.42 -43.3 79.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.816 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -58.48 -41.96 86.45 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.62 -43.39 90.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.692 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.1 mmm -62.02 -35.58 79.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.685 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.9 m -61.13 -44.37 97.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.014 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -59.8 -34.96 73.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.382 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.1 tp -61.18 -46.7 89.42 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.121 0.486 . . . . 0.0 110.384 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.47 -160.71 33.43 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -140.55 23.33 2.31 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.634 0.254 . . . . 0.0 110.78 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -63.57 -42.86 98.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.97 0.414 . . . . 0.0 110.24 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.6 mt -92.8 175.85 6.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.996 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.469 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -72.93 161.32 30.84 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.679 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -91.66 -22.5 20.23 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.928 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -87.92 -25.26 23.31 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.152 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.638 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.4 -61.28 0.45 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.141 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.638 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 20.3 m -67.39 -40.18 84.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.486 ' N ' HG23 ' A' ' 121' ' ' VAL . 81.2 m-20 -56.86 -47.0 81.43 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.521 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -86.02 -40.33 15.9 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.6 tmm? -59.57 -46.52 88.67 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.015 0.436 . . . . 0.0 109.896 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 125' ' ' ILE . 91.9 mt -69.09 -16.58 20.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.475 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 -78.64 -50.53 11.31 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.085 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 129' ' ' ASP . 42.3 tp10 -87.65 -67.54 0.82 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.071 -0.651 . . . . 0.0 110.861 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.34 -26.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.745 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 127' ' ' GLU . 25.4 t0 -87.98 128.27 35.38 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.061 0.457 . . . . 0.0 111.091 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.673 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.47 -43.36 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.442 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -65.4 -40.31 93.25 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.132 0.491 . . . . 0.0 110.15 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.37 -2.0 58.92 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' GLY . 55.2 p-10 -89.47 -8.97 51.78 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 57.44 115.47 0.01 OUTLIER Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.24 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.434 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 20.3 pt20 -160.65 133.6 6.47 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.0 t -123.46 136.96 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.04 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -151.41 172.42 15.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.252 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -54.77 -46.75 74.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.161 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 139' ' ' GLU . 55.4 mp0 -58.73 -44.37 90.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.639 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 93.3 mt-10 -72.09 -29.33 64.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.753 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.86 -44.02 77.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.631 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 94.3 t -59.1 -46.34 91.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.289 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -69.37 -29.03 66.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.132 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.8 ttp -59.74 -42.82 94.03 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.832 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.49 138.87 50.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.912 0.387 . . . . 0.0 110.745 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 81.4 m -163.29 77.69 0.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.658 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.13 -27.75 68.95 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.451 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.695 -179.882 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.067 0 CA-C-O 120.433 0.159 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -54.78 -50.55 68.21 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.0 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -63.77 -44.08 94.47 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.715 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -62.57 -45.92 90.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.484 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -69.82 -35.72 75.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.923 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.506 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -63.13 -37.78 88.58 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.511 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -58.43 -46.29 86.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.535 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.4 m -80.87 -18.87 45.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.746 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.51 -43.08 98.26 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.792 0.329 . . . . 0.0 111.291 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.9 m-85 -58.06 -49.22 77.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.541 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 6.3 t0 -73.17 -13.43 61.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.693 0.282 . . . . 0.0 111.229 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -44.49 -33.48 1.74 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.965 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.413 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 7.2 p-10 -53.97 -45.67 71.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.858 0.361 . . . . 0.0 110.96 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -149.07 -150.89 5.34 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 24.9 p-10 -70.16 -47.4 61.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.901 0.382 . . . . 0.0 110.983 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.53 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.79 107.84 0.3 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.445 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 6.3 m -166.21 139.5 4.11 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.112 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.2 mp -120.66 110.6 28.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.553 ' CG2' HG22 ' A' ' 62' ' ' THR . 2.8 p -130.99 169.33 15.98 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.978 0.418 . . . . 0.0 110.554 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.424 HG22 HG21 ' A' ' 52' ' ' ILE . 51.2 p -63.09 -31.45 72.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.304 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -62.14 -42.37 99.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.978 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.445 ' OE1' ' O ' ' A' ' 26' ' ' THR . 81.4 mt-10 -66.66 -45.9 77.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.004 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.92 -42.9 97.25 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.38 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.81 -25.04 28.52 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.9 m -63.96 -44.15 93.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.865 0.365 . . . . 0.0 110.743 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.414 ' H ' HG23 ' A' ' 35' ' ' VAL . 5.2 t -55.54 -20.43 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.521 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.513 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 87.5 mmm -48.97 -34.86 13.85 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.613 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -63.12 -46.39 87.53 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 118.056 -1.458 . . . . 0.0 111.83 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.5 p -60.85 -30.85 70.36 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 41' ' ' GLN . 24.8 mt -96.7 2.04 51.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.046 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.94 -67.91 0.02 OUTLIER Glycine 0 N--CA 1.467 0.743 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 39' ' ' LEU . 86.0 mt-30 -143.6 110.09 5.48 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -123.73 75.05 55.65 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.469 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 46' ' ' ALA . 99.3 Cg_exo -36.4 -35.74 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.743 1.629 . . . . 0.0 112.139 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.418 ' N ' ' HB3' ' A' ' 120' ' ' GLU . 5.8 m -37.84 -31.51 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.734 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.513 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.2 mt-10 -87.34 -35.97 18.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.336 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.52 -51.96 67.68 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -68.4 -47.17 68.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.25 0.548 . . . . 0.0 109.969 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.507 HD22 ' CE ' ' A' ' 51' ' ' MET . 85.0 mt -64.08 -26.8 68.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.967 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 45' ' ' GLU . 58.7 tp60 -38.77 -46.42 1.26 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.72 0.295 . . . . 0.0 110.543 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.13 -41.72 66.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.536 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.507 ' CE ' HD22 ' A' ' 48' ' ' LEU . 40.1 ttp -62.17 -41.73 98.59 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.086 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.424 HG21 HG22 ' A' ' 29' ' ' THR . 96.6 mt -60.94 -51.97 67.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.354 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.621 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 17.3 m120 -64.35 -40.08 95.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.668 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -55.53 -59.6 4.6 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.266 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.79 -34.42 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.012 0.434 . . . . 0.0 110.756 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 62' ' ' THR . 55.3 t0 -80.76 -13.56 58.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.53 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.2 16.12 0.14 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.294 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 56' ' ' ASP . 21.5 p-10 -66.04 -24.61 66.77 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -154.58 -25.57 0.04 OUTLIER Glycine 0 C--N 1.337 0.637 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.6 ' C ' ' H ' ' A' ' 62' ' ' THR . 10.9 p30 -179.99 150.84 0.39 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.405 ' C ' ' OD2' ' A' ' 56' ' ' ASP . . . -65.55 32.5 0.13 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.6 ' H ' ' C ' ' A' ' 60' ' ' ASN . 65.7 p -130.46 148.86 52.32 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.1 mt -118.47 133.9 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.069 0.461 . . . . 0.0 110.45 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.34 169.09 18.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.48 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.435 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -67.3 -49.47 43.37 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.212 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.8 Cg_exo -52.08 -45.29 39.91 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.927 1.751 . . . . 0.0 111.925 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.03 -37.01 72.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.661 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -60.58 -46.46 90.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.007 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.8 mt -62.27 -44.29 96.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.861 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.0 m -65.22 -44.61 87.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.916 0.389 . . . . 0.0 110.287 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 44.8 ttp -62.05 -41.91 98.63 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.812 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 76' ' ' MET . 60.2 mmm -63.29 -40.9 98.66 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.598 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.97 -35.81 77.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.778 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -87.76 -56.24 3.43 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.752 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -63.15 -43.27 98.77 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.138 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 72' ' ' MET . 50.8 mmm -108.9 131.56 54.91 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.943 0.401 . . . . 0.0 110.162 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 78' ' ' ASP . 29.0 tptt -83.12 150.07 26.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.792 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 77' ' ' LYS . 5.7 m-20 -55.45 -159.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.481 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.8 p -96.16 -0.3 50.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.479 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -82.87 2.48 34.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.128 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 83' ' ' GLU . 1.6 m -62.07 -35.63 79.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.971 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -37.92 -29.69 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.839 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 81' ' ' SER . 71.5 mm-40 -74.15 -56.85 4.42 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.065 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -64.71 -38.76 92.08 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.67 -19.29 14.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.462 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.1 ttt-85 -57.65 -44.04 85.37 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 118.79 -1.164 . . . . 0.0 110.201 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -65.96 -32.99 74.79 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.745 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -63.02 -27.96 69.77 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -55.61 -46.0 77.39 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.358 0.599 . . . . 0.0 110.432 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -74.44 -51.12 15.82 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.779 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.0 t -64.06 -47.92 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.082 0.468 . . . . 0.0 110.57 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.476 ' CE2' HD12 ' A' ' 100' ' ' ILE . 39.3 t80 -63.41 -45.9 88.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.246 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.479 ' OD2' ' N ' ' A' ' 96' ' ' GLY . 36.0 t70 -127.06 105.06 8.33 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.602 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -68.56 -42.09 78.85 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.935 0.398 . . . . 0.0 111.079 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 97' ' ' ASN . 1.5 p-10 -60.04 -46.59 89.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.801 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.479 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 73.78 -41.81 1.05 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.432 ' H ' ' C ' ' A' ' 95' ' ' ASP . 77.1 m-20 -80.25 -13.56 59.12 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.957 0.408 . . . . 0.0 110.002 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.96 161.22 12.81 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -113.25 149.9 33.17 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.694 0.283 . . . . 0.0 110.475 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.476 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -96.87 116.55 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.954 0.407 . . . . 0.0 111.177 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.2 p -84.35 170.72 13.34 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.309 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.59 86.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.136 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.17 -47.21 84.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.917 0.389 . . . . 0.0 110.548 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.55 -36.04 75.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.487 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.35 -40.08 95.22 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.619 0.723 . . . . 0.0 110.68 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -52.44 -45.12 65.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.625 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -61.51 -45.13 95.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.057 0.456 . . . . 0.0 110.437 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.85 -44.94 98.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.321 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 48.3 mmm -64.41 -37.07 86.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.457 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 82.6 m -61.08 -46.18 91.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.846 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -67.08 -24.56 65.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.19 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.0 tp -61.47 -44.87 96.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.923 0.392 . . . . 0.0 110.846 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.52 -148.81 15.57 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -140.39 25.92 2.2 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.498 0.19 . . . . 0.0 111.048 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -64.79 -45.35 86.66 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.954 0.407 . . . . 0.0 110.926 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.8 mt -113.55 170.64 8.09 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.991 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.482 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -69.43 161.54 29.23 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.934 0.397 . . . . 0.0 110.981 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -92.1 -24.0 19.27 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.806 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -88.06 -20.37 25.84 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.579 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.67 -67.42 0.16 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.579 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.9 m -64.48 -35.15 73.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -57.69 -66.52 0.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -64.37 -43.71 93.66 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.459 ' C ' ' SD ' ' A' ' 124' ' ' MET . 16.1 tmm? -57.32 -48.69 78.32 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.85 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.24 -23.79 30.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.209 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -77.17 -46.81 22.13 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 119.0 -1.08 . . . . 0.0 111.439 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -85.39 -68.22 0.74 Allowed 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.066 -0.653 . . . . 0.0 111.503 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.0 -33.37 0.08 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.45 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -94.66 146.73 23.94 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.826 0.346 . . . . 0.0 110.722 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.665 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -89.36 -17.35 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 179.461 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -65.48 -44.47 87.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.051 0.453 . . . . 0.0 110.552 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.44 -11.11 5.64 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 41.1 p-10 -89.08 -19.36 25.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.923 0.392 . . . . 0.0 110.501 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.546 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 55.38 106.12 0.01 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.476 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 11.1 pt20 -140.12 134.75 31.71 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 92.3 t -116.97 132.06 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.96 0.41 . . . . 0.0 110.201 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -142.75 175.41 9.83 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.566 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -58.16 -45.87 86.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.162 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 54.2 mp0 -63.63 -36.87 85.24 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.442 -178.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.476 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 78.3 mt-10 -67.14 -33.92 76.46 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.073 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -61.98 -40.6 96.19 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.45 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.7 t -57.22 -45.74 84.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.513 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -82.84 -15.84 50.02 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.836 0.35 . . . . 0.0 111.217 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 43.8 ttp -60.97 -41.03 95.59 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.906 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 78.2 mtm -118.54 141.69 48.33 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.815 0.341 . . . . 0.0 110.694 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.6 m -159.55 84.51 0.77 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.809 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.7 -40.47 72.85 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.124 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.501 -179.548 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.085 0 CA-C-O 120.766 0.317 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -57.89 -44.61 86.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.483 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -62.66 -45.8 91.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.841 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -63.86 -46.75 83.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.736 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.52 -34.52 77.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.444 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.51 -13.83 61.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.762 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -55.95 -48.96 74.81 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.642 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -71.78 -30.01 65.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.934 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.6 tp -61.31 -42.41 98.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.38 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -60.11 -49.86 75.97 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.032 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 3.5 t70 -76.58 -14.39 60.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.245 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -43.67 -32.79 1.06 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.985 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 24.2 p-10 -53.8 -43.1 69.04 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.196 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -143.81 -155.89 6.6 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 29.1 p-10 -75.29 -47.26 28.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.846 0.355 . . . . 0.0 111.066 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.92 107.36 0.28 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 23.6 m -166.63 155.72 10.88 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.164 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.429 ' N ' HG22 ' A' ' 26' ' ' THR . 5.2 mp -122.79 91.1 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.069 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.3 p -98.09 173.02 7.24 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.414 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.401 ' HB ' HE22 ' A' ' 49' ' ' GLN . 63.4 p -63.55 -32.6 74.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.998 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -62.7 -41.48 99.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.912 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 26' ' ' THR . 83.9 mt-10 -66.73 -44.48 81.43 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.336 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.0 tp -63.19 -45.75 90.28 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.938 0.399 . . . . 0.0 110.66 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -45.96 -25.21 1.6 Allowed Glycine 0 C--O 1.226 -0.377 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.401 ' C ' ' N ' ' A' ' 36' ' ' MET . 14.7 m -63.23 -42.35 99.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.867 0.365 . . . . 0.0 110.026 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 82.6 t -49.46 -18.76 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.285 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.401 ' N ' ' C ' ' A' ' 34' ' ' THR . 89.2 mmm -59.62 -41.01 89.46 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.097 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.5 ttt85 -65.43 -43.87 89.13 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 118.185 -1.406 . . . . 0.0 111.133 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.3 p -58.14 -33.1 68.8 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.852 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.639 HD13 HD22 ' A' ' 42' ' ' ASN . 91.2 mt -97.33 7.05 47.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.611 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 42.96 97.21 0.01 OUTLIER Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 40' ' ' GLY . 87.0 mt-30 41.12 94.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.687 0.28 . . . . 0.0 110.485 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.639 HD22 HD13 ' A' ' 39' ' ' LEU . 48.8 t30 -130.35 75.68 78.8 Favored Pre-proline 0 N--CA 1.464 0.275 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 46' ' ' ALA . 95.0 Cg_exo -33.93 -26.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.367 2.044 . . . . 0.0 112.668 178.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.58 ' N ' ' O ' ' A' ' 42' ' ' ASN . 80.4 m -38.65 -25.97 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.564 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' PRO . 84.4 mt-10 -89.44 -33.38 16.84 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.499 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -56.58 -53.41 57.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.212 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.414 ' OE1' ' O ' ' A' ' 115' ' ' LYS . 1.5 tm-20 -67.96 -41.39 82.52 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.47 HD12 ' O ' ' A' ' 44' ' ' THR . 96.2 mt -73.02 -14.09 61.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.741 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' A' ' 45' ' ' GLU . 73.4 tp60 -53.08 -47.3 68.64 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -67.05 -37.13 83.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.97 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.0 ttp -60.32 -40.79 91.84 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.27 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.23 -48.15 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.653 0.263 . . . . 0.0 111.378 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.609 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 93.6 m-20 -62.03 -39.58 92.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.301 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -55.8 -57.51 11.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.068 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 p -74.92 -29.35 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.274 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 62' ' ' THR . 42.8 t0 -85.15 -12.99 51.52 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.584 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -71.8 2.63 5.12 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.181 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.5 p-10 -52.51 -26.79 14.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -155.64 -27.69 0.03 OUTLIER Glycine 0 C--N 1.339 0.704 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.571 ' C ' ' H ' ' A' ' 62' ' ' THR . 17.7 p30 -177.51 145.71 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.18 36.02 0.09 OUTLIER Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.571 ' H ' ' C ' ' A' ' 60' ' ' ASN . 72.5 p -133.45 152.59 51.93 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.7 mt -122.39 136.39 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.99 0.424 . . . . 0.0 110.253 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.6 OUTLIER -72.64 172.47 10.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.189 -179.464 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.445 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -72.88 -48.73 8.07 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.28 -178.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.9 Cg_exo -53.89 -39.79 83.15 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.279 1.986 . . . . 0.0 111.849 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -76.4 -35.25 58.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.876 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -59.75 -50.29 74.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.066 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -66.27 -42.17 88.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.618 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.9 m -63.43 -48.34 78.2 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.996 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 45.6 ttp -62.82 -44.84 95.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.585 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 42.9 mmm -64.47 -39.54 94.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.703 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.16 -46.26 90.28 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.97 0.414 . . . . 0.0 110.255 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -72.33 -44.64 62.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.335 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -69.6 -46.39 66.41 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.869 0.366 . . . . 0.0 111.644 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 16.3 mmm -101.59 131.06 47.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.671 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 78' ' ' ASP . 48.2 tptt -84.68 148.2 26.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.885 0.374 . . . . 0.0 110.311 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 77' ' ' LYS . 85.7 m-20 -48.85 -179.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.289 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.43 HG22 HG23 ' A' ' 146' ' ' THR . 3.6 p -80.93 -8.86 59.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.422 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.02 -8.95 49.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.415 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 82' ' ' GLU . 9.4 m -61.01 -25.42 66.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 81' ' ' SER . 82.2 tt0 -37.2 -48.05 0.83 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.759 0.314 . . . . 0.0 110.833 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -71.14 -44.14 66.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.253 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -63.95 -39.01 93.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.019 0.438 . . . . 0.0 110.104 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.3 -23.33 33.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 56.1 ttt-85 -56.89 -43.17 81.03 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 118.698 -1.201 . . . . 0.0 109.848 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -63.11 -34.76 78.3 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.64 -22.28 64.42 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -56.91 -49.81 74.46 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.317 0.579 . . . . 0.0 110.971 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -63.69 -45.99 87.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.992 -1.003 . . . . 0.0 111.309 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.5 t -66.22 -48.39 81.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.975 0.417 . . . . 0.0 110.183 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -64.45 -48.33 75.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.615 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 96' ' ' GLY . 42.4 t0 -102.19 102.3 12.71 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.892 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.57 -41.52 88.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.106 0.479 . . . . 0.0 109.893 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -73.25 -42.67 62.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.261 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.456 ' H ' ' CG ' ' A' ' 93' ' ' ASP . . . 76.75 -51.29 3.06 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -76.39 -14.53 60.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.067 0.46 . . . . 0.0 110.114 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.16 162.42 12.42 Favored Glycine 0 N--CA 1.465 0.592 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -112.13 150.44 30.77 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 95.6 mt -88.42 122.52 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.065 0.46 . . . . 0.0 111.114 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.6 p -88.78 176.39 7.09 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.205 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.5 -36.44 82.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.808 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.71 -52.61 64.96 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.476 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -67.95 -37.44 81.59 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.198 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.8 tp -62.59 -41.29 98.86 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.57 0.7 . . . . 0.0 110.298 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -55.7 -43.5 76.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.711 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -55.84 -41.72 74.71 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.4 t -66.35 -42.55 90.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.651 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 63.7 mmm -60.97 -38.03 84.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.617 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.3 m -61.17 -39.84 91.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.654 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -57.55 -40.21 78.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.558 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.4 tp -62.14 -43.68 98.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 0.0 110.138 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 146.31 -144.77 13.21 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -137.32 28.81 2.76 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.647 0.26 . . . . 0.0 110.403 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.414 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 48.7 mtmt -62.39 -42.06 99.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.218 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.468 HD22 HD21 ' A' ' 48' ' ' LEU . 14.2 mt -95.83 168.26 10.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.154 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.472 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -63.76 161.7 14.72 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.819 0.342 . . . . 0.0 110.326 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -91.72 -22.42 20.22 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.539 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 120' ' ' GLU . 78.0 tt0 -86.17 -23.95 26.33 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.418 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.606 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -35.78 -64.38 0.31 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.564 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 14.4 m -63.93 -36.74 77.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.544 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.401 ' N ' HG23 ' A' ' 121' ' ' VAL . 43.8 m-20 -55.88 -66.67 0.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.596 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -69.69 -37.88 76.79 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.434 ' C ' ' SD ' ' A' ' 124' ' ' MET . 16.1 tmm? -59.07 -47.34 85.6 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.598 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.4 mt -70.18 -20.42 22.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.896 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -89.66 -60.24 1.99 Allowed 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.592 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -63.68 -68.34 0.35 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 119.519 -0.873 . . . . 0.0 111.405 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 39' ' ' LEU . . . -45.13 -26.98 0.53 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.42 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -87.76 126.12 34.82 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.028 0.442 . . . . 0.0 111.15 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.618 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -77.31 -23.45 14.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.422 179.255 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -74.95 -41.8 58.89 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.153 0.502 . . . . 0.0 110.004 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.79 2.24 56.44 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 41.7 p-10 -88.13 -18.54 28.57 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.36 111.15 0.04 OUTLIER Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -162.81 139.46 7.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.756 0.312 . . . . 0.0 110.26 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.9 t -126.22 132.98 69.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.182 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -146.73 166.76 25.65 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.187 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -49.35 -37.42 24.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.649 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -59.77 -33.94 72.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.015 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -75.5 -37.06 60.41 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -61.29 -49.77 75.71 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.8 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.5 t -49.39 -48.24 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.42 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -68.91 -39.43 79.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.9 ttp -60.61 -44.73 95.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.768 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.412 ' O ' ' OG1' ' A' ' 146' ' ' THR . 67.1 mtt -89.18 121.18 31.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.898 0.38 . . . . 0.0 110.43 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.43 HG23 HG22 ' A' ' 79' ' ' THR . 12.1 m -167.36 82.81 0.21 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.47 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.43 -46.2 89.65 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.815 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.456 -179.851 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.592 0.234 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.41 -45.14 55.41 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.488 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -63.05 -44.01 97.07 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.907 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -63.84 -46.52 84.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.293 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -67.38 -43.58 81.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.904 0.383 . . . . 0.0 111.174 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.34 -36.48 80.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.409 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -55.72 -51.07 68.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.975 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -72.77 -23.45 60.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.735 0.302 . . . . 0.0 110.763 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.08 -42.24 99.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.705 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.406 ' O ' ' CD ' ' A' ' 31' ' ' GLU . 79.4 m-85 -59.55 -49.0 79.47 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.169 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.7 t0 -74.81 -13.67 60.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.528 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -43.09 -32.64 0.72 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.998 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 10.9 p-10 -53.3 -45.6 69.04 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.65 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -148.79 -149.18 4.91 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 32.2 p-10 -72.09 -46.89 55.03 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.698 0.285 . . . . 0.0 111.208 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.99 107.57 0.29 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 m -166.0 142.61 5.18 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.099 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.61 108.05 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.536 HG22 HG22 ' A' ' 62' ' ' THR . 2.4 p -128.39 169.82 13.82 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.965 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.735 HG21 HE22 ' A' ' 49' ' ' GLN . 75.7 p -64.77 -32.38 74.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.985 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -62.35 -41.42 98.58 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.579 -0.449 . . . . 0.0 109.901 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.406 ' CD ' ' O ' ' A' ' 19' ' ' PHE . 89.2 mt-10 -63.49 -45.82 88.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.808 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.8 tp -63.87 -45.0 91.39 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.122 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.87 -24.24 7.98 Favored Glycine 0 C--O 1.224 -0.493 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.5 m -64.98 -42.95 94.08 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.256 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.8 t -53.86 -18.23 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.291 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.43 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 91.3 mmm -57.36 -35.35 69.84 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.389 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -63.62 -43.94 95.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 118.004 -1.478 . . . . 0.0 110.148 -178.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.8 p -61.06 -35.76 77.8 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.844 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 41' ' ' GLN . 25.7 mt -96.36 3.61 52.8 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.944 0.402 . . . . 0.0 110.314 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.51 -66.9 0.02 OUTLIER Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 39' ' ' LEU . 80.8 mt-30 -145.05 104.8 4.01 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' A' ' 44' ' ' THR . 50.2 t30 -123.61 73.75 52.87 Favored Pre-proline 0 N--CA 1.466 0.371 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.159 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' A' ' 46' ' ' ALA . 80.4 Cg_exo -35.05 -32.61 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.58 2.186 . . . . 0.0 112.504 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.457 ' O ' HD12 ' A' ' 48' ' ' LEU . 29.1 m -38.25 -31.04 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.593 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 92.5 mt-10 -86.8 -35.89 18.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.327 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -57.44 -49.98 74.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.694 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.505 ' HB2' HG23 ' A' ' 117' ' ' THR . 1.4 tm-20 -70.47 -45.72 65.18 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.141 0.496 . . . . 0.0 109.666 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 44' ' ' THR . 86.6 mt -63.62 -31.43 72.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.948 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.735 HE22 HG21 ' A' ' 29' ' ' THR . 67.3 tp60 -40.17 -54.79 2.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.681 0.276 . . . . 0.0 110.997 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -63.6 -41.52 98.32 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.722 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.6 ttp -61.26 -38.95 88.55 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.201 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.5 mt -62.94 -46.61 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.329 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.626 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 92.3 m-20 -62.81 -41.28 99.24 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.838 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -57.88 -57.16 14.01 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.644 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 p -70.45 -29.31 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.156 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 62' ' ' THR . 38.7 t0 -89.13 -12.48 40.93 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.849 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -71.62 13.46 0.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.484 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.472 ' H ' ' C ' ' A' ' 56' ' ' ASP . 38.9 p-10 -66.81 -28.79 68.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -149.62 -32.12 0.05 OUTLIER Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.628 ' C ' ' H ' ' A' ' 62' ' ' THR . 11.3 p30 -177.11 153.04 0.94 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.551 -0.324 . . . . 0.0 110.202 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.39 30.93 0.1 OUTLIER Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.628 ' H ' ' C ' ' A' ' 60' ' ' ASN . 57.9 p -127.56 146.07 50.64 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.4 mt -116.66 139.74 42.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.652 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.35 176.08 2.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.604 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.516 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -85.67 -46.68 0.6 Allowed Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.667 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 32.4 Cg_exo -55.89 -45.02 41.85 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.272 1.981 . . . . 0.0 111.756 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -70.05 -36.98 75.41 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -57.45 -41.77 81.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.458 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.17 -43.87 98.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.59 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.8 m -64.14 -43.19 96.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.875 0.369 . . . . 0.0 110.365 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 62.1 ttp -59.13 -43.62 92.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.527 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 88.5 mmm -64.83 -38.13 89.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.78 -46.3 84.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -72.88 -45.67 56.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.841 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -64.72 -45.06 88.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.056 0.455 . . . . 0.0 110.537 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 28.6 mmt -93.91 128.07 40.01 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.79 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -85.18 148.26 26.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.307 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -52.96 164.77 0.36 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.357 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 75.4 p -67.19 -21.5 65.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.634 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.13 -7.23 8.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.038 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.6 m -53.47 -34.73 59.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.447 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -38.17 -45.13 0.91 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -69.28 -44.87 70.97 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.008 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.56 -36.48 81.03 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.0 0.428 . . . . 0.0 110.296 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.47 -20.98 24.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -55.58 -45.19 77.43 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 118.758 -1.177 . . . . 0.0 109.539 -177.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -68.07 -33.09 73.89 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.195 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.96 -27.71 69.59 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -57.31 -51.39 69.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.294 0.568 . . . . 0.0 110.94 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -69.36 -45.22 69.9 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.699 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.6 t -68.13 -50.58 57.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.918 0.389 . . . . 0.0 110.769 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -63.39 -47.43 82.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.223 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.408 ' OD2' ' N ' ' A' ' 96' ' ' GLY . 22.5 t0 -110.07 107.63 17.55 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.801 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -68.91 -41.24 78.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.173 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 97' ' ' ASN . 1.1 p-10 -68.63 -37.39 79.68 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.257 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.408 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 67.69 -64.88 0.3 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 95' ' ' ASP . 56.0 m-80 -63.1 -14.38 47.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.958 0.409 . . . . 0.0 110.41 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.57 162.01 12.59 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -112.16 145.64 39.48 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 75.7 mt -83.72 125.08 40.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.038 0.447 . . . . 0.0 111.087 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.7 p -83.68 172.15 12.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.043 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.14 -39.07 92.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.012 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.62 76.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.869 0.366 . . . . 0.0 111.108 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.3 -33.18 74.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.652 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.6 tp -61.91 -43.11 99.52 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.408 0.623 . . . . 0.0 111.257 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -55.52 -43.22 75.54 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.883 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -60.35 -43.96 96.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.102 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 84.2 t -63.2 -45.22 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.695 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 86.7 mmm -63.61 -37.46 87.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.337 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 m -60.75 -41.02 94.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.603 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -55.5 -28.38 54.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.011 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.8 tp -60.88 -43.39 98.5 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.035 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 152.8 -141.76 8.71 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -137.58 27.23 2.78 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.7 0.286 . . . . 0.0 110.522 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -62.69 -43.43 98.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.013 0.435 . . . . 0.0 110.356 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 56.3 mt -108.9 -178.67 3.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.689 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.505 HG23 ' HB2' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -76.85 161.76 28.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.66 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -92.15 -22.12 20.03 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.099 0.476 . . . . 0.0 110.526 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -86.99 -24.17 24.78 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.14 -67.57 0.14 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.309 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.581 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 19.3 m -64.46 -34.24 68.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -57.08 -67.43 0.32 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.589 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -68.88 -38.01 79.41 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.418 ' C ' ' SD ' ' A' ' 124' ' ' MET . 15.2 tmm? -59.88 -47.09 87.18 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.035 0.445 . . . . 0.0 110.103 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 125' ' ' ILE . 97.6 mt -68.84 -16.86 21.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.144 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -80.18 -51.61 8.76 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.08 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 129' ' ' ASP . 44.1 tp10 -86.2 -68.2 0.76 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 118.978 -1.089 . . . . 0.0 111.362 -177.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 124' ' ' MET . . . -37.44 -25.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.635 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 127' ' ' GLU . 40.0 t0 -88.57 126.71 35.4 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.165 0.507 . . . . 0.0 110.849 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -65.46 -41.19 90.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.95 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.97 -42.87 99.61 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.755 0.312 . . . . 0.0 110.501 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.45 -0.92 62.83 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 50.2 p-10 -94.26 -18.57 21.53 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.894 0.378 . . . . 0.0 110.097 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.513 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 64.84 121.22 0.01 OUTLIER Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -164.45 144.5 7.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.57 -0.315 . . . . 0.0 110.272 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 72.7 t -128.62 134.36 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.39 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -150.98 176.3 11.25 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.105 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -56.15 -46.75 79.14 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.338 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -55.53 -37.92 68.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.579 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -69.16 -39.68 78.62 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.446 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -61.92 -43.12 99.5 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.0 t -58.03 -45.93 88.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.769 0.319 . . . . 0.0 110.657 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -77.07 -24.32 51.92 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.684 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 44.5 ttp -63.88 -41.14 97.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.727 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.415 ' O ' ' OG1' ' A' ' 146' ' ' THR . 64.6 mtt -91.36 130.38 37.22 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.929 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 145' ' ' MET . 36.0 m -167.44 67.8 0.09 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.583 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.42 87.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.32 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 66.4 mttm . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.913 179.606 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.057 0 CA-C-O 120.626 0.251 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -43.95 -48.24 8.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.653 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -65.97 -39.8 90.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.67 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -65.36 -48.14 73.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.237 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -64.14 -33.96 76.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.512 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.64 -19.88 12.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.543 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -57.45 -49.25 76.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.823 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.4 m -60.93 -40.84 94.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.552 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.55 -42.85 99.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.982 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -59.31 -49.84 76.27 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.849 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.466 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.5 t0 -75.97 -15.62 60.13 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.644 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -43.58 -33.25 1.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.787 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.433 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 14.5 p-10 -53.43 -43.45 68.02 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.466 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -145.57 -153.69 5.95 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 26.7 p-10 -74.79 -47.26 31.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 110.59 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.71 107.22 0.28 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 178.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.629 ' C ' HD12 ' A' ' 27' ' ' ILE . 8.4 m -166.65 149.91 6.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.143 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.629 HD12 ' C ' ' A' ' 26' ' ' THR . 2.8 mp -119.52 109.49 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.505 HG22 HG22 ' A' ' 62' ' ' THR . 4.1 p -130.98 169.68 15.5 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.908 0.385 . . . . 0.0 110.473 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.507 ' CB ' HE22 ' A' ' 49' ' ' GLN . 82.4 p -63.43 -29.57 70.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.182 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -62.16 -41.25 98.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.252 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.448 ' OE2' ' O ' ' A' ' 26' ' ' THR . 89.6 mt-10 -67.0 -45.72 76.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.98 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.3 tp -65.96 -44.43 85.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.409 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.93 -22.5 4.57 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.5 m -67.06 -30.2 70.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.78 0.324 . . . . 0.0 110.446 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.4 t -62.24 -22.99 30.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.809 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.0 mmm -56.0 -37.14 68.74 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.702 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -63.19 -44.2 96.05 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 116.771 -1.971 . . . . 0.0 110.06 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 91.6 p -60.45 -37.9 82.44 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.166 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 41' ' ' GLN . 39.1 mt -94.71 5.05 53.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.28 0.562 . . . . 0.0 110.505 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.46 -67.62 0.26 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 39' ' ' LEU . 84.1 mt-30 -147.87 104.98 3.63 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 44' ' ' THR . 58.7 t30 -123.24 76.8 52.48 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.06 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' A' ' 46' ' ' ALA . 72.0 Cg_exo -36.63 -29.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.582 2.188 . . . . 0.0 112.653 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.434 ' N ' ' HB3' ' A' ' 120' ' ' GLU . 11.4 m -38.46 -31.98 0.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.358 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 49' ' ' GLN . 96.8 mt-10 -88.77 -36.19 16.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.195 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -55.01 -49.8 70.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.558 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -69.85 -49.14 55.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.26 0.552 . . . . 0.0 110.258 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.91 -21.36 65.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.683 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.507 HE22 ' CB ' ' A' ' 29' ' ' THR . 71.2 tp60 -45.55 -47.44 14.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.209 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 68.1 t0 -70.89 -38.6 73.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.492 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.1 ttp -62.38 -42.83 99.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.922 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 87.1 mt -63.53 -46.28 95.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.541 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.669 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 87.3 m-20 -64.02 -41.79 97.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.62 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -59.27 -59.15 5.92 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.491 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.8 p -66.07 -31.82 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.0 110.847 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.546 ' OD2' ' N ' ' A' ' 62' ' ' THR . 45.5 t0 -87.28 -12.6 46.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.737 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.24 13.01 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.048 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 56' ' ' ASP . 16.7 p-10 -63.98 -33.84 76.65 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.47 -26.41 0.08 OUTLIER Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.591 ' C ' ' H ' ' A' ' 62' ' ' THR . 16.5 p30 -178.25 148.21 0.47 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.513 -0.343 . . . . 0.0 110.262 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.92 34.23 0.1 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.591 ' H ' ' C ' ' A' ' 60' ' ' ASN . 70.7 p -129.68 151.49 50.21 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.0 mt -119.62 134.12 64.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.821 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -77.09 -155.43 0.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.042 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.49 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -96.52 -47.86 0.24 Allowed Pre-proline 0 N--CA 1.469 0.485 0 CA-C-O 120.501 0.191 . . . . 0.0 110.845 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 42.6 Cg_exo -54.93 -36.06 91.07 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.115 1.877 . . . . 0.0 111.606 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -83.61 -28.69 28.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.794 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -59.38 -46.42 88.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.7 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.0 -43.48 95.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.822 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.7 m -63.6 -45.29 91.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.113 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 46.8 ttp -62.18 -44.44 96.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.782 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 47.8 mmm -63.39 -42.2 98.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.718 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.77 -48.65 80.82 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.686 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -71.03 -50.13 37.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.565 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -64.67 -41.8 95.82 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.371 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.505 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 32.1 mmm -121.17 127.02 51.13 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.219 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -82.77 153.14 25.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.675 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -52.54 -179.96 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.282 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.0 p -80.97 -9.74 59.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.651 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -65.95 -21.65 66.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.419 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.7 m -50.58 -32.25 18.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.407 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -38.19 -45.71 0.98 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.716 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -69.12 -46.6 67.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.145 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -65.02 -49.52 69.89 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.9 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.5 mt -56.37 -21.14 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -57.94 -44.94 87.24 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 118.466 -1.294 . . . . 0.0 109.649 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -66.16 -25.95 67.19 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.6 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.81 -14.14 58.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.071 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -56.56 -50.68 71.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.298 0.57 . . . . 0.0 111.121 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -63.37 -44.49 94.64 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.203 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.6 t -66.64 -45.63 87.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.807 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.429 ' CE2' ' CD1' ' A' ' 100' ' ' ILE . 19.3 t80 -62.55 -47.23 84.79 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.643 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.431 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 37.3 t0 -119.94 106.56 12.16 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.242 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -68.14 -44.29 76.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.011 0.434 . . . . 0.0 110.58 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.431 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 0.9 OUTLIER -62.36 -44.47 96.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.779 -179.312 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.1 -47.41 1.05 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -74.6 -14.44 60.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.017 0.437 . . . . 0.0 110.541 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.79 161.79 12.64 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -112.19 144.38 41.68 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.429 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 64.7 mt -74.95 129.49 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.902 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.5 p -83.05 168.79 16.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.284 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.86 97.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.85 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.14 -41.7 94.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.701 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -67.32 -37.36 83.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.086 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.2 tp -60.21 -43.19 96.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.2 0.524 . . . . 0.0 110.682 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -54.07 -40.68 67.39 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.846 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -59.09 -42.2 89.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.893 0.377 . . . . 0.0 110.002 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.11 -44.92 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.745 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 80.9 mmm -63.51 -35.48 80.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.568 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.4 m -61.23 -41.71 97.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.251 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -59.8 -39.16 84.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.634 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.39 -44.29 97.4 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.582 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.69 -143.95 10.03 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -144.33 30.49 1.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.817 0.342 . . . . 0.0 110.766 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -62.87 -40.8 98.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.414 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.5 mt -105.25 165.94 10.76 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.485 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -65.15 161.52 18.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 0.0 110.51 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.445 ' C ' ' OE1' ' A' ' 120' ' ' GLU . 83.8 m-20 -91.28 -20.37 21.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 178.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -89.3 -26.11 21.31 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.684 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -34.91 -65.18 0.23 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.559 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.684 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 31.0 m -68.6 -27.46 36.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -178.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -63.25 -43.78 97.03 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.614 -0.435 . . . . 0.0 112.002 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -88.46 -41.07 13.0 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.471 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 15.0 tmm? -60.57 -42.67 97.11 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.898 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 125' ' ' ILE . 96.6 mt -69.98 -15.88 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -87.2 -66.69 0.88 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 118.971 -1.092 . . . . 0.0 112.003 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 128' ' ' ALA . 50.9 tp10 -70.97 -68.5 0.43 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.304 -0.959 . . . . 0.0 111.939 -176.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 124' ' ' MET . . . -37.31 -40.01 0.32 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.699 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -88.42 124.64 34.15 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.066 0.46 . . . . 0.0 110.436 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.697 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -72.24 -16.03 18.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.281 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.461 ' C ' ' H ' ' A' ' 133' ' ' ASP . 51.0 m-20 -65.36 -45.65 83.28 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.623 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.07 -11.48 2.67 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 42.0 p30 -88.51 -17.41 30.35 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.097 0.475 . . . . 0.0 110.15 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 58.35 120.73 0.01 OUTLIER Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.443 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 10.4 pt20 -161.02 137.88 8.77 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.4 t -125.59 134.17 67.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.874 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.468 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.4 t30 -148.98 159.56 44.1 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.232 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -40.04 -35.36 0.37 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.334 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.468 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 53.1 mp0 -65.8 -42.32 90.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.17 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 80.3 mt-10 -71.83 -30.18 65.2 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.538 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -58.5 -45.57 88.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.248 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 58.9 t -60.19 -48.2 89.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.914 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -70.05 -32.13 70.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.833 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 37.6 ttp -56.62 -47.69 79.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.696 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 69.7 mtm -106.1 134.1 49.76 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.844 0.354 . . . . 0.0 110.613 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 88.7 m -160.14 81.69 0.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.325 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 76' ' ' MET . . . -65.95 -40.52 91.41 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.885 0.374 . . . . 0.0 110.571 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.627 179.997 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.035 0 CA-C-O 120.571 0.224 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -54.7 -48.23 72.72 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.537 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -65.67 -40.84 92.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.824 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -62.04 -44.03 97.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.631 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -66.96 -37.58 84.54 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.998 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.482 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.0 -27.99 65.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.779 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -57.77 -46.95 83.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.526 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 m -77.9 -21.51 51.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.693 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.37 -42.81 99.7 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.431 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.482 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.2 m-85 -60.17 -51.01 71.43 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.462 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.1 t0 -76.89 -14.35 59.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.893 0.377 . . . . 0.0 111.358 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -45.56 -32.67 2.39 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.893 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 8.8 p-10 -53.73 -46.11 70.73 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.542 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -144.37 -151.62 5.48 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 30.7 p-10 -72.97 -47.19 47.54 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.074 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.7 107.37 0.28 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 178.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.425 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 4.5 m -166.62 139.28 3.72 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.38 -0.482 . . . . 0.0 111.179 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 27' ' ' ILE . 5.2 mp -115.13 109.23 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.596 HG22 HG22 ' A' ' 62' ' ' THR . 2.6 p -128.66 170.31 13.42 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.817 0.342 . . . . 0.0 110.442 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.635 ' CB ' HE22 ' A' ' 49' ' ' GLN . 67.3 p -64.66 -33.11 75.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.788 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -61.71 -41.32 97.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.011 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 26' ' ' THR . 90.1 mt-10 -63.49 -45.71 89.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.863 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.2 tp -64.1 -43.35 95.61 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.149 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.78 -26.1 53.29 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.2 m -63.93 -41.41 97.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.843 0.354 . . . . 0.0 110.084 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.7 t -56.24 -23.56 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.363 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.483 ' O ' ' N ' ' A' ' 40' ' ' GLY . 62.1 mmm -48.14 -30.27 4.41 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.671 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -64.38 -45.64 86.81 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 118.042 -1.463 . . . . 0.0 110.975 -178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -63.94 -21.98 66.72 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.852 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 41' ' ' GLN . 16.8 mt -107.75 3.7 24.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.086 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.19 -71.2 0.02 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 39' ' ' LEU . 87.8 mt-30 -145.43 109.47 4.84 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 44' ' ' THR . 41.3 t30 -125.61 70.87 65.55 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.552 ' O ' ' N ' ' A' ' 46' ' ' ALA . 84.8 Cg_exo -32.94 -30.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.65 2.233 . . . . 0.0 112.792 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.542 ' N ' ' O ' ' A' ' 42' ' ' ASN . 26.1 m -39.29 -30.15 0.06 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.545 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.417 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.9 mt-10 -86.67 -34.85 19.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.332 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -59.04 -50.14 75.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.799 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.15 -46.13 71.63 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 51' ' ' MET . 84.5 mt -64.81 -31.07 72.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.382 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.635 HE22 ' CB ' ' A' ' 29' ' ' THR . 61.1 tp60 -37.5 -51.36 1.14 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.74 0.305 . . . . 0.0 110.761 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.22 -40.33 90.22 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.259 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 48' ' ' LEU . 33.1 ttp -62.45 -40.98 98.37 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.948 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.415 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 83.5 mt -61.99 -49.9 82.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.142 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.603 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 89.9 m-20 -62.99 -40.36 97.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.597 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -55.19 -61.52 2.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.213 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.87 -30.21 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.341 . . . . 0.0 111.28 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 62' ' ' THR . 50.6 t0 -84.63 -13.24 52.15 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.574 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -71.99 13.07 0.33 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.871 0.367 . . . . 0.0 110.284 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.5 p30 -65.58 -28.92 69.49 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.535 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -150.48 -22.34 0.06 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.552 ' C ' ' H ' ' A' ' 62' ' ' THR . 3.3 p30 173.14 151.87 0.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.99 34.71 0.15 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.596 HG22 HG22 ' A' ' 28' ' ' THR . 81.7 p -134.33 149.49 50.87 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.6 mt -120.98 134.57 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.26 162.4 28.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.41 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.471 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -64.56 -48.12 74.99 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.513 -179.076 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 50.5 Cg_exo -51.3 -37.29 59.76 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.195 1.93 . . . . 0.0 111.71 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -87.59 -22.3 24.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.836 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.42 -47.14 87.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.048 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.54 -42.89 98.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.549 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.8 m -63.95 -46.08 86.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.647 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.6 ttp -61.69 -47.56 84.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.077 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.9 mmm -65.76 -37.85 87.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.282 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.53 -50.01 75.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.031 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -71.51 -43.75 65.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.203 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.73 -43.56 88.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.733 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.431 ' O ' ' O ' ' A' ' 73' ' ' ALA . 22.4 mmm -104.35 127.44 52.01 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.094 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.7 tptt -84.96 141.17 30.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.38 . . . . 0.0 110.712 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' LYS . 95.0 m-20 -48.92 179.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.226 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.8 p -75.53 -6.76 51.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.418 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.44 -15.54 62.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.509 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.0 m -61.92 -19.87 63.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.548 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -48.19 -44.76 33.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.342 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.95 -39.52 79.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.905 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.82 -45.22 83.11 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.006 0.431 . . . . 0.0 110.152 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.2 mt -66.04 -19.04 25.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.525 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -58.47 -45.38 88.73 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.218 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.64 -31.81 73.04 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.928 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.406 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -72.03 -14.69 61.94 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.138 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -57.94 -48.99 78.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.297 0.57 . . . . 0.0 111.116 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -64.09 -45.58 88.07 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.36 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.7 t -76.17 -51.54 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.381 . . . . 0.0 110.894 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.446 ' CE2' HD12 ' A' ' 100' ' ' ILE . 26.3 t80 -61.98 -47.22 85.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.598 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.43 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 18.2 t70 -108.95 94.15 4.89 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.21 -41.04 74.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.02 0.438 . . . . 0.0 110.578 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 19.9 p-10 -62.48 -39.74 94.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.969 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.44 -67.33 0.97 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.56 -16.52 63.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.917 0.389 . . . . 0.0 110.228 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.78 162.0 12.57 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.2 155.4 24.04 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.811 0.338 . . . . 0.0 110.237 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.446 HD12 ' CE2' ' A' ' 92' ' ' PHE . 94.0 mt -79.76 126.04 39.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.965 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.3 p -82.45 168.94 16.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.181 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.07 89.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.557 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.59 -47.4 83.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.65 -32.8 72.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.5 tp -61.57 -41.69 97.77 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.423 0.63 . . . . 0.0 110.691 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -56.51 -43.23 79.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.845 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -58.47 -41.96 86.42 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.7 t -66.64 -43.35 90.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.656 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.0 mmm -62.01 -35.65 79.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.634 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.4 m -61.04 -44.39 97.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.071 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -59.8 -34.99 73.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.348 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.0 tp -61.12 -46.75 89.29 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.068 0.461 . . . . 0.0 110.375 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.46 -160.71 33.42 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -140.53 23.38 2.31 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.654 0.264 . . . . 0.0 110.835 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -63.66 -42.82 98.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.983 0.42 . . . . 0.0 110.237 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.7 mt -92.8 175.8 6.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.965 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.468 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -72.87 161.33 30.84 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.672 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -91.69 -22.5 20.2 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.945 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -87.88 -25.35 23.31 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.167 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.637 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.44 -61.19 0.46 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.114 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.637 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 20.4 m -67.4 -40.21 84.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.492 ' N ' HG23 ' A' ' 121' ' ' VAL . 81.2 m-20 -56.76 -47.1 80.86 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.51 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -86.0 -40.3 15.95 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.6 tmm? -59.52 -46.49 88.69 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.061 0.458 . . . . 0.0 109.954 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 125' ' ' ILE . 91.3 mt -69.2 -16.49 20.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.409 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -78.62 -50.61 11.19 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 119.397 -0.921 . . . . 0.0 112.09 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' ASP . 42.4 tp10 -87.64 -67.47 0.82 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.897 -178.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.37 -26.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.784 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' GLU . 25.4 t0 -88.02 128.32 35.4 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.092 0.472 . . . . 0.0 111.073 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.666 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.51 -43.42 90.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.404 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -65.35 -40.28 93.41 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.122 0.487 . . . . 0.0 110.164 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.3 -1.98 58.67 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.334 -1.107 . . . . 0.0 110.334 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 134' ' ' GLY . 55.3 p-10 -89.53 -8.96 51.66 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 57.44 115.43 0.01 OUTLIER Glycine 0 CA--C 1.522 0.525 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.229 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 20.3 pt20 -160.62 133.59 6.5 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.4 t -123.45 136.92 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.066 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -151.36 172.5 15.82 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.221 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -54.8 -46.82 74.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.152 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 139' ' ' GLU . 55.5 mp0 -58.65 -44.32 90.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.71 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 93.3 mt-10 -72.09 -29.34 64.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.763 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.9 -43.99 77.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.587 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 94.7 t -59.1 -46.32 91.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.301 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.33 -29.13 66.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.136 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.7 ttp -59.69 -42.87 93.91 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.841 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.48 138.81 50.64 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.913 0.387 . . . . 0.0 110.754 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 80.8 m -163.19 77.73 0.43 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.664 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.19 -27.74 68.9 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.414 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.86 -1.067 . . . . 0.0 110.625 -179.853 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.163 0 CA-C-O 120.81 0.338 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -54.33 -42.25 69.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.044 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -67.78 -41.79 82.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.381 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -62.57 -43.76 98.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.956 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -67.2 -35.77 80.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.398 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.51 -24.17 66.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.768 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -55.4 -46.5 76.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.777 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.4 m -80.68 -19.41 45.26 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.808 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.18 -41.95 96.89 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.019 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.421 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.2 m-85 -58.84 -46.13 88.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.852 0.358 . . . . 0.0 111.107 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.3 t0 -79.58 -13.47 59.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.461 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -43.02 -32.77 0.71 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.867 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' CG ' ' OE2' ' A' ' 31' ' ' GLU . 10.9 p-10 -52.91 -45.13 67.44 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.49 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.433 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . -149.66 -151.26 5.46 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 21.3 p-10 -71.2 -46.86 60.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.712 0.292 . . . . 0.0 111.005 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.03 107.39 0.28 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.595 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.8 m -166.59 136.22 3.09 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.191 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 27' ' ' ILE . 1.9 mp -110.58 118.27 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.464 HG22 HG22 ' A' ' 62' ' ' THR . 2.0 p -134.73 167.08 21.5 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.881 0.372 . . . . 0.0 110.285 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.536 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.3 p -64.13 -33.65 76.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.283 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -62.56 -40.16 95.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.707 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.457 ' OE2' ' O ' ' A' ' 26' ' ' THR . 88.9 mt-10 -64.68 -48.51 74.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.366 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.8 tp -64.42 -43.75 93.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.252 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.31 -24.69 17.01 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -64.08 -41.04 97.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.851 0.358 . . . . 0.0 110.151 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.04 -22.47 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.207 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.6 mmm -48.78 -33.56 10.6 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.969 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -64.3 -45.5 87.69 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 118.163 -1.415 . . . . 0.0 110.272 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.3 p -59.0 -30.65 68.14 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.356 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 41' ' ' GLN . 9.3 mt -102.33 5.47 39.89 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.966 0.412 . . . . 0.0 110.443 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.27 -69.79 0.03 OUTLIER Glycine 0 N--CA 1.465 0.588 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 39' ' ' LEU . 85.7 mt-30 -143.25 116.29 8.88 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.1 t30 -132.66 69.75 79.45 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.906 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 46' ' ' ALA . 92.0 Cg_exo -33.1 -33.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 122.527 2.151 . . . . 0.0 112.49 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 42' ' ' ASN . 12.4 m -38.99 -29.35 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.476 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 43' ' ' PRO . 90.6 mt-10 -87.65 -35.22 18.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.463 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -61.26 -49.17 78.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.027 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.434 ' HB2' HG23 ' A' ' 117' ' ' THR . 3.1 tm-20 -68.03 -48.61 65.18 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.403 0.621 . . . . 0.0 109.889 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.515 HD22 ' CE ' ' A' ' 51' ' ' MET . 87.4 mt -62.62 -22.75 66.64 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.018 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.536 HE22 ' CB ' ' A' ' 29' ' ' THR . 47.9 tp60 -40.21 -49.58 2.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 110.532 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.69 -39.8 73.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.472 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.515 ' CE ' HD22 ' A' ' 48' ' ' LEU . 36.1 ttp -61.54 -40.59 95.23 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.765 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.78 -46.93 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.658 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.653 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 28.3 m120 -65.17 -39.84 93.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.333 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -58.08 -57.23 13.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.434 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 p -68.31 -32.83 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.936 0.398 . . . . 0.0 110.964 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.0 t0 -86.08 -13.03 48.51 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.812 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.653 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.04 15.42 0.16 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.056 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 56' ' ' ASP . 38.7 p-10 -66.66 -23.55 66.16 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.39 -22.56 0.03 OUTLIER Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.588 ' C ' ' H ' ' A' ' 62' ' ' THR . 4.6 p30 179.31 146.55 0.19 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.76 33.71 0.18 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.588 ' H ' ' C ' ' A' ' 60' ' ' ASN . 80.6 p -132.15 143.93 50.33 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.88 135.12 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.057 0.456 . . . . 0.0 110.175 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.42 172.34 4.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.441 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.438 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -72.53 -49.59 8.56 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.761 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 53.2 Cg_exo -52.07 -43.26 53.95 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.87 1.714 . . . . 0.0 111.902 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.46 -37.43 77.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 110.867 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -60.42 -45.38 93.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.962 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.9 mt -62.39 -44.57 96.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.523 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.5 m -67.45 -45.43 76.03 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 111.242 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.4 ttp -61.17 -43.69 98.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.928 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 87.0 mmm -64.75 -39.36 93.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.206 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.435 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.89 -42.83 94.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.89 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -71.52 -41.78 68.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.237 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -64.76 -40.92 96.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.86 0.362 . . . . 0.0 110.422 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.435 ' O ' ' O ' ' A' ' 73' ' ' ALA . 14.2 mmt -95.21 129.82 42.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.129 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -86.84 142.8 27.8 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -50.35 168.77 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.425 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.0 p -75.15 -15.21 60.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.683 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.98 -16.5 64.08 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.908 0.385 . . . . 0.0 110.439 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 82' ' ' GLU . 1.1 m -60.41 -23.76 64.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.759 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 81' ' ' SER . 81.2 tt0 -36.75 -48.49 0.73 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.893 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -70.76 -43.52 68.62 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.262 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -63.88 -39.59 94.55 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.961 0.41 . . . . 0.0 110.025 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.5 mt -66.95 -21.92 28.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.287 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -57.97 -43.6 86.58 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 119.047 -1.061 . . . . 0.0 110.063 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -63.74 -34.76 78.61 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.846 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.8 -19.91 66.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.056 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -56.57 -48.75 76.7 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.261 0.553 . . . . 0.0 110.848 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -68.29 -44.71 74.86 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.462 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.7 t -66.3 -48.37 81.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.443 ' CE2' HD12 ' A' ' 100' ' ' ILE . 23.4 t80 -64.01 -47.11 81.58 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.654 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.405 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 18.4 t70 -120.35 100.14 6.99 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -66.74 -39.75 88.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.745 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' ASN . 2.0 p-10 -65.66 -40.59 92.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.102 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.62 -59.49 0.48 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 95' ' ' ASP . 54.0 m-80 -61.88 -17.44 56.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.986 0.422 . . . . 0.0 110.2 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.405 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.56 160.91 12.96 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -113.23 155.56 24.85 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.443 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -95.74 118.25 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.966 0.412 . . . . 0.0 111.12 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.9 p -85.53 171.38 11.78 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.89 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.74 -35.73 78.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.551 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.5 -50.78 72.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.158 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -69.29 -37.36 77.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.922 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.03 -39.4 94.62 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.538 0.685 . . . . 0.0 111.07 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -54.22 -43.62 70.98 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.121 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -63.1 -39.49 94.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.3 t -61.82 -45.26 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.151 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 37.7 mmm -64.31 -37.94 89.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.562 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.0 m -60.58 -40.16 90.73 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -61.25 -38.12 85.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.204 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 tp -61.53 -44.09 97.69 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.907 0.385 . . . . 0.0 110.25 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.98 -154.71 25.68 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -139.02 23.35 2.6 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.722 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -62.66 -43.22 99.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 0.0 110.314 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.9 mt -99.95 169.07 9.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.525 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.493 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -68.35 162.17 25.85 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.556 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -92.15 -22.28 19.94 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.434 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -87.26 -24.47 24.36 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.58 -66.06 0.21 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.254 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.626 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.7 m -65.19 -35.28 75.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.363 -178.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -60.51 -46.75 88.98 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.54 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -84.87 -40.4 17.12 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.3 tmm? -58.91 -47.21 85.79 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 125' ' ' ILE . 94.2 mt -69.16 -18.37 22.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.553 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -77.4 -51.39 10.89 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.274 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 129' ' ' ASP . 34.9 tp10 -86.31 -68.67 0.72 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.341 -0.943 . . . . 0.0 111.456 -177.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.69 -21.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.877 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 127' ' ' GLU . 38.7 t0 -90.14 125.02 35.3 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.07 0.462 . . . . 0.0 110.657 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.643 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.46 -32.09 56.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.018 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -72.19 -45.8 58.9 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.907 0.384 . . . . 0.0 110.347 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.68 -5.47 61.16 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 134' ' ' GLY . 35.2 p30 -89.94 -9.67 47.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.962 0.411 . . . . 0.0 109.934 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 58.22 117.93 0.01 OUTLIER Glycine 0 CA--C 1.519 0.294 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 8.2 pt20 -159.76 140.11 11.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.53 -0.335 . . . . 0.0 110.137 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.7 t -126.23 133.24 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.915 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.544 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.8 t30 -150.69 175.39 12.0 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.337 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -57.67 -52.1 66.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.761 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.544 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 57.2 mp0 -55.93 -35.02 66.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.668 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 79.4 mt-10 -69.55 -39.25 77.53 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.694 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -61.26 -45.33 94.97 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.753 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.1 t -58.01 -45.9 87.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -74.2 -30.84 62.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.413 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.4 ttp -60.08 -40.62 90.21 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.621 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 72.9 mtm -105.21 141.73 36.24 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.921 0.391 . . . . 0.0 110.589 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.1 m -167.3 72.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.119 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.58 -41.83 97.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.587 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 C--O 1.218 -0.561 0 CA-C-O 118.066 -0.968 . . . . 0.0 110.269 -179.89 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.065 0 CA-C-O 120.394 0.14 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -54.83 -50.58 68.24 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.997 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -63.74 -44.06 94.63 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.772 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -62.57 -45.94 90.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.484 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -69.69 -35.84 75.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.959 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -63.08 -37.79 88.59 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.492 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -58.47 -46.27 86.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.522 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -80.92 -18.82 45.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.735 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.49 -43.14 98.13 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.746 0.308 . . . . 0.0 111.283 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 83.0 m-85 -57.97 -49.27 77.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.586 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 6.3 t0 -73.15 -13.4 61.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.756 0.313 . . . . 0.0 111.27 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -44.49 -33.52 1.75 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.761 0.315 . . . . 0.0 110.959 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.414 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 7.2 p-10 -53.98 -45.69 71.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.86 0.362 . . . . 0.0 110.946 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.443 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . -149.01 -150.86 5.32 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 25.1 p-10 -70.2 -47.37 61.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.948 0.404 . . . . 0.0 111.006 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.527 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.81 107.81 0.3 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.444 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 6.2 m -166.21 139.46 4.09 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.139 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.2 mp -120.63 110.51 28.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.552 ' CG2' HG22 ' A' ' 62' ' ' THR . 2.8 p -130.95 169.38 15.88 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.025 0.44 . . . . 0.0 110.566 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.421 HG22 HG21 ' A' ' 52' ' ' ILE . 51.2 p -63.07 -31.43 72.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.394 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -62.11 -42.35 99.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.99 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 26' ' ' THR . 81.5 mt-10 -66.74 -45.84 77.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.004 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.9 tp -63.93 -42.9 97.24 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.396 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.76 -25.11 28.42 Favored Glycine 0 C--O 1.226 -0.36 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.0 m -63.96 -44.1 93.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.934 0.397 . . . . 0.0 110.796 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.3 t -55.54 -20.49 7.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.527 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.509 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 87.4 mmm -48.9 -34.89 13.62 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.625 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -63.12 -46.4 87.5 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 118.005 -1.478 . . . . 0.0 111.851 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.0 p -60.75 -30.89 70.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 41' ' ' GLN . 24.9 mt -96.75 2.13 51.62 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.974 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.92 -67.94 0.02 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.532 ' N ' ' O ' ' A' ' 39' ' ' LEU . 86.1 mt-30 -143.59 110.07 5.47 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -123.72 75.03 55.56 Favored Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.461 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.577 ' O ' ' N ' ' A' ' 46' ' ' ALA . 99.5 Cg_exo -36.45 -35.69 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.732 1.621 . . . . 0.0 112.13 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.421 ' N ' ' HB3' ' A' ' 120' ' ' GLU . 5.9 m -37.83 -31.49 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.763 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.509 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.2 mt-10 -87.35 -36.03 18.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.316 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.47 -51.97 67.6 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.866 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -68.39 -47.21 67.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.304 0.573 . . . . 0.0 109.958 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.51 HD22 ' CE ' ' A' ' 51' ' ' MET . 84.7 mt -64.09 -26.81 68.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.917 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 48' ' ' LEU . 58.7 tp60 -38.82 -46.35 1.27 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.751 0.31 . . . . 0.0 110.566 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.17 -41.69 66.74 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.54 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.51 ' CE ' HD22 ' A' ' 48' ' ' LEU . 40.0 ttp -62.14 -41.73 98.55 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.076 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.421 HG21 HG22 ' A' ' 29' ' ' THR . 96.6 mt -60.92 -51.99 66.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.39 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.625 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 17.3 m120 -64.29 -40.03 95.13 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.71 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -55.61 -59.58 4.65 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.259 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.79 -34.43 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.99 0.424 . . . . 0.0 110.762 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 62' ' ' THR . 55.3 t0 -80.73 -13.59 58.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.533 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.13 16.11 0.14 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.274 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 56' ' ' ASP . 21.5 p-10 -66.07 -24.61 66.75 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -154.54 -25.55 0.04 OUTLIER Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.604 ' C ' ' H ' ' A' ' 62' ' ' THR . 10.9 p30 179.96 150.84 0.39 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.403 ' C ' ' OD2' ' A' ' 56' ' ' ASP . . . -65.48 32.45 0.12 Allowed Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.604 ' H ' ' C ' ' A' ' 60' ' ' ASN . 66.5 p -130.39 148.91 52.26 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.0 mt -118.5 133.86 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.987 0.423 . . . . 0.0 110.514 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.32 169.08 18.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.475 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.436 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -67.29 -49.52 43.37 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.191 -179.027 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.8 Cg_exo -52.08 -45.31 39.77 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.995 1.797 . . . . 0.0 111.898 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.96 -37.02 72.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.694 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -60.69 -46.37 90.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.964 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.3 mt -62.22 -44.37 96.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.857 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.1 m -65.15 -44.63 87.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.904 0.383 . . . . 0.0 110.304 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 44.9 ttp -62.07 -41.83 98.57 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.853 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 76' ' ' MET . 60.3 mmm -63.35 -40.86 98.43 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.585 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.0 -35.84 77.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.739 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -87.71 -56.27 3.42 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.735 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -63.13 -43.31 98.74 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.123 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 72' ' ' MET . 50.8 mmm -108.88 131.51 54.94 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.863 0.363 . . . . 0.0 110.214 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 78' ' ' ASP . 29.0 tptt -83.12 150.07 26.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.764 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 77' ' ' LYS . 5.7 m-20 -55.51 -159.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.421 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.8 p -96.19 -0.27 50.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.916 0.388 . . . . 0.0 110.499 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -82.87 2.48 34.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.119 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 83' ' ' GLU . 1.6 m -62.09 -35.6 79.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.959 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -37.99 -29.61 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.861 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 81' ' ' SER . 71.5 mm-40 -74.17 -56.87 4.39 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -64.71 -38.73 91.99 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.154 0.502 . . . . 0.0 109.656 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.7 -19.29 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.482 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.1 ttt-85 -57.69 -44.01 85.54 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.171 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -65.9 -33.02 74.87 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.785 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -63.0 -27.96 69.78 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -55.63 -46.0 77.47 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.38 0.609 . . . . 0.0 110.405 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -74.42 -51.08 15.97 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.757 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.21 -47.79 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.04 0.448 . . . . 0.0 110.553 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.473 ' CE2' HD12 ' A' ' 100' ' ' ILE . 39.2 t80 -63.5 -45.83 88.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.239 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.48 ' OD2' ' N ' ' A' ' 96' ' ' GLY . 36.0 t70 -127.16 105.08 8.33 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.586 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -68.55 -42.12 78.82 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.897 0.379 . . . . 0.0 111.059 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' A' ' 97' ' ' ASN . 1.5 p-10 -59.95 -46.62 88.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.846 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.48 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 73.77 -41.77 1.05 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.43 ' H ' ' C ' ' A' ' 95' ' ' ASP . 77.1 m-20 -80.24 -13.55 59.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.929 0.395 . . . . 0.0 110.046 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.94 161.28 12.8 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -113.29 149.82 33.35 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.7 0.286 . . . . 0.0 110.511 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.473 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -96.79 116.55 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.99 0.424 . . . . 0.0 111.191 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.9 p -84.39 170.76 13.24 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.3 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.57 -37.52 86.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.157 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.27 -47.16 84.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.978 0.418 . . . . 0.0 110.577 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.55 -35.99 75.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.495 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.6 tp -62.33 -40.15 95.41 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.63 0.728 . . . . 0.0 110.668 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -52.44 -45.02 65.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.649 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -61.64 -45.04 95.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.971 0.415 . . . . 0.0 110.396 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.9 t -63.91 -44.89 98.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.309 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 48.4 mmm -64.38 -37.12 86.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.514 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 83.1 m -61.04 -46.13 91.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -67.13 -24.54 65.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.216 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.1 tp -61.51 -44.89 96.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.893 0.378 . . . . 0.0 110.824 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.53 -148.79 15.54 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -140.36 25.84 2.21 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.502 0.192 . . . . 0.0 111.056 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -64.75 -45.34 86.84 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.979 0.418 . . . . 0.0 110.958 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.6 mt -113.54 170.67 8.07 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.943 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.48 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -69.51 161.54 29.32 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.014 0.435 . . . . 0.0 110.952 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -92.1 -23.93 19.29 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.805 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -88.06 -20.39 25.81 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.58 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.7 -67.39 0.16 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.58 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 18.0 m -64.53 -35.15 73.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -57.68 -66.46 0.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -64.35 -43.79 93.48 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.465 ' C ' ' SD ' ' A' ' 124' ' ' MET . 16.1 tmm? -57.31 -48.69 78.3 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.832 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.22 -23.78 30.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.219 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -77.08 -46.86 22.17 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.499 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -85.38 -68.28 0.74 Allowed 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.486 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.01 -33.3 0.08 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.503 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -94.72 146.77 23.94 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.819 0.342 . . . . 0.0 110.702 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.662 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -89.41 -17.37 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -65.46 -44.48 87.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.055 0.455 . . . . 0.0 110.531 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.37 -11.01 5.61 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 41.3 p-10 -89.12 -19.39 25.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.87 0.367 . . . . 0.0 110.483 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.549 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 55.36 106.24 0.01 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.477 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 11.1 pt20 -140.15 134.7 31.6 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.7 t -116.93 132.04 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.007 0.432 . . . . 0.0 110.225 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -142.74 175.44 9.81 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.579 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -58.22 -45.83 86.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.147 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.481 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 54.0 mp0 -63.66 -36.92 85.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.407 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.477 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 78.3 mt-10 -67.09 -33.85 76.38 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.137 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -62.09 -40.55 96.2 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.466 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.0 t -57.18 -45.78 84.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.516 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -82.86 -15.82 50.02 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.838 0.351 . . . . 0.0 111.224 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 43.8 ttp -60.99 -41.05 95.73 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.882 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 78.2 mtm -118.49 141.72 48.29 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.779 0.323 . . . . 0.0 110.683 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 81.5 m -159.56 84.5 0.76 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.798 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.58 -40.51 73.23 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.186 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.912 -1.042 . . . . 0.0 110.5 -179.563 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.06 0 CA-C-O 120.64 0.257 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -44.0 -48.21 8.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.852 0.358 . . . . 0.0 110.699 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -66.0 -39.8 90.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.582 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -65.38 -48.15 73.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.216 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -64.12 -34.03 77.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.476 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.57 -19.93 11.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.541 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -57.38 -49.3 76.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.865 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.8 m -60.95 -40.82 94.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.56 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.55 -42.86 99.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.003 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -59.33 -49.9 76.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.804 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.466 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.6 t0 -75.88 -15.61 60.18 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.682 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -43.6 -33.2 1.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.818 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.437 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 14.4 p-10 -53.4 -43.44 67.92 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.485 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -145.62 -153.7 5.95 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 26.7 p-10 -74.79 -47.27 31.7 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.59 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.69 107.27 0.28 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.638 ' C ' HD12 ' A' ' 27' ' ' ILE . 8.4 m -166.7 149.93 6.86 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.128 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.638 HD12 ' C ' ' A' ' 26' ' ' THR . 2.8 mp -119.52 109.47 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.503 HG22 HG22 ' A' ' 62' ' ' THR . 4.1 p -130.91 169.71 15.41 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.896 0.379 . . . . 0.0 110.506 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.508 ' CB ' HE22 ' A' ' 49' ' ' GLN . 82.5 p -63.51 -29.56 70.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.173 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -62.11 -41.28 98.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.236 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.445 ' OE2' ' O ' ' A' ' 26' ' ' THR . 89.6 mt-10 -66.99 -45.74 76.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.0 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.1 tp -65.92 -44.52 84.93 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.382 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.91 -22.49 4.52 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.3 m -67.03 -30.15 70.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.789 0.328 . . . . 0.0 110.478 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.6 t -62.34 -22.96 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 94.9 mmm -56.05 -37.11 68.83 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 120.199 -0.601 . . . . 0.0 109.701 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -63.17 -44.2 96.12 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 116.806 -1.958 . . . . 0.0 110.114 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 91.7 p -60.48 -37.87 82.43 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.16 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.413 ' O ' ' N ' ' A' ' 41' ' ' GLN . 39.1 mt -94.74 5.05 53.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.302 0.572 . . . . 0.0 110.528 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.49 -67.62 0.26 Allowed Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 39' ' ' LEU . 84.1 mt-30 -147.86 104.99 3.63 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.431 ' O ' ' N ' ' A' ' 44' ' ' THR . 58.7 t30 -123.25 76.84 52.61 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.028 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' A' ' 46' ' ' ALA . 72.1 Cg_exo -36.74 -29.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.595 2.196 . . . . 0.0 112.603 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.437 ' N ' ' HB3' ' A' ' 120' ' ' GLU . 11.5 m -38.43 -31.93 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.418 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 49' ' ' GLN . 96.9 mt-10 -88.86 -36.14 16.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.117 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -55.08 -49.8 70.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.536 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -69.85 -49.21 54.69 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.174 0.511 . . . . 0.0 110.155 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.89 -21.35 65.94 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.663 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.508 HE22 ' CB ' ' A' ' 29' ' ' THR . 71.3 tp60 -45.5 -47.47 14.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.221 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 68.1 t0 -70.85 -38.63 73.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.519 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.0 ttp -62.37 -42.78 99.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.914 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.411 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 87.5 mt -63.7 -46.22 95.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.488 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.667 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 87.3 m-20 -63.95 -41.86 97.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.6 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -59.27 -59.17 5.89 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.477 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.8 p -66.1 -31.74 55.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.754 0.312 . . . . 0.0 110.834 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.541 ' OD2' ' N ' ' A' ' 62' ' ' THR . 45.5 t0 -87.38 -12.58 45.89 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.69 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.28 13.06 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.07 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' A' ' 56' ' ' ASP . 16.8 p-10 -64.03 -33.83 76.63 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.44 -26.45 0.08 OUTLIER Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.594 ' C ' ' H ' ' A' ' 62' ' ' THR . 16.5 p30 -178.19 148.25 0.48 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.545 -0.327 . . . . 0.0 110.297 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.97 34.25 0.1 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.594 ' H ' ' C ' ' A' ' 60' ' ' ASN . 70.2 p -129.68 151.48 50.23 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.0 mt -119.59 134.15 64.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.82 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -77.05 -155.47 0.07 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.028 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.497 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -96.51 -47.89 0.24 Allowed Pre-proline 0 N--CA 1.469 0.496 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.824 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 42.9 Cg_exo -54.94 -36.01 91.01 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.107 1.872 . . . . 0.0 111.629 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -83.62 -28.66 28.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.795 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -59.44 -46.4 88.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.685 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.96 -43.5 95.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.854 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.9 m -63.64 -45.26 91.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.103 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 46.6 ttp -62.18 -44.41 96.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.806 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 47.8 mmm -63.38 -42.23 98.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.767 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.72 -48.66 80.81 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.768 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -71.04 -50.15 37.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.554 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -64.64 -41.78 95.9 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.396 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.505 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 32.1 mmm -121.21 127.0 51.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.197 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -82.69 153.12 25.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.672 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -52.5 -179.96 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.263 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.4 p -80.99 -9.69 59.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.641 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -65.97 -21.69 66.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.39 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.3 m -50.59 -32.2 18.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.423 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -38.23 -45.72 1.0 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.685 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -69.1 -46.63 67.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.17 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -65.07 -49.43 70.07 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.939 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.6 mt -56.42 -21.13 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -57.94 -44.95 87.27 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 118.386 -1.326 . . . . 0.0 109.652 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -66.07 -26.02 67.3 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.62 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.74 -14.16 58.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.122 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -56.61 -50.62 71.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.292 0.568 . . . . 0.0 111.137 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -63.39 -44.52 94.47 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.164 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.58 -45.64 88.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.581 -0.447 . . . . 0.0 109.866 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.429 ' CE2' ' CD1' ' A' ' 100' ' ' ILE . 19.1 t80 -62.54 -47.17 85.05 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.697 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 37.3 t0 -119.94 106.53 12.13 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.208 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -68.1 -44.32 76.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.072 0.463 . . . . 0.0 110.648 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.0 OUTLIER -62.26 -44.59 96.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.752 -179.351 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.1 -47.38 1.05 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -74.59 -14.43 60.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.016 0.436 . . . . 0.0 110.538 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.82 161.81 12.63 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -112.15 144.38 41.63 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.429 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 64.6 mt -74.95 129.49 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.861 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.6 p -83.09 168.79 16.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.293 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.88 97.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.857 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.11 -41.69 94.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.69 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -67.34 -37.33 83.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.084 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.2 tp -60.31 -43.17 96.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.192 0.52 . . . . 0.0 110.654 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -54.0 -40.76 67.26 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.789 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -59.05 -42.24 89.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.935 0.398 . . . . 0.0 109.987 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.02 -44.97 97.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.715 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 80.9 mmm -63.53 -35.47 80.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.562 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.3 m -61.21 -41.72 97.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.273 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -59.79 -39.15 83.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.663 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.1 tp -61.4 -44.33 97.33 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.534 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.77 -143.91 9.97 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -144.36 30.49 1.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.34 . . . . 0.0 110.775 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -62.85 -40.86 98.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.389 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.6 mt -105.19 165.93 10.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.788 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.486 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -65.16 161.58 18.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.877 0.37 . . . . 0.0 110.526 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.44 ' C ' ' OE1' ' A' ' 120' ' ' GLU . 83.8 m-20 -91.39 -20.25 22.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.851 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -89.34 -26.13 21.25 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.682 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -34.89 -65.17 0.23 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.565 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.682 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 31.0 m -68.65 -27.5 36.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 111.639 0.236 . . . . 0.0 111.639 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -63.21 -43.84 96.98 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.998 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -88.42 -41.02 13.07 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.47 ' C ' ' SD ' ' A' ' 124' ' ' MET . 15.0 tmm? -60.56 -42.72 97.19 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.858 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 125' ' ' ILE . 96.6 mt -70.02 -15.82 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -87.17 -66.76 0.88 Allowed 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.975 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -70.96 -68.53 0.43 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.949 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 124' ' ' MET . . . -37.3 -40.01 0.32 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.675 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -88.42 124.66 34.17 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.078 0.466 . . . . 0.0 110.466 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -72.25 -16.05 18.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.239 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 133' ' ' ASP . 51.0 m-20 -65.33 -45.65 83.4 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.994 0.426 . . . . 0.0 110.664 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.1 -11.56 2.67 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 42.0 p30 -88.45 -17.39 30.49 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.067 0.46 . . . . 0.0 110.14 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 58.33 120.7 0.01 OUTLIER Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.443 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 10.4 pt20 -160.97 137.87 8.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.711 0.291 . . . . 0.0 110.282 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.2 t -125.58 134.24 67.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.834 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.472 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.3 t30 -148.99 159.64 44.03 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.232 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -40.13 -35.34 0.38 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.289 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.472 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 53.0 mp0 -65.81 -42.29 90.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.177 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 80.2 mt-10 -71.75 -30.27 65.41 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.524 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -58.52 -45.5 88.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.21 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.3 -48.16 89.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.862 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -70.07 -32.15 70.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.778 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 37.6 ttp -56.62 -47.71 79.08 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.722 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 69.7 mtm -106.09 134.1 49.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 110.658 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 88.8 m -160.1 81.58 0.7 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.351 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 76' ' ' MET . . . -65.79 -40.62 92.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.939 0.399 . . . . 0.0 110.607 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.632 -179.972 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.134 0 N-CA-C 111.482 0.178 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -41.25 -45.78 3.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.851 0.358 . . . . 0.0 110.963 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -66.78 -39.62 87.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.795 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -62.76 -43.22 99.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.484 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.06 -40.82 91.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.752 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.78 -20.42 49.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.652 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -49.36 -47.95 47.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.817 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.3 m -77.72 -20.36 53.66 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.019 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.6 tp -64.04 -40.69 96.87 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.837 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.468 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 76.3 m-85 -57.69 -45.41 85.7 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.354 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 9.7 t0 -86.16 -20.35 28.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -44.06 -33.17 1.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.806 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.41 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 4.5 p-10 -56.0 -46.14 78.81 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 110.82 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -140.25 -152.61 5.85 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 28.2 p-10 -74.4 -47.09 36.1 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.728 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.71 107.09 0.28 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 178.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 6.3 m -166.44 148.82 6.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.199 0.499 . . . . 0.0 111.436 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.73 74.02 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.504 HG22 HG22 ' A' ' 62' ' ' THR . 9.7 p -86.96 166.18 15.3 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.541 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -66.31 -28.55 68.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.961 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -61.91 -40.21 94.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.925 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.468 ' OE1' ' O ' ' A' ' 19' ' ' PHE . 86.7 mt-10 -66.76 -40.47 88.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.959 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.7 tp -62.8 -43.54 98.54 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.63 -33.22 47.94 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 m -64.58 -44.62 90.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.91 0.355 . . . . 0.0 110.857 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.4 t -55.95 -17.34 3.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.113 0.483 . . . . 0.0 110.287 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.545 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 88.9 mmm -52.72 -40.81 63.38 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.733 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.2 ttt85 -64.27 -46.01 85.57 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 118.202 -1.399 . . . . 0.0 110.2 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.8 p -64.3 -19.23 65.29 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.63 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.812 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 36.4 mt -94.41 6.6 48.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.682 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 43.75 78.67 0.07 OUTLIER Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 40' ' ' GLY . 85.7 mt-30 52.76 117.23 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.852 0.358 . . . . 0.0 110.723 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' A' ' 44' ' ' THR . 35.2 t-20 -148.85 68.76 9.84 Favored Pre-proline 0 C--O 1.235 0.303 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.657 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.582 ' O ' ' N ' ' A' ' 46' ' ' ALA . 86.7 Cg_exo -35.85 -31.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 122.533 2.156 . . . . 0.0 111.983 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.449 ' N ' ' O ' ' A' ' 42' ' ' ASN . 29.5 m -38.58 -27.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.299 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.545 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 87.7 mt-10 -89.52 -32.44 17.17 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.848 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.33 -51.88 67.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.994 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.456 ' HB2' HG23 ' A' ' 117' ' ' THR . 2.2 tm-20 -67.5 -46.06 73.99 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.192 0.52 . . . . 0.0 109.661 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 44' ' ' THR . 96.8 mt -63.6 -27.6 69.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.403 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -39.51 -53.66 2.04 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.811 0.339 . . . . 0.0 110.85 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -65.9 -38.26 88.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.24 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.5 ttp -62.33 -40.18 95.51 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 97.8 mt -62.04 -46.42 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.649 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 9.4 m120 -62.38 -42.43 99.41 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.666 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.68 -55.66 31.57 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.119 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.87 -34.88 62.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.891 0.377 . . . . 0.0 111.065 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.531 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.9 t0 -82.92 -13.43 56.09 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.408 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.12 9.0 1.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.778 0.323 . . . . 0.0 110.154 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 12.6 p30 -61.56 -25.18 67.15 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.484 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -157.83 -19.97 0.03 OUTLIER Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.623 ' C ' ' H ' ' A' ' 62' ' ' THR . 5.1 p30 177.08 141.82 0.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.72 32.25 0.08 OUTLIER Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.623 ' H ' ' C ' ' A' ' 60' ' ' ASN . 64.0 p -130.29 150.08 51.69 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-O 121.002 0.43 . . . . 0.0 110.273 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.3 mt -116.98 138.93 46.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.144 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.53 166.14 19.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.444 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.429 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -62.95 -50.52 76.59 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.761 -179.119 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.4 Cg_exo -50.92 -44.88 39.32 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.994 1.796 . . . . 0.0 111.778 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.95 -36.32 72.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.977 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -60.03 -45.85 91.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.224 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.08 -44.5 95.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.625 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.5 m -67.4 -44.45 78.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.194 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.0 ttp -61.42 -40.13 93.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.05 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 76.3 mmm -63.01 -38.6 91.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.848 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.07 96.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.02 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -68.43 -45.55 72.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.11 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.59 -41.78 83.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.924 0.393 . . . . 0.0 110.366 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.8 mmt -86.92 164.47 16.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.086 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -116.24 153.61 31.58 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.004 0.43 . . . . 0.0 110.145 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -59.29 160.46 6.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.26 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.4 p -64.17 -30.06 71.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.546 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.43 -10.05 22.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.206 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -57.04 -32.85 66.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.513 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -49.43 -50.23 41.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.735 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.02 -41.92 94.88 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.005 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -66.27 -45.74 79.45 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.476 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.3 mt -64.9 -20.59 27.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -59.74 -42.18 92.61 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 119.079 -1.048 . . . . 0.0 110.184 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -61.46 -35.88 78.87 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.496 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.18 -13.39 60.45 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -48.02 -51.05 25.59 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.981 0.419 . . . . 0.0 111.41 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -59.78 -46.86 87.89 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.784 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.86 -44.35 81.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.991 0.424 . . . . 0.0 110.451 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -59.46 -44.41 92.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.567 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.435 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 33.0 t70 -138.82 100.73 4.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.24 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.1 -39.96 82.71 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.175 0.512 . . . . 0.0 110.164 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.435 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.2 p-10 -60.22 -42.54 95.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.291 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.71 -56.99 0.51 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -70.78 -13.59 62.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.146 0.498 . . . . 0.0 110.28 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.66 161.12 12.86 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -115.0 150.89 35.13 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.7 mt -85.19 123.18 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.025 0.44 . . . . 0.0 110.343 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.2 p -80.02 168.14 19.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.026 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.48 82.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.62 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.21 -45.3 93.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.056 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.97 -37.68 75.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.251 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.7 tp -61.94 -42.96 99.7 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.263 0.554 . . . . 0.0 111.257 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -52.56 -43.25 65.1 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.012 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -55.4 -42.75 74.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.199 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.63 -42.43 95.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.279 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 58.3 mmm -57.56 -34.78 69.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.476 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 80.3 m -60.19 -42.34 94.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.458 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -58.6 -38.73 78.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.9 tp -61.29 -46.35 90.71 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.025 0.44 . . . . 0.0 110.117 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.85 -154.89 25.97 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.237 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -143.24 11.8 1.75 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.737 -0.231 . . . . 0.0 110.76 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -63.92 -44.01 94.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.102 0.477 . . . . 0.0 110.631 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.6 mt -79.75 160.29 26.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.978 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.48 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.6 OUTLIER -68.5 161.69 27.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.273 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -92.33 -21.03 20.5 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.098 0.475 . . . . 0.0 110.45 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -85.45 -26.93 26.03 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.24 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.613 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.59 -63.55 0.35 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.613 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 11.3 m -69.09 -31.32 49.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 121.236 -0.185 . . . . 0.0 111.497 -178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -58.94 -67.08 0.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.717 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.58 -45.15 72.79 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.517 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 13.3 tmm? -52.91 -50.3 64.2 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 125' ' ' ILE . 95.9 mt -64.62 -18.38 23.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.653 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -87.92 -57.88 2.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.297 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 128' ' ' ALA . 51.1 tp10 -81.92 -67.78 0.75 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.236 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.812 ' HB2' ' O ' ' A' ' 39' ' ' LEU . . . -36.78 -35.65 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 56.6 t0 -87.69 146.18 25.81 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.298 0.57 . . . . 0.0 110.519 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.567 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -89.39 -14.94 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.783 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 133' ' ' ASP . 44.8 m-20 -73.59 -45.27 54.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.016 0.436 . . . . 0.0 110.4 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.29 -10.29 3.65 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 131' ' ' ASP . 35.3 p30 -89.84 -10.42 45.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.233 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 62.28 122.93 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -161.7 119.61 2.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.859 0.362 . . . . 0.0 110.073 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.61 128.9 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.13 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.526 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 45.3 t30 -155.08 166.32 33.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.063 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.402 ' O ' ' CD1' ' A' ' 138' ' ' TYR . 2.6 t80 -48.82 -23.06 0.95 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.415 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 50.0 mp0 -66.4 -35.74 81.09 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.153 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -84.97 -20.83 29.97 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.582 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -61.94 -46.84 87.56 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.102 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 29.5 t -58.22 -45.95 88.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.105 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -71.4 -36.07 71.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.332 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 61.4 ttp -58.09 -43.03 86.83 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.128 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 70.6 mtm -112.76 129.28 56.48 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.84 0.353 . . . . 0.0 110.377 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 m -162.81 85.8 0.55 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.047 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.13 -43.93 93.75 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.645 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.55 179.846 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.574 0.226 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -54.68 -48.25 72.62 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.538 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -65.7 -40.81 92.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -61.95 -44.08 97.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.67 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -67.06 -37.51 84.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.01 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.481 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.02 -27.92 65.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.826 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -57.81 -46.91 83.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.537 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.7 m -77.92 -21.51 51.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.68 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.4 -42.76 99.68 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.436 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.481 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.1 m-85 -60.2 -50.96 71.61 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.478 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.1 t0 -76.93 -14.35 59.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.912 0.387 . . . . 0.0 111.335 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -45.59 -32.68 2.44 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.84 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 8.8 p-10 -53.72 -46.08 70.7 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.57 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -144.36 -151.58 5.47 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 30.8 p-10 -72.97 -47.25 47.01 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.09 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.72 107.36 0.28 Allowed Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 178.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.426 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 4.7 m -166.59 139.32 3.76 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.129 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 27' ' ' ILE . 5.2 mp -115.04 109.19 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.594 HG22 HG22 ' A' ' 62' ' ' THR . 2.6 p -128.68 170.31 13.43 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.847 0.356 . . . . 0.0 110.418 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.636 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.2 p -64.69 -33.12 75.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.805 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -61.62 -41.4 97.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.053 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 26' ' ' THR . 90.0 mt-10 -63.41 -45.69 89.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.915 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.1 tp -64.13 -43.36 95.5 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.113 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.77 -26.1 53.24 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.1 m -63.87 -41.46 97.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.85 0.357 . . . . 0.0 110.071 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.1 t -56.28 -23.52 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.352 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.48 ' O ' ' N ' ' A' ' 40' ' ' GLY . 62.1 mmm -48.17 -30.21 4.42 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.679 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -64.41 -45.65 86.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.003 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.1 p -63.91 -21.99 66.72 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.856 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 41' ' ' GLN . 16.8 mt -107.7 3.68 24.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.094 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.15 -71.19 0.02 OUTLIER Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 39' ' ' LEU . 87.8 mt-30 -145.46 109.44 4.83 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 44' ' ' THR . 41.4 t30 -125.58 70.88 65.34 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.149 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 46' ' ' ALA . 85.4 Cg_exo -32.92 -30.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 122.66 2.24 . . . . 0.0 112.785 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.542 ' N ' ' O ' ' A' ' 42' ' ' ASN . 26.2 m -39.27 -30.15 0.05 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.522 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.418 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.9 mt-10 -86.7 -34.86 19.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.27 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -59.12 -50.08 75.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.779 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.13 -46.15 71.65 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.166 0.508 . . . . 0.0 109.655 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 51' ' ' MET . 84.5 mt -64.79 -31.15 72.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.359 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.636 HE22 ' CB ' ' A' ' 29' ' ' THR . 61.1 tp60 -37.47 -51.3 1.13 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.72 0.295 . . . . 0.0 110.838 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.25 -40.35 90.14 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.27 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.463 ' N ' ' O ' ' A' ' 48' ' ' LEU . 33.1 ttp -62.45 -40.95 98.27 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.0 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 83.5 mt -62.04 -49.88 82.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.145 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.602 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 89.8 m-20 -63.0 -40.38 97.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.585 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -55.19 -61.54 2.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.193 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.9 -30.12 43.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.779 0.323 . . . . 0.0 111.285 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 62' ' ' THR . 50.6 t0 -84.68 -13.21 52.11 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.528 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -71.97 13.0 0.33 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.868 0.366 . . . . 0.0 110.295 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.7 p30 -65.57 -28.86 69.45 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.539 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -150.55 -22.4 0.06 OUTLIER Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.557 ' C ' ' H ' ' A' ' 62' ' ' THR . 3.3 p30 173.13 151.88 0.08 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.99 34.76 0.14 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.594 HG22 HG22 ' A' ' 28' ' ' THR . 81.7 p -134.39 149.48 50.81 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.3 mt -121.02 134.52 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.14 162.44 28.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.416 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.471 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -64.65 -48.14 74.33 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.478 -179.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 50.3 Cg_exo -51.17 -37.36 58.49 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.171 1.914 . . . . 0.0 111.739 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -87.61 -22.3 24.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.35 -47.2 86.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.852 0.358 . . . . 0.0 111.028 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.5 -42.89 98.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.567 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.4 m -63.92 -46.11 86.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.668 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.7 ttp -61.76 -47.45 85.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.077 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 82.0 mmm -65.82 -37.79 87.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.271 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.62 -49.97 75.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.031 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -71.5 -43.76 65.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.196 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.72 -43.61 88.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.7 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 73' ' ' ALA . 22.3 mmm -104.31 127.46 51.96 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.07 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.7 tptt -84.97 141.11 30.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.931 0.396 . . . . 0.0 110.711 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 77' ' ' LYS . 95.0 m-20 -48.9 179.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.266 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.3 p -75.47 -6.77 51.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.456 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.47 -15.53 62.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.511 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.9 m -61.89 -19.91 63.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.527 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -48.2 -44.72 33.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.33 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.99 -39.49 79.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.894 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -65.89 -45.13 83.16 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.01 0.433 . . . . 0.0 110.197 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.3 mt -66.05 -19.09 25.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.494 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -58.43 -45.42 88.52 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 118.971 -1.092 . . . . 0.0 110.156 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.62 -31.79 73.01 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.923 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -72.08 -14.61 61.9 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.16 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -57.97 -48.98 78.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.328 0.585 . . . . 0.0 111.092 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -64.1 -45.57 88.05 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.358 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -76.2 -51.58 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 110.849 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.443 ' CE2' HD12 ' A' ' 100' ' ' ILE . 26.3 t80 -62.02 -47.17 85.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.625 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 18.2 t70 -108.98 94.24 4.94 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.29 -41.02 73.93 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 110.535 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 19.8 p-10 -62.52 -39.71 94.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.961 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.44 -67.29 0.97 Allowed Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.57 -16.56 63.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.009 0.433 . . . . 0.0 110.242 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.82 161.99 12.57 Favored Glycine 0 N--CA 1.465 0.575 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.28 155.33 24.24 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.775 0.321 . . . . 0.0 110.23 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.443 HD12 ' CE2' ' A' ' 92' ' ' PHE . 94.2 mt -79.66 125.99 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.974 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.4 p -82.39 168.94 17.0 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.128 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.51 -38.04 89.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.513 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.65 -47.3 84.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.916 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.67 -32.88 73.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.958 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.4 tp -61.52 -41.7 97.71 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.382 0.61 . . . . 0.0 110.706 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -56.43 -43.31 79.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.77 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -58.49 -41.88 86.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.3 t -66.68 -43.37 90.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.646 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.0 mmm -62.03 -35.59 79.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.642 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.2 m -61.09 -44.37 97.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.055 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -59.76 -35.0 73.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.378 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.0 tp -61.18 -46.73 89.28 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.081 0.467 . . . . 0.0 110.391 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.5 -160.71 33.43 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -140.53 23.35 2.31 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.603 0.24 . . . . 0.0 110.746 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -63.61 -42.79 98.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.962 0.41 . . . . 0.0 110.277 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.7 mt -92.88 175.8 6.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.972 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.467 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -72.85 161.29 30.9 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.668 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -91.66 -22.44 20.25 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.979 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -87.91 -25.32 23.29 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.174 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.639 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.41 -61.24 0.46 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.123 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.639 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 20.2 m -67.39 -40.21 84.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.509 ' N ' HG23 ' A' ' 121' ' ' VAL . 81.2 m-20 -56.73 -47.05 80.88 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.595 -178.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -86.03 -40.28 15.95 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.7 tmm? -59.56 -46.53 88.63 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.081 0.467 . . . . 0.0 109.914 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 125' ' ' ILE . 91.5 mt -69.1 -16.61 21.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.424 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -78.6 -50.51 11.38 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 119.394 -0.922 . . . . 0.0 112.148 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 129' ' ' ASP . 42.4 tp10 -87.69 -67.52 0.82 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.834 -178.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.33 -26.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.794 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 127' ' ' GLU . 25.4 t0 -87.95 128.26 35.37 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.058 0.456 . . . . 0.0 111.132 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.664 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.48 -43.38 90.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.457 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -65.35 -40.33 93.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.19 0.519 . . . . 0.0 110.178 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.33 -1.97 58.84 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' GLY . 55.2 p-10 -89.49 -8.98 51.73 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 57.38 115.48 0.01 OUTLIER Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 20.3 pt20 -160.64 133.64 6.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.2 t -123.47 136.89 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.081 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -151.35 172.49 15.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.243 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -54.86 -46.78 74.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.13 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 139' ' ' GLU . 55.2 mp0 -58.68 -44.36 90.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.657 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 93.4 mt-10 -72.0 -29.41 64.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.775 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.89 -43.98 77.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.586 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 94.1 t -59.16 -46.29 92.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.26 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.35 -29.09 66.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.124 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.8 ttp -59.7 -42.88 93.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.796 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.46 138.84 50.6 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.963 0.411 . . . . 0.0 110.731 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.2 m -163.24 77.72 0.43 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.661 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.16 -27.76 68.93 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.438 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 117.884 -1.055 . . . . 0.0 110.665 -179.864 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 120.776 0.322 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -54.18 -42.33 69.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.098 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -67.81 -41.71 82.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.375 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -62.63 -43.68 98.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.982 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -67.25 -35.75 80.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.437 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.414 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.49 -24.19 66.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.699 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -55.37 -46.51 76.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.79 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.3 m -80.65 -19.5 45.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.783 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.17 -41.96 96.92 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.052 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.425 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.3 m-85 -58.84 -46.1 88.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.871 0.367 . . . . 0.0 111.144 -178.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.448 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.3 t0 -79.57 -13.47 59.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.499 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -42.99 -32.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.915 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' CG ' ' OE2' ' A' ' 31' ' ' GLU . 10.9 p-10 -52.9 -45.13 67.41 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.481 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.436 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . -149.64 -151.21 5.44 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 21.2 p-10 -71.21 -46.9 60.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.685 0.278 . . . . 0.0 110.957 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.531 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.04 107.34 0.28 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.593 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.7 m -166.51 136.22 3.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.215 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.608 HD12 ' N ' ' A' ' 27' ' ' ILE . 1.9 mp -110.53 118.3 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.459 HG22 HG22 ' A' ' 62' ' ' THR . 2.0 p -134.76 167.05 21.56 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.897 0.38 . . . . 0.0 110.291 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.541 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.3 p -64.08 -33.69 76.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.31 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -62.57 -40.16 95.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.701 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.456 ' OE2' ' O ' ' A' ' 26' ' ' THR . 88.9 mt-10 -64.66 -48.56 74.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.313 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.38 -43.72 93.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.321 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.31 -24.72 17.09 Favored Glycine 0 C--O 1.224 -0.469 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -64.05 -40.99 97.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.873 0.368 . . . . 0.0 110.226 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.15 -22.37 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.205 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.6 mmm -48.87 -33.45 10.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.021 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -64.32 -45.47 87.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 118.152 -1.419 . . . . 0.0 110.278 -178.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.1 p -59.04 -30.67 68.2 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.301 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 41' ' ' GLN . 9.2 mt -102.3 5.45 39.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.974 0.416 . . . . 0.0 110.472 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.26 -69.79 0.03 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 39' ' ' LEU . 85.8 mt-30 -143.28 116.25 8.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.132 -0.534 . . . . 0.0 109.589 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.1 t30 -132.58 69.69 79.61 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.945 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.549 ' O ' ' N ' ' A' ' 46' ' ' ALA . 91.4 Cg_exo -33.0 -33.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 122.545 2.164 . . . . 0.0 112.476 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.477 ' N ' ' O ' ' A' ' 42' ' ' ASN . 12.7 m -39.07 -29.33 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.371 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 43' ' ' PRO . 90.6 mt-10 -87.67 -35.17 18.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.486 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -61.23 -49.22 78.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.998 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.433 ' HB2' HG23 ' A' ' 117' ' ' THR . 3.1 tm-20 -68.09 -48.48 65.39 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.397 0.617 . . . . 0.0 109.951 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.513 HD22 ' CE ' ' A' ' 51' ' ' MET . 87.3 mt -62.72 -22.68 66.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.009 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.541 HE22 ' CB ' ' A' ' 29' ' ' THR . 48.0 tp60 -40.27 -49.6 2.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.87 0.367 . . . . 0.0 110.475 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.64 -39.85 73.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.478 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.513 ' CE ' HD22 ' A' ' 48' ' ' LEU . 36.1 ttp -61.56 -40.55 95.11 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.743 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.82 -46.91 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.586 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.652 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 28.3 m120 -65.13 -39.91 93.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.358 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -58.03 -57.22 13.79 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.474 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 p -68.26 -32.85 57.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.923 0.392 . . . . 0.0 110.997 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.511 ' OD2' ' N ' ' A' ' 62' ' ' THR . 42.9 t0 -86.06 -13.08 48.43 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.805 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.06 15.43 0.16 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 56' ' ' ASP . 38.7 p-10 -66.74 -23.48 66.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.4 -22.61 0.03 OUTLIER Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.591 ' C ' ' H ' ' A' ' 62' ' ' THR . 4.6 p30 179.34 146.51 0.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.75 33.78 0.18 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.591 ' H ' ' C ' ' A' ' 60' ' ' ASN . 80.6 p -132.2 143.94 50.3 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.92 135.15 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.034 0.445 . . . . 0.0 110.191 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.38 172.4 4.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.456 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.436 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -72.6 -49.57 8.38 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.764 -179.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 53.2 Cg_exo -52.03 -43.31 53.41 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.885 1.723 . . . . 0.0 111.88 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.45 -37.46 77.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.846 0.355 . . . . 0.0 110.898 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -60.34 -45.4 93.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.926 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.0 mt -62.39 -44.62 96.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.503 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.6 m -67.4 -45.49 76.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.736 0.303 . . . . 0.0 111.231 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.4 ttp -61.09 -43.72 98.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.977 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 87.0 mmm -64.75 -39.35 93.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.223 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.91 -42.88 94.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.838 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -71.51 -41.7 68.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.279 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -64.74 -40.94 96.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.804 0.335 . . . . 0.0 110.436 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 73' ' ' ALA . 14.2 mmt -95.27 129.84 42.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.079 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -86.81 142.81 27.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -50.41 168.87 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.379 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.3 p -75.24 -15.21 60.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.645 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.98 -16.46 64.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.449 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.1 m -60.46 -23.7 64.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.758 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -36.75 -48.45 0.73 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.931 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -70.79 -43.54 68.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.247 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -63.78 -39.63 94.73 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.012 0.434 . . . . 0.0 110.085 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.6 mt -66.98 -21.89 28.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.231 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -57.96 -43.65 86.56 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.085 -1.046 . . . . 0.0 110.053 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -63.7 -34.74 78.54 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.889 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.83 -19.85 66.03 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.081 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -56.64 -48.8 76.74 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.253 0.549 . . . . 0.0 110.817 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -68.19 -44.69 75.29 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.471 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.9 t -66.34 -48.39 81.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.441 ' CE2' HD12 ' A' ' 100' ' ' ILE . 23.4 t80 -63.96 -47.19 81.38 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.632 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.408 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 18.4 t70 -120.32 100.17 7.01 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -66.71 -39.75 88.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.812 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 97' ' ' ASN . 2.0 p-10 -65.67 -40.6 92.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.104 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.62 -59.48 0.48 Allowed Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 95' ' ' ASP . 54.0 m-80 -61.86 -17.41 56.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.978 0.418 . . . . 0.0 110.201 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.408 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.58 160.91 12.96 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -113.33 155.55 24.98 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.441 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -95.77 118.22 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.04 0.448 . . . . 0.0 111.072 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.9 p -85.53 171.37 11.79 Favored 'General case' 0 C--N 1.335 -0.063 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.908 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.68 -35.76 78.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.572 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.43 -50.86 72.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.131 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.28 -37.37 77.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.919 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.06 -39.34 94.43 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.478 0.656 . . . . 0.0 111.089 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -54.18 -43.67 70.86 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.131 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -63.09 -39.49 94.87 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.85 -45.22 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.192 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 37.8 mmm -64.3 -38.05 89.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.483 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.8 m -60.57 -40.09 90.38 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -61.27 -38.11 85.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.175 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 tp -61.6 -44.07 97.68 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.868 0.366 . . . . 0.0 110.213 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.97 -154.78 25.78 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -138.97 23.42 2.6 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.577 -0.312 . . . . 0.0 110.728 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -62.67 -43.26 99.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.06 0.457 . . . . 0.0 110.309 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.9 mt -99.91 169.06 9.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.54 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.49 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -68.34 162.11 25.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.86 0.362 . . . . 0.0 110.51 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -92.14 -22.21 19.99 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.421 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -87.29 -24.47 24.33 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.625 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.65 -66.06 0.21 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.196 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.625 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.6 m -65.09 -35.31 75.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.416 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -60.47 -46.8 88.75 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.558 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -84.92 -40.34 17.13 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.4 tmm? -58.92 -47.22 85.8 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 125' ' ' ILE . 94.4 mt -69.18 -18.32 22.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.578 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -77.43 -51.37 10.89 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 119.044 -1.063 . . . . 0.0 111.307 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 129' ' ' ASP . 34.7 tp10 -86.32 -68.7 0.72 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.46 -177.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.64 -21.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 127' ' ' GLU . 38.7 t0 -90.16 125.06 35.33 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.139 0.495 . . . . 0.0 110.606 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.647 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.5 -31.99 56.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.052 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -72.16 -45.84 58.81 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.93 0.395 . . . . 0.0 110.362 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.63 -5.41 61.15 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 134' ' ' GLY . 35.3 p30 -89.95 -9.69 47.85 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 58.24 117.92 0.01 OUTLIER Glycine 0 CA--C 1.519 0.335 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 8.2 pt20 -159.73 140.13 11.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.161 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.5 t -126.25 133.35 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.544 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.9 t30 -150.74 175.34 12.07 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.323 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -57.69 -52.09 66.85 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.766 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.544 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 57.2 mp0 -55.88 -35.04 66.07 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.736 -178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 79.3 mt-10 -69.46 -39.31 77.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.712 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -61.21 -45.38 94.83 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.0 t -57.94 -46.0 87.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -74.12 -30.92 62.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.397 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.4 ttp -60.03 -40.66 90.12 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.623 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.403 ' O ' ' OG1' ' A' ' 146' ' ' THR . 72.9 mtm -105.18 141.69 36.28 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.888 0.375 . . . . 0.0 110.631 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 145' ' ' MET . 62.9 m -167.23 72.06 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.104 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.61 -41.79 97.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.561 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 C--O 1.218 -0.559 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.263 -179.906 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.149 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -41.28 -45.7 3.02 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.819 0.342 . . . . 0.0 110.949 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -66.88 -39.62 87.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.724 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -62.74 -43.19 99.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.508 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.06 -40.84 91.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.767 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.79 -20.41 49.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.617 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -49.42 -47.94 47.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.793 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.0 m -77.74 -20.35 53.61 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.994 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.9 tp -64.06 -40.67 96.8 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.785 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.47 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 76.2 m-85 -57.67 -45.47 85.52 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.354 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 9.8 t0 -86.06 -20.42 28.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -44.04 -33.18 1.37 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.794 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.409 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 4.5 p-10 -55.91 -46.16 78.5 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.88 0.371 . . . . 0.0 110.839 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -140.32 -152.62 5.84 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 28.1 p-10 -74.48 -46.99 35.99 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.711 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.73 107.08 0.28 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 6.3 m -166.46 148.77 6.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.178 0.489 . . . . 0.0 111.445 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.66 74.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.507 HG22 HG22 ' A' ' 62' ' ' THR . 9.7 p -86.93 166.16 15.33 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.998 0.428 . . . . 0.0 110.53 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -66.28 -28.62 68.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.972 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -61.89 -40.21 94.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.914 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.47 ' OE1' ' O ' ' A' ' 19' ' ' PHE . 86.7 mt-10 -66.73 -40.44 88.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.977 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.7 tp -62.82 -43.56 98.47 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.61 -33.2 47.83 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 m -64.58 -44.64 90.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.949 0.374 . . . . 0.0 110.865 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.3 t -55.9 -17.36 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.297 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.544 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 88.9 mmm -52.73 -40.8 63.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.709 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.1 ttt85 -64.23 -46.05 85.5 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 118.165 -1.414 . . . . 0.0 110.229 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.2 p -64.28 -19.24 65.27 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.657 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.81 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 36.4 mt -94.34 6.54 48.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.731 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 43.72 78.78 0.07 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.491 ' O ' ' O ' ' A' ' 40' ' ' GLY . 85.7 mt-30 52.65 117.2 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.845 0.355 . . . . 0.0 110.783 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 44' ' ' THR . 35.2 t-20 -148.8 68.75 9.88 Favored Pre-proline 0 C--O 1.235 0.294 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.745 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.586 ' O ' ' N ' ' A' ' 46' ' ' ALA . 86.9 Cg_exo -35.85 -31.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.455 2.103 . . . . 0.0 111.978 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.451 ' N ' ' O ' ' A' ' 42' ' ' ASN . 29.9 m -38.57 -27.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.287 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.544 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 87.7 mt-10 -89.52 -32.43 17.18 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.818 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.41 -51.87 68.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.014 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.451 ' HB2' HG23 ' A' ' 117' ' ' THR . 2.2 tm-20 -67.43 -46.07 74.21 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.18 0.514 . . . . 0.0 109.683 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 44' ' ' THR . 96.9 mt -63.64 -27.64 69.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.344 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -39.54 -53.61 2.07 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.815 0.341 . . . . 0.0 110.804 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -65.94 -38.26 88.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.261 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.5 ttp -62.34 -40.18 95.52 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 98.0 mt -62.05 -46.4 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.646 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 9.5 m120 -62.38 -42.38 99.37 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.679 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.73 -55.62 32.05 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.167 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 p -69.87 -34.89 62.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 120.894 0.378 . . . . 0.0 111.089 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.9 t0 -82.89 -13.45 56.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.404 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.646 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.08 8.92 1.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.819 0.342 . . . . 0.0 110.179 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 12.6 p30 -61.6 -25.09 67.12 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -157.83 -19.98 0.03 OUTLIER Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.619 ' C ' ' H ' ' A' ' 62' ' ' THR . 5.1 p30 177.07 141.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.73 32.24 0.08 OUTLIER Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.619 ' H ' ' C ' ' A' ' 60' ' ' ASN . 63.8 p -130.3 150.12 51.68 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-O 120.983 0.42 . . . . 0.0 110.266 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.6 mt -117.05 138.97 45.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.145 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.56 166.16 19.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.381 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.432 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -62.93 -50.55 76.52 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.756 -179.138 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.5 Cg_exo -50.89 -44.95 38.82 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.999 1.799 . . . . 0.0 111.788 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.94 -36.27 72.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.984 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -60.07 -45.83 91.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.194 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.08 -44.59 95.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.561 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.2 m -67.36 -44.39 79.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.27 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.9 ttp -61.47 -40.14 93.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.02 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 76.0 mmm -63.02 -38.58 91.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.805 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.11 96.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.008 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -68.43 -45.56 72.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.081 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.57 -41.79 83.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.976 0.417 . . . . 0.0 110.36 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.8 mmt -86.93 164.42 16.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.137 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -116.2 153.55 31.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.954 0.406 . . . . 0.0 110.154 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -59.26 160.44 6.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.31 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.6 p -64.14 -30.04 71.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.571 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -64.42 -10.04 22.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.182 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -57.08 -32.78 66.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.535 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -49.49 -50.23 42.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.712 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.02 -41.9 94.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.038 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -66.31 -45.71 79.4 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.469 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.4 mt -64.91 -20.61 27.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -59.67 -42.23 92.41 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.245 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -61.49 -35.89 78.94 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.468 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.13 -13.42 60.47 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -47.98 -51.1 25.13 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.013 0.435 . . . . 0.0 111.421 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -59.76 -46.82 87.97 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.822 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.87 -44.35 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.979 0.418 . . . . 0.0 110.451 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -59.44 -44.35 92.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.573 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 33.0 t70 -138.9 100.65 4.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.267 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.07 -39.98 82.83 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.209 0.528 . . . . 0.0 110.154 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.2 p-10 -60.18 -42.61 95.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.286 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.71 -56.98 0.51 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -70.69 -13.68 62.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.156 0.503 . . . . 0.0 110.286 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.63 161.12 12.87 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -115.04 150.93 35.11 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.5 mt -85.24 123.18 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.999 0.428 . . . . 0.0 110.375 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.2 p -80.01 168.12 19.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.049 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.3 -36.44 82.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.615 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.18 -45.24 94.26 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.082 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -70.08 -37.66 75.51 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.192 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.2 tp -62.0 -42.86 99.61 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.23 0.538 . . . . 0.0 111.248 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -52.62 -43.23 65.26 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.02 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -55.39 -42.73 74.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.914 0.388 . . . . 0.0 110.231 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.5 t -64.63 -42.44 95.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.259 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 58.3 mmm -57.56 -34.75 69.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.461 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.1 m -60.26 -42.37 95.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.37 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -58.57 -38.73 78.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.9 tp -61.35 -46.29 90.83 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 120.952 0.406 . . . . 0.0 110.126 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.9 -154.91 26.0 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -143.29 11.89 1.75 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.703 -0.249 . . . . 0.0 110.759 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -63.97 -43.99 94.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.114 0.483 . . . . 0.0 110.612 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.4 mt -79.77 160.3 26.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.99 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.475 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.6 OUTLIER -68.46 161.7 27.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.245 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -92.37 -21.07 20.45 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.063 0.458 . . . . 0.0 110.404 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -85.43 -26.93 26.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.234 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.59 -63.57 0.34 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -178.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.61 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 11.3 m -69.1 -31.35 49.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.457 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -58.86 -67.15 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.721 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.56 -45.19 72.75 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.519 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 13.3 tmm? -52.85 -50.27 64.1 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.419 HG22 ' O ' ' A' ' 125' ' ' ILE . 95.9 mt -64.6 -18.4 23.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.655 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -87.92 -57.86 2.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.306 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 128' ' ' ALA . 51.0 tp10 -81.96 -67.79 0.75 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.248 -178.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.81 ' HB2' ' O ' ' A' ' 39' ' ' LEU . . . -36.77 -35.64 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 56.7 t0 -87.69 146.15 25.82 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.258 0.551 . . . . 0.0 110.576 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.566 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -89.36 -15.02 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.778 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 133' ' ' ASP . 44.9 m-20 -73.54 -45.29 54.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.994 0.426 . . . . 0.0 110.427 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.39 -10.3 3.75 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 131' ' ' ASP . 35.2 p30 -89.88 -10.4 45.39 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.816 0.341 . . . . 0.0 110.172 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 62.18 122.99 0.01 OUTLIER Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -161.69 119.65 2.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.913 0.387 . . . . 0.0 110.08 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.65 128.91 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.128 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.525 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 45.3 t30 -155.07 166.26 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.064 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.4 ' O ' ' CD1' ' A' ' 138' ' ' TYR . 2.6 t80 -48.79 -23.04 0.93 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.444 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.539 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 50.1 mp0 -66.42 -35.75 81.08 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.151 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -84.95 -20.83 30.0 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.633 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.04 -46.68 88.1 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.141 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 29.8 t -58.28 -46.0 89.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.028 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -71.33 -36.12 71.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.305 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 61.5 ttp -57.99 -43.04 86.36 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.193 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 70.7 mtm -112.85 129.26 56.51 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.85 0.357 . . . . 0.0 110.328 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.6 m -162.78 85.82 0.55 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.064 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.15 -43.81 94.05 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.675 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.516 179.834 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.067 0 CA-C-O 120.586 0.231 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -47.63 -48.63 28.53 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.118 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -59.48 -44.87 92.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.83 0.347 . . . . 0.0 110.442 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -63.37 -39.68 95.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.693 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.31 -41.3 85.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.824 0.345 . . . . 0.0 111.158 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.47 -22.69 66.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.829 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -55.57 -47.89 75.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.2 m -81.37 -17.2 49.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.553 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.96 -43.72 98.03 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.423 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.417 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.5 m-85 -60.52 -50.36 73.86 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.553 -178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.3 t0 -77.13 -14.56 59.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.188 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -45.11 -32.91 1.95 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.209 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.449 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 18.0 p-10 -54.73 -45.99 74.19 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.824 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -144.04 -151.1 5.38 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 32.2 p-10 -73.06 -47.08 47.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.675 0.274 . . . . 0.0 110.772 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.73 107.31 0.28 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.427 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 4.9 m -166.24 142.77 5.0 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.745 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.02 103.46 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.405 HG22 HG22 ' A' ' 62' ' ' THR . 2.9 p -123.14 169.93 10.73 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.091 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.606 ' CB ' HE22 ' A' ' 49' ' ' GLN . 60.2 p -63.1 -35.35 79.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.833 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -60.34 -38.48 83.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.449 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 87.7 mt-10 -65.59 -43.12 90.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.097 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.76 -41.9 97.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.227 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.82 -28.67 17.21 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.1 m -64.58 -44.15 91.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 0.0 110.762 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.2 t -57.09 -17.6 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.194 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.543 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 87.6 mmm -53.01 -38.58 62.44 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.199 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.6 ttt85 -64.27 -46.04 85.44 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 117.412 -1.715 . . . . 0.0 110.668 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 93.5 p -63.4 -19.9 65.08 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.553 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.882 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 52.5 mt -99.64 6.16 45.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.882 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 34.8 94.62 0.01 OUTLIER Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 40' ' ' GLY . 84.1 mt-30 52.3 110.1 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.599 0.238 . . . . 0.0 110.418 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 44' ' ' THR . 49.9 t30 -145.71 63.94 9.9 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.701 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 46' ' ' ALA . 88.7 Cg_exo -34.71 -30.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.56 2.173 . . . . 0.0 112.32 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.498 ' N ' ' O ' ' A' ' 42' ' ' ASN . 23.4 m -40.14 -29.51 0.08 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.123 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.543 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 90.7 mt-10 -89.73 -29.89 18.41 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.763 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -60.83 -49.15 78.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.82 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.47 ' HB2' HG23 ' A' ' 117' ' ' THR . 2.2 tm-20 -72.17 -43.18 64.99 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.296 0.569 . . . . 0.0 109.755 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.591 HD21 HD21 ' A' ' 116' ' ' LEU . 96.3 mt -68.0 -25.05 65.22 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.212 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.606 HE22 ' CB ' ' A' ' 29' ' ' THR . 53.7 tp60 -40.85 -41.86 1.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.0 110.582 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -77.7 -36.75 50.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.492 ' CE ' HD22 ' A' ' 48' ' ' LEU . 32.5 ttp -59.98 -37.3 79.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.628 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.589 HG21 HG22 ' A' ' 29' ' ' THR . 96.8 mt -63.5 -44.78 98.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.043 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.675 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 19.5 m120 -62.57 -39.86 95.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.342 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -56.62 -56.44 21.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.273 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.471 HG13 ' N ' ' A' ' 56' ' ' ASP . 15.0 p -74.14 -40.32 51.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.883 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.504 ' OD2' ' N ' ' A' ' 62' ' ' THR . 44.4 t0 -71.18 -13.3 61.88 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.52 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.675 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.25 8.97 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.099 0.476 . . . . 0.0 110.346 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 56' ' ' ASP . 10.3 p-10 -59.73 -26.72 65.88 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -155.08 -24.42 0.03 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.549 ' C ' ' H ' ' A' ' 62' ' ' THR . 10.0 p30 176.15 151.17 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.29 36.32 0.09 OUTLIER Glycine 0 CA--C 1.535 1.306 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.549 ' H ' ' C ' ' A' ' 60' ' ' ASN . 44.2 p -137.38 153.34 50.21 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.5 mt -127.43 137.02 58.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.972 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -81.21 164.55 22.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.083 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.427 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -62.07 -50.13 81.87 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.232 -179.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.5 Cg_exo -50.12 -41.74 48.44 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.08 1.853 . . . . 0.0 112.046 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -80.77 -29.79 36.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.118 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -59.48 -45.07 92.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.989 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.42 -43.14 99.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.305 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.9 m -64.36 -44.92 89.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.869 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 46.9 ttp -60.08 -44.66 94.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.855 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 79.4 mmm -63.82 -40.86 97.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.266 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.408 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -61.27 -47.77 84.51 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.957 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -71.27 -46.28 61.29 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.458 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -66.72 -45.28 79.2 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.927 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.408 ' O ' ' O ' ' A' ' 73' ' ' ALA . 17.8 mmm -99.5 -176.68 3.35 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.054 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -128.51 152.15 48.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.153 0.501 . . . . 0.0 110.169 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -54.21 177.66 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.341 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.3 p -80.47 -15.81 55.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.582 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -66.38 -13.65 60.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.395 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 83' ' ' GLU . 72.7 m -53.38 -34.27 57.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.601 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -39.08 -28.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.381 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 81' ' ' SER . 75.8 mm-40 -85.35 -54.79 4.37 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.042 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -58.56 -36.29 73.69 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.905 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.427 ' O ' HG22 ' A' ' 85' ' ' ILE . 96.6 mt -63.55 -20.04 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -61.0 -45.09 96.24 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 118.409 -1.316 . . . . 0.0 109.588 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -64.61 -21.8 66.81 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.189 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.4 -17.54 48.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.439 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -57.01 -50.19 73.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.376 0.607 . . . . 0.0 110.572 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -68.62 -44.95 73.16 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.864 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.6 t -65.32 -49.07 80.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.069 0.462 . . . . 0.0 110.022 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.683 ' CE2' HD12 ' A' ' 100' ' ' ILE . 51.6 t80 -62.59 -45.19 94.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.905 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.411 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 22.2 t0 -120.53 104.52 10.03 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.119 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -66.36 -41.22 89.82 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.029 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -70.39 -41.66 72.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.063 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.89 -52.98 0.74 Allowed Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -64.02 -20.08 65.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.934 0.397 . . . . 0.0 110.297 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.411 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.66 161.01 12.9 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -113.34 148.31 35.96 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.683 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -84.96 123.62 39.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.9 p -87.35 176.7 7.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.122 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.64 -36.49 83.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.963 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.57 -51.35 69.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.878 0.371 . . . . 0.0 110.977 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.39 -30.54 66.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 49.4 tp -61.69 -41.04 97.04 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.23 0.538 . . . . 0.0 111.106 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -54.22 -41.49 68.73 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.881 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -57.92 -42.69 85.33 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.3 t -65.57 -43.2 94.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.668 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 91.6 mmm -62.55 -37.23 85.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.476 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.8 m -59.43 -40.48 86.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.657 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -58.6 -38.73 78.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.724 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.0 tp -61.01 -45.1 96.2 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.547 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.09 -145.3 12.03 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -143.6 16.38 1.82 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.761 0.315 . . . . 0.0 110.679 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -61.86 -44.91 95.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.997 0.427 . . . . 0.0 110.468 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.591 HD21 HD21 ' A' ' 48' ' ' LEU . 82.8 mt -82.08 161.34 22.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.966 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.474 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -66.02 161.7 21.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.653 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -91.63 -19.62 22.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.866 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -87.67 -28.14 22.01 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.622 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.32 -66.85 0.17 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.622 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.4 m -64.05 -39.33 85.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 111.909 0.336 . . . . 0.0 111.909 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.469 ' N ' HG23 ' A' ' 121' ' ' VAL . 84.8 m-20 -54.27 -65.91 0.49 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.676 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 127' ' ' GLU . 80.6 mm-40 -70.42 -44.93 66.89 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.661 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 18.9 tmm? -53.0 -47.62 68.13 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 120.486 -0.486 . . . . 0.0 109.879 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.403 ' O ' HG22 ' A' ' 125' ' ' ILE . 97.7 mt -67.19 -19.73 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.356 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -91.24 -66.84 0.89 Allowed 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.984 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 123' ' ' GLU . 24.9 tp10 -65.24 -68.53 0.36 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.21 -177.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.882 ' HB2' ' O ' ' A' ' 39' ' ' LEU . . . -37.21 -37.67 0.18 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.48 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 66.0 t0 -87.5 138.23 31.65 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.207 0.527 . . . . 0.0 110.591 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.59 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -85.8 -16.09 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.335 -179.7 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -73.08 -46.54 50.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.121 0.486 . . . . 0.0 110.141 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.96 -2.59 54.92 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 52.1 p30 -88.67 -22.3 23.49 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 64.6 103.72 0.01 OUTLIER Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -147.77 140.77 24.95 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.784 0.326 . . . . 0.0 110.158 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.2 t -128.93 134.32 64.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.314 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.527 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 53.3 t30 -151.57 -179.09 7.11 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.624 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -57.28 -48.15 79.63 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.267 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.527 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 55.9 mp0 -50.91 -43.66 59.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.352 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -67.69 -39.82 84.42 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.91 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -60.72 -43.65 97.61 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.598 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.3 t -54.19 -43.89 62.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.345 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -84.25 -19.38 33.99 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.064 -0.255 . . . . 0.0 111.223 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 41.1 ttp -65.07 -41.3 95.2 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.949 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 51.7 mtm -103.67 132.68 49.71 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.847 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.4 m -166.83 81.77 0.24 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.061 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.8 -37.19 75.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.342 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.1 mttm . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.458 179.948 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.883 0.373 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -51.5 -43.22 62.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.748 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -66.94 -46.38 74.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.874 0.368 . . . . 0.0 111.03 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -61.62 -44.81 96.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.792 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -67.96 -40.96 83.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.628 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.13 -28.42 67.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.022 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -55.58 -45.84 77.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.673 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.7 m -81.61 -17.83 46.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.723 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.7 tp -65.51 -42.36 92.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.918 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.403 ' O ' ' CD ' ' A' ' 31' ' ' GLU . 73.3 m-85 -61.06 -45.95 92.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.309 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 4.7 t0 -81.93 -15.66 53.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.357 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -42.82 -32.5 0.62 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.114 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.433 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 9.2 p-10 -53.67 -46.7 70.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.896 0.379 . . . . 0.0 110.712 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.433 ' N ' ' CG ' ' A' ' 22' ' ' ASP . . . -145.67 -147.33 4.58 Favored Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 20.5 p-10 -76.46 -47.57 22.51 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.898 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.01 106.97 0.27 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 95.7 m -166.72 143.13 4.64 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.968 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.05 117.06 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.849 0.357 . . . . 0.0 110.113 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.691 HG22 HG22 ' A' ' 62' ' ' THR . 12.4 p -133.38 165.57 24.52 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.403 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.538 ' CB ' HE22 ' A' ' 49' ' ' GLN . 79.9 p -63.02 -35.13 79.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.33 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -61.26 -38.58 87.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.021 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.413 ' OE2' ' CG ' ' A' ' 22' ' ' ASP . 91.3 mt-10 -64.62 -49.13 72.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.359 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.37 -43.65 98.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.182 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.2 -23.94 4.47 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.3 m -64.9 -42.51 94.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.914 0.388 . . . . 0.0 110.545 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.3 t -54.59 -16.3 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.219 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.452 ' O ' ' N ' ' A' ' 40' ' ' GLY . 53.4 mmm -58.73 -37.27 75.8 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -62.48 -46.13 89.89 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 116.727 -1.989 . . . . 0.0 110.618 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.7 p -60.12 -36.17 76.88 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.034 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 41' ' ' GLN . 44.7 mt -95.87 2.08 53.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.701 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 66.2 -66.44 0.15 Allowed Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 39' ' ' LEU . 74.6 mt-30 -141.66 122.77 14.67 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.3 t-20 -141.5 71.15 26.19 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.636 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 46' ' ' ALA . 73.1 Cg_exo -37.42 -30.45 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.222 1.948 . . . . 0.0 112.136 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 42' ' ' ASN . 25.1 m -39.04 -27.62 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.488 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 49' ' ' GLN . 86.7 mt-10 -90.31 -36.92 14.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.011 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -56.27 -48.88 75.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.411 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -70.5 -45.08 66.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.289 0.566 . . . . 0.0 110.071 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.521 HD21 HD22 ' A' ' 116' ' ' LEU . 96.0 mt -70.08 -20.05 63.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.82 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.538 HE22 ' CB ' ' A' ' 29' ' ' THR . 67.3 tp60 -46.48 -46.22 18.84 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.608 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -75.06 -35.29 61.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.242 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.433 ' CE ' HD22 ' A' ' 48' ' ' LEU . 33.2 ttp -63.71 -43.03 97.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.016 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 96.7 mt -62.76 -46.21 96.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.753 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.697 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 24.1 m120 -64.65 -40.7 95.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.766 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -60.08 -56.84 16.72 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.42 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 56' ' ' ASP . 11.3 p -69.68 -37.01 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.016 0.436 . . . . 0.0 110.94 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.549 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.5 t0 -79.06 -12.6 60.02 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.446 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.697 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.15 15.43 0.16 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.314 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 10.5 p30 -65.76 -21.87 66.54 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.412 ' H ' ' H ' ' A' ' 60' ' ' ASN . . . -167.82 -9.56 0.03 OUTLIER Glycine 0 C--N 1.333 0.4 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.576 ' C ' ' H ' ' A' ' 62' ' ' THR . 1.9 p30 169.42 140.58 0.02 OUTLIER 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.02 35.77 0.11 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.691 HG22 HG22 ' A' ' 28' ' ' THR . 69.5 p -135.94 155.0 50.93 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 90.9 mt -130.13 132.02 65.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.213 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.14 151.99 42.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.627 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.442 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -54.83 -51.24 80.75 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.778 -179.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 52.1 Cg_exo -49.17 -49.84 14.36 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.855 1.704 . . . . 0.0 112.059 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -68.56 -33.66 74.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.465 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -61.94 -43.82 98.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.96 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.8 mt -59.2 -45.58 90.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.753 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.3 m -63.83 -44.73 92.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.543 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 36.3 ttp -59.99 -45.34 93.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.578 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.3 mmm -64.64 -39.41 93.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.534 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.34 -39.05 78.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.743 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -77.92 -51.47 10.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.383 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -65.56 -44.27 87.27 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.498 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.2 mmm -99.74 126.46 45.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.348 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -86.76 143.89 27.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.537 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 80' ' ' ASP . 97.2 m-20 -49.35 158.58 0.38 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.418 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 35.8 p -54.9 -8.74 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.643 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 78' ' ' ASP . 80.3 m-20 -67.11 -8.64 32.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.156 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.6 m -59.4 -29.51 67.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.688 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -37.85 -49.21 1.19 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.839 0.352 . . . . 0.0 110.994 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.73 -55.02 19.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.872 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -59.68 -32.31 70.38 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.055 0.455 . . . . 0.0 110.622 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 85' ' ' ILE . 83.0 mt -69.23 -15.07 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.998 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -59.71 -48.93 79.71 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 117.546 -1.662 . . . . 0.0 110.395 -177.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.21 -32.55 74.28 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.471 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.66 -36.04 73.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.731 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -50.58 -51.12 51.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.324 0.583 . . . . 0.0 110.928 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -69.3 -44.4 71.85 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.32 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.16 -51.44 48.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.132 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.555 ' CE2' HD12 ' A' ' 100' ' ' ILE . 66.8 t80 -63.44 -47.42 81.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.389 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.463 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 17.9 t0 -107.83 105.33 15.1 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.131 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -71.67 -44.88 63.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.664 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 45.2 p-10 -67.07 -33.62 75.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.137 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.529 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 66.52 -74.87 0.15 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -53.66 -13.09 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.876 0.369 . . . . 0.0 110.343 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.422 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.52 161.77 12.67 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -112.34 155.91 23.34 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.555 HD12 ' CE2' ' A' ' 92' ' ' PHE . 94.6 mt -99.79 117.47 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.749 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.6 p -82.15 175.68 10.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.123 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.91 -37.06 85.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.838 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.54 -52.44 64.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.785 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -67.66 -31.18 70.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.67 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.1 tp -64.2 -41.35 97.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.451 0.644 . . . . 0.0 110.975 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -53.9 -39.2 65.57 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.002 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -63.83 -41.17 97.9 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.1 t -64.17 -42.66 96.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.44 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 54.0 mmm -62.4 -40.75 97.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.983 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.8 m -61.74 -40.22 94.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.564 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -58.82 -40.55 84.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.616 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.9 tp -61.33 -44.25 97.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.946 0.403 . . . . 0.0 110.528 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 161.85 -151.91 22.17 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -138.34 29.22 2.46 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.794 0.33 . . . . 0.0 110.619 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -67.46 -45.32 76.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.793 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.521 HD22 HD21 ' A' ' 48' ' ' LEU . 19.7 mt -100.68 166.94 10.63 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.853 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.52 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -69.49 161.57 29.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.188 -179.564 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -92.69 -21.54 19.94 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.902 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -87.41 -23.6 24.47 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.635 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -35.1 -68.08 0.13 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.603 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.521 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 9.8 m -63.87 -42.15 94.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.517 ' N ' HG23 ' A' ' 121' ' ' VAL . 87.6 m-20 -48.3 -67.06 0.3 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.752 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.459 ' O ' ' OE1' ' A' ' 127' ' ' GLU . 80.3 mm-40 -70.44 -40.02 74.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.404 ' SD ' ' C ' ' A' ' 124' ' ' MET . 17.7 tmm? -57.22 -38.94 74.49 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.684 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.9 mt -77.89 -23.79 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.929 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -77.5 -46.93 20.9 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 118.682 -1.207 . . . . 0.0 111.698 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 123' ' ' GLU . 19.6 mp0 -80.08 -68.45 0.67 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.667 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.56 -48.9 1.04 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.69 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -88.51 131.07 35.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.901 0.381 . . . . 0.0 110.27 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.549 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -82.3 -10.7 12.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.129 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 133' ' ' ASP . 89.2 m-20 -64.39 -40.42 95.76 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.099 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.65 -8.4 4.32 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 134' ' ' GLY . 26.2 p-10 -88.32 -12.72 42.65 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 39.36 98.06 0.01 OUTLIER Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 13.3 pt20 -131.06 136.94 48.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.056 0.455 . . . . 0.0 110.311 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.0 t -115.29 134.82 57.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.097 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.515 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 53.1 t30 -152.64 176.74 11.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.605 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -58.84 -48.02 82.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.339 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.515 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 58.0 mp0 -57.42 -25.53 59.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.295 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 81.2 mt-10 -84.87 -33.64 22.78 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.08 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -65.72 -46.89 77.24 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.654 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 50.3 t -56.26 -44.57 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 120.792 0.33 . . . . 0.0 110.22 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -71.56 -38.05 71.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.202 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 50.2 ttp -60.43 -48.59 81.08 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.306 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 49.1 mtm -88.61 120.77 30.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.928 0.394 . . . . 0.0 110.782 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.0 m -165.77 99.14 0.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.729 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.94 -38.33 88.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.584 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.8 mttm . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.531 179.938 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.037 0 CA-C-O 120.598 0.237 . . . . 0.0 111.301 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -54.64 -48.25 72.5 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.556 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -65.74 -40.79 92.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.837 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -61.99 -44.1 97.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.633 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -66.99 -37.54 84.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.988 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.479 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.06 -27.9 65.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.803 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -57.83 -46.94 84.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.533 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.8 m -77.9 -21.5 51.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.65 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.36 -42.82 99.7 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.444 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.2 m-85 -60.21 -50.92 71.74 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.476 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.1 t0 -77.01 -14.26 59.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.83 0.347 . . . . 0.0 111.315 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -45.61 -32.69 2.45 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.831 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 8.8 p-10 -53.72 -46.11 70.69 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.557 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -144.34 -151.61 5.48 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 30.8 p-10 -72.95 -47.24 47.23 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.068 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.525 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.71 107.38 0.28 Allowed Glycine 0 CA--C 1.521 0.452 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.425 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 4.6 m -166.63 139.23 3.7 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.121 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 27' ' ' ILE . 5.2 mp -115.02 109.18 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.593 HG22 HG22 ' A' ' 62' ' ' THR . 2.6 p -128.65 170.32 13.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.824 0.345 . . . . 0.0 110.447 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.638 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.0 p -64.74 -33.05 75.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.801 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -61.63 -41.42 97.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.935 0.397 . . . . 0.0 109.998 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.425 ' OE1' ' O ' ' A' ' 26' ' ' THR . 90.1 mt-10 -63.45 -45.68 89.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.856 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.0 tp -64.2 -43.29 95.49 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.115 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.78 -26.16 53.42 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.2 m -63.87 -41.42 97.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.858 0.361 . . . . 0.0 110.143 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.3 t -56.18 -23.62 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.333 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.479 ' O ' ' N ' ' A' ' 40' ' ' GLY . 62.1 mmm -48.06 -30.33 4.33 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.721 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -64.34 -45.61 87.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 118.042 -1.463 . . . . 0.0 111.049 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 77.9 p -63.98 -21.95 66.71 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.136 -0.625 . . . . 0.0 109.808 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 41' ' ' GLN . 16.9 mt -107.8 3.75 24.79 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.04 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.16 -71.21 0.02 OUTLIER Glycine 0 N--CA 1.465 0.592 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 39' ' ' LEU . 87.8 mt-30 -145.45 109.46 4.83 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 44' ' ' THR . 41.4 t30 -125.59 70.93 65.52 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.12 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.551 ' O ' ' N ' ' A' ' 46' ' ' ALA . 85.3 Cg_exo -33.04 -30.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.595 2.196 . . . . 0.0 112.808 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 42' ' ' ASN . 26.2 m -39.31 -30.19 0.06 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.543 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.417 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.9 mt-10 -86.64 -34.88 19.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.305 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -59.04 -50.04 75.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.821 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.15 -46.21 71.4 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 51' ' ' MET . 84.6 mt -64.79 -31.03 72.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.4 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.638 HE22 ' CB ' ' A' ' 29' ' ' THR . 61.1 tp60 -37.62 -51.2 1.19 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.732 0.301 . . . . 0.0 110.769 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.3 -40.34 89.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.232 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' LEU . 33.1 ttp -62.38 -41.05 98.33 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.981 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 83.9 mt -62.0 -49.95 82.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.114 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.61 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 89.9 m-20 -62.89 -40.46 97.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.582 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -55.17 -61.5 2.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.206 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.93 -30.12 43.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.804 0.335 . . . . 0.0 111.241 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 62' ' ' THR . 50.7 t0 -84.71 -13.24 51.97 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.513 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -71.94 13.05 0.32 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.926 0.394 . . . . 0.0 110.339 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.8 p30 -65.56 -28.89 69.48 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.535 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -150.49 -22.49 0.06 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.558 ' C ' ' H ' ' A' ' 62' ' ' THR . 3.3 p30 173.19 151.88 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.95 34.7 0.14 Allowed Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.593 HG22 HG22 ' A' ' 28' ' ' THR . 81.9 p -134.37 149.45 50.83 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.4 mt -120.99 134.52 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.933 0.397 . . . . 0.0 109.942 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.16 162.43 28.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.416 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.472 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -64.68 -48.05 74.37 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.467 -179.051 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 50.6 Cg_exo -51.28 -37.36 59.73 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.167 1.911 . . . . 0.0 111.692 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -87.55 -22.32 24.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.78 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.45 -47.11 87.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.021 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.54 -42.88 98.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.517 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 78.7 m -63.97 -46.09 86.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.648 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.7 ttp -61.71 -47.5 85.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.066 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.9 mmm -65.87 -37.76 87.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.265 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.61 -49.96 75.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.039 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -71.51 -43.8 65.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.159 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.72 -43.59 88.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.764 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.432 ' O ' ' O ' ' A' ' 73' ' ' ALA . 22.3 mmm -104.27 127.47 51.91 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.116 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.7 tptt -84.97 141.14 30.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.874 0.368 . . . . 0.0 110.748 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' LYS . 95.0 m-20 -48.87 179.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.262 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.5 p -75.51 -6.74 51.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.437 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.48 -15.52 62.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.545 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.9 m -61.89 -19.92 63.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.549 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -48.19 -44.69 32.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.358 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.96 -39.56 79.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.9 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.87 -45.12 83.25 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.989 0.423 . . . . 0.0 110.202 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.5 mt -66.12 -19.04 25.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.472 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -58.41 -45.44 88.4 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 118.97 -1.092 . . . . 0.0 110.19 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -65.56 -31.88 73.17 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.948 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.412 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -72.03 -14.64 61.93 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.185 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -57.98 -49.0 78.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.244 0.545 . . . . 0.0 111.061 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -64.09 -45.6 87.98 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.316 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -76.18 -51.54 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 0.0 110.908 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.442 ' CE2' HD12 ' A' ' 100' ' ' ILE . 26.2 t80 -61.99 -47.19 85.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.62 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.427 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 18.2 t70 -108.95 94.15 4.89 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.22 -40.97 74.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.965 0.412 . . . . 0.0 110.553 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 19.8 p-10 -62.61 -39.65 94.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.976 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.44 -67.3 0.97 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.58 -16.56 63.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.022 0.439 . . . . 0.0 110.247 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.76 162.04 12.56 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.23 155.39 24.09 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.713 0.292 . . . . 0.0 110.258 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.442 HD12 ' CE2' ' A' ' 92' ' ' PHE . 94.1 mt -79.75 126.02 39.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.938 0.399 . . . . 0.0 110.988 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.3 p -82.36 168.95 17.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.196 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.04 89.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.51 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.63 -47.38 84.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.863 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.67 -32.87 73.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.6 tp -61.58 -41.63 97.68 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.41 0.624 . . . . 0.0 110.712 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -56.46 -43.35 79.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.8 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -58.5 -41.88 86.35 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.67 -43.4 90.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.624 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.0 mmm -61.99 -35.68 79.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.605 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.6 m -61.04 -44.43 97.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.044 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -59.76 -34.98 73.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.376 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.0 tp -61.17 -46.73 89.31 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.051 0.453 . . . . 0.0 110.36 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.5 -160.74 33.47 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -140.51 23.35 2.32 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.64 0.257 . . . . 0.0 110.828 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -63.65 -42.8 98.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.963 0.411 . . . . 0.0 110.269 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.3 mt -92.84 175.79 6.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.006 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.469 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -72.83 161.29 30.91 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.695 179.844 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -91.66 -22.46 20.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.946 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -87.89 -25.37 23.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.126 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.64 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.4 -61.27 0.45 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.086 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.64 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 20.2 m -67.33 -40.2 84.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.492 ' N ' HG23 ' A' ' 121' ' ' VAL . 81.2 m-20 -56.81 -47.06 81.1 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.52 -178.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -86.01 -40.32 15.92 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.7 tmm? -59.51 -46.51 88.61 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.094 0.473 . . . . 0.0 109.956 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 125' ' ' ILE . 91.5 mt -69.15 -16.56 20.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.413 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -78.61 -50.56 11.29 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 119.389 -0.924 . . . . 0.0 112.13 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' ASP . 42.3 tp10 -87.61 -67.51 0.82 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.888 -178.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.43 -25.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.763 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' GLU . 25.4 t0 -88.06 128.26 35.41 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.062 0.458 . . . . 0.0 111.056 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.668 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.46 -43.45 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.416 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -65.27 -40.4 93.86 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.136 0.493 . . . . 0.0 110.185 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.4 -2.03 58.94 Favored Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' GLY . 55.2 p-10 -89.44 -9.0 51.8 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 57.46 115.49 0.01 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.435 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 20.3 pt20 -160.69 133.6 6.44 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.46 136.92 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.056 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -151.36 172.43 15.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.23 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -54.78 -46.83 74.47 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.096 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 139' ' ' GLU . 55.3 mp0 -58.64 -44.35 90.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.709 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 93.4 mt-10 -72.05 -29.4 64.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.727 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.92 -43.91 77.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.605 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 93.8 t -59.22 -46.23 92.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.312 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.38 -29.1 66.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.128 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.7 ttp -59.71 -42.81 93.9 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.853 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.49 138.82 50.63 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.961 0.41 . . . . 0.0 110.756 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 81.9 m -163.22 77.77 0.43 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.671 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.15 -27.76 68.95 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.464 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.222 -0.391 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.624 -179.857 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.219 0 CA-C-O 120.75 0.31 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -54.22 -42.27 69.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.096 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -67.84 -41.73 82.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.34 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -62.62 -43.76 97.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.914 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -67.19 -35.71 80.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.431 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.413 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.57 -24.11 66.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.699 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -55.45 -46.46 76.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.783 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.4 m -80.66 -19.54 45.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.756 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.16 -41.95 96.95 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.013 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.42 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.1 m-85 -58.84 -46.11 88.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.831 0.348 . . . . 0.0 111.115 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.448 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.3 t0 -79.56 -13.49 59.5 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.468 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -42.97 -32.87 0.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.821 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.451 ' CG ' ' OE2' ' A' ' 31' ' ' GLU . 10.9 p-10 -52.93 -45.1 67.48 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.447 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.433 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . -149.68 -151.3 5.47 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 21.2 p-10 -71.1 -46.9 60.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.759 0.314 . . . . 0.0 111.009 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.534 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.02 107.4 0.28 Allowed Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.592 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.7 m -166.6 136.2 3.08 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.188 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.608 HD12 ' N ' ' A' ' 27' ' ' ILE . 1.9 mp -110.55 118.33 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.457 HG22 HG22 ' A' ' 62' ' ' THR . 2.0 p -134.78 167.04 21.59 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.863 0.363 . . . . 0.0 110.327 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.538 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.3 p -64.12 -33.64 76.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.296 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -62.51 -40.22 96.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.691 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.455 ' OE2' ' O ' ' A' ' 26' ' ' THR . 89.0 mt-10 -64.68 -48.46 74.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.373 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.6 tp -64.44 -43.72 93.42 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.296 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.29 -24.73 17.07 Favored Glycine 0 C--O 1.224 -0.487 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -64.09 -40.99 97.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.863 0.363 . . . . 0.0 110.197 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.3 t -57.05 -22.45 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.276 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.7 mmm -48.79 -33.53 10.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.992 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -64.33 -45.51 87.55 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 118.219 -1.392 . . . . 0.0 110.241 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.3 p -58.96 -30.68 68.09 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.367 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 41' ' ' GLN . 9.2 mt -102.34 5.47 39.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.99 0.424 . . . . 0.0 110.492 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.31 -69.83 0.03 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 39' ' ' LEU . 85.8 mt-30 -143.27 116.21 8.82 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.1 t30 -132.61 69.71 79.55 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.934 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 46' ' ' ALA . 90.7 Cg_exo -32.98 -33.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.541 2.16 . . . . 0.0 112.463 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 42' ' ' ASN . 12.6 m -39.0 -29.35 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.398 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 43' ' ' PRO . 90.6 mt-10 -87.69 -35.21 18.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.449 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -61.22 -49.22 78.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.998 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.437 ' HB2' HG23 ' A' ' 117' ' ' THR . 3.1 tm-20 -68.01 -48.6 65.27 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.437 0.637 . . . . 0.0 109.89 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.511 HD22 ' CE ' ' A' ' 51' ' ' MET . 87.2 mt -62.65 -22.75 66.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.012 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.538 HE22 ' CB ' ' A' ' 29' ' ' THR . 47.9 tp60 -40.25 -49.56 2.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.877 0.37 . . . . 0.0 110.519 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.69 -39.78 73.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.483 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.511 ' CE ' HD22 ' A' ' 48' ' ' LEU . 36.1 ttp -61.62 -40.54 95.21 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.73 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.85 -46.83 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.624 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.655 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 28.2 m120 -65.19 -39.83 93.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.342 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -58.1 -57.24 13.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.443 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.4 p -68.3 -32.83 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.949 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 62' ' ' THR . 42.9 t0 -86.02 -13.12 48.45 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.768 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.05 15.46 0.16 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.07 -179.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 56' ' ' ASP . 38.7 p-10 -66.75 -23.5 66.1 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.41 -22.54 0.03 OUTLIER Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.591 ' C ' ' H ' ' A' ' 62' ' ' THR . 4.6 p30 179.35 146.5 0.19 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.72 33.71 0.17 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.591 ' H ' ' C ' ' A' ' 60' ' ' ASN . 80.8 p -132.17 143.94 50.33 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.93 135.11 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.999 0.428 . . . . 0.0 110.172 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.39 172.39 4.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.486 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.436 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -72.59 -49.59 8.4 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.759 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 52.5 Cg_exo -52.01 -43.29 53.49 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.833 1.688 . . . . 0.0 111.931 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.45 -37.45 77.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 110.874 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -60.3 -45.45 93.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.967 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.2 mt -62.39 -44.63 95.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.487 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.2 m -67.38 -45.51 76.06 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.757 0.313 . . . . 0.0 111.223 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.4 ttp -61.13 -43.74 98.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.89 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 86.9 mmm -64.76 -39.33 93.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.215 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.91 -42.84 94.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.873 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -71.52 -41.77 68.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.268 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -64.72 -40.94 96.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.887 0.375 . . . . 0.0 110.412 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.434 ' O ' ' O ' ' A' ' 73' ' ' ALA . 14.2 mmt -95.22 129.85 42.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.074 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -86.87 142.82 27.77 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -50.35 168.86 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.414 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.8 p -75.23 -15.2 60.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.647 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.97 -16.49 64.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.424 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 82' ' ' GLU . 1.1 m -60.45 -23.67 64.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.717 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 81' ' ' SER . 81.2 tt0 -36.83 -48.45 0.74 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.62 0.248 . . . . 0.0 110.897 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -70.85 -43.47 68.44 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.181 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.87 -39.59 94.55 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.994 0.426 . . . . 0.0 110.086 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 81.0 mt -66.96 -21.91 28.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.242 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 -58.04 -43.61 86.93 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 119.031 -1.067 . . . . 0.0 110.014 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -63.65 -34.82 78.69 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.851 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.79 -19.9 66.06 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.039 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -56.6 -48.81 76.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.321 0.582 . . . . 0.0 110.838 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -68.23 -44.67 75.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.474 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.8 t -66.34 -48.34 81.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.442 ' CE2' HD12 ' A' ' 100' ' ' ILE . 23.7 t80 -64.04 -47.09 81.57 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.617 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.407 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 18.3 t70 -120.37 100.1 6.96 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -66.63 -39.84 88.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.182 0.515 . . . . 0.0 109.804 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 97' ' ' ASN . 2.0 p-10 -65.58 -40.66 92.97 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.105 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.67 -59.54 0.48 Allowed Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 95' ' ' ASP . 54.0 m-80 -61.78 -17.46 56.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.994 0.426 . . . . 0.0 110.228 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.407 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.55 160.9 12.96 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -113.31 155.57 24.92 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.442 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -95.78 118.27 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.07 0.462 . . . . 0.0 111.108 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.0 p -85.52 171.41 11.77 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.898 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.72 -35.75 78.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.579 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.84 72.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.078 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.28 -37.36 77.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.928 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.02 -39.38 94.58 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.476 0.655 . . . . 0.0 111.07 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -54.24 -43.64 71.07 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.116 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -63.13 -39.47 94.77 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.702 -0.399 . . . . 0.0 109.937 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.1 t -61.84 -45.19 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.176 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 37.7 mmm -64.27 -38.02 89.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.553 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.0 m -60.58 -40.11 90.51 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -61.25 -38.08 85.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.22 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.3 tp -61.65 -44.0 97.8 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.862 0.363 . . . . 0.0 110.249 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.95 -154.71 25.68 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -139.02 23.33 2.6 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.624 -0.288 . . . . 0.0 110.763 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -62.57 -43.25 99.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.069 0.461 . . . . 0.0 110.386 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.402 ' CD2' HD21 ' A' ' 48' ' ' LEU . 29.0 mt -99.91 169.13 9.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.536 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.492 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -68.42 162.14 26.08 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.579 179.761 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -92.09 -22.27 20.0 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.432 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -87.26 -24.48 24.36 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.618 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.57 -66.09 0.21 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.241 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.618 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.7 m -65.17 -35.26 74.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.417 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -60.48 -46.81 88.72 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.586 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -84.85 -40.4 17.16 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.4 tmm? -58.89 -47.24 85.66 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 125' ' ' ILE . 94.4 mt -69.13 -18.32 22.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.6 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -77.4 -51.4 10.87 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 119.016 -1.074 . . . . 0.0 111.317 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 129' ' ' ASP . 34.7 tp10 -86.3 -68.7 0.72 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.492 -177.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.63 -21.54 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 127' ' ' GLU . 38.7 t0 -90.12 125.12 35.33 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.135 0.493 . . . . 0.0 110.625 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.644 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.58 -32.0 56.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.995 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -72.18 -45.83 58.77 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.95 0.405 . . . . 0.0 110.328 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.67 -5.45 61.19 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 134' ' ' GLY . 35.0 p30 -90.0 -9.69 47.75 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 58.26 117.9 0.01 OUTLIER Glycine 0 CA--C 1.519 0.323 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 8.2 pt20 -159.72 140.15 12.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.539 -0.331 . . . . 0.0 110.146 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.6 t -126.24 133.32 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.93 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.542 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.8 t30 -150.76 175.36 12.06 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.305 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -57.66 -52.1 66.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.765 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.542 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 57.3 mp0 -55.9 -35.04 66.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.708 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 79.4 mt-10 -69.51 -39.3 77.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.694 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -61.21 -45.39 94.78 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.0 t -57.94 -45.94 87.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -74.17 -30.83 62.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.442 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.4 ttp -60.07 -40.61 90.13 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.627 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.405 ' O ' ' OG1' ' A' ' 146' ' ' THR . 73.0 mtm -105.25 141.7 36.32 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.905 0.383 . . . . 0.0 110.635 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 145' ' ' MET . 63.0 m -167.23 72.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.146 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.8 97.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.617 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 C--O 1.219 -0.535 0 CA-C-O 118.105 -0.95 . . . . 0.0 110.228 -179.93 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.172 0 N-CA-C 111.487 0.18 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -41.21 -45.84 2.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.771 0.319 . . . . 0.0 110.929 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -66.82 -39.57 87.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.753 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -62.83 -43.12 99.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.539 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.09 -40.82 91.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.766 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.81 -20.33 49.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.654 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -49.43 -47.94 47.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.822 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.5 m -77.69 -20.38 53.74 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.035 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.8 tp -64.06 -40.69 96.83 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.802 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.471 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 76.2 m-85 -57.64 -45.49 85.39 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.339 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 9.7 t0 -86.1 -20.36 28.83 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -44.07 -33.13 1.37 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.821 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.415 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 4.4 p-10 -56.01 -46.12 78.85 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.888 0.375 . . . . 0.0 110.858 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -140.31 -152.62 5.84 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 28.1 p-10 -74.38 -47.1 36.2 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 122.679 -0.307 . . . . 0.0 110.74 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.498 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.72 107.13 0.28 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 6.2 m -166.44 148.82 6.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.123 0.462 . . . . 0.0 111.407 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.71 74.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.508 HG22 HG22 ' A' ' 62' ' ' THR . 9.7 p -86.97 166.16 15.3 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.51 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -66.3 -28.62 68.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.925 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -61.86 -40.19 94.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.961 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.471 ' OE1' ' O ' ' A' ' 19' ' ' PHE . 86.6 mt-10 -66.7 -40.51 88.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.954 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.7 tp -62.82 -43.55 98.5 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.61 -33.19 47.76 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 m -64.6 -44.69 89.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.922 0.361 . . . . 0.0 110.84 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.2 t -55.87 -17.36 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.331 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.542 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 88.9 mmm -52.71 -40.75 63.29 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.745 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.3 ttt85 -64.29 -46.01 85.5 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 118.159 -1.417 . . . . 0.0 110.181 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.0 p -64.33 -19.2 65.29 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.653 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.815 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 36.4 mt -94.4 6.57 48.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.727 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 43.76 78.69 0.07 OUTLIER Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 40' ' ' GLY . 85.7 mt-30 52.67 117.23 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.869 0.366 . . . . 0.0 110.733 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 44' ' ' THR . 35.3 t-20 -148.81 68.76 9.87 Favored Pre-proline 0 C--O 1.235 0.3 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.643 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.588 ' O ' ' N ' ' A' ' 46' ' ' ALA . 87.3 Cg_exo -35.77 -31.27 0.08 OUTLIER 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.507 2.138 . . . . 0.0 112.012 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 42' ' ' ASN . 29.5 m -38.49 -27.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.319 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.542 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 87.6 mt-10 -89.43 -32.4 17.26 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.588 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.46 -51.82 68.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.974 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.449 ' HB2' HG23 ' A' ' 117' ' ' THR . 2.2 tm-20 -67.51 -46.04 74.04 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 44' ' ' THR . 97.0 mt -63.6 -27.6 69.35 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.396 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -39.54 -53.65 2.06 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.818 0.342 . . . . 0.0 110.792 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -65.94 -38.25 88.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.197 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.5 ttp -62.42 -40.16 95.65 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 97.9 mt -61.99 -46.43 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.644 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 9.5 m120 -62.31 -42.41 99.35 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.725 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.74 -55.6 32.3 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.134 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.9 -34.85 62.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.934 0.397 . . . . 0.0 111.123 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 62' ' ' THR . 44.0 t0 -82.94 -13.41 56.08 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.377 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.06 8.87 1.1 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.788 0.327 . . . . 0.0 110.151 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 12.7 p30 -61.54 -25.09 67.07 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -157.87 -19.94 0.03 OUTLIER Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.62 ' C ' ' H ' ' A' ' 62' ' ' THR . 5.1 p30 177.07 141.86 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.76 32.27 0.09 OUTLIER Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.62 ' H ' ' C ' ' A' ' 60' ' ' ASN . 64.2 p -130.29 150.14 51.66 Favored 'General case' 0 C--N 1.337 0.053 0 CA-C-O 120.973 0.416 . . . . 0.0 110.288 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.5 mt -117.08 138.96 46.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.138 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.51 166.13 19.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.436 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.431 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -62.97 -50.5 76.56 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.803 -179.19 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.5 Cg_exo -50.85 -44.94 38.7 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.984 1.79 . . . . 0.0 111.824 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.89 -36.35 72.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.924 0.393 . . . . 0.0 110.994 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -59.99 -45.86 91.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.246 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.08 -44.54 95.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.594 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.7 m -67.41 -44.4 78.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.254 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.9 ttp -61.43 -40.13 93.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.023 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 76.1 mmm -63.05 -38.55 91.64 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.841 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.09 96.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.028 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -68.48 -45.53 72.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.052 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.61 -41.78 83.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.955 0.407 . . . . 0.0 110.33 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.8 mmt -86.96 164.42 16.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.14 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -116.22 153.61 31.56 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.043 0.449 . . . . 0.0 110.154 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -59.26 160.47 6.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.302 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.8 p -64.13 -30.08 71.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.586 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -64.47 -10.01 22.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.158 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -57.08 -32.82 66.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.516 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -49.44 -50.22 41.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.723 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -65.08 -41.89 94.6 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.987 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -66.32 -45.66 79.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.497 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.4 mt -64.91 -20.6 27.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.8 ttt-85 -59.68 -42.19 92.39 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.206 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -61.48 -35.88 78.89 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.477 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.17 -13.4 60.46 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -47.96 -51.12 24.92 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.0 0.428 . . . . 0.0 111.424 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -59.75 -46.85 87.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.825 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 85.0 t -68.84 -44.34 81.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.958 0.409 . . . . 0.0 110.466 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -59.44 -44.43 92.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.529 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 33.0 t70 -138.84 100.67 4.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.231 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.04 -40.01 82.94 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.207 0.527 . . . . 0.0 110.198 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.3 p-10 -60.13 -42.6 95.14 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.327 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.67 -56.97 0.5 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -70.75 -13.63 62.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.078 0.466 . . . . 0.0 110.267 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.6 161.19 12.85 Favored Glycine 0 N--CA 1.464 0.541 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -115.13 150.92 35.26 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.8 mt -85.25 123.16 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 121.002 0.43 . . . . 0.0 110.339 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.2 p -79.99 168.13 19.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.034 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.25 -36.49 82.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.611 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.17 -45.31 93.97 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.095 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -69.99 -37.68 75.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.208 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.4 tp -62.01 -42.89 99.65 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.241 0.544 . . . . 0.0 111.276 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -52.57 -43.21 65.1 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.055 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -55.5 -42.73 74.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.164 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.4 t -64.58 -42.48 95.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.292 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 58.5 mmm -57.56 -34.74 69.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.467 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.7 m -60.24 -42.3 94.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.445 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -58.66 -38.68 78.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.824 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 40.0 tp -61.31 -46.34 90.7 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.048 0.451 . . . . 0.0 110.13 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.89 -154.91 26.0 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -143.22 11.81 1.76 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.693 -0.253 . . . . 0.0 110.78 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -63.93 -43.96 94.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.153 0.502 . . . . 0.0 110.657 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.5 mt -79.75 160.32 26.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.033 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.479 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -68.51 161.67 27.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.221 -179.71 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -92.33 -21.06 20.48 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.112 0.482 . . . . 0.0 110.448 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -85.45 -26.91 26.06 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.219 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.612 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.68 -63.49 0.35 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.612 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 11.3 m -69.09 -31.38 49.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 121.234 -0.186 . . . . 0.0 111.46 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -58.82 -67.15 0.39 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.699 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.58 -45.14 72.8 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.521 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 13.3 tmm? -52.93 -50.3 64.28 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 125' ' ' ILE . 95.9 mt -64.61 -18.37 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.669 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -87.92 -57.91 2.76 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 119.904 -0.718 . . . . 0.0 112.25 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 128' ' ' ALA . 51.0 tp10 -81.95 -67.7 0.76 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.271 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.815 ' HB2' ' O ' ' A' ' 39' ' ' LEU . . . -36.83 -35.65 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 56.6 t0 -87.71 146.11 25.83 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.277 0.56 . . . . 0.0 110.568 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.566 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -89.39 -14.85 9.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.809 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 133' ' ' ASP . 44.8 m-20 -73.54 -45.36 54.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.032 0.444 . . . . 0.0 110.407 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.35 -10.28 3.73 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 131' ' ' ASP . 35.4 p30 -89.88 -10.4 45.42 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.836 0.351 . . . . 0.0 110.195 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 62.25 123.0 0.01 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -161.72 119.61 2.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.889 0.376 . . . . 0.0 110.101 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.67 128.93 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.093 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.523 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 45.2 t30 -155.1 166.2 34.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.071 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.401 ' O ' ' CD1' ' A' ' 138' ' ' TYR . 2.6 t80 -48.79 -23.02 0.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.459 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 50.1 mp0 -66.42 -35.74 81.06 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.152 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -84.97 -20.78 30.04 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.56 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.04 -46.7 87.99 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 121.134 -0.227 . . . . 0.0 111.166 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 30.1 t -58.31 -45.98 89.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.005 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -71.36 -36.14 71.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.293 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 61.5 ttp -57.94 -43.09 86.14 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.207 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 70.7 mtm -112.72 129.33 56.45 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.818 0.342 . . . . 0.0 110.414 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.5 m -162.88 85.77 0.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.096 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.1 -43.91 93.9 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.676 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 C--O 1.219 -0.527 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.507 179.879 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.07 0 CA-C-O 120.525 0.203 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -47.67 -48.62 28.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.102 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -59.44 -44.86 92.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.89 0.376 . . . . 0.0 110.484 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -63.42 -39.66 95.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.664 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.29 -41.29 85.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.343 . . . . 0.0 111.143 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.44 -22.72 66.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.82 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -55.59 -47.81 75.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.21 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.9 m -81.47 -17.19 49.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.476 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.93 -43.77 97.9 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.435 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.416 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.7 m-85 -60.48 -50.39 73.75 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.565 -179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.3 t0 -77.08 -14.64 59.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.191 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -45.01 -32.93 1.84 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.228 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.447 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 18.0 p-10 -54.71 -46.01 74.12 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 120.966 -0.293 . . . . 0.0 110.875 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -144.0 -151.09 5.38 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 32.3 p-10 -73.08 -47.03 47.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.714 0.292 . . . . 0.0 110.81 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.77 107.29 0.28 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.428 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 4.9 m -166.2 142.79 5.04 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.771 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.03 103.42 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.404 HG22 HG22 ' A' ' 62' ' ' THR . 2.9 p -123.11 169.96 10.69 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.1 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.605 ' CB ' HE22 ' A' ' 49' ' ' GLN . 61.1 p -63.14 -35.32 79.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.861 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -60.35 -38.46 83.88 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.447 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 87.7 mt-10 -65.64 -43.11 90.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.091 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.66 -41.96 98.14 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.258 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.71 -28.8 17.05 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.2 m -64.54 -44.15 91.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.95 0.405 . . . . 0.0 110.729 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.2 t -57.1 -17.61 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.175 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.541 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 87.7 mmm -53.03 -38.52 62.45 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.266 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.7 ttt85 -64.28 -45.97 85.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 117.444 -1.702 . . . . 0.0 110.722 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 92.8 p -63.41 -19.96 65.14 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.538 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.882 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 52.4 mt -99.58 6.12 45.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.904 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 34.9 94.55 0.01 OUTLIER Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.487 ' O ' ' O ' ' A' ' 40' ' ' GLY . 84.1 mt-30 52.23 110.25 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.619 0.247 . . . . 0.0 110.369 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 44' ' ' THR . 49.9 t30 -145.82 63.98 9.81 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.704 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.574 ' O ' ' N ' ' A' ' 46' ' ' ALA . 89.3 Cg_exo -34.72 -29.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.612 2.208 . . . . 0.0 112.325 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 42' ' ' ASN . 23.3 m -40.13 -29.61 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.124 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.541 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 90.7 mt-10 -89.63 -29.93 18.49 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.802 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -60.84 -49.15 78.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.822 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.469 ' HB2' HG23 ' A' ' 117' ' ' THR . 2.2 tm-20 -72.18 -43.18 64.96 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.25 0.548 . . . . 0.0 109.751 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.585 HD21 HD21 ' A' ' 116' ' ' LEU . 96.3 mt -67.97 -25.12 65.27 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.203 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.605 HE22 ' CB ' ' A' ' 29' ' ' THR . 53.8 tp60 -40.76 -41.89 1.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.603 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -77.64 -36.83 51.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.862 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.492 ' CE ' HD22 ' A' ' 48' ' ' LEU . 32.6 ttp -59.96 -37.28 79.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.677 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.59 HG21 HG22 ' A' ' 29' ' ' THR . 96.8 mt -63.44 -44.89 99.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.027 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.673 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 19.6 m120 -62.54 -39.84 94.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.37 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -56.62 -56.42 21.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.294 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.476 HG13 ' N ' ' A' ' 56' ' ' ASP . 15.0 p -74.12 -40.38 51.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.851 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.502 ' OD2' ' N ' ' A' ' 62' ' ' THR . 44.4 t0 -71.2 -13.21 61.85 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.561 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.673 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.35 8.98 1.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.31 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 56' ' ' ASP . 10.4 p-10 -59.67 -26.76 65.82 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -155.06 -24.41 0.03 OUTLIER Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.551 ' C ' ' H ' ' A' ' 62' ' ' THR . 9.9 p30 176.19 151.19 0.14 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.582 -0.309 . . . . 0.0 110.178 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.28 36.35 0.09 OUTLIER Glycine 0 CA--C 1.535 1.294 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.551 ' H ' ' C ' ' A' ' 60' ' ' ASN . 44.2 p -137.45 153.31 50.12 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.5 mt -127.38 136.98 59.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.971 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -81.18 164.59 22.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.137 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.431 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -62.13 -50.11 81.71 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.227 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.6 Cg_exo -50.07 -41.73 48.0 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.074 1.849 . . . . 0.0 112.065 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -80.78 -29.83 36.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.111 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -59.53 -45.0 93.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.026 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.39 -43.21 99.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.279 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.1 m -64.43 -44.83 89.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.85 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.0 ttp -60.1 -44.69 94.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.829 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 79.4 mmm -63.8 -40.91 97.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.258 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.407 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -61.21 -47.86 84.18 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.865 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -71.25 -46.25 61.43 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.496 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -66.79 -45.19 79.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.993 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.407 ' O ' ' O ' ' A' ' 73' ' ' ALA . 17.8 mmm -99.5 -176.69 3.36 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.057 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -128.49 152.19 48.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.112 0.482 . . . . 0.0 110.177 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -54.2 177.74 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.359 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.2 p -80.6 -15.74 55.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.544 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -66.39 -13.67 61.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.397 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 83' ' ' GLU . 72.8 m -53.35 -34.38 57.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.548 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -39.0 -28.83 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.365 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 81' ' ' SER . 75.8 mm-40 -85.36 -54.84 4.33 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.004 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -58.48 -36.3 73.53 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.984 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.431 ' O ' HG22 ' A' ' 85' ' ' ILE . 96.7 mt -63.58 -20.04 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.1 ttt-85 -60.99 -45.06 96.34 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 118.351 -1.34 . . . . 0.0 109.627 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -64.67 -21.74 66.81 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.172 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.41 -17.51 48.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.466 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -57.05 -50.19 73.52 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.305 0.574 . . . . 0.0 110.556 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -68.6 -44.92 73.29 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.898 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.2 t -65.33 -49.09 80.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.028 0.442 . . . . 0.0 109.986 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.679 ' CE2' HD12 ' A' ' 100' ' ' ILE . 51.7 t80 -62.61 -45.19 94.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.878 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.412 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 22.2 t0 -120.54 104.57 10.07 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.056 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -66.38 -41.21 89.71 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.037 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -70.49 -41.55 72.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.042 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.91 -53.04 0.75 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -64.04 -20.05 65.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.98 0.419 . . . . 0.0 110.315 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.412 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.67 161.0 12.9 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -113.34 148.29 35.99 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.679 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -84.9 123.55 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.0 p -87.27 176.76 7.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.129 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.57 84.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.979 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.55 -51.32 69.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.886 0.374 . . . . 0.0 110.983 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -71.4 -30.51 66.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 49.6 tp -61.78 -41.02 97.18 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.235 0.54 . . . . 0.0 111.093 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -54.18 -41.49 68.59 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.918 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -57.94 -42.73 85.49 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.3 t -65.59 -43.1 94.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.691 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 91.6 mmm -62.59 -37.25 85.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.44 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.8 m -59.44 -40.49 86.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.639 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -58.59 -38.76 78.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.737 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.0 tp -61.07 -44.99 96.54 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.551 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.05 -145.37 12.16 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -143.52 16.3 1.83 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.827 0.346 . . . . 0.0 110.748 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -61.79 -44.93 95.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.014 0.435 . . . . 0.0 110.424 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.585 HD21 HD21 ' A' ' 48' ' ' LEU . 82.8 mt -82.12 161.38 22.86 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.981 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.471 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -66.13 161.73 21.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.685 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -91.58 -19.63 22.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.863 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -87.69 -28.11 22.01 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.63 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.34 -66.9 0.17 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.63 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.4 m -63.97 -39.32 85.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.468 ' N ' HG23 ' A' ' 121' ' ' VAL . 84.9 m-20 -54.33 -65.89 0.49 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.674 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 127' ' ' GLU . 80.6 mm-40 -70.42 -44.9 66.95 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.656 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 18.9 tmm? -53.04 -47.58 68.29 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.899 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 97.6 mt -67.18 -19.72 25.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.346 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -91.28 -66.72 0.9 Allowed 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.033 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 123' ' ' GLU . 25.0 tp10 -65.26 -68.62 0.35 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.161 -177.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.882 ' HB2' ' O ' ' A' ' 39' ' ' LEU . . . -37.11 -37.72 0.17 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.481 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 66.1 t0 -87.52 138.29 31.6 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.246 0.546 . . . . 0.0 110.583 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.592 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -85.82 -16.14 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.319 -179.683 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -73.06 -46.53 51.12 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.126 0.488 . . . . 0.0 110.146 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.95 -2.58 54.93 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 52.1 p30 -88.66 -22.25 23.52 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 64.65 103.64 0.01 OUTLIER Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -147.76 140.82 24.99 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.788 0.328 . . . . 0.0 110.141 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.1 t -128.95 134.31 64.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.313 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.526 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 53.4 t30 -151.56 -179.12 7.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.603 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -57.26 -48.14 79.63 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.259 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.526 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 55.8 mp0 -50.93 -43.66 60.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.353 -178.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -67.6 -39.84 84.76 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.967 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -60.71 -43.68 97.52 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.571 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.4 t -54.22 -43.92 62.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.239 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -84.29 -19.31 34.01 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.211 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 41.1 ttp -65.08 -41.32 95.15 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.94 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.404 ' O ' ' OG1' ' A' ' 146' ' ' THR . 51.7 mtm -103.71 132.7 49.73 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.867 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 145' ' ' MET . 43.6 m -166.83 81.79 0.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.053 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.77 -37.28 75.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.292 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.1 mttm . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.509 179.921 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.912 0.387 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -51.48 -43.23 62.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.738 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -66.97 -46.35 74.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.022 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -61.67 -44.78 96.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.795 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -67.98 -40.89 83.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.642 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.19 -28.42 67.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.971 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -55.56 -45.85 77.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.695 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.0 m -81.58 -17.88 46.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.733 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.5 tp -65.45 -42.36 92.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.952 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.401 ' O ' ' CD ' ' A' ' 31' ' ' GLU . 73.6 m-85 -61.05 -45.95 92.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.333 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 4.7 t0 -81.98 -15.65 53.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.341 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -42.84 -32.51 0.63 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.105 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.437 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 9.1 p-10 -53.59 -46.75 70.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.887 0.375 . . . . 0.0 110.72 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.437 ' N ' ' CG ' ' A' ' 22' ' ' ASP . . . -145.67 -147.3 4.58 Favored Glycine 0 N--CA 1.466 0.696 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 20.3 p-10 -76.53 -47.56 22.29 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.921 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.02 107.02 0.27 Allowed Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 177.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 96.0 m -166.73 143.14 4.64 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.936 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.06 117.09 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.831 0.348 . . . . 0.0 110.095 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.689 HG22 HG22 ' A' ' 62' ' ' THR . 12.3 p -133.38 165.6 24.47 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.429 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.536 ' CB ' HE22 ' A' ' 49' ' ' GLN . 80.2 p -63.08 -35.14 79.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.274 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -61.27 -38.48 86.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.076 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.415 ' OE2' ' CG ' ' A' ' 22' ' ' ASP . 91.3 mt-10 -64.71 -49.16 71.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.336 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.32 -43.6 98.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.277 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.17 -24.02 4.48 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.7 m -64.91 -42.47 94.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.903 0.382 . . . . 0.0 110.509 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.5 t -54.55 -16.33 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.26 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.453 ' O ' ' N ' ' A' ' 40' ' ' GLY . 53.4 mmm -58.71 -37.27 75.77 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -62.46 -46.16 89.76 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 116.724 -1.99 . . . . 0.0 110.66 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.9 p -60.11 -36.15 76.8 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.101 -178.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 41' ' ' GLN . 44.6 mt -95.85 2.08 53.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.723 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 66.25 -66.47 0.15 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' A' ' 39' ' ' LEU . 74.6 mt-30 -141.7 122.75 14.61 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.5 t-20 -141.43 71.11 26.55 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.653 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' ALA . 73.2 Cg_exo -37.45 -30.41 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.172 1.915 . . . . 0.0 112.186 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 42' ' ' ASN . 25.2 m -39.05 -27.61 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.477 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 49' ' ' GLN . 86.7 mt-10 -90.31 -36.92 14.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.005 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -56.28 -48.89 75.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.399 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -70.5 -45.02 66.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.292 0.568 . . . . 0.0 110.133 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.516 HD21 HD22 ' A' ' 116' ' ' LEU . 96.0 mt -70.06 -20.12 63.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.804 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.536 HE22 ' CB ' ' A' ' 29' ' ' THR . 67.4 tp60 -46.39 -46.23 18.37 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.67 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -75.08 -35.28 61.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.199 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.431 ' CE ' HD22 ' A' ' 48' ' ' LEU . 33.1 ttp -63.63 -43.05 97.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.077 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 96.7 mt -62.8 -46.19 96.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.752 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.693 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 24.0 m120 -64.66 -40.69 95.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.738 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.08 -56.84 16.74 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.421 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 56' ' ' ASP . 11.3 p -69.7 -36.96 72.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.985 0.421 . . . . 0.0 110.95 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.551 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.4 t0 -79.03 -12.7 60.03 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.423 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.693 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.12 15.46 0.16 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.349 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 10.4 p30 -65.75 -21.91 66.55 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.415 ' H ' ' H ' ' A' ' 60' ' ' ASN . . . -167.81 -9.62 0.03 OUTLIER Glycine 0 C--N 1.333 0.392 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.579 ' C ' ' H ' ' A' ' 62' ' ' THR . 2.0 p30 169.37 140.46 0.02 OUTLIER 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.0 35.88 0.1 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.689 HG22 HG22 ' A' ' 28' ' ' THR . 69.0 p -136.02 154.94 50.91 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 90.8 mt -130.05 132.08 65.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.219 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.14 151.99 42.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.612 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.445 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -54.87 -51.27 80.66 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.768 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 52.4 Cg_exo -49.12 -49.82 14.38 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.863 1.709 . . . . 0.0 112.106 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -68.6 -33.65 74.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.412 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -61.98 -43.77 98.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.997 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.2 mt -59.2 -45.61 90.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.789 0.328 . . . . 0.0 110.734 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.4 m -63.85 -44.73 92.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.463 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 36.4 ttp -60.01 -45.33 93.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.515 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.2 mmm -64.68 -39.33 93.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.565 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.32 -39.15 78.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.67 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -77.86 -51.46 10.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.424 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -65.6 -44.26 87.13 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.47 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.2 mmm -99.72 126.47 45.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.358 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -86.74 143.87 27.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.501 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 80' ' ' ASP . 97.2 m-20 -49.42 158.59 0.4 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.431 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 35.7 p -54.88 -8.73 0.28 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.642 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 78' ' ' ASP . 80.1 m-20 -67.11 -8.66 32.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.109 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.4 m -59.37 -29.61 67.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.637 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -37.87 -49.15 1.19 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.006 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.66 -55.08 19.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.909 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -59.63 -32.36 70.36 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.083 0.468 . . . . 0.0 110.629 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 85' ' ' ILE . 82.6 mt -69.2 -15.07 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -59.76 -48.88 79.91 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 117.508 -1.677 . . . . 0.0 110.377 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.2 -32.58 74.34 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.498 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.63 -35.98 73.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.789 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -50.59 -51.12 51.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.341 0.591 . . . . 0.0 110.908 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -69.24 -44.54 71.79 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.292 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.09 -51.45 48.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.113 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.558 ' CE2' HD12 ' A' ' 100' ' ' ILE . 66.6 t80 -63.45 -47.47 81.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.396 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.465 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 17.9 t0 -107.77 105.41 15.23 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.087 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -71.75 -44.87 63.32 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.598 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 44.9 p-10 -67.14 -33.64 75.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.054 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.526 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 66.56 -74.88 0.15 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -53.64 -13.07 0.58 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.922 0.391 . . . . 0.0 110.392 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.423 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.53 161.78 12.66 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -112.33 155.91 23.32 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.558 HD12 ' CE2' ' A' ' 92' ' ' PHE . 94.4 mt -99.78 117.43 44.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.7 p -82.1 175.69 10.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.151 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.95 -37.02 84.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.826 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.56 -52.43 64.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.791 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -67.7 -31.17 70.94 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.654 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.0 tp -64.15 -41.4 97.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.501 0.667 . . . . 0.0 110.997 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -53.86 -39.26 65.49 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.964 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -63.79 -41.23 97.98 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.1 -42.68 96.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.498 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 54.0 mmm -62.37 -40.75 97.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.979 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.4 m -61.69 -40.3 94.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.556 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -58.89 -40.45 84.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.614 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.9 tp -61.31 -44.27 97.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.964 0.411 . . . . 0.0 110.541 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 161.85 -151.91 22.16 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -138.31 29.15 2.47 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.806 0.336 . . . . 0.0 110.66 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -67.45 -45.32 76.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.824 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.516 HD22 HD21 ' A' ' 48' ' ' LEU . 19.6 mt -100.62 166.89 10.67 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.871 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.519 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -69.49 161.61 29.16 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.177 -179.595 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -92.71 -21.57 19.9 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.888 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -87.42 -23.56 24.47 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.637 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -35.09 -68.09 0.13 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.577 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.523 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 9.8 m -63.88 -42.09 94.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.517 ' N ' HG23 ' A' ' 121' ' ' VAL . 87.6 m-20 -48.33 -67.01 0.31 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.748 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.463 ' O ' ' OE1' ' A' ' 127' ' ' GLU . 80.3 mm-40 -70.54 -40.0 73.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.745 0.307 . . . . 0.0 111.801 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.404 ' SD ' ' C ' ' A' ' 124' ' ' MET . 17.7 tmm? -57.26 -38.93 74.62 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.669 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.8 mt -77.9 -23.76 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -77.61 -46.82 20.98 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 118.674 -1.211 . . . . 0.0 111.657 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 123' ' ' GLU . 19.6 mp0 -80.13 -68.41 0.68 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.661 -177.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.56 -49.02 1.05 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.629 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -88.46 131.07 35.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.896 0.379 . . . . 0.0 110.255 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.546 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -82.31 -10.69 12.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.148 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 133' ' ' ASP . 89.2 m-20 -64.35 -40.42 95.83 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.118 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.61 -8.4 4.28 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' A' ' 134' ' ' GLY . 26.1 p-10 -88.26 -12.72 42.84 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 39.39 98.07 0.01 OUTLIER Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.435 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 13.3 pt20 -131.09 136.94 48.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.021 0.439 . . . . 0.0 110.334 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.0 t -115.3 134.92 56.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.089 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.515 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 52.9 t30 -152.71 176.67 11.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.659 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -58.8 -47.97 82.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.406 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.515 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 58.0 mp0 -57.43 -25.54 59.79 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.293 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 81.1 mt-10 -84.82 -33.71 22.86 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.1 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -65.71 -46.84 77.44 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.634 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 50.3 t -56.35 -44.49 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 120.789 0.328 . . . . 0.0 110.253 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -71.63 -38.03 70.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.155 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 50.2 ttp -60.48 -48.55 81.26 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.291 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 49.1 mtm -88.62 120.81 30.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.945 0.402 . . . . 0.0 110.778 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.1 m -165.75 99.12 0.67 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.76 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.96 -38.31 88.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.582 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.8 mttm . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 117.821 -1.085 . . . . 0.0 110.509 179.982 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -88.71 117.41 27.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.476 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -82.74 -36.37 25.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.606 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 43.4 tp -99.28 122.69 42.78 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.137 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 p -137.9 158.9 43.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.328 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -67.76 -33.52 75.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.651 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -53.78 -44.12 69.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.826 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -57.65 -42.09 82.77 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.617 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.04 -43.16 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.575 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.97 -29.72 57.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.265 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -54.65 -48.32 72.45 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.528 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -65.62 -40.85 93.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.865 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -62.01 -44.05 97.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.659 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -66.98 -37.57 84.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.988 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.482 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.03 -27.9 65.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.806 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -57.81 -46.9 84.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.525 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 m -77.98 -21.41 50.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.691 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.0 tp -62.41 -42.83 99.73 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.419 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.482 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.3 m-85 -60.15 -51.02 71.4 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.439 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.2 t0 -76.9 -14.32 59.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.872 0.368 . . . . 0.0 111.366 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -45.59 -32.68 2.43 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.805 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 8.8 p-10 -53.72 -46.1 70.71 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.53 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.434 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -144.36 -151.6 5.47 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 30.8 p-10 -72.93 -47.28 47.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.733 0.301 . . . . 0.0 111.106 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.71 107.35 0.28 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 178.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.43 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 4.6 m -166.61 139.3 3.74 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.151 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 27' ' ' ILE . 5.2 mp -115.13 109.23 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.594 HG22 HG22 ' A' ' 62' ' ' THR . 2.6 p -128.72 170.24 13.53 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.882 0.373 . . . . 0.0 110.372 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.638 ' CB ' HE22 ' A' ' 49' ' ' GLN . 67.2 p -64.68 -33.05 75.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.789 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -61.69 -41.45 97.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.395 . . . . 0.0 109.983 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 26' ' ' THR . 90.0 mt-10 -63.4 -45.73 89.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.897 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.9 tp -64.16 -43.3 95.6 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.106 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.81 -26.07 53.5 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.1 m -63.9 -41.45 97.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.885 0.374 . . . . 0.0 110.098 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.1 t -56.23 -23.61 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.365 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.478 ' O ' ' N ' ' A' ' 40' ' ' GLY . 62.3 mmm -48.06 -30.27 4.29 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.667 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -64.36 -45.68 86.71 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 118.077 -1.449 . . . . 0.0 110.999 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -63.95 -21.96 66.71 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.837 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 41' ' ' GLN . 16.8 mt -107.73 3.7 24.87 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.097 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.2 -71.29 0.02 OUTLIER Glycine 0 N--CA 1.465 0.602 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 39' ' ' LEU . 87.8 mt-30 -145.44 109.45 4.83 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 44' ' ' THR . 41.4 t30 -125.56 70.88 65.21 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.091 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.551 ' O ' ' N ' ' A' ' 46' ' ' ALA . 84.7 Cg_exo -33.02 -30.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 122.63 2.22 . . . . 0.0 112.715 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 42' ' ' ASN . 26.3 m -39.27 -30.19 0.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.503 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.419 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.9 mt-10 -86.61 -34.96 19.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.291 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -59.07 -50.04 75.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.834 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.15 -46.07 71.78 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.176 0.512 . . . . 0.0 109.671 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 51' ' ' MET . 84.7 mt -64.87 -31.14 72.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.338 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.638 HE22 ' CB ' ' A' ' 29' ' ' THR . 61.1 tp60 -37.42 -51.29 1.11 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.879 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.31 -40.32 89.89 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.228 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 48' ' ' LEU . 33.1 ttp -62.44 -41.02 98.44 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.934 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.413 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 83.4 mt -61.98 -49.85 82.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.182 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.604 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 89.8 m-20 -62.95 -40.46 97.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.56 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -55.18 -61.5 2.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.238 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.92 -30.12 43.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.261 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 62' ' ' THR . 50.6 t0 -84.66 -13.2 52.19 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.568 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.02 13.06 0.33 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.859 0.362 . . . . 0.0 110.254 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.8 p30 -65.54 -28.9 69.5 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -150.53 -22.37 0.06 OUTLIER Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 62' ' ' THR . 3.3 p30 173.17 151.84 0.08 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.93 34.64 0.14 Allowed Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.594 HG22 HG22 ' A' ' 28' ' ' THR . 81.9 p -134.34 149.46 50.86 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.4 mt -120.98 134.48 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.14 162.36 28.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.461 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.473 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -64.61 -48.16 74.56 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.432 -179.045 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 50.2 Cg_exo -51.17 -37.44 58.72 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.195 1.93 . . . . 0.0 111.719 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -87.48 -22.33 24.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.31 -47.25 86.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.014 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.44 -42.94 98.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.543 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.1 m -63.97 -46.08 86.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.672 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.6 ttp -61.66 -47.57 84.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.062 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 82.0 mmm -65.75 -37.82 87.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.275 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.62 -49.97 75.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.01 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -71.46 -43.83 65.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.18 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.69 -43.64 88.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.681 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.434 ' O ' ' O ' ' A' ' 73' ' ' ALA . 22.4 mmm -104.3 127.47 51.94 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.08 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.7 tptt -84.99 141.18 30.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.893 0.378 . . . . 0.0 110.706 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.422 ' O ' ' O ' ' A' ' 77' ' ' LYS . 95.1 m-20 -48.93 179.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.239 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.6 p -75.5 -6.74 51.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.444 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.52 -15.43 62.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.567 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.1 m -61.94 -19.94 63.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.539 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -48.15 -44.71 32.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.374 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.97 -39.51 79.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.913 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.86 -45.15 83.22 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.023 0.439 . . . . 0.0 110.187 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.2 mt -66.1 -19.05 25.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.514 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -58.43 -45.41 88.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.205 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.63 -31.83 73.07 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.916 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -72.04 -14.62 61.92 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.212 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -58.04 -48.96 78.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.292 0.567 . . . . 0.0 111.046 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -64.1 -45.6 87.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.328 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.14 -51.59 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.897 0.379 . . . . 0.0 110.896 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.441 ' CE2' HD12 ' A' ' 100' ' ' ILE . 26.3 t80 -61.95 -47.2 85.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.628 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.422 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 18.1 t70 -108.97 94.21 4.93 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.24 -41.03 74.08 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.001 0.429 . . . . 0.0 110.536 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 20.1 p-10 -62.49 -39.75 94.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.021 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.51 -67.34 0.99 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.59 -16.53 63.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.93 0.395 . . . . 0.0 110.25 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.71 162.03 12.57 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.29 155.38 24.17 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.786 0.327 . . . . 0.0 110.247 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.441 HD12 ' CE2' ' A' ' 92' ' ' PHE . 94.2 mt -79.73 125.99 39.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.978 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.4 p -82.39 169.01 16.94 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.141 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.56 -37.98 89.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.499 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.72 -47.36 83.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.847 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.66 -32.83 72.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.955 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.5 tp -61.59 -41.7 97.81 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.405 0.622 . . . . 0.0 110.68 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -56.42 -43.3 79.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.816 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -58.48 -41.96 86.45 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.62 -43.39 90.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.692 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.1 mmm -62.02 -35.58 79.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.685 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.9 m -61.13 -44.37 97.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.014 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -59.8 -34.96 73.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.382 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.1 tp -61.18 -46.7 89.42 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.121 0.486 . . . . 0.0 110.384 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.47 -160.71 33.43 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -140.55 23.33 2.31 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.634 0.254 . . . . 0.0 110.78 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -63.57 -42.86 98.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.97 0.414 . . . . 0.0 110.24 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.6 mt -92.8 175.85 6.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.996 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.469 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -72.93 161.32 30.84 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.679 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -91.66 -22.5 20.23 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.928 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -87.92 -25.26 23.31 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.152 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.638 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.4 -61.28 0.45 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.141 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.638 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 20.3 m -67.39 -40.18 84.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.486 ' N ' HG23 ' A' ' 121' ' ' VAL . 81.2 m-20 -56.86 -47.0 81.43 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.521 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -86.02 -40.33 15.9 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.6 tmm? -59.57 -46.52 88.67 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.015 0.436 . . . . 0.0 109.896 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 125' ' ' ILE . 91.9 mt -69.09 -16.58 20.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.475 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 -78.64 -50.53 11.31 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.085 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 129' ' ' ASP . 42.3 tp10 -87.65 -67.54 0.82 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.071 -0.651 . . . . 0.0 110.861 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.34 -26.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.745 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 127' ' ' GLU . 25.4 t0 -87.98 128.27 35.38 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.061 0.457 . . . . 0.0 111.091 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.673 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.47 -43.36 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.442 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -65.4 -40.31 93.25 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.132 0.491 . . . . 0.0 110.15 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.37 -2.0 58.92 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' GLY . 55.2 p-10 -89.47 -8.97 51.78 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 57.44 115.47 0.01 OUTLIER Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.24 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.434 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 20.3 pt20 -160.65 133.6 6.47 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.0 t -123.46 136.96 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.04 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -151.41 172.42 15.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.252 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -54.77 -46.75 74.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.161 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 139' ' ' GLU . 55.4 mp0 -58.73 -44.37 90.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.639 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 93.3 mt-10 -72.09 -29.33 64.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.753 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.86 -44.02 77.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.631 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 94.3 t -59.1 -46.34 91.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.289 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -69.37 -29.03 66.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.132 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.8 ttp -59.74 -42.82 94.03 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.832 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.49 138.87 50.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.912 0.387 . . . . 0.0 110.745 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 81.4 m -163.29 77.69 0.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.658 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.13 -27.75 68.95 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.451 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.695 -179.882 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -107.75 102.8 11.99 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.972 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -78.51 -8.58 58.71 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 49.8 tp -102.41 121.58 42.61 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.16 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.8 p -135.56 163.95 28.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.72 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -61.43 -31.44 71.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.369 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.89 -43.49 98.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.515 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -66.51 -41.15 89.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.931 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.23 -42.83 96.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.81 79.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.083 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -54.78 -50.55 68.21 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.0 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -63.77 -44.08 94.47 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.715 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -62.57 -45.92 90.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.484 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -69.82 -35.72 75.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.923 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.506 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -63.13 -37.78 88.58 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.511 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -58.43 -46.29 86.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.535 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.4 m -80.87 -18.87 45.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.746 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.51 -43.08 98.26 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.792 0.329 . . . . 0.0 111.291 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.9 m-85 -58.06 -49.22 77.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.541 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 6.3 t0 -73.17 -13.43 61.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.693 0.282 . . . . 0.0 111.229 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -44.49 -33.48 1.74 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.965 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.413 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 7.2 p-10 -53.97 -45.67 71.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.858 0.361 . . . . 0.0 110.96 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -149.07 -150.89 5.34 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 24.9 p-10 -70.16 -47.4 61.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.901 0.382 . . . . 0.0 110.983 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.53 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.79 107.84 0.3 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.445 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 6.3 m -166.21 139.5 4.11 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.112 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.2 mp -120.66 110.6 28.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.553 ' CG2' HG22 ' A' ' 62' ' ' THR . 2.8 p -130.99 169.33 15.98 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.978 0.418 . . . . 0.0 110.554 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.424 HG22 HG21 ' A' ' 52' ' ' ILE . 51.2 p -63.09 -31.45 72.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.304 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -62.14 -42.37 99.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.978 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.445 ' OE1' ' O ' ' A' ' 26' ' ' THR . 81.4 mt-10 -66.66 -45.9 77.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.004 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.92 -42.9 97.25 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.38 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.81 -25.04 28.52 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.9 m -63.96 -44.15 93.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.865 0.365 . . . . 0.0 110.743 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.414 ' H ' HG23 ' A' ' 35' ' ' VAL . 5.2 t -55.54 -20.43 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.521 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.513 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 87.5 mmm -48.97 -34.86 13.85 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.613 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -63.12 -46.39 87.53 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 118.056 -1.458 . . . . 0.0 111.83 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.5 p -60.85 -30.85 70.36 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 41' ' ' GLN . 24.8 mt -96.7 2.04 51.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.046 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.94 -67.91 0.02 OUTLIER Glycine 0 N--CA 1.467 0.743 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 39' ' ' LEU . 86.0 mt-30 -143.6 110.09 5.48 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -123.73 75.05 55.65 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.469 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 46' ' ' ALA . 99.3 Cg_exo -36.4 -35.74 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.743 1.629 . . . . 0.0 112.139 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.418 ' N ' ' HB3' ' A' ' 120' ' ' GLU . 5.8 m -37.84 -31.51 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.734 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.513 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.2 mt-10 -87.34 -35.97 18.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.336 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.52 -51.96 67.68 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -68.4 -47.17 68.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.25 0.548 . . . . 0.0 109.969 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.507 HD22 ' CE ' ' A' ' 51' ' ' MET . 85.0 mt -64.08 -26.8 68.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.967 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 45' ' ' GLU . 58.7 tp60 -38.77 -46.42 1.26 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.72 0.295 . . . . 0.0 110.543 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.13 -41.72 66.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.536 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.507 ' CE ' HD22 ' A' ' 48' ' ' LEU . 40.1 ttp -62.17 -41.73 98.59 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.086 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.424 HG21 HG22 ' A' ' 29' ' ' THR . 96.6 mt -60.94 -51.97 67.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.354 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.621 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 17.3 m120 -64.35 -40.08 95.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.668 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -55.53 -59.6 4.6 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.266 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.79 -34.42 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.012 0.434 . . . . 0.0 110.756 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 62' ' ' THR . 55.3 t0 -80.76 -13.56 58.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.53 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.2 16.12 0.14 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.294 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 56' ' ' ASP . 21.5 p-10 -66.04 -24.61 66.77 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -154.58 -25.57 0.04 OUTLIER Glycine 0 C--N 1.337 0.637 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.6 ' C ' ' H ' ' A' ' 62' ' ' THR . 10.9 p30 -179.99 150.84 0.39 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.405 ' C ' ' OD2' ' A' ' 56' ' ' ASP . . . -65.55 32.5 0.13 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.6 ' H ' ' C ' ' A' ' 60' ' ' ASN . 65.7 p -130.46 148.86 52.32 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.1 mt -118.47 133.9 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.069 0.461 . . . . 0.0 110.45 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.34 169.09 18.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.48 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.435 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -67.3 -49.47 43.37 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.212 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.8 Cg_exo -52.08 -45.29 39.91 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.927 1.751 . . . . 0.0 111.925 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.03 -37.01 72.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.661 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -60.58 -46.46 90.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.007 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.8 mt -62.27 -44.29 96.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.861 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.0 m -65.22 -44.61 87.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.916 0.389 . . . . 0.0 110.287 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 44.8 ttp -62.05 -41.91 98.63 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.812 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 76' ' ' MET . 60.2 mmm -63.29 -40.9 98.66 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.598 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.97 -35.81 77.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.778 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -87.76 -56.24 3.43 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.752 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -63.15 -43.27 98.77 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.138 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 72' ' ' MET . 50.8 mmm -108.9 131.56 54.91 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.943 0.401 . . . . 0.0 110.162 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 78' ' ' ASP . 29.0 tptt -83.12 150.07 26.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.792 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 77' ' ' LYS . 5.7 m-20 -55.45 -159.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.481 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.8 p -96.16 -0.3 50.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.479 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -82.87 2.48 34.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.128 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 83' ' ' GLU . 1.6 m -62.07 -35.63 79.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.971 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -37.92 -29.69 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.839 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 81' ' ' SER . 71.5 mm-40 -74.15 -56.85 4.42 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.065 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -64.71 -38.76 92.08 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.67 -19.29 14.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.462 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.1 ttt-85 -57.65 -44.04 85.37 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 118.79 -1.164 . . . . 0.0 110.201 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -65.96 -32.99 74.79 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.745 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -63.02 -27.96 69.77 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -55.61 -46.0 77.39 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.358 0.599 . . . . 0.0 110.432 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -74.44 -51.12 15.82 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.779 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.0 t -64.06 -47.92 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.082 0.468 . . . . 0.0 110.57 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.476 ' CE2' HD12 ' A' ' 100' ' ' ILE . 39.3 t80 -63.41 -45.9 88.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.246 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.479 ' OD2' ' N ' ' A' ' 96' ' ' GLY . 36.0 t70 -127.06 105.06 8.33 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.602 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -68.56 -42.09 78.85 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.935 0.398 . . . . 0.0 111.079 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 97' ' ' ASN . 1.5 p-10 -60.04 -46.59 89.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.801 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.479 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 73.78 -41.81 1.05 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.432 ' H ' ' C ' ' A' ' 95' ' ' ASP . 77.1 m-20 -80.25 -13.56 59.12 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.957 0.408 . . . . 0.0 110.002 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.96 161.22 12.81 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -113.25 149.9 33.17 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.694 0.283 . . . . 0.0 110.475 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.476 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -96.87 116.55 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.954 0.407 . . . . 0.0 111.177 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.2 p -84.35 170.72 13.34 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.309 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.59 86.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.136 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.17 -47.21 84.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.917 0.389 . . . . 0.0 110.548 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.55 -36.04 75.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.487 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.35 -40.08 95.22 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.619 0.723 . . . . 0.0 110.68 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -52.44 -45.12 65.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.625 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -61.51 -45.13 95.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.057 0.456 . . . . 0.0 110.437 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.85 -44.94 98.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.321 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 48.3 mmm -64.41 -37.07 86.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.457 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 82.6 m -61.08 -46.18 91.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.846 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -67.08 -24.56 65.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.19 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.0 tp -61.47 -44.87 96.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.923 0.392 . . . . 0.0 110.846 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.52 -148.81 15.57 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -140.39 25.92 2.2 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.498 0.19 . . . . 0.0 111.048 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -64.79 -45.35 86.66 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.954 0.407 . . . . 0.0 110.926 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.8 mt -113.55 170.64 8.09 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.991 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.482 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -69.43 161.54 29.23 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.934 0.397 . . . . 0.0 110.981 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -92.1 -24.0 19.27 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.806 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -88.06 -20.37 25.84 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.579 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.67 -67.42 0.16 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.579 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.9 m -64.48 -35.15 73.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -57.69 -66.52 0.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -64.37 -43.71 93.66 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.459 ' C ' ' SD ' ' A' ' 124' ' ' MET . 16.1 tmm? -57.32 -48.69 78.32 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.85 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.24 -23.79 30.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.209 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -77.17 -46.81 22.13 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 119.0 -1.08 . . . . 0.0 111.439 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -85.39 -68.22 0.74 Allowed 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.066 -0.653 . . . . 0.0 111.503 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.0 -33.37 0.08 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.45 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -94.66 146.73 23.94 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.826 0.346 . . . . 0.0 110.722 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.665 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -89.36 -17.35 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 179.461 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -65.48 -44.47 87.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.051 0.453 . . . . 0.0 110.552 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.44 -11.11 5.64 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 41.1 p-10 -89.08 -19.36 25.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.923 0.392 . . . . 0.0 110.501 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.546 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 55.38 106.12 0.01 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.476 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 11.1 pt20 -140.12 134.75 31.71 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 92.3 t -116.97 132.06 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.96 0.41 . . . . 0.0 110.201 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -142.75 175.41 9.83 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.566 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -58.16 -45.87 86.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.162 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 54.2 mp0 -63.63 -36.87 85.24 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.442 -178.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.476 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 78.3 mt-10 -67.14 -33.92 76.46 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.073 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -61.98 -40.6 96.19 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.45 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.7 t -57.22 -45.74 84.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.513 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -82.84 -15.84 50.02 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.836 0.35 . . . . 0.0 111.217 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 43.8 ttp -60.97 -41.03 95.59 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.906 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 78.2 mtm -118.54 141.69 48.33 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.815 0.341 . . . . 0.0 110.694 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.6 m -159.55 84.51 0.77 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.809 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.7 -40.47 72.85 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.124 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.501 -179.548 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -92.3 105.12 17.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.98 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -73.69 -16.05 61.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.157 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 54.9 tp -89.56 123.74 33.92 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.391 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.8 p -142.74 152.9 42.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.152 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -61.25 -20.89 63.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.38 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -60.74 -41.49 95.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.747 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -61.63 -44.27 97.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.525 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.6 mt -64.5 -43.46 96.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.673 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.97 -19.8 0.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.965 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -57.89 -44.61 86.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.483 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -62.66 -45.8 91.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.841 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -63.86 -46.75 83.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.736 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.52 -34.52 77.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.444 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.51 -13.83 61.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.762 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -55.95 -48.96 74.81 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.642 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -71.78 -30.01 65.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.934 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.6 tp -61.31 -42.41 98.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.38 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -60.11 -49.86 75.97 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.032 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 3.5 t70 -76.58 -14.39 60.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.245 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -43.67 -32.79 1.06 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.985 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 24.2 p-10 -53.8 -43.1 69.04 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.196 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -143.81 -155.89 6.6 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 29.1 p-10 -75.29 -47.26 28.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.846 0.355 . . . . 0.0 111.066 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.92 107.36 0.28 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 23.6 m -166.63 155.72 10.88 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.164 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.429 ' N ' HG22 ' A' ' 26' ' ' THR . 5.2 mp -122.79 91.1 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.069 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.3 p -98.09 173.02 7.24 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.414 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.401 ' HB ' HE22 ' A' ' 49' ' ' GLN . 63.4 p -63.55 -32.6 74.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.998 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -62.7 -41.48 99.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.912 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 26' ' ' THR . 83.9 mt-10 -66.73 -44.48 81.43 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.336 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.0 tp -63.19 -45.75 90.28 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.938 0.399 . . . . 0.0 110.66 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -45.96 -25.21 1.6 Allowed Glycine 0 C--O 1.226 -0.377 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.401 ' C ' ' N ' ' A' ' 36' ' ' MET . 14.7 m -63.23 -42.35 99.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.867 0.365 . . . . 0.0 110.026 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 82.6 t -49.46 -18.76 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.285 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.401 ' N ' ' C ' ' A' ' 34' ' ' THR . 89.2 mmm -59.62 -41.01 89.46 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.097 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.5 ttt85 -65.43 -43.87 89.13 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 118.185 -1.406 . . . . 0.0 111.133 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.3 p -58.14 -33.1 68.8 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.852 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.639 HD13 HD22 ' A' ' 42' ' ' ASN . 91.2 mt -97.33 7.05 47.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.611 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 42.96 97.21 0.01 OUTLIER Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 40' ' ' GLY . 87.0 mt-30 41.12 94.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.687 0.28 . . . . 0.0 110.485 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.639 HD22 HD13 ' A' ' 39' ' ' LEU . 48.8 t30 -130.35 75.68 78.8 Favored Pre-proline 0 N--CA 1.464 0.275 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 46' ' ' ALA . 95.0 Cg_exo -33.93 -26.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.367 2.044 . . . . 0.0 112.668 178.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.58 ' N ' ' O ' ' A' ' 42' ' ' ASN . 80.4 m -38.65 -25.97 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.564 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' PRO . 84.4 mt-10 -89.44 -33.38 16.84 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.499 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -56.58 -53.41 57.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.212 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.414 ' OE1' ' O ' ' A' ' 115' ' ' LYS . 1.5 tm-20 -67.96 -41.39 82.52 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.47 HD12 ' O ' ' A' ' 44' ' ' THR . 96.2 mt -73.02 -14.09 61.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.741 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' A' ' 45' ' ' GLU . 73.4 tp60 -53.08 -47.3 68.64 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -67.05 -37.13 83.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.97 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.0 ttp -60.32 -40.79 91.84 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.27 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.23 -48.15 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.653 0.263 . . . . 0.0 111.378 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.609 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 93.6 m-20 -62.03 -39.58 92.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.301 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -55.8 -57.51 11.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.068 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 p -74.92 -29.35 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.274 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 62' ' ' THR . 42.8 t0 -85.15 -12.99 51.52 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.584 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -71.8 2.63 5.12 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.181 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.5 p-10 -52.51 -26.79 14.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -155.64 -27.69 0.03 OUTLIER Glycine 0 C--N 1.339 0.704 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.571 ' C ' ' H ' ' A' ' 62' ' ' THR . 17.7 p30 -177.51 145.71 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.18 36.02 0.09 OUTLIER Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.571 ' H ' ' C ' ' A' ' 60' ' ' ASN . 72.5 p -133.45 152.59 51.93 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.7 mt -122.39 136.39 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.99 0.424 . . . . 0.0 110.253 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.6 OUTLIER -72.64 172.47 10.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.189 -179.464 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.445 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -72.88 -48.73 8.07 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.28 -178.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.9 Cg_exo -53.89 -39.79 83.15 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.279 1.986 . . . . 0.0 111.849 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -76.4 -35.25 58.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.876 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -59.75 -50.29 74.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.066 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -66.27 -42.17 88.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.618 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.9 m -63.43 -48.34 78.2 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.996 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 45.6 ttp -62.82 -44.84 95.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.585 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 42.9 mmm -64.47 -39.54 94.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.703 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.16 -46.26 90.28 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.97 0.414 . . . . 0.0 110.255 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -72.33 -44.64 62.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.335 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -69.6 -46.39 66.41 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.869 0.366 . . . . 0.0 111.644 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 16.3 mmm -101.59 131.06 47.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.671 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 78' ' ' ASP . 48.2 tptt -84.68 148.2 26.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.885 0.374 . . . . 0.0 110.311 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 77' ' ' LYS . 85.7 m-20 -48.85 -179.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.289 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.43 HG22 HG23 ' A' ' 146' ' ' THR . 3.6 p -80.93 -8.86 59.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.422 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.02 -8.95 49.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.415 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 82' ' ' GLU . 9.4 m -61.01 -25.42 66.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 81' ' ' SER . 82.2 tt0 -37.2 -48.05 0.83 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.759 0.314 . . . . 0.0 110.833 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -71.14 -44.14 66.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.253 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -63.95 -39.01 93.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.019 0.438 . . . . 0.0 110.104 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.3 -23.33 33.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 56.1 ttt-85 -56.89 -43.17 81.03 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 118.698 -1.201 . . . . 0.0 109.848 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -63.11 -34.76 78.3 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.64 -22.28 64.42 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -56.91 -49.81 74.46 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.317 0.579 . . . . 0.0 110.971 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -63.69 -45.99 87.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.992 -1.003 . . . . 0.0 111.309 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.5 t -66.22 -48.39 81.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.975 0.417 . . . . 0.0 110.183 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -64.45 -48.33 75.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.615 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 96' ' ' GLY . 42.4 t0 -102.19 102.3 12.71 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.892 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.57 -41.52 88.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.106 0.479 . . . . 0.0 109.893 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -73.25 -42.67 62.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.261 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.456 ' H ' ' CG ' ' A' ' 93' ' ' ASP . . . 76.75 -51.29 3.06 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -76.39 -14.53 60.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.067 0.46 . . . . 0.0 110.114 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.16 162.42 12.42 Favored Glycine 0 N--CA 1.465 0.592 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -112.13 150.44 30.77 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 95.6 mt -88.42 122.52 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.065 0.46 . . . . 0.0 111.114 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.6 p -88.78 176.39 7.09 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.205 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.5 -36.44 82.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.808 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.71 -52.61 64.96 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.476 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -67.95 -37.44 81.59 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.198 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.8 tp -62.59 -41.29 98.86 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.57 0.7 . . . . 0.0 110.298 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -55.7 -43.5 76.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.711 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -55.84 -41.72 74.71 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.4 t -66.35 -42.55 90.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.651 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 63.7 mmm -60.97 -38.03 84.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.617 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.3 m -61.17 -39.84 91.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.654 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -57.55 -40.21 78.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.558 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.4 tp -62.14 -43.68 98.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 0.0 110.138 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 146.31 -144.77 13.21 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -137.32 28.81 2.76 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.647 0.26 . . . . 0.0 110.403 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.414 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 48.7 mtmt -62.39 -42.06 99.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.218 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.468 HD22 HD21 ' A' ' 48' ' ' LEU . 14.2 mt -95.83 168.26 10.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.154 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.472 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -63.76 161.7 14.72 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.819 0.342 . . . . 0.0 110.326 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -91.72 -22.42 20.22 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.539 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 120' ' ' GLU . 78.0 tt0 -86.17 -23.95 26.33 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.418 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.606 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -35.78 -64.38 0.31 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.564 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 14.4 m -63.93 -36.74 77.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.544 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.401 ' N ' HG23 ' A' ' 121' ' ' VAL . 43.8 m-20 -55.88 -66.67 0.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.596 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -69.69 -37.88 76.79 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.434 ' C ' ' SD ' ' A' ' 124' ' ' MET . 16.1 tmm? -59.07 -47.34 85.6 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.598 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.4 mt -70.18 -20.42 22.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.896 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -89.66 -60.24 1.99 Allowed 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.592 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -63.68 -68.34 0.35 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 119.519 -0.873 . . . . 0.0 111.405 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 39' ' ' LEU . . . -45.13 -26.98 0.53 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.42 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -87.76 126.12 34.82 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.028 0.442 . . . . 0.0 111.15 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.618 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -77.31 -23.45 14.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.422 179.255 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -74.95 -41.8 58.89 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.153 0.502 . . . . 0.0 110.004 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.79 2.24 56.44 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 41.7 p-10 -88.13 -18.54 28.57 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.36 111.15 0.04 OUTLIER Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -162.81 139.46 7.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.756 0.312 . . . . 0.0 110.26 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.9 t -126.22 132.98 69.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.182 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -146.73 166.76 25.65 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.187 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -49.35 -37.42 24.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.649 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -59.77 -33.94 72.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.015 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -75.5 -37.06 60.41 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -61.29 -49.77 75.71 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.8 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.5 t -49.39 -48.24 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.42 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -68.91 -39.43 79.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.9 ttp -60.61 -44.73 95.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.768 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.412 ' O ' ' OG1' ' A' ' 146' ' ' THR . 67.1 mtt -89.18 121.18 31.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.898 0.38 . . . . 0.0 110.43 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.43 HG23 HG22 ' A' ' 79' ' ' THR . 12.1 m -167.36 82.81 0.21 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.47 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.43 -46.2 89.65 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.815 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.456 -179.851 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -65.98 133.04 50.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.319 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.58 -25.54 45.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.457 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 53.3 tp -95.24 128.18 41.88 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.124 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.8 p -136.71 149.91 48.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.968 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -68.91 -20.25 64.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.247 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -59.16 -42.46 90.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.346 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.89 -45.04 91.16 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.915 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.8 mt -64.97 -42.9 95.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.799 0.333 . . . . 0.0 110.837 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -48.56 -26.7 2.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.183 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.41 -45.14 55.41 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.488 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -63.05 -44.01 97.07 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.907 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -63.84 -46.52 84.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.293 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -67.38 -43.58 81.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.904 0.383 . . . . 0.0 111.174 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.34 -36.48 80.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.409 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -55.72 -51.07 68.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.975 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -72.77 -23.45 60.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.735 0.302 . . . . 0.0 110.763 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.08 -42.24 99.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.705 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.406 ' O ' ' CD ' ' A' ' 31' ' ' GLU . 79.4 m-85 -59.55 -49.0 79.47 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.169 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.7 t0 -74.81 -13.67 60.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.528 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -43.09 -32.64 0.72 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.998 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 10.9 p-10 -53.3 -45.6 69.04 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.65 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -148.79 -149.18 4.91 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 32.2 p-10 -72.09 -46.89 55.03 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.698 0.285 . . . . 0.0 111.208 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.99 107.57 0.29 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 m -166.0 142.61 5.18 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.099 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.61 108.05 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.536 HG22 HG22 ' A' ' 62' ' ' THR . 2.4 p -128.39 169.82 13.82 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.965 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.735 HG21 HE22 ' A' ' 49' ' ' GLN . 75.7 p -64.77 -32.38 74.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.985 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -62.35 -41.42 98.58 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.579 -0.449 . . . . 0.0 109.901 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.406 ' CD ' ' O ' ' A' ' 19' ' ' PHE . 89.2 mt-10 -63.49 -45.82 88.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.808 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.8 tp -63.87 -45.0 91.39 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.122 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.87 -24.24 7.98 Favored Glycine 0 C--O 1.224 -0.493 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.5 m -64.98 -42.95 94.08 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.256 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.8 t -53.86 -18.23 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.291 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.43 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 91.3 mmm -57.36 -35.35 69.84 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.389 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -63.62 -43.94 95.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 118.004 -1.478 . . . . 0.0 110.148 -178.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.8 p -61.06 -35.76 77.8 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.844 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 41' ' ' GLN . 25.7 mt -96.36 3.61 52.8 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.944 0.402 . . . . 0.0 110.314 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.51 -66.9 0.02 OUTLIER Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 39' ' ' LEU . 80.8 mt-30 -145.05 104.8 4.01 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' A' ' 44' ' ' THR . 50.2 t30 -123.61 73.75 52.87 Favored Pre-proline 0 N--CA 1.466 0.371 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.159 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' A' ' 46' ' ' ALA . 80.4 Cg_exo -35.05 -32.61 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.58 2.186 . . . . 0.0 112.504 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.457 ' O ' HD12 ' A' ' 48' ' ' LEU . 29.1 m -38.25 -31.04 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.593 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 92.5 mt-10 -86.8 -35.89 18.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.327 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -57.44 -49.98 74.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.694 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.505 ' HB2' HG23 ' A' ' 117' ' ' THR . 1.4 tm-20 -70.47 -45.72 65.18 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.141 0.496 . . . . 0.0 109.666 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 44' ' ' THR . 86.6 mt -63.62 -31.43 72.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.948 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.735 HE22 HG21 ' A' ' 29' ' ' THR . 67.3 tp60 -40.17 -54.79 2.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.681 0.276 . . . . 0.0 110.997 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -63.6 -41.52 98.32 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.722 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.6 ttp -61.26 -38.95 88.55 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.201 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.5 mt -62.94 -46.61 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.329 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.626 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 92.3 m-20 -62.81 -41.28 99.24 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.838 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -57.88 -57.16 14.01 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.644 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 p -70.45 -29.31 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.156 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 62' ' ' THR . 38.7 t0 -89.13 -12.48 40.93 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.849 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -71.62 13.46 0.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.484 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.472 ' H ' ' C ' ' A' ' 56' ' ' ASP . 38.9 p-10 -66.81 -28.79 68.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -149.62 -32.12 0.05 OUTLIER Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.628 ' C ' ' H ' ' A' ' 62' ' ' THR . 11.3 p30 -177.11 153.04 0.94 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.551 -0.324 . . . . 0.0 110.202 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.39 30.93 0.1 OUTLIER Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.628 ' H ' ' C ' ' A' ' 60' ' ' ASN . 57.9 p -127.56 146.07 50.64 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.4 mt -116.66 139.74 42.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.652 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.35 176.08 2.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.604 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.516 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -85.67 -46.68 0.6 Allowed Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.667 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 32.4 Cg_exo -55.89 -45.02 41.85 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.272 1.981 . . . . 0.0 111.756 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -70.05 -36.98 75.41 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -57.45 -41.77 81.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.458 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.17 -43.87 98.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.59 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.8 m -64.14 -43.19 96.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.875 0.369 . . . . 0.0 110.365 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 62.1 ttp -59.13 -43.62 92.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.527 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 88.5 mmm -64.83 -38.13 89.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.78 -46.3 84.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -72.88 -45.67 56.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.841 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -64.72 -45.06 88.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.056 0.455 . . . . 0.0 110.537 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 28.6 mmt -93.91 128.07 40.01 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.79 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -85.18 148.26 26.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.307 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -52.96 164.77 0.36 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.357 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 75.4 p -67.19 -21.5 65.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.634 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.13 -7.23 8.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.038 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.6 m -53.47 -34.73 59.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.447 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -38.17 -45.13 0.91 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -69.28 -44.87 70.97 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.008 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.56 -36.48 81.03 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.0 0.428 . . . . 0.0 110.296 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.47 -20.98 24.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -55.58 -45.19 77.43 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 118.758 -1.177 . . . . 0.0 109.539 -177.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -68.07 -33.09 73.89 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.195 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.96 -27.71 69.59 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -57.31 -51.39 69.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.294 0.568 . . . . 0.0 110.94 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -69.36 -45.22 69.9 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.699 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.6 t -68.13 -50.58 57.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.918 0.389 . . . . 0.0 110.769 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -63.39 -47.43 82.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.223 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.408 ' OD2' ' N ' ' A' ' 96' ' ' GLY . 22.5 t0 -110.07 107.63 17.55 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.801 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -68.91 -41.24 78.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.173 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 97' ' ' ASN . 1.1 p-10 -68.63 -37.39 79.68 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.257 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.408 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 67.69 -64.88 0.3 Allowed Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 95' ' ' ASP . 56.0 m-80 -63.1 -14.38 47.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.958 0.409 . . . . 0.0 110.41 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.57 162.01 12.59 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -112.16 145.64 39.48 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 75.7 mt -83.72 125.08 40.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.038 0.447 . . . . 0.0 111.087 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.7 p -83.68 172.15 12.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.043 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.14 -39.07 92.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.012 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.62 76.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.869 0.366 . . . . 0.0 111.108 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.3 -33.18 74.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.652 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.6 tp -61.91 -43.11 99.52 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.408 0.623 . . . . 0.0 111.257 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -55.52 -43.22 75.54 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.883 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -60.35 -43.96 96.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.102 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 84.2 t -63.2 -45.22 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.695 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 86.7 mmm -63.61 -37.46 87.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.337 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 m -60.75 -41.02 94.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.603 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -55.5 -28.38 54.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.011 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.8 tp -60.88 -43.39 98.5 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.035 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 152.8 -141.76 8.71 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -137.58 27.23 2.78 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.7 0.286 . . . . 0.0 110.522 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -62.69 -43.43 98.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.013 0.435 . . . . 0.0 110.356 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 56.3 mt -108.9 -178.67 3.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.689 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.505 HG23 ' HB2' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -76.85 161.76 28.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.66 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -92.15 -22.12 20.03 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.099 0.476 . . . . 0.0 110.526 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -86.99 -24.17 24.78 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.14 -67.57 0.14 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.309 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.581 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 19.3 m -64.46 -34.24 68.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -57.08 -67.43 0.32 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.589 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -68.88 -38.01 79.41 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.418 ' C ' ' SD ' ' A' ' 124' ' ' MET . 15.2 tmm? -59.88 -47.09 87.18 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.035 0.445 . . . . 0.0 110.103 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 125' ' ' ILE . 97.6 mt -68.84 -16.86 21.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.144 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -80.18 -51.61 8.76 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.08 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 129' ' ' ASP . 44.1 tp10 -86.2 -68.2 0.76 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 118.978 -1.089 . . . . 0.0 111.362 -177.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 124' ' ' MET . . . -37.44 -25.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.635 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 127' ' ' GLU . 40.0 t0 -88.57 126.71 35.4 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.165 0.507 . . . . 0.0 110.849 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -65.46 -41.19 90.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.95 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.97 -42.87 99.61 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.755 0.312 . . . . 0.0 110.501 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.45 -0.92 62.83 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 50.2 p-10 -94.26 -18.57 21.53 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.894 0.378 . . . . 0.0 110.097 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.513 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 64.84 121.22 0.01 OUTLIER Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -164.45 144.5 7.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.57 -0.315 . . . . 0.0 110.272 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 72.7 t -128.62 134.36 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.39 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -150.98 176.3 11.25 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.105 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -56.15 -46.75 79.14 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.338 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -55.53 -37.92 68.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.579 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -69.16 -39.68 78.62 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.446 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -61.92 -43.12 99.5 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.0 t -58.03 -45.93 88.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.769 0.319 . . . . 0.0 110.657 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -77.07 -24.32 51.92 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.684 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 44.5 ttp -63.88 -41.14 97.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.727 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.415 ' O ' ' OG1' ' A' ' 146' ' ' THR . 64.6 mtt -91.36 130.38 37.22 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.929 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 145' ' ' MET . 36.0 m -167.44 67.8 0.09 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.583 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.42 87.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.32 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 66.4 mttm . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.913 179.606 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -81.88 115.42 21.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.444 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -81.42 -4.56 56.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.54 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 36.4 tp -84.77 123.55 30.55 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.15 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.5 p -79.83 156.17 27.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.136 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -75.84 -23.15 55.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.955 0.407 . . . . 0.0 110.216 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -62.03 -43.69 98.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.798 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -64.31 -41.99 96.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.881 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 91.3 mt -64.24 -43.54 97.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.722 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.82 -41.28 64.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.84 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -43.95 -48.24 8.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.653 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -65.97 -39.8 90.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.67 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -65.36 -48.14 73.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.237 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -64.14 -33.96 76.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.512 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.64 -19.88 12.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.543 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -57.45 -49.25 76.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.823 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.4 m -60.93 -40.84 94.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.552 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.55 -42.85 99.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.982 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -59.31 -49.84 76.27 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.849 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.466 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.5 t0 -75.97 -15.62 60.13 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.644 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -43.58 -33.25 1.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.787 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.433 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 14.5 p-10 -53.43 -43.45 68.02 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.466 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -145.57 -153.69 5.95 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 26.7 p-10 -74.79 -47.26 31.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 110.59 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.71 107.22 0.28 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 178.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.629 ' C ' HD12 ' A' ' 27' ' ' ILE . 8.4 m -166.65 149.91 6.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.143 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.629 HD12 ' C ' ' A' ' 26' ' ' THR . 2.8 mp -119.52 109.49 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.505 HG22 HG22 ' A' ' 62' ' ' THR . 4.1 p -130.98 169.68 15.5 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.908 0.385 . . . . 0.0 110.473 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.507 ' CB ' HE22 ' A' ' 49' ' ' GLN . 82.4 p -63.43 -29.57 70.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.182 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -62.16 -41.25 98.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.252 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.448 ' OE2' ' O ' ' A' ' 26' ' ' THR . 89.6 mt-10 -67.0 -45.72 76.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.98 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.3 tp -65.96 -44.43 85.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.409 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.93 -22.5 4.57 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.5 m -67.06 -30.2 70.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.78 0.324 . . . . 0.0 110.446 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.4 t -62.24 -22.99 30.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.809 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.0 mmm -56.0 -37.14 68.74 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.702 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -63.19 -44.2 96.05 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 116.771 -1.971 . . . . 0.0 110.06 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 91.6 p -60.45 -37.9 82.44 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.166 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 41' ' ' GLN . 39.1 mt -94.71 5.05 53.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.28 0.562 . . . . 0.0 110.505 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.46 -67.62 0.26 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 39' ' ' LEU . 84.1 mt-30 -147.87 104.98 3.63 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 44' ' ' THR . 58.7 t30 -123.24 76.8 52.48 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.06 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' A' ' 46' ' ' ALA . 72.0 Cg_exo -36.63 -29.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.582 2.188 . . . . 0.0 112.653 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.434 ' N ' ' HB3' ' A' ' 120' ' ' GLU . 11.4 m -38.46 -31.98 0.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.358 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 49' ' ' GLN . 96.8 mt-10 -88.77 -36.19 16.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.195 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -55.01 -49.8 70.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.558 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -69.85 -49.14 55.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.26 0.552 . . . . 0.0 110.258 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.91 -21.36 65.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.683 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.507 HE22 ' CB ' ' A' ' 29' ' ' THR . 71.2 tp60 -45.55 -47.44 14.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.209 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 68.1 t0 -70.89 -38.6 73.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.492 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.1 ttp -62.38 -42.83 99.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.922 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 87.1 mt -63.53 -46.28 95.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.541 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.669 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 87.3 m-20 -64.02 -41.79 97.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.62 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -59.27 -59.15 5.92 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.491 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.8 p -66.07 -31.82 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.0 110.847 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.546 ' OD2' ' N ' ' A' ' 62' ' ' THR . 45.5 t0 -87.28 -12.6 46.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.737 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.24 13.01 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.048 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 56' ' ' ASP . 16.7 p-10 -63.98 -33.84 76.65 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.47 -26.41 0.08 OUTLIER Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.591 ' C ' ' H ' ' A' ' 62' ' ' THR . 16.5 p30 -178.25 148.21 0.47 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.513 -0.343 . . . . 0.0 110.262 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.92 34.23 0.1 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.591 ' H ' ' C ' ' A' ' 60' ' ' ASN . 70.7 p -129.68 151.49 50.21 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.0 mt -119.62 134.12 64.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.821 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -77.09 -155.43 0.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.042 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.49 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -96.52 -47.86 0.24 Allowed Pre-proline 0 N--CA 1.469 0.485 0 CA-C-O 120.501 0.191 . . . . 0.0 110.845 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 42.6 Cg_exo -54.93 -36.06 91.07 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.115 1.877 . . . . 0.0 111.606 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -83.61 -28.69 28.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.794 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -59.38 -46.42 88.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.7 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.0 -43.48 95.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.822 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.7 m -63.6 -45.29 91.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.113 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 46.8 ttp -62.18 -44.44 96.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.782 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 47.8 mmm -63.39 -42.2 98.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.718 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.77 -48.65 80.82 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.686 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -71.03 -50.13 37.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.565 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -64.67 -41.8 95.82 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.371 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.505 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 32.1 mmm -121.17 127.02 51.13 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.219 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -82.77 153.14 25.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.675 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -52.54 -179.96 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.282 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.0 p -80.97 -9.74 59.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.651 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -65.95 -21.65 66.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.419 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.7 m -50.58 -32.25 18.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.407 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -38.19 -45.71 0.98 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.716 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -69.12 -46.6 67.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.145 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -65.02 -49.52 69.89 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.9 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.5 mt -56.37 -21.14 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -57.94 -44.94 87.24 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 118.466 -1.294 . . . . 0.0 109.649 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -66.16 -25.95 67.19 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.6 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.81 -14.14 58.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.071 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -56.56 -50.68 71.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.298 0.57 . . . . 0.0 111.121 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -63.37 -44.49 94.64 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.203 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.6 t -66.64 -45.63 87.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.807 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.429 ' CE2' ' CD1' ' A' ' 100' ' ' ILE . 19.3 t80 -62.55 -47.23 84.79 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.643 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.431 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 37.3 t0 -119.94 106.56 12.16 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.242 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -68.14 -44.29 76.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.011 0.434 . . . . 0.0 110.58 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.431 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 0.9 OUTLIER -62.36 -44.47 96.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.779 -179.312 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.1 -47.41 1.05 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -74.6 -14.44 60.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.017 0.437 . . . . 0.0 110.541 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.79 161.79 12.64 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -112.19 144.38 41.68 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.429 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 64.7 mt -74.95 129.49 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.902 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.5 p -83.05 168.79 16.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.284 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.86 97.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.85 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.14 -41.7 94.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.701 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -67.32 -37.36 83.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.086 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.2 tp -60.21 -43.19 96.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.2 0.524 . . . . 0.0 110.682 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -54.07 -40.68 67.39 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.846 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -59.09 -42.2 89.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.893 0.377 . . . . 0.0 110.002 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.11 -44.92 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.745 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 80.9 mmm -63.51 -35.48 80.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.568 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.4 m -61.23 -41.71 97.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.251 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -59.8 -39.16 84.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.634 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.39 -44.29 97.4 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.582 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.69 -143.95 10.03 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -144.33 30.49 1.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.817 0.342 . . . . 0.0 110.766 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -62.87 -40.8 98.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.414 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.5 mt -105.25 165.94 10.76 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.485 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -65.15 161.52 18.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 0.0 110.51 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.445 ' C ' ' OE1' ' A' ' 120' ' ' GLU . 83.8 m-20 -91.28 -20.37 21.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 178.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -89.3 -26.11 21.31 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.684 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -34.91 -65.18 0.23 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.559 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.684 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 31.0 m -68.6 -27.46 36.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -178.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -63.25 -43.78 97.03 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.614 -0.435 . . . . 0.0 112.002 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -88.46 -41.07 13.0 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.471 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 15.0 tmm? -60.57 -42.67 97.11 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.898 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 125' ' ' ILE . 96.6 mt -69.98 -15.88 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -87.2 -66.69 0.88 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 118.971 -1.092 . . . . 0.0 112.003 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 128' ' ' ALA . 50.9 tp10 -70.97 -68.5 0.43 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.304 -0.959 . . . . 0.0 111.939 -176.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 124' ' ' MET . . . -37.31 -40.01 0.32 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.699 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -88.42 124.64 34.15 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.066 0.46 . . . . 0.0 110.436 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.697 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -72.24 -16.03 18.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.281 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.461 ' C ' ' H ' ' A' ' 133' ' ' ASP . 51.0 m-20 -65.36 -45.65 83.28 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.623 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.07 -11.48 2.67 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 42.0 p30 -88.51 -17.41 30.35 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.097 0.475 . . . . 0.0 110.15 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 58.35 120.73 0.01 OUTLIER Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.443 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 10.4 pt20 -161.02 137.88 8.77 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.4 t -125.59 134.17 67.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.874 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.468 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.4 t30 -148.98 159.56 44.1 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.232 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -40.04 -35.36 0.37 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.334 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.468 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 53.1 mp0 -65.8 -42.32 90.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.17 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 80.3 mt-10 -71.83 -30.18 65.2 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.538 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -58.5 -45.57 88.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.248 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 58.9 t -60.19 -48.2 89.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.914 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -70.05 -32.13 70.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.833 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.483 ' SD ' ' C37' ' A' ' 205' ' ' 4DY . 37.6 ttp -56.62 -47.69 79.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.696 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 69.7 mtm -106.1 134.1 49.76 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.844 0.354 . . . . 0.0 110.613 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 88.7 m -160.14 81.69 0.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.325 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 76' ' ' MET . . . -65.95 -40.52 91.41 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.885 0.374 . . . . 0.0 110.571 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.627 179.997 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' 4DY . . . . . 0.483 ' C37' ' SD ' ' A' ' 144' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -88.73 117.49 27.74 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.43 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -82.8 -36.34 25.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.607 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 43.3 tp -99.24 122.67 42.72 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.178 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 p -137.92 158.88 43.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.327 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -67.75 -33.58 75.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.582 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -53.73 -44.15 69.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.843 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -57.67 -42.09 82.86 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.6 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.99 -43.22 96.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.577 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.87 -29.79 56.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.288 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -54.7 -48.23 72.72 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.537 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -65.67 -40.84 92.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.824 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -62.04 -44.03 97.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.631 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -66.96 -37.58 84.54 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.998 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.482 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.0 -27.99 65.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.779 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -57.77 -46.95 83.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.526 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 m -77.9 -21.51 51.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.693 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.37 -42.81 99.7 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.431 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.482 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.2 m-85 -60.17 -51.01 71.43 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.462 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.1 t0 -76.89 -14.35 59.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.893 0.377 . . . . 0.0 111.358 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -45.56 -32.67 2.39 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.893 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 8.8 p-10 -53.73 -46.11 70.73 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.542 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -144.37 -151.62 5.48 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 30.7 p-10 -72.97 -47.19 47.54 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.074 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.7 107.37 0.28 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 178.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 4.5 m -166.62 139.28 3.72 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.38 -0.482 . . . . 0.0 111.179 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 27' ' ' ILE . 5.2 mp -115.13 109.23 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.596 HG22 HG22 ' A' ' 62' ' ' THR . 2.6 p -128.66 170.31 13.42 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.817 0.342 . . . . 0.0 110.442 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.635 ' CB ' HE22 ' A' ' 49' ' ' GLN . 67.3 p -64.66 -33.11 75.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.788 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -61.71 -41.32 97.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.011 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 26' ' ' THR . 90.1 mt-10 -63.49 -45.71 89.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.863 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.2 tp -64.1 -43.35 95.61 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.149 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.78 -26.1 53.29 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.2 m -63.93 -41.41 97.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.843 0.354 . . . . 0.0 110.084 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.7 t -56.24 -23.56 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.363 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.483 ' O ' ' N ' ' A' ' 40' ' ' GLY . 62.1 mmm -48.14 -30.27 4.41 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.671 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -64.38 -45.64 86.81 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 118.042 -1.463 . . . . 0.0 110.975 -178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -63.94 -21.98 66.72 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.852 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 41' ' ' GLN . 16.8 mt -107.75 3.7 24.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.086 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.19 -71.2 0.02 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 39' ' ' LEU . 87.8 mt-30 -145.43 109.47 4.84 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 44' ' ' THR . 41.3 t30 -125.61 70.87 65.55 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.552 ' O ' ' N ' ' A' ' 46' ' ' ALA . 84.8 Cg_exo -32.94 -30.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.65 2.233 . . . . 0.0 112.792 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.542 ' N ' ' O ' ' A' ' 42' ' ' ASN . 26.1 m -39.29 -30.15 0.06 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.545 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.417 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.9 mt-10 -86.67 -34.85 19.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.332 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -59.04 -50.14 75.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.799 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.15 -46.13 71.63 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 51' ' ' MET . 84.5 mt -64.81 -31.07 72.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.382 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.635 HE22 ' CB ' ' A' ' 29' ' ' THR . 61.1 tp60 -37.5 -51.36 1.14 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.74 0.305 . . . . 0.0 110.761 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.22 -40.33 90.22 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.259 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 48' ' ' LEU . 33.1 ttp -62.45 -40.98 98.37 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.948 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.415 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 83.5 mt -61.99 -49.9 82.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.142 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.603 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 89.9 m-20 -62.99 -40.36 97.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.597 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -55.19 -61.52 2.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.213 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.87 -30.21 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.341 . . . . 0.0 111.28 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 62' ' ' THR . 50.6 t0 -84.63 -13.24 52.15 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.574 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -71.99 13.07 0.33 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.871 0.367 . . . . 0.0 110.284 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.5 p30 -65.58 -28.92 69.49 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.535 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -150.48 -22.34 0.06 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.552 ' C ' ' H ' ' A' ' 62' ' ' THR . 3.3 p30 173.14 151.87 0.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.99 34.71 0.15 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.596 HG22 HG22 ' A' ' 28' ' ' THR . 81.7 p -134.33 149.49 50.87 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.6 mt -120.98 134.57 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.26 162.4 28.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.41 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.471 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -64.56 -48.12 74.99 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.513 -179.076 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 50.5 Cg_exo -51.3 -37.29 59.76 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.195 1.93 . . . . 0.0 111.71 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -87.59 -22.3 24.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.836 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.42 -47.14 87.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.048 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.54 -42.89 98.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.549 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.8 m -63.95 -46.08 86.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.647 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.6 ttp -61.69 -47.56 84.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.077 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.9 mmm -65.76 -37.85 87.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.282 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.53 -50.01 75.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.031 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -71.51 -43.75 65.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.203 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.73 -43.56 88.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.733 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.431 ' O ' ' O ' ' A' ' 73' ' ' ALA . 22.4 mmm -104.35 127.44 52.01 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.094 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.7 tptt -84.96 141.17 30.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.38 . . . . 0.0 110.712 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' LYS . 95.0 m-20 -48.92 179.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.226 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.8 p -75.53 -6.76 51.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.418 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.44 -15.54 62.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.509 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.0 m -61.92 -19.87 63.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.548 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -48.19 -44.76 33.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.342 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.95 -39.52 79.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.905 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.82 -45.22 83.11 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.006 0.431 . . . . 0.0 110.152 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.2 mt -66.04 -19.04 25.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.525 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -58.47 -45.38 88.73 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.218 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.64 -31.81 73.04 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.928 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.406 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -72.03 -14.69 61.94 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.138 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -57.94 -48.99 78.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.297 0.57 . . . . 0.0 111.116 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -64.09 -45.58 88.07 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.36 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.7 t -76.17 -51.54 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.381 . . . . 0.0 110.894 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.446 ' CE2' HD12 ' A' ' 100' ' ' ILE . 26.3 t80 -61.98 -47.22 85.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.598 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.43 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 18.2 t70 -108.95 94.15 4.89 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.21 -41.04 74.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.02 0.438 . . . . 0.0 110.578 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 19.9 p-10 -62.48 -39.74 94.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.969 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.44 -67.33 0.97 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.56 -16.52 63.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.917 0.389 . . . . 0.0 110.228 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.78 162.0 12.57 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.2 155.4 24.04 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.811 0.338 . . . . 0.0 110.237 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.446 HD12 ' CE2' ' A' ' 92' ' ' PHE . 94.0 mt -79.76 126.04 39.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.965 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.3 p -82.45 168.94 16.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.181 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.07 89.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.557 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.59 -47.4 83.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.65 -32.8 72.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.5 tp -61.57 -41.69 97.77 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.423 0.63 . . . . 0.0 110.691 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -56.51 -43.23 79.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.845 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -58.47 -41.96 86.42 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.7 t -66.64 -43.35 90.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.656 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.0 mmm -62.01 -35.65 79.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.634 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.4 m -61.04 -44.39 97.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.071 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -59.8 -34.99 73.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.348 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.0 tp -61.12 -46.75 89.29 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.068 0.461 . . . . 0.0 110.375 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.46 -160.71 33.42 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -140.53 23.38 2.31 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.654 0.264 . . . . 0.0 110.835 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -63.66 -42.82 98.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.983 0.42 . . . . 0.0 110.237 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.7 mt -92.8 175.8 6.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.965 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.468 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -72.87 161.33 30.84 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.672 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -91.69 -22.5 20.2 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.945 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -87.88 -25.35 23.31 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.167 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.637 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.44 -61.19 0.46 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.114 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.637 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 20.4 m -67.4 -40.21 84.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.492 ' N ' HG23 ' A' ' 121' ' ' VAL . 81.2 m-20 -56.76 -47.1 80.86 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.51 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -86.0 -40.3 15.95 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.6 tmm? -59.52 -46.49 88.69 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.061 0.458 . . . . 0.0 109.954 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 125' ' ' ILE . 91.3 mt -69.2 -16.49 20.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.409 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -78.62 -50.61 11.19 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 119.397 -0.921 . . . . 0.0 112.09 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' ASP . 42.4 tp10 -87.64 -67.47 0.82 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.897 -178.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.37 -26.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.784 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' GLU . 25.4 t0 -88.02 128.32 35.4 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.092 0.472 . . . . 0.0 111.073 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.666 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.51 -43.42 90.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.404 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -65.35 -40.28 93.41 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.122 0.487 . . . . 0.0 110.164 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.3 -1.98 58.67 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.334 -1.107 . . . . 0.0 110.334 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 134' ' ' GLY . 55.3 p-10 -89.53 -8.96 51.66 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 57.44 115.43 0.01 OUTLIER Glycine 0 CA--C 1.522 0.525 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.229 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 20.3 pt20 -160.62 133.59 6.5 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.4 t -123.45 136.92 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.066 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -151.36 172.5 15.82 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.221 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -54.8 -46.82 74.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.152 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 139' ' ' GLU . 55.5 mp0 -58.65 -44.32 90.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.71 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 93.3 mt-10 -72.09 -29.34 64.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.763 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.9 -43.99 77.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.587 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 94.7 t -59.1 -46.32 91.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.301 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.33 -29.13 66.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.136 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.7 ttp -59.69 -42.87 93.91 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.841 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.48 138.81 50.64 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.913 0.387 . . . . 0.0 110.754 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 80.8 m -163.19 77.73 0.43 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.664 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.19 -27.74 68.9 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.414 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.86 -1.067 . . . . 0.0 110.625 -179.853 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 4' ' ' LEU . 43.5 t0 -88.7 115.92 26.59 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.699 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -78.81 -25.38 44.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.547 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.419 ' O ' ' OD1' ' A' ' 2' ' ' ASP . 37.1 tp -109.52 120.29 42.03 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.024 0.44 . . . . 0.0 110.33 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.2 p -139.05 158.8 43.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.043 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -68.7 -20.9 64.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -56.59 -39.29 73.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.15 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.28 -40.28 95.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.624 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.26 -43.59 97.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 121.074 -0.251 . . . . 0.0 110.863 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.25 -18.81 6.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.216 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -54.33 -42.25 69.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.044 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -67.78 -41.79 82.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.381 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -62.57 -43.76 98.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.956 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -67.2 -35.77 80.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.398 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.51 -24.17 66.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.768 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -55.4 -46.5 76.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.777 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.4 m -80.68 -19.41 45.26 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.808 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.9 tp -64.18 -41.95 96.89 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.019 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.421 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.2 m-85 -58.84 -46.13 88.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.852 0.358 . . . . 0.0 111.107 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.3 t0 -79.58 -13.47 59.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.461 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -43.02 -32.77 0.71 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.867 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' CG ' ' OE2' ' A' ' 31' ' ' GLU . 10.9 p-10 -52.91 -45.13 67.44 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.49 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.433 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . -149.66 -151.26 5.46 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 21.3 p-10 -71.2 -46.86 60.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.712 0.292 . . . . 0.0 111.005 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.03 107.39 0.28 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.595 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.8 m -166.59 136.22 3.09 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.191 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 27' ' ' ILE . 1.9 mp -110.58 118.27 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.464 HG22 HG22 ' A' ' 62' ' ' THR . 2.0 p -134.73 167.08 21.5 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.881 0.372 . . . . 0.0 110.285 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.536 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.3 p -64.13 -33.65 76.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.283 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -62.56 -40.16 95.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.707 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.457 ' OE2' ' O ' ' A' ' 26' ' ' THR . 88.9 mt-10 -64.68 -48.51 74.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.366 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.8 tp -64.42 -43.75 93.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.252 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.31 -24.69 17.01 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -64.08 -41.04 97.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.851 0.358 . . . . 0.0 110.151 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.04 -22.47 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.207 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.6 mmm -48.78 -33.56 10.6 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.969 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -64.3 -45.5 87.69 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 118.163 -1.415 . . . . 0.0 110.272 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.3 p -59.0 -30.65 68.14 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.356 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 41' ' ' GLN . 9.3 mt -102.33 5.47 39.89 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.966 0.412 . . . . 0.0 110.443 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.27 -69.79 0.03 OUTLIER Glycine 0 N--CA 1.465 0.588 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 39' ' ' LEU . 85.7 mt-30 -143.25 116.29 8.88 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.1 t30 -132.66 69.75 79.45 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.906 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 46' ' ' ALA . 92.0 Cg_exo -33.1 -33.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 122.527 2.151 . . . . 0.0 112.49 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 42' ' ' ASN . 12.4 m -38.99 -29.35 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.476 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 43' ' ' PRO . 90.6 mt-10 -87.65 -35.22 18.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.463 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -61.26 -49.17 78.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.027 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.434 ' HB2' HG23 ' A' ' 117' ' ' THR . 3.1 tm-20 -68.03 -48.61 65.18 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.403 0.621 . . . . 0.0 109.889 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.515 HD22 ' CE ' ' A' ' 51' ' ' MET . 87.4 mt -62.62 -22.75 66.64 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.018 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.536 HE22 ' CB ' ' A' ' 29' ' ' THR . 47.9 tp60 -40.21 -49.58 2.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 110.532 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.69 -39.8 73.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.472 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.515 ' CE ' HD22 ' A' ' 48' ' ' LEU . 36.1 ttp -61.54 -40.59 95.23 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.765 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.78 -46.93 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.658 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.653 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 28.3 m120 -65.17 -39.84 93.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.333 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -58.08 -57.23 13.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.434 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 p -68.31 -32.83 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.936 0.398 . . . . 0.0 110.964 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.0 t0 -86.08 -13.03 48.51 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.812 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.653 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.04 15.42 0.16 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.056 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 56' ' ' ASP . 38.7 p-10 -66.66 -23.55 66.16 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.39 -22.56 0.03 OUTLIER Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.588 ' C ' ' H ' ' A' ' 62' ' ' THR . 4.6 p30 179.31 146.55 0.19 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.76 33.71 0.18 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.588 ' H ' ' C ' ' A' ' 60' ' ' ASN . 80.6 p -132.15 143.93 50.33 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.88 135.12 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.057 0.456 . . . . 0.0 110.175 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.42 172.34 4.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.441 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.438 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -72.53 -49.59 8.56 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.761 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 53.2 Cg_exo -52.07 -43.26 53.95 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.87 1.714 . . . . 0.0 111.902 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.46 -37.43 77.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 110.867 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -60.42 -45.38 93.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.962 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.9 mt -62.39 -44.57 96.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.523 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.5 m -67.45 -45.43 76.03 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 111.242 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.4 ttp -61.17 -43.69 98.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.928 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 87.0 mmm -64.75 -39.36 93.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.206 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.435 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.89 -42.83 94.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.89 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -71.52 -41.78 68.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.237 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -64.76 -40.92 96.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.86 0.362 . . . . 0.0 110.422 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.435 ' O ' ' O ' ' A' ' 73' ' ' ALA . 14.2 mmt -95.21 129.82 42.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.129 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -86.84 142.8 27.8 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -50.35 168.77 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.425 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.0 p -75.15 -15.21 60.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.683 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.98 -16.5 64.08 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.908 0.385 . . . . 0.0 110.439 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 82' ' ' GLU . 1.1 m -60.41 -23.76 64.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.759 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 81' ' ' SER . 81.2 tt0 -36.75 -48.49 0.73 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.893 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -70.76 -43.52 68.62 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.262 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -63.88 -39.59 94.55 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.961 0.41 . . . . 0.0 110.025 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.5 mt -66.95 -21.92 28.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.287 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -57.97 -43.6 86.58 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 119.047 -1.061 . . . . 0.0 110.063 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -63.74 -34.76 78.61 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.846 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.8 -19.91 66.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.056 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -56.57 -48.75 76.7 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.261 0.553 . . . . 0.0 110.848 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -68.29 -44.71 74.86 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.462 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.7 t -66.3 -48.37 81.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.443 ' CE2' HD12 ' A' ' 100' ' ' ILE . 23.4 t80 -64.01 -47.11 81.58 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.654 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.405 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 18.4 t70 -120.35 100.14 6.99 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -66.74 -39.75 88.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.745 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' ASN . 2.0 p-10 -65.66 -40.59 92.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.102 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.62 -59.49 0.48 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 95' ' ' ASP . 54.0 m-80 -61.88 -17.44 56.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.986 0.422 . . . . 0.0 110.2 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.405 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.56 160.91 12.96 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -113.23 155.56 24.85 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.443 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -95.74 118.25 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.966 0.412 . . . . 0.0 111.12 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.9 p -85.53 171.38 11.78 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.89 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.74 -35.73 78.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.551 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.5 -50.78 72.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.158 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -69.29 -37.36 77.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.922 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.03 -39.4 94.62 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.538 0.685 . . . . 0.0 111.07 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -54.22 -43.62 70.98 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.121 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -63.1 -39.49 94.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.3 t -61.82 -45.26 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.151 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 37.7 mmm -64.31 -37.94 89.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.562 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.0 m -60.58 -40.16 90.73 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -61.25 -38.12 85.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.204 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 tp -61.53 -44.09 97.69 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.907 0.385 . . . . 0.0 110.25 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.98 -154.71 25.68 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -139.02 23.35 2.6 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.722 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -62.66 -43.22 99.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 0.0 110.314 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.9 mt -99.95 169.07 9.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.525 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.493 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -68.35 162.17 25.85 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.556 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -92.15 -22.28 19.94 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.434 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -87.26 -24.47 24.36 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.58 -66.06 0.21 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.254 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.626 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.7 m -65.19 -35.28 75.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.363 -178.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -60.51 -46.75 88.98 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.54 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -84.87 -40.4 17.12 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.3 tmm? -58.91 -47.21 85.79 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 125' ' ' ILE . 94.2 mt -69.16 -18.37 22.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.553 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -77.4 -51.39 10.89 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.274 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 129' ' ' ASP . 34.9 tp10 -86.31 -68.67 0.72 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.341 -0.943 . . . . 0.0 111.456 -177.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.69 -21.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.877 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 127' ' ' GLU . 38.7 t0 -90.14 125.02 35.3 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.07 0.462 . . . . 0.0 110.657 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.643 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.46 -32.09 56.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.018 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -72.19 -45.8 58.9 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.907 0.384 . . . . 0.0 110.347 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.68 -5.47 61.16 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 134' ' ' GLY . 35.2 p30 -89.94 -9.67 47.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.962 0.411 . . . . 0.0 109.934 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 58.22 117.93 0.01 OUTLIER Glycine 0 CA--C 1.519 0.294 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 8.2 pt20 -159.76 140.11 11.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.53 -0.335 . . . . 0.0 110.137 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.7 t -126.23 133.24 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.915 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.544 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.8 t30 -150.69 175.39 12.0 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.337 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -57.67 -52.1 66.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.761 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.544 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 57.2 mp0 -55.93 -35.02 66.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.668 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 79.4 mt-10 -69.55 -39.25 77.53 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.694 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -61.26 -45.33 94.97 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.753 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.1 t -58.01 -45.9 87.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -74.2 -30.84 62.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.413 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.4 ttp -60.08 -40.62 90.21 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.621 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 72.9 mtm -105.21 141.73 36.24 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.921 0.391 . . . . 0.0 110.589 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.1 m -167.3 72.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.119 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.58 -41.83 97.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.587 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 C--O 1.218 -0.561 0 CA-C-O 118.066 -0.968 . . . . 0.0 110.269 -179.89 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -107.79 102.8 11.98 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.974 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -78.48 -8.58 58.68 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 50.0 tp -102.46 121.59 42.64 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.167 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.2 p -135.52 163.96 28.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.685 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -61.39 -31.51 71.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.372 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.86 -43.55 98.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.472 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -66.57 -41.08 89.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.868 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.22 -42.92 96.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.048 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.36 -36.78 78.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.155 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -54.83 -50.58 68.24 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.997 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -63.74 -44.06 94.63 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.772 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -62.57 -45.94 90.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.484 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -69.69 -35.84 75.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.959 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -63.08 -37.79 88.59 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.492 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -58.47 -46.27 86.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.522 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -80.92 -18.82 45.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.735 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.49 -43.14 98.13 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.746 0.308 . . . . 0.0 111.283 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 83.0 m-85 -57.97 -49.27 77.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.586 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 6.3 t0 -73.15 -13.4 61.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.756 0.313 . . . . 0.0 111.27 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -44.49 -33.52 1.75 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.761 0.315 . . . . 0.0 110.959 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.414 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 7.2 p-10 -53.98 -45.69 71.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.86 0.362 . . . . 0.0 110.946 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.443 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . -149.01 -150.86 5.32 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 25.1 p-10 -70.2 -47.37 61.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.948 0.404 . . . . 0.0 111.006 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.527 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.81 107.81 0.3 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.444 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 6.2 m -166.21 139.46 4.09 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.139 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.2 mp -120.63 110.51 28.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.552 ' CG2' HG22 ' A' ' 62' ' ' THR . 2.8 p -130.95 169.38 15.88 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.025 0.44 . . . . 0.0 110.566 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.421 HG22 HG21 ' A' ' 52' ' ' ILE . 51.2 p -63.07 -31.43 72.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.394 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -62.11 -42.35 99.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.99 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 26' ' ' THR . 81.5 mt-10 -66.74 -45.84 77.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.004 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.9 tp -63.93 -42.9 97.24 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.396 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.76 -25.11 28.42 Favored Glycine 0 C--O 1.226 -0.36 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.0 m -63.96 -44.1 93.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.934 0.397 . . . . 0.0 110.796 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.3 t -55.54 -20.49 7.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.527 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.509 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 87.4 mmm -48.9 -34.89 13.62 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.625 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -63.12 -46.4 87.5 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 118.005 -1.478 . . . . 0.0 111.851 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.0 p -60.75 -30.89 70.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 41' ' ' GLN . 24.9 mt -96.75 2.13 51.62 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.974 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.92 -67.94 0.02 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.532 ' N ' ' O ' ' A' ' 39' ' ' LEU . 86.1 mt-30 -143.59 110.07 5.47 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -123.72 75.03 55.56 Favored Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.461 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.577 ' O ' ' N ' ' A' ' 46' ' ' ALA . 99.5 Cg_exo -36.45 -35.69 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.732 1.621 . . . . 0.0 112.13 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.421 ' N ' ' HB3' ' A' ' 120' ' ' GLU . 5.9 m -37.83 -31.49 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.763 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.509 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.2 mt-10 -87.35 -36.03 18.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.316 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.47 -51.97 67.6 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.866 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -68.39 -47.21 67.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.304 0.573 . . . . 0.0 109.958 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.51 HD22 ' CE ' ' A' ' 51' ' ' MET . 84.7 mt -64.09 -26.81 68.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.917 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 48' ' ' LEU . 58.7 tp60 -38.82 -46.35 1.27 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.751 0.31 . . . . 0.0 110.566 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.17 -41.69 66.74 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.54 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.51 ' CE ' HD22 ' A' ' 48' ' ' LEU . 40.0 ttp -62.14 -41.73 98.55 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.076 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.421 HG21 HG22 ' A' ' 29' ' ' THR . 96.6 mt -60.92 -51.99 66.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.39 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.625 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 17.3 m120 -64.29 -40.03 95.13 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.71 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -55.61 -59.58 4.65 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.259 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.79 -34.43 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.99 0.424 . . . . 0.0 110.762 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 62' ' ' THR . 55.3 t0 -80.73 -13.59 58.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.533 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.13 16.11 0.14 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.274 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 56' ' ' ASP . 21.5 p-10 -66.07 -24.61 66.75 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -154.54 -25.55 0.04 OUTLIER Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.604 ' C ' ' H ' ' A' ' 62' ' ' THR . 10.9 p30 179.96 150.84 0.39 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.403 ' C ' ' OD2' ' A' ' 56' ' ' ASP . . . -65.48 32.45 0.12 Allowed Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.604 ' H ' ' C ' ' A' ' 60' ' ' ASN . 66.5 p -130.39 148.91 52.26 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.0 mt -118.5 133.86 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.987 0.423 . . . . 0.0 110.514 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.32 169.08 18.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.475 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.436 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -67.29 -49.52 43.37 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.191 -179.027 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.8 Cg_exo -52.08 -45.31 39.77 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.995 1.797 . . . . 0.0 111.898 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.96 -37.02 72.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.694 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -60.69 -46.37 90.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.964 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.3 mt -62.22 -44.37 96.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.857 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.1 m -65.15 -44.63 87.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.904 0.383 . . . . 0.0 110.304 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 44.9 ttp -62.07 -41.83 98.57 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.853 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 76' ' ' MET . 60.3 mmm -63.35 -40.86 98.43 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.585 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.0 -35.84 77.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.739 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -87.71 -56.27 3.42 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.735 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -63.13 -43.31 98.74 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.123 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 72' ' ' MET . 50.8 mmm -108.88 131.51 54.94 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.863 0.363 . . . . 0.0 110.214 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 78' ' ' ASP . 29.0 tptt -83.12 150.07 26.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.764 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 77' ' ' LYS . 5.7 m-20 -55.51 -159.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.421 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.8 p -96.19 -0.27 50.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.916 0.388 . . . . 0.0 110.499 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -82.87 2.48 34.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.119 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 83' ' ' GLU . 1.6 m -62.09 -35.6 79.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.959 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -37.99 -29.61 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.861 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 81' ' ' SER . 71.5 mm-40 -74.17 -56.87 4.39 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -64.71 -38.73 91.99 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.154 0.502 . . . . 0.0 109.656 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.7 -19.29 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.482 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.1 ttt-85 -57.69 -44.01 85.54 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.171 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -65.9 -33.02 74.87 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.785 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -63.0 -27.96 69.78 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -55.63 -46.0 77.47 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.38 0.609 . . . . 0.0 110.405 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -74.42 -51.08 15.97 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.757 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.21 -47.79 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.04 0.448 . . . . 0.0 110.553 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.473 ' CE2' HD12 ' A' ' 100' ' ' ILE . 39.2 t80 -63.5 -45.83 88.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.239 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.48 ' OD2' ' N ' ' A' ' 96' ' ' GLY . 36.0 t70 -127.16 105.08 8.33 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.586 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -68.55 -42.12 78.82 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.897 0.379 . . . . 0.0 111.059 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' A' ' 97' ' ' ASN . 1.5 p-10 -59.95 -46.62 88.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.846 -178.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.48 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 73.77 -41.77 1.05 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.43 ' H ' ' C ' ' A' ' 95' ' ' ASP . 77.1 m-20 -80.24 -13.55 59.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.929 0.395 . . . . 0.0 110.046 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.94 161.28 12.8 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -113.29 149.82 33.35 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.7 0.286 . . . . 0.0 110.511 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.473 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -96.79 116.55 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.99 0.424 . . . . 0.0 111.191 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.9 p -84.39 170.76 13.24 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.3 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.57 -37.52 86.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.157 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.27 -47.16 84.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.978 0.418 . . . . 0.0 110.577 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.55 -35.99 75.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.495 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.6 tp -62.33 -40.15 95.41 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.63 0.728 . . . . 0.0 110.668 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -52.44 -45.02 65.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.649 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -61.64 -45.04 95.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.971 0.415 . . . . 0.0 110.396 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.9 t -63.91 -44.89 98.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.309 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 48.4 mmm -64.38 -37.12 86.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.514 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 83.1 m -61.04 -46.13 91.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -67.13 -24.54 65.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.216 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.1 tp -61.51 -44.89 96.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.893 0.378 . . . . 0.0 110.824 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.53 -148.79 15.54 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -140.36 25.84 2.21 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.502 0.192 . . . . 0.0 111.056 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -64.75 -45.34 86.84 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.979 0.418 . . . . 0.0 110.958 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.6 mt -113.54 170.67 8.07 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.943 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.48 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -69.51 161.54 29.32 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.014 0.435 . . . . 0.0 110.952 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -92.1 -23.93 19.29 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.805 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -88.06 -20.39 25.81 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.58 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.7 -67.39 0.16 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.58 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 18.0 m -64.53 -35.15 73.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -57.68 -66.46 0.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -64.35 -43.79 93.48 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.465 ' C ' ' SD ' ' A' ' 124' ' ' MET . 16.1 tmm? -57.31 -48.69 78.3 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.832 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.22 -23.78 30.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.219 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -77.08 -46.86 22.17 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.499 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -85.38 -68.28 0.74 Allowed 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.486 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.01 -33.3 0.08 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.503 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -94.72 146.77 23.94 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.819 0.342 . . . . 0.0 110.702 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.662 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -89.41 -17.37 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -65.46 -44.48 87.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.055 0.455 . . . . 0.0 110.531 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.37 -11.01 5.61 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 41.3 p-10 -89.12 -19.39 25.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.87 0.367 . . . . 0.0 110.483 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.549 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 55.36 106.24 0.01 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.477 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 11.1 pt20 -140.15 134.7 31.6 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.7 t -116.93 132.04 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.007 0.432 . . . . 0.0 110.225 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -142.74 175.44 9.81 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.579 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -58.22 -45.83 86.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.147 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.481 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 54.0 mp0 -63.66 -36.92 85.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.407 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.477 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 78.3 mt-10 -67.09 -33.85 76.38 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.137 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -62.09 -40.55 96.2 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.466 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.0 t -57.18 -45.78 84.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.516 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -82.86 -15.82 50.02 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.838 0.351 . . . . 0.0 111.224 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 43.8 ttp -60.99 -41.05 95.73 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.882 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 78.2 mtm -118.49 141.72 48.29 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.779 0.323 . . . . 0.0 110.683 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 81.5 m -159.56 84.5 0.76 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.798 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.58 -40.51 73.23 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.186 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.912 -1.042 . . . . 0.0 110.5 -179.563 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -81.83 115.42 21.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.451 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -81.41 -4.56 56.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.549 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 36.3 tp -84.78 123.52 30.52 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.16 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.5 p -79.74 156.19 27.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.132 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -75.89 -23.12 55.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.258 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -62.08 -43.7 98.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.782 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -64.25 -42.07 96.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.787 0.327 . . . . 0.0 110.847 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 91.4 mt -64.25 -43.49 97.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.719 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.86 -41.24 64.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -44.0 -48.21 8.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.852 0.358 . . . . 0.0 110.699 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -66.0 -39.8 90.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.582 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -65.38 -48.15 73.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.216 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -64.12 -34.03 77.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.476 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.57 -19.93 11.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.541 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -57.38 -49.3 76.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.865 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.8 m -60.95 -40.82 94.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.56 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.55 -42.86 99.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.003 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -59.33 -49.9 76.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.804 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.466 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.6 t0 -75.88 -15.61 60.18 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.682 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -43.6 -33.2 1.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.818 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.437 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 14.4 p-10 -53.4 -43.44 67.92 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.485 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -145.62 -153.7 5.95 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 26.7 p-10 -74.79 -47.27 31.7 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.59 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.69 107.27 0.28 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.638 ' C ' HD12 ' A' ' 27' ' ' ILE . 8.4 m -166.7 149.93 6.86 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.128 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.638 HD12 ' C ' ' A' ' 26' ' ' THR . 2.8 mp -119.52 109.47 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.503 HG22 HG22 ' A' ' 62' ' ' THR . 4.1 p -130.91 169.71 15.41 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.896 0.379 . . . . 0.0 110.506 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.508 ' CB ' HE22 ' A' ' 49' ' ' GLN . 82.5 p -63.51 -29.56 70.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.173 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -62.11 -41.28 98.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.236 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.445 ' OE2' ' O ' ' A' ' 26' ' ' THR . 89.6 mt-10 -66.99 -45.74 76.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.0 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.1 tp -65.92 -44.52 84.93 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.382 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.91 -22.49 4.52 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.3 m -67.03 -30.15 70.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.789 0.328 . . . . 0.0 110.478 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.6 t -62.34 -22.96 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 94.9 mmm -56.05 -37.11 68.83 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 120.199 -0.601 . . . . 0.0 109.701 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -63.17 -44.2 96.12 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 116.806 -1.958 . . . . 0.0 110.114 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 91.7 p -60.48 -37.87 82.43 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.16 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.413 ' O ' ' N ' ' A' ' 41' ' ' GLN . 39.1 mt -94.74 5.05 53.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.302 0.572 . . . . 0.0 110.528 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.49 -67.62 0.26 Allowed Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 39' ' ' LEU . 84.1 mt-30 -147.86 104.99 3.63 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.431 ' O ' ' N ' ' A' ' 44' ' ' THR . 58.7 t30 -123.25 76.84 52.61 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.028 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' A' ' 46' ' ' ALA . 72.1 Cg_exo -36.74 -29.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.595 2.196 . . . . 0.0 112.603 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.437 ' N ' ' HB3' ' A' ' 120' ' ' GLU . 11.5 m -38.43 -31.93 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.418 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 49' ' ' GLN . 96.9 mt-10 -88.86 -36.14 16.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.117 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -55.08 -49.8 70.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.536 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -69.85 -49.21 54.69 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.174 0.511 . . . . 0.0 110.155 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.89 -21.35 65.94 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.663 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.508 HE22 ' CB ' ' A' ' 29' ' ' THR . 71.3 tp60 -45.5 -47.47 14.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.221 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 68.1 t0 -70.85 -38.63 73.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.519 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 39.0 ttp -62.37 -42.78 99.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.914 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.411 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 87.5 mt -63.7 -46.22 95.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.488 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.667 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 87.3 m-20 -63.95 -41.86 97.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.6 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -59.27 -59.17 5.89 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.477 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.8 p -66.1 -31.74 55.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.754 0.312 . . . . 0.0 110.834 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.541 ' OD2' ' N ' ' A' ' 62' ' ' THR . 45.5 t0 -87.38 -12.58 45.89 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.69 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.28 13.06 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.07 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' A' ' 56' ' ' ASP . 16.8 p-10 -64.03 -33.83 76.63 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.44 -26.45 0.08 OUTLIER Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.594 ' C ' ' H ' ' A' ' 62' ' ' THR . 16.5 p30 -178.19 148.25 0.48 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.545 -0.327 . . . . 0.0 110.297 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.97 34.25 0.1 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.594 ' H ' ' C ' ' A' ' 60' ' ' ASN . 70.2 p -129.68 151.48 50.23 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.0 mt -119.59 134.15 64.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.82 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -77.05 -155.47 0.07 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.028 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.497 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -96.51 -47.89 0.24 Allowed Pre-proline 0 N--CA 1.469 0.496 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.824 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 42.9 Cg_exo -54.94 -36.01 91.01 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.107 1.872 . . . . 0.0 111.629 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -83.62 -28.66 28.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.795 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -59.44 -46.4 88.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.685 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.96 -43.5 95.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.854 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.9 m -63.64 -45.26 91.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.103 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 46.6 ttp -62.18 -44.41 96.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.806 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 47.8 mmm -63.38 -42.23 98.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.767 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.72 -48.66 80.81 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.768 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -71.04 -50.15 37.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.554 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -64.64 -41.78 95.9 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.396 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.505 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 32.1 mmm -121.21 127.0 51.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.197 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -82.69 153.12 25.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.672 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -52.5 -179.96 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.263 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.4 p -80.99 -9.69 59.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.641 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -65.97 -21.69 66.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.39 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.3 m -50.59 -32.2 18.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.423 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -38.23 -45.72 1.0 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.685 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -69.1 -46.63 67.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.17 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -65.07 -49.43 70.07 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.939 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.6 mt -56.42 -21.13 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -57.94 -44.95 87.27 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 118.386 -1.326 . . . . 0.0 109.652 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -66.07 -26.02 67.3 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.62 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.74 -14.16 58.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.122 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -56.61 -50.62 71.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.292 0.568 . . . . 0.0 111.137 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -63.39 -44.52 94.47 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.164 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.58 -45.64 88.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.581 -0.447 . . . . 0.0 109.866 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.429 ' CE2' ' CD1' ' A' ' 100' ' ' ILE . 19.1 t80 -62.54 -47.17 85.05 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.697 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 37.3 t0 -119.94 106.53 12.13 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.208 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -68.1 -44.32 76.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.072 0.463 . . . . 0.0 110.648 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.0 OUTLIER -62.26 -44.59 96.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.752 -179.351 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.1 -47.38 1.05 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -74.59 -14.43 60.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.016 0.436 . . . . 0.0 110.538 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.82 161.81 12.63 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -112.15 144.38 41.63 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.429 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 64.6 mt -74.95 129.49 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.861 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.6 p -83.09 168.79 16.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.293 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.88 97.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.857 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.11 -41.69 94.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.69 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -67.34 -37.33 83.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.084 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.2 tp -60.31 -43.17 96.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.192 0.52 . . . . 0.0 110.654 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -54.0 -40.76 67.26 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.789 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -59.05 -42.24 89.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.935 0.398 . . . . 0.0 109.987 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.02 -44.97 97.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.715 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 80.9 mmm -63.53 -35.47 80.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.562 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.3 m -61.21 -41.72 97.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.273 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -59.79 -39.15 83.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.663 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.1 tp -61.4 -44.33 97.33 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.534 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.77 -143.91 9.97 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -144.36 30.49 1.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.34 . . . . 0.0 110.775 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -62.85 -40.86 98.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.389 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.6 mt -105.19 165.93 10.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.788 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.486 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -65.16 161.58 18.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.877 0.37 . . . . 0.0 110.526 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.44 ' C ' ' OE1' ' A' ' 120' ' ' GLU . 83.8 m-20 -91.39 -20.25 22.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.851 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -89.34 -26.13 21.25 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.682 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -34.89 -65.17 0.23 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.565 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.682 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 31.0 m -68.65 -27.5 36.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 111.639 0.236 . . . . 0.0 111.639 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -63.21 -43.84 96.98 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.998 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -88.42 -41.02 13.07 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.47 ' C ' ' SD ' ' A' ' 124' ' ' MET . 15.0 tmm? -60.56 -42.72 97.19 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.858 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 125' ' ' ILE . 96.6 mt -70.02 -15.82 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -87.17 -66.76 0.88 Allowed 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.975 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -70.96 -68.53 0.43 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.949 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 124' ' ' MET . . . -37.3 -40.01 0.32 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.675 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -88.42 124.66 34.17 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.078 0.466 . . . . 0.0 110.466 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -72.25 -16.05 18.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.239 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 133' ' ' ASP . 51.0 m-20 -65.33 -45.65 83.4 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.994 0.426 . . . . 0.0 110.664 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.1 -11.56 2.67 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 42.0 p30 -88.45 -17.39 30.49 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.067 0.46 . . . . 0.0 110.14 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 58.33 120.7 0.01 OUTLIER Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.443 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 10.4 pt20 -160.97 137.87 8.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.711 0.291 . . . . 0.0 110.282 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.2 t -125.58 134.24 67.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.834 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.472 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.3 t30 -148.99 159.64 44.03 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.232 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -40.13 -35.34 0.38 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.289 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.472 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 53.0 mp0 -65.81 -42.29 90.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.177 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 80.2 mt-10 -71.75 -30.27 65.41 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.524 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -58.52 -45.5 88.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.21 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.3 -48.16 89.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.862 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -70.07 -32.15 70.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.778 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.486 ' SD ' ' C37' ' A' ' 205' ' ' 4DY . 37.6 ttp -56.62 -47.71 79.08 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.722 -178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 69.7 mtm -106.09 134.1 49.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 110.658 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 88.8 m -160.1 81.58 0.7 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.351 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 76' ' ' MET . . . -65.79 -40.62 92.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.939 0.399 . . . . 0.0 110.607 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.632 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' 4DY . . . . . 0.486 ' C37' ' SD ' ' A' ' 144' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -88.49 114.0 24.65 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.649 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -81.21 -16.87 51.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.417 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 32.4 tp -113.03 117.71 32.79 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.914 0.388 . . . . 0.0 110.034 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.2 p -139.12 157.52 45.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.171 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -71.33 -22.1 61.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.996 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.05 -43.08 77.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.077 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -62.37 -44.19 97.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.467 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.1 mt -64.34 -43.3 97.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.8 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.4 -45.35 69.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.482 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -41.25 -45.78 3.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.851 0.358 . . . . 0.0 110.963 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -66.78 -39.62 87.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.795 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -62.76 -43.22 99.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.484 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.06 -40.82 91.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.752 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.78 -20.42 49.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.652 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -49.36 -47.95 47.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.817 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.3 m -77.72 -20.36 53.66 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.019 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.6 tp -64.04 -40.69 96.87 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.837 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.468 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 76.3 m-85 -57.69 -45.41 85.7 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.354 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 9.7 t0 -86.16 -20.35 28.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -44.06 -33.17 1.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.806 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.41 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 4.5 p-10 -56.0 -46.14 78.81 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 110.82 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -140.25 -152.61 5.85 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 28.2 p-10 -74.4 -47.09 36.1 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.728 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.71 107.09 0.28 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 178.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 6.3 m -166.44 148.82 6.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.199 0.499 . . . . 0.0 111.436 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.73 74.02 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.504 HG22 HG22 ' A' ' 62' ' ' THR . 9.7 p -86.96 166.18 15.3 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.541 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -66.31 -28.55 68.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.961 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -61.91 -40.21 94.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.925 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.468 ' OE1' ' O ' ' A' ' 19' ' ' PHE . 86.7 mt-10 -66.76 -40.47 88.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.959 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.7 tp -62.8 -43.54 98.54 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.63 -33.22 47.94 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 m -64.58 -44.62 90.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.91 0.355 . . . . 0.0 110.857 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.4 t -55.95 -17.34 3.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.113 0.483 . . . . 0.0 110.287 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.545 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 88.9 mmm -52.72 -40.81 63.38 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.733 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.2 ttt85 -64.27 -46.01 85.57 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 118.202 -1.399 . . . . 0.0 110.2 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.8 p -64.3 -19.23 65.29 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.63 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.812 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 36.4 mt -94.41 6.6 48.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.682 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 43.75 78.67 0.07 OUTLIER Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 40' ' ' GLY . 85.7 mt-30 52.76 117.23 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.852 0.358 . . . . 0.0 110.723 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' A' ' 44' ' ' THR . 35.2 t-20 -148.85 68.76 9.84 Favored Pre-proline 0 C--O 1.235 0.303 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.657 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.582 ' O ' ' N ' ' A' ' 46' ' ' ALA . 86.7 Cg_exo -35.85 -31.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 122.533 2.156 . . . . 0.0 111.983 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.449 ' N ' ' O ' ' A' ' 42' ' ' ASN . 29.5 m -38.58 -27.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.299 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.545 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 87.7 mt-10 -89.52 -32.44 17.17 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.848 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.33 -51.88 67.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.994 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.456 ' HB2' HG23 ' A' ' 117' ' ' THR . 2.2 tm-20 -67.5 -46.06 73.99 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.192 0.52 . . . . 0.0 109.661 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 44' ' ' THR . 96.8 mt -63.6 -27.6 69.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.403 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -39.51 -53.66 2.04 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.811 0.339 . . . . 0.0 110.85 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -65.9 -38.26 88.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.24 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.5 ttp -62.33 -40.18 95.51 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 97.8 mt -62.04 -46.42 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.649 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 9.4 m120 -62.38 -42.43 99.41 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.666 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.68 -55.66 31.57 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.119 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.87 -34.88 62.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.891 0.377 . . . . 0.0 111.065 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.531 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.9 t0 -82.92 -13.43 56.09 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.408 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.12 9.0 1.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.778 0.323 . . . . 0.0 110.154 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 12.6 p30 -61.56 -25.18 67.15 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.484 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -157.83 -19.97 0.03 OUTLIER Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.623 ' C ' ' H ' ' A' ' 62' ' ' THR . 5.1 p30 177.08 141.82 0.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.72 32.25 0.08 OUTLIER Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.623 ' H ' ' C ' ' A' ' 60' ' ' ASN . 64.0 p -130.29 150.08 51.69 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-O 121.002 0.43 . . . . 0.0 110.273 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.3 mt -116.98 138.93 46.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.144 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.53 166.14 19.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.444 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.429 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -62.95 -50.52 76.59 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.761 -179.119 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.4 Cg_exo -50.92 -44.88 39.32 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.994 1.796 . . . . 0.0 111.778 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.95 -36.32 72.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.977 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -60.03 -45.85 91.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.224 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.08 -44.5 95.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.625 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.5 m -67.4 -44.45 78.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.194 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.0 ttp -61.42 -40.13 93.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.05 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 76.3 mmm -63.01 -38.6 91.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.848 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.07 96.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.02 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -68.43 -45.55 72.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.11 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.59 -41.78 83.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.924 0.393 . . . . 0.0 110.366 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.8 mmt -86.92 164.47 16.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.086 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -116.24 153.61 31.58 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.004 0.43 . . . . 0.0 110.145 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -59.29 160.46 6.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.26 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.4 p -64.17 -30.06 71.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.546 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.43 -10.05 22.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.206 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -57.04 -32.85 66.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.513 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -49.43 -50.23 41.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.735 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.02 -41.92 94.88 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.005 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -66.27 -45.74 79.45 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.476 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.3 mt -64.9 -20.59 27.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -59.74 -42.18 92.61 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 119.079 -1.048 . . . . 0.0 110.184 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -61.46 -35.88 78.87 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.496 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.18 -13.39 60.45 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -48.02 -51.05 25.59 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.981 0.419 . . . . 0.0 111.41 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -59.78 -46.86 87.89 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.784 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.86 -44.35 81.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.991 0.424 . . . . 0.0 110.451 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -59.46 -44.41 92.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.567 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.435 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 33.0 t70 -138.82 100.73 4.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.24 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.1 -39.96 82.71 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.175 0.512 . . . . 0.0 110.164 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.435 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.2 p-10 -60.22 -42.54 95.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.291 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.71 -56.99 0.51 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -70.78 -13.59 62.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.146 0.498 . . . . 0.0 110.28 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.66 161.12 12.86 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -115.0 150.89 35.13 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.7 mt -85.19 123.18 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.025 0.44 . . . . 0.0 110.343 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.2 p -80.02 168.14 19.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.026 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.48 82.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.62 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.21 -45.3 93.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.056 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.97 -37.68 75.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.251 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.7 tp -61.94 -42.96 99.7 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.263 0.554 . . . . 0.0 111.257 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -52.56 -43.25 65.1 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.012 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -55.4 -42.75 74.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.199 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.63 -42.43 95.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.279 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 58.3 mmm -57.56 -34.78 69.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.476 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 80.3 m -60.19 -42.34 94.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.458 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -58.6 -38.73 78.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.9 tp -61.29 -46.35 90.71 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.025 0.44 . . . . 0.0 110.117 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.85 -154.89 25.97 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.237 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -143.24 11.8 1.75 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.737 -0.231 . . . . 0.0 110.76 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -63.92 -44.01 94.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.102 0.477 . . . . 0.0 110.631 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.6 mt -79.75 160.29 26.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.978 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.48 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.6 OUTLIER -68.5 161.69 27.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.273 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -92.33 -21.03 20.5 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.098 0.475 . . . . 0.0 110.45 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -85.45 -26.93 26.03 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.24 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.613 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.59 -63.55 0.35 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.613 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 11.3 m -69.09 -31.32 49.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 121.236 -0.185 . . . . 0.0 111.497 -178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -58.94 -67.08 0.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.717 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.58 -45.15 72.79 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.517 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 13.3 tmm? -52.91 -50.3 64.2 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 125' ' ' ILE . 95.9 mt -64.62 -18.38 23.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.653 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -87.92 -57.88 2.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.297 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 128' ' ' ALA . 51.1 tp10 -81.92 -67.78 0.75 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.236 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.812 ' HB2' ' O ' ' A' ' 39' ' ' LEU . . . -36.78 -35.65 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 56.6 t0 -87.69 146.18 25.81 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.298 0.57 . . . . 0.0 110.519 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.567 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -89.39 -14.94 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.783 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 133' ' ' ASP . 44.8 m-20 -73.59 -45.27 54.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.016 0.436 . . . . 0.0 110.4 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.29 -10.29 3.65 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 131' ' ' ASP . 35.3 p30 -89.84 -10.42 45.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.233 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 62.28 122.93 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -161.7 119.61 2.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.859 0.362 . . . . 0.0 110.073 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.61 128.9 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.13 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.526 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 45.3 t30 -155.08 166.32 33.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.063 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.402 ' O ' ' CD1' ' A' ' 138' ' ' TYR . 2.6 t80 -48.82 -23.06 0.95 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.415 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 50.0 mp0 -66.4 -35.74 81.09 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.153 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -84.97 -20.83 29.97 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.582 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -61.94 -46.84 87.56 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.102 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 29.5 t -58.22 -45.95 88.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.105 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -71.4 -36.07 71.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.332 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 61.4 ttp -58.09 -43.03 86.83 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.128 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 70.6 mtm -112.76 129.28 56.48 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.84 0.353 . . . . 0.0 110.377 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 m -162.81 85.8 0.55 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.047 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.13 -43.93 93.75 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.645 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.55 179.846 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -88.72 117.43 27.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.416 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -82.77 -36.37 25.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.596 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 43.4 tp -99.29 122.6 42.67 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.146 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 p -137.87 158.95 43.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.348 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -67.78 -33.57 75.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.599 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -53.73 -44.13 69.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.857 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -57.63 -42.05 82.57 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.67 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.09 -43.15 95.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.57 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.93 -29.73 56.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.281 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -54.68 -48.25 72.62 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.538 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -65.7 -40.81 92.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -61.95 -44.08 97.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.67 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -67.06 -37.51 84.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.01 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.481 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.02 -27.92 65.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.826 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -57.81 -46.91 83.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.537 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.7 m -77.92 -21.51 51.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.68 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.4 -42.76 99.68 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.436 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.481 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.1 m-85 -60.2 -50.96 71.61 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.478 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.1 t0 -76.93 -14.35 59.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.912 0.387 . . . . 0.0 111.335 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -45.59 -32.68 2.44 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.84 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 8.8 p-10 -53.72 -46.08 70.7 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.57 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -144.36 -151.58 5.47 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 30.8 p-10 -72.97 -47.25 47.01 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.09 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.72 107.36 0.28 Allowed Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 178.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 4.7 m -166.59 139.32 3.76 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.129 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 27' ' ' ILE . 5.2 mp -115.04 109.19 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.594 HG22 HG22 ' A' ' 62' ' ' THR . 2.6 p -128.68 170.31 13.43 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.847 0.356 . . . . 0.0 110.418 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.636 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.2 p -64.69 -33.12 75.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.805 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -61.62 -41.4 97.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.053 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 26' ' ' THR . 90.0 mt-10 -63.41 -45.69 89.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.915 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.1 tp -64.13 -43.36 95.5 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.113 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.77 -26.1 53.24 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.1 m -63.87 -41.46 97.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.85 0.357 . . . . 0.0 110.071 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.1 t -56.28 -23.52 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.352 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.48 ' O ' ' N ' ' A' ' 40' ' ' GLY . 62.1 mmm -48.17 -30.21 4.42 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.679 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -64.41 -45.65 86.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.003 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.1 p -63.91 -21.99 66.72 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.856 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 41' ' ' GLN . 16.8 mt -107.7 3.68 24.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.094 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.15 -71.19 0.02 OUTLIER Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 39' ' ' LEU . 87.8 mt-30 -145.46 109.44 4.83 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 44' ' ' THR . 41.4 t30 -125.58 70.88 65.34 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.149 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 46' ' ' ALA . 85.4 Cg_exo -32.92 -30.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 122.66 2.24 . . . . 0.0 112.785 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.542 ' N ' ' O ' ' A' ' 42' ' ' ASN . 26.2 m -39.27 -30.15 0.05 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.522 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.418 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.9 mt-10 -86.7 -34.86 19.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.27 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -59.12 -50.08 75.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.779 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.13 -46.15 71.65 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.166 0.508 . . . . 0.0 109.655 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 51' ' ' MET . 84.5 mt -64.79 -31.15 72.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.359 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.636 HE22 ' CB ' ' A' ' 29' ' ' THR . 61.1 tp60 -37.47 -51.3 1.13 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.72 0.295 . . . . 0.0 110.838 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.25 -40.35 90.14 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.27 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.463 ' N ' ' O ' ' A' ' 48' ' ' LEU . 33.1 ttp -62.45 -40.95 98.27 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.0 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 83.5 mt -62.04 -49.88 82.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.145 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.602 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 89.8 m-20 -63.0 -40.38 97.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.585 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -55.19 -61.54 2.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.193 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.9 -30.12 43.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.779 0.323 . . . . 0.0 111.285 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 62' ' ' THR . 50.6 t0 -84.68 -13.21 52.11 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.528 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -71.97 13.0 0.33 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.868 0.366 . . . . 0.0 110.295 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.7 p30 -65.57 -28.86 69.45 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.539 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -150.55 -22.4 0.06 OUTLIER Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.557 ' C ' ' H ' ' A' ' 62' ' ' THR . 3.3 p30 173.13 151.88 0.08 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.99 34.76 0.14 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.594 HG22 HG22 ' A' ' 28' ' ' THR . 81.7 p -134.39 149.48 50.81 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.3 mt -121.02 134.52 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.14 162.44 28.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.416 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.471 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -64.65 -48.14 74.33 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.478 -179.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 50.3 Cg_exo -51.17 -37.36 58.49 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.171 1.914 . . . . 0.0 111.739 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -87.61 -22.3 24.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.35 -47.2 86.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.852 0.358 . . . . 0.0 111.028 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.5 -42.89 98.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.567 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.4 m -63.92 -46.11 86.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.668 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.7 ttp -61.76 -47.45 85.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.077 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 82.0 mmm -65.82 -37.79 87.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.271 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.62 -49.97 75.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.031 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -71.5 -43.76 65.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.196 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.72 -43.61 88.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.7 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 73' ' ' ALA . 22.3 mmm -104.31 127.46 51.96 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.07 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.7 tptt -84.97 141.11 30.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.931 0.396 . . . . 0.0 110.711 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 77' ' ' LYS . 95.0 m-20 -48.9 179.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.266 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.3 p -75.47 -6.77 51.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.456 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.47 -15.53 62.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.511 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.9 m -61.89 -19.91 63.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.527 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -48.2 -44.72 33.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.33 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.99 -39.49 79.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.894 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -65.89 -45.13 83.16 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.01 0.433 . . . . 0.0 110.197 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.3 mt -66.05 -19.09 25.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.494 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -58.43 -45.42 88.52 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 118.971 -1.092 . . . . 0.0 110.156 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.62 -31.79 73.01 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.923 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -72.08 -14.61 61.9 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.16 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -57.97 -48.98 78.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.328 0.585 . . . . 0.0 111.092 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -64.1 -45.57 88.05 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.358 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -76.2 -51.58 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 110.849 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.443 ' CE2' HD12 ' A' ' 100' ' ' ILE . 26.3 t80 -62.02 -47.17 85.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.625 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 18.2 t70 -108.98 94.24 4.94 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.29 -41.02 73.93 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 110.535 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 19.8 p-10 -62.52 -39.71 94.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.961 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.44 -67.29 0.97 Allowed Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.57 -16.56 63.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.009 0.433 . . . . 0.0 110.242 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.82 161.99 12.57 Favored Glycine 0 N--CA 1.465 0.575 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.28 155.33 24.24 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.775 0.321 . . . . 0.0 110.23 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.443 HD12 ' CE2' ' A' ' 92' ' ' PHE . 94.2 mt -79.66 125.99 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.974 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.4 p -82.39 168.94 17.0 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.128 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.51 -38.04 89.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.513 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.65 -47.3 84.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.916 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.67 -32.88 73.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.958 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.4 tp -61.52 -41.7 97.71 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.382 0.61 . . . . 0.0 110.706 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -56.43 -43.31 79.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.77 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -58.49 -41.88 86.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.3 t -66.68 -43.37 90.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.646 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.0 mmm -62.03 -35.59 79.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.642 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.2 m -61.09 -44.37 97.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.055 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -59.76 -35.0 73.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.378 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.0 tp -61.18 -46.73 89.28 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.081 0.467 . . . . 0.0 110.391 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.5 -160.71 33.43 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -140.53 23.35 2.31 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.603 0.24 . . . . 0.0 110.746 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -63.61 -42.79 98.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.962 0.41 . . . . 0.0 110.277 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.7 mt -92.88 175.8 6.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.972 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.467 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -72.85 161.29 30.9 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.668 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -91.66 -22.44 20.25 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.979 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -87.91 -25.32 23.29 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.174 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.639 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.41 -61.24 0.46 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.123 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.639 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 20.2 m -67.39 -40.21 84.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.509 ' N ' HG23 ' A' ' 121' ' ' VAL . 81.2 m-20 -56.73 -47.05 80.88 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.595 -178.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -86.03 -40.28 15.95 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.7 tmm? -59.56 -46.53 88.63 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.081 0.467 . . . . 0.0 109.914 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 125' ' ' ILE . 91.5 mt -69.1 -16.61 21.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.424 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -78.6 -50.51 11.38 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 119.394 -0.922 . . . . 0.0 112.148 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 129' ' ' ASP . 42.4 tp10 -87.69 -67.52 0.82 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.834 -178.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.33 -26.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.794 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 127' ' ' GLU . 25.4 t0 -87.95 128.26 35.37 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.058 0.456 . . . . 0.0 111.132 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.664 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.48 -43.38 90.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.457 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -65.35 -40.33 93.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.19 0.519 . . . . 0.0 110.178 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.33 -1.97 58.84 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' GLY . 55.2 p-10 -89.49 -8.98 51.73 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 57.38 115.48 0.01 OUTLIER Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 20.3 pt20 -160.64 133.64 6.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.2 t -123.47 136.89 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.081 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -151.35 172.49 15.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.243 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -54.86 -46.78 74.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.13 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 139' ' ' GLU . 55.2 mp0 -58.68 -44.36 90.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.657 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 93.4 mt-10 -72.0 -29.41 64.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.775 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.89 -43.98 77.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.586 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 94.1 t -59.16 -46.29 92.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.26 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.35 -29.09 66.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.124 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.8 ttp -59.7 -42.88 93.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.796 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.46 138.84 50.6 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.963 0.411 . . . . 0.0 110.731 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.2 m -163.24 77.72 0.43 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.661 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.16 -27.76 68.93 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.438 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 117.884 -1.055 . . . . 0.0 110.665 -179.864 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 4' ' ' LEU . 43.6 t0 -88.76 115.87 26.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.71 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -78.81 -25.32 44.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.573 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.419 ' O ' ' OD1' ' A' ' 2' ' ' ASP . 37.3 tp -109.52 120.28 42.0 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.953 0.406 . . . . 0.0 110.352 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.4 p -139.09 158.75 43.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.045 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -68.65 -20.88 64.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.801 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -56.59 -39.23 73.19 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.221 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.38 -40.24 95.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.584 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.26 -43.51 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 121.049 -0.261 . . . . 0.0 110.905 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.3 -18.89 7.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.143 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -54.18 -42.33 69.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.098 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -67.81 -41.71 82.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.375 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -62.63 -43.68 98.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.982 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -67.25 -35.75 80.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.437 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.414 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.49 -24.19 66.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.699 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -55.37 -46.51 76.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.79 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.3 m -80.65 -19.5 45.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.783 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.17 -41.96 96.92 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.052 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.425 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.3 m-85 -58.84 -46.1 88.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.871 0.367 . . . . 0.0 111.144 -178.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.448 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.3 t0 -79.57 -13.47 59.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.499 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -42.99 -32.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.915 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' CG ' ' OE2' ' A' ' 31' ' ' GLU . 10.9 p-10 -52.9 -45.13 67.41 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.481 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.436 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . -149.64 -151.21 5.44 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 21.2 p-10 -71.21 -46.9 60.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.685 0.278 . . . . 0.0 110.957 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.531 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.04 107.34 0.28 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.593 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.7 m -166.51 136.22 3.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.215 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.608 HD12 ' N ' ' A' ' 27' ' ' ILE . 1.9 mp -110.53 118.3 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.459 HG22 HG22 ' A' ' 62' ' ' THR . 2.0 p -134.76 167.05 21.56 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.897 0.38 . . . . 0.0 110.291 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.541 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.3 p -64.08 -33.69 76.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.31 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -62.57 -40.16 95.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.701 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.456 ' OE2' ' O ' ' A' ' 26' ' ' THR . 88.9 mt-10 -64.66 -48.56 74.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.313 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.38 -43.72 93.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.321 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.31 -24.72 17.09 Favored Glycine 0 C--O 1.224 -0.469 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -64.05 -40.99 97.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.873 0.368 . . . . 0.0 110.226 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.15 -22.37 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.205 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.6 mmm -48.87 -33.45 10.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.021 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -64.32 -45.47 87.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 118.152 -1.419 . . . . 0.0 110.278 -178.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.1 p -59.04 -30.67 68.2 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.301 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 41' ' ' GLN . 9.2 mt -102.3 5.45 39.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.974 0.416 . . . . 0.0 110.472 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.26 -69.79 0.03 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 39' ' ' LEU . 85.8 mt-30 -143.28 116.25 8.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.132 -0.534 . . . . 0.0 109.589 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.1 t30 -132.58 69.69 79.61 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.945 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.549 ' O ' ' N ' ' A' ' 46' ' ' ALA . 91.4 Cg_exo -33.0 -33.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 122.545 2.164 . . . . 0.0 112.476 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.477 ' N ' ' O ' ' A' ' 42' ' ' ASN . 12.7 m -39.07 -29.33 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.371 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 43' ' ' PRO . 90.6 mt-10 -87.67 -35.17 18.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.486 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -61.23 -49.22 78.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.998 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.433 ' HB2' HG23 ' A' ' 117' ' ' THR . 3.1 tm-20 -68.09 -48.48 65.39 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.397 0.617 . . . . 0.0 109.951 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.513 HD22 ' CE ' ' A' ' 51' ' ' MET . 87.3 mt -62.72 -22.68 66.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.009 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.541 HE22 ' CB ' ' A' ' 29' ' ' THR . 48.0 tp60 -40.27 -49.6 2.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.87 0.367 . . . . 0.0 110.475 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.64 -39.85 73.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.478 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.513 ' CE ' HD22 ' A' ' 48' ' ' LEU . 36.1 ttp -61.56 -40.55 95.11 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.743 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.82 -46.91 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.586 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.652 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 28.3 m120 -65.13 -39.91 93.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.358 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -58.03 -57.22 13.79 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.474 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 p -68.26 -32.85 57.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.923 0.392 . . . . 0.0 110.997 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.511 ' OD2' ' N ' ' A' ' 62' ' ' THR . 42.9 t0 -86.06 -13.08 48.43 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.805 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.06 15.43 0.16 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 56' ' ' ASP . 38.7 p-10 -66.74 -23.48 66.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.4 -22.61 0.03 OUTLIER Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.591 ' C ' ' H ' ' A' ' 62' ' ' THR . 4.6 p30 179.34 146.51 0.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.75 33.78 0.18 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.591 ' H ' ' C ' ' A' ' 60' ' ' ASN . 80.6 p -132.2 143.94 50.3 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.92 135.15 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.034 0.445 . . . . 0.0 110.191 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.38 172.4 4.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.456 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.436 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -72.6 -49.57 8.38 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.764 -179.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 53.2 Cg_exo -52.03 -43.31 53.41 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.885 1.723 . . . . 0.0 111.88 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.45 -37.46 77.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.846 0.355 . . . . 0.0 110.898 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -60.34 -45.4 93.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.926 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.0 mt -62.39 -44.62 96.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.503 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.6 m -67.4 -45.49 76.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.736 0.303 . . . . 0.0 111.231 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.4 ttp -61.09 -43.72 98.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.977 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 87.0 mmm -64.75 -39.35 93.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.223 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.91 -42.88 94.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.838 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -71.51 -41.7 68.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.279 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -64.74 -40.94 96.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.804 0.335 . . . . 0.0 110.436 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 73' ' ' ALA . 14.2 mmt -95.27 129.84 42.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.079 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -86.81 142.81 27.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -50.41 168.87 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.379 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.3 p -75.24 -15.21 60.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.645 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.98 -16.46 64.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.449 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.1 m -60.46 -23.7 64.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.758 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -36.75 -48.45 0.73 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.931 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -70.79 -43.54 68.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.247 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -63.78 -39.63 94.73 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.012 0.434 . . . . 0.0 110.085 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.6 mt -66.98 -21.89 28.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.231 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -57.96 -43.65 86.56 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.085 -1.046 . . . . 0.0 110.053 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -63.7 -34.74 78.54 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.889 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.83 -19.85 66.03 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.081 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -56.64 -48.8 76.74 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.253 0.549 . . . . 0.0 110.817 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -68.19 -44.69 75.29 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.471 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.9 t -66.34 -48.39 81.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.441 ' CE2' HD12 ' A' ' 100' ' ' ILE . 23.4 t80 -63.96 -47.19 81.38 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.632 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.408 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 18.4 t70 -120.32 100.17 7.01 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -66.71 -39.75 88.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.812 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 97' ' ' ASN . 2.0 p-10 -65.67 -40.6 92.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.104 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.62 -59.48 0.48 Allowed Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 95' ' ' ASP . 54.0 m-80 -61.86 -17.41 56.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.978 0.418 . . . . 0.0 110.201 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.408 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.58 160.91 12.96 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -113.33 155.55 24.98 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.441 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -95.77 118.22 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.04 0.448 . . . . 0.0 111.072 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.9 p -85.53 171.37 11.79 Favored 'General case' 0 C--N 1.335 -0.063 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.908 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.68 -35.76 78.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.572 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.43 -50.86 72.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.131 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.28 -37.37 77.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.919 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.06 -39.34 94.43 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.478 0.656 . . . . 0.0 111.089 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -54.18 -43.67 70.86 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.131 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -63.09 -39.49 94.87 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.85 -45.22 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.192 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 37.8 mmm -64.3 -38.05 89.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.483 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.8 m -60.57 -40.09 90.38 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -61.27 -38.11 85.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.175 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 tp -61.6 -44.07 97.68 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.868 0.366 . . . . 0.0 110.213 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.97 -154.78 25.78 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -138.97 23.42 2.6 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.577 -0.312 . . . . 0.0 110.728 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -62.67 -43.26 99.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.06 0.457 . . . . 0.0 110.309 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.9 mt -99.91 169.06 9.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.54 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.49 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -68.34 162.11 25.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.86 0.362 . . . . 0.0 110.51 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -92.14 -22.21 19.99 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.421 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -87.29 -24.47 24.33 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.625 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.65 -66.06 0.21 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.196 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.625 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.6 m -65.09 -35.31 75.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.416 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -60.47 -46.8 88.75 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.558 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -84.92 -40.34 17.13 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.4 tmm? -58.92 -47.22 85.8 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 125' ' ' ILE . 94.4 mt -69.18 -18.32 22.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.578 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -77.43 -51.37 10.89 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 119.044 -1.063 . . . . 0.0 111.307 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 129' ' ' ASP . 34.7 tp10 -86.32 -68.7 0.72 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.46 -177.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.64 -21.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 127' ' ' GLU . 38.7 t0 -90.16 125.06 35.33 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.139 0.495 . . . . 0.0 110.606 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.647 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.5 -31.99 56.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.052 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -72.16 -45.84 58.81 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.93 0.395 . . . . 0.0 110.362 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.63 -5.41 61.15 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 134' ' ' GLY . 35.3 p30 -89.95 -9.69 47.85 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 58.24 117.92 0.01 OUTLIER Glycine 0 CA--C 1.519 0.335 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 8.2 pt20 -159.73 140.13 11.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.161 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.5 t -126.25 133.35 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.544 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.9 t30 -150.74 175.34 12.07 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.323 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -57.69 -52.09 66.85 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.766 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.544 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 57.2 mp0 -55.88 -35.04 66.07 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.736 -178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 79.3 mt-10 -69.46 -39.31 77.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.712 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -61.21 -45.38 94.83 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.0 t -57.94 -46.0 87.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -74.12 -30.92 62.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.397 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.4 ttp -60.03 -40.66 90.12 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.623 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.403 ' O ' ' OG1' ' A' ' 146' ' ' THR . 72.9 mtm -105.18 141.69 36.28 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.888 0.375 . . . . 0.0 110.631 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 145' ' ' MET . 62.9 m -167.23 72.06 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.104 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.61 -41.79 97.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.561 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 C--O 1.218 -0.559 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.263 -179.906 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 4' ' ' LEU . 66.7 t0 -88.49 113.95 24.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.643 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -81.16 -16.86 51.68 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.386 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.408 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 32.3 tp -113.0 117.64 32.61 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.929 0.395 . . . . 0.0 110.068 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.4 p -139.14 157.5 45.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.168 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -71.3 -22.1 61.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.016 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.06 -43.07 77.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.058 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -62.37 -44.26 96.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.464 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.3 mt -64.26 -43.37 97.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.779 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.37 69.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.518 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -41.28 -45.7 3.02 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.819 0.342 . . . . 0.0 110.949 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -66.88 -39.62 87.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.724 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -62.74 -43.19 99.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.508 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.06 -40.84 91.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.767 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.79 -20.41 49.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.617 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -49.42 -47.94 47.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.793 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.0 m -77.74 -20.35 53.61 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.994 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.9 tp -64.06 -40.67 96.8 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.785 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.47 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 76.2 m-85 -57.67 -45.47 85.52 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.354 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 9.8 t0 -86.06 -20.42 28.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -44.04 -33.18 1.37 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.794 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.409 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 4.5 p-10 -55.91 -46.16 78.5 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.88 0.371 . . . . 0.0 110.839 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -140.32 -152.62 5.84 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 28.1 p-10 -74.48 -46.99 35.99 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.711 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.73 107.08 0.28 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 6.3 m -166.46 148.77 6.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.178 0.489 . . . . 0.0 111.445 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.66 74.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.507 HG22 HG22 ' A' ' 62' ' ' THR . 9.7 p -86.93 166.16 15.33 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.998 0.428 . . . . 0.0 110.53 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -66.28 -28.62 68.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.972 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -61.89 -40.21 94.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.914 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.47 ' OE1' ' O ' ' A' ' 19' ' ' PHE . 86.7 mt-10 -66.73 -40.44 88.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.977 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.7 tp -62.82 -43.56 98.47 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.61 -33.2 47.83 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 m -64.58 -44.64 90.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.949 0.374 . . . . 0.0 110.865 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.3 t -55.9 -17.36 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.297 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.544 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 88.9 mmm -52.73 -40.8 63.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.709 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.1 ttt85 -64.23 -46.05 85.5 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 118.165 -1.414 . . . . 0.0 110.229 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.2 p -64.28 -19.24 65.27 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.657 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.81 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 36.4 mt -94.34 6.54 48.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.731 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 43.72 78.78 0.07 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.491 ' O ' ' O ' ' A' ' 40' ' ' GLY . 85.7 mt-30 52.65 117.2 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.845 0.355 . . . . 0.0 110.783 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 44' ' ' THR . 35.2 t-20 -148.8 68.75 9.88 Favored Pre-proline 0 C--O 1.235 0.294 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.745 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.586 ' O ' ' N ' ' A' ' 46' ' ' ALA . 86.9 Cg_exo -35.85 -31.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.455 2.103 . . . . 0.0 111.978 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.451 ' N ' ' O ' ' A' ' 42' ' ' ASN . 29.9 m -38.57 -27.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.287 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.544 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 87.7 mt-10 -89.52 -32.43 17.18 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.818 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.41 -51.87 68.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.014 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.451 ' HB2' HG23 ' A' ' 117' ' ' THR . 2.2 tm-20 -67.43 -46.07 74.21 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.18 0.514 . . . . 0.0 109.683 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 44' ' ' THR . 96.9 mt -63.64 -27.64 69.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.344 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -39.54 -53.61 2.07 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.815 0.341 . . . . 0.0 110.804 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -65.94 -38.26 88.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.261 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.5 ttp -62.34 -40.18 95.52 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 98.0 mt -62.05 -46.4 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.646 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 9.5 m120 -62.38 -42.38 99.37 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.679 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.73 -55.62 32.05 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.167 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 p -69.87 -34.89 62.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 120.894 0.378 . . . . 0.0 111.089 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.9 t0 -82.89 -13.45 56.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.404 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.646 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.08 8.92 1.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.819 0.342 . . . . 0.0 110.179 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 12.6 p30 -61.6 -25.09 67.12 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -157.83 -19.98 0.03 OUTLIER Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.619 ' C ' ' H ' ' A' ' 62' ' ' THR . 5.1 p30 177.07 141.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.73 32.24 0.08 OUTLIER Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.619 ' H ' ' C ' ' A' ' 60' ' ' ASN . 63.8 p -130.3 150.12 51.68 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-O 120.983 0.42 . . . . 0.0 110.266 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.6 mt -117.05 138.97 45.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.145 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.56 166.16 19.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.381 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.432 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -62.93 -50.55 76.52 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.756 -179.138 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.5 Cg_exo -50.89 -44.95 38.82 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.999 1.799 . . . . 0.0 111.788 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.94 -36.27 72.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.984 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -60.07 -45.83 91.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.194 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.08 -44.59 95.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.561 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.2 m -67.36 -44.39 79.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.27 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.9 ttp -61.47 -40.14 93.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.02 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 76.0 mmm -63.02 -38.58 91.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.805 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.11 96.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.008 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -68.43 -45.56 72.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.081 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.57 -41.79 83.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.976 0.417 . . . . 0.0 110.36 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.8 mmt -86.93 164.42 16.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.137 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -116.2 153.55 31.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.954 0.406 . . . . 0.0 110.154 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -59.26 160.44 6.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.31 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.6 p -64.14 -30.04 71.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.571 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -64.42 -10.04 22.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.182 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -57.08 -32.78 66.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.535 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -49.49 -50.23 42.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.712 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.02 -41.9 94.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.038 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -66.31 -45.71 79.4 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.469 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.4 mt -64.91 -20.61 27.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -59.67 -42.23 92.41 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.245 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -61.49 -35.89 78.94 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.468 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.13 -13.42 60.47 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -47.98 -51.1 25.13 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.013 0.435 . . . . 0.0 111.421 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -59.76 -46.82 87.97 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.822 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.87 -44.35 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.979 0.418 . . . . 0.0 110.451 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -59.44 -44.35 92.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.573 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 33.0 t70 -138.9 100.65 4.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.267 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.07 -39.98 82.83 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.209 0.528 . . . . 0.0 110.154 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.2 p-10 -60.18 -42.61 95.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.286 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.71 -56.98 0.51 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -70.69 -13.68 62.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.156 0.503 . . . . 0.0 110.286 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.63 161.12 12.87 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -115.04 150.93 35.11 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.5 mt -85.24 123.18 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.999 0.428 . . . . 0.0 110.375 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.2 p -80.01 168.12 19.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.049 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.3 -36.44 82.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.615 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.18 -45.24 94.26 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.082 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -70.08 -37.66 75.51 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.192 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.2 tp -62.0 -42.86 99.61 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.23 0.538 . . . . 0.0 111.248 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -52.62 -43.23 65.26 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.02 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -55.39 -42.73 74.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.914 0.388 . . . . 0.0 110.231 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.5 t -64.63 -42.44 95.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.259 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 58.3 mmm -57.56 -34.75 69.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.461 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.1 m -60.26 -42.37 95.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.37 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -58.57 -38.73 78.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.9 tp -61.35 -46.29 90.83 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 120.952 0.406 . . . . 0.0 110.126 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.9 -154.91 26.0 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -143.29 11.89 1.75 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.703 -0.249 . . . . 0.0 110.759 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -63.97 -43.99 94.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.114 0.483 . . . . 0.0 110.612 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.4 mt -79.77 160.3 26.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.99 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.475 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.6 OUTLIER -68.46 161.7 27.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.245 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -92.37 -21.07 20.45 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.063 0.458 . . . . 0.0 110.404 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -85.43 -26.93 26.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.234 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.59 -63.57 0.34 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -178.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.61 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 11.3 m -69.1 -31.35 49.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.457 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -58.86 -67.15 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.721 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.56 -45.19 72.75 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.519 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 13.3 tmm? -52.85 -50.27 64.1 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.419 HG22 ' O ' ' A' ' 125' ' ' ILE . 95.9 mt -64.6 -18.4 23.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.655 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -87.92 -57.86 2.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.306 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 128' ' ' ALA . 51.0 tp10 -81.96 -67.79 0.75 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.248 -178.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.81 ' HB2' ' O ' ' A' ' 39' ' ' LEU . . . -36.77 -35.64 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 56.7 t0 -87.69 146.15 25.82 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.258 0.551 . . . . 0.0 110.576 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.566 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -89.36 -15.02 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.778 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 133' ' ' ASP . 44.9 m-20 -73.54 -45.29 54.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.994 0.426 . . . . 0.0 110.427 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.39 -10.3 3.75 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 131' ' ' ASP . 35.2 p30 -89.88 -10.4 45.39 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.816 0.341 . . . . 0.0 110.172 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 62.18 122.99 0.01 OUTLIER Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -161.69 119.65 2.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.913 0.387 . . . . 0.0 110.08 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.65 128.91 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.128 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.525 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 45.3 t30 -155.07 166.26 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.064 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.4 ' O ' ' CD1' ' A' ' 138' ' ' TYR . 2.6 t80 -48.79 -23.04 0.93 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.444 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.539 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 50.1 mp0 -66.42 -35.75 81.08 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.151 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -84.95 -20.83 30.0 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.633 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.04 -46.68 88.1 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.141 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 29.8 t -58.28 -46.0 89.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.028 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -71.33 -36.12 71.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.305 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 61.5 ttp -57.99 -43.04 86.36 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.193 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 70.7 mtm -112.85 129.26 56.51 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.85 0.357 . . . . 0.0 110.328 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.6 m -162.78 85.82 0.55 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.064 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.15 -43.81 94.05 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.675 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.516 179.834 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.411 ' OD2' ' O ' ' A' ' 4' ' ' LEU . 67.3 t0 -92.55 115.91 28.53 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.034 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -68.81 -30.01 68.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.192 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.411 ' O ' ' OD2' ' A' ' 2' ' ' ASP . 46.8 tp -102.03 128.17 48.59 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.648 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.5 p -134.61 158.43 44.05 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.354 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -66.16 -21.97 66.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.707 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -63.15 -44.2 96.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.531 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.88 -41.58 91.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.966 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 89.6 mt -64.62 -43.03 96.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.472 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.77 -39.9 68.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.233 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -47.63 -48.63 28.53 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.118 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -59.48 -44.87 92.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.83 0.347 . . . . 0.0 110.442 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -63.37 -39.68 95.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.693 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.31 -41.3 85.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.824 0.345 . . . . 0.0 111.158 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.47 -22.69 66.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.829 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -55.57 -47.89 75.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.2 m -81.37 -17.2 49.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.553 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.96 -43.72 98.03 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.423 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.417 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.5 m-85 -60.52 -50.36 73.86 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.553 -178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.3 t0 -77.13 -14.56 59.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.188 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -45.11 -32.91 1.95 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.209 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.449 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 18.0 p-10 -54.73 -45.99 74.19 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.824 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -144.04 -151.1 5.38 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 32.2 p-10 -73.06 -47.08 47.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.675 0.274 . . . . 0.0 110.772 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.73 107.31 0.28 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.427 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 4.9 m -166.24 142.77 5.0 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.745 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.02 103.46 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.405 HG22 HG22 ' A' ' 62' ' ' THR . 2.9 p -123.14 169.93 10.73 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.091 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.606 ' CB ' HE22 ' A' ' 49' ' ' GLN . 60.2 p -63.1 -35.35 79.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.833 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -60.34 -38.48 83.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 87.7 mt-10 -65.59 -43.12 90.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.097 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.76 -41.9 97.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.227 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.82 -28.67 17.21 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.1 m -64.58 -44.15 91.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 0.0 110.762 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.2 t -57.09 -17.6 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.194 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.543 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 87.6 mmm -53.01 -38.58 62.44 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.199 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.6 ttt85 -64.27 -46.04 85.44 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 117.412 -1.715 . . . . 0.0 110.668 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 93.5 p -63.4 -19.9 65.08 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.553 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.882 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 52.5 mt -99.64 6.16 45.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.882 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 34.8 94.62 0.01 OUTLIER Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 40' ' ' GLY . 84.1 mt-30 52.3 110.1 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.599 0.238 . . . . 0.0 110.418 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 44' ' ' THR . 49.9 t30 -145.71 63.94 9.9 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.701 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 46' ' ' ALA . 88.7 Cg_exo -34.71 -30.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.56 2.173 . . . . 0.0 112.32 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.498 ' N ' ' O ' ' A' ' 42' ' ' ASN . 23.4 m -40.14 -29.51 0.08 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.123 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.543 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 90.7 mt-10 -89.73 -29.89 18.41 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.763 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -60.83 -49.15 78.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.82 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.47 ' HB2' HG23 ' A' ' 117' ' ' THR . 2.2 tm-20 -72.17 -43.18 64.99 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.296 0.569 . . . . 0.0 109.755 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.591 HD21 HD21 ' A' ' 116' ' ' LEU . 96.3 mt -68.0 -25.05 65.22 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.212 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.606 HE22 ' CB ' ' A' ' 29' ' ' THR . 53.7 tp60 -40.85 -41.86 1.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.0 110.582 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -77.7 -36.75 50.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.492 ' CE ' HD22 ' A' ' 48' ' ' LEU . 32.5 ttp -59.98 -37.3 79.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.628 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.589 HG21 HG22 ' A' ' 29' ' ' THR . 96.8 mt -63.5 -44.78 98.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.043 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.675 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 19.5 m120 -62.57 -39.86 95.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.342 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -56.62 -56.44 21.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.273 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.471 HG13 ' N ' ' A' ' 56' ' ' ASP . 15.0 p -74.14 -40.32 51.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.883 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.504 ' OD2' ' N ' ' A' ' 62' ' ' THR . 44.4 t0 -71.18 -13.3 61.88 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.52 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.675 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.25 8.97 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.099 0.476 . . . . 0.0 110.346 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 56' ' ' ASP . 10.3 p-10 -59.73 -26.72 65.88 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -155.08 -24.42 0.03 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.549 ' C ' ' H ' ' A' ' 62' ' ' THR . 10.0 p30 176.15 151.17 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.29 36.32 0.09 OUTLIER Glycine 0 CA--C 1.535 1.306 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.549 ' H ' ' C ' ' A' ' 60' ' ' ASN . 44.2 p -137.38 153.34 50.21 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.5 mt -127.43 137.02 58.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.972 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -81.21 164.55 22.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.083 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.427 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -62.07 -50.13 81.87 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.232 -179.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.5 Cg_exo -50.12 -41.74 48.44 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.08 1.853 . . . . 0.0 112.046 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -80.77 -29.79 36.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.118 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -59.48 -45.07 92.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.989 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.42 -43.14 99.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.305 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.9 m -64.36 -44.92 89.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.869 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 46.9 ttp -60.08 -44.66 94.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.855 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 79.4 mmm -63.82 -40.86 97.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.266 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.408 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -61.27 -47.77 84.51 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.957 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -71.27 -46.28 61.29 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.458 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -66.72 -45.28 79.2 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.927 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.408 ' O ' ' O ' ' A' ' 73' ' ' ALA . 17.8 mmm -99.5 -176.68 3.35 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.054 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -128.51 152.15 48.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.153 0.501 . . . . 0.0 110.169 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -54.21 177.66 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.341 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.3 p -80.47 -15.81 55.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.582 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -66.38 -13.65 60.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.395 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 83' ' ' GLU . 72.7 m -53.38 -34.27 57.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.601 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -39.08 -28.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.381 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 81' ' ' SER . 75.8 mm-40 -85.35 -54.79 4.37 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.042 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -58.56 -36.29 73.69 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.905 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.427 ' O ' HG22 ' A' ' 85' ' ' ILE . 96.6 mt -63.55 -20.04 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -61.0 -45.09 96.24 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 118.409 -1.316 . . . . 0.0 109.588 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -64.61 -21.8 66.81 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.189 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.4 -17.54 48.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.439 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -57.01 -50.19 73.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.376 0.607 . . . . 0.0 110.572 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -68.62 -44.95 73.16 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.864 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.6 t -65.32 -49.07 80.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.069 0.462 . . . . 0.0 110.022 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.683 ' CE2' HD12 ' A' ' 100' ' ' ILE . 51.6 t80 -62.59 -45.19 94.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.905 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.411 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 22.2 t0 -120.53 104.52 10.03 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.119 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -66.36 -41.22 89.82 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.029 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -70.39 -41.66 72.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.063 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.89 -52.98 0.74 Allowed Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -64.02 -20.08 65.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.934 0.397 . . . . 0.0 110.297 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.411 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.66 161.01 12.9 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -113.34 148.31 35.96 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.683 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -84.96 123.62 39.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.9 p -87.35 176.7 7.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.122 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.64 -36.49 83.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.963 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.57 -51.35 69.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.878 0.371 . . . . 0.0 110.977 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.39 -30.54 66.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 49.4 tp -61.69 -41.04 97.04 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.23 0.538 . . . . 0.0 111.106 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -54.22 -41.49 68.73 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.881 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -57.92 -42.69 85.33 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.3 t -65.57 -43.2 94.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.668 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 91.6 mmm -62.55 -37.23 85.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.476 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.8 m -59.43 -40.48 86.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.657 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -58.6 -38.73 78.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.724 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.0 tp -61.01 -45.1 96.2 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.547 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.09 -145.3 12.03 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -143.6 16.38 1.82 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.761 0.315 . . . . 0.0 110.679 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -61.86 -44.91 95.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.997 0.427 . . . . 0.0 110.468 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.591 HD21 HD21 ' A' ' 48' ' ' LEU . 82.8 mt -82.08 161.34 22.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.966 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.474 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -66.02 161.7 21.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.653 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -91.63 -19.62 22.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.866 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -87.67 -28.14 22.01 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.622 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.32 -66.85 0.17 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.622 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.4 m -64.05 -39.33 85.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 111.909 0.336 . . . . 0.0 111.909 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.469 ' N ' HG23 ' A' ' 121' ' ' VAL . 84.8 m-20 -54.27 -65.91 0.49 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.676 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 127' ' ' GLU . 80.6 mm-40 -70.42 -44.93 66.89 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.661 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 18.9 tmm? -53.0 -47.62 68.13 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 120.486 -0.486 . . . . 0.0 109.879 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.403 ' O ' HG22 ' A' ' 125' ' ' ILE . 97.7 mt -67.19 -19.73 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.356 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -91.24 -66.84 0.89 Allowed 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.984 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 123' ' ' GLU . 24.9 tp10 -65.24 -68.53 0.36 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.21 -177.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.882 ' HB2' ' O ' ' A' ' 39' ' ' LEU . . . -37.21 -37.67 0.18 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.48 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 66.0 t0 -87.5 138.23 31.65 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.207 0.527 . . . . 0.0 110.591 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.59 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -85.8 -16.09 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.335 -179.7 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -73.08 -46.54 50.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.121 0.486 . . . . 0.0 110.141 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.96 -2.59 54.92 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 52.1 p30 -88.67 -22.3 23.49 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 64.6 103.72 0.01 OUTLIER Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -147.77 140.77 24.95 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.784 0.326 . . . . 0.0 110.158 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.2 t -128.93 134.32 64.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.314 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.527 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 53.3 t30 -151.57 -179.09 7.11 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.624 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -57.28 -48.15 79.63 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.267 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.527 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 55.9 mp0 -50.91 -43.66 59.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.352 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -67.69 -39.82 84.42 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.91 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -60.72 -43.65 97.61 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.598 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.3 t -54.19 -43.89 62.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.345 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -84.25 -19.38 33.99 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.064 -0.255 . . . . 0.0 111.223 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 41.1 ttp -65.07 -41.3 95.2 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.949 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 51.7 mtm -103.67 132.68 49.71 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.847 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.4 m -166.83 81.77 0.24 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.061 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.8 -37.19 75.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.342 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.1 mttm . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.458 179.948 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -91.92 107.58 19.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.128 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -135.58 166.37 23.38 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.014 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 36.8 tp -96.11 126.57 41.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.245 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.1 p -127.27 160.05 32.5 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.611 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.63 -19.23 62.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.564 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -67.14 -42.0 85.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.063 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -62.98 -42.09 99.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.872 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.2 mt -69.75 -31.39 48.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.679 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.19 -29.55 70.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.881 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -51.5 -43.22 62.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.748 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -66.94 -46.38 74.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.874 0.368 . . . . 0.0 111.03 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -61.62 -44.81 96.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.792 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -67.96 -40.96 83.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.628 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.13 -28.42 67.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.022 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -55.58 -45.84 77.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.673 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.7 m -81.61 -17.83 46.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.723 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.7 tp -65.51 -42.36 92.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.918 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.403 ' O ' ' CD ' ' A' ' 31' ' ' GLU . 73.3 m-85 -61.06 -45.95 92.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.309 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 4.7 t0 -81.93 -15.66 53.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.357 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -42.82 -32.5 0.62 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.114 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.433 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 9.2 p-10 -53.67 -46.7 70.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.896 0.379 . . . . 0.0 110.712 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.433 ' N ' ' CG ' ' A' ' 22' ' ' ASP . . . -145.67 -147.33 4.58 Favored Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 20.5 p-10 -76.46 -47.57 22.51 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.898 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.01 106.97 0.27 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 95.7 m -166.72 143.13 4.64 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.968 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.05 117.06 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.849 0.357 . . . . 0.0 110.113 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.691 HG22 HG22 ' A' ' 62' ' ' THR . 12.4 p -133.38 165.57 24.52 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.403 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.538 ' CB ' HE22 ' A' ' 49' ' ' GLN . 79.9 p -63.02 -35.13 79.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.33 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -61.26 -38.58 87.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.021 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.413 ' OE2' ' CG ' ' A' ' 22' ' ' ASP . 91.3 mt-10 -64.62 -49.13 72.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.359 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.37 -43.65 98.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.182 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.2 -23.94 4.47 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.3 m -64.9 -42.51 94.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.914 0.388 . . . . 0.0 110.545 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.3 t -54.59 -16.3 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.219 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.452 ' O ' ' N ' ' A' ' 40' ' ' GLY . 53.4 mmm -58.73 -37.27 75.8 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -62.48 -46.13 89.89 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 116.727 -1.989 . . . . 0.0 110.618 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.7 p -60.12 -36.17 76.88 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.034 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 41' ' ' GLN . 44.7 mt -95.87 2.08 53.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.701 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 66.2 -66.44 0.15 Allowed Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 39' ' ' LEU . 74.6 mt-30 -141.66 122.77 14.67 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.3 t-20 -141.5 71.15 26.19 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.636 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 46' ' ' ALA . 73.1 Cg_exo -37.42 -30.45 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.222 1.948 . . . . 0.0 112.136 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 42' ' ' ASN . 25.1 m -39.04 -27.62 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.488 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 49' ' ' GLN . 86.7 mt-10 -90.31 -36.92 14.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.011 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -56.27 -48.88 75.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.411 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -70.5 -45.08 66.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.289 0.566 . . . . 0.0 110.071 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.521 HD21 HD22 ' A' ' 116' ' ' LEU . 96.0 mt -70.08 -20.05 63.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.82 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.538 HE22 ' CB ' ' A' ' 29' ' ' THR . 67.3 tp60 -46.48 -46.22 18.84 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.608 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -75.06 -35.29 61.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.242 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.433 ' CE ' HD22 ' A' ' 48' ' ' LEU . 33.2 ttp -63.71 -43.03 97.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.016 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 96.7 mt -62.76 -46.21 96.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.753 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.697 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 24.1 m120 -64.65 -40.7 95.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.766 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -60.08 -56.84 16.72 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.42 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 56' ' ' ASP . 11.3 p -69.68 -37.01 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.016 0.436 . . . . 0.0 110.94 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.549 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.5 t0 -79.06 -12.6 60.02 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.446 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.697 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.15 15.43 0.16 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.314 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 10.5 p30 -65.76 -21.87 66.54 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.412 ' H ' ' H ' ' A' ' 60' ' ' ASN . . . -167.82 -9.56 0.03 OUTLIER Glycine 0 C--N 1.333 0.4 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.576 ' C ' ' H ' ' A' ' 62' ' ' THR . 1.9 p30 169.42 140.58 0.02 OUTLIER 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.02 35.77 0.11 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.691 HG22 HG22 ' A' ' 28' ' ' THR . 69.5 p -135.94 155.0 50.93 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 90.9 mt -130.13 132.02 65.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.213 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.14 151.99 42.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.627 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.442 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -54.83 -51.24 80.75 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.778 -179.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 52.1 Cg_exo -49.17 -49.84 14.36 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.855 1.704 . . . . 0.0 112.059 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -68.56 -33.66 74.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.465 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -61.94 -43.82 98.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.96 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.8 mt -59.2 -45.58 90.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.753 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.3 m -63.83 -44.73 92.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.543 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 36.3 ttp -59.99 -45.34 93.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.578 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.3 mmm -64.64 -39.41 93.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.534 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.34 -39.05 78.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.743 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -77.92 -51.47 10.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.383 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -65.56 -44.27 87.27 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.498 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.2 mmm -99.74 126.46 45.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.348 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -86.76 143.89 27.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.537 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 80' ' ' ASP . 97.2 m-20 -49.35 158.58 0.38 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.418 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 35.8 p -54.9 -8.74 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.643 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 78' ' ' ASP . 80.3 m-20 -67.11 -8.64 32.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.156 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.6 m -59.4 -29.51 67.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.688 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -37.85 -49.21 1.19 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.839 0.352 . . . . 0.0 110.994 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.73 -55.02 19.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.872 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -59.68 -32.31 70.38 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.055 0.455 . . . . 0.0 110.622 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 85' ' ' ILE . 83.0 mt -69.23 -15.07 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.998 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -59.71 -48.93 79.71 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 117.546 -1.662 . . . . 0.0 110.395 -177.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.21 -32.55 74.28 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.471 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.66 -36.04 73.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.731 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -50.58 -51.12 51.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.324 0.583 . . . . 0.0 110.928 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -69.3 -44.4 71.85 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.32 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.16 -51.44 48.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.132 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.555 ' CE2' HD12 ' A' ' 100' ' ' ILE . 66.8 t80 -63.44 -47.42 81.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.389 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.463 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 17.9 t0 -107.83 105.33 15.1 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.131 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -71.67 -44.88 63.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.664 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 45.2 p-10 -67.07 -33.62 75.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.137 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.529 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 66.52 -74.87 0.15 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -53.66 -13.09 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.876 0.369 . . . . 0.0 110.343 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.422 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.52 161.77 12.67 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -112.34 155.91 23.34 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.555 HD12 ' CE2' ' A' ' 92' ' ' PHE . 94.6 mt -99.79 117.47 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.749 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.6 p -82.15 175.68 10.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.123 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.91 -37.06 85.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.838 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.54 -52.44 64.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.785 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -67.66 -31.18 70.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.67 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.1 tp -64.2 -41.35 97.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.451 0.644 . . . . 0.0 110.975 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -53.9 -39.2 65.57 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.002 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -63.83 -41.17 97.9 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.1 t -64.17 -42.66 96.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.44 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 54.0 mmm -62.4 -40.75 97.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.983 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.8 m -61.74 -40.22 94.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.564 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -58.82 -40.55 84.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.616 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.9 tp -61.33 -44.25 97.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.946 0.403 . . . . 0.0 110.528 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 161.85 -151.91 22.17 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -138.34 29.22 2.46 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.794 0.33 . . . . 0.0 110.619 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -67.46 -45.32 76.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.793 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.521 HD22 HD21 ' A' ' 48' ' ' LEU . 19.7 mt -100.68 166.94 10.63 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.853 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.52 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -69.49 161.57 29.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.188 -179.564 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -92.69 -21.54 19.94 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.902 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -87.41 -23.6 24.47 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.635 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -35.1 -68.08 0.13 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.603 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.521 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 9.8 m -63.87 -42.15 94.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.517 ' N ' HG23 ' A' ' 121' ' ' VAL . 87.6 m-20 -48.3 -67.06 0.3 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.752 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.459 ' O ' ' OE1' ' A' ' 127' ' ' GLU . 80.3 mm-40 -70.44 -40.02 74.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.404 ' SD ' ' C ' ' A' ' 124' ' ' MET . 17.7 tmm? -57.22 -38.94 74.49 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.684 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.9 mt -77.89 -23.79 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.929 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -77.5 -46.93 20.9 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 118.682 -1.207 . . . . 0.0 111.698 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 123' ' ' GLU . 19.6 mp0 -80.08 -68.45 0.67 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.667 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.56 -48.9 1.04 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.69 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -88.51 131.07 35.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.901 0.381 . . . . 0.0 110.27 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.549 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -82.3 -10.7 12.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.129 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 133' ' ' ASP . 89.2 m-20 -64.39 -40.42 95.76 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.099 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.65 -8.4 4.32 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 134' ' ' GLY . 26.2 p-10 -88.32 -12.72 42.65 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 39.36 98.06 0.01 OUTLIER Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 13.3 pt20 -131.06 136.94 48.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.056 0.455 . . . . 0.0 110.311 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.0 t -115.29 134.82 57.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.097 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.515 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 53.1 t30 -152.64 176.74 11.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.605 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -58.84 -48.02 82.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.339 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.515 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 58.0 mp0 -57.42 -25.53 59.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.295 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 81.2 mt-10 -84.87 -33.64 22.78 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.08 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -65.72 -46.89 77.24 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.654 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 50.3 t -56.26 -44.57 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 120.792 0.33 . . . . 0.0 110.22 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -71.56 -38.05 71.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.202 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 50.2 ttp -60.43 -48.59 81.08 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.306 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 49.1 mtm -88.61 120.77 30.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.928 0.394 . . . . 0.0 110.782 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.0 m -165.77 99.14 0.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.729 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.94 -38.33 88.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.584 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.8 mttm . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.531 179.938 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -88.69 117.48 27.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.398 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -82.82 -36.35 25.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.602 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 43.3 tp -99.27 122.66 42.74 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.16 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 p -137.94 158.87 43.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.295 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -67.72 -33.57 75.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.633 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -53.69 -44.15 69.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.871 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -57.64 -42.16 82.86 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.572 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.98 -43.18 96.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.606 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.92 -29.77 56.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.301 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -54.64 -48.25 72.5 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.556 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -65.74 -40.79 92.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.837 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -61.99 -44.1 97.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.633 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -66.99 -37.54 84.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.988 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.479 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -59.06 -27.9 65.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.803 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -57.83 -46.94 84.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.533 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.8 m -77.9 -21.5 51.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.65 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.36 -42.82 99.7 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.444 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 82.2 m-85 -60.21 -50.92 71.74 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.476 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.1 t0 -77.01 -14.26 59.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.83 0.347 . . . . 0.0 111.315 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -45.61 -32.69 2.45 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.831 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 8.8 p-10 -53.72 -46.11 70.69 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.557 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . -144.34 -151.61 5.48 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 30.8 p-10 -72.95 -47.24 47.23 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.068 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.525 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.71 107.38 0.28 Allowed Glycine 0 CA--C 1.521 0.452 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.425 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 4.6 m -166.63 139.23 3.7 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.121 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 27' ' ' ILE . 5.2 mp -115.02 109.18 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.593 HG22 HG22 ' A' ' 62' ' ' THR . 2.6 p -128.65 170.32 13.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.824 0.345 . . . . 0.0 110.447 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.638 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.0 p -64.74 -33.05 75.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.801 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -61.63 -41.42 97.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.935 0.397 . . . . 0.0 109.998 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.425 ' OE1' ' O ' ' A' ' 26' ' ' THR . 90.1 mt-10 -63.45 -45.68 89.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.856 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.0 tp -64.2 -43.29 95.49 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.115 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.78 -26.16 53.42 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.2 m -63.87 -41.42 97.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.858 0.361 . . . . 0.0 110.143 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.3 t -56.18 -23.62 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.333 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.479 ' O ' ' N ' ' A' ' 40' ' ' GLY . 62.1 mmm -48.06 -30.33 4.33 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.721 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -64.34 -45.61 87.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 118.042 -1.463 . . . . 0.0 111.049 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 77.9 p -63.98 -21.95 66.71 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.136 -0.625 . . . . 0.0 109.808 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 41' ' ' GLN . 16.9 mt -107.8 3.75 24.79 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.04 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 62.16 -71.21 0.02 OUTLIER Glycine 0 N--CA 1.465 0.592 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 39' ' ' LEU . 87.8 mt-30 -145.45 109.46 4.83 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 44' ' ' THR . 41.4 t30 -125.59 70.93 65.52 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.12 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.551 ' O ' ' N ' ' A' ' 46' ' ' ALA . 85.3 Cg_exo -33.04 -30.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.595 2.196 . . . . 0.0 112.808 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 42' ' ' ASN . 26.2 m -39.31 -30.19 0.06 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.543 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.417 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 93.9 mt-10 -86.64 -34.88 19.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.305 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -59.04 -50.04 75.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.821 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.15 -46.21 71.4 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 51' ' ' MET . 84.6 mt -64.79 -31.03 72.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.4 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.638 HE22 ' CB ' ' A' ' 29' ' ' THR . 61.1 tp60 -37.62 -51.2 1.19 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.732 0.301 . . . . 0.0 110.769 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.3 -40.34 89.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.232 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' LEU . 33.1 ttp -62.38 -41.05 98.33 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.981 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 83.9 mt -62.0 -49.95 82.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.114 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.61 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 89.9 m-20 -62.89 -40.46 97.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.582 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -55.17 -61.5 2.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.206 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.93 -30.12 43.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.804 0.335 . . . . 0.0 111.241 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 62' ' ' THR . 50.7 t0 -84.71 -13.24 51.97 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.513 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -71.94 13.05 0.32 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.926 0.394 . . . . 0.0 110.339 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.8 p30 -65.56 -28.89 69.48 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.535 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -150.49 -22.49 0.06 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.558 ' C ' ' H ' ' A' ' 62' ' ' THR . 3.3 p30 173.19 151.88 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.95 34.7 0.14 Allowed Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.593 HG22 HG22 ' A' ' 28' ' ' THR . 81.9 p -134.37 149.45 50.83 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.4 mt -120.99 134.52 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.933 0.397 . . . . 0.0 109.942 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.16 162.43 28.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.416 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.472 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -64.68 -48.05 74.37 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.467 -179.051 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 50.6 Cg_exo -51.28 -37.36 59.73 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.167 1.911 . . . . 0.0 111.692 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -87.55 -22.32 24.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.78 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -61.45 -47.11 87.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.021 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.54 -42.88 98.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.517 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 78.7 m -63.97 -46.09 86.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.648 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.7 ttp -61.71 -47.5 85.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.066 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.9 mmm -65.87 -37.76 87.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.265 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.61 -49.96 75.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.039 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -71.51 -43.8 65.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.159 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.72 -43.59 88.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.764 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.432 ' O ' ' O ' ' A' ' 73' ' ' ALA . 22.3 mmm -104.27 127.47 51.91 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.116 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.7 tptt -84.97 141.14 30.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.874 0.368 . . . . 0.0 110.748 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' LYS . 95.0 m-20 -48.87 179.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.262 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.5 p -75.51 -6.74 51.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.437 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.48 -15.52 62.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.545 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.9 m -61.89 -19.92 63.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.549 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -48.19 -44.69 32.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.358 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.96 -39.56 79.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.9 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.87 -45.12 83.25 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.989 0.423 . . . . 0.0 110.202 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.5 mt -66.12 -19.04 25.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.472 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -58.41 -45.44 88.4 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 118.97 -1.092 . . . . 0.0 110.19 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -65.56 -31.88 73.17 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.948 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.412 ' O ' ' CB ' ' A' ' 92' ' ' PHE . . . -72.03 -14.64 61.93 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.185 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -57.98 -49.0 78.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.244 0.545 . . . . 0.0 111.061 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -64.09 -45.6 87.98 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.316 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -76.18 -51.54 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 0.0 110.908 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.442 ' CE2' HD12 ' A' ' 100' ' ' ILE . 26.2 t80 -61.99 -47.19 85.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.62 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.427 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 18.2 t70 -108.95 94.15 4.89 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.22 -40.97 74.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.965 0.412 . . . . 0.0 110.553 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 19.8 p-10 -62.61 -39.65 94.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.976 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.44 -67.3 0.97 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.58 -16.56 63.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.022 0.439 . . . . 0.0 110.247 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.76 162.04 12.56 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.23 155.39 24.09 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.713 0.292 . . . . 0.0 110.258 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.442 HD12 ' CE2' ' A' ' 92' ' ' PHE . 94.1 mt -79.75 126.02 39.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.938 0.399 . . . . 0.0 110.988 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.3 p -82.36 168.95 17.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.196 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.04 89.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.51 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.63 -47.38 84.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.863 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -68.67 -32.87 73.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.6 tp -61.58 -41.63 97.68 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.41 0.624 . . . . 0.0 110.712 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -56.46 -43.35 79.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.8 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -58.5 -41.88 86.35 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.67 -43.4 90.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.624 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.0 mmm -61.99 -35.68 79.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.605 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.6 m -61.04 -44.43 97.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.044 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -59.76 -34.98 73.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.376 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.0 tp -61.17 -46.73 89.31 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.051 0.453 . . . . 0.0 110.36 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.5 -160.74 33.47 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -140.51 23.35 2.32 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.64 0.257 . . . . 0.0 110.828 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -63.65 -42.8 98.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.963 0.411 . . . . 0.0 110.269 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.3 mt -92.84 175.79 6.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.006 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.469 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -72.83 161.29 30.91 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.695 179.844 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -91.66 -22.46 20.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.946 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -87.89 -25.37 23.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.126 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.64 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.4 -61.27 0.45 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.086 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.64 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 20.2 m -67.33 -40.2 84.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.492 ' N ' HG23 ' A' ' 121' ' ' VAL . 81.2 m-20 -56.81 -47.06 81.1 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.52 -178.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -86.01 -40.32 15.92 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.7 tmm? -59.51 -46.51 88.61 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.094 0.473 . . . . 0.0 109.956 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 125' ' ' ILE . 91.5 mt -69.15 -16.56 20.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.413 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -78.61 -50.56 11.29 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 119.389 -0.924 . . . . 0.0 112.13 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' ASP . 42.3 tp10 -87.61 -67.51 0.82 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.888 -178.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.43 -25.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.763 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' GLU . 25.4 t0 -88.06 128.26 35.41 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.062 0.458 . . . . 0.0 111.056 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.668 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.46 -43.45 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.416 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -65.27 -40.4 93.86 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.136 0.493 . . . . 0.0 110.185 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.4 -2.03 58.94 Favored Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' GLY . 55.2 p-10 -89.44 -9.0 51.8 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 57.46 115.49 0.01 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.435 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 20.3 pt20 -160.69 133.6 6.44 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.46 136.92 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.056 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -151.36 172.43 15.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.23 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -54.78 -46.83 74.47 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.096 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 139' ' ' GLU . 55.3 mp0 -58.64 -44.35 90.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.709 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 93.4 mt-10 -72.05 -29.4 64.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.727 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.92 -43.91 77.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.605 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 93.8 t -59.22 -46.23 92.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.312 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.38 -29.1 66.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.128 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.7 ttp -59.71 -42.81 93.9 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.853 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.49 138.82 50.63 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.961 0.41 . . . . 0.0 110.756 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 81.9 m -163.22 77.77 0.43 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.671 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.15 -27.76 68.95 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.464 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.222 -0.391 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.624 -179.857 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 4' ' ' LEU . 43.6 t0 -88.72 115.92 26.61 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.745 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -78.81 -25.38 44.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.532 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.415 ' O ' ' OD1' ' A' ' 2' ' ' ASP . 37.5 tp -109.5 120.22 41.84 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.024 0.44 . . . . 0.0 110.339 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.4 p -139.04 158.74 43.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.095 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -68.66 -20.89 64.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.823 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -56.55 -39.35 73.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.21 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -64.25 -40.27 95.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.621 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.26 -43.59 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.883 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.25 -18.89 6.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.157 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -54.22 -42.27 69.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.096 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -67.84 -41.73 82.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.34 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -62.62 -43.76 97.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.914 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -67.19 -35.71 80.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.431 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.413 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.57 -24.11 66.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.699 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -55.45 -46.46 76.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.783 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.4 m -80.66 -19.54 45.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.756 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.16 -41.95 96.95 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.013 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.42 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.1 m-85 -58.84 -46.11 88.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.831 0.348 . . . . 0.0 111.115 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.448 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.3 t0 -79.56 -13.49 59.5 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.468 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -42.97 -32.87 0.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.821 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.451 ' CG ' ' OE2' ' A' ' 31' ' ' GLU . 10.9 p-10 -52.93 -45.1 67.48 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.447 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.433 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . -149.68 -151.3 5.47 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 21.2 p-10 -71.1 -46.9 60.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.759 0.314 . . . . 0.0 111.009 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.534 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.02 107.4 0.28 Allowed Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.592 ' C ' HD12 ' A' ' 27' ' ' ILE . 5.7 m -166.6 136.2 3.08 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.188 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.608 HD12 ' N ' ' A' ' 27' ' ' ILE . 1.9 mp -110.55 118.33 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.457 HG22 HG22 ' A' ' 62' ' ' THR . 2.0 p -134.78 167.04 21.59 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.863 0.363 . . . . 0.0 110.327 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.538 ' CB ' HE22 ' A' ' 49' ' ' GLN . 68.3 p -64.12 -33.64 76.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.296 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -62.51 -40.22 96.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.691 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.455 ' OE2' ' O ' ' A' ' 26' ' ' THR . 89.0 mt-10 -64.68 -48.46 74.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.373 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.6 tp -64.44 -43.72 93.42 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.296 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.29 -24.73 17.07 Favored Glycine 0 C--O 1.224 -0.487 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -64.09 -40.99 97.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.863 0.363 . . . . 0.0 110.197 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.3 t -57.05 -22.45 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.276 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.7 mmm -48.79 -33.53 10.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.992 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -64.33 -45.51 87.55 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 118.219 -1.392 . . . . 0.0 110.241 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.3 p -58.96 -30.68 68.09 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.367 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 41' ' ' GLN . 9.2 mt -102.34 5.47 39.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.99 0.424 . . . . 0.0 110.492 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.31 -69.83 0.03 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 39' ' ' LEU . 85.8 mt-30 -143.27 116.21 8.82 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.1 t30 -132.61 69.71 79.55 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.934 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 46' ' ' ALA . 90.7 Cg_exo -32.98 -33.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.541 2.16 . . . . 0.0 112.463 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 42' ' ' ASN . 12.6 m -39.0 -29.35 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.398 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 43' ' ' PRO . 90.6 mt-10 -87.69 -35.21 18.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.449 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -61.22 -49.22 78.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.998 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.437 ' HB2' HG23 ' A' ' 117' ' ' THR . 3.1 tm-20 -68.01 -48.6 65.27 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.437 0.637 . . . . 0.0 109.89 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.511 HD22 ' CE ' ' A' ' 51' ' ' MET . 87.2 mt -62.65 -22.75 66.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.012 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.538 HE22 ' CB ' ' A' ' 29' ' ' THR . 47.9 tp60 -40.25 -49.56 2.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.877 0.37 . . . . 0.0 110.519 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.69 -39.78 73.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.483 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.511 ' CE ' HD22 ' A' ' 48' ' ' LEU . 36.1 ttp -61.62 -40.54 95.21 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.73 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.85 -46.83 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.624 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.655 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 28.2 m120 -65.19 -39.83 93.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.342 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -58.1 -57.24 13.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.443 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.4 p -68.3 -32.83 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.949 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 62' ' ' THR . 42.9 t0 -86.02 -13.12 48.45 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.768 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.05 15.46 0.16 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.07 -179.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 56' ' ' ASP . 38.7 p-10 -66.75 -23.5 66.1 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.41 -22.54 0.03 OUTLIER Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.591 ' C ' ' H ' ' A' ' 62' ' ' THR . 4.6 p30 179.35 146.5 0.19 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.72 33.71 0.17 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.591 ' H ' ' C ' ' A' ' 60' ' ' ASN . 80.8 p -132.17 143.94 50.33 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.93 135.11 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.999 0.428 . . . . 0.0 110.172 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.39 172.39 4.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.486 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.436 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -72.59 -49.59 8.4 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.759 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 52.5 Cg_exo -52.01 -43.29 53.49 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.833 1.688 . . . . 0.0 111.931 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.45 -37.45 77.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 110.874 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -60.3 -45.45 93.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.967 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.2 mt -62.39 -44.63 95.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.487 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.2 m -67.38 -45.51 76.06 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.757 0.313 . . . . 0.0 111.223 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.4 ttp -61.13 -43.74 98.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.89 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 86.9 mmm -64.76 -39.33 93.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.215 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -59.91 -42.84 94.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.873 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -71.52 -41.77 68.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.268 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -64.72 -40.94 96.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.887 0.375 . . . . 0.0 110.412 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.434 ' O ' ' O ' ' A' ' 73' ' ' ALA . 14.2 mmt -95.22 129.85 42.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.074 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -86.87 142.82 27.77 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -50.35 168.86 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.414 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.8 p -75.23 -15.2 60.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.647 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.97 -16.49 64.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.424 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 82' ' ' GLU . 1.1 m -60.45 -23.67 64.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.717 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 81' ' ' SER . 81.2 tt0 -36.83 -48.45 0.74 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.62 0.248 . . . . 0.0 110.897 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -70.85 -43.47 68.44 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.181 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.87 -39.59 94.55 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.994 0.426 . . . . 0.0 110.086 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 81.0 mt -66.96 -21.91 28.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.242 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 -58.04 -43.61 86.93 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 119.031 -1.067 . . . . 0.0 110.014 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -63.65 -34.82 78.69 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.851 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.79 -19.9 66.06 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.039 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -56.6 -48.81 76.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.321 0.582 . . . . 0.0 110.838 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -68.23 -44.67 75.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.474 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.8 t -66.34 -48.34 81.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.442 ' CE2' HD12 ' A' ' 100' ' ' ILE . 23.7 t80 -64.04 -47.09 81.57 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.617 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.407 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 18.3 t70 -120.37 100.1 6.96 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -66.63 -39.84 88.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.182 0.515 . . . . 0.0 109.804 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 97' ' ' ASN . 2.0 p-10 -65.58 -40.66 92.97 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.105 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.67 -59.54 0.48 Allowed Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 95' ' ' ASP . 54.0 m-80 -61.78 -17.46 56.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.994 0.426 . . . . 0.0 110.228 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.407 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.55 160.9 12.96 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -113.31 155.57 24.92 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.442 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -95.78 118.27 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.07 0.462 . . . . 0.0 111.108 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.0 p -85.52 171.41 11.77 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.898 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.72 -35.75 78.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.579 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.84 72.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.078 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.28 -37.36 77.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.928 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.02 -39.38 94.58 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.476 0.655 . . . . 0.0 111.07 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -54.24 -43.64 71.07 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.116 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -63.13 -39.47 94.77 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.702 -0.399 . . . . 0.0 109.937 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.1 t -61.84 -45.19 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.176 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 37.7 mmm -64.27 -38.02 89.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.553 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.0 m -60.58 -40.11 90.51 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -61.25 -38.08 85.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.22 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.3 tp -61.65 -44.0 97.8 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.862 0.363 . . . . 0.0 110.249 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.95 -154.71 25.68 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -139.02 23.33 2.6 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.624 -0.288 . . . . 0.0 110.763 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -62.57 -43.25 99.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.069 0.461 . . . . 0.0 110.386 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.402 ' CD2' HD21 ' A' ' 48' ' ' LEU . 29.0 mt -99.91 169.13 9.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.536 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.492 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -68.42 162.14 26.08 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.579 179.761 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -92.09 -22.27 20.0 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.432 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -87.26 -24.48 24.36 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.618 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.57 -66.09 0.21 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.241 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.618 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.7 m -65.17 -35.26 74.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.417 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -60.48 -46.81 88.72 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.586 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -84.85 -40.4 17.16 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 124' ' ' MET . 14.4 tmm? -58.89 -47.24 85.66 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 125' ' ' ILE . 94.4 mt -69.13 -18.32 22.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.6 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -77.4 -51.4 10.87 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 119.016 -1.074 . . . . 0.0 111.317 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 129' ' ' ASP . 34.7 tp10 -86.3 -68.7 0.72 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.492 -177.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -38.63 -21.54 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 127' ' ' GLU . 38.7 t0 -90.12 125.12 35.33 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.135 0.493 . . . . 0.0 110.625 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.644 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.58 -32.0 56.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.995 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -72.18 -45.83 58.77 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.95 0.405 . . . . 0.0 110.328 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.67 -5.45 61.19 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 134' ' ' GLY . 35.0 p30 -90.0 -9.69 47.75 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 58.26 117.9 0.01 OUTLIER Glycine 0 CA--C 1.519 0.323 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 8.2 pt20 -159.72 140.15 12.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.539 -0.331 . . . . 0.0 110.146 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.6 t -126.24 133.32 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.93 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.542 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 56.8 t30 -150.76 175.36 12.06 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.305 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -57.66 -52.1 66.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.765 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.542 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 57.3 mp0 -55.9 -35.04 66.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.708 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 79.4 mt-10 -69.51 -39.3 77.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.694 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -61.21 -45.39 94.78 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.0 t -57.94 -45.94 87.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -74.17 -30.83 62.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.442 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.4 ttp -60.07 -40.61 90.13 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.627 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.405 ' O ' ' OG1' ' A' ' 146' ' ' THR . 73.0 mtm -105.25 141.7 36.32 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.905 0.383 . . . . 0.0 110.635 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 145' ' ' MET . 63.0 m -167.23 72.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.146 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.8 97.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.617 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 C--O 1.219 -0.535 0 CA-C-O 118.105 -0.95 . . . . 0.0 110.228 -179.93 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 4' ' ' LEU . 66.8 t0 -88.44 113.97 24.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.651 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -81.16 -16.93 51.52 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.398 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.405 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 32.3 tp -112.96 117.66 32.68 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.908 0.385 . . . . 0.0 110.074 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.1 p -139.08 157.46 45.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.223 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -71.24 -22.11 62.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.021 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.12 -43.04 77.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.031 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -62.4 -44.19 97.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.454 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.3 mt -64.3 -43.29 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.842 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.4 -45.36 69.29 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.487 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -41.21 -45.84 2.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.771 0.319 . . . . 0.0 110.929 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -66.82 -39.57 87.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.753 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -62.83 -43.12 99.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.539 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.09 -40.82 91.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.766 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.81 -20.33 49.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.654 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -49.43 -47.94 47.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.822 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.5 m -77.69 -20.38 53.74 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.035 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.8 tp -64.06 -40.69 96.83 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.802 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.471 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 76.2 m-85 -57.64 -45.49 85.39 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.339 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 9.7 t0 -86.1 -20.36 28.83 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -44.07 -33.13 1.37 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.821 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.415 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 4.4 p-10 -56.01 -46.12 78.85 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.888 0.375 . . . . 0.0 110.858 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -140.31 -152.62 5.84 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 28.1 p-10 -74.38 -47.1 36.2 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 122.679 -0.307 . . . . 0.0 110.74 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.498 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.72 107.13 0.28 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 6.2 m -166.44 148.82 6.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.123 0.462 . . . . 0.0 111.407 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.71 74.08 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.508 HG22 HG22 ' A' ' 62' ' ' THR . 9.7 p -86.97 166.16 15.3 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.51 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -66.3 -28.62 68.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.925 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -61.86 -40.19 94.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.961 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.471 ' OE1' ' O ' ' A' ' 19' ' ' PHE . 86.6 mt-10 -66.7 -40.51 88.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.954 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.7 tp -62.82 -43.55 98.5 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.61 -33.19 47.76 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 m -64.6 -44.69 89.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.922 0.361 . . . . 0.0 110.84 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.2 t -55.87 -17.36 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.331 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.542 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 88.9 mmm -52.71 -40.75 63.29 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.745 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.3 ttt85 -64.29 -46.01 85.5 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 118.159 -1.417 . . . . 0.0 110.181 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.0 p -64.33 -19.2 65.29 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.653 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.815 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 36.4 mt -94.4 6.57 48.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.727 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 43.76 78.69 0.07 OUTLIER Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 40' ' ' GLY . 85.7 mt-30 52.67 117.23 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.869 0.366 . . . . 0.0 110.733 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 44' ' ' THR . 35.3 t-20 -148.81 68.76 9.87 Favored Pre-proline 0 C--O 1.235 0.3 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.643 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.588 ' O ' ' N ' ' A' ' 46' ' ' ALA . 87.3 Cg_exo -35.77 -31.27 0.08 OUTLIER 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.507 2.138 . . . . 0.0 112.012 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 42' ' ' ASN . 29.5 m -38.49 -27.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.319 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.542 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 87.6 mt-10 -89.43 -32.4 17.26 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.588 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -58.46 -51.82 68.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.974 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.449 ' HB2' HG23 ' A' ' 117' ' ' THR . 2.2 tm-20 -67.51 -46.04 74.04 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 44' ' ' THR . 97.0 mt -63.6 -27.6 69.35 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.396 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -39.54 -53.65 2.06 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.818 0.342 . . . . 0.0 110.792 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -65.94 -38.25 88.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.197 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 32.5 ttp -62.42 -40.16 95.65 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 97.9 mt -61.99 -46.43 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.644 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 9.5 m120 -62.31 -42.41 99.35 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.725 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.74 -55.6 32.3 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.134 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.9 -34.85 62.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.934 0.397 . . . . 0.0 111.123 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 62' ' ' THR . 44.0 t0 -82.94 -13.41 56.08 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.377 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.06 8.87 1.1 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.788 0.327 . . . . 0.0 110.151 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 12.7 p30 -61.54 -25.09 67.07 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -157.87 -19.94 0.03 OUTLIER Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.62 ' C ' ' H ' ' A' ' 62' ' ' THR . 5.1 p30 177.07 141.86 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.76 32.27 0.09 OUTLIER Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.62 ' H ' ' C ' ' A' ' 60' ' ' ASN . 64.2 p -130.29 150.14 51.66 Favored 'General case' 0 C--N 1.337 0.053 0 CA-C-O 120.973 0.416 . . . . 0.0 110.288 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 91.5 mt -117.08 138.96 46.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.138 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.51 166.13 19.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.436 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.431 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -62.97 -50.5 76.56 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.803 -179.19 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.5 Cg_exo -50.85 -44.94 38.7 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.984 1.79 . . . . 0.0 111.824 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.89 -36.35 72.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.924 0.393 . . . . 0.0 110.994 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -59.99 -45.86 91.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.246 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.08 -44.54 95.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.594 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.7 m -67.41 -44.4 78.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.254 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.9 ttp -61.43 -40.13 93.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.023 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 76.1 mmm -63.05 -38.55 91.64 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.841 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.09 96.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.028 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -68.48 -45.53 72.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.052 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.61 -41.78 83.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.955 0.407 . . . . 0.0 110.33 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.8 mmt -86.96 164.42 16.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.14 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -116.22 153.61 31.56 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.043 0.449 . . . . 0.0 110.154 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -59.26 160.47 6.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.302 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.8 p -64.13 -30.08 71.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.586 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -64.47 -10.01 22.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.158 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -57.08 -32.82 66.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.516 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -49.44 -50.22 41.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.723 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -65.08 -41.89 94.6 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.987 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -66.32 -45.66 79.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.497 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.4 mt -64.91 -20.6 27.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.8 ttt-85 -59.68 -42.19 92.39 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.206 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -61.48 -35.88 78.89 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.477 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.17 -13.4 60.46 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -47.96 -51.12 24.92 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.0 0.428 . . . . 0.0 111.424 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -59.75 -46.85 87.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.825 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 85.0 t -68.84 -44.34 81.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.958 0.409 . . . . 0.0 110.466 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -59.44 -44.43 92.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.529 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 33.0 t70 -138.84 100.67 4.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.231 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.04 -40.01 82.94 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.207 0.527 . . . . 0.0 110.198 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.3 p-10 -60.13 -42.6 95.14 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.327 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.67 -56.97 0.5 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -70.75 -13.63 62.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.078 0.466 . . . . 0.0 110.267 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.6 161.19 12.85 Favored Glycine 0 N--CA 1.464 0.541 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -115.13 150.92 35.26 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.8 mt -85.25 123.16 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 121.002 0.43 . . . . 0.0 110.339 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.2 p -79.99 168.13 19.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.034 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.25 -36.49 82.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.611 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.17 -45.31 93.97 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.095 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -69.99 -37.68 75.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.208 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.4 tp -62.01 -42.89 99.65 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.241 0.544 . . . . 0.0 111.276 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -52.57 -43.21 65.1 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.055 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -55.5 -42.73 74.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.164 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.4 t -64.58 -42.48 95.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.292 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 58.5 mmm -57.56 -34.74 69.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.467 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.7 m -60.24 -42.3 94.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.445 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -58.66 -38.68 78.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.824 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 40.0 tp -61.31 -46.34 90.7 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.048 0.451 . . . . 0.0 110.13 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.89 -154.91 26.0 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -143.22 11.81 1.76 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.693 -0.253 . . . . 0.0 110.78 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -63.93 -43.96 94.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.153 0.502 . . . . 0.0 110.657 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.5 mt -79.75 160.32 26.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.033 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.479 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -68.51 161.67 27.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.221 -179.71 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -92.33 -21.06 20.48 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.112 0.482 . . . . 0.0 110.448 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -85.45 -26.91 26.06 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.219 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.612 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.68 -63.49 0.35 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.612 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 11.3 m -69.09 -31.38 49.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 121.234 -0.186 . . . . 0.0 111.46 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -58.82 -67.15 0.39 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.699 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.58 -45.14 72.8 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.521 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 13.3 tmm? -52.93 -50.3 64.28 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 125' ' ' ILE . 95.9 mt -64.61 -18.37 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.669 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -87.92 -57.91 2.76 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 119.904 -0.718 . . . . 0.0 112.25 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 128' ' ' ALA . 51.0 tp10 -81.95 -67.7 0.76 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.271 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.815 ' HB2' ' O ' ' A' ' 39' ' ' LEU . . . -36.83 -35.65 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 56.6 t0 -87.71 146.11 25.83 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.277 0.56 . . . . 0.0 110.568 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.566 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -89.39 -14.85 9.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.809 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 133' ' ' ASP . 44.8 m-20 -73.54 -45.36 54.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.032 0.444 . . . . 0.0 110.407 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.35 -10.28 3.73 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 131' ' ' ASP . 35.4 p30 -89.88 -10.4 45.42 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.836 0.351 . . . . 0.0 110.195 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 62.25 123.0 0.01 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -161.72 119.61 2.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.889 0.376 . . . . 0.0 110.101 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.67 128.93 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.093 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.523 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 45.2 t30 -155.1 166.2 34.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.071 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.401 ' O ' ' CD1' ' A' ' 138' ' ' TYR . 2.6 t80 -48.79 -23.02 0.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.459 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 50.1 mp0 -66.42 -35.74 81.06 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.152 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -84.97 -20.78 30.04 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.56 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.04 -46.7 87.99 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 121.134 -0.227 . . . . 0.0 111.166 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 30.1 t -58.31 -45.98 89.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.005 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -71.36 -36.14 71.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.293 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 61.5 ttp -57.94 -43.09 86.14 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.207 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 70.7 mtm -112.72 129.33 56.45 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.818 0.342 . . . . 0.0 110.414 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.5 m -162.88 85.77 0.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.096 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.1 -43.91 93.9 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.676 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.0 mttm . . . . . 0 C--O 1.219 -0.527 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.507 179.879 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.413 ' OD2' ' O ' ' A' ' 4' ' ' LEU . 67.3 t0 -92.62 115.95 28.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.016 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -68.81 -30.08 68.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.195 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.413 ' O ' ' OD2' ' A' ' 2' ' ' ASP . 46.9 tp -102.0 128.18 48.55 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.675 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.0 p -134.58 158.39 44.12 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.382 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -66.15 -21.98 66.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.713 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -63.13 -44.21 96.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.531 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -65.9 -41.49 91.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.031 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 89.7 mt -64.58 -43.11 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.484 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.74 -39.93 68.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.181 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -47.67 -48.62 28.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.102 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -59.44 -44.86 92.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.89 0.376 . . . . 0.0 110.484 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -63.42 -39.66 95.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.664 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.29 -41.29 85.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.343 . . . . 0.0 111.143 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.44 -22.72 66.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.82 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -55.59 -47.81 75.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.21 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.9 m -81.47 -17.19 49.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.476 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.93 -43.77 97.9 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.435 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.416 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 80.7 m-85 -60.48 -50.39 73.75 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.565 -179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 5.3 t0 -77.08 -14.64 59.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.191 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -45.01 -32.93 1.84 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.228 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.447 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 18.0 p-10 -54.71 -46.01 74.12 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 120.966 -0.293 . . . . 0.0 110.875 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 20' ' ' ASP . . . -144.0 -151.09 5.38 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 32.3 p-10 -73.08 -47.03 47.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.714 0.292 . . . . 0.0 110.81 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -166.77 107.29 0.28 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.428 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 4.9 m -166.2 142.79 5.04 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.771 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.03 103.42 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.404 HG22 HG22 ' A' ' 62' ' ' THR . 2.9 p -123.11 169.96 10.69 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.1 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.605 ' CB ' HE22 ' A' ' 49' ' ' GLN . 61.1 p -63.14 -35.32 79.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.861 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -60.35 -38.46 83.88 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.447 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 87.7 mt-10 -65.64 -43.11 90.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.091 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.66 -41.96 98.14 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.258 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.71 -28.8 17.05 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.2 m -64.54 -44.15 91.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.95 0.405 . . . . 0.0 110.729 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.2 t -57.1 -17.61 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.175 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.541 ' SD ' ' OE1' ' A' ' 45' ' ' GLU . 87.7 mmm -53.03 -38.52 62.45 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.266 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.7 ttt85 -64.28 -45.97 85.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 117.444 -1.702 . . . . 0.0 110.722 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 92.8 p -63.41 -19.96 65.14 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.538 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.882 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 52.4 mt -99.58 6.12 45.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.904 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . 34.9 94.55 0.01 OUTLIER Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.487 ' O ' ' O ' ' A' ' 40' ' ' GLY . 84.1 mt-30 52.23 110.25 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.619 0.247 . . . . 0.0 110.369 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 44' ' ' THR . 49.9 t30 -145.82 63.98 9.81 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.704 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.574 ' O ' ' N ' ' A' ' 46' ' ' ALA . 89.3 Cg_exo -34.72 -29.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.612 2.208 . . . . 0.0 112.325 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 42' ' ' ASN . 23.3 m -40.13 -29.61 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.124 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.541 ' OE1' ' SD ' ' A' ' 36' ' ' MET . 90.7 mt-10 -89.63 -29.93 18.49 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.802 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -60.84 -49.15 78.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.822 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.469 ' HB2' HG23 ' A' ' 117' ' ' THR . 2.2 tm-20 -72.18 -43.18 64.96 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.25 0.548 . . . . 0.0 109.751 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.585 HD21 HD21 ' A' ' 116' ' ' LEU . 96.3 mt -67.97 -25.12 65.27 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.203 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.605 HE22 ' CB ' ' A' ' 29' ' ' THR . 53.8 tp60 -40.76 -41.89 1.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.603 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -77.64 -36.83 51.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.862 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.492 ' CE ' HD22 ' A' ' 48' ' ' LEU . 32.6 ttp -59.96 -37.28 79.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.677 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.59 HG21 HG22 ' A' ' 29' ' ' THR . 96.8 mt -63.44 -44.89 99.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.027 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.673 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 19.6 m120 -62.54 -39.84 94.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.37 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -56.62 -56.42 21.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.294 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.476 HG13 ' N ' ' A' ' 56' ' ' ASP . 15.0 p -74.12 -40.38 51.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.851 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.502 ' OD2' ' N ' ' A' ' 62' ' ' THR . 44.4 t0 -71.2 -13.21 61.85 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.561 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.673 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.35 8.98 1.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.31 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 56' ' ' ASP . 10.4 p-10 -59.67 -26.76 65.82 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -155.06 -24.41 0.03 OUTLIER Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.551 ' C ' ' H ' ' A' ' 62' ' ' THR . 9.9 p30 176.19 151.19 0.14 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.582 -0.309 . . . . 0.0 110.178 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.28 36.35 0.09 OUTLIER Glycine 0 CA--C 1.535 1.294 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.551 ' H ' ' C ' ' A' ' 60' ' ' ASN . 44.2 p -137.45 153.31 50.12 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.5 mt -127.38 136.98 59.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.971 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -81.18 164.59 22.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.137 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.431 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -62.13 -50.11 81.71 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.227 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 51.6 Cg_exo -50.07 -41.73 48.0 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.074 1.849 . . . . 0.0 112.065 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -80.78 -29.83 36.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.111 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -59.53 -45.0 93.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.026 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.39 -43.21 99.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.279 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.1 m -64.43 -44.83 89.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.85 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.0 ttp -60.1 -44.69 94.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.829 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 79.4 mmm -63.8 -40.91 97.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.258 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.407 ' O ' ' O ' ' A' ' 76' ' ' MET . . . -61.21 -47.86 84.18 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.865 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -71.25 -46.25 61.43 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.496 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -66.79 -45.19 79.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.993 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.407 ' O ' ' O ' ' A' ' 73' ' ' ALA . 17.8 mmm -99.5 -176.69 3.36 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.057 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -128.49 152.19 48.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.112 0.482 . . . . 0.0 110.177 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -54.2 177.74 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.359 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.2 p -80.6 -15.74 55.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.544 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -66.39 -13.67 61.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.397 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 83' ' ' GLU . 72.8 m -53.35 -34.38 57.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.548 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -39.0 -28.83 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.365 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 81' ' ' SER . 75.8 mm-40 -85.36 -54.84 4.33 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.004 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -58.48 -36.3 73.53 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.984 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.431 ' O ' HG22 ' A' ' 85' ' ' ILE . 96.7 mt -63.58 -20.04 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.1 ttt-85 -60.99 -45.06 96.34 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 118.351 -1.34 . . . . 0.0 109.627 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -64.67 -21.74 66.81 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.172 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.41 -17.51 48.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.466 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -57.05 -50.19 73.52 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.305 0.574 . . . . 0.0 110.556 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -68.6 -44.92 73.29 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.898 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.2 t -65.33 -49.09 80.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.028 0.442 . . . . 0.0 109.986 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.679 ' CE2' HD12 ' A' ' 100' ' ' ILE . 51.7 t80 -62.61 -45.19 94.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.878 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.412 ' OD2' ' O ' ' A' ' 98' ' ' GLY . 22.2 t0 -120.54 104.57 10.07 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.056 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -66.38 -41.21 89.71 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.037 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -70.49 -41.55 72.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.042 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.91 -53.04 0.75 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -64.04 -20.05 65.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.98 0.419 . . . . 0.0 110.315 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.412 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.67 161.0 12.9 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -113.34 148.29 35.99 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.679 HD12 ' CE2' ' A' ' 92' ' ' PHE . 96.7 mt -84.9 123.55 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.0 p -87.27 176.76 7.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.129 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.57 84.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.979 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.55 -51.32 69.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.886 0.374 . . . . 0.0 110.983 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -71.4 -30.51 66.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 49.6 tp -61.78 -41.02 97.18 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.235 0.54 . . . . 0.0 111.093 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -54.18 -41.49 68.59 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.918 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -57.94 -42.73 85.49 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.3 t -65.59 -43.1 94.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.691 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 91.6 mmm -62.59 -37.25 85.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.44 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.8 m -59.44 -40.49 86.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.639 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -58.59 -38.76 78.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.737 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.0 tp -61.07 -44.99 96.54 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.551 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.05 -145.37 12.16 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -143.52 16.3 1.83 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.827 0.346 . . . . 0.0 110.748 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -61.79 -44.93 95.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.014 0.435 . . . . 0.0 110.424 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.585 HD21 HD21 ' A' ' 48' ' ' LEU . 82.8 mt -82.12 161.38 22.86 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.981 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.471 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -66.13 161.73 21.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.685 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -91.58 -19.63 22.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.863 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -87.69 -28.11 22.01 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.63 ' CD ' ' H ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -35.34 -66.9 0.17 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.63 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 17.4 m -63.97 -39.32 85.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.468 ' N ' HG23 ' A' ' 121' ' ' VAL . 84.9 m-20 -54.33 -65.89 0.49 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.674 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 127' ' ' GLU . 80.6 mm-40 -70.42 -44.9 66.95 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.656 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 18.9 tmm? -53.04 -47.58 68.29 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.899 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 97.6 mt -67.18 -19.72 25.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.346 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -91.28 -66.72 0.9 Allowed 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.033 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 123' ' ' GLU . 25.0 tp10 -65.26 -68.62 0.35 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.161 -177.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.882 ' HB2' ' O ' ' A' ' 39' ' ' LEU . . . -37.11 -37.72 0.17 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.481 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 66.1 t0 -87.52 138.29 31.6 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.246 0.546 . . . . 0.0 110.583 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.592 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -85.82 -16.14 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.319 -179.683 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -73.06 -46.53 51.12 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.126 0.488 . . . . 0.0 110.146 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.95 -2.58 54.93 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 52.1 p30 -88.66 -22.25 23.52 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 64.65 103.64 0.01 OUTLIER Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -147.76 140.82 24.99 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.788 0.328 . . . . 0.0 110.141 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.1 t -128.95 134.31 64.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.313 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.526 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 53.4 t30 -151.56 -179.12 7.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.603 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -57.26 -48.14 79.63 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.259 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.526 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 55.8 mp0 -50.93 -43.66 60.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.353 -178.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -67.6 -39.84 84.76 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.967 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -60.71 -43.68 97.52 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.571 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.4 t -54.22 -43.92 62.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.239 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -84.29 -19.31 34.01 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.211 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 41.1 ttp -65.08 -41.32 95.15 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.94 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.404 ' O ' ' OG1' ' A' ' 146' ' ' THR . 51.7 mtm -103.71 132.7 49.73 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.867 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 145' ' ' MET . 43.6 m -166.83 81.79 0.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.053 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.77 -37.28 75.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.292 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 69.1 mttm . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.509 179.921 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -91.98 107.58 19.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.08 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -135.53 166.38 23.34 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.093 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 36.7 tp -96.1 126.55 41.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.263 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.2 p -127.26 160.04 32.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.668 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.59 -19.27 62.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.565 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -67.21 -42.03 84.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.967 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -62.97 -42.01 99.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.906 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.4 mt -69.83 -31.39 48.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.608 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.2 -29.56 70.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -51.48 -43.23 62.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.738 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -66.97 -46.35 74.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.022 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -61.67 -44.78 96.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.795 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -67.98 -40.89 83.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.642 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.19 -28.42 67.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.971 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -55.56 -45.85 77.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.695 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.0 m -81.58 -17.88 46.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.733 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.5 tp -65.45 -42.36 92.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.952 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.401 ' O ' ' CD ' ' A' ' 31' ' ' GLU . 73.6 m-85 -61.05 -45.95 92.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.333 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 4.7 t0 -81.98 -15.65 53.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.341 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -42.84 -32.51 0.63 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.105 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.437 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 9.1 p-10 -53.59 -46.75 70.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.887 0.375 . . . . 0.0 110.72 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.437 ' N ' ' CG ' ' A' ' 22' ' ' ASP . . . -145.67 -147.3 4.58 Favored Glycine 0 N--CA 1.466 0.696 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 20.3 p-10 -76.53 -47.56 22.29 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.921 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -167.02 107.02 0.27 Allowed Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 177.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 96.0 m -166.73 143.14 4.64 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.936 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.06 117.09 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.831 0.348 . . . . 0.0 110.095 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.689 HG22 HG22 ' A' ' 62' ' ' THR . 12.3 p -133.38 165.6 24.47 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.429 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.536 ' CB ' HE22 ' A' ' 49' ' ' GLN . 80.2 p -63.08 -35.14 79.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.274 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -61.27 -38.48 86.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.076 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.415 ' OE2' ' CG ' ' A' ' 22' ' ' ASP . 91.3 mt-10 -64.71 -49.16 71.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.336 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.32 -43.6 98.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.277 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.17 -24.02 4.48 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.7 m -64.91 -42.47 94.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.903 0.382 . . . . 0.0 110.509 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.5 t -54.55 -16.33 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.26 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.453 ' O ' ' N ' ' A' ' 40' ' ' GLY . 53.4 mmm -58.71 -37.27 75.77 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -62.46 -46.16 89.76 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 116.724 -1.99 . . . . 0.0 110.66 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.9 p -60.11 -36.15 76.8 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.101 -178.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 41' ' ' GLN . 44.6 mt -95.85 2.08 53.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.723 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 36' ' ' MET . . . 66.25 -66.47 0.15 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' A' ' 39' ' ' LEU . 74.6 mt-30 -141.7 122.75 14.61 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 44' ' ' THR . 40.5 t-20 -141.43 71.11 26.55 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.653 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' ALA . 73.2 Cg_exo -37.45 -30.41 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.172 1.915 . . . . 0.0 112.186 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 42' ' ' ASN . 25.2 m -39.05 -27.61 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.477 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 49' ' ' GLN . 86.7 mt-10 -90.31 -36.92 14.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.005 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 43' ' ' PRO . . . -56.28 -48.89 75.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.399 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -70.5 -45.02 66.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.292 0.568 . . . . 0.0 110.133 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.516 HD21 HD22 ' A' ' 116' ' ' LEU . 96.0 mt -70.06 -20.12 63.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.804 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.536 HE22 ' CB ' ' A' ' 29' ' ' THR . 67.4 tp60 -46.39 -46.23 18.37 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.67 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -75.08 -35.28 61.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.199 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.431 ' CE ' HD22 ' A' ' 48' ' ' LEU . 33.1 ttp -63.63 -43.05 97.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.077 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 56' ' ' ASP . 96.7 mt -62.8 -46.19 96.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.752 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.693 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 24.0 m120 -64.66 -40.69 95.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.738 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.08 -56.84 16.74 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.421 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 56' ' ' ASP . 11.3 p -69.7 -36.96 72.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.985 0.421 . . . . 0.0 110.95 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.551 ' OD2' ' N ' ' A' ' 62' ' ' THR . 43.4 t0 -79.03 -12.7 60.03 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.423 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.693 ' HB2' ' O ' ' A' ' 53' ' ' ASN . . . -72.12 15.46 0.16 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.349 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 10.4 p30 -65.75 -21.91 66.55 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.415 ' H ' ' H ' ' A' ' 60' ' ' ASN . . . -167.81 -9.62 0.03 OUTLIER Glycine 0 C--N 1.333 0.392 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.579 ' C ' ' H ' ' A' ' 62' ' ' THR . 2.0 p30 169.37 140.46 0.02 OUTLIER 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.0 35.88 0.1 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.689 HG22 HG22 ' A' ' 28' ' ' THR . 69.0 p -136.02 154.94 50.91 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 90.8 mt -130.05 132.08 65.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.219 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.14 151.99 42.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.612 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.445 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -54.87 -51.27 80.66 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.768 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 52.4 Cg_exo -49.12 -49.82 14.38 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.863 1.709 . . . . 0.0 112.106 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -68.6 -33.65 74.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.412 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -61.98 -43.77 98.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.997 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.2 mt -59.2 -45.61 90.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.789 0.328 . . . . 0.0 110.734 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.4 m -63.85 -44.73 92.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.463 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 36.4 ttp -60.01 -45.33 93.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.515 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.2 mmm -64.68 -39.33 93.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.565 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.32 -39.15 78.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.67 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -77.86 -51.46 10.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.424 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -65.6 -44.26 87.13 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.47 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.2 mmm -99.72 126.47 45.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.358 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -86.74 143.87 27.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.501 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 80' ' ' ASP . 97.2 m-20 -49.42 158.59 0.4 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.431 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 35.7 p -54.88 -8.73 0.28 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.642 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 78' ' ' ASP . 80.1 m-20 -67.11 -8.66 32.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.109 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.4 m -59.37 -29.61 67.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.637 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -37.87 -49.15 1.19 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.006 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -65.66 -55.08 19.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.909 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -59.63 -32.36 70.36 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.083 0.468 . . . . 0.0 110.629 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 85' ' ' ILE . 82.6 mt -69.2 -15.07 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -59.76 -48.88 79.91 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 117.508 -1.677 . . . . 0.0 110.377 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.2 -32.58 74.34 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.498 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.63 -35.98 73.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.789 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -50.59 -51.12 51.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.341 0.591 . . . . 0.0 110.908 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -69.24 -44.54 71.79 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.292 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.09 -51.45 48.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.113 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.558 ' CE2' HD12 ' A' ' 100' ' ' ILE . 66.6 t80 -63.45 -47.47 81.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.396 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.465 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 17.9 t0 -107.77 105.41 15.23 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.087 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -71.75 -44.87 63.32 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.598 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 44.9 p-10 -67.14 -33.64 75.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.054 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.526 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 66.56 -74.88 0.15 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -53.64 -13.07 0.58 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.922 0.391 . . . . 0.0 110.392 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.423 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -111.53 161.78 12.66 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -112.33 155.91 23.32 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.558 HD12 ' CE2' ' A' ' 92' ' ' PHE . 94.4 mt -99.78 117.43 44.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.7 p -82.1 175.69 10.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.151 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.95 -37.02 84.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.826 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.56 -52.43 64.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.791 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -67.7 -31.17 70.94 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.654 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.0 tp -64.15 -41.4 97.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.501 0.667 . . . . 0.0 110.997 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -53.86 -39.26 65.49 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.964 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -63.79 -41.23 97.98 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.1 -42.68 96.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.498 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 54.0 mmm -62.37 -40.75 97.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.979 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.4 m -61.69 -40.3 94.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.556 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -58.89 -40.45 84.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.614 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.9 tp -61.31 -44.27 97.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.964 0.411 . . . . 0.0 110.541 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 161.85 -151.91 22.16 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -138.31 29.15 2.47 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.806 0.336 . . . . 0.0 110.66 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -67.45 -45.32 76.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.824 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.516 HD22 HD21 ' A' ' 48' ' ' LEU . 19.6 mt -100.62 166.89 10.67 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.871 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.519 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -69.49 161.61 29.16 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.177 -179.595 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -92.71 -21.57 19.9 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.888 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -87.42 -23.56 24.47 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.637 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -35.09 -68.09 0.13 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.577 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.523 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 9.8 m -63.88 -42.09 94.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.517 ' N ' HG23 ' A' ' 121' ' ' VAL . 87.6 m-20 -48.33 -67.01 0.31 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.748 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.463 ' O ' ' OE1' ' A' ' 127' ' ' GLU . 80.3 mm-40 -70.54 -40.0 73.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.745 0.307 . . . . 0.0 111.801 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.404 ' SD ' ' C ' ' A' ' 124' ' ' MET . 17.7 tmm? -57.26 -38.93 74.62 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.669 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.8 mt -77.9 -23.76 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -77.61 -46.82 20.98 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 118.674 -1.211 . . . . 0.0 111.657 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 123' ' ' GLU . 19.6 mp0 -80.13 -68.41 0.68 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.661 -177.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -37.56 -49.02 1.05 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.629 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -88.46 131.07 35.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.896 0.379 . . . . 0.0 110.255 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.546 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -82.31 -10.69 12.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.148 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 133' ' ' ASP . 89.2 m-20 -64.35 -40.42 95.83 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.118 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.61 -8.4 4.28 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' A' ' 134' ' ' GLY . 26.1 p-10 -88.26 -12.72 42.84 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 133' ' ' ASP . . . 39.39 98.07 0.01 OUTLIER Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.435 ' O ' ' OE1' ' A' ' 140' ' ' GLU . 13.3 pt20 -131.09 136.94 48.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.021 0.439 . . . . 0.0 110.334 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.0 t -115.3 134.92 56.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.089 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.515 ' ND2' ' OE1' ' A' ' 139' ' ' GLU . 52.9 t30 -152.71 176.67 11.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.659 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -58.8 -47.97 82.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.406 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.515 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 58.0 mp0 -57.43 -25.54 59.79 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.293 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 135' ' ' GLN . 81.1 mt-10 -84.82 -33.71 22.86 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.1 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -65.71 -46.84 77.44 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.634 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 50.3 t -56.35 -44.49 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 120.789 0.328 . . . . 0.0 110.253 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -71.63 -38.03 70.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.155 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 50.2 ttp -60.48 -48.55 81.26 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.291 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 49.1 mtm -88.62 120.81 30.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.945 0.402 . . . . 0.0 110.778 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.1 m -165.75 99.12 0.67 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.76 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.96 -38.31 88.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.582 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.8 mttm . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 117.821 -1.085 . . . . 0.0 110.509 179.982 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' 4DY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_